data_2kjl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kjl _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.696 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.85 -27.87 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.675 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -33.29 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.3 m -134.94 37.32 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.696 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 69.6 p -119.43 152.37 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.492 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.2 ptp180 -151.42 168.93 23.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.587 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.0 t30 56.2 30.87 17.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.662 0.744 . . . . 0.0 110.135 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -78.34 113.52 16.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.178 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.96 146.47 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.4 tp -82.37 141.98 32.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -131.9 165.93 22.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.986 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.524 HD21 ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER 71.42 7.17 5.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.574 . . . . 0.0 111.584 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.4 9.9 Favored Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 91.75 18.66 43.49 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.946 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HG2' HG23 ' A' ' 56' ' ' THR . 28.3 mtp180 -103.43 -16.92 15.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.729 0.3 . . . . 0.0 110.3 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -128.58 129.39 45.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.413 ' HB2' HD21 ' A' ' 37' ' ' LEU . 52.8 tp -100.71 104.98 16.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.358 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.4 tmm_? -104.35 124.73 49.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.414 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.92 153.25 32.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.587 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 32.7 mt-10 -103.4 110.34 22.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.6 p -119.74 139.6 52.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.087 0.47 . . . . 0.0 111.415 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.49 144.11 44.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.222 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -89.25 -171.57 3.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.279 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.2 -21.53 65.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.64 -19.0 29.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.285 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.11 0.62 41.46 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 66.1 m-20 -80.83 136.3 36.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.422 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 49.5 m0 -77.98 119.48 21.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.005 0.431 . . . . 0.0 110.077 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.32 132.31 65.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -83.08 107.89 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.654 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 21.0 m -110.89 146.1 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.8 mt-10 -133.15 130.68 39.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.392 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.554 HD12 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -123.04 120.09 32.27 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.246 0.546 . . . . 0.0 110.101 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.647 ' O ' HG22 ' A' ' 39' ' ' THR . 9.3 m-20 -69.32 106.23 2.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.623 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 12' ' ' LEU . 21.2 mt -62.71 -40.23 96.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.929 0.871 . . . . 0.0 109.75 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.6 p-10 -64.27 -5.04 4.33 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.639 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.58 -16.14 16.18 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.556 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.554 HG12 HD12 ' A' ' 35' ' ' LEU . 2.5 pp -142.08 14.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.29 130.75 70.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.97 157.54 21.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.335 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.3 t30 -111.97 113.94 26.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.044 0.45 . . . . 0.0 110.527 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -101.51 81.44 2.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.639 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 49.93 47.92 22.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.384 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 90.64 39.09 5.98 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.863 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -158.09 113.57 2.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 58.0 m-85 -60.27 136.64 58.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 0.0 111.007 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -127.22 114.49 17.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.168 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -71.22 114.53 9.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.8 28.64 6.89 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.705 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -98.5 -52.08 1.36 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.927 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 3.1 tt0 72.85 141.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.134 0.573 . . . . 0.0 111.213 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 94.6 m-20 70.48 37.87 1.43 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.544 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.7 p90 -81.4 -27.26 34.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.577 HG23 ' HG2' ' A' ' 17' ' ' ARG . 11.9 p -65.16 -19.54 66.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.699 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 8.3 pt-20 -77.32 -14.82 59.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.197 0.522 . . . . 0.0 110.136 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.588 HG21 ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -125.89 12.89 7.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.664 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.27 145.71 47.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.554 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -139.3 169.22 18.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.476 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.439 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.2 t70 47.39 54.57 9.39 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.353 0.408 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.34 114.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 112.153 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -128.45 121.97 30.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.124 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.4 t80 -92.04 134.73 34.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -123.22 85.44 51.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.927 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 25.8 Cg_endo -62.22 -45.13 16.39 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 123.622 2.882 . . . . 0.0 113.89 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.809 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.55 0.214 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 64.2 Cg_endo -74.04 106.58 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.465 2.11 . . . . 0.0 111.678 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.489 HD11 HH21 ' A' ' 77' ' ' ARG . 0.8 OUTLIER -132.35 140.92 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.975 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -114.15 124.02 51.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.148 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.489 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.08 142.71 48.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 110.434 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.56 167.66 26.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.709 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.71 115.13 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.672 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.0 mp -97.87 121.44 39.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.462 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.549 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.1 pt-20 . . . . . 0 C--O 1.217 -0.647 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -147.73 134.59 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.465 0.65 . . . . 0.0 111.492 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -140.72 118.82 11.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.052 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 p-10 -64.37 114.73 4.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.469 0.652 . . . . 0.0 111.659 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.672 ' HB2' HD22 ' A' ' 80' ' ' LEU . 30.0 mmt180 -115.84 174.21 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.413 ' HB2' HD13 ' A' ' 75' ' ' ILE . 4.6 p-10 -144.04 144.93 31.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -129.45 145.66 35.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.393 0.616 . . . . 0.0 111.082 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.42 ' HB3' HD21 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -81.57 107.17 14.11 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.61 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.685 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.3 mt -78.75 4.2 14.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.355 . . . . 0.0 110.995 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.42 HD21 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.34 -18.99 64.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 109.814 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -24.46 67.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.003 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' A' ' 94' ' ' LEU . 14.7 mt -81.28 124.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -121.0 167.5 12.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.946 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.0 t30 -109.71 121.26 44.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.8 t -112.77 94.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.24 22.98 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.827 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.26 22.15 6.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.082 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 14.9 ptp180 -132.39 143.01 49.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.374 0.587 . . . . 0.0 111.15 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.654 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 67.3 mt -92.22 122.69 34.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.25 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.91 135.86 42.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -82.29 146.27 29.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.198 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.258 -179.799 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.732 0.301 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.2 -25.72 24.42 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.91 -33.76 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.24 0.543 . . . . 0.0 110.676 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 22.5 m -130.04 30.51 4.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.367 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 68.7 m -115.99 154.76 29.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 0.0 112.103 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.45 171.76 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.322 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.547 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.6 t-20 55.38 31.12 16.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.559 0.537 . . . . 0.0 110.694 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 66' ' ' PRO . . . -78.51 113.86 16.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.425 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.48 151.34 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.825 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.837 HD12 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -90.78 134.52 34.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.2 m -120.69 164.39 16.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.419 ' N ' HG22 ' A' ' 13' ' ' THR . 0.2 OUTLIER 73.63 5.07 4.87 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.69 0.619 . . . . 0.0 111.342 177.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.94 13.89 41.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.478 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 109.68 20.68 7.56 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG2' HG21 ' A' ' 56' ' ' THR . 22.5 mtp180 -104.27 -21.34 13.54 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 8.9 m -123.75 131.14 53.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.066 0.46 . . . . 0.0 111.723 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.445 ' HB2' HD22 ' A' ' 37' ' ' LEU . 58.3 tp -103.62 105.51 15.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.263 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.503 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.6 tmm_? -103.81 124.35 48.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.219 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.493 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -147.27 150.25 34.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.801 0.334 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 11.4 mt-10 -107.35 112.41 25.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.7 t -125.67 147.9 49.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.232 0.539 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.89 145.17 40.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 178.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.476 ' HB3' HG22 ' A' ' 31' ' ' VAL . 31.5 p-10 -87.8 -171.38 3.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.07 68.32 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.45 -24.55 50.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.431 . . . . 0.0 110.923 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.89 11.51 32.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.2 t30 -94.77 146.12 24.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -72.87 125.64 28.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.654 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 25' ' ' ASN . 4.0 t -129.33 126.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -81.49 122.94 28.17 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.806 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 1.4 t -125.21 151.33 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.688 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.02 136.46 40.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD11 HG12 ' A' ' 40' ' ' ILE . 13.1 tp -130.63 126.11 35.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 39' ' ' THR . 5.5 m-20 -72.33 107.02 4.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.837 HD11 HD12 ' A' ' 12' ' ' LEU . 47.7 mt -63.61 -41.4 98.31 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.874 0.845 . . . . 0.0 108.97 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.577 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -62.59 -4.77 2.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.527 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -104.54 -15.76 15.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.55 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.499 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.6 pp -140.54 13.25 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.26 130.78 70.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.42 160.52 22.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.298 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -111.81 116.83 31.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 110.173 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -102.93 84.12 2.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.916 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 p30 46.01 43.15 10.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.322 1.049 . . . . 0.0 112.953 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 98.82 37.13 4.28 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.911 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -157.3 117.06 3.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -60.85 136.51 58.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -129.29 114.26 16.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -67.84 115.32 7.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 39.71 3.52 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.993 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -109.83 -55.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.591 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.0 tt0 76.02 138.48 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.564 0.746 . . . . 0.0 111.875 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.4 t30 68.29 40.17 2.14 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.93 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 11.2 p90 -76.19 -30.37 58.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.758 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.576 HG21 ' HG2' ' A' ' 17' ' ' ARG . 42.5 p -61.85 -21.45 64.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.018 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 58' ' ' THR . 1.1 pt-20 -72.16 -15.68 61.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.336 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.597 HG22 ' HG3' ' A' ' 57' ' ' GLU . 60.7 p -125.42 2.79 7.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -115.92 149.31 38.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.24 172.43 12.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.28 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 48.78 52.31 14.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.068 0.461 . . . . 0.0 110.202 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.44 109.18 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.45 0.643 . . . . 0.0 111.754 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.432 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.9 122.96 39.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.62 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 94' ' ' LEU . 10.2 t80 -91.6 135.11 34.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.736 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -123.66 87.07 52.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.083 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 9.4 Cg_endo -58.13 -38.27 92.11 Favored 'Trans proline' 0 CA--C 1.514 -0.515 0 C-N-CA 123.725 2.95 . . . . 0.0 114.836 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.718 ' HD3' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.03 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.875 0.369 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.9 Cg_endo -72.89 109.68 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.52 2.146 . . . . 0.0 112.017 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.652 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 141.1 43.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -112.68 127.23 56.06 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.976 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.652 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.91 141.81 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.965 0.412 . . . . 0.0 109.904 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.09 169.42 23.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.06 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.545 ' HG2' ' CB ' ' A' ' 61' ' ' ASP . 4.2 mmt180 -85.97 115.19 23.43 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 90' ' ' ARG . 3.0 mp -101.86 134.64 44.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.09 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.762 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.79 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.762 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.1 pt-20 . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -140.66 136.08 32.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.946 0.879 . . . . 0.0 111.725 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -139.8 125.54 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.102 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 3.7 p-10 -67.53 114.59 6.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 112.078 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.638 ' HB2' HD21 ' A' ' 80' ' ' LEU . 29.3 mmt180 -115.34 173.31 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.91 147.85 37.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.47 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 9.8 p -133.12 146.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.021 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.502 ' HB3' HD21 ' A' ' 95' ' ' ASN . 75.3 m-20 -82.91 110.58 18.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.728 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -79.28 3.95 16.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.502 HD21 ' HB3' ' A' ' 93' ' ' ASN . 22.3 m-80 -63.19 -14.36 48.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.053 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -24.93 67.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.586 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -79.22 126.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.836 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -118.91 160.56 21.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.932 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.27 120.95 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.621 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 52.9 t -112.48 93.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.38 25.73 13.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.84 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.96 14.86 15.95 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.621 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 14.4 ptp180 -124.17 134.57 53.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.347 . . . . 0.0 110.212 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.806 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 79.3 mt -85.17 120.31 26.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.4 t -128.46 136.37 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.914 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -87.59 143.69 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.893 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.964 179.31 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 p90 . . . . . 0 C--O 1.231 0.094 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.723 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.29 -21.25 48.24 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.929 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.66 -35.41 70.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.377 0.608 . . . . 0.0 110.186 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -140.29 46.56 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.951 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.723 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 88.9 p -116.1 155.79 27.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 111.29 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -149.33 163.99 36.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 91.3 m-20 51.24 35.96 14.82 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.506 0.504 . . . . 0.0 111.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -79.11 113.81 17.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.411 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -144.67 149.72 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -83.99 142.46 30.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 m -127.87 164.96 21.1 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 7.2 t-20 73.29 9.23 5.2 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 123.575 0.547 . . . . 0.0 110.861 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.12 13.92 50.67 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 108.47 15.94 12.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.056 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.587 ' HG2' HG23 ' A' ' 56' ' ' THR . 23.6 mtp180 -99.51 -16.98 18.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.583 0.23 . . . . 0.0 111.035 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -131.3 131.0 43.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.026 0.441 . . . . 0.0 111.67 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.473 ' HB2' HD21 ' A' ' 37' ' ' LEU . 59.4 tp -98.55 105.09 17.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.796 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -104.91 123.87 48.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.47 41.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -112.4 113.08 25.09 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -126.49 141.07 52.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.095 0.474 . . . . 0.0 111.589 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -67.79 144.06 55.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.448 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HB3' HG22 ' A' ' 31' ' ' VAL . 26.6 p-10 -85.9 -173.85 4.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.509 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.86 75.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.741 0.305 . . . . 0.0 111.527 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.53 -24.24 63.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.082 0.468 . . . . 0.0 111.096 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.84 35.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.721 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 t30 -91.69 146.44 23.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -75.0 124.1 26.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.293 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -127.54 154.59 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.3 m -104.73 114.16 28.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.898 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.0 p -110.7 134.08 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.495 0.664 . . . . 0.0 111.413 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.45 131.83 50.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.647 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.516 HD11 HG12 ' A' ' 40' ' ' ILE . 12.9 tp -131.44 119.59 21.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.955 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 39' ' ' THR . 9.6 t70 -68.88 111.32 4.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.74 HD11 HD13 ' A' ' 12' ' ' LEU . 33.8 mt -61.73 -45.16 95.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.681 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -63.5 -3.8 2.37 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -101.3 -13.13 18.17 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.823 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.516 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.53 11.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.46 129.54 70.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.46 160.3 22.11 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.312 -0.946 . . . . 0.0 112.518 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -110.88 109.61 19.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.52 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.53 76.56 6.57 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.002 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 39.3 62.07 1.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.802 0.841 . . . . 0.0 112.14 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 88.89 36.89 7.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.794 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -163.24 118.13 1.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.77 0.285 . . . . 0.0 110.483 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CG ' ' HB ' ' A' ' 92' ' ' VAL . 41.5 m-85 -61.57 138.51 58.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.959 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.52 116.14 15.59 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.648 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.24 115.02 8.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.04 38.87 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -110.66 -50.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.258 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.523 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 1.7 tt0 74.76 144.32 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.218 0.607 . . . . 0.0 111.527 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.681 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 10.9 m120 64.02 46.03 3.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.749 0.785 . . . . 0.0 111.117 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -85.16 -28.56 25.42 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.39 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.587 HG23 ' HG2' ' A' ' 17' ' ' ARG . 77.7 p -68.58 -19.58 64.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.559 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 12.2 pt-20 -71.37 -17.52 62.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.797 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 57' ' ' GLU . 62.8 p -124.33 9.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.905 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 56' ' ' THR . . . -115.69 150.37 36.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.093 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -137.04 170.09 16.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t70 43.54 57.21 4.04 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.594 0.558 . . . . 0.0 111.33 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -87.94 113.39 25.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.187 0.518 . . . . 0.0 112.241 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 121.86 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.866 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.609 ' CE1' HD11 ' A' ' 94' ' ' LEU . 12.8 t80 -91.47 132.1 36.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.292 0.567 . . . . 0.0 111.679 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.18 87.74 40.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 11.2 Cg_endo -57.63 -37.24 97.56 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 123.951 3.101 . . . . 0.0 114.105 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 C--N 1.295 -1.775 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.059 0.456 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HG3' ' HB1' ' A' ' 4' ' ' ALA . 60.2 Cg_endo -73.62 109.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.941 2.428 . . . . 0.0 111.882 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.48 HD13 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 140.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -112.07 124.63 52.83 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.105 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.483 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.89 141.48 50.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.856 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.23 170.56 20.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.276 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.47 115.14 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -100.63 125.98 47.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.913 0.387 . . . . 0.0 111.575 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.695 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.5 pt-20 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -136.11 139.87 43.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.63 0.729 . . . . 0.0 111.424 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -139.48 109.75 6.52 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.1 p-10 -62.83 114.09 3.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.393 0.616 . . . . 0.0 111.374 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.603 ' HB2' HD21 ' A' ' 80' ' ' LEU . 31.2 mmt180 -115.06 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.519 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.84 148.34 32.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.453 ' HB ' ' CG ' ' A' ' 48' ' ' PHE . 12.7 p -135.31 143.56 36.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.375 0.607 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 95' ' ' ASN . 7.5 m-20 -84.02 106.22 15.51 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.887 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.609 HD11 ' CE1' ' A' ' 64' ' ' PHE . 6.0 mt -75.67 2.17 12.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 93' ' ' ASN . 22.4 m-80 -62.32 -17.22 58.21 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.697 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -21.55 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.155 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.8 mt -86.74 125.2 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -118.25 159.9 22.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -102.04 119.04 38.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.202 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 41.0 t -111.84 96.62 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.317 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 61.69 20.74 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.466 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 33' ' ' SER . . . 108.62 18.41 9.58 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.33 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 5.5 ptp180 -125.86 150.63 47.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.898 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 78.6 mt -97.78 118.1 33.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.5 p -118.42 126.19 74.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -86.78 144.38 27.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.763 178.4 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.414 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 4.9 p90 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.656 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.18 -30.08 59.16 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.003 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.87 -32.55 65.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.306 0.574 . . . . 0.0 111.196 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 56.2 m -136.69 41.12 2.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.209 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.656 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.8 p -115.96 145.15 43.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 111.419 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.88 166.03 27.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.016 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.22 31.07 13.4 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.641 0.588 . . . . 0.0 111.309 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 66' ' ' PRO . . . -77.59 114.85 16.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.601 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.14 149.58 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.147 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -86.93 134.5 33.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.708 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 14' ' ' ASN . 9.1 m -123.32 165.36 17.11 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.118 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER 71.24 8.79 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.229 0.612 . . . . 0.0 111.325 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 22.17 22.3 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.01 14.11 37.51 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.576 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.574 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.3 mtp180 -98.08 -17.11 19.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.402 0.144 . . . . 0.0 111.02 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 26.5 m -130.6 124.52 31.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.6 tp -95.7 105.92 17.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -103.32 124.15 48.12 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -147.42 145.06 29.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.027 0.441 . . . . 0.0 111.153 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -100.25 113.46 26.16 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 6' ' ' SER . 20.1 t -128.02 143.85 51.09 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.949 0.404 . . . . 0.0 110.441 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 144.46 48.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.729 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -84.42 -171.44 3.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.704 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.1 72.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.513 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.68 -24.44 63.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.32 38.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.498 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -96.49 143.85 27.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -73.66 122.72 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 112.026 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 153.76 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.94 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 m -108.55 111.0 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 104' ' ' LEU . 9.3 t -112.62 155.97 23.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.135 0.493 . . . . 0.0 111.184 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.2 mt-10 -137.87 131.96 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.868 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.84 117.45 20.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.519 ' O ' HG21 ' A' ' 39' ' ' THR . 21.5 m-20 -68.15 107.04 2.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 109.579 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -59.19 -45.89 89.87 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.504 0.668 . . . . 0.0 110.536 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -62.7 -5.26 2.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.818 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.519 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.56 -14.23 18.29 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.992 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.485 HG22 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.11 10.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.08 129.94 71.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.77 158.65 20.86 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.883 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.446 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 12.1 t30 -110.7 111.48 22.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -93.07 79.29 4.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.537 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.4 49.84 4.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.174 0.921 . . . . 0.0 112.811 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 102.33 33.09 4.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.233 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -162.38 123.5 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.118 0.459 . . . . 0.0 111.061 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -64.08 139.79 58.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.18 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -133.02 117.49 17.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.65 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.17 114.59 8.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.26 34.86 5.2 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.759 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -107.7 -49.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.06 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.5 tt0 72.07 145.46 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.568 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.3 m-20 69.91 34.89 2.42 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.486 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.5 p90 -77.77 -28.46 50.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.574 HG21 ' HG2' ' A' ' 17' ' ' ARG . 40.0 p -68.86 -28.52 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.293 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HG3' HG22 ' A' ' 58' ' ' THR . 6.3 pt-20 -70.82 -13.83 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 109.979 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 57' ' ' GLU . 61.0 p -126.09 17.51 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.04 163.5 26.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.09 166.39 29.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.35 61.43 3.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 110.749 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.464 HG21 ' HB1' ' A' ' 78' ' ' ALA . 1.8 mt -93.61 116.76 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.704 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.517 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.48 126.77 30.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.28 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CE1' HD12 ' A' ' 94' ' ' LEU . 16.5 t80 -92.2 137.93 31.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.349 0.595 . . . . 0.0 112.206 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -119.44 84.56 29.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.567 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.735 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 Cg_endo -58.72 -39.15 84.83 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.566 2.844 . . . . 0.0 114.177 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.735 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.244 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.611 0.244 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.548 ' HG3' ' HB1' ' A' ' 4' ' ' ALA . 59.7 Cg_endo -74.57 107.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.21 1.94 . . . . 0.0 111.452 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.73 141.61 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.9 124.94 53.76 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.222 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.517 ' HD3' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.62 141.11 50.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.23 179.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.27 166.17 30.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.628 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 11.8 mmt180 -85.69 115.18 23.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -98.05 129.83 44.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.232 0.539 . . . . 0.0 112.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.051 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.7 pt-20 . . . . . 0 C--O 1.223 -0.303 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -147.76 128.2 14.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.0 110.135 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -137.42 120.94 17.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.7 p-10 -64.62 125.53 25.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.557 ' HB2' HD21 ' A' ' 80' ' ' LEU . 34.6 mmt180 -120.57 178.09 4.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.752 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -144.73 147.69 33.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 p -136.22 140.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.582 0.706 . . . . 0.0 110.999 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.458 ' HB3' HD21 ' A' ' 95' ' ' ASN . 26.0 m-80 -79.2 108.42 12.69 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.641 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.653 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -78.97 5.82 10.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.331 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.458 HD21 ' HB3' ' A' ' 93' ' ' ASN . 18.8 m-80 -67.23 -8.61 33.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 110.281 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -15.61 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.932 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 94' ' ' LEU . 13.0 mt -89.05 126.13 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -115.87 169.93 8.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.508 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -115.2 118.77 34.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.226 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -113.75 100.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.57 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.73 24.64 13.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.37 0.605 . . . . 0.0 110.801 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.99 23.0 10.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.304 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.5 ptp180 -129.92 134.76 47.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.951 0.376 . . . . 0.0 110.069 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 33' ' ' SER . 2.1 mp -83.67 128.41 34.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.2 130.29 21.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.99 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -82.04 145.92 29.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.249 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.738 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.417 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 11.7 p90 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -52.4 -26.39 12.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.465 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.65 -29.63 27.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.011 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 25.5 m -141.47 34.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.632 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 66.7 m -115.64 152.92 32.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.389 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -150.38 167.64 26.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.96 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 74.0 m-20 55.6 31.71 17.77 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.524 0.515 . . . . 0.0 111.457 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -73.41 114.47 11.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.314 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.8 t -142.3 150.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.083 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.621 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.1 138.35 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 14' ' ' ASN . 8.7 m -125.81 165.3 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 9.3 t30 72.49 6.36 5.44 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.57 0.544 . . . . 0.0 111.531 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.71 28.74 11.81 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.512 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 93.28 20.92 31.2 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.5 mtp180 -106.78 -13.99 15.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.687 0.28 . . . . 0.0 110.275 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 28.7 m -133.15 129.24 37.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.913 0.387 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.496 ' CD2' HD12 ' A' ' 97' ' ' ILE . 55.5 tp -100.33 108.7 20.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.609 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.7 tmm_? -103.96 123.54 47.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.75 151.0 36.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.006 0.431 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.7 mt-10 -106.44 114.47 28.61 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.601 ' HB2' ' HG ' ' A' ' 7' ' ' SER . 12.6 t -130.32 147.93 52.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.307 0.575 . . . . 0.0 111.677 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.74 144.72 36.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.829 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -87.72 -168.6 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.791 0.329 . . . . 0.0 111.645 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.81 75.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.44 -24.24 61.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.147 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.8 5.84 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -86.48 144.69 27.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -77.47 125.34 29.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.482 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.15 131.75 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.869 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -83.58 110.05 17.92 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.533 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.8 p -111.36 143.43 42.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.321 0.581 . . . . 0.0 111.642 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.466 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -130.7 133.15 45.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.34 119.17 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.5 m-20 -68.88 108.48 3.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.621 HD11 HD11 ' A' ' 12' ' ' LEU . 55.3 mt -59.28 -46.76 87.66 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.108 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -62.77 -4.91 2.33 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.85 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.12 -13.97 20.68 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.872 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -143.99 12.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.008 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -126.63 130.83 71.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.22 163.06 19.36 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.819 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.14 108.75 17.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 0.0 110.328 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -101.67 82.93 2.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.301 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 48.99 57.21 6.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.124 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.563 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.14 41.86 20.84 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -159.39 113.0 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.538 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.0 m-85 -58.76 136.28 57.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.244 0.545 . . . . 0.0 111.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -123.74 114.77 20.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.51 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.78 114.47 8.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.62 35.4 4.92 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.647 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.18 -49.54 0.82 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.148 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 28.9 tt0 70.15 145.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.026 0.53 . . . . 0.0 111.123 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.644 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.8 m120 72.35 31.78 1.77 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.215 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.584 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.1 p90 -76.57 -31.51 57.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.1 p -64.12 -27.18 68.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.876 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.3 pt-20 -72.04 -14.41 61.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.199 0.523 . . . . 0.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.572 HG22 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -125.09 14.05 8.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.922 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.8 157.32 37.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.654 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -148.93 170.66 17.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.322 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t70 49.07 52.44 14.37 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.385 0.428 . . . . 0.0 110.74 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.422 HG21 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -84.79 112.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -126.54 124.89 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.643 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.621 ' CE1' HD11 ' A' ' 94' ' ' LEU . 14.8 t80 -91.6 137.65 32.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.352 0.596 . . . . 0.0 111.486 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -122.89 82.3 49.92 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 6.9 Cg_endo -56.94 -43.07 57.68 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.384 2.723 . . . . 0.0 113.947 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.459 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 3.3 mptt . . . . . 0 C--N 1.295 -1.791 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.438 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 42.8 Cg_endo -70.01 108.94 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.568 2.179 . . . . 0.0 112.072 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 91' ' ' ASP . 1.1 pp -136.34 142.19 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.532 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.06 126.96 56.05 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.964 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.506 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.75 142.39 50.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.099 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.16 171.1 19.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.718 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.3 mmt180 -85.12 115.87 23.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.613 HD23 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -101.74 124.71 47.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.941 0.4 . . . . 0.0 111.666 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.469 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.726 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.3 pt-20 . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -140.43 139.71 35.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.036 0.922 . . . . 0.0 111.503 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -138.79 112.73 8.5 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.682 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.559 ' HB3' ' CD ' ' A' ' 79' ' ' ARG . 5.4 p-10 -64.43 113.15 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.518 0.675 . . . . 0.0 111.341 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.613 ' HB2' HD23 ' A' ' 80' ' ' LEU . 25.7 mmt180 -114.39 177.11 4.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HB2' HD12 ' A' ' 75' ' ' ILE . 7.7 p-10 -142.57 148.74 38.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.538 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -134.31 147.59 30.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.493 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.473 ' HB3' HD21 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -85.42 110.09 18.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.709 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.621 HD11 ' CE1' ' A' ' 64' ' ' PHE . 5.5 mt -77.5 2.48 16.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.293 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' A' ' 93' ' ' ASN . 16.6 m-80 -62.73 -12.75 25.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 109.91 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.693 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -69.51 -18.06 63.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.692 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 94' ' ' LEU . 11.9 mt -87.06 123.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.443 0.64 . . . . 0.0 110.626 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -116.96 164.6 14.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.217 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.6 t30 -108.27 121.06 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 61.4 t -113.01 94.62 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.69 22.56 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.985 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.62 16.73 9.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.594 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.2 ptp180 -129.22 143.71 50.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 82.7 mt -89.37 133.23 34.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.71 131.4 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -82.48 145.78 29.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.693 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 57.6 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.47 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 p90 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.743 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.15 -24.1 51.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.422 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -59.16 -24.24 62.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -148.01 39.32 0.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.743 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.7 p -116.22 158.27 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.938 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.412 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.3 ptp180 -155.32 166.8 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.517 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.8 m-20 52.89 35.47 19.12 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.788 0.68 . . . . 0.0 111.332 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -79.31 114.36 18.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.427 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 t -143.84 151.58 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.655 HD12 HD12 ' A' ' 37' ' ' LEU . 1.1 tp -85.17 145.22 27.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 14' ' ' ASN . 8.1 m -131.99 164.73 25.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 73.77 5.22 4.83 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.602 0.564 . . . . 0.0 111.234 177.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.06 23.58 19.65 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 99.1 16.86 29.07 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.824 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.7 mtp180 -100.75 -18.38 16.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.581 0.229 . . . . 0.0 110.783 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 50.5 m -130.22 128.42 41.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 0.0 111.54 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD2' HD12 ' A' ' 97' ' ' ILE . 58.8 tp -97.59 108.8 21.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.72 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.2 tmm_? -103.4 124.94 49.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.25 138.95 20.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -98.83 109.85 22.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD11 ' A' ' 104' ' ' LEU . 3.3 m -121.29 144.28 48.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.028 0.442 . . . . 0.0 111.035 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.29 143.32 47.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.94 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.44 ' HB3' HG22 ' A' ' 31' ' ' VAL . 25.2 p-10 -90.26 -172.77 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.595 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.51 66.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.721 0.296 . . . . 0.0 111.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.18 -25.03 59.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.114 0.483 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.21 39.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.515 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.7 t-20 -88.94 146.32 24.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -78.55 119.63 22.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.057 0.456 . . . . 0.0 110.99 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -115.9 125.18 72.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.801 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.5 m -80.36 107.3 13.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.4 t -112.52 149.23 32.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.325 0.583 . . . . 0.0 110.584 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.9 mt-10 -134.96 131.77 37.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.85 119.18 23.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.629 ' O ' HG23 ' A' ' 39' ' ' THR . 47.4 m-20 -68.41 108.73 3.37 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.028 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.655 HD12 HD12 ' A' ' 12' ' ' LEU . 68.3 mt -61.86 -42.35 98.95 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.55 -5.21 2.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.09 -12.08 16.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.439 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 39' ' ' THR . 2.5 pp -141.94 10.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 130.44 70.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.59 160.79 20.95 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.966 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -110.94 107.85 17.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.505 0.669 . . . . 0.0 110.214 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -87.83 75.73 8.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.107 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 39.16 59.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 112.588 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 91.36 36.29 6.64 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.551 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -165.5 121.72 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.7 m-85 -60.93 143.78 54.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.346 0.593 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -132.91 115.81 15.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.422 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -73.01 115.08 11.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 31.91 6.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.784 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -102.03 -50.8 1.13 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.194 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.7 tt0 72.61 144.96 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.901 0.48 . . . . 0.0 111.422 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 2.6 t-20 68.74 34.71 3.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.244 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.2 p90 -77.27 -28.49 53.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.95 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.576 HG21 ' HG2' ' A' ' 17' ' ' ARG . 33.0 p -64.63 -22.23 66.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.555 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.6 pt-20 -73.16 -15.32 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.038 0.446 . . . . 0.0 110.371 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.8 p -128.19 16.32 6.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.271 0.558 . . . . 0.0 110.031 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.21 150.27 50.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.144 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.578 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.32 173.07 11.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.503 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.477 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 48.43 50.86 16.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.545 0.528 . . . . 0.0 110.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.05 108.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.337 0.589 . . . . 0.0 111.536 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.52 123.16 37.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.68 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 94' ' ' LEU . 18.3 t80 -92.15 135.32 34.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.247 0.546 . . . . 0.0 111.895 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.431 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 16.5 t60 -124.5 89.33 52.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.04 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.2 Cg_endo -57.11 -36.86 99.31 Favored 'Trans proline' 0 CA--C 1.51 -0.712 0 C-N-CA 124.11 3.207 . . . . 0.0 114.633 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.656 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 56.9 Cg_endo -71.37 110.43 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.779 2.32 . . . . 0.0 112.642 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.68 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 140.24 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.52 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -111.66 126.83 55.45 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.081 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.68 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.0 142.53 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.84 24.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.675 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.578 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.4 mmt180 -86.3 115.09 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.32 124.06 45.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.365 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.4 pt-20 . . . . . 0 C--O 1.22 -0.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.12 142.61 36.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.784 0.802 . . . . 0.0 111.417 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -140.99 112.04 7.2 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.073 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.2 p-10 -62.02 115.27 3.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.31 0.576 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -116.44 175.44 5.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.953 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.39 149.08 38.88 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.521 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -137.52 143.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.459 0.647 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.41 ' HB3' HD21 ' A' ' 95' ' ' ASN . 36.5 m-20 -79.36 110.04 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.551 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.616 HD11 ' CE1' ' A' ' 64' ' ' PHE . 4.5 mt -79.04 1.11 25.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.798 0.332 . . . . 0.0 111.238 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 93' ' ' ASN . 14.9 m-80 -61.93 -13.87 29.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -26.5 67.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.447 0.641 . . . . 0.0 109.39 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 94' ' ' LEU . 11.2 mt -80.13 127.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.415 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -121.01 161.99 20.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -104.88 120.6 41.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.024 0.44 . . . . 0.0 110.63 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.56 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 60.2 t -113.1 94.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.32 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.94 24.91 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.714 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 23.14 8.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.0 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.56 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 7.6 ptp180 -130.6 134.15 46.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.95 0.375 . . . . 0.0 110.271 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.2 mp -80.89 119.46 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.401 HG23 ' HG3' ' A' ' 103' ' ' ARG . 48.3 t -127.14 125.37 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.226 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.56 144.02 34.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.205 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.909 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.7 p90 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.698 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.3 -27.68 37.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.62 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.38 -31.83 66.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 110.976 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.9 m -138.11 41.31 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.698 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.2 p -122.67 154.55 37.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.597 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -151.37 167.51 27.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 84.9 m-20 53.69 34.43 18.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.659 0.599 . . . . 0.0 111.214 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -80.03 112.96 17.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.91 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.25 153.64 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.043 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.778 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.58 142.78 27.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 14' ' ' ASN . 20.4 m -130.37 163.53 26.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.4 t30 72.67 9.06 5.63 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.725 0.641 . . . . 0.0 111.657 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 25.27 15.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.037 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 93.08 26.18 17.16 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.611 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HG2' HG22 ' A' ' 56' ' ' THR . 24.7 mtp180 -108.09 -18.3 13.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.835 0.35 . . . . 0.0 110.196 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 42.1 m -128.73 129.91 46.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.768 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 37' ' ' LEU . 57.1 tp -102.77 111.99 24.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.578 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -110.4 126.05 53.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.043 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.456 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.16 138.46 20.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 110.6 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.6 mt-10 -96.09 110.04 22.36 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 6' ' ' SER . 5.1 p -117.5 141.16 48.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.133 0.492 . . . . 0.0 111.643 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.16 143.89 40.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.771 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 p30 -90.58 -172.98 3.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.74 -34.07 70.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.627 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.64 -17.9 61.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.277 0.56 . . . . 0.0 110.83 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.45 6.71 56.41 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.6 t-20 -86.9 142.26 28.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.474 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.1 m0 -77.63 116.73 18.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.025 0.44 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.57 122.57 67.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 m -76.4 109.75 10.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.729 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 24.0 m -109.93 143.46 39.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.0 mt-10 -135.5 132.72 37.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.556 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.582 HD12 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -136.74 119.58 16.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.653 ' O ' HG23 ' A' ' 39' ' ' THR . 18.2 m-20 -69.67 110.34 4.82 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.722 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.778 HD11 HD11 ' A' ' 12' ' ' LEU . 11.1 mt -60.6 -39.96 90.03 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.836 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -64.45 -5.93 6.3 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.492 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.56 -9.77 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.658 -178.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.582 HG12 HD12 ' A' ' 35' ' ' LEU . 2.6 pp -143.16 10.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.71 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.43 131.16 70.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.12 158.03 20.2 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.755 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -111.45 108.53 18.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.15 0.5 . . . . 0.0 110.319 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -93.58 78.99 4.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.317 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 41.24 60.73 1.98 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.817 0.847 . . . . 0.0 112.432 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.23 35.5 9.59 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.771 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -158.5 117.35 3.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.801 -0.235 . . . . 0.0 110.736 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -62.93 139.48 58.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -133.5 116.78 16.37 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.43 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -69.67 115.62 9.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 39.14 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.873 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -111.58 -51.21 0.58 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.375 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.4 tt0 72.98 144.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.23 0.612 . . . . 0.0 111.344 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.7 m-20 72.47 28.99 2.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.82 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -74.1 -29.16 61.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.548 HG22 ' HG2' ' A' ' 17' ' ' ARG . 17.8 p -67.7 -20.43 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.004 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.551 ' HG3' HG22 ' A' ' 58' ' ' THR . 4.2 pt-20 -76.49 -12.91 60.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.551 HG22 ' HG3' ' A' ' 57' ' ' GLU . 81.8 p -127.1 13.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.974 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.31 150.91 51.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.589 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.06 173.42 11.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.998 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.412 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 47.5 58.79 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 110.423 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.48 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 1.8 mt -94.9 110.7 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.4 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 126.41 39.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.413 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 94' ' ' LEU . 9.0 t80 -91.38 134.99 34.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.363 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -120.34 84.66 35.45 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.336 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -56.77 -41.11 79.07 Favored 'Trans proline' 0 CA--C 1.512 -0.607 0 C-N-CA 123.254 2.636 . . . . 0.0 113.89 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.774 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.743 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 58.9 Cg_endo -71.99 111.08 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.592 2.194 . . . . 0.0 112.669 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -134.37 141.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -112.24 125.43 54.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.499 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.05 142.5 49.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.147 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.479 ' HB1' HG23 ' A' ' 62' ' ' ILE . . . -161.71 169.72 20.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.223 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -86.0 115.0 23.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 90' ' ' ARG . 4.6 mp -101.4 131.51 47.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.824 0.345 . . . . 0.0 111.303 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.765 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.022 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.765 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 98.4 m-85 -135.95 136.36 40.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.707 0.765 . . . . 0.0 111.332 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -138.29 119.14 14.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.701 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 12.6 p-10 -64.49 113.26 3.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.433 0.635 . . . . 0.0 111.332 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 80' ' ' LEU . 31.0 mmt180 -115.0 176.47 5.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -144.44 151.95 39.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.9 p -139.6 146.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.209 0.528 . . . . 0.0 110.78 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.447 ' HB3' HD21 ' A' ' 95' ' ' ASN . 40.5 m-80 -81.73 111.73 18.25 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.775 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 64' ' ' PHE . 5.3 mt -80.55 -0.75 39.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.306 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' ' 93' ' ' ASN . 23.7 m-80 -62.08 -14.22 34.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -24.2 65.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -80.85 126.9 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.319 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -120.66 162.69 19.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.07 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -105.77 118.44 36.59 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.215 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.5 t -113.52 96.95 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.563 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.8 t30 59.87 24.7 13.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 111.482 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.94 24.32 7.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.998 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -132.9 139.25 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.322 0.561 . . . . 0.0 110.978 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.729 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 53.8 mt -84.99 117.29 23.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 47.3 t -122.78 122.47 65.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.818 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.84 143.85 34.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--O 1.249 1.074 0 O-C-N 123.722 0.639 . . . . 0.0 111.659 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.46 -25.85 38.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.156 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.61 -30.56 55.09 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.9 m -136.64 33.09 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.417 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.442 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 69.4 m -120.22 156.45 31.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.022 0.439 . . . . 0.0 112.041 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.98 170.79 19.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.525 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 95.6 m-20 53.02 33.56 15.09 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.683 0.614 . . . . 0.0 111.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -75.45 114.14 13.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.95 157.02 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.551 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.794 HD11 HD12 ' A' ' 37' ' ' LEU . 1.1 tp -94.34 134.54 36.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 109.882 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -119.42 163.32 17.4 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.091 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.0 t30 70.27 9.61 7.05 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.712 0.632 . . . . 0.0 111.561 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.2 26.72 17.75 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.902 -0.665 . . . . 0.0 111.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.513 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 95.33 22.8 21.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.969 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 28.9 mtp180 -106.33 -18.0 14.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.845 0.355 . . . . 0.0 110.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -132.52 127.76 35.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.094 0.473 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 37' ' ' LEU . 55.5 tp -95.69 105.18 17.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.611 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -102.09 124.17 47.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.039 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.73 29.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.2 mt-10 -99.59 109.14 21.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 6.3 p -116.43 140.23 49.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.3 143.38 40.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' HB3' HG23 ' A' ' 31' ' ' VAL . 23.9 p-10 -87.26 -176.45 5.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.363 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.94 -30.55 66.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.533 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.68 -24.57 59.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.18 5.35 40.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.835 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.2 t-20 -89.01 144.77 25.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.404 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.5 m0 -77.65 121.1 23.51 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.978 0.418 . . . . 0.0 110.968 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -118.95 125.12 74.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.791 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -80.16 110.23 15.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB3' HD11 ' A' ' 104' ' ' LEU . 8.2 t -111.75 150.03 30.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 110.555 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.556 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.2 mt-10 -134.93 131.56 37.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.383 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.9 116.24 19.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 39' ' ' THR . 12.8 m-20 -67.61 107.68 2.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.509 0.671 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.794 HD12 HD11 ' A' ' 12' ' ' LEU . 38.0 mt -59.92 -42.5 94.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.453 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 2.4 p-10 -63.43 -5.67 3.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.8 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -105.66 -10.29 16.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.575 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.478 HD13 ' CG1' ' A' ' 41' ' ' ILE . 2.6 pp -142.78 10.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 111.769 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -127.57 131.22 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.68 159.14 20.91 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.071 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -111.06 112.55 24.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -99.36 76.82 2.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 52.25 58.22 5.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.563 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.612 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.99 32.47 29.26 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.358 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -149.44 122.06 8.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.9 m-85 -66.3 135.18 54.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.809 0.337 . . . . 0.0 110.837 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -128.34 117.17 20.97 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -71.34 115.51 10.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.33 33.27 5.74 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.107 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -103.95 -51.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.107 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 28.5 tt0 70.69 143.31 0.05 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.089 0.556 . . . . 0.0 110.689 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.657 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 11.7 m120 76.89 31.23 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.322 0.649 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.575 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.4 p90 -80.69 -29.7 36.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.246 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.536 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.1 p -65.64 -17.36 64.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.007 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 12.4 pt-20 -80.25 -15.55 56.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.148 0.499 . . . . 0.0 109.996 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.561 HG22 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -124.6 14.66 8.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.23 150.1 49.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.682 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.756 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -141.03 172.81 12.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 43.67 58.17 3.65 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.859 0.724 . . . . 0.0 111.129 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.439 HG23 ' HB1' ' A' ' 78' ' ' ALA . 2.4 mt -88.75 111.39 22.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.203 0.525 . . . . 0.0 112.139 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.55 123.21 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.069 179.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.658 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.2 t80 -92.88 134.6 34.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.14 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 8.1 t-160 -126.19 89.42 52.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 20.7 Cg_endo -62.42 -36.58 65.61 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.886 3.058 . . . . 0.0 114.144 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.308 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.654 0.264 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 53.0 Cg_endo -71.47 110.42 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.833 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.726 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.42 141.36 42.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -114.13 127.91 56.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.369 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.726 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.01 141.8 51.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.203 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.54 168.94 23.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.812 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.756 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.1 mmt85 -85.54 114.9 22.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.612 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -100.26 129.18 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.65 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.67 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.963 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.4 pt-20 . . . . . 0 C--O 1.221 -0.399 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -140.57 132.99 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.863 0.839 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -137.8 112.95 9.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.211 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.5 p-10 -64.02 116.08 5.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.291 0.567 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.563 ' HB2' HD23 ' A' ' 80' ' ' LEU . 36.4 mmt180 -115.84 174.54 5.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -141.46 142.97 33.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.484 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.6 p -130.33 148.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.485 ' HB3' HD21 ' A' ' 95' ' ' ASN . 12.6 m120 -83.45 110.59 18.31 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.04 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.658 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.99 1.18 32.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.562 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.485 HD21 ' HB3' ' A' ' 93' ' ' ASN . 20.6 m-80 -60.73 -17.29 47.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.429 . . . . 0.0 110.486 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.04 66.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.256 0.55 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -81.75 132.86 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.29 167.36 14.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -113.05 123.42 50.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.097 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.538 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 39.2 t -114.07 93.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.97 27.69 13.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.827 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.34 19.27 8.06 Favored Glycine 0 C--N 1.32 -0.353 0 C-N-CA 120.293 -0.956 . . . . 0.0 114.133 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 6.6 ptp180 -130.55 141.79 50.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.388 0.594 . . . . 0.0 111.116 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 33' ' ' SER . 2.3 mp -90.58 124.02 34.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.621 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.1 p -132.56 128.24 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -84.98 145.49 27.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.491 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.743 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.0 p90 . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -58.67 -19.29 38.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.081 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.88 -38.35 70.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.443 0.64 . . . . 0.0 109.945 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 61.0 m -130.01 33.83 4.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.517 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.0 m -120.02 155.23 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.0 ptp180 -151.78 170.77 18.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.479 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.5 m-20 54.18 32.52 16.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.14 0.495 . . . . 0.0 110.906 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -75.33 113.36 12.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.961 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.98 155.29 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.555 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.694 HD13 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -92.15 138.05 31.85 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.9 m -123.91 163.59 20.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.128 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 71.0 6.53 5.9 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.665 0.603 . . . . 0.0 111.666 178.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.38 23.63 14.0 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.539 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.36 17.77 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.812 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG2' HG23 ' A' ' 56' ' ' THR . 29.8 mtp180 -100.07 -18.11 17.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.592 0.234 . . . . 0.0 110.922 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.8 m -131.39 124.76 30.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.075 0.464 . . . . 0.0 111.52 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.497 ' CD2' HD12 ' A' ' 97' ' ' ILE . 60.4 tp -92.77 104.95 17.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.493 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.8 tmm_? -101.78 125.46 48.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.091 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.37 144.47 25.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 6.8 mt-10 -98.6 108.84 21.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.7 p -115.87 141.25 48.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.584 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.12 141.09 42.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' HB3' HG23 ' A' ' 31' ' ' VAL . 29.0 p-10 -86.87 -175.33 5.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.311 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.09 68.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.74 -23.87 61.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.067 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.11 8.58 44.28 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.262 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.5 t-20 -93.72 147.25 23.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -77.61 117.87 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.508 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 25' ' ' ASN . 9.8 t -113.25 122.95 68.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.2 m -78.58 105.22 9.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -111.1 154.04 24.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.2 mt-10 -139.57 132.47 29.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.42 114.88 18.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 39' ' ' THR . 21.3 m-20 -65.4 107.34 1.62 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.104 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.694 HD11 HD13 ' A' ' 12' ' ' LEU . 85.6 mt -60.32 -45.59 92.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.652 0.739 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -62.62 -5.23 2.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.79 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.07 -13.15 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.036 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.496 HG23 HG21 ' A' ' 39' ' ' THR . 2.6 pp -142.95 12.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 111.923 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.64 131.45 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.85 156.85 19.67 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.442 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.445 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.2 t30 -111.58 107.19 16.26 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.52 82.16 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 40.6 51.98 3.02 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.319 1.012 . . . . 0.0 113.329 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 99.44 35.08 4.81 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.145 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -163.2 122.07 2.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.774 0.287 . . . . 0.0 110.628 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 47.1 m-85 -65.17 141.09 58.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 111.325 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.21 117.87 19.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.411 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -73.01 114.44 11.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.77 29.3 6.99 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.67 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.86 -53.76 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.978 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 31.5 tt0 73.07 143.89 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.387 0.675 . . . . 0.0 111.474 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.518 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 83.6 m-20 74.25 29.03 1.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.383 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -75.75 -33.44 60.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.517 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HG2' ' A' ' 17' ' ' ARG . 22.6 p -61.71 -30.38 70.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' HG3' HG22 ' A' ' 58' ' ' THR . 4.8 pt-20 -68.3 -13.58 62.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.837 0.351 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 57' ' ' GLU . 76.6 p -126.22 13.63 7.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 109.924 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.51 146.11 50.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.625 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -136.91 172.86 12.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.637 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER 46.79 52.39 11.44 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.828 0.705 . . . . 0.0 110.473 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.438 HG21 ' HB1' ' A' ' 78' ' ' ALA . 2.8 mt -84.62 112.01 21.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.0 111.659 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.48 124.61 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.548 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.699 ' CE1' HD13 ' A' ' 94' ' ' LEU . 21.5 t80 -92.37 136.66 33.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.363 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -122.72 85.65 49.48 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 18.7 Cg_endo -62.32 -43.7 21.97 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 123.228 2.619 . . . . 0.0 113.671 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.729 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.58 109.83 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.662 2.241 . . . . 0.0 112.369 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.443 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -133.51 141.58 43.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.526 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -114.29 125.79 54.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.176 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.47 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.21 141.39 51.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.87 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.55 167.53 26.95 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.042 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.592 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.2 mmt180 -85.16 114.59 22.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.65 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -98.22 121.56 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.923 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.8 pt-20 . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -143.28 128.92 19.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.04 111.63 8.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.224 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.4 p-10 -65.65 120.29 12.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 112.445 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.65 ' HB2' HD21 ' A' ' 80' ' ' LEU . 36.3 mmt180 -115.94 174.88 5.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.979 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -139.42 150.62 45.47 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -140.54 144.66 26.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.391 0.615 . . . . 0.0 110.912 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.484 ' HB3' HD21 ' A' ' 95' ' ' ASN . 38.0 m-80 -80.87 109.0 15.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.699 HD13 ' CE1' ' A' ' 64' ' ' PHE . 3.8 mt -79.01 1.12 25.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.453 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 93' ' ' ASN . 15.6 m-80 -60.8 -16.63 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.273 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -23.52 67.42 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.941 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.52 HD11 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -82.22 125.61 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -117.0 163.34 16.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.219 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.65 117.66 34.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.51 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 48.5 t -113.11 94.22 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 57.75 27.32 14.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.598 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.98 23.69 8.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.485 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -131.61 134.48 46.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.079 0.439 . . . . 0.0 110.38 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 mp -85.92 124.36 32.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.3 p -137.1 131.62 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.593 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.52 145.91 29.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.978 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.196 -179.82 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.3 p90 . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.16 -24.55 41.99 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.635 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.19 -33.35 65.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.006 0.432 . . . . 0.0 110.926 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -132.38 33.24 3.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.167 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 71.8 m -119.38 156.6 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.433 . . . . 0.0 111.699 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -153.09 169.94 21.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.0 m120 52.92 33.88 15.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.686 0.617 . . . . 0.0 111.176 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.77 113.38 16.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.749 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 t -143.44 156.3 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.783 HD13 HD11 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -91.39 141.61 28.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 7.9 m -125.39 165.05 19.09 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.2 t-20 71.1 8.85 6.58 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.623 0.577 . . . . 0.0 111.657 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.02 26.3 16.89 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 95.05 27.09 11.35 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.054 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.559 ' HG2' HG23 ' A' ' 56' ' ' THR . 28.7 mtp180 -111.37 -17.09 13.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.704 0.288 . . . . 0.0 110.497 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 40.4 m -128.76 126.44 39.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' CD2' HD11 ' A' ' 97' ' ' ILE . 39.6 tp -94.97 107.54 19.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.578 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.62 124.83 50.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.26 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -150.72 148.48 28.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.671 0.272 . . . . 0.0 111.12 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.9 mt-10 -103.67 109.47 21.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.512 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -118.59 148.17 42.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -79.86 141.99 35.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -89.46 -175.03 4.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.602 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.46 -28.86 69.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 111.04 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.04 -24.57 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.09 5.84 46.28 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.571 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.7 m-80 -95.18 149.28 21.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.424 0.29 . . . . 0.0 111.069 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.483 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 54.3 m0 -81.4 110.43 16.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 109.922 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG12 ' CA ' ' A' ' 102' ' ' GLY . 1.0 OUTLIER -112.17 121.81 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.048 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -74.78 114.71 13.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.804 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.0 t -112.87 149.94 32.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -136.11 131.68 35.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.14 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.457 HD11 HG12 ' A' ' 40' ' ' ILE . 15.8 tp -129.05 118.75 23.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.0 0.429 . . . . 0.0 110.611 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 39' ' ' THR . 2.9 m-20 -68.07 110.02 3.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.755 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.783 HD11 HD13 ' A' ' 12' ' ' LEU . 23.8 mt -62.06 -39.16 91.43 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.491 0.662 . . . . 0.0 109.604 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.53 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -63.53 -6.12 4.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.227 178.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -101.89 -15.2 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.243 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.486 HD11 ' CG1' ' A' ' 41' ' ' ILE . 2.6 pp -141.36 10.8 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.524 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -127.25 129.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.06 158.32 21.46 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.11 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.406 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.0 t30 -110.89 114.17 27.29 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.18 82.35 1.66 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.288 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 53.29 65.1 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.247 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.86 34.72 62.13 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.816 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -156.26 120.36 4.46 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.629 -0.336 . . . . 0.0 110.182 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.512 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 46.6 m-85 -62.08 142.98 57.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.148 0.499 . . . . 0.0 111.198 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -132.13 117.07 17.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.461 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -74.08 114.05 11.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.55 31.44 6.1 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.581 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.39 -51.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.084 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 25.8 tt0 73.26 143.09 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.188 0.595 . . . . 0.0 112.063 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 t30 68.78 31.78 4.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.694 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.0 p90 -72.31 -27.96 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.559 HG23 ' HG2' ' A' ' 17' ' ' ARG . 20.1 p -63.81 -19.6 65.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.111 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -74.58 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.134 0.493 . . . . 0.0 110.371 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -126.83 14.08 7.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.75 143.91 51.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.856 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.755 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.62 173.96 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.338 179.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 17.6 t0 48.17 50.61 16.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.234 0.54 . . . . 0.0 110.315 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.75 108.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.049 0.452 . . . . 0.0 111.738 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -125.46 123.95 40.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.047 178.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' HD13 ' A' ' 94' ' ' LEU . 4.5 t80 -91.28 130.61 37.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.927 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.0 t60 -121.11 85.46 41.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.538 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.2 Cg_endo -56.3 -36.37 96.89 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 123.933 3.088 . . . . 0.0 114.677 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.264 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.919 0.39 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 41.7 Cg_endo -68.07 112.1 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.681 2.254 . . . . 0.0 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.434 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -134.12 141.5 43.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.8 tm? -112.75 124.21 52.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.303 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.487 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.05 140.73 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.958 0.408 . . . . 0.0 109.961 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.0 169.83 22.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.839 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.4 mmt85 -86.34 115.59 23.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 90' ' ' ARG . 4.9 mp -101.5 128.8 47.58 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 123.463 0.477 . . . . 0.0 111.074 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.72 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.9 pt-20 . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 90.5 m-85 -134.5 138.59 44.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.761 0.791 . . . . 0.0 111.575 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -139.64 118.12 12.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.649 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.4 p-10 -65.02 112.37 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.344 0.592 . . . . 0.0 111.283 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.601 ' HB2' HD23 ' A' ' 80' ' ' LEU . 28.2 mmt180 -115.41 174.56 5.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -141.9 152.44 43.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.512 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -138.67 144.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.45 ' HB3' HD21 ' A' ' 95' ' ' ASN . 6.4 m-20 -82.62 110.37 17.63 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.672 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.65 ' HB3' HD13 ' A' ' 97' ' ' ILE . 8.5 mt -79.49 3.05 19.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.308 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.45 HD21 ' HB3' ' A' ' 93' ' ' ASN . 32.5 m-80 -62.19 -14.07 34.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.199 0.523 . . . . 0.0 109.819 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -21.21 66.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.186 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -83.6 127.94 39.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 0.0 111.505 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -121.45 160.91 23.17 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.125 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -108.43 120.73 43.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.071 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.52 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 48.3 t -113.72 94.38 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.001 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.48 23.48 12.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.498 ' CA ' HG12 ' A' ' 31' ' ' VAL . . . 114.15 14.34 9.23 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 119.287 -1.435 . . . . 0.0 113.695 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.8 ptp180 -130.18 135.57 48.31 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.425 -0.456 . . . . 0.0 111.161 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.804 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.8 mt -87.84 125.45 34.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.101 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.3 p -137.99 136.37 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.652 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -85.83 145.73 27.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.091 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.8 p90 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.55 -27.31 37.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.942 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.13 -31.37 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 m -130.16 31.0 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.548 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 73.4 m -116.83 156.8 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.455 0.645 . . . . 0.0 112.204 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -152.33 170.87 19.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.084 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.546 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.9 t-20 56.11 30.4 16.32 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.624 0.578 . . . . 0.0 110.266 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -76.98 113.04 14.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.64 147.13 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.648 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.61 HD11 HD13 ' A' ' 37' ' ' LEU . 1.5 tp -84.46 140.82 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.432 HG21 ' N ' ' A' ' 14' ' ' ASN . 10.8 m -126.26 163.24 23.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.025 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.1 t-20 72.05 8.97 6.03 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.619 0.574 . . . . 0.0 111.607 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.6 23.25 24.21 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 97.49 24.92 11.47 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.101 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.554 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.2 mtp180 -107.59 -18.15 13.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.864 0.364 . . . . 0.0 110.288 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 m -130.1 128.51 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.358 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.47 ' HB2' HD23 ' A' ' 37' ' ' LEU . 49.5 tp -97.32 108.65 21.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.648 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.2 tmm_? -105.42 123.98 48.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.309 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.08 26.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -106.09 110.05 22.18 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.513 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 41.8 t -121.69 145.6 47.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.87 144.01 52.64 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.277 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.454 ' HB3' HG23 ' A' ' 31' ' ' VAL . 22.6 p-10 -88.13 -167.52 1.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.952 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.24 68.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.599 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.34 -23.56 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.209 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.68 0.59 32.4 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.888 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 56.5 t30 -83.53 143.01 30.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -75.41 119.85 20.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.134 0.492 . . . . 0.0 110.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 25' ' ' ASN . 4.1 t -117.92 124.42 73.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.317 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.417 HG23 ' HG2' ' A' ' 22' ' ' GLU . 7.8 m -77.18 107.15 9.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.434 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.09 141.32 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.243 0.544 . . . . 0.0 111.088 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.0 mt-10 -130.14 131.01 45.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.664 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.541 HD11 HG12 ' A' ' 40' ' ' ILE . 15.2 tp -125.15 120.35 31.12 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.613 ' O ' HG23 ' A' ' 39' ' ' THR . 53.6 m-20 -68.61 107.77 3.09 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.369 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.61 HD13 HD11 ' A' ' 12' ' ' LEU . 37.8 mt -60.36 -39.79 88.45 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.873 0.844 . . . . 0.0 109.621 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.662 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.5 p-10 -63.35 -5.04 3.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.758 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -107.63 -9.16 15.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.786 -179.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.541 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.62 10.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.527 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.91 132.4 68.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.7 158.18 22.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.426 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -112.02 114.2 26.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.777 0.322 . . . . 0.0 110.214 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -105.5 82.94 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.545 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.04 52.8 12.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.908 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.54 35.69 22.06 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -148.53 118.05 6.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.482 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.7 m-85 -63.97 134.99 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.165 0.507 . . . . 0.0 110.571 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -126.58 116.51 21.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.456 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -72.88 114.13 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.47 30.47 6.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.923 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.58 -50.44 1.2 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.895 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 23.4 tt0 70.68 144.97 0.06 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.127 0.571 . . . . 0.0 111.345 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 6.3 m-20 71.08 33.65 2.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.343 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.527 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.91 -27.46 39.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.933 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.554 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.9 p -65.72 -17.29 64.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.977 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.552 ' OE1' ' HB3' ' A' ' 54' ' ' ASN . 7.9 pt-20 -76.8 -18.19 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 109.852 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -123.31 9.79 9.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.473 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -118.85 144.05 46.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.24 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -136.02 166.93 22.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.095 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 45.74 55.86 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.459 HG23 HD23 ' A' ' 76' ' ' LEU . 3.2 mt -83.18 106.61 14.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.308 0.575 . . . . 0.0 110.806 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.537 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -109.86 118.43 36.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.562 ' HB2' HD21 ' A' ' 12' ' ' LEU . 7.1 t80 -93.1 128.59 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.065 0.459 . . . . 0.0 111.103 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 39.7 t60 -124.38 88.77 52.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.151 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 19.7 Cg_endo -59.99 -35.94 91.47 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 124.156 3.237 . . . . 0.0 115.163 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.459 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.894 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.587 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 CA--C 1.522 -0.105 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 60.2 Cg_endo -72.87 112.36 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.154 1.903 . . . . 0.0 112.21 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.452 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -132.14 141.72 44.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 64' ' ' PHE . 1.8 tm? -114.93 122.57 46.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.93 140.42 50.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.345 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -156.63 166.67 32.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.298 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.2 mmt180 -85.58 114.75 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.589 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.4 mp -99.35 127.75 45.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.199 0.523 . . . . 0.0 111.164 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.607 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.6 pt-20 . . . . . 0 C--O 1.22 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -145.9 129.38 16.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.47 117.98 12.17 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.971 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.7 p-10 -66.61 114.01 5.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.0 111.706 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.531 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -115.78 172.21 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.69 146.45 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.0 p -128.2 150.64 34.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.74 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.457 ' HB3' HD21 ' A' ' 95' ' ' ASN . 78.2 m-20 -87.07 103.98 15.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.892 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.533 ' HB3' HD12 ' A' ' 97' ' ' ILE . 7.9 mt -75.43 0.53 16.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.81 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.491 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 26.0 m-80 -60.9 -19.94 61.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.7 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -65.73 -22.01 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.783 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.6 mt -82.95 128.39 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.184 0.516 . . . . 0.0 111.267 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -119.1 168.29 10.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.81 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -112.59 121.05 43.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.474 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -112.25 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.401 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.89 24.73 13.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.556 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.78 20.58 8.37 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.699 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.474 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.5 ptp180 -129.8 139.98 51.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.152 0.476 . . . . 0.0 110.037 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 76.0 mt -87.08 124.05 32.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 0.0 110.992 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.6 p -127.98 128.78 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -84.12 146.73 27.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.551 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.947 0.78 . . . . 0.0 111.266 178.492 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 p90 . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.306 0.574 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.745 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.3 -25.47 34.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.196 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -53.84 -33.07 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.037 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.14 37.39 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.987 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.745 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.3 p -115.28 157.26 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 111.466 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -147.91 169.73 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.469 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 25.6 m-80 50.45 34.44 9.29 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.748 0.655 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -85.74 112.42 21.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.39 178.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.306 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.799 HD12 HD12 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.15 146.54 28.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.0 m -132.12 161.5 33.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.4 t-20 74.04 9.48 4.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.692 0.62 . . . . 0.0 111.178 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.74 24.85 22.22 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 97.07 23.16 15.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.98 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.551 ' HG2' HG23 ' A' ' 56' ' ' THR . 31.0 mtp180 -107.99 -17.07 14.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.588 0.232 . . . . 0.0 110.525 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.6 m -129.99 127.95 41.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.585 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.69 107.39 19.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmm_? -104.54 124.64 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.079 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.43 151.28 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.63 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.75 ' HG2' HG23 ' A' ' 32' ' ' THR . 13.8 mt-10 -113.06 110.96 21.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.1 t -123.17 147.5 46.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.77 143.68 43.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.922 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.475 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.5 p-10 -91.31 -175.09 4.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.809 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.37 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 111.463 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.76 -24.85 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.828 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.75 10.38 37.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.648 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.6 t-20 -96.13 146.79 24.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.427 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.8 m0 -77.07 121.43 23.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -120.5 120.89 64.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.724 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.75 HG23 ' HG2' ' A' ' 22' ' ' GLU . 11.2 m -81.73 109.47 16.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -113.26 150.74 32.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.137 0.494 . . . . 0.0 111.585 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.0 mt-10 -132.7 135.03 45.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.71 116.24 18.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' HG21 ' A' ' 39' ' ' THR . 16.0 m-20 -68.32 109.81 3.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.526 0.679 . . . . 0.0 110.196 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.799 HD12 HD12 ' A' ' 12' ' ' LEU . 15.9 mt -61.42 -41.02 96.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -65.02 -4.91 5.19 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.192 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.53 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -104.66 -14.15 15.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.455 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.505 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -141.28 10.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.13 132.09 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.216 -0.303 . . . . 0.0 110.23 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.87 159.74 22.24 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.256 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -111.51 116.65 31.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 0.0 110.198 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.29 85.15 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 40.66 59.41 2.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.0 112.943 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 86.43 38.6 8.2 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.997 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -162.11 124.23 2.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -67.07 138.81 57.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.109 0.48 . . . . 0.0 110.633 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.443 HE21 ' HB2' ' A' ' 49' ' ' GLN . 2.4 tt0 -130.1 116.94 19.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.607 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -69.42 115.64 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.642 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 30.13 6.35 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.199 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -100.5 -53.59 1.05 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.071 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.5 tt0 73.55 139.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.377 0.608 . . . . 0.0 111.738 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 t30 70.35 36.69 1.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.133 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -76.1 -26.93 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.041 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.551 HG23 ' HG2' ' A' ' 17' ' ' ARG . 36.3 p -63.66 -24.31 67.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.46 ' CG ' HG21 ' A' ' 58' ' ' THR . 1.7 pt-20 -70.24 -17.1 63.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.269 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.46 HG21 ' CG ' ' A' ' 57' ' ' GLU . 81.7 p -125.78 16.0 8.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.503 0.668 . . . . 0.0 109.984 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.94 150.1 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.623 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -143.4 172.5 12.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.479 -179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.3 t70 48.22 57.22 6.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.082 0.467 . . . . 0.0 110.012 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -91.93 113.86 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.498 -177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 129.67 39.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.5 t80 -92.29 139.63 30.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 112.223 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -120.38 82.06 31.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.75 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.797 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.8 Cg_endo -55.88 -45.84 35.81 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 123.908 3.072 . . . . 0.0 114.539 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.797 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.879 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.107 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.51 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.4 Cg_endo -72.5 110.85 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.476 2.118 . . . . 0.0 111.533 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -134.73 141.97 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.57 124.73 53.06 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.918 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.518 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.06 144.36 48.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.496 . . . . 0.0 110.498 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.04 170.55 19.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.87 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.623 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -85.48 114.86 22.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.15 126.37 46.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.261 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.682 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.8 pt-20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -138.36 139.28 38.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.769 0.795 . . . . 0.0 111.257 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -138.7 111.64 7.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.281 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.558 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.2 p-10 -63.4 111.92 2.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.692 0.758 . . . . 0.0 111.777 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.64 ' HB2' HD23 ' A' ' 80' ' ' LEU . 33.2 mmt180 -114.56 175.22 5.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 75' ' ' ILE . 5.9 p-10 -143.55 146.12 33.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.451 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.4 p -128.86 144.23 38.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.616 0.722 . . . . 0.0 111.096 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.445 ' HB3' HD21 ' A' ' 95' ' ' ASN . 36.9 m-20 -79.87 106.11 11.65 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.732 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.663 ' HB3' HD11 ' A' ' 97' ' ' ILE . 3.8 mt -78.57 1.83 21.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.51 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -59.92 -19.95 54.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.426 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -62.92 -22.95 67.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.188 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.663 HD11 ' HB3' ' A' ' 94' ' ' LEU . 14.2 mt -83.8 128.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.011 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.471 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 38.6 tt0 -122.4 162.34 21.79 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.944 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.471 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 4.8 t30 -102.01 117.91 35.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.179 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 51.3 t -113.0 95.82 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.343 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.29 23.36 13.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.239 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.06 8.23 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.428 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 17.9 ptp180 -130.39 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.807 0.304 . . . . 0.0 110.259 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.05 115.6 23.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.8 t -117.93 121.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -81.49 146.47 30.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.166 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 C--O 1.247 0.957 0 O-C-N 123.67 0.607 . . . . 0.0 111.372 178.329 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.562 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.73 -25.36 54.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -55.61 -32.51 63.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 110.923 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.0 m -133.04 32.3 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.562 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 65.8 m -116.53 156.51 26.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.593 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.6 ptp180 -153.41 168.79 24.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.616 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.537 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 55.6 t30 55.44 31.25 16.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.431 0.634 . . . . 0.0 110.806 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -78.24 114.73 17.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.904 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 153.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.739 HD12 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -89.23 146.0 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.4 m -131.68 165.47 23.63 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.4 t-20 71.81 8.31 6.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 111.638 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.21 25.08 14.88 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.524 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 95.33 27.96 10.25 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.783 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.589 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -112.71 -15.49 12.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.815 0.34 . . . . 0.0 110.413 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.2 m -129.85 130.23 44.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 0.0 111.717 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' HD23 ' A' ' 37' ' ' LEU . 57.1 tp -99.28 111.47 23.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.508 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.509 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -113.07 124.29 52.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.55 153.53 33.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 9.0 mt-10 -106.05 109.92 22.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -117.98 143.61 46.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.56 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.84 144.27 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.682 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -88.42 -173.7 4.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.952 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.35 67.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.99 -24.48 55.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.945 0.402 . . . . 0.0 111.294 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.46 0.76 32.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.512 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.5 t30 -82.8 143.56 30.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -77.5 129.14 35.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.38 123.72 65.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.558 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -77.29 107.79 9.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.467 ' HB2' HD12 ' A' ' 104' ' ' LEU . 5.8 m -110.3 143.44 40.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.305 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.509 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -128.06 143.51 51.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -141.82 120.53 12.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 39' ' ' THR . 14.4 m-20 -70.45 107.16 3.7 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 110.004 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 12' ' ' LEU . 52.6 mt -60.69 -40.59 92.76 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.797 0.808 . . . . 0.0 109.675 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 5.2 p-10 -63.02 -4.95 2.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.86 -12.19 15.95 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.706 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.506 HG21 HG21 ' A' ' 39' ' ' THR . 2.4 pp -141.24 10.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.018 0.437 . . . . 0.0 112.11 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.32 129.36 70.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 158.1 21.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.189 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.431 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.0 t30 -111.56 114.73 28.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.111 0.481 . . . . 0.0 109.973 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -103.74 87.28 2.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.258 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.9 p30 45.24 57.51 4.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.561 0.744 . . . . 0.0 112.46 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.62 36.24 26.66 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.998 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -150.57 115.33 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.53 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.8 m-85 -61.8 135.72 57.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.634 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -129.69 115.06 16.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -69.67 114.89 8.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.0 5.95 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.823 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.11 -53.41 0.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.685 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.1 tt0 74.91 144.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.22 0.608 . . . . 0.0 110.961 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.694 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.7 m-20 68.36 36.94 2.86 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.265 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.26 -29.27 47.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.589 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.8 p -63.79 -23.28 67.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.044 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.694 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.9 pt-20 -71.39 -16.12 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 109.843 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 57' ' ' GLU . 76.8 p -126.04 9.15 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -119.52 142.31 48.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.157 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 169.28 17.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.776 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.6 t70 47.22 54.91 8.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.072 0.463 . . . . 0.0 110.973 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.434 HG21 ' HB1' ' A' ' 78' ' ' ALA . 2.1 mt -88.57 109.45 20.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 124.45 41.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.803 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.62 ' CE1' HD13 ' A' ' 94' ' ' LEU . 14.3 t80 -92.08 137.19 32.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.718 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.437 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t60 -123.97 86.71 53.57 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.976 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 5.7 Cg_endo -53.09 -41.0 75.0 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 124.575 3.517 . . . . 0.0 115.131 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.497 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.302 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 CA--C 1.518 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.9 Cg_endo -73.22 112.93 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.754 2.303 . . . . 0.0 112.206 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 pp -134.45 140.71 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -110.78 125.02 53.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -119.31 139.86 51.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.652 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB1' HG21 ' A' ' 62' ' ' ILE . . . -161.77 168.36 23.33 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.043 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.555 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 4.2 mmt85 -85.82 114.86 23.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.613 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.3 131.73 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.897 0.38 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.751 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 C--O 1.221 -0.414 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -142.61 137.56 30.13 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.815 0.817 . . . . 0.0 111.204 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.56 117.45 13.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.499 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.0 p-10 -66.11 113.28 4.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.572 ' HB2' HD23 ' A' ' 80' ' ' LEU . 33.6 mmt180 -115.05 172.23 7.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.86 151.61 47.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.53 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.8 p -139.68 144.68 28.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.38 0.61 . . . . 0.0 110.755 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.474 ' HB3' HD21 ' A' ' 95' ' ' ASN . 31.0 m-80 -81.69 110.31 16.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.756 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 64' ' ' PHE . 4.7 mt -79.33 3.02 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.115 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.474 HD21 ' HB3' ' A' ' 93' ' ' ASN . 25.8 m-80 -62.86 -18.29 62.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.55 -28.36 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.908 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -77.75 130.19 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.494 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -125.96 166.28 17.23 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.3 t30 -109.06 123.9 49.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.69 94.04 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.0 t30 58.82 27.15 15.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.916 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 20.96 7.97 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.814 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 12.7 ptp180 -131.25 139.6 49.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.356 0.578 . . . . 0.0 110.612 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.467 HD12 ' HB2' ' A' ' 33' ' ' SER . 1.8 mp -90.29 124.9 35.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.792 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.23 130.65 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.435 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 3.3 p90 -79.97 145.16 32.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.475 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.489 0.493 . . . . 0.0 111.114 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.712 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.13 -23.25 54.41 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.798 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.93 -23.37 63.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 111.038 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.0 m -148.6 38.03 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.712 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.8 p -116.74 153.29 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.467 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 9.6 t-20 54.23 30.64 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.534 0.522 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -75.12 113.54 12.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -143.38 149.17 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.934 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.79 HD12 HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -84.04 144.56 29.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 m -131.33 161.36 32.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.655 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.54 10.44 5.68 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 123.559 0.537 . . . . 0.0 111.237 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.13 24.84 23.61 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.453 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.507 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 96.86 22.02 19.31 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.851 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.558 ' HG2' HG22 ' A' ' 56' ' ' THR . 30.6 mtp180 -104.85 -19.03 14.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.626 0.251 . . . . 0.0 110.407 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 34.5 m -130.44 126.75 37.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.779 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.454 ' CD2' HD13 ' A' ' 97' ' ' ILE . 61.0 tp -96.97 109.55 22.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.517 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.1 tmm_? -109.08 124.24 50.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.52 149.91 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.0 mt-10 -104.67 112.2 25.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.9 p -124.21 147.51 47.98 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 111.844 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.29 144.52 36.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.575 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 8.5 p30 -86.07 -175.0 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.52 69.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.84 -23.51 59.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.56 3.2 30.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.959 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.445 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 5.2 t30 -86.07 145.57 27.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.113 0.456 . . . . 0.0 110.078 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -74.14 126.03 29.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.718 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 t -126.99 128.97 71.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -86.7 112.99 22.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -112.1 151.81 28.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.039 0.447 . . . . 0.0 110.749 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.431 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -139.05 132.0 29.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.196 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.585 HD11 HG12 ' A' ' 40' ' ' ILE . 12.8 tp -133.76 123.99 25.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.01 0.433 . . . . 0.0 110.122 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' THR . 38.9 m-20 -72.21 108.36 5.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.79 HD13 HD12 ' A' ' 12' ' ' LEU . 24.8 mt -59.53 -45.88 90.49 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.087 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.433 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -63.97 -5.08 3.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.674 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.73 -9.79 20.54 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.056 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.585 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.23 11.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 111.669 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.64 132.55 68.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.03 157.97 21.32 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.774 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.3 t30 -110.13 106.31 15.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.48 80.99 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.189 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 51.15 56.64 7.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.143 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.53 39.32 18.52 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.273 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -157.41 117.78 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 0.0 110.366 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.4 m-85 -61.95 137.76 58.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.315 0.578 . . . . 0.0 111.701 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -133.36 118.47 18.51 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.03 115.22 10.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 29.21 6.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.13 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.463 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.99 -53.26 1.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.086 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 35.1 tt0 72.13 141.93 0.06 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.309 0.644 . . . . 0.0 111.136 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.564 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 79.9 m-20 76.83 30.63 0.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.937 0.895 . . . . 0.0 110.997 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.5 p90 -78.0 -29.28 49.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.374 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.558 HG22 ' HG2' ' A' ' 17' ' ' ARG . 53.8 p -66.02 -25.16 66.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.558 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 4.7 pt-20 -70.63 -19.3 62.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.273 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -122.68 15.74 10.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.332 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.92 151.22 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.59 173.09 11.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.251 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.491 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 5.6 t70 47.53 52.41 12.47 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.563 0.54 . . . . 0.0 110.449 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.39 108.75 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.333 0.587 . . . . 0.0 111.74 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.52 123.16 39.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.561 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.634 ' CE1' HD13 ' A' ' 94' ' ' LEU . 9.8 t80 -91.77 133.81 35.28 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.015 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -121.67 86.54 45.15 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.491 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.2 Cg_endo -56.34 -38.6 94.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.754 2.969 . . . . 0.0 113.727 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.65 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.46 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.8 Cg_endo -72.75 109.03 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.365 2.043 . . . . 0.0 112.0 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.26 141.61 42.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.3 tm? -112.04 123.41 50.19 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.91 138.75 53.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.609 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.35 168.19 27.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.006 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.9 mmt180 -85.79 115.0 23.18 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.591 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -98.45 124.36 43.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 . . . . . 0 C--O 1.223 -0.34 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.66 130.2 16.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.268 0.556 . . . . 0.0 110.294 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.19 117.76 13.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.157 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.9 p-10 -66.68 120.07 12.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.438 0.637 . . . . 0.0 112.209 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.53 ' HB2' HD23 ' A' ' 80' ' ' LEU . 32.3 mmt180 -116.42 177.67 4.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -143.91 147.51 34.09 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.2 p -135.3 144.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.791 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.439 ' HB3' HD21 ' A' ' 95' ' ' ASN . 60.7 m-20 -81.53 110.12 16.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.634 HD13 ' CE1' ' A' ' 64' ' ' PHE . 5.9 mt -78.24 2.45 18.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' A' ' 93' ' ' ASN . 19.6 m-80 -63.61 -16.19 60.23 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -25.05 67.45 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.538 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.9 mt -80.11 121.47 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.783 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -113.7 164.01 14.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.019 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.0 t30 -107.13 116.38 31.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.71 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 60.6 t -112.16 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.06 0.457 . . . . 0.0 110.279 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.18 24.73 14.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.762 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.4 19.14 9.57 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.509 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -130.59 142.81 50.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.039 0.42 . . . . 0.0 110.606 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mp -85.01 119.24 25.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.0 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.31 123.59 70.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.885 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -81.69 145.17 30.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.452 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.596 178.369 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.2 p90 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.17 -25.89 35.39 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.787 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.54 -31.8 66.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.209 0.528 . . . . 0.0 110.631 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.1 m -130.15 34.96 4.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.971 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.1 m -117.32 158.54 24.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 0.0 112.027 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -155.97 166.22 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.966 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.8 t-20 54.71 33.97 20.63 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.619 0.574 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.87 113.85 16.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.217 0.532 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.71 155.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.735 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -94.79 135.29 36.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 14' ' ' ASN . 11.2 m -120.31 165.36 14.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.691 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.0 t-20 74.12 5.98 4.72 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.575 0.547 . . . . 0.0 111.067 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.94 16.16 39.67 Favored Glycine 0 CA--C 1.506 -0.48 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 105.3 27.03 5.99 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 56' ' ' THR . 28.1 mtp180 -110.86 -18.16 13.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.645 0.26 . . . . 0.0 110.455 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 63.1 m -129.6 128.46 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.369 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.9 tp -97.85 110.05 22.69 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.627 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.3 tmm_? -108.47 124.16 49.99 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.71 151.32 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.949 0.404 . . . . 0.0 110.191 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.2 mt-10 -106.94 113.17 26.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' SER . 7.8 p -124.22 146.78 48.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.184 0.516 . . . . 0.0 112.228 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.58 144.88 39.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.02 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -86.25 -173.17 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.804 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.19 73.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.149 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.58 -24.19 63.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.726 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.7 44.23 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.463 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.3 t-20 -84.35 144.89 28.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.169 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -76.25 121.19 22.56 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 t -120.67 154.99 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.374 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -107.53 112.96 25.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.468 ' HB2' HD12 ' A' ' 104' ' ' LEU . 11.6 m -112.97 144.23 42.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.237 0.541 . . . . 0.0 111.386 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.2 mt-10 -132.8 131.52 41.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.623 HD12 HG12 ' A' ' 40' ' ' ILE . 12.1 tp -131.49 120.53 23.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.191 0.519 . . . . 0.0 109.907 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.586 ' O ' HG21 ' A' ' 39' ' ' THR . 36.0 m-20 -70.04 110.01 4.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.179 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 12' ' ' LEU . 37.7 mt -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.874 0.845 . . . . 0.0 109.151 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.5 OUTLIER -63.22 -3.66 2.0 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.548 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.586 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.89 -14.62 15.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.326 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 35' ' ' LEU . 2.6 pp -141.7 13.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.53 131.89 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.21 158.12 21.46 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.569 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.432 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.8 t30 -110.35 106.79 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.05 84.13 3.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 53.09 59.32 4.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.258 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.56 40.27 39.21 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.729 -1.225 . . . . 0.0 111.969 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -160.32 121.15 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 49.4 m-85 -63.69 138.83 58.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 111.228 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -134.48 117.08 15.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -69.51 115.79 9.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.883 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.7 36.79 3.89 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.219 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.25 -52.12 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.615 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.7 tt0 73.57 143.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.56 0.695 . . . . 0.0 111.976 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t30 66.64 31.76 7.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.421 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -69.46 -27.38 65.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.571 HG22 ' HG2' ' A' ' 17' ' ' ARG . 17.0 p -64.38 -17.6 63.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.513 ' HG3' HG22 ' A' ' 58' ' ' THR . 5.5 pt-20 -72.7 -21.78 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.513 HG22 ' HG3' ' A' ' 57' ' ' GLU . 66.6 p -122.91 12.91 9.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -121.86 145.7 47.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.223 0.535 . . . . 0.0 111.311 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.5 171.27 14.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.222 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.1 t70 45.45 56.1 6.0 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.538 0.524 . . . . 0.0 110.963 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 78' ' ' ALA . 2.3 mt -88.42 111.28 22.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.051 0.453 . . . . 0.0 112.03 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 125.25 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.91 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 94' ' ' LEU . 25.3 t80 -91.09 137.05 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.297 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -121.27 86.76 43.68 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.316 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.549 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 8.5 Cg_endo -57.4 -44.58 41.31 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.442 2.761 . . . . 0.0 113.921 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? . . . . . 0 C--N 1.295 -1.768 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.802 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.639 0.257 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 56.5 Cg_endo -73.21 110.0 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.737 2.291 . . . . 0.0 112.141 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.5 141.98 39.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.508 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.5 124.96 53.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.333 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.495 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.93 145.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.006 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -162.14 169.7 20.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.59 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.1 mmt180 -86.89 115.33 24.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.579 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.6 mp -99.35 123.0 43.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.025 0.44 . . . . 0.0 110.762 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.359 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.8 pt-20 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -141.38 135.13 30.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.968 0.89 . . . . 0.0 111.133 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -130.68 108.13 9.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.7 p-10 -67.1 112.37 4.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.371 0.605 . . . . 0.0 110.61 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HB2' HD23 ' A' ' 80' ' ' LEU . 35.9 mmt180 -113.62 177.41 4.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.726 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.17 148.9 39.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.1 p -136.81 145.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.375 0.607 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.428 ' HB3' HD21 ' A' ' 95' ' ' ASN . 13.5 m120 -83.11 114.03 21.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.153 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' A' ' 64' ' ' PHE . 2.2 mt -82.02 2.11 32.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 111.106 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' A' ' 93' ' ' ASN . 25.2 m-80 -63.45 -10.48 17.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.299 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.587 ' HD2' ' N ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -70.27 -20.13 63.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.017 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.3 mt -85.18 131.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.63 159.19 27.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.231 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.9 t30 -106.28 118.97 38.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.536 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 39.4 t -113.0 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.035 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 60.07 21.87 11.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.825 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.43 23.39 6.32 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.55 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.5 ptp180 -132.57 141.07 48.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.122 0.461 . . . . 0.0 110.594 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.468 HD12 ' HB2' ' A' ' 33' ' ' SER . 1.2 mp -89.9 118.17 29.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.653 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.75 127.3 68.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.321 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -82.75 144.91 29.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.583 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.317 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.7 p90 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.63 -24.5 21.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.52 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.51 -29.9 59.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -138.78 35.04 2.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.7 m -115.92 155.67 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 111.825 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.76 164.5 36.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.552 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 53.3 36.34 22.54 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.615 0.572 . . . . 0.0 111.484 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -77.44 113.43 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.691 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 t -142.28 150.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.87 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.1 tp -85.91 143.98 27.91 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 14' ' ' ASN . 12.9 m -130.37 162.44 29.08 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.4 t-20 73.76 9.14 4.88 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 0.0 111.216 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.95 19.45 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 96.79 21.0 22.56 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.074 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.551 ' HG2' HG23 ' A' ' 56' ' ' THR . 31.5 mtp180 -102.74 -18.16 15.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.728 0.299 . . . . 0.0 110.697 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 92.9 m -130.49 129.24 42.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.098 0.475 . . . . 0.0 111.773 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 37' ' ' LEU . 56.9 tp -95.6 110.86 22.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.278 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.7 tmm_? -109.05 123.75 49.66 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.44 145.17 29.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.0 mt-10 -102.05 110.69 22.73 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.4 t -125.9 147.84 49.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 111.754 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.68 145.64 38.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.37 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -87.16 -172.85 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.459 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.02 -14.29 62.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.256 0.55 . . . . 0.0 111.773 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.23 -17.22 31.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.252 0.549 . . . . 0.0 110.141 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.03 56.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.547 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 63.2 t30 -90.47 145.99 24.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -79.8 126.66 31.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.029 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.862 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -91.06 113.38 25.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.471 ' HB2' HD12 ' A' ' 104' ' ' LEU . 2.3 m -110.75 142.6 42.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.094 0.473 . . . . 0.0 111.89 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.83 131.5 42.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.051 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.19 122.89 24.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.092 0.472 . . . . 0.0 110.128 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 39' ' ' THR . 74.1 m-20 -69.37 109.45 4.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.323 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.529 HD11 HD13 ' A' ' 12' ' ' LEU . 18.9 mt -61.89 -43.17 99.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.742 0.782 . . . . 0.0 109.655 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.428 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.23 -4.65 1.86 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.516 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.455 HG21 HG21 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -102.35 -15.06 16.67 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.355 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.472 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.6 pp -141.54 13.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -128.08 129.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.08 154.84 20.02 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.617 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.452 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -111.06 111.42 22.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.381 . . . . 0.0 110.154 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.09 85.25 2.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.984 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.0 58.73 5.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.623 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 80.57 34.31 28.75 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.746 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -153.28 119.58 5.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.577 0.227 . . . . 0.0 111.148 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 48.8 m-85 -67.19 137.59 56.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.226 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.2 117.14 17.08 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -68.61 116.15 8.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.776 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.33 25.98 8.5 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.946 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.42 -52.63 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.917 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 2.8 tt0 74.59 143.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.52 0.676 . . . . 0.0 111.883 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 t30 68.52 35.41 3.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.357 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.6 p90 -76.9 -24.35 52.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.611 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.551 HG23 ' HG2' ' A' ' 17' ' ' ARG . 13.1 p -67.58 -21.57 65.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.925 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HG3' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -74.85 -15.8 60.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.254 0.549 . . . . 0.0 109.713 179.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.543 HG21 ' HG3' ' A' ' 57' ' ' GLU . 77.9 p -126.14 14.18 7.82 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.061 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.47 141.33 52.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.755 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.679 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -135.52 168.97 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.501 -179.228 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.463 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 48.65 50.99 16.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.105 0.479 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 78' ' ' ALA . 2.6 mt -83.58 112.41 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.426 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.43 123.07 37.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.684 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.3 t80 -92.09 131.18 37.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.684 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.426 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 20.8 t60 -120.19 87.15 39.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 9.9 Cg_endo -55.21 -33.18 83.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 124.387 3.391 . . . . 0.0 115.279 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.882 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.502 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.226 -0.156 0 CA-C-O 120.902 0.382 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.525 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 57.2 Cg_endo -71.07 114.02 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.508 2.139 . . . . 0.0 112.898 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.414 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 141.59 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -113.3 127.97 56.32 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.298 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.498 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.48 141.35 51.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 110.315 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.43 168.17 25.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.003 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.679 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.8 mmt180 -85.25 115.44 23.03 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -98.13 120.9 39.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 111.627 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.78 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 pt-20 . . . . . 0 C--O 1.222 -0.352 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.78 128.94 15.64 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.381 0.61 . . . . 0.0 109.78 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.58 110.79 6.96 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.0 p-10 -58.8 120.2 8.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.999 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.605 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.5 mmt180 -120.87 173.43 7.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.065 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.42 144.33 33.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 p -131.03 148.8 33.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.362 0.601 . . . . 0.0 111.389 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.412 ' HB3' HD21 ' A' ' 95' ' ' ASN . 0.8 OUTLIER -82.04 107.28 14.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.751 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.673 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.3 mt -79.85 5.57 13.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.525 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 16.1 m-80 -65.28 -17.18 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.041 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.94 -25.31 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.386 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 94' ' ' LEU . 12.2 mt -79.13 129.87 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.207 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -124.09 163.39 21.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.59 122.06 45.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.954 0.407 . . . . 0.0 110.733 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 60.9 t -112.63 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.521 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 60.79 19.19 9.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 111.523 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.47 20.55 8.51 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.068 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 15.8 ptp180 -130.14 138.01 50.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 33' ' ' SER . 2.1 mp -84.14 123.73 30.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.64 127.65 56.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -79.16 145.6 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.404 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.1 p90 . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.788 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.97 -24.56 54.02 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.733 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.51 -33.16 67.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.71 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -129.09 31.42 4.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.788 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 37.5 p -121.14 155.92 33.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -151.21 170.49 19.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.2 m120 54.79 30.92 14.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.533 0.521 . . . . 0.0 111.34 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -75.7 114.23 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.602 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.4 t -142.39 149.64 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.858 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.556 HD12 HD13 ' A' ' 37' ' ' LEU . 1.2 tp -86.35 138.36 31.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.453 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 14.1 m -123.24 164.0 19.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.629 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.5 t-20 71.33 9.58 6.55 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.552 0.533 . . . . 0.0 111.259 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.63 17.19 46.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 107.4 19.43 9.35 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.069 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG2' HG23 ' A' ' 56' ' ' THR . 25.1 mtp180 -102.77 -20.0 14.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 110.675 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.453 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.6 m -128.45 126.75 41.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 0.0 111.811 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -96.66 105.55 17.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.96 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 tmm_? -101.38 123.61 45.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.53 140.94 22.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.642 0.258 . . . . 0.0 110.552 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 4.0 mt-10 -98.55 109.48 22.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.1 p -118.1 142.29 47.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.19 0.519 . . . . 0.0 111.42 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.93 143.13 47.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.889 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -91.17 -174.05 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.56 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.27 -26.74 63.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.1 -24.0 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.951 0.405 . . . . 0.0 111.258 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.64 4.83 42.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.637 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.9 t-20 -91.03 144.57 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.44 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.9 m0 -77.21 126.52 31.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.963 0.411 . . . . 0.0 110.815 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.49 125.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 m -74.93 107.28 6.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' ' HG ' ' A' ' 104' ' ' LEU . 13.8 m -111.22 143.42 42.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.177 0.513 . . . . 0.0 111.365 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 10.2 mt-10 -130.19 131.78 45.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.565 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 113.77 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 39' ' ' THR . 26.9 m-20 -67.43 108.72 2.91 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.782 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.556 HD13 HD12 ' A' ' 12' ' ' LEU . 26.5 mt -60.71 -39.46 88.66 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.797 0.808 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.631 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -64.12 -3.82 3.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.68 -14.51 15.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.254 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.528 HG21 HG22 ' A' ' 39' ' ' THR . 2.5 pp -140.43 13.95 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.56 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -129.29 131.45 67.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.86 157.81 22.02 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.353 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -111.8 112.73 24.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.847 0.355 . . . . 0.0 110.472 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -106.9 86.46 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 53.68 52.25 13.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.153 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.31 37.95 23.05 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.746 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.59 120.98 7.35 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.5 m-85 -67.24 132.72 48.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.038 0.447 . . . . 0.0 110.98 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -125.18 117.61 24.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.218 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.46 115.36 10.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.584 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 22.03 11.63 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.347 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -90.18 -51.18 2.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.987 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.8 tt0 72.57 142.14 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 6.6 t-20 67.04 38.83 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.987 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.27 -26.7 47.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.709 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.576 HG23 ' HG2' ' A' ' 17' ' ' ARG . 41.6 p -64.01 -21.95 66.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.627 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.9 pt-20 -74.65 -14.05 60.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.114 0.483 . . . . 0.0 109.998 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.576 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.8 p -128.35 15.93 6.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.86 148.91 52.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.904 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -142.59 172.7 12.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.888 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.455 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 2.0 t70 46.7 53.35 10.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.556 0.535 . . . . 0.0 110.778 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.427 HG23 ' HB1' ' A' ' 78' ' ' ALA . 2.3 mt -85.31 114.17 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.42 0.629 . . . . 0.0 111.707 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.91 120.47 29.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.129 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.605 ' CE1' HD11 ' A' ' 94' ' ' LEU . 12.0 t80 -92.22 132.27 36.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.717 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 3.0 t60 -123.55 89.31 51.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 11.9 Cg_endo -59.04 -38.4 87.74 Favored 'Trans proline' 0 N--CA 1.479 0.662 0 C-N-CA 124.106 3.204 . . . . 0.0 115.085 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.885 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.677 0.275 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.2 Cg_endo -71.71 110.46 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.16 1.907 . . . . 0.0 112.24 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.463 HD13 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.43 141.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.84 125.31 53.93 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.136 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.508 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.24 140.76 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 110.235 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.53 168.51 25.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.549 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -86.23 115.07 23.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.613 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 2.3 mp -99.15 126.51 44.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.798 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.1 pt-20 . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -142.75 127.81 18.51 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 113.89 12.34 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 6.6 p-10 -65.87 114.65 5.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.486 0.66 . . . . 0.0 111.507 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.575 ' HB2' HD23 ' A' ' 80' ' ' LEU . 38.4 mmt180 -114.27 179.56 3.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.938 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.12 148.87 39.03 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -133.05 140.05 48.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.806 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.484 ' HB3' HD21 ' A' ' 95' ' ' ASN . 5.8 m-20 -82.76 104.99 13.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.174 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.605 HD11 ' CE1' ' A' ' 64' ' ' PHE . 7.1 mt -74.0 1.41 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.586 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 93' ' ' ASN . 28.9 m-80 -61.28 -17.53 53.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.322 0.582 . . . . 0.0 109.779 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -25.58 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.149 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -80.81 126.84 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.752 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -117.46 163.09 16.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.809 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.7 t30 -107.88 120.31 41.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.127 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.494 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.3 t -114.02 94.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.503 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.27 27.97 17.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.222 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.04 26.34 7.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.617 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.8 ptp180 -133.15 137.08 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.991 0.395 . . . . 0.0 110.297 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.523 ' HG ' ' CB ' ' A' ' 33' ' ' SER . 74.6 mt -85.6 122.66 30.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.774 0.321 . . . . 0.0 110.188 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.4 t -132.85 128.04 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.523 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -79.24 146.02 33.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 -179.737 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.329 0.585 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.715 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.86 -21.74 63.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.735 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.21 -30.67 68.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 m -139.18 39.43 2.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.749 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.715 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 89.3 p -113.64 156.98 22.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -149.03 163.28 37.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.427 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 92.5 m-20 51.42 35.48 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.909 0.756 . . . . 0.0 111.429 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -76.59 112.61 13.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.755 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 t -142.99 155.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -89.02 148.43 23.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.3 m -131.89 162.01 31.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.362 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 3.7 t-20 70.62 12.76 7.33 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 123.699 0.625 . . . . 0.0 111.327 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.47 19.2 33.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.565 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 100.69 24.04 9.6 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.563 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.5 mtp180 -105.56 -19.44 13.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.545 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.0 m -129.79 125.84 36.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.295 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 12' ' ' LEU . 48.5 tp -94.08 107.36 19.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.426 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.527 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 tmm_? -102.03 123.12 45.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.452 ' HB2' HD13 ' A' ' 104' ' ' LEU . . . -148.19 138.86 22.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.926 0.394 . . . . 0.0 110.655 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 32' ' ' THR . 4.3 mt-10 -103.24 110.76 22.85 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.7 t -124.12 146.86 48.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 111.085 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.84 145.28 45.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.732 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -83.41 -172.08 3.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -33.6 74.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.951 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.34 -24.41 59.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.212 0.53 . . . . 0.0 110.776 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.83 8.47 27.97 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.855 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 59.0 t30 -86.15 145.08 27.16 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -77.64 117.8 19.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.066 0.46 . . . . 0.0 111.1 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.92 153.15 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.6 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 22' ' ' GLU . 47.4 m -114.68 122.3 46.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.903 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t -124.52 151.15 45.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 0.0 110.493 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -133.62 131.23 39.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.627 HD13 HG12 ' A' ' 40' ' ' ILE . 14.2 tp -127.47 120.29 28.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 0.0 110.278 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.557 ' O ' HG21 ' A' ' 39' ' ' THR . 32.3 m-20 -68.41 107.5 2.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.737 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -62.2 -40.47 96.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.724 0.773 . . . . 0.0 109.227 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.1 p-10 -64.31 -4.95 4.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.528 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.557 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -106.21 -12.06 15.85 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.414 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.627 HG12 HD13 ' A' ' 35' ' ' LEU . 2.6 pp -141.71 11.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 112.083 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.536 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.3 mt -128.1 131.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.48 157.64 20.94 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.782 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -111.62 108.4 17.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.998 0.428 . . . . 0.0 110.094 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -96.5 78.1 2.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.628 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 48.97 63.77 1.99 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.057 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.11 34.69 36.68 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.542 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -155.41 114.74 3.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.762 -0.257 . . . . 0.0 110.576 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.487 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.0 m-85 -60.75 140.99 57.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 111.389 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.66 117.33 16.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.502 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -71.66 115.11 10.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.8 28.15 7.56 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.843 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.52 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -97.41 -52.48 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.452 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.7 tt0 73.26 141.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.263 0.625 . . . . 0.0 111.475 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.6 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 7.4 m-20 71.0 34.56 1.84 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.631 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.9 p90 -77.5 -31.11 53.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.563 HG21 ' HG2' ' A' ' 17' ' ' ARG . 26.8 p -62.54 -26.65 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.931 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 17.7 pt-20 -70.31 -14.85 62.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.325 0.583 . . . . 0.0 109.955 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.546 HG22 ' HG3' ' A' ' 57' ' ' GLU . 70.1 p -127.03 13.97 7.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.3 145.09 51.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.144 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.16 172.63 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.606 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.459 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 49.14 48.36 20.99 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.059 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.37 108.2 15.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.0 111.43 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -125.08 125.63 44.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.66 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.674 ' CE1' HD11 ' A' ' 94' ' ' LEU . 8.9 t80 -92.28 134.78 34.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.351 0.596 . . . . 0.0 111.879 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -121.65 85.3 43.82 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.156 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -53.91 -35.5 80.31 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.15 3.233 . . . . 0.0 114.472 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.498 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.436 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.452 ' HG3' ' HB1' ' A' ' 4' ' ' ALA . 59.0 Cg_endo -71.51 110.65 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.302 2.002 . . . . 0.0 112.033 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.666 HD12 HH21 ' A' ' 77' ' ' ARG . 1.3 pp -135.76 141.54 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.8 tm? -111.84 124.14 51.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.666 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.98 142.66 47.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.4 167.83 26.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.543 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.2 mmt180 -86.27 114.55 23.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.549 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.5 mp -99.19 126.97 45.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.368 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.1 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.661 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 24.4 pt-20 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.16 137.55 32.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.673 0.749 . . . . 0.0 111.011 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.16 112.78 8.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.207 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -63.32 110.35 1.88 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.635 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.7 mmt180 -115.09 170.45 8.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HB2' HD11 ' A' ' 75' ' ' ILE . 3.4 p30 -135.98 153.96 51.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.487 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -138.73 144.74 29.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.398 0.618 . . . . 0.0 110.685 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.442 ' HB3' HD21 ' A' ' 95' ' ' ASN . 1.0 OUTLIER -80.2 111.39 16.52 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.854 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 64' ' ' PHE . 6.6 mt -82.32 4.59 23.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.489 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 93' ' ' ASN . 25.4 m-80 -63.35 -18.65 63.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.153 0.502 . . . . 0.0 109.799 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.98 -24.48 67.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.075 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.636 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.2 mt -80.36 127.49 39.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.358 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -117.66 166.69 12.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.345 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -110.21 118.31 36.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.52 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -108.61 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 59.91 22.84 11.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.269 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.55 19.04 8.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.772 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -130.36 141.06 50.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.277 0.538 . . . . 0.0 110.55 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.903 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 82.0 mt -83.95 120.46 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.017 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 60.0 t -125.31 124.29 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.298 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.82 143.9 32.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.619 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.691 ' HA ' HE21 ' A' ' 107' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.547 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.778 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.85 -19.49 29.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.74 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.38 -24.32 67.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.323 0.582 . . . . 0.0 109.909 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.6 m -142.11 36.86 1.56 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.705 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.778 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 60.5 p -125.68 153.36 43.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 110.681 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -149.57 171.8 16.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.3 m-20 55.02 30.97 15.17 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.686 0.617 . . . . 0.0 110.984 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -73.8 114.59 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.758 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 t -144.22 149.72 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.512 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.776 HD12 HD13 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -85.48 139.08 31.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 179.309 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.7 m -121.08 165.57 15.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.401 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 69.46 8.18 6.63 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.397 0.436 . . . . 0.0 111.34 178.012 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.48 23.92 27.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.721 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 101.88 23.4 9.3 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.057 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.6 mtp180 -109.89 -15.65 14.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.64 0.257 . . . . 0.0 110.524 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 31.3 m -130.3 126.99 38.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.615 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.485 ' HB2' HD22 ' A' ' 37' ' ' LEU . 58.0 tp -97.54 107.1 19.53 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.1 tmm_? -104.35 125.22 50.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.127 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.05 138.0 20.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.398 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.2 mt-10 -94.8 109.24 21.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.5 p -114.68 142.82 45.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.423 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.33 141.99 43.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.538 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' HB3' HG23 ' A' ' 31' ' ' VAL . 30.9 p-10 -88.09 -178.79 6.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.265 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.02 62.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.9 0.381 . . . . 0.0 111.715 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.26 -23.91 60.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 0.0 111.545 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.46 36.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.9 t-20 -95.99 144.82 25.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.414 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.6 m0 -76.18 123.0 25.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.934 0.397 . . . . 0.0 110.988 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 25' ' ' ASN . 5.2 t -119.47 124.2 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.437 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 m -78.05 107.73 10.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 t -110.83 149.64 30.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.317 0.58 . . . . 0.0 110.524 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 8.1 mt-10 -135.25 131.25 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.403 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.77 114.86 17.82 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.701 ' O ' HG23 ' A' ' 39' ' ' THR . 29.7 m-20 -67.87 109.42 3.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.139 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.776 HD13 HD12 ' A' ' 12' ' ' LEU . 25.3 mt -60.77 -40.08 91.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.259 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.562 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.6 OUTLIER -64.01 -4.61 3.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -105.17 -13.69 15.63 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.525 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.518 HG23 HG22 ' A' ' 39' ' ' THR . 2.6 pp -141.14 12.64 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.85 130.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.2 158.49 21.59 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.404 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -111.33 110.35 20.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.93 77.2 2.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.145 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 53.02 59.39 4.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.514 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.21 34.55 36.65 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.69 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -149.67 110.7 4.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.2 m-85 -59.09 137.09 58.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.074 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.441 HE21 ' HB2' ' A' ' 49' ' ' GLN . 2.7 tt0 -132.25 117.39 18.15 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.902 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -70.79 114.71 9.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.62 27.02 7.34 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.295 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.86 -52.53 1.5 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.247 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.7 tt0 73.69 142.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.496 0.665 . . . . 0.0 111.45 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.65 38.54 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.377 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.558 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.23 -27.21 47.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.579 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.2 p -62.63 -28.21 69.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.956 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.551 ' HG3' HG22 ' A' ' 58' ' ' THR . 2.3 pt-20 -70.39 -18.16 63.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.373 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.551 HG22 ' HG3' ' A' ' 57' ' ' GLU . 70.6 p -122.56 14.78 10.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.16 149.49 46.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -135.15 170.64 15.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.4 t70 43.17 57.64 3.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.475 0.484 . . . . 0.0 111.56 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.53 109.03 19.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.277 0.561 . . . . 0.0 112.077 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 126.22 42.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.324 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.632 ' CE1' HD12 ' A' ' 94' ' ' LEU . 19.4 t80 -91.35 136.73 32.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.277 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -118.36 83.03 19.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.367 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.538 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.6 Cg_endo -57.35 -43.64 50.17 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.345 2.697 . . . . 0.0 113.702 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mptt . . . . . 0 C--N 1.297 -1.692 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.669 179.771 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 120.59 0.233 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 44.7 Cg_endo -69.39 108.32 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.28 1.987 . . . . 0.0 111.196 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.53 142.48 40.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -112.02 126.62 55.35 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.487 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.83 141.45 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.35 168.6 21.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.757 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.7 mmt180 -86.07 115.15 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.579 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.87 131.85 45.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.875 0.369 . . . . 0.0 111.096 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.245 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.4 pt-20 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.9 p90 -144.65 128.74 17.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.87 118.9 16.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.485 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 8.8 p-10 -60.22 115.06 3.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.544 0.687 . . . . 0.0 112.561 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.548 ' HB2' HD23 ' A' ' 80' ' ' LEU . 28.9 mmt180 -115.3 175.11 5.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.33 146.09 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.459 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.6 p -136.22 143.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.905 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.463 ' HB3' HD21 ' A' ' 95' ' ' ASN . 23.0 m-80 -81.91 110.89 17.6 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.327 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.632 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.0 mt -79.26 0.88 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.4 m-80 -61.32 -16.29 44.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.426 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.4 -29.95 71.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 109.715 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 94' ' ' LEU . 15.0 mt -74.9 130.93 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.871 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.456 ' HG3' HG12 ' A' ' 105' ' ' VAL . 10.9 pt20 -122.9 167.9 12.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.64 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.2 t30 -112.25 121.91 46.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.306 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.1 t -113.15 94.13 2.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.341 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.43 26.32 12.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.104 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.79 19.38 8.25 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.885 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.7 ptp180 -130.55 135.03 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.22 0.51 . . . . 0.0 110.863 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.06 124.66 32.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.456 HG12 ' HG3' ' A' ' 98' ' ' GLN . 6.9 p -135.04 132.22 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -78.86 140.01 38.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.403 1.081 . . . . 0.0 112.921 -178.671 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.77 -23.92 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.57 -32.81 63.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.7 m -137.64 38.61 2.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.45 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 66.7 m -117.31 154.6 30.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.366 0.603 . . . . 0.0 112.033 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.35 164.44 34.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.596 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.505 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 85.3 m-20 54.93 32.64 18.37 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -74.72 113.4 11.95 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.4 147.85 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.88 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 37' ' ' LEU . 1.5 tp -85.37 132.69 34.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.243 0.544 . . . . 0.0 109.725 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.483 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.4 m -118.87 165.21 14.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.667 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.0 t-20 70.65 8.7 6.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.049 0.54 . . . . 0.0 111.659 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.0 13.5 52.69 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.696 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.487 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 109.85 19.65 8.07 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 56' ' ' THR . 18.5 mtp180 -105.92 -16.73 14.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.648 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 24.7 m -130.27 121.49 26.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.353 . . . . 0.0 111.78 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' CD2' HD11 ' A' ' 97' ' ' ILE . 63.1 tp -92.56 105.28 17.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 tmm_? -100.95 124.1 46.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.65 139.22 25.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.9 mt-10 -97.96 113.12 24.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.7 p -125.03 145.6 49.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.449 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -76.6 144.17 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.46 -171.8 2.89 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.188 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -32.17 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 111.74 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.03 -24.52 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.198 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.24 53.1 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -88.81 142.46 27.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.449 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.0 m0 -74.91 125.64 29.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 t -124.64 137.45 57.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.539 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.4 m -94.81 109.91 21.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 104' ' ' LEU . 9.7 t -111.38 151.92 27.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 110.672 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.22 132.35 35.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.91 116.34 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 11.0 m-20 -67.22 108.54 2.74 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.194 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.635 HD13 HD12 ' A' ' 12' ' ' LEU . 42.7 mt -59.34 -46.44 88.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -61.98 -4.84 1.78 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.895 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.534 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.72 -12.16 19.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.463 HG21 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.55 12.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.34 132.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.8 158.82 20.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.751 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -112.96 109.44 18.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.51 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -99.42 84.12 2.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.585 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.23 46.91 24.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.422 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.74 43.11 5.85 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.679 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -160.47 114.06 2.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.489 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.7 m-85 -59.91 138.49 57.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.045 0.45 . . . . 0.0 111.272 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -131.07 116.21 17.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -69.33 115.13 8.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.939 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.16 31.45 6.2 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.236 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.54 -51.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.176 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.9 tt0 72.84 146.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.218 0.607 . . . . 0.0 111.172 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.563 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.3 m-20 73.08 30.07 1.67 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.0 p90 -76.29 -31.43 58.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.555 HG22 ' HG2' ' A' ' 17' ' ' ARG . 20.0 p -62.45 -30.5 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.882 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.5 pt-20 -67.79 -15.59 63.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 110.477 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 57' ' ' GLU . 67.2 p -124.1 10.74 8.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.426 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.63 147.3 47.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.05 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.91 166.11 24.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.329 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.5 t70 49.08 56.03 8.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.022 0.439 . . . . 0.0 110.639 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.39 109.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.213 0.53 . . . . 0.0 111.603 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.91 123.72 41.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.812 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 94' ' ' LEU . 13.6 t80 -92.51 135.49 34.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.691 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 13.7 t60 -123.2 86.61 51.5 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 11.5 Cg_endo -57.06 -37.68 97.74 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 124.213 3.276 . . . . 0.0 114.839 -177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.463 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 56.4 Cg_endo -71.74 109.51 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.076 1.851 . . . . 0.0 112.087 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.69 141.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.71 126.28 55.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.504 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.65 139.83 53.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.035 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.626 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.95 167.72 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.959 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.2 mmt180 -84.78 115.59 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.589 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -100.61 126.57 47.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.82 0.343 . . . . 0.0 111.445 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.604 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.9 pt-20 . . . . . 0 C--O 1.22 -0.491 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.06 129.42 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -139.59 117.46 11.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 5.6 p-10 -63.3 122.89 17.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.302 0.572 . . . . 0.0 111.353 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.567 ' HB2' HD21 ' A' ' 80' ' ' LEU . 38.1 mmt180 -115.94 179.49 3.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.5 146.63 32.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.0 p -136.24 146.93 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-O 121.325 0.583 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.418 ' HB3' HD21 ' A' ' 95' ' ' ASN . 10.2 m120 -81.83 109.64 16.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.191 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.677 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.2 mt -80.14 4.45 17.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.384 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.463 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 17.4 m-80 -65.14 -10.82 33.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.271 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.38 -18.78 63.05 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 109.653 178.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.505 HD13 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.049 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -122.25 161.78 22.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.927 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -105.69 117.66 34.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.569 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 53.4 t -113.73 96.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.78 23.15 13.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.78 21.59 9.01 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.38 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.2 ptp180 -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 110.857 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.498 HD12 ' HB3' ' A' ' 33' ' ' SER . 3.0 mp -84.34 129.21 34.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 131.54 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.22 145.53 27.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.231 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 86.5 mm-40 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.468 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.3 p90 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -23.63 13.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.688 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.84 -34.52 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.671 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.7 m -134.96 36.2 3.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 70.4 m -119.95 153.43 35.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 111.458 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -150.02 169.75 20.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.578 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t-20 56.89 28.21 14.23 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.438 0.461 . . . . 0.0 110.692 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -74.45 113.78 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.87 153.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.801 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.696 HD13 HD12 ' A' ' 37' ' ' LEU . 1.1 tp -88.82 136.01 33.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.648 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 23.9 m -116.77 163.06 16.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.5 t-20 71.26 6.57 5.84 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.491 0.494 . . . . 0.0 111.554 177.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.4 22.95 27.9 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.634 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.548 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 103.26 21.07 10.28 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.154 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG2' HG23 ' A' ' 56' ' ' THR . 24.5 mtp180 -107.27 -16.42 14.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.514 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.648 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.0 m -131.72 130.48 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 111.624 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.484 ' HB2' HD23 ' A' ' 37' ' ' LEU . 54.4 tp -99.91 108.7 21.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -110.7 125.13 53.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.088 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.417 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -146.84 155.09 42.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.639 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -107.85 112.87 25.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.537 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 5.1 p -123.97 146.22 48.64 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.442 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -78.94 143.86 35.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -90.23 -171.99 3.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.9 -27.37 69.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 0.0 111.214 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -73.54 -20.88 60.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.555 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.42 10.22 54.11 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.6 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.8 t-20 -96.31 145.06 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.442 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 43.8 m0 -77.21 125.53 29.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.47 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 140.85 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 m -91.77 112.88 24.99 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.5 m -111.21 146.96 36.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 0.0 111.187 -178.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.6 mt-10 -133.39 139.72 46.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.06 113.85 8.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.632 ' O ' HG23 ' A' ' 39' ' ' THR . 20.8 m-20 -67.57 110.99 3.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.142 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.696 HD12 HD13 ' A' ' 12' ' ' LEU . 80.4 mt -61.23 -43.13 99.37 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.678 0.751 . . . . 0.0 109.778 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.5 -3.79 2.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.796 -179.902 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.32 -9.59 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.291 179.45 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.51 HG22 HG22 ' A' ' 39' ' ' THR . 2.5 pp -144.08 10.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 132.59 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -128.92 159.05 22.15 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.87 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.47 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.3 t30 -111.43 113.34 25.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -97.76 78.57 2.61 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.07 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 40.4 63.5 1.1 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.143 0.902 . . . . 0.0 112.48 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 83.87 38.21 10.69 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -159.27 115.86 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.705 -0.291 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.51 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 40.4 m-85 -60.96 138.0 58.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -128.06 115.23 18.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.483 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -73.98 113.68 11.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.12 41.27 3.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -112.53 -50.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.601 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 20.0 tt0 73.32 141.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.309 0.643 . . . . 0.0 112.033 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 5.8 t-20 68.58 38.56 2.28 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.078 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.51 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.2 p90 -77.13 -26.6 53.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.529 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HG2' ' A' ' 17' ' ' ARG . 38.4 p -64.14 -19.78 65.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.634 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HG3' HG22 ' A' ' 58' ' ' THR . 6.1 pt-20 -74.76 -19.68 60.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.148 0.499 . . . . 0.0 109.848 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 57' ' ' GLU . 72.6 p -123.34 18.12 9.8 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.936 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -133.56 150.35 51.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.88 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.733 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.82 172.86 12.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.209 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 3.5 t70 44.91 55.1 6.34 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.786 0.679 . . . . 0.0 110.997 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.411 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.03 109.13 17.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 112.033 -178.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -120.11 123.24 42.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.122 179.18 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.592 ' CE1' HD11 ' A' ' 94' ' ' LEU . 11.3 t80 -93.38 133.49 36.58 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.671 -178.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.417 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t60 -124.81 87.41 55.02 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.378 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.7 Cg_endo -55.99 -34.5 92.39 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.157 3.238 . . . . 0.0 114.14 -178.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.5 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.962 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 120.925 0.393 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.2 Cg_endo -73.63 109.2 2.81 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.524 2.149 . . . . 0.0 111.584 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.561 HD13 HH21 ' A' ' 77' ' ' ARG . 1.2 pp -134.43 142.25 41.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -113.41 123.97 51.33 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.284 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.561 HH21 HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.5 139.45 52.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.909 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.15 169.44 24.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.733 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.9 mmt85 -85.1 115.12 22.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.521 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -101.63 130.54 48.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.698 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.739 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.211 179.211 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.739 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 16.3 pt-20 . . . . . 0 C--O 1.22 -0.491 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.57 133.4 34.41 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.962 0.887 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -138.67 118.45 13.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.594 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.8 p-10 -66.57 118.42 10.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.542 0.686 . . . . 0.0 111.009 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.521 ' HB2' HD21 ' A' ' 80' ' ' LEU . 32.4 mmt180 -114.06 175.0 5.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.7 148.34 40.62 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.51 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.4 p -136.8 144.11 33.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.588 0.709 . . . . 0.0 111.402 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.43 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -78.62 107.48 11.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.576 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.592 HD11 ' CE1' ' A' ' 64' ' ' PHE . 7.6 mt -79.97 3.43 20.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.265 0.555 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -61.5 -19.08 61.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.915 178.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -64.67 -21.94 66.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.512 179.279 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 10.6 mt -85.38 126.96 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -125.09 151.65 45.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.206 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 1.5 t30 -92.17 117.67 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.586 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 58.3 t -113.65 97.13 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.595 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.75 25.9 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.719 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.54 20.74 9.84 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.527 178.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -131.09 140.76 50.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.931 0.366 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.473 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.7 mp -86.07 115.69 23.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.9 t -115.04 121.92 68.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.688 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -83.33 144.82 29.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.529 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.468 179.26 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.9 p90 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.79 -25.33 27.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.595 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -53.94 -32.48 53.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.068 0.461 . . . . 0.0 110.973 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.6 m -134.82 33.38 3.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.3 m -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 112.355 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -154.02 169.22 24.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.575 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.3 t30 56.13 32.43 20.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.423 0.63 . . . . 0.0 110.476 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.89 113.7 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.446 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 t -143.43 146.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -80.88 143.26 32.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.01 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 14' ' ' ASN . 8.8 m -128.5 163.31 25.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.416 ' N ' HG23 ' A' ' 13' ' ' THR . 0.2 OUTLIER 72.12 6.15 5.49 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.676 0.61 . . . . 0.0 111.472 178.437 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.6 23.8 17.66 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 100.55 14.95 30.94 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.193 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.614 ' HG2' HG22 ' A' ' 56' ' ' THR . 24.5 mtp180 -98.75 -16.76 18.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.82 -0.224 . . . . 0.0 111.034 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 31.7 m -133.27 129.97 38.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.0 111.873 -178.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.99 108.39 21.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 tmm_? -106.61 124.45 49.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.152 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.93 159.9 44.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 5.1 mt-10 -114.91 110.4 19.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' SER . 48.2 t -119.7 144.67 47.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.15 144.34 48.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.614 179.385 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.447 ' HB3' HG23 ' A' ' 31' ' ' VAL . 7.1 p30 -90.89 -171.74 3.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.29 68.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 0.0 111.7 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.19 -24.47 60.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.444 . . . . 0.0 111.123 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.18 -0.95 33.21 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.709 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.6 t30 -83.63 144.95 29.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -75.3 125.23 28.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.509 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 25' ' ' ASN . 4.2 t -120.73 130.62 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 m -80.22 106.94 12.61 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.598 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.4 m -110.08 135.75 50.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.434 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.4 mt-10 -126.87 131.95 51.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.539 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.78 116.21 19.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 39' ' ' THR . 16.2 m-20 -67.3 109.41 3.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.647 HD11 HD12 ' A' ' 12' ' ' LEU . 34.6 mt -59.59 -46.56 88.57 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.652 0.739 . . . . 0.0 110.052 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.642 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 10.3 t70 -63.79 -4.41 3.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.09 -11.67 20.32 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.571 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.482 HG21 HG21 ' A' ' 39' ' ' THR . 2.6 pp -145.82 13.41 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 121.066 0.46 . . . . 0.0 112.053 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.55 130.85 70.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.36 159.03 21.85 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.509 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -111.19 111.43 22.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -105.74 85.96 2.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.735 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 51.59 50.97 17.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.306 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.17 41.19 10.48 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.193 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -158.18 118.27 3.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.0 m-85 -63.71 136.37 57.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.119 0.485 . . . . 0.0 110.607 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -128.78 115.64 18.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.151 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -69.49 115.04 8.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.13 22.63 8.16 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.41 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -92.99 -54.37 1.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.382 -0.914 . . . . 0.0 114.002 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.5 tt0 72.59 139.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.188 0.595 . . . . 0.0 110.803 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.7 m120 74.1 39.78 0.48 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.615 0.721 . . . . 0.0 110.516 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.3 p90 -84.79 -26.33 27.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.282 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.614 HG22 ' HG2' ' A' ' 17' ' ' ARG . 71.2 p -68.4 -17.95 64.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.393 -179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 9.5 pt-20 -78.03 -13.13 59.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.235 0.54 . . . . 0.0 109.857 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.594 HG22 ' HG3' ' A' ' 57' ' ' GLU . 73.5 p -127.67 14.97 7.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.772 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.46 149.95 49.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.848 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.593 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -140.79 171.01 14.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.82 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.512 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 49.02 54.69 10.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.952 0.406 . . . . 0.0 110.393 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.66 108.91 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.306 0.574 . . . . 0.0 112.326 -177.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 123.63 40.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.551 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE1' HD13 ' A' ' 94' ' ' LEU . 15.3 t80 -91.67 133.28 35.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.781 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.82 87.94 43.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.143 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -36.8 79.67 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 123.633 2.889 . . . . 0.0 113.623 -178.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.745 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -72.23 110.48 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.762 2.308 . . . . 0.0 112.467 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.696 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.38 141.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.31 128.44 56.47 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.696 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.94 144.57 49.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.059 0.457 . . . . 0.0 110.21 178.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.37 170.05 18.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.93 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.593 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -85.91 115.71 23.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 90' ' ' ARG . 3.2 mp -98.52 127.15 44.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.096 0.474 . . . . 0.0 111.629 -178.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.806 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.9 pt-20 . . . . . 0 C--O 1.22 -0.479 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -147.19 132.98 18.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.847 0.832 . . . . 0.0 111.034 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -140.19 120.45 13.89 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.752 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.8 p-10 -67.13 116.4 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.184 0.516 . . . . 0.0 111.585 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.688 ' HB2' HD23 ' A' ' 80' ' ' LEU . 32.1 mmt180 -116.79 177.51 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.94 147.15 32.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.484 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -134.37 143.38 38.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.389 0.614 . . . . 0.0 110.86 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.495 ' HB3' HD21 ' A' ' 95' ' ' ASN . 31.1 m-80 -82.83 110.7 18.07 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.817 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD13 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -80.61 3.15 22.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.495 HD21 ' HB3' ' A' ' 93' ' ' ASN . 18.9 m-80 -61.47 -15.47 37.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.015 178.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -64.29 -23.5 67.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.139 178.703 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 94' ' ' LEU . 10.6 mt -84.54 124.19 39.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.005 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -119.65 163.79 16.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.714 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.9 t30 -106.22 120.19 41.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.061 0.458 . . . . 0.0 111.635 -178.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.513 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.8 t -112.61 94.14 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.349 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.22 23.43 13.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.929 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 20.85 7.95 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.549 178.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.8 ptp180 -130.29 138.96 50.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.996 0.398 . . . . 0.0 110.477 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.598 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 64.1 mt -85.47 117.48 24.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.461 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 61.7 t -121.56 123.45 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -85.89 145.75 27.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 77.5 mt-30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.584 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.749 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.06 -29.13 63.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.643 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.43 -33.55 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.168 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 58.7 m -134.13 35.83 3.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.749 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.7 p -117.21 155.88 28.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.443 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.31 167.62 28.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 55.01 32.53 18.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.63 0.581 . . . . 0.0 111.17 -179.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -77.08 113.76 15.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.56 151.61 19.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.298 -178.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.621 HD13 HD12 ' A' ' 37' ' ' LEU . 1.2 tp -87.58 142.37 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.434 HG21 ' N ' ' A' ' 14' ' ' ASN . 11.7 m -129.68 163.58 25.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.934 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.6 t-20 73.12 9.12 5.34 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.165 0.586 . . . . 0.0 111.441 178.258 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.8 25.92 16.33 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 94.92 22.18 23.86 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 56' ' ' THR . 32.9 mtp180 -106.32 -18.74 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.607 0.242 . . . . 0.0 110.641 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.4 m -128.37 125.64 39.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 111.846 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 37' ' ' LEU . 65.4 tp -96.17 106.73 18.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.853 178.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -103.02 124.28 48.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.1 142.71 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 111.114 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.3 mt-10 -98.94 110.03 22.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 6' ' ' SER . 15.4 t -122.36 139.52 53.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.32 144.07 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.892 179.85 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' HB3' HG22 ' A' ' 31' ' ' VAL . 8.9 p30 -91.42 -170.25 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -33.83 66.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -76.29 -22.53 54.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 110.992 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.95 33.82 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.694 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 m-80 -84.84 141.63 30.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.561 0.18 . . . . 0.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 54.0 m0 -72.51 124.33 24.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 111.149 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 25' ' ' ASN . 6.3 t -116.57 119.77 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.924 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.7 m -78.43 104.34 8.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.478 ' HB3' HD11 ' A' ' 104' ' ' LEU . 8.7 t -111.52 152.94 26.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.149 0.5 . . . . 0.0 110.425 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.0 mt-10 -134.74 131.37 37.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.486 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.584 HD12 HG12 ' A' ' 40' ' ' ILE . 12.0 tp -125.52 115.09 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.775 178.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.568 ' O ' HG21 ' A' ' 39' ' ' THR . 27.6 m-20 -66.28 109.13 2.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.914 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 12' ' ' LEU . 37.2 mt -60.8 -43.44 98.13 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.702 0.763 . . . . 0.0 109.499 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.35 -5.43 3.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.487 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.568 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.16 -14.59 17.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.426 -179.263 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.584 HG12 HD12 ' A' ' 35' ' ' LEU . 2.6 pp -144.51 13.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.52 130.3 70.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.52 160.89 21.62 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.221 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.18 112.8 24.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -109.52 87.16 2.44 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.299 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.27 58.62 5.07 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.6 179.046 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 69.72 42.53 70.81 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.992 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -158.3 117.17 3.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.492 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 57.4 m-85 -61.9 138.56 58.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.227 0.537 . . . . 0.0 110.79 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.45 116.68 20.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.303 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.24 115.02 8.95 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.3 28.75 7.04 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.15 -52.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.878 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 27.9 tt0 73.05 143.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 0.0 111.021 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.59 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 80.4 m-20 69.14 36.66 2.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.576 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -77.28 -30.08 54.14 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.606 HG22 ' HG2' ' A' ' 17' ' ' ARG . 21.4 p -63.9 -23.98 67.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.187 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.1 pt-20 -73.69 -15.75 61.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.211 0.529 . . . . 0.0 109.929 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.579 HG21 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -123.86 14.26 9.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.996 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.58 154.43 47.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.546 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.95 173.65 11.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.042 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.539 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 13.4 t70 50.45 53.31 13.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.11 0.481 . . . . 0.0 110.211 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.52 109.24 19.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.513 . . . . 0.0 111.947 -178.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.7 123.93 38.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.762 178.8 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.664 ' CE1' HD13 ' A' ' 94' ' ' LEU . 24.2 t80 -92.58 136.04 33.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.27 0.557 . . . . 0.0 112.01 -178.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -123.32 89.75 50.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.987 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 12.7 Cg_endo -60.63 -41.01 50.84 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.836 3.024 . . . . 0.0 114.519 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.671 0.272 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.552 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 52.7 Cg_endo -71.49 108.12 2.31 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.287 1.991 . . . . 0.0 111.331 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.449 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -131.87 140.74 47.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -112.41 125.0 53.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.085 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.487 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.58 139.56 52.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 179.285 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.16 169.55 23.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.792 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 5.0 mmt85 -84.96 115.67 22.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -101.26 132.11 46.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.56 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.785 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.055 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.785 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.0 pt-20 . . . . . 0 C--O 1.22 -0.475 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 85.4 m-85 -138.7 130.45 27.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.064 0.459 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -138.88 123.31 18.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.436 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.9 p-10 -61.81 116.89 5.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.357 0.598 . . . . 0.0 112.423 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.622 ' HB2' HD23 ' A' ' 80' ' ' LEU . 37.8 mmt180 -114.69 179.29 3.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -143.51 151.0 39.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.903 0.382 . . . . 0.0 110.023 -179.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.492 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.5 p -138.85 145.24 28.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.362 0.601 . . . . 0.0 110.918 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HB3' HD21 ' A' ' 95' ' ' ASN . 29.8 m-80 -82.66 109.95 17.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.572 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.664 HD13 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -81.0 3.72 22.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.011 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.552 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -63.11 -17.87 62.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.726 178.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -29.24 69.71 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.944 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -77.24 127.3 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.403 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -121.19 165.97 14.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -110.77 117.95 34.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.2 t -113.14 96.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.337 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.43 22.21 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.051 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 22.67 8.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.592 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -130.21 136.38 49.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.177 0.488 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -80.65 116.76 20.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 0.0 110.888 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.89 123.96 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.48 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -82.06 145.69 30.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.868 0.366 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.994 178.875 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.748 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -24.74 63.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.73 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.13 -33.64 67.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.106 0.479 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.2 m -133.42 36.86 3.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.362 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.5 p -117.28 155.82 28.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.162 0.505 . . . . 0.0 111.815 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.09 168.4 22.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.414 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.8 m-20 52.23 33.95 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.386 0.613 . . . . 0.0 110.701 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 66' ' ' PRO . . . -84.55 114.43 21.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.331 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 64' ' ' PHE . 5.9 m -147.27 177.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.22 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.497 HD11 HD12 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.9 139.42 39.66 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.055 179.247 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 14' ' ' ASN . 26.0 m -123.98 162.98 22.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.482 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.9 t-20 74.03 7.64 4.78 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.671 0.607 . . . . 0.0 111.009 178.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.28 22.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.95 21.54 13.71 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.924 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HG2' HG23 ' A' ' 56' ' ' THR . 32.9 mtp180 -104.42 -19.09 14.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.4 m -127.54 126.53 42.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.006 0.432 . . . . 0.0 111.362 -178.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.463 ' CD2' HD13 ' A' ' 97' ' ' ILE . 54.7 tp -95.56 106.82 18.95 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.584 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -106.21 123.9 48.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.887 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.93 137.35 19.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.381 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.9 mt-10 -96.24 109.27 21.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' SER . 16.5 t -118.57 143.7 46.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.963 0.411 . . . . 0.0 110.139 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 143.48 50.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.835 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.472 ' HB3' HG23 ' A' ' 31' ' ' VAL . 24.7 p-10 -85.28 -172.4 4.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.68 -21.5 65.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.47 -22.08 26.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.94 3.59 34.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.4 t30 -88.29 146.65 25.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -75.62 126.68 31.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 25' ' ' ASN . 10.8 t -124.46 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 m -80.06 109.02 14.11 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.458 ' HB2' HD13 ' A' ' 104' ' ' LEU . 1.9 m -109.78 139.04 45.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.909 0.385 . . . . 0.0 110.376 -178.563 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.49 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.69 130.99 42.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.91 117.6 21.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' HG23 ' A' ' 39' ' ' THR . 27.0 m-20 -68.59 107.72 3.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.967 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.497 HD12 HD11 ' A' ' 12' ' ' LEU . 24.6 mt -60.59 -40.27 91.13 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.592 0.71 . . . . 0.0 110.569 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.66 -5.28 2.56 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -104.93 -14.37 15.48 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.481 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 39' ' ' THR . 2.6 pp -141.28 11.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.53 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.32 156.74 21.01 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.802 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -110.19 108.71 18.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.283 0.563 . . . . 0.0 109.547 178.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -100.19 82.53 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.1 60.88 3.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.298 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.22 35.86 36.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.693 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -154.97 121.33 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.842 -0.21 . . . . 0.0 110.649 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.4 m-85 -65.41 138.46 58.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.084 0.468 . . . . 0.0 111.07 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -130.45 116.85 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.744 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.51 114.31 9.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.91 29.15 7.41 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.828 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.79 -53.06 1.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.43 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 2.4 tt0 76.96 142.54 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.303 0.641 . . . . 0.0 111.333 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.66 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.1 m-20 66.72 38.84 3.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.024 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.512 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.5 p90 -79.43 -28.1 41.71 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 17' ' ' ARG . 34.8 p -65.51 -25.17 67.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.601 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 5.4 pt-20 -72.59 -12.36 61.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.328 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.618 HG22 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -130.37 15.93 5.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.31 0.576 . . . . 0.0 109.805 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.15 144.53 51.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.642 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -134.46 173.08 12.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.285 -179.683 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.444 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER 46.01 54.38 8.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.684 0.615 . . . . 0.0 111.046 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.415 HG22 HD22 ' A' ' 12' ' ' LEU . 2.2 mt -89.33 112.77 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.778 -178.212 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.86 125.23 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.847 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.603 ' CE1' HD11 ' A' ' 94' ' ' LEU . 21.5 t80 -92.61 133.75 35.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.516 0.674 . . . . 0.0 112.435 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -117.57 87.71 26.8 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.525 177.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 Cg_endo -58.42 -42.95 50.25 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 124.067 3.178 . . . . 0.0 114.637 -177.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.633 -178.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.554 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.2 Cg_endo -72.38 109.63 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.327 2.018 . . . . 0.0 111.977 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.627 HD13 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -133.04 140.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.93 126.57 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.465 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.627 HH21 HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.01 143.45 49.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.184 179.028 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.65 168.01 22.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.99 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.642 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.5 mmt180 -86.32 114.66 23.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.603 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.0 mp -97.43 127.27 43.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 110.465 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.1 tmt_? . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.743 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.647 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.8 pt-20 . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.49 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.3 p90 -142.28 138.18 31.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.98 0.895 . . . . 0.0 111.488 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -133.86 111.24 10.32 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.221 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.2 p-10 -64.21 114.97 4.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.018 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -114.18 176.72 4.92 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -145.76 142.46 28.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.467 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.68 144.3 37.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.063 -178.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 95' ' ' ASN . 43.7 m-20 -81.35 111.66 17.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.696 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 64' ' ' PHE . 3.7 mt -81.35 3.72 23.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.681 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.554 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 25.6 m-80 -63.47 -18.03 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.102 0.477 . . . . 0.0 109.773 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -61.87 -28.15 69.29 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.798 178.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.0 mt -78.09 124.55 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.167 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -114.99 163.29 15.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.359 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.8 t30 -111.99 119.99 40.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.3 t -113.57 95.03 3.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.727 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.8 25.54 15.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.56 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.97 23.38 7.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.391 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.28 137.54 50.03 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 122.458 -0.436 . . . . 0.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.0 mp -90.31 128.74 36.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.607 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.3 p -142.44 132.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -79.07 145.32 33.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.961 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.333 -179.075 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 p90 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.735 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.17 -25.61 61.72 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.823 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.28 -20.8 63.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.089 -179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 32.3 m -145.14 35.51 1.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.835 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.735 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.7 p -116.61 158.13 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.49 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.1 ptp180 -152.58 167.82 27.62 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 m120 50.21 36.38 12.4 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.942 0.776 . . . . 0.0 111.566 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -78.07 113.7 16.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.04 148.89 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.804 HD13 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -82.59 147.68 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.3 m -132.12 163.05 29.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.07 4.5 5.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.615 0.572 . . . . 0.0 111.543 178.142 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.65 23.22 19.15 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 100.97 22.82 10.36 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.979 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.565 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.4 mtp180 -106.59 -18.28 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.671 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 67.7 m -132.37 128.03 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.927 0.394 . . . . 0.0 111.355 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.43 ' HB2' HD22 ' A' ' 37' ' ' LEU . 42.9 tp -96.72 108.77 21.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.021 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.5 tmm_? -103.28 124.37 48.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.9 138.47 20.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.568 0.223 . . . . 0.0 110.628 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 5.9 mt-10 -97.82 108.87 21.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 6' ' ' SER . 2.2 p -119.13 141.43 48.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.086 0.469 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.6 143.46 44.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -85.15 -173.61 4.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.414 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.84 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.797 0.332 . . . . 0.0 111.449 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 111.231 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.65 3.38 34.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.78 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.1 m-80 -89.75 144.18 26.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.335 0.112 . . . . 0.0 110.819 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -72.79 128.85 36.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 0.0 111.533 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.11 119.63 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.352 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 m -75.09 106.5 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.588 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.0 m -110.74 144.01 40.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.204 0.526 . . . . 0.0 111.259 -178.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.6 mt-10 -133.39 134.97 44.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.648 HD13 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -132.32 118.1 19.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.626 ' O ' HG21 ' A' ' 39' ' ' THR . 42.6 m-20 -67.42 107.43 2.43 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.391 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.804 HD11 HD13 ' A' ' 12' ' ' LEU . 46.9 mt -60.67 -42.46 97.11 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.598 0.713 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -63.8 -5.78 4.78 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.672 179.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.626 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.36 -10.61 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.207 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.648 HG12 HD13 ' A' ' 35' ' ' LEU . 2.5 pp -145.01 11.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.05 0.453 . . . . 0.0 112.07 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 131.16 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 157.16 20.76 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . 0.4 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 11.0 t30 -111.1 109.97 20.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.179 0.514 . . . . 0.0 110.38 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -89.63 78.8 6.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.261 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 39.63 48.63 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.003 0.921 . . . . 0.0 113.109 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 103.45 36.07 3.41 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.851 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -162.26 120.19 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.3 m-85 -65.29 135.1 54.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -125.78 117.14 22.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.638 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.61 114.05 10.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 29.04 5.93 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.398 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.3 -51.6 1.13 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.687 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 28.9 tt0 72.56 143.53 0.06 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.049 0.54 . . . . 0.0 110.915 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 73.0 31.31 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.652 0.781 . . . . 0.0 111.501 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.558 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.3 p90 -77.56 -27.7 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.565 HG21 ' HG2' ' A' ' 17' ' ' ARG . 28.9 p -64.92 -22.53 67.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.826 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.51 ' HG3' HG23 ' A' ' 58' ' ' THR . 3.9 pt-20 -73.86 -18.47 60.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.045 0.45 . . . . 0.0 110.087 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.51 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.9 p -123.34 15.46 9.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.194 0.521 . . . . 0.0 110.064 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.45 153.15 45.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.617 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -146.22 170.43 16.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.162 -179.942 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.457 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 4.3 t70 46.11 56.06 6.54 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.946 0.403 . . . . 0.0 110.436 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.46 HG21 HD23 ' A' ' 76' ' ' LEU . 2.6 mt -85.03 106.38 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.274 0.559 . . . . 0.0 111.333 -177.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.544 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.63 118.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.902 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CE1' HD11 ' A' ' 94' ' ' LEU . 8.5 t80 -92.82 127.53 38.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.0 110.924 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.41 86.31 38.77 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.424 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.681 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 14.6 Cg_endo -58.8 -38.3 89.42 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 123.414 2.743 . . . . 0.0 112.618 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.681 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.397 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.863 0.363 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.6 Cg_endo -73.61 108.38 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.776 2.318 . . . . 0.0 112.4 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.578 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.13 140.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.523 HD22 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.245 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.578 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.84 140.64 49.64 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.966 0.413 . . . . 0.0 109.898 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.64 169.11 25.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.579 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.1 mmt180 -85.87 114.56 22.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -99.65 121.4 41.17 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.296 0.57 . . . . 0.0 111.099 -178.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.022 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.764 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.2 pt-20 . . . . . 0 C--O 1.218 -0.605 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 44.4 p90 -138.47 140.7 39.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.682 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -137.79 120.64 16.43 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.421 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -64.05 112.93 3.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.482 0.658 . . . . 0.0 111.202 -179.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.728 ' HB2' HD21 ' A' ' 80' ' ' LEU . 26.5 mmt180 -114.93 172.6 6.95 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.309 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -140.74 151.44 44.48 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.476 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -136.1 142.05 39.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.398 0.618 . . . . 0.0 110.34 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 26.7 m-80 -81.24 109.19 15.52 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.569 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.586 HD11 ' CE1' ' A' ' 64' ' ' PHE . 8.2 mt -79.62 0.75 28.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.952 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.406 HD21 ' HB3' ' A' ' 93' ' ' ASN . 22.8 m-80 -62.82 -13.63 35.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 0.0 109.504 177.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -67.13 -24.38 65.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.046 178.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -83.11 125.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.147 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.62 159.37 24.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.6 t30 -102.87 117.95 35.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.46 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -111.97 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.824 0.345 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.54 21.64 12.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.27 25.87 5.91 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.53 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -132.66 139.68 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.094 0.447 . . . . 0.0 110.798 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 75.0 mt -87.12 116.31 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 110.534 178.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.6 p -125.6 130.42 72.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.865 0.364 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -86.71 143.66 27.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.292 179.844 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 p90 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -25.37 19.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.453 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.43 -34.41 57.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.578 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.4 m -136.04 36.03 2.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.348 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 67.6 m -116.05 157.1 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.336 0.589 . . . . 0.0 112.19 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.0 ptp180 -154.59 166.63 32.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.442 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 10.0 m120 51.92 38.18 22.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.648 0.593 . . . . 0.0 111.336 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -81.93 114.0 20.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.66 159.03 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.78 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -95.38 138.52 32.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.3 m -122.53 165.38 16.49 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.566 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 71.59 6.22 5.64 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.525 0.516 . . . . 0.0 111.484 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.06 21.4 23.11 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.535 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 99.75 24.27 10.11 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.786 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.569 ' HG2' HG23 ' A' ' 56' ' ' THR . 27.1 mtp180 -107.29 -18.47 13.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.797 0.332 . . . . 0.0 110.486 -179.25 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 61.3 m -129.13 126.06 38.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.073 0.463 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 97' ' ' ILE . 47.4 tp -94.42 107.62 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.274 178.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -101.69 124.5 47.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.873 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.26 140.4 22.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.586 0.232 . . . . 0.0 110.873 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' SER . 6.9 mt-10 -99.07 109.69 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -122.01 145.2 48.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.329 0.585 . . . . 0.0 111.209 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.4 144.43 40.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.401 179.109 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -89.05 -171.21 3.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.645 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.73 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.149 0.499 . . . . 0.0 111.234 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.47 -23.7 53.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.2 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.56 1.67 43.5 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.841 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.5 t-20 -85.2 145.34 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -77.07 126.56 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.895 0.379 . . . . 0.0 110.634 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.27 126.55 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.304 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.8 m -79.69 106.18 11.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.549 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 4.4 m -110.43 144.98 38.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.083 0.468 . . . . 0.0 111.446 -177.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 14.6 mt-10 -135.23 133.31 38.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.8 120.02 26.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.5 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -68.2 107.01 2.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.663 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 12' ' ' LEU . 53.5 mt -61.69 -45.66 93.06 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.461 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.74 -5.53 2.83 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -102.05 -11.5 18.84 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.21 -179.611 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.448 HD11 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -143.89 11.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.002 0.429 . . . . 0.0 112.113 -179.57 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 132.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.47 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.75 159.99 21.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.75 -179.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.78 111.74 23.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.23 0.538 . . . . 0.0 109.732 179.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -105.93 87.53 2.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.373 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.08 57.93 6.11 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.624 0.578 . . . . 0.0 112.161 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.582 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.78 42.85 52.6 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.982 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -161.07 120.67 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.505 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 59.0 m-85 -62.66 142.17 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.81 115.95 15.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -70.09 116.11 10.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.232 0.539 . . . . 0.0 109.681 178.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.06 31.45 6.58 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.752 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.45 -51.6 1.11 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.084 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 3.6 tt0 70.75 143.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.016 0.526 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 92.0 m-20 76.36 29.19 0.73 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.526 0.73 . . . . 0.0 111.189 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -77.5 -32.15 54.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.753 0.311 . . . . 0.0 110.591 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.569 HG23 ' HG2' ' A' ' 17' ' ' ARG . 24.6 p -63.56 -26.67 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.6 pt-20 -70.74 -16.37 62.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.728 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.56 HG21 ' HG3' ' A' ' 57' ' ' GLU . 60.2 p -124.31 12.97 8.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.268 0.556 . . . . 0.0 110.351 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.97 152.8 43.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.188 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.691 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.71 173.7 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 11.3 t70 47.92 52.88 12.3 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.321 0.581 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 mt -85.93 110.25 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.011 -177.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.1 120.5 33.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.232 178.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.595 ' CE1' HD13 ' A' ' 94' ' ' LEU . 10.0 t80 -91.58 128.47 37.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.78 -178.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 m170 -120.18 87.7 40.11 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.027 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 10.3 Cg_endo -56.29 -32.66 88.81 Favored 'Trans proline' 0 CA--C 1.505 -0.959 0 C-N-CA 124.086 3.191 . . . . 0.0 113.752 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.949 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 67.4 Cg_endo -74.84 108.66 2.76 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.65 2.233 . . . . 0.0 112.468 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.672 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.64 141.09 41.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.384 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -112.69 125.85 54.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.243 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.672 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.1 139.75 52.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.078 0.466 . . . . 0.0 110.302 178.828 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.72 168.34 27.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.13 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.691 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.3 mmt85 -85.29 116.0 23.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.582 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -101.1 133.43 45.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.717 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.717 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.647 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 93.2 m-85 -137.04 137.2 39.12 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.002 0.906 . . . . 0.0 111.672 -178.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -139.72 119.8 13.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.597 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 p-10 -66.11 114.05 4.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.573 ' HB2' HD21 ' A' ' 80' ' ' LEU . 35.6 mmt180 -114.44 172.31 7.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -137.02 149.07 47.23 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.505 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -134.5 146.46 30.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.306 0.574 . . . . 0.0 110.891 -179.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.459 ' HB3' HD21 ' A' ' 95' ' ' ASN . 34.8 m-80 -82.12 109.71 16.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.454 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.595 HD13 ' CE1' ' A' ' 64' ' ' PHE . 6.7 mt -80.05 2.46 23.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.932 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.459 HD21 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.45 -12.08 28.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.428 0.632 . . . . 0.0 109.842 178.004 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.606 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.7 -21.53 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.657 178.658 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 94' ' ' LEU . 10.7 mt -85.98 124.29 40.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.315 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -120.05 167.09 12.55 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.432 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.82 122.07 46.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.4 t -112.4 93.89 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.22 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.4 t30 58.29 25.65 12.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.064 179.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.5 18.78 8.77 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.849 178.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.9 ptp180 -130.78 136.46 48.74 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.314 -0.521 . . . . 0.0 110.42 179.258 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 69.8 mt -83.19 126.22 32.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -134.82 128.1 49.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.179 0.514 . . . . 0.0 111.265 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.83 146.06 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.811 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 24.4 mm-40 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.353 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.03 -23.73 21.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.798 -179.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.62 -30.39 68.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.866 179.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.4 m -133.57 32.49 3.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 66.4 m -121.33 156.62 32.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 112.248 -179.05 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -154.86 170.74 20.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.491 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 81.7 m-20 55.01 32.33 17.93 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.622 0.576 . . . . 0.0 110.918 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -77.23 113.76 15.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -142.5 151.76 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.692 HD12 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.35 135.43 33.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.129 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.426 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.8 m -121.8 167.14 13.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.892 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.7 t-20 70.15 6.87 5.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.993 0.517 . . . . 0.0 111.589 178.446 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 22.82 24.76 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 100.45 16.77 26.09 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.584 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 26.1 mtp180 -102.51 -15.51 16.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.677 0.275 . . . . 0.0 110.377 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 25.0 m -130.86 129.46 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.824 0.345 . . . . 0.0 111.714 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' HD22 ' A' ' 37' ' ' LEU . 57.3 tp -100.7 107.94 19.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.652 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -105.17 123.37 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 104' ' ' LEU . . . -149.14 146.88 27.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.491 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.7 mt-10 -103.3 109.55 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 6' ' ' SER . 6.5 p -115.13 140.84 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.339 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -74.72 143.2 44.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.341 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' HB3' HG23 ' A' ' 31' ' ' VAL . 24.4 p-10 -85.94 -177.16 6.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.661 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.64 -15.92 61.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -86.33 -24.34 25.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.42 7.21 30.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.541 -179.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 14.5 t-20 -97.27 147.33 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.453 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 51.9 m0 -78.06 128.84 34.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.962 0.411 . . . . 0.0 110.584 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 25' ' ' ASN . 6.5 t -123.58 128.64 74.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.45 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 m -82.32 110.38 17.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.832 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.1 t -111.57 148.72 32.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.545 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -135.43 132.12 37.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.648 HD11 HG12 ' A' ' 40' ' ' ILE . 13.7 tp -133.88 116.71 15.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.44 178.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.6 ' O ' HG22 ' A' ' 39' ' ' THR . 19.3 m-20 -68.01 107.77 2.82 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.649 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.692 HD11 HD12 ' A' ' 12' ' ' LEU . 53.7 mt -57.54 -45.21 85.34 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.475 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.54 ' HB2' ' HG1' ' A' ' 56' ' ' THR . 0.4 OUTLIER -62.94 -5.04 2.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.973 -179.42 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -103.09 -10.76 18.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.819 -179.846 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.97 12.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.867 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -128.29 131.68 68.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -127.41 159.31 21.38 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 -178.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -112.49 108.15 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 19.4 t-20 -101.16 79.91 2.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.855 0.36 . . . . 0.0 110.131 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 53.15 57.74 5.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.19 36.45 35.02 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.739 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 61.7 m-70 -147.89 111.88 5.14 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.027 0.131 . . . . 0.0 110.82 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.6 m-85 -60.96 132.01 52.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.864 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -124.78 117.44 24.18 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.161 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -72.76 114.7 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.54 26.78 7.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.106 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.26 -52.48 1.46 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.602 -179.136 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.3 tt0 75.12 145.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.377 0.671 . . . . 0.0 110.884 -178.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.9 m-20 72.92 29.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.406 0.683 . . . . 0.0 111.939 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -77.04 -27.57 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.54 ' HG1' ' HB2' ' A' ' 38' ' ' ASP . 14.9 p -66.95 -28.11 68.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -178.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.541 ' HG3' HG22 ' A' ' 58' ' ' THR . 4.6 pt-20 -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.541 HG22 ' HG3' ' A' ' 57' ' ' GLU . 69.9 p -121.79 13.74 10.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -122.84 151.89 41.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.903 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.52 167.9 21.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.449 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 1.6 t70 49.39 51.98 15.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.101 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.58 110.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.262 0.553 . . . . 0.0 111.384 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 122.18 32.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.643 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.634 ' CE1' HD11 ' A' ' 94' ' ' LEU . 9.4 t80 -91.97 131.84 36.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.358 0.599 . . . . 0.0 111.483 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -121.84 87.65 46.78 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.908 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.8 Cg_endo -58.61 -35.21 98.97 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.748 2.965 . . . . 0.0 113.872 -178.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.442 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.835 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.169 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.417 ' HA ' ' OE1' ' A' ' 73' ' ' GLN . 5.9 tp60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.2 Cg_endo -72.91 106.64 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.32 2.013 . . . . 0.0 112.044 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.753 HD12 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -136.14 141.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -111.64 127.99 55.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.202 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.753 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.84 143.72 49.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.21 166.57 25.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.839 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 5.4 mmt180 -85.63 115.06 23.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.575 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -99.15 124.68 44.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 111.596 -178.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.94 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.551 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -144.13 132.39 21.89 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.46 111.45 7.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.702 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.6 p-10 -64.42 114.08 4.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.551 ' HB2' HD22 ' A' ' 80' ' ' LEU . 39.2 mmt180 -115.67 177.39 4.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.08 178.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . 0.481 ' HB2' HD11 ' A' ' 75' ' ' ILE . 3.6 p30 -143.37 148.76 36.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -132.07 145.56 34.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.325 0.583 . . . . 0.0 110.746 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HB3' HD21 ' A' ' 95' ' ' ASN . 9.0 m120 -83.66 109.25 17.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.608 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.634 HD11 ' CE1' ' A' ' 64' ' ' PHE . 6.9 mt -78.06 1.78 19.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.441 -179.18 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 93' ' ' ASN . 20.3 m-80 -65.6 -8.73 21.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.073 0.463 . . . . 0.0 110.04 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -20.22 61.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.252 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.6 mt -84.64 122.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.384 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.2 t30 -105.15 119.32 38.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.112 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.569 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.02 93.87 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.394 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.25 25.77 14.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.565 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.5 8.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.482 178.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 11.8 ptp180 -130.05 138.64 50.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.14 0.47 . . . . 0.0 110.815 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.832 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.3 mt -85.92 114.26 22.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.79 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.405 HG22 ' HG3' ' A' ' 103' ' ' ARG . 40.0 t -123.0 123.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.546 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -79.37 145.65 33.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.695 0.622 . . . . 0.0 111.829 179.454 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.73 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -19.2 44.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.329 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.78 -27.65 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.106 0.479 . . . . 0.0 110.721 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -143.86 39.57 1.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.73 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.9 p -115.69 155.36 27.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.72 -178.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -151.6 164.77 36.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.799 179.444 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 52.85 35.29 18.53 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.715 0.634 . . . . 0.0 111.239 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -76.65 114.34 15.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.56 154.37 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.85 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.692 HD12 HD13 ' A' ' 37' ' ' LEU . 1.7 tp -91.08 141.15 29.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.4 m -126.25 162.73 24.78 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.2 t-20 72.5 9.39 5.73 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.688 0.618 . . . . 0.0 111.121 178.082 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.68 21.2 34.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.308 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 103.16 20.43 11.23 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.245 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.54 ' HG2' HG22 ' A' ' 56' ' ' THR . 21.5 mtp180 -103.75 -18.97 14.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.864 0.364 . . . . 0.0 110.42 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 49.3 m -129.45 128.44 42.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 112.114 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 37' ' ' LEU . 50.6 tp -97.79 110.19 22.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.1 tmm_? -114.37 124.69 52.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 -178.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.59 162.65 40.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.926 0.393 . . . . 0.0 111.053 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.8 mt-10 -110.47 114.61 28.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 6' ' ' SER . 30.3 t -131.53 142.74 50.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.732 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 145.32 49.28 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.24 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 31' ' ' VAL . 32.4 p-10 -85.92 -167.48 1.87 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.677 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.402 ' H ' ' HA ' ' A' ' 101' ' ' ASN . . . -63.41 -34.95 78.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.711 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.8 -23.73 61.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.883 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 10.03 35.43 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.0 t30 -91.0 145.35 24.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . 0.461 ' HB3' HH12 ' A' ' 8' ' ' ARG . 33.9 m0 -73.17 122.92 22.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.047 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 25' ' ' ASN . 4.9 t -126.1 143.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.7 m -99.76 111.28 23.62 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.541 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.3 143.97 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.204 0.526 . . . . 0.0 111.816 -178.461 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.6 mt-10 -130.37 133.33 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.348 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.586 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -131.07 117.74 19.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.176 178.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.667 ' O ' HG23 ' A' ' 39' ' ' THR . 29.9 m-20 -69.0 109.78 4.13 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.81 178.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.692 HD13 HD12 ' A' ' 12' ' ' LEU . 40.2 mt -60.61 -40.0 90.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.82 0.819 . . . . 0.0 109.927 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -63.16 -5.35 3.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.78 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.45 -12.53 15.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.478 -179.332 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.586 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.36 12.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.8 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.59 159.48 22.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.361 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.14 111.86 23.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.085 0.469 . . . . 0.0 109.827 179.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -104.48 87.97 2.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.9 t70 49.3 59.24 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.046 178.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.66 40.96 36.51 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.601 179.016 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . 0.414 ' N ' HD22 ' A' ' 80' ' ' LEU . 44.2 t-80 -159.22 127.14 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.484 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 52.6 m-85 -68.0 139.41 56.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -132.11 116.38 16.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.427 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -70.5 115.12 9.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 28.23 6.77 Favored Glycine 0 C--N 1.32 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.462 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.19 -50.37 1.46 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.513 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 9.7 tt0 73.92 143.46 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.208 0.603 . . . . 0.0 111.727 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.621 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 95.8 m-20 65.64 38.66 5.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.597 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.29 -30.0 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.608 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 17' ' ' ARG . 74.3 p -62.91 -23.05 67.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.75 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 8.0 pt-20 -72.3 -14.98 61.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.276 0.56 . . . . 0.0 110.031 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.569 HG23 ' HG3' ' A' ' 57' ' ' GLU . 68.0 p -126.19 7.02 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.119 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.9 144.76 49.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.33 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -138.27 172.32 13.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.053 -179.317 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.6 t70 48.15 50.96 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.071 0.462 . . . . 0.0 110.125 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.497 ' C ' ' HE ' ' A' ' 63' ' ' ARG . 2.8 mt -83.11 105.8 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.192 0.52 . . . . 0.0 110.691 -178.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.546 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -112.23 118.63 35.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.313 -179.848 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.624 ' CE1' HD11 ' A' ' 94' ' ' LEU . 6.2 t80 -93.04 124.69 37.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.863 0.363 . . . . 0.0 110.709 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -118.44 88.99 35.28 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.2 Cg_endo -57.65 -35.13 98.91 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 123.934 3.089 . . . . 0.0 113.538 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.431 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.73 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.766 0.317 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.7 Cg_endo -74.39 108.16 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.368 2.046 . . . . 0.0 111.897 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.612 HD12 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -131.7 141.53 45.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.46 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.517 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -112.73 123.43 50.29 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.271 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.612 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -119.85 138.16 53.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB2' HG22 ' A' ' 62' ' ' ILE . . . -155.9 166.39 33.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.397 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.5 mmt180 -85.83 114.5 22.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 90' ' ' ARG . 2.5 mp -99.42 129.22 45.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.056 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.743 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.5 pt-20 . . . . . 0 C--O 1.22 -0.499 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -134.61 139.36 45.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.655 0.741 . . . . 0.0 111.577 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -139.18 119.19 13.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.348 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -66.45 116.81 7.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.576 0.703 . . . . 0.0 112.557 -178.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.578 ' HB2' HD21 ' A' ' 80' ' ' LEU . 24.2 mmt180 -116.9 172.61 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -141.56 147.22 37.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.484 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.1 p -134.0 151.34 32.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.212 0.529 . . . . 0.0 111.126 -178.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.444 ' HB3' HD21 ' A' ' 95' ' ' ASN . 37.1 m-80 -83.34 112.5 19.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.887 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.624 HD11 ' CE1' ' A' ' 64' ' ' PHE . 6.3 mt -82.33 3.44 27.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.916 0.389 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.444 HD21 ' HB3' ' A' ' 93' ' ' ASN . 20.7 m-80 -65.2 -16.78 63.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.52 67.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.127 179.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.463 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.9 mt -82.69 126.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.22 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.432 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 49.6 tt0 -120.29 162.94 18.58 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -106.55 119.96 40.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.023 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.7 t -109.67 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.481 179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.402 ' HA ' ' H ' ' A' ' 26' ' ' ALA . 63.4 t30 60.06 21.69 10.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.026 179.044 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.44 17.57 7.04 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.995 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.29 146.05 51.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.084 0.442 . . . . 0.0 110.856 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 73.4 mt -89.5 119.04 29.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.102 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 57.7 t -121.22 123.4 69.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.624 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.12 145.14 32.53 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.469 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.333 179.88 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 121.059 0.457 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.26 -26.13 37.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.896 -178.356 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.56 -32.09 64.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.0 m -132.76 32.94 3.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 62.0 m -115.08 152.76 31.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 111.515 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -145.78 163.93 33.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.022 -179.312 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.437 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 9.9 m120 52.66 33.28 13.43 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.727 0.642 . . . . 0.0 111.761 179.14 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -74.89 114.01 12.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.4 t -141.56 152.36 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.057 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.779 HD11 HD13 ' A' ' 37' ' ' LEU . 1.1 tp -87.41 140.71 29.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 14' ' ' ASN . 12.2 m -126.48 163.7 22.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.034 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.7 t-20 73.23 5.69 5.11 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.687 0.617 . . . . 0.0 111.368 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.85 23.4 15.51 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.52 21.63 16.41 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.942 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HG2' HG23 ' A' ' 56' ' ' THR . 29.8 mtp180 -104.12 -19.1 14.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.652 0.263 . . . . 0.0 110.811 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.7 m -129.26 126.94 40.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.955 0.407 . . . . 0.0 111.703 -178.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.484 ' HB2' HD22 ' A' ' 37' ' ' LEU . 58.8 tp -94.68 105.67 17.62 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.014 178.176 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.437 ' NH2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 tmm_? -101.97 123.68 46.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -147.32 144.13 28.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 111.137 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HG2' HG21 ' A' ' 32' ' ' THR . 3.9 mt-10 -105.17 113.02 26.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 45.4 t -127.17 147.63 50.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.199 0.523 . . . . 0.0 111.674 -178.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.72 145.67 40.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.426 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB3' HG23 ' A' ' 31' ' ' VAL . 7.7 p30 -93.05 -173.43 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.521 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -34.38 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 112.204 -178.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.26 -20.29 61.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 4.16 54.67 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.926 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -87.59 143.69 27.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -73.86 122.23 22.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 25' ' ' ASN . 8.2 t -120.52 146.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.616 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.427 HG21 ' HG2' ' A' ' 22' ' ' GLU . 37.0 m -114.86 110.15 19.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.899 0.38 . . . . 0.0 110.191 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -118.29 164.18 15.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 112.102 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.404 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.5 mt-10 -136.69 140.04 42.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.229 -179.389 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.01 113.88 13.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.291 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' THR . 26.8 m-20 -66.65 108.65 2.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 12' ' ' LEU . 54.1 mt -59.92 -47.39 85.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.212 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.592 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -64.2 -4.54 3.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.928 -179.447 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.14 -14.72 20.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.908 179.731 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.476 HG21 HG21 ' A' ' 39' ' ' THR . 2.6 pp -143.96 13.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 3.0 mt -126.4 131.42 71.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.15 160.1 19.75 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.837 -178.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.36 104.41 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -92.77 75.48 4.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.791 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 48.93 65.8 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.023 178.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.5 34.79 34.72 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.778 178.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -159.33 120.61 3.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.519 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 61.9 m-85 -63.25 143.54 57.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 111.271 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -133.82 117.4 16.81 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -72.7 114.58 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 40.58 3.08 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.98 -49.23 0.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.281 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.592 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.2 tt0 71.52 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.328 0.651 . . . . 0.0 111.582 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 91.5 m-20 71.06 35.19 1.68 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.523 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.575 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.79 -32.08 40.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 17' ' ' ARG . 23.8 p -63.47 -30.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.523 -179.159 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 20.2 pt-20 -67.19 -17.0 64.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.075 0.464 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.524 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.7 p -122.56 12.71 10.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.69 149.95 48.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.47 169.09 18.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.45 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 49.05 57.93 5.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 76' ' ' LEU . 2.6 mt -88.06 111.59 22.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.371 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.574 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -116.66 118.83 33.66 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.882 179.624 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.663 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.8 t80 -92.77 128.06 38.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 178.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 4.0 t-160 -117.19 84.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 19.5 Cg_endo -58.95 -44.9 31.71 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.613 2.875 . . . . 0.0 114.488 -177.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.845 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.58 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.3 Cg_endo -75.25 111.46 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.447 2.098 . . . . 0.0 111.766 178.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.466 HD12 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -132.48 140.47 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.06 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.65 121.15 43.28 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.243 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.574 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.85 140.12 50.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.904 0.383 . . . . 0.0 110.201 179.261 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.83 169.36 23.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.6 mmt180 -85.12 115.15 22.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.502 HD23 ' HB2' ' A' ' 90' ' ' ARG . 4.2 mp -100.9 130.82 46.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 -178.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.02 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.6 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -134.58 141.25 46.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.808 0.813 . . . . 0.0 111.725 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -140.18 112.71 7.92 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -68.28 115.49 7.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.376 0.608 . . . . 0.0 111.169 -179.064 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.502 ' HB2' HD23 ' A' ' 80' ' ' LEU . 34.9 mmt180 -116.16 177.28 4.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.414 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -140.32 148.73 41.81 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.519 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.8 p -132.74 148.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.549 -179.473 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -86.11 109.01 18.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.995 -179.064 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.663 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.2 mt -78.98 4.04 15.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 93' ' ' ASN . 15.4 m-80 -64.63 -12.58 47.31 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -16.69 63.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.183 179.096 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 94' ' ' LEU . 10.8 mt -88.28 122.59 40.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.618 0.723 . . . . 0.0 111.362 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -110.71 166.42 11.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.592 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.7 t30 -114.94 115.71 27.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.566 178.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 56.2 t -112.69 101.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.36 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t30 60.33 21.68 11.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.006 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.58 11.27 27.32 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.597 178.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.4 ptp180 -118.16 141.48 48.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 0.0 110.506 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' A' ' 21' ' ' ALA . 79.1 mt -89.63 126.45 35.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.769 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.8 p -134.41 134.67 54.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.248 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -88.79 144.86 25.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.815 0.697 . . . . 0.0 111.506 178.885 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 121.032 0.444 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.647 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.61 -24.07 45.28 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.384 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.54 -31.67 64.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.4 m -144.85 42.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.647 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.3 p -115.54 149.4 38.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.022 0.439 . . . . 0.0 111.253 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.15 166.19 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.1 m-20 52.05 33.25 11.65 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.677 0.61 . . . . 0.0 111.734 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -77.05 114.54 15.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.086 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.18 155.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.891 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.824 HD13 HD13 ' A' ' 37' ' ' LEU . 1.4 tp -91.66 143.31 26.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.0 110.135 179.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.9 m -129.67 165.23 22.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.765 -179.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.1 t-20 72.06 9.82 6.05 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.512 0.507 . . . . 0.0 110.947 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 8.8 57.99 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 112.36 25.75 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.099 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HG2' HG23 ' A' ' 56' ' ' THR . 21.6 mtp180 -108.45 -18.56 13.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 0.0 110.521 -178.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.48 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 46.7 m -127.68 126.57 42.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -178.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' CD2' HD12 ' A' ' 97' ' ' ILE . 45.6 tp -98.01 108.84 21.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.158 178.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.521 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -104.14 122.52 45.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HB3' HD13 ' A' ' 104' ' ' LEU . . . -146.89 137.61 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.743 0.306 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.6 mt-10 -98.25 110.84 23.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.761 0.315 . . . . 0.0 110.285 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' SER . 49.6 t -125.83 147.88 49.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.853 0.359 . . . . 0.0 110.814 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.2 145.72 43.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.274 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -85.58 -168.56 2.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.724 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -32.99 74.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.163 0.506 . . . . 0.0 111.289 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.31 -24.31 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.32 4.25 40.88 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.398 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 m-80 -83.78 139.06 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.262 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.8 m0 -72.51 121.95 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.984 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.0 t -123.26 150.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -99.32 109.63 22.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.592 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.5 m -109.38 139.44 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.256 0.55 . . . . 0.0 111.43 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.521 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.0 mt-10 -130.39 131.79 45.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.041 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.507 HD11 HG12 ' A' ' 40' ' ' ILE . 13.3 tp -131.96 124.01 28.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 178.603 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.533 ' O ' HG21 ' A' ' 39' ' ' THR . 39.0 m-20 -72.25 108.64 5.5 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.123 179.179 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.824 HD13 HD13 ' A' ' 12' ' ' LEU . 34.8 mt -61.1 -41.24 96.31 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.618 0.723 . . . . 0.0 109.718 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.36 -5.91 4.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.471 179.639 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -103.91 -12.05 17.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.401 -179.231 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.507 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.0 12.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.536 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.53 132.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.34 157.32 21.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.567 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -110.88 110.31 20.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -103.17 87.05 2.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 48.34 54.8 9.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.551 179.201 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.67 41.99 12.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.997 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -158.72 118.26 3.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 53.3 m-85 -64.56 137.29 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.78 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.433 HE21 ' HB2' ' A' ' 49' ' ' GLN . 1.8 tt0 -131.26 115.83 16.82 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.281 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -69.13 116.08 9.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.439 178.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.7 33.28 5.37 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.168 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -104.1 -52.66 0.88 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.15 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 35.4 tt0 73.65 142.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 111.213 -179.254 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.545 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.2 m-20 71.92 34.99 1.41 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 111.602 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.4 p90 -78.84 -27.91 44.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 17' ' ' ARG . 62.1 p -66.31 -24.0 66.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.615 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.591 ' HG3' HG22 ' A' ' 58' ' ' THR . 4.3 pt-20 -74.91 -11.27 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -129.29 14.97 6.16 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.443 0.639 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.4 153.48 47.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.33 171.57 14.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.204 -179.673 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.571 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 12.7 t70 46.51 55.11 7.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.401 0.438 . . . . 0.0 110.541 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.459 HG22 HD22 ' A' ' 76' ' ' LEU . 2.6 mt -84.72 107.35 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.261 0.553 . . . . 0.0 111.664 -178.026 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.546 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -114.34 118.2 33.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.23 179.728 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.628 ' CE1' HD11 ' A' ' 94' ' ' LEU . 8.1 t80 -92.99 128.76 38.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 111.302 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -120.49 87.86 41.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.744 177.794 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.643 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -58.86 -35.73 98.13 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.678 2.919 . . . . 0.0 112.693 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.643 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.437 178.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.516 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 66.2 Cg_endo -75.46 108.74 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.82 2.347 . . . . 0.0 112.032 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.658 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.8 141.19 43.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.254 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -112.59 123.87 51.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.395 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.658 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.28 139.21 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.26 166.63 32.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.426 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.627 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.0 mmt85 -85.9 115.04 23.28 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.616 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.8 mp -98.73 126.48 44.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.248 -178.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.067 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 8.4 pt-20 . . . . . 0 C--O 1.221 -0.444 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -146.78 132.3 18.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 0.0 110.623 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -133.68 119.61 19.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.024 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.8 p-10 -65.65 112.02 3.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 111.454 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' ARG . . . . . 0.616 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -115.08 171.29 7.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.188 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -141.42 147.01 37.27 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.474 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.7 p -132.82 147.95 31.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.902 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.448 ' HB3' HD21 ' A' ' 95' ' ' ASN . 41.6 m-80 -83.2 111.94 19.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.628 HD11 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.35 3.3 21.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.448 HD21 ' HB3' ' A' ' 93' ' ' ASN . 31.3 m-80 -63.23 -16.5 60.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.089 0.471 . . . . 0.0 109.863 178.514 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -28.68 70.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.553 0.692 . . . . 0.0 109.978 178.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 94' ' ' LEU . 13.5 mt -76.44 123.65 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.212 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -116.06 164.02 15.07 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -111.31 118.26 35.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.133 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.9 t -109.85 94.44 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.19 25.16 13.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.045 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.13 17.22 9.67 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.887 177.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.1 ptp180 -130.37 135.99 48.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.133 0.467 . . . . 0.0 110.612 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . 0.592 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 71.1 mt -84.48 125.04 32.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -133.66 132.32 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.21 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.41 144.82 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.371 179.015 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.541 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 12.9 m -158.3 179.84 8.78 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -64.9 -33.34 75.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.696 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.85 -27.87 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.675 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -33.29 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.488 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.3 m -134.94 37.32 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.696 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 69.6 p -119.43 152.37 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.492 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.527 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.2 ptp180 -151.42 168.93 23.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.587 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.0 t30 56.2 30.87 17.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.662 0.744 . . . . 0.0 110.135 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -78.34 113.52 16.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.178 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.96 146.47 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.552 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.4 tp -82.37 141.98 32.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -131.9 165.93 22.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.986 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.524 HD21 ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER 71.42 7.17 5.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.574 . . . . 0.0 111.584 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.4 9.9 Favored Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 91.75 18.66 43.49 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.946 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HG2' HG23 ' A' ' 56' ' ' THR . 28.3 mtp180 -103.43 -16.92 15.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.729 0.3 . . . . 0.0 110.3 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -128.58 129.39 45.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.413 ' HB2' HD21 ' A' ' 37' ' ' LEU . 52.8 tp -100.71 104.98 16.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.358 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.4 tmm_? -104.35 124.73 49.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.414 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.92 153.25 32.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.587 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 32.7 mt-10 -103.4 110.34 22.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.6 p -119.74 139.6 52.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.087 0.47 . . . . 0.0 111.415 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.538 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.49 144.11 44.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.222 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -89.25 -171.57 3.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.279 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.2 -21.53 65.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.64 -19.0 29.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.285 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.11 0.62 41.46 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.538 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 66.1 m-20 -80.83 136.3 36.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.422 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 49.5 m0 -77.98 119.48 21.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.005 0.431 . . . . 0.0 110.077 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.32 132.31 65.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -83.08 107.89 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.654 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 21.0 m -110.89 146.1 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.8 mt-10 -133.15 130.68 39.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.392 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.554 HD12 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -123.04 120.09 32.27 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.246 0.546 . . . . 0.0 110.101 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.647 ' O ' HG22 ' A' ' 39' ' ' THR . 9.3 m-20 -69.32 106.23 2.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.623 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.48 HD13 HD13 ' A' ' 12' ' ' LEU . 21.2 mt -62.71 -40.23 96.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.929 0.871 . . . . 0.0 109.75 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.6 p-10 -64.27 -5.04 4.33 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.639 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.647 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.58 -16.14 16.18 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.556 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.554 HG12 HD12 ' A' ' 35' ' ' LEU . 2.5 pp -142.08 14.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.29 130.75 70.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.97 157.54 21.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.335 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.3 t30 -111.97 113.94 26.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.044 0.45 . . . . 0.0 110.527 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -101.51 81.44 2.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.639 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.0 m-20 49.93 47.92 22.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.384 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 90.64 39.09 5.98 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.863 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -158.09 113.57 2.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 58.0 m-85 -60.27 136.64 58.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 0.0 111.007 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -127.22 114.49 17.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.168 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -71.22 114.53 9.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.8 28.64 6.89 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.705 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -98.5 -52.08 1.36 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.927 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 3.1 tt0 72.85 141.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.134 0.573 . . . . 0.0 111.213 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.65 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 94.6 m-20 70.48 37.87 1.43 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.544 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.7 p90 -81.4 -27.26 34.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.577 HG23 ' HG2' ' A' ' 17' ' ' ARG . 11.9 p -65.16 -19.54 66.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.699 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 8.3 pt-20 -77.32 -14.82 59.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.197 0.522 . . . . 0.0 110.136 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.588 HG21 ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -125.89 12.89 7.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.664 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.27 145.71 47.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.554 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.451 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -139.3 169.22 18.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.476 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.439 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.2 t70 47.39 54.57 9.39 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.353 0.408 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.34 114.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 112.153 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.449 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -128.45 121.97 30.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.124 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.685 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.4 t80 -92.04 134.73 34.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.494 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 3.3 t-160 -123.22 85.44 51.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 25.8 Cg_endo -62.22 -45.13 16.39 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 123.622 2.882 . . . . 0.0 113.89 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.43 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -121.95 81.57 1.84 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.9 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.494 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 3.3 tt0 -65.21 111.78 3.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.404 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.11 -142.03 8.14 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 124.493 1.121 . . . . 0.0 113.94 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -6.88 58.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.082 0.468 . . . . 0.0 110.651 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.78 -20.21 33.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.63 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.92 42.5 24.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.564 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -98.57 120.72 58.5 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.016 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 64.2 Cg_endo -74.04 106.58 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.465 2.11 . . . . 0.0 111.678 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.489 HD11 HH21 ' A' ' 77' ' ' ARG . 0.8 OUTLIER -132.35 140.92 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.975 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -114.15 124.02 51.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.148 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.489 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.08 142.71 48.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 110.434 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.56 167.66 26.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.709 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.555 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.71 115.13 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.672 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.0 mp -97.87 121.44 39.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.462 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.585 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.549 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.07 174.26 6.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.5 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 71.7 m -61.36 -24.56 66.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -73.11 -29.15 62.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.56 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 34.38 2.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.256 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.626 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 11.1 pt-20 -112.08 -168.18 1.28 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -147.73 134.59 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.465 0.65 . . . . 0.0 111.492 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -140.72 118.82 11.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.052 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.555 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 p-10 -64.37 114.73 4.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.469 0.652 . . . . 0.0 111.659 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.672 ' HB2' HD22 ' A' ' 80' ' ' LEU . 30.0 mmt180 -115.84 174.21 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.413 ' HB2' HD13 ' A' ' 75' ' ' ILE . 4.6 p-10 -144.04 144.93 31.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -129.45 145.66 35.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.393 0.616 . . . . 0.0 111.082 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.42 ' HB3' HD21 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -81.57 107.17 14.11 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.61 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.685 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.3 mt -78.75 4.2 14.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.355 . . . . 0.0 110.995 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.42 HD21 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.34 -18.99 64.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 109.814 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.73 -24.46 67.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.003 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.55 HD11 ' HB3' ' A' ' 94' ' ' LEU . 14.7 mt -81.28 124.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.541 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 22.7 mt-30 -121.0 167.5 12.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.946 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.583 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.0 t30 -109.71 121.26 44.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.534 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.8 t -112.77 94.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.24 22.98 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.827 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.26 22.15 6.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.082 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 14.9 ptp180 -132.39 143.01 49.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.374 0.587 . . . . 0.0 111.15 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.654 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 67.3 mt -92.22 122.69 34.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.25 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.9 p -138.91 135.86 42.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -82.29 146.27 29.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.198 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.258 -179.799 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.473 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 16.6 tpp . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.436 ' H ' ' HG3' ' A' ' 1' ' ' MET . 17.5 m -132.83 174.86 9.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -56.16 -37.97 70.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.203 0.314 . . . . 0.0 110.635 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.542 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.2 -25.72 24.42 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.473 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 4.1 t70 -56.91 -33.76 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.24 0.543 . . . . 0.0 110.676 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 22.5 m -130.04 30.51 4.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.367 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 68.7 m -115.99 154.76 29.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 0.0 112.103 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.45 171.76 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.322 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.547 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.6 t-20 55.38 31.12 16.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.559 0.537 . . . . 0.0 110.694 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 66' ' ' PRO . . . -78.51 113.86 16.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.425 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.48 151.34 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.825 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.837 HD12 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -90.78 134.52 34.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.2 m -120.69 164.39 16.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.419 ' N ' HG22 ' A' ' 13' ' ' THR . 0.2 OUTLIER 73.63 5.07 4.87 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.69 0.619 . . . . 0.0 111.342 177.741 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.94 13.89 41.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.478 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 109.68 20.68 7.56 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG2' HG21 ' A' ' 56' ' ' THR . 22.5 mtp180 -104.27 -21.34 13.54 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.517 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 8.9 m -123.75 131.14 53.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.066 0.46 . . . . 0.0 111.723 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.445 ' HB2' HD22 ' A' ' 37' ' ' LEU . 58.3 tp -103.62 105.51 15.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.263 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.503 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.6 tmm_? -103.81 124.35 48.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.219 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.493 ' HB3' HD12 ' A' ' 104' ' ' LEU . . . -147.27 150.25 34.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.801 0.334 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.547 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 11.4 mt-10 -107.35 112.41 25.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.597 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.7 t -125.67 147.9 49.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.232 0.539 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.89 145.17 40.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 178.868 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.476 ' HB3' HG22 ' A' ' 31' ' ' VAL . 31.5 p-10 -87.8 -171.38 3.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.07 68.32 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.45 -24.55 50.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.431 . . . . 0.0 110.923 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.89 11.51 32.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.2 t30 -94.77 146.12 24.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -72.87 125.64 28.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.654 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.476 HG22 ' HB3' ' A' ' 25' ' ' ASN . 4.0 t -129.33 126.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -81.49 122.94 28.17 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.806 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 1.4 t -125.21 151.33 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.688 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.503 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.02 136.46 40.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD11 HG12 ' A' ' 40' ' ' ILE . 13.1 tp -130.63 126.11 35.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' O ' HG22 ' A' ' 39' ' ' THR . 5.5 m-20 -72.33 107.02 4.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.837 HD11 HD12 ' A' ' 12' ' ' LEU . 47.7 mt -63.61 -41.4 98.31 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.874 0.845 . . . . 0.0 108.97 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.577 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -62.59 -4.77 2.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.527 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.514 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -104.54 -15.76 15.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.55 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.499 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.6 pp -140.54 13.25 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.26 130.78 70.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.42 160.52 22.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.298 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -111.81 116.83 31.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 110.173 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -102.93 84.12 2.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.916 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.472 ' HB2' ' H ' ' A' ' 83' ' ' CYS . 3.5 p30 46.01 43.15 10.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.322 1.049 . . . . 0.0 112.953 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.559 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 98.82 37.13 4.28 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.911 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -157.3 117.06 3.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.47 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -60.85 136.51 58.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -129.29 114.26 16.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -67.84 115.32 7.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 39.71 3.52 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.993 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.513 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -109.83 -55.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.591 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.577 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.0 tt0 76.02 138.48 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.564 0.746 . . . . 0.0 111.875 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.4 t30 68.29 40.17 2.14 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.93 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 11.2 p90 -76.19 -30.37 58.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.758 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.576 HG21 ' HG2' ' A' ' 17' ' ' ARG . 42.5 p -61.85 -21.45 64.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.018 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 58' ' ' THR . 1.1 pt-20 -72.16 -15.68 61.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.336 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.597 HG22 ' HG3' ' A' ' 57' ' ' GLU . 60.7 p -125.42 2.79 7.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -115.92 149.31 38.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.24 172.43 12.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.28 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 48.78 52.31 14.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.068 0.461 . . . . 0.0 110.202 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -86.44 109.18 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.45 0.643 . . . . 0.0 111.754 -177.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.432 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.9 122.96 39.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.62 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.638 ' CE1' HD11 ' A' ' 94' ' ' LEU . 10.2 t80 -91.6 135.11 34.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.736 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.5 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 2.1 t60 -123.66 87.07 52.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.083 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.718 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 9.4 Cg_endo -58.13 -38.27 92.11 Favored 'Trans proline' 0 CA--C 1.514 -0.515 0 C-N-CA 123.725 2.95 . . . . 0.0 114.836 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.718 ' HD3' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.2 85.13 2.36 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.03 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.5 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 20.8 tt0 -67.2 116.4 7.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.329 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.26 -148.89 8.13 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 124.305 1.003 . . . . 0.0 113.239 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.77 -2.72 55.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.455 0.645 . . . . 0.0 109.57 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.42 -22.51 51.43 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.831 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 57.22 42.5 25.29 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 124.104 0.877 . . . . 0.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -102.12 119.49 56.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.9 Cg_endo -72.89 109.68 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.52 2.146 . . . . 0.0 112.017 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.652 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 141.1 43.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.357 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.521 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -112.68 127.23 56.06 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.976 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.652 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.91 141.81 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.965 0.412 . . . . 0.0 109.904 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.09 169.42 23.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.06 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.545 ' HG2' ' CB ' ' A' ' 61' ' ' ASP . 4.2 mmt180 -85.97 115.19 23.43 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 90' ' ' ARG . 3.0 mp -101.86 134.64 44.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.09 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.762 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.2 135.72 39.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.79 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.508 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 3.9 m-20 -90.96 172.27 8.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.756 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.472 ' H ' ' HB2' ' A' ' 45' ' ' ASP . 29.9 t -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.22 0.533 . . . . 0.0 110.743 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -72.32 -26.35 61.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.035 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.68 40.07 2.81 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.762 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.1 pt-20 -125.98 -165.45 1.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -140.66 136.08 32.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.946 0.879 . . . . 0.0 111.725 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -139.8 125.54 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.102 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.488 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 3.7 p-10 -67.53 114.59 6.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 112.078 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.638 ' HB2' HD21 ' A' ' 80' ' ' LEU . 29.3 mmt180 -115.34 173.31 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.91 147.85 37.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.47 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 9.8 p -133.12 146.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.021 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.502 ' HB3' HD21 ' A' ' 95' ' ' ASN . 75.3 m-20 -82.91 110.58 18.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.728 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.638 HD11 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -79.28 3.95 16.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.502 HD21 ' HB3' ' A' ' 93' ' ' ASN . 22.3 m-80 -63.19 -14.36 48.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.053 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -24.93 67.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.586 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -79.22 126.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.836 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -118.91 160.56 21.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.932 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.27 120.95 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.621 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 52.9 t -112.48 93.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.38 25.73 13.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.84 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.96 14.86 15.95 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.621 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 14.4 ptp180 -124.17 134.57 53.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.347 . . . . 0.0 110.212 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.806 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 79.3 mt -85.17 120.31 26.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.4 t -128.46 136.37 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.914 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.1 p90 -87.59 143.69 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.893 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.964 179.31 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 6.2 ptt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -99.7 -166.08 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -62.91 -35.4 79.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.723 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.29 -21.25 48.24 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.929 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.525 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 9.2 t70 -57.66 -35.41 70.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.377 0.608 . . . . 0.0 110.186 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -140.29 46.56 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.951 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.723 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 88.9 p -116.1 155.79 27.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 111.29 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -149.33 163.99 36.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.509 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 91.3 m-20 51.24 35.96 14.82 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.506 0.504 . . . . 0.0 111.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -79.11 113.81 17.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.411 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -144.67 149.72 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -83.99 142.46 30.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 m -127.87 164.96 21.1 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.456 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 7.2 t-20 73.29 9.23 5.2 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 123.575 0.547 . . . . 0.0 110.861 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.12 13.92 50.67 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 108.47 15.94 12.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.056 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.587 ' HG2' HG23 ' A' ' 56' ' ' THR . 23.6 mtp180 -99.51 -16.98 18.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.583 0.23 . . . . 0.0 111.035 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -131.3 131.0 43.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.026 0.441 . . . . 0.0 111.67 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.473 ' HB2' HD21 ' A' ' 37' ' ' LEU . 59.4 tp -98.55 105.09 17.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.796 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -104.91 123.87 48.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.47 41.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.509 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -112.4 113.08 25.09 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -126.49 141.07 52.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.095 0.474 . . . . 0.0 111.589 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -67.79 144.06 55.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.448 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.452 ' HB3' HG22 ' A' ' 31' ' ' VAL . 26.6 p-10 -85.9 -173.85 4.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.509 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.86 75.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.741 0.305 . . . . 0.0 111.527 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.53 -24.24 63.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.082 0.468 . . . . 0.0 111.096 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.84 35.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.721 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 t30 -91.69 146.44 23.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -75.0 124.1 26.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.293 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -127.54 154.59 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.3 m -104.73 114.16 28.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.898 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.0 p -110.7 134.08 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.495 0.664 . . . . 0.0 111.413 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.45 131.83 50.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.647 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.516 HD11 HG12 ' A' ' 40' ' ' ILE . 12.9 tp -131.44 119.59 21.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.955 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.61 ' O ' HG22 ' A' ' 39' ' ' THR . 9.6 t70 -68.88 111.32 4.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.74 HD11 HD13 ' A' ' 12' ' ' LEU . 33.8 mt -61.73 -45.16 95.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.681 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -63.5 -3.8 2.37 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.61 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -101.3 -13.13 18.17 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.823 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.516 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.53 11.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.46 129.54 70.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.46 160.3 22.11 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.312 -0.946 . . . . 0.0 112.518 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 13.6 t30 -110.88 109.61 19.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.52 179.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.53 76.56 6.57 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.002 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 39.3 62.07 1.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.802 0.841 . . . . 0.0 112.14 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 88.89 36.89 7.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.794 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -163.24 118.13 1.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.77 0.285 . . . . 0.0 110.483 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.453 ' CG ' ' HB ' ' A' ' 92' ' ' VAL . 41.5 m-85 -61.57 138.51 58.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.959 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.52 116.14 15.59 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.648 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.24 115.02 8.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.04 38.87 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -110.66 -50.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.258 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.523 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 1.7 tt0 74.76 144.32 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.218 0.607 . . . . 0.0 111.527 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.681 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 10.9 m120 64.02 46.03 3.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.749 0.785 . . . . 0.0 111.117 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -85.16 -28.56 25.42 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.39 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.587 HG23 ' HG2' ' A' ' 17' ' ' ARG . 77.7 p -68.58 -19.58 64.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.559 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 12.2 pt-20 -71.37 -17.52 62.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.797 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 57' ' ' GLU . 62.8 p -124.33 9.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.905 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.521 ' HB3' ' HA ' ' A' ' 56' ' ' THR . . . -115.69 150.37 36.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.093 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -137.04 170.09 16.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.3 t70 43.54 57.21 4.04 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.594 0.558 . . . . 0.0 111.33 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -87.94 113.39 25.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.187 0.518 . . . . 0.0 112.241 -177.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 121.86 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.866 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.609 ' CE1' HD11 ' A' ' 94' ' ' LEU . 12.8 t80 -91.47 132.1 36.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.292 0.567 . . . . 0.0 111.679 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.417 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -120.18 87.74 40.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 11.2 Cg_endo -57.63 -37.24 97.56 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 123.951 3.101 . . . . 0.0 114.105 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.31 83.64 2.18 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 28.0 tt0 -68.63 115.5 8.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.842 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.52 -149.81 4.9 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.001 -0.999 . . . . 0.0 113.921 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -9.44 58.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.402 0.62 . . . . 0.0 109.706 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.59 -27.55 61.36 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.785 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 54.47 43.12 30.84 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.474 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -107.31 129.92 23.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.377 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.518 ' HG3' ' HB1' ' A' ' 4' ' ' ALA . 60.2 Cg_endo -73.62 109.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.941 2.428 . . . . 0.0 111.882 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.48 HD13 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 140.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.77 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -112.07 124.63 52.83 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.105 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.483 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.89 141.48 50.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.856 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.23 170.56 20.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.276 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.551 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.47 115.14 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.603 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -100.63 125.98 47.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.913 0.387 . . . . 0.0 111.575 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.695 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -74.26 139.64 44.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.49 171.27 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.4 m -60.06 -23.94 64.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.88 -25.7 62.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.35 0.595 . . . . 0.0 110.235 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.06 40.83 3.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.703 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.695 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.5 pt-20 -123.33 -163.44 1.12 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -136.11 139.87 43.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.63 0.729 . . . . 0.0 111.424 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -139.48 109.75 6.52 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.1 p-10 -62.83 114.09 3.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.393 0.616 . . . . 0.0 111.374 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.603 ' HB2' HD21 ' A' ' 80' ' ' LEU . 31.2 mmt180 -115.06 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.519 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.84 148.34 32.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.453 ' HB ' ' CG ' ' A' ' 48' ' ' PHE . 12.7 p -135.31 143.56 36.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.375 0.607 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 95' ' ' ASN . 7.5 m-20 -84.02 106.22 15.51 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.887 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.609 HD11 ' CE1' ' A' ' 64' ' ' PHE . 6.0 mt -75.67 2.17 12.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 93' ' ' ASN . 22.4 m-80 -62.32 -17.22 58.21 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.697 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -21.55 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.155 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.574 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.8 mt -86.74 125.2 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -118.25 159.9 22.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.56 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -102.04 119.04 38.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.202 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 41.0 t -111.84 96.62 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.317 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 61.69 20.74 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.466 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.425 ' O ' ' HB3' ' A' ' 33' ' ' SER . . . 108.62 18.41 9.58 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.33 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.56 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 5.5 ptp180 -125.86 150.63 47.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.898 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 78.6 mt -97.78 118.1 33.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.574 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.5 p -118.42 126.19 74.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -86.78 144.38 27.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.763 178.4 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 4.7 tpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.439 ' HA ' ' HG3' ' A' ' 98' ' ' GLN . 11.6 m -129.02 -177.28 4.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.635 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.414 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 4.9 p90 -63.35 -30.42 71.55 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.656 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.18 -30.08 59.16 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.003 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.509 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 8.8 t70 -56.87 -32.55 65.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.306 0.574 . . . . 0.0 111.196 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 56.2 m -136.69 41.12 2.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.209 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.656 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.8 p -115.96 145.15 43.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 111.419 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.88 166.03 27.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.016 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.22 31.07 13.4 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.641 0.588 . . . . 0.0 111.309 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 66' ' ' PRO . . . -77.59 114.85 16.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.601 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.14 149.58 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.147 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -86.93 134.5 33.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.708 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.403 HG22 ' N ' ' A' ' 14' ' ' ASN . 9.1 m -123.32 165.36 17.11 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.118 -178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER 71.24 8.79 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.229 0.612 . . . . 0.0 111.325 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 22.17 22.3 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.01 14.11 37.51 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.576 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.574 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.3 mtp180 -98.08 -17.11 19.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.402 0.144 . . . . 0.0 111.02 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.499 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 26.5 m -130.6 124.52 31.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 60.6 tp -95.7 105.92 17.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -103.32 124.15 48.12 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.4 ' HB1' HD21 ' A' ' 104' ' ' LEU . . . -147.42 145.06 29.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.027 0.441 . . . . 0.0 111.153 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.2 mt-10 -100.25 113.46 26.16 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.525 ' HA ' ' O ' ' A' ' 6' ' ' SER . 20.1 t -128.02 143.85 51.09 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.949 0.404 . . . . 0.0 110.441 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.08 144.46 48.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.729 179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -84.42 -171.44 3.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.704 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.1 72.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.513 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.68 -24.44 63.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.32 38.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.498 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -96.49 143.85 27.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -73.66 122.72 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 112.026 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 153.76 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.94 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.2 m -108.55 111.0 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 104' ' ' LEU . 9.3 t -112.62 155.97 23.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.135 0.493 . . . . 0.0 111.184 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.2 mt-10 -137.87 131.96 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.868 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.84 117.45 20.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.519 ' O ' HG21 ' A' ' 39' ' ' THR . 21.5 m-20 -68.15 107.04 2.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 109.579 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.64 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -59.19 -45.89 89.87 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.504 0.668 . . . . 0.0 110.536 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.415 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -62.7 -5.26 2.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.818 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.519 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.56 -14.23 18.29 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.992 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.485 HG22 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.11 10.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.08 129.94 71.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.77 158.65 20.86 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.883 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.446 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 12.1 t30 -110.7 111.48 22.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -93.07 79.29 4.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.537 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.4 49.84 4.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.174 0.921 . . . . 0.0 112.811 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.491 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 102.33 33.09 4.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.233 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -162.38 123.5 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.118 0.459 . . . . 0.0 111.061 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.442 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -64.08 139.79 58.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.18 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -133.02 117.49 17.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.65 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.17 114.59 8.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.26 34.86 5.2 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.759 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.473 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -107.7 -49.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.06 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.457 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.5 tt0 72.07 145.46 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.568 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.3 m-20 69.91 34.89 2.42 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.486 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.5 p90 -77.77 -28.46 50.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.574 HG21 ' HG2' ' A' ' 17' ' ' ARG . 40.0 p -68.86 -28.52 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.293 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' HG3' HG22 ' A' ' 58' ' ' THR . 6.3 pt-20 -70.82 -13.83 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 109.979 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.57 HG22 ' HG3' ' A' ' 57' ' ' GLU . 61.0 p -126.09 17.51 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.04 163.5 26.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.09 166.39 29.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.35 61.43 3.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 110.749 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.464 HG21 ' HB1' ' A' ' 78' ' ' ALA . 1.8 mt -93.61 116.76 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.704 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.517 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.48 126.77 30.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.28 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.653 ' CE1' HD12 ' A' ' 94' ' ' LEU . 16.5 t80 -92.2 137.93 31.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.349 0.595 . . . . 0.0 112.206 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.735 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 11.0 t-160 -119.44 84.56 29.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.567 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.735 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 Cg_endo -58.72 -39.15 84.83 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.566 2.844 . . . . 0.0 114.177 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.735 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -127.64 87.07 2.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.244 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.735 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 4.4 tt0 -70.55 113.76 7.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.603 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.17 -145.85 8.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.305 1.003 . . . . 0.0 113.148 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.47 -1.76 51.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.62 -21.92 47.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.699 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 55.45 40.02 31.22 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -99.46 115.81 65.4 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.522 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.548 ' HG3' ' HB1' ' A' ' 4' ' ' ALA . 59.7 Cg_endo -74.57 107.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.21 1.94 . . . . 0.0 111.452 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.73 141.61 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.51 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.9 124.94 53.76 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.222 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' HD3' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.62 141.11 50.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.23 179.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.27 166.17 30.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.628 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 11.8 mmt180 -85.69 115.18 23.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.557 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -98.05 129.83 44.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.232 0.539 . . . . 0.0 112.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.651 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -80.55 143.39 33.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.051 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.558 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 2.3 p-10 -98.56 177.84 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.87 -24.07 67.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -79.4 -28.49 41.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.799 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.28 40.63 1.36 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.073 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.651 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.7 pt-20 -112.6 -163.99 0.89 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -147.76 128.2 14.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.0 110.135 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -137.42 120.94 17.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.606 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.7 p-10 -64.62 125.53 25.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.557 ' HB2' HD21 ' A' ' 80' ' ' LEU . 34.6 mmt180 -120.57 178.09 4.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.752 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -144.73 147.69 33.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.442 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 p -136.22 140.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.582 0.706 . . . . 0.0 110.999 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.458 ' HB3' HD21 ' A' ' 95' ' ' ASN . 26.0 m-80 -79.2 108.42 12.69 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.641 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.653 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -78.97 5.82 10.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.331 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.458 HD21 ' HB3' ' A' ' 93' ' ' ASN . 18.8 m-80 -67.23 -8.61 33.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 110.281 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.84 -15.61 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.932 179.015 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.499 HD13 ' HB3' ' A' ' 94' ' ' LEU . 13.0 mt -89.05 126.13 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.439 ' HG3' ' HA ' ' A' ' 2' ' ' SER . 2.1 mp0 -115.87 169.93 8.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.508 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -115.2 118.77 34.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.226 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.457 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -113.75 100.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.57 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.73 24.64 13.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.37 0.605 . . . . 0.0 110.801 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.99 23.0 10.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.304 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.5 ptp180 -129.92 134.76 47.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.951 0.376 . . . . 0.0 110.069 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.477 HD12 ' HB3' ' A' ' 33' ' ' SER . 2.1 mp -83.67 128.41 34.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.2 130.29 21.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.99 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -82.04 145.92 29.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.249 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.738 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.2 tpp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.806 0.336 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -151.35 -169.29 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.417 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 11.7 p90 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -52.4 -26.39 12.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.465 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.65 -29.63 27.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.011 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.54 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 25.5 m -141.47 34.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.632 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 66.7 m -115.64 152.92 32.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.389 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -150.38 167.64 26.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.96 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.419 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 74.0 m-20 55.6 31.71 17.77 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.524 0.515 . . . . 0.0 111.457 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.497 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -73.41 114.47 11.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.314 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.8 t -142.3 150.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.083 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.621 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.1 138.35 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.418 HG21 ' N ' ' A' ' 14' ' ' ASN . 8.7 m -125.81 165.3 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 9.3 t30 72.49 6.36 5.44 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.57 0.544 . . . . 0.0 111.531 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.71 28.74 11.81 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.512 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 93.28 20.92 31.2 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.5 mtp180 -106.78 -13.99 15.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.687 0.28 . . . . 0.0 110.275 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 28.7 m -133.15 129.24 37.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.913 0.387 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.496 ' CD2' HD12 ' A' ' 97' ' ' ILE . 55.5 tp -100.33 108.7 20.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.609 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.466 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.7 tmm_? -103.96 123.54 47.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.75 151.0 36.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.006 0.431 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.632 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.7 mt-10 -106.44 114.47 28.61 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.601 ' HB2' ' HG ' ' A' ' 7' ' ' SER . 12.6 t -130.32 147.93 52.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.307 0.575 . . . . 0.0 111.677 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.495 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.74 144.72 36.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.829 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -87.72 -168.6 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.791 0.329 . . . . 0.0 111.645 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.81 75.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.44 -24.24 61.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.147 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.8 5.84 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -86.48 144.69 27.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -77.47 125.34 29.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.482 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.15 131.75 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.869 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -83.58 110.05 17.92 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.533 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.8 p -111.36 143.43 42.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.321 0.581 . . . . 0.0 111.642 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.466 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -130.7 133.15 45.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.34 119.17 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.507 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.5 m-20 -68.88 108.48 3.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.621 HD11 HD11 ' A' ' 12' ' ' LEU . 55.3 mt -59.28 -46.76 87.66 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.108 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -62.77 -4.91 2.33 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.85 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.483 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.12 -13.97 20.68 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.872 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.463 HD11 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -143.99 12.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.008 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.584 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -126.63 130.83 71.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.22 163.06 19.36 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.819 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.14 108.75 17.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 0.0 110.328 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -101.67 82.93 2.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.301 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.4 m-20 48.99 57.21 6.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.124 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.563 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.14 41.86 20.84 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -159.39 113.0 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.538 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.0 m-85 -58.76 136.28 57.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.244 0.545 . . . . 0.0 111.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -123.74 114.77 20.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.51 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.78 114.47 8.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.62 35.4 4.92 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.647 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.417 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.18 -49.54 0.82 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.148 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 28.9 tt0 70.15 145.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.026 0.53 . . . . 0.0 111.123 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.644 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.8 m120 72.35 31.78 1.77 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.215 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.584 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.1 p90 -76.57 -31.51 57.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.552 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.1 p -64.12 -27.18 68.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.876 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.644 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.3 pt-20 -72.04 -14.41 61.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.199 0.523 . . . . 0.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.572 HG22 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -125.09 14.05 8.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.922 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.8 157.32 37.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.654 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.718 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -148.93 170.66 17.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.322 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.2 t70 49.07 52.44 14.37 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.385 0.428 . . . . 0.0 110.74 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.422 HG21 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -84.79 112.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.47 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -126.54 124.89 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.643 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.621 ' CE1' HD11 ' A' ' 94' ' ' LEU . 14.8 t80 -91.6 137.65 32.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.352 0.596 . . . . 0.0 111.486 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.679 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 7.6 t-160 -122.89 82.3 49.92 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.497 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 6.9 Cg_endo -56.94 -43.07 57.68 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.384 2.723 . . . . 0.0 113.947 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.459 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 3.3 mptt -120.2 83.71 2.1 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.679 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 1.8 tt0 -66.84 109.04 2.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.421 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.29 -140.74 12.74 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 124.376 1.047 . . . . 0.0 114.129 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.13 -9.46 59.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.886 0.374 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.91 44.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.111 0.481 . . . . 0.0 109.787 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.71 41.15 31.39 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.477 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 123.05 48.33 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.833 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 42.8 Cg_endo -70.01 108.94 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.568 2.179 . . . . 0.0 112.072 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.426 HD12 ' HB2' ' A' ' 91' ' ' ASP . 1.1 pp -136.34 142.19 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.532 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.06 126.96 56.05 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.964 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.506 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.75 142.39 50.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.099 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.502 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.16 171.1 19.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.718 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.3 mmt180 -85.12 115.87 23.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.613 HD23 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -101.74 124.71 47.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.941 0.4 . . . . 0.0 111.666 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.726 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -79.29 142.95 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.469 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.673 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -105.93 171.8 7.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.495 ' HG ' ' CG ' ' A' ' 45' ' ' ASP . 75.9 m -56.14 -27.28 53.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -69.27 -27.3 65.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.351 0.596 . . . . 0.0 109.924 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 102.08 38.27 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.146 177.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.726 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.3 pt-20 -122.03 -165.86 1.32 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -140.43 139.71 35.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.036 0.922 . . . . 0.0 111.503 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -138.79 112.73 8.5 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.682 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.559 ' HB3' ' CD ' ' A' ' 79' ' ' ARG . 5.4 p-10 -64.43 113.15 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.518 0.675 . . . . 0.0 111.341 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.613 ' HB2' HD23 ' A' ' 80' ' ' LEU . 25.7 mmt180 -114.39 177.11 4.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.426 ' HB2' HD12 ' A' ' 75' ' ' ILE . 7.7 p-10 -142.57 148.74 38.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.538 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -134.31 147.59 30.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.493 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.473 ' HB3' HD21 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -85.42 110.09 18.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.709 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.621 HD11 ' CE1' ' A' ' 64' ' ' PHE . 5.5 mt -77.5 2.48 16.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.293 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.473 HD21 ' HB3' ' A' ' 93' ' ' ASN . 16.6 m-80 -62.73 -12.75 25.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 109.91 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.693 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -69.51 -18.06 63.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.692 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 94' ' ' LEU . 11.9 mt -87.06 123.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.443 0.64 . . . . 0.0 110.626 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -116.96 164.6 14.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.217 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.6 t30 -108.27 121.06 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.603 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 61.4 t -113.01 94.62 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.69 22.56 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.985 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.62 16.73 9.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.594 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.603 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.2 ptp180 -129.22 143.71 50.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.533 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 82.7 mt -89.37 133.23 34.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.71 131.4 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -82.48 145.78 29.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.693 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 57.6 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.47 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' HB3' ' HB2' ' A' ' 5' ' ' ASP . 15.3 tpt . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.738 0.304 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -155.17 -172.16 4.07 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -66.24 -33.95 76.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.743 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.15 -24.1 51.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.422 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.408 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 17.3 t0 -59.16 -24.24 62.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -148.01 39.32 0.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.743 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.7 p -116.22 158.27 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.938 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.412 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.3 ptp180 -155.32 166.8 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.517 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.497 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.8 m-20 52.89 35.47 19.12 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.788 0.68 . . . . 0.0 111.332 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -79.31 114.36 18.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.427 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 t -143.84 151.58 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.655 HD12 HD12 ' A' ' 37' ' ' LEU . 1.1 tp -85.17 145.22 27.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 14' ' ' ASN . 8.1 m -131.99 164.73 25.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.481 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 73.77 5.22 4.83 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.602 0.564 . . . . 0.0 111.234 177.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.06 23.58 19.65 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 99.1 16.86 29.07 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.824 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.7 mtp180 -100.75 -18.38 16.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.581 0.229 . . . . 0.0 110.783 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 50.5 m -130.22 128.42 41.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 0.0 111.54 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.438 ' CD2' HD12 ' A' ' 97' ' ' ILE . 58.8 tp -97.59 108.8 21.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.72 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.2 tmm_? -103.4 124.94 49.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.25 138.95 20.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.497 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -98.83 109.85 22.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD11 ' A' ' 104' ' ' LEU . 3.3 m -121.29 144.28 48.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.028 0.442 . . . . 0.0 111.035 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.569 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.29 143.32 47.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.94 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.44 ' HB3' HG22 ' A' ' 31' ' ' VAL . 25.2 p-10 -90.26 -172.77 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.595 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.51 66.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.721 0.296 . . . . 0.0 111.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.18 -25.03 59.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.114 0.483 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.21 39.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.515 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.569 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.7 t-20 -88.94 146.32 24.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -78.55 119.63 22.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.057 0.456 . . . . 0.0 110.99 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -115.9 125.18 72.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.801 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.5 m -80.36 107.3 13.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.4 t -112.52 149.23 32.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.325 0.583 . . . . 0.0 110.584 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.9 mt-10 -134.96 131.77 37.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.85 119.18 23.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.629 ' O ' HG23 ' A' ' 39' ' ' THR . 47.4 m-20 -68.41 108.73 3.37 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.028 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.655 HD12 HD12 ' A' ' 12' ' ' LEU . 68.3 mt -61.86 -42.35 98.95 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.55 -5.21 2.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.629 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.09 -12.08 16.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.439 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.519 HG21 HG22 ' A' ' 39' ' ' THR . 2.5 pp -141.94 10.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 130.44 70.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.59 160.79 20.95 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.966 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -110.94 107.85 17.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.505 0.669 . . . . 0.0 110.214 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -87.83 75.73 8.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.107 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.435 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 7.1 p-10 39.16 59.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 112.588 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.516 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 91.36 36.29 6.64 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.551 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -165.5 121.72 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.521 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.7 m-85 -60.93 143.78 54.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.346 0.593 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -132.91 115.81 15.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.422 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -73.01 115.08 11.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 31.91 6.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.784 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -102.03 -50.8 1.13 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.194 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.7 tt0 72.61 144.96 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.901 0.48 . . . . 0.0 111.422 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.483 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 2.6 t-20 68.74 34.71 3.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.244 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.2 p90 -77.27 -28.49 53.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.95 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.576 HG21 ' HG2' ' A' ' 17' ' ' ARG . 33.0 p -64.63 -22.23 66.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.555 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.6 pt-20 -73.16 -15.32 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.038 0.446 . . . . 0.0 110.371 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.8 p -128.19 16.32 6.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.271 0.558 . . . . 0.0 110.031 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.21 150.27 50.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.144 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.578 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.32 173.07 11.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.503 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.477 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 48.43 50.86 16.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.545 0.528 . . . . 0.0 110.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.05 108.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.337 0.589 . . . . 0.0 111.536 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.52 123.16 37.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.68 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.616 ' CE1' HD11 ' A' ' 94' ' ' LEU . 18.3 t80 -92.15 135.32 34.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.247 0.546 . . . . 0.0 111.895 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.526 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 16.5 t60 -124.5 89.33 52.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.04 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.503 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.2 Cg_endo -57.11 -36.86 99.31 Favored 'Trans proline' 0 CA--C 1.51 -0.712 0 C-N-CA 124.11 3.207 . . . . 0.0 114.633 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.503 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.08 88.78 2.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.656 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.526 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 14.7 tt0 -70.42 114.25 8.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.095 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -153.01 7.33 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.025 0.828 . . . . 0.0 113.714 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.76 -13.37 60.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.224 0.535 . . . . 0.0 109.694 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.15 59.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 49.3 52.56 14.21 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.879 0.737 . . . . 0.0 110.764 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -104.97 124.51 36.44 Favored Pre-proline 0 N--CA 1.447 -0.59 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.522 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 56.9 Cg_endo -71.37 110.43 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.779 2.32 . . . . 0.0 112.642 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.68 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 140.24 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.52 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -111.66 126.83 55.45 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.081 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.68 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.0 142.53 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.84 24.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.675 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.578 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.4 mmt180 -86.3 115.09 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.32 124.06 45.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.365 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.78 137.37 40.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.872 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.37 166.27 12.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.435 ' SG ' ' HB3' ' A' ' 45' ' ' ASP . 95.9 m -58.57 -20.93 51.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.418 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.06 -26.83 63.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.282 0.563 . . . . 0.0 110.56 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.92 41.14 2.93 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.4 pt-20 -126.97 -163.72 1.28 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.12 142.61 36.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.784 0.802 . . . . 0.0 111.417 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -140.99 112.04 7.2 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.073 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.2 p-10 -62.02 115.27 3.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.31 0.576 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -116.44 175.44 5.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.953 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.39 149.08 38.88 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.521 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -137.52 143.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.459 0.647 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.41 ' HB3' HD21 ' A' ' 95' ' ' ASN . 36.5 m-20 -79.36 110.04 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.551 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.616 HD11 ' CE1' ' A' ' 64' ' ' PHE . 4.5 mt -79.04 1.11 25.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.798 0.332 . . . . 0.0 111.238 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.41 HD21 ' HB3' ' A' ' 93' ' ' ASN . 14.9 m-80 -61.93 -13.87 29.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -26.5 67.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.447 0.641 . . . . 0.0 109.39 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.503 HD11 ' HB3' ' A' ' 94' ' ' LEU . 11.2 mt -80.13 127.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.415 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -121.01 161.99 20.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -104.88 120.6 41.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.024 0.44 . . . . 0.0 110.63 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.56 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 60.2 t -113.1 94.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.32 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.94 24.91 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.714 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 23.14 8.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.0 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.56 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 7.6 ptp180 -130.6 134.15 46.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.95 0.375 . . . . 0.0 110.271 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.473 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.2 mp -80.89 119.46 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.401 HG23 ' HG3' ' A' ' 103' ' ' ARG . 48.3 t -127.14 125.37 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.226 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.56 144.02 34.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.205 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.909 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 p 177.48 -178.88 0.21 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -63.6 -31.17 72.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.698 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.3 -27.68 37.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.62 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.38 -31.83 66.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 110.976 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.522 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.9 m -138.11 41.31 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.698 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.2 p -122.67 154.55 37.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.597 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.444 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -151.37 167.51 27.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.424 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 84.9 m-20 53.69 34.43 18.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.659 0.599 . . . . 0.0 111.214 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -80.03 112.96 17.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.91 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.25 153.64 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.043 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.778 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.58 142.78 27.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.441 HG21 ' N ' ' A' ' 14' ' ' ASN . 20.4 m -130.37 163.53 26.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.4 t30 72.67 9.06 5.63 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.725 0.641 . . . . 0.0 111.657 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 25.27 15.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.037 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 93.08 26.18 17.16 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.611 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.548 ' HG2' HG22 ' A' ' 56' ' ' THR . 24.7 mtp180 -108.09 -18.3 13.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.835 0.35 . . . . 0.0 110.196 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 42.1 m -128.73 129.91 46.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.768 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.44 ' HB2' HD22 ' A' ' 37' ' ' LEU . 57.1 tp -102.77 111.99 24.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.578 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.524 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -110.4 126.05 53.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.043 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.456 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.16 138.46 20.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 110.6 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.6 mt-10 -96.09 110.04 22.36 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 6' ' ' SER . 5.1 p -117.5 141.16 48.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.133 0.492 . . . . 0.0 111.643 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.485 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.16 143.89 40.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.771 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 p30 -90.58 -172.98 3.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.74 -34.07 70.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.627 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.64 -17.9 61.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.277 0.56 . . . . 0.0 110.83 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.45 6.71 56.41 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.6 t-20 -86.9 142.26 28.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.474 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.1 m0 -77.63 116.73 18.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.025 0.44 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.57 122.57 67.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 m -76.4 109.75 10.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.729 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 24.0 m -109.93 143.46 39.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.524 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.0 mt-10 -135.5 132.72 37.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.556 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.582 HD12 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -136.74 119.58 16.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.653 ' O ' HG23 ' A' ' 39' ' ' THR . 18.2 m-20 -69.67 110.34 4.82 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.722 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.778 HD11 HD11 ' A' ' 12' ' ' LEU . 11.1 mt -60.6 -39.96 90.03 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.836 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.553 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -64.45 -5.93 6.3 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.492 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.56 -9.77 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.658 -178.999 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.582 HG12 HD12 ' A' ' 35' ' ' LEU . 2.6 pp -143.16 10.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.71 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.43 131.16 70.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.452 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.12 158.03 20.2 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.755 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -111.45 108.53 18.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.15 0.5 . . . . 0.0 110.319 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -93.58 78.99 4.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.317 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 41.24 60.73 1.98 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.817 0.847 . . . . 0.0 112.432 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.538 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.23 35.5 9.59 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.771 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -158.5 117.35 3.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.801 -0.235 . . . . 0.0 110.736 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -62.93 139.48 58.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -133.5 116.78 16.37 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.43 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.6 m95 -69.67 115.62 9.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 39.14 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.873 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -111.58 -51.21 0.58 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.375 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.4 tt0 72.98 144.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.23 0.612 . . . . 0.0 111.344 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.534 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.7 m-20 72.47 28.99 2.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.82 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -74.1 -29.16 61.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.548 HG22 ' HG2' ' A' ' 17' ' ' ARG . 17.8 p -67.7 -20.43 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.004 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.551 ' HG3' HG22 ' A' ' 58' ' ' THR . 4.2 pt-20 -76.49 -12.91 60.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.551 HG22 ' HG3' ' A' ' 57' ' ' GLU . 81.8 p -127.1 13.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.974 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.31 150.91 51.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.589 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.06 173.42 11.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.998 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 47.5 58.79 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 110.423 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.48 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 1.8 mt -94.9 110.7 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.4 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 126.41 39.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.413 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.684 ' CE1' HD11 ' A' ' 94' ' ' LEU . 9.0 t80 -91.38 134.99 34.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.363 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.558 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 8.8 t-160 -120.34 84.66 35.45 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.336 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.59 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -56.77 -41.11 79.07 Favored 'Trans proline' 0 CA--C 1.512 -0.607 0 C-N-CA 123.254 2.636 . . . . 0.0 113.89 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.59 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -121.46 82.54 1.95 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.743 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.558 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 13.1 tt0 -69.68 113.64 7.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.88 -151.16 7.25 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.4 1.062 . . . . 0.0 114.138 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.88 -9.07 58.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.99 -25.1 47.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 47.61 55.06 8.89 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.929 0.768 . . . . 0.0 110.47 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -118.09 127.22 26.74 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.058 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.521 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 58.9 Cg_endo -71.99 111.08 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.592 2.194 . . . . 0.0 112.669 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -134.37 141.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.523 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -112.24 125.43 54.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.499 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.05 142.5 49.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.147 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.479 ' HB1' HG23 ' A' ' 62' ' ' ILE . . . -161.71 169.72 20.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.223 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -86.0 115.0 23.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.586 HD23 ' HB2' ' A' ' 90' ' ' ARG . 4.6 mp -101.4 131.51 47.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.824 0.345 . . . . 0.0 111.303 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.765 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -75.87 136.17 40.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.022 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.507 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 4.1 m-20 -94.72 172.6 8.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.54 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.8 t -61.18 -25.85 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -69.51 -19.32 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.76 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.85 37.66 6.33 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.765 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -122.64 -169.1 1.85 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.477 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 98.4 m-85 -135.95 136.36 40.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.707 0.765 . . . . 0.0 111.332 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -138.29 119.14 14.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.701 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 12.6 p-10 -64.49 113.26 3.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.433 0.635 . . . . 0.0 111.332 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.586 ' HB2' HD23 ' A' ' 80' ' ' LEU . 31.0 mmt180 -115.0 176.47 5.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -144.44 151.95 39.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.9 p -139.6 146.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.209 0.528 . . . . 0.0 110.78 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.447 ' HB3' HD21 ' A' ' 95' ' ' ASN . 40.5 m-80 -81.73 111.73 18.25 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.775 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.684 HD11 ' CE1' ' A' ' 64' ' ' PHE . 5.3 mt -80.55 -0.75 39.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.306 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.447 HD21 ' HB3' ' A' ' 93' ' ' ASN . 23.7 m-80 -62.08 -14.22 34.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.05 -24.2 65.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -80.85 126.9 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.319 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -120.66 162.69 19.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.07 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -105.77 118.44 36.59 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.215 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.553 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.5 t -113.52 96.95 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.563 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.8 t30 59.87 24.7 13.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 111.482 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.94 24.32 7.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.998 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.553 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -132.9 139.25 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.322 0.561 . . . . 0.0 110.978 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.729 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 53.8 mt -84.99 117.29 23.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 47.3 t -122.78 122.47 65.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.818 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.84 143.85 34.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--O 1.249 1.074 0 O-C-N 123.722 0.639 . . . . 0.0 111.659 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.3 tpp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.678 0.275 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -142.89 -172.44 3.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.96 -38.05 89.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.44 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.46 -25.85 38.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.156 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.61 -30.56 55.09 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.9 m -136.64 33.09 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.417 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.442 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 69.4 m -120.22 156.45 31.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.022 0.439 . . . . 0.0 112.041 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.98 170.79 19.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.525 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 95.6 m-20 53.02 33.56 15.09 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.683 0.614 . . . . 0.0 111.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.438 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -75.45 114.14 13.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.95 157.02 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.551 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.794 HD11 HD12 ' A' ' 37' ' ' LEU . 1.1 tp -94.34 134.54 36.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 109.882 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -119.42 163.32 17.4 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.091 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.0 t30 70.27 9.61 7.05 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.712 0.632 . . . . 0.0 111.561 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.2 26.72 17.75 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.902 -0.665 . . . . 0.0 111.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.513 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 95.33 22.8 21.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.969 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 28.9 mtp180 -106.33 -18.0 14.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.845 0.355 . . . . 0.0 110.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.463 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -132.52 127.76 35.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.094 0.473 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.443 ' HB2' HD21 ' A' ' 37' ' ' LEU . 55.5 tp -95.69 105.18 17.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.611 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.556 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -102.09 124.17 47.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.039 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.73 29.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.525 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.2 mt-10 -99.59 109.14 21.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 6.3 p -116.43 140.23 49.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.3 143.38 40.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' HB3' HG23 ' A' ' 31' ' ' VAL . 23.9 p-10 -87.26 -176.45 5.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.363 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.94 -30.55 66.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.533 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.68 -24.57 59.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.18 5.35 40.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.835 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.2 t-20 -89.01 144.77 25.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.404 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.5 m0 -77.65 121.1 23.51 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.978 0.418 . . . . 0.0 110.968 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.418 HG23 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -118.95 125.12 74.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.791 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -80.16 110.23 15.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.45 ' HB3' HD11 ' A' ' 104' ' ' LEU . 8.2 t -111.75 150.03 30.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 110.555 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.556 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.2 mt-10 -134.93 131.56 37.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.383 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.9 116.24 19.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.54 ' O ' HG23 ' A' ' 39' ' ' THR . 12.8 m-20 -67.61 107.68 2.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.509 0.671 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.794 HD12 HD11 ' A' ' 12' ' ' LEU . 38.0 mt -59.92 -42.5 94.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.453 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.508 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 2.4 p-10 -63.43 -5.67 3.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.8 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -105.66 -10.29 16.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.575 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.478 HD13 ' CG1' ' A' ' 41' ' ' ILE . 2.6 pp -142.78 10.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 111.769 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -127.57 131.22 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.68 159.14 20.91 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.071 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -111.06 112.55 24.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -99.36 76.82 2.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 52.25 58.22 5.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.563 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.612 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.99 32.47 29.26 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.358 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -149.44 122.06 8.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.9 m-85 -66.3 135.18 54.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.809 0.337 . . . . 0.0 110.837 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -128.34 117.17 20.97 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -71.34 115.51 10.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.33 33.27 5.74 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.107 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.454 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -103.95 -51.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.107 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.535 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 28.5 tt0 70.69 143.31 0.05 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.089 0.556 . . . . 0.0 110.689 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.657 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 11.7 m120 76.89 31.23 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.322 0.649 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.575 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.4 p90 -80.69 -29.7 36.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.246 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.536 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.1 p -65.64 -17.36 64.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.007 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.657 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 12.4 pt-20 -80.25 -15.55 56.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.148 0.499 . . . . 0.0 109.996 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.561 HG22 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -124.6 14.66 8.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.23 150.1 49.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.682 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.756 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -141.03 172.81 12.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 t70 43.67 58.17 3.65 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.859 0.724 . . . . 0.0 111.129 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.439 HG23 ' HB1' ' A' ' 78' ' ' ALA . 2.4 mt -88.75 111.39 22.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.203 0.525 . . . . 0.0 112.139 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.462 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.55 123.21 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.069 179.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.658 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.2 t80 -92.88 134.6 34.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.14 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 8.1 t-160 -126.19 89.42 52.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 20.7 Cg_endo -62.42 -36.58 65.61 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.886 3.058 . . . . 0.0 114.144 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.419 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.89 84.6 2.26 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.308 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.417 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 8.8 tt0 -71.04 117.05 12.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.625 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.13 -147.45 21.6 Favored Glycine 0 C--N 1.334 0.456 0 O-C-N 123.9 0.75 . . . . 0.0 113.509 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.88 -9.45 58.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.45 0.643 . . . . 0.0 109.557 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.19 -27.64 59.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.347 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 55.41 51.11 13.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.988 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -104.17 124.31 37.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.459 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.447 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 53.0 Cg_endo -71.47 110.42 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.833 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.726 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.42 141.36 42.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -114.13 127.91 56.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.369 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.726 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.01 141.8 51.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.203 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.54 168.94 23.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.812 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.756 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.1 mmt85 -85.54 114.9 22.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.612 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -100.26 129.18 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.65 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.67 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.47 137.13 40.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.963 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.634 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 1.1 m-20 -91.17 174.45 7.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 35.4 t -64.66 -25.1 67.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -73.58 -18.87 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.823 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.98 41.77 3.97 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.67 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.4 pt-20 -123.37 -162.63 1.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -140.57 132.99 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.863 0.839 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -137.8 112.95 9.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.211 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.5 p-10 -64.02 116.08 5.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.291 0.567 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.563 ' HB2' HD23 ' A' ' 80' ' ' LEU . 36.4 mmt180 -115.84 174.54 5.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -141.46 142.97 33.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.484 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.6 p -130.33 148.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.485 ' HB3' HD21 ' A' ' 95' ' ' ASN . 12.6 m120 -83.45 110.59 18.31 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.04 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.658 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.99 1.18 32.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.562 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.485 HD21 ' HB3' ' A' ' 93' ' ' ASN . 20.6 m-80 -60.73 -17.29 47.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.429 . . . . 0.0 110.486 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.04 66.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.256 0.55 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -81.75 132.86 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.29 167.36 14.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.57 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -113.05 123.42 50.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.097 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.538 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 39.2 t -114.07 93.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.97 27.69 13.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.827 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.34 19.27 8.06 Favored Glycine 0 C--N 1.32 -0.353 0 C-N-CA 120.293 -0.956 . . . . 0.0 114.133 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 6.6 ptp180 -130.55 141.79 50.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.388 0.594 . . . . 0.0 111.116 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 33' ' ' SER . 2.3 mp -90.58 124.02 34.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.621 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.1 p -132.56 128.24 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -84.98 145.49 27.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.491 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.743 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.571 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 7.5 ptt? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.404 ' H ' ' HG3' ' A' ' 1' ' ' MET . 3.5 m -104.99 -165.74 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -58.2 -37.38 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -58.67 -19.29 38.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.081 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.571 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 5.7 t70 -55.88 -38.35 70.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.443 0.64 . . . . 0.0 109.945 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 61.0 m -130.01 33.83 4.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.517 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.0 m -120.02 155.23 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.0 ptp180 -151.78 170.77 18.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.479 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.5 m-20 54.18 32.52 16.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.14 0.495 . . . . 0.0 110.906 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -75.33 113.36 12.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.961 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.98 155.29 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.555 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.694 HD13 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -92.15 138.05 31.85 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.455 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.9 m -123.91 163.59 20.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.128 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 71.0 6.53 5.9 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.665 0.603 . . . . 0.0 111.666 178.04 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.38 23.63 14.0 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.539 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.36 17.77 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.812 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG2' HG23 ' A' ' 56' ' ' THR . 29.8 mtp180 -100.07 -18.11 17.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.592 0.234 . . . . 0.0 110.922 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.8 m -131.39 124.76 30.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.075 0.464 . . . . 0.0 111.52 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.497 ' CD2' HD12 ' A' ' 97' ' ' ILE . 60.4 tp -92.77 104.95 17.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.8 tmm_? -101.78 125.46 48.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.091 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.37 144.47 25.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.479 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 6.8 mt-10 -98.6 108.84 21.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.492 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.7 p -115.87 141.25 48.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.584 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.557 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.12 141.09 42.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' HB3' HG23 ' A' ' 31' ' ' VAL . 29.0 p-10 -86.87 -175.33 5.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.311 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.09 68.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.74 -23.87 61.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.067 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.11 8.58 44.28 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.262 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.5 t-20 -93.72 147.25 23.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -77.61 117.87 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.508 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG23 ' HB3' ' A' ' 25' ' ' ASN . 9.8 t -113.25 122.95 68.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.2 m -78.58 105.22 9.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -111.1 154.04 24.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.2 mt-10 -139.57 132.47 29.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.42 114.88 18.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 39' ' ' THR . 21.3 m-20 -65.4 107.34 1.62 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.104 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.694 HD11 HD13 ' A' ' 12' ' ' LEU . 85.6 mt -60.32 -45.59 92.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.652 0.739 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -62.62 -5.23 2.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.79 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.07 -13.15 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.036 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.496 HG23 HG21 ' A' ' 39' ' ' THR . 2.6 pp -142.95 12.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 111.923 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.64 131.45 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.85 156.85 19.67 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.442 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.445 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.2 t30 -111.58 107.19 16.26 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.52 82.16 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 5.2 p-10 40.6 51.98 3.02 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.319 1.012 . . . . 0.0 113.329 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 99.44 35.08 4.81 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.145 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -163.2 122.07 2.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.774 0.287 . . . . 0.0 110.628 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 47.1 m-85 -65.17 141.09 58.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 111.325 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.21 117.87 19.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.411 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -73.01 114.44 11.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.77 29.3 6.99 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.67 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.472 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.86 -53.76 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.978 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.46 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 31.5 tt0 73.07 143.89 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.387 0.675 . . . . 0.0 111.474 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.518 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 83.6 m-20 74.25 29.03 1.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.383 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -75.75 -33.44 60.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.517 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HG2' ' A' ' 17' ' ' ARG . 22.6 p -61.71 -30.38 70.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' HG3' HG22 ' A' ' 58' ' ' THR . 4.8 pt-20 -68.3 -13.58 62.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.837 0.351 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.52 HG22 ' HG3' ' A' ' 57' ' ' GLU . 76.6 p -126.22 13.63 7.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 109.924 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.51 146.11 50.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.625 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -136.91 172.86 12.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.637 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER 46.79 52.39 11.44 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.828 0.705 . . . . 0.0 110.473 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.438 HG21 ' HB1' ' A' ' 78' ' ' ALA . 2.8 mt -84.62 112.01 21.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.0 111.659 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.48 124.61 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.548 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.699 ' CE1' HD13 ' A' ' 94' ' ' LEU . 21.5 t80 -92.37 136.66 33.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.363 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.701 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.9 t-160 -122.72 85.65 49.48 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.458 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 18.7 Cg_endo -62.32 -43.7 21.97 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 123.228 2.619 . . . . 0.0 113.671 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.458 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -118.65 82.42 1.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.729 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.701 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 2.4 tt0 -66.85 113.69 5.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.521 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.21 -142.43 10.15 Favored Glycine 0 C--N 1.335 0.525 0 O-C-N 124.407 1.067 . . . . 0.0 113.374 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.77 -9.75 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.982 0.42 . . . . 0.0 109.918 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.33 57.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.795 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 54.16 46.52 25.16 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.469 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.27 124.1 36.21 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.405 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.58 109.83 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.662 2.241 . . . . 0.0 112.369 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.443 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -133.51 141.58 43.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.526 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -114.29 125.79 54.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.176 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.47 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.21 141.39 51.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.87 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.55 167.53 26.95 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.042 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.592 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.2 mmt180 -85.16 114.59 22.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.65 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -98.22 121.56 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.614 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -77.68 142.18 38.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.923 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.577 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.7 p-10 -96.69 178.8 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.222 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -63.15 -21.91 66.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -79.48 -28.19 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.128 0.489 . . . . 0.0 110.77 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.58 32.41 2.94 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.026 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.614 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.8 pt-20 -104.25 -166.12 1.22 Allowed 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -143.28 128.92 19.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.04 111.63 8.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.224 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.633 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.4 p-10 -65.65 120.29 12.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 112.445 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.65 ' HB2' HD21 ' A' ' 80' ' ' LEU . 36.3 mmt180 -115.94 174.88 5.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.979 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -139.42 150.62 45.47 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -140.54 144.66 26.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.391 0.615 . . . . 0.0 110.912 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.484 ' HB3' HD21 ' A' ' 95' ' ' ASN . 38.0 m-80 -80.87 109.0 15.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.699 HD13 ' CE1' ' A' ' 64' ' ' PHE . 3.8 mt -79.01 1.12 25.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.453 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 93' ' ' ASN . 15.6 m-80 -60.8 -16.63 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.273 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -23.52 67.42 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.941 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.52 HD11 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -82.22 125.61 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -117.0 163.34 16.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.219 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.65 117.66 34.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.51 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 48.5 t -113.11 94.22 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 57.75 27.32 14.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.598 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.98 23.69 8.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.485 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -131.61 134.48 46.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.079 0.439 . . . . 0.0 110.38 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 mp -85.92 124.36 32.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.3 p -137.1 131.62 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.593 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.52 145.91 29.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.978 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.196 -179.82 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 tpp . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.837 0.351 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.9 m -153.97 -164.49 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -55.93 -37.26 68.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.147 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.481 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.16 -24.55 41.99 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.635 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.19 -33.35 65.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.006 0.432 . . . . 0.0 110.926 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -132.38 33.24 3.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.167 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.512 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 71.8 m -119.38 156.6 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.433 . . . . 0.0 111.699 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -153.09 169.94 21.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.416 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.0 m120 52.92 33.88 15.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.686 0.617 . . . . 0.0 111.176 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.77 113.38 16.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.749 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 t -143.44 156.3 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.783 HD13 HD11 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -91.39 141.61 28.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 7.9 m -125.39 165.05 19.09 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.2 t-20 71.1 8.85 6.58 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.623 0.577 . . . . 0.0 111.657 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.02 26.3 16.89 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 95.05 27.09 11.35 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.054 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.559 ' HG2' HG23 ' A' ' 56' ' ' THR . 28.7 mtp180 -111.37 -17.09 13.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.704 0.288 . . . . 0.0 110.497 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.507 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 40.4 m -128.76 126.44 39.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.485 ' CD2' HD11 ' A' ' 97' ' ' ILE . 39.6 tp -94.97 107.54 19.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.578 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -107.62 124.83 50.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.26 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.429 ' HB2' HD11 ' A' ' 104' ' ' LEU . . . -150.72 148.48 28.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.671 0.272 . . . . 0.0 111.12 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.9 mt-10 -103.67 109.47 21.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.512 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -118.59 148.17 42.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -79.86 141.99 35.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.3 p30 -89.46 -175.03 4.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.602 -179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.46 -28.86 69.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 111.04 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.04 -24.57 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.09 5.84 46.28 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.571 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.7 m-80 -95.18 149.28 21.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.424 0.29 . . . . 0.0 111.069 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.483 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 54.3 m0 -81.4 110.43 16.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 109.922 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG12 ' CA ' ' A' ' 102' ' ' GLY . 1.0 OUTLIER -112.17 121.81 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.048 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -74.78 114.71 13.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.804 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.0 t -112.87 149.94 32.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -136.11 131.68 35.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.14 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.457 HD11 HG12 ' A' ' 40' ' ' ILE . 15.8 tp -129.05 118.75 23.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.0 0.429 . . . . 0.0 110.611 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' HG23 ' A' ' 39' ' ' THR . 2.9 m-20 -68.07 110.02 3.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.755 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.783 HD11 HD13 ' A' ' 12' ' ' LEU . 23.8 mt -62.06 -39.16 91.43 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.491 0.662 . . . . 0.0 109.604 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.53 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -63.53 -6.12 4.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.227 178.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.462 HG22 HG21 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -101.89 -15.2 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.243 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.486 HD11 ' CG1' ' A' ' 41' ' ' ILE . 2.6 pp -141.36 10.8 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.524 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -127.25 129.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.06 158.32 21.46 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.11 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.406 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.0 t30 -110.89 114.17 27.29 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.18 82.35 1.66 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.288 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 53.29 65.1 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.247 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.547 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.86 34.72 62.13 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.816 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -156.26 120.36 4.46 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.629 -0.336 . . . . 0.0 110.182 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.512 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 46.6 m-85 -62.08 142.98 57.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.148 0.499 . . . . 0.0 111.198 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -132.13 117.07 17.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.461 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -74.08 114.05 11.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.55 31.44 6.1 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.581 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.556 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.39 -51.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.084 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.53 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 25.8 tt0 73.26 143.09 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.188 0.595 . . . . 0.0 112.063 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 t30 68.78 31.78 4.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.694 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.524 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.0 p90 -72.31 -27.96 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.559 HG23 ' HG2' ' A' ' 17' ' ' ARG . 20.1 p -63.81 -19.6 65.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.111 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -74.58 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.134 0.493 . . . . 0.0 110.371 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.519 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -126.83 14.08 7.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.75 143.91 51.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.856 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.755 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.62 173.96 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.338 179.295 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 17.6 t0 48.17 50.61 16.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.234 0.54 . . . . 0.0 110.315 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.75 108.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.049 0.452 . . . . 0.0 111.738 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -125.46 123.95 40.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.047 178.851 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' HD13 ' A' ' 94' ' ' LEU . 4.5 t80 -91.28 130.61 37.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.927 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.408 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.0 t60 -121.11 85.46 41.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.538 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.414 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.2 Cg_endo -56.3 -36.37 96.89 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 123.933 3.088 . . . . 0.0 114.677 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -118.87 80.57 1.56 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.264 -179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -66.15 114.46 5.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.577 0.227 . . . . 0.0 111.321 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.22 -144.16 14.37 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 124.148 0.905 . . . . 0.0 113.76 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.4 -10.04 58.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.22 -25.09 57.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.841 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 54.54 44.01 29.39 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -102.44 124.38 39.63 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.401 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 41.7 Cg_endo -68.07 112.1 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.681 2.254 . . . . 0.0 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.434 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -134.12 141.5 43.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.8 tm? -112.75 124.21 52.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.303 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.487 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.05 140.73 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.958 0.408 . . . . 0.0 109.961 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.0 169.83 22.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.839 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.755 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.4 mmt85 -86.34 115.59 23.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.601 HD23 ' HB2' ' A' ' 90' ' ' ARG . 4.9 mp -101.5 128.8 47.58 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 123.463 0.477 . . . . 0.0 111.074 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.72 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -78.8 138.6 38.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.439 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 10.2 m-20 -95.16 169.16 10.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.62 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.63 -25.04 64.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.91 0.386 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.77 -20.89 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.441 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 38.27 4.26 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.81 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.72 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.9 pt-20 -122.44 -172.42 2.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.43 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 90.5 m-85 -134.5 138.59 44.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.761 0.791 . . . . 0.0 111.575 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -139.64 118.12 12.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.649 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.4 p-10 -65.02 112.37 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.344 0.592 . . . . 0.0 111.283 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.601 ' HB2' HD23 ' A' ' 80' ' ' LEU . 28.2 mmt180 -115.41 174.56 5.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -141.9 152.44 43.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.512 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -138.67 144.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.45 ' HB3' HD21 ' A' ' 95' ' ' ASN . 6.4 m-20 -82.62 110.37 17.63 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.672 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.65 ' HB3' HD13 ' A' ' 97' ' ' ILE . 8.5 mt -79.49 3.05 19.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.308 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.45 HD21 ' HB3' ' A' ' 93' ' ' ASN . 32.5 m-80 -62.19 -14.07 34.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.199 0.523 . . . . 0.0 109.819 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -21.21 66.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.186 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -83.6 127.94 39.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 0.0 111.505 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -121.45 160.91 23.17 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.125 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -108.43 120.73 43.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.071 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.52 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 48.3 t -113.72 94.38 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.001 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.48 23.48 12.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.498 ' CA ' HG12 ' A' ' 31' ' ' VAL . . . 114.15 14.34 9.23 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 119.287 -1.435 . . . . 0.0 113.695 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.52 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.8 ptp180 -130.18 135.57 48.31 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.425 -0.456 . . . . 0.0 111.161 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.804 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.8 mt -87.84 125.45 34.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.101 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.3 p -137.99 136.37 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.652 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -85.83 145.73 27.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.091 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.58 0.228 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -157.15 174.39 15.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -58.11 -39.17 77.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.157 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.548 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.55 -27.31 37.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.942 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.13 -31.37 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 m -130.16 31.0 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.548 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 73.4 m -116.83 156.8 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.455 0.645 . . . . 0.0 112.204 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -152.33 170.87 19.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.084 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.546 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.9 t-20 56.11 30.4 16.32 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.624 0.578 . . . . 0.0 110.266 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -76.98 113.04 14.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.64 147.13 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.648 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.61 HD11 HD13 ' A' ' 37' ' ' LEU . 1.5 tp -84.46 140.82 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.432 HG21 ' N ' ' A' ' 14' ' ' ASN . 10.8 m -126.26 163.24 23.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.025 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.1 t-20 72.05 8.97 6.03 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.619 0.574 . . . . 0.0 111.607 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.6 23.25 24.21 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 97.49 24.92 11.47 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.101 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.554 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.2 mtp180 -107.59 -18.15 13.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.864 0.364 . . . . 0.0 110.288 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 m -130.1 128.51 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.358 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.47 ' HB2' HD23 ' A' ' 37' ' ' LEU . 49.5 tp -97.32 108.65 21.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.648 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.2 tmm_? -105.42 123.98 48.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.309 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.08 26.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -106.09 110.05 22.18 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.513 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 41.8 t -121.69 145.6 47.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.87 144.01 52.64 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.277 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.454 ' HB3' HG23 ' A' ' 31' ' ' VAL . 22.6 p-10 -88.13 -167.52 1.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.952 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.24 68.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.599 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.34 -23.56 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.209 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.68 0.59 32.4 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.888 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 56.5 t30 -83.53 143.01 30.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -75.41 119.85 20.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.134 0.492 . . . . 0.0 110.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.454 HG23 ' HB3' ' A' ' 25' ' ' ASN . 4.1 t -117.92 124.42 73.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.317 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.417 HG23 ' HG2' ' A' ' 22' ' ' GLU . 7.8 m -77.18 107.15 9.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.434 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.09 141.32 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.243 0.544 . . . . 0.0 111.088 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.0 mt-10 -130.14 131.01 45.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.664 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.541 HD11 HG12 ' A' ' 40' ' ' ILE . 15.2 tp -125.15 120.35 31.12 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.613 ' O ' HG23 ' A' ' 39' ' ' THR . 53.6 m-20 -68.61 107.77 3.09 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.369 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.61 HD13 HD11 ' A' ' 12' ' ' LEU . 37.8 mt -60.36 -39.79 88.45 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.873 0.844 . . . . 0.0 109.621 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.662 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.5 p-10 -63.35 -5.04 3.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.758 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -107.63 -9.16 15.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.786 -179.338 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.541 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.62 10.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.527 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.91 132.4 68.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.7 158.18 22.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.426 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -112.02 114.2 26.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.777 0.322 . . . . 0.0 110.214 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -105.5 82.94 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.545 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 5.3 m-20 54.04 52.8 12.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.908 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.54 35.69 22.06 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -148.53 118.05 6.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.482 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.7 m-85 -63.97 134.99 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.165 0.507 . . . . 0.0 110.571 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -126.58 116.51 21.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.456 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -72.88 114.13 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.47 30.47 6.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.923 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.58 -50.44 1.2 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.895 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 23.4 tt0 70.68 144.97 0.06 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.127 0.571 . . . . 0.0 111.345 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 6.3 m-20 71.08 33.65 2.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.343 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.527 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.91 -27.46 39.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.933 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.554 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.9 p -65.72 -17.29 64.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.977 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.552 ' OE1' ' HB3' ' A' ' 54' ' ' ASN . 7.9 pt-20 -76.8 -18.19 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 109.852 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.534 HG22 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -123.31 9.79 9.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.473 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -118.85 144.05 46.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.24 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -136.02 166.93 22.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.095 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 45.74 55.86 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.459 HG23 HD23 ' A' ' 76' ' ' LEU . 3.2 mt -83.18 106.61 14.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.308 0.575 . . . . 0.0 110.806 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.537 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -109.86 118.43 36.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.562 ' HB2' HD21 ' A' ' 12' ' ' LEU . 7.1 t80 -93.1 128.59 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.065 0.459 . . . . 0.0 111.103 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.515 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 39.7 t60 -124.38 88.77 52.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.151 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 19.7 Cg_endo -59.99 -35.94 91.47 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 124.156 3.237 . . . . 0.0 115.163 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.459 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -127.07 90.25 3.12 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.587 -178.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 17.5 tt0 -69.97 109.54 4.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.52 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.36 -148.77 33.12 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.165 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.67 -1.05 53.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.377 0.608 . . . . 0.0 109.797 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.45 -20.08 30.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.584 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 54.87 43.17 30.4 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.706 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.48 ' HB2' ' HB3' ' A' ' 68' ' ' GLU . 15.6 mm100 -90.5 114.48 61.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.32 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 60.2 Cg_endo -72.87 112.36 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.154 1.903 . . . . 0.0 112.21 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.452 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -132.14 141.72 44.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 64' ' ' PHE . 1.8 tm? -114.93 122.57 46.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.537 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.93 140.42 50.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.345 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -156.63 166.67 32.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.298 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.2 mmt180 -85.58 114.75 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.589 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.4 mp -99.35 127.75 45.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.199 0.523 . . . . 0.0 111.164 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.607 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.38 142.84 29.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.636 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -99.62 172.94 6.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.127 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.13 -27.65 62.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -75.77 -28.19 58.32 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.707 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.63 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.636 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 9.6 pt-20 -105.98 -167.36 1.3 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -145.9 129.38 16.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.47 117.98 12.17 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.971 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.494 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.7 p-10 -66.61 114.01 5.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.0 111.706 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.531 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -115.78 172.21 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.69 146.45 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.482 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.0 p -128.2 150.64 34.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.74 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.457 ' HB3' HD21 ' A' ' 95' ' ' ASN . 78.2 m-20 -87.07 103.98 15.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.892 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.533 ' HB3' HD12 ' A' ' 97' ' ' ILE . 7.9 mt -75.43 0.53 16.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.81 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.491 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 26.0 m-80 -60.9 -19.94 61.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.7 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -65.73 -22.01 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.783 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.533 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.6 mt -82.95 128.39 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.184 0.516 . . . . 0.0 111.267 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -119.1 168.29 10.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.81 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.445 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -112.59 121.05 43.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.474 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -112.25 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.401 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.89 24.73 13.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.556 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.78 20.58 8.37 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.699 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.474 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.5 ptp180 -129.8 139.98 51.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.152 0.476 . . . . 0.0 110.037 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.434 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 76.0 mt -87.08 124.05 32.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 0.0 110.992 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.6 p -127.98 128.78 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -84.12 146.73 27.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.551 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.947 0.78 . . . . 0.0 111.266 178.492 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.869 0.366 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -162.74 -175.27 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -59.45 -34.32 72.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.306 0.574 . . . . 0.0 109.615 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.745 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.3 -25.47 34.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.196 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -53.84 -33.07 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.037 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.14 37.39 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.987 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.745 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.3 p -115.28 157.26 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 111.466 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.55 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -147.91 169.73 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.469 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 25.6 m-80 50.45 34.44 9.29 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.748 0.655 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.518 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -85.74 112.42 21.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.39 178.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.306 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.799 HD12 HD12 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.15 146.54 28.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.0 m -132.12 161.5 33.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.464 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.4 t-20 74.04 9.48 4.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.692 0.62 . . . . 0.0 111.178 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.74 24.85 22.22 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 97.07 23.16 15.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.98 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.551 ' HG2' HG23 ' A' ' 56' ' ' THR . 31.0 mtp180 -107.99 -17.07 14.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.588 0.232 . . . . 0.0 110.525 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.439 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.6 m -129.99 127.95 41.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.585 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.69 107.39 19.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.528 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmm_? -104.54 124.64 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.079 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.43 151.28 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.63 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.75 ' HG2' HG23 ' A' ' 32' ' ' THR . 13.8 mt-10 -113.06 110.96 21.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.1 t -123.17 147.5 46.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.476 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.77 143.68 43.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.922 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.475 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.5 p-10 -91.31 -175.09 4.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.809 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.37 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 111.463 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.76 -24.85 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.828 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.75 10.38 37.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.648 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.6 t-20 -96.13 146.79 24.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.427 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.8 m0 -77.07 121.43 23.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.475 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -120.5 120.89 64.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.724 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.75 HG23 ' HG2' ' A' ' 22' ' ' GLU . 11.2 m -81.73 109.47 16.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -113.26 150.74 32.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.137 0.494 . . . . 0.0 111.585 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.528 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.0 mt-10 -132.7 135.03 45.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.71 116.24 18.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.53 ' O ' HG21 ' A' ' 39' ' ' THR . 16.0 m-20 -68.32 109.81 3.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.526 0.679 . . . . 0.0 110.196 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.799 HD12 HD12 ' A' ' 12' ' ' LEU . 15.9 mt -61.42 -41.02 96.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -65.02 -4.91 5.19 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.192 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.53 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -104.66 -14.15 15.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.455 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.505 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -141.28 10.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.13 132.09 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.216 -0.303 . . . . 0.0 110.23 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.87 159.74 22.24 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.256 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -111.51 116.65 31.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 0.0 110.198 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.29 85.15 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 40.66 59.41 2.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.0 112.943 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 86.43 38.6 8.2 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.997 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 50.6 t-80 -162.11 124.23 2.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.451 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -67.07 138.81 57.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.109 0.48 . . . . 0.0 110.633 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.443 HE21 ' HB2' ' A' ' 49' ' ' GLN . 2.4 tt0 -130.1 116.94 19.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.607 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.9 m95 -69.42 115.64 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.642 178.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 30.13 6.35 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.199 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.539 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -100.5 -53.59 1.05 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.071 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.523 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.5 tt0 73.55 139.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.377 0.608 . . . . 0.0 111.738 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 t30 70.35 36.69 1.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.133 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -76.1 -26.93 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.041 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.551 HG23 ' HG2' ' A' ' 17' ' ' ARG . 36.3 p -63.66 -24.31 67.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.46 ' CG ' HG21 ' A' ' 58' ' ' THR . 1.7 pt-20 -70.24 -17.1 63.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.269 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.46 HG21 ' CG ' ' A' ' 57' ' ' GLU . 81.7 p -125.78 16.0 8.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.503 0.668 . . . . 0.0 109.984 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.94 150.1 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.623 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -143.4 172.5 12.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.479 -179.636 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.3 t70 48.22 57.22 6.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.082 0.467 . . . . 0.0 110.012 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.413 HG22 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -91.93 113.86 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.498 -177.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.69 129.67 39.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 178.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.647 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.5 t80 -92.29 139.63 30.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 112.223 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.516 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 5.5 t-160 -120.38 82.06 31.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.75 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.797 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.8 Cg_endo -55.88 -45.84 35.81 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 123.908 3.072 . . . . 0.0 114.539 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.797 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -124.52 85.31 2.4 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.107 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.516 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 5.1 tt0 -69.73 114.3 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.613 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.35 -145.41 6.09 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 124.596 1.185 . . . . 0.0 113.528 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.33 -5.81 58.84 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.62 -23.59 56.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.32 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 54.57 45.78 26.19 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.216 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -112.22 122.57 36.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.69 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.51 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.4 Cg_endo -72.5 110.85 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.476 2.118 . . . . 0.0 111.533 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -134.73 141.97 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.47 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.57 124.73 53.06 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.918 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.518 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.06 144.36 48.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.496 . . . . 0.0 110.498 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.04 170.55 19.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.87 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.623 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -85.48 114.86 22.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.64 HD23 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.15 126.37 46.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.682 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -73.6 136.29 43.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.261 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.08 173.18 7.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.185 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.54 -21.55 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.423 . . . . 0.0 110.729 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -71.68 -19.97 62.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.611 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.27 37.95 6.1 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.682 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.8 pt-20 -124.32 -162.92 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -138.36 139.28 38.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.769 0.795 . . . . 0.0 111.257 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -138.7 111.64 7.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.281 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.558 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.2 p-10 -63.4 111.92 2.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.692 0.758 . . . . 0.0 111.777 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.64 ' HB2' HD23 ' A' ' 80' ' ' LEU . 33.2 mmt180 -114.56 175.22 5.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 75' ' ' ILE . 5.9 p-10 -143.55 146.12 33.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.451 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.4 p -128.86 144.23 38.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.616 0.722 . . . . 0.0 111.096 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.445 ' HB3' HD21 ' A' ' 95' ' ' ASN . 36.9 m-20 -79.87 106.11 11.65 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.732 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.663 ' HB3' HD11 ' A' ' 97' ' ' ILE . 3.8 mt -78.57 1.83 21.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.51 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -59.92 -19.95 54.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.426 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.431 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -62.92 -22.95 67.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.188 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.663 HD11 ' HB3' ' A' ' 94' ' ' LEU . 14.2 mt -83.8 128.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.011 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.471 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 38.6 tt0 -122.4 162.34 21.79 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.944 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.471 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 4.8 t30 -102.01 117.91 35.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.179 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.432 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 51.3 t -113.0 95.82 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.343 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.29 23.36 13.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.239 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.06 8.23 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.428 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.453 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 17.9 ptp180 -130.39 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.807 0.304 . . . . 0.0 110.259 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.05 115.6 23.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.554 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.8 t -117.93 121.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -81.49 146.47 30.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.166 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 . . . . . 0 C--O 1.247 0.957 0 O-C-N 123.67 0.607 . . . . 0.0 111.372 178.329 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 tpp . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.607 0.241 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 p -174.16 -177.94 1.38 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.276 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -62.66 -32.93 74.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.562 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.73 -25.36 54.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -55.61 -32.51 63.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 110.923 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.0 m -133.04 32.3 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.562 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 65.8 m -116.53 156.51 26.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.593 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.6 ptp180 -153.41 168.79 24.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.616 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.537 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 55.6 t30 55.44 31.25 16.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.431 0.634 . . . . 0.0 110.806 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -78.24 114.73 17.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.904 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 153.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.739 HD12 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -89.23 146.0 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.4 m -131.68 165.47 23.63 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.4 t-20 71.81 8.31 6.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 111.638 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.21 25.08 14.88 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.524 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 95.33 27.96 10.25 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.783 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.589 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -112.71 -15.49 12.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.815 0.34 . . . . 0.0 110.413 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.417 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.2 m -129.85 130.23 44.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 0.0 111.717 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' HD23 ' A' ' 37' ' ' LEU . 57.1 tp -99.28 111.47 23.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.508 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.509 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -113.07 124.29 52.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.55 153.53 33.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.537 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 9.0 mt-10 -106.05 109.92 22.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -117.98 143.61 46.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.56 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.84 144.27 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.682 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -88.42 -173.7 4.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.952 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.35 67.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.99 -24.48 55.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.945 0.402 . . . . 0.0 111.294 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.46 0.76 32.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.512 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.5 t30 -82.8 143.56 30.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -77.5 129.14 35.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.38 123.72 65.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.558 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -77.29 107.79 9.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.467 ' HB2' HD12 ' A' ' 104' ' ' LEU . 5.8 m -110.3 143.44 40.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.305 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.509 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -128.06 143.51 51.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -141.82 120.53 12.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.569 ' O ' HG22 ' A' ' 39' ' ' THR . 14.4 m-20 -70.45 107.16 3.7 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 110.004 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.739 HD11 HD12 ' A' ' 12' ' ' LEU . 52.6 mt -60.69 -40.59 92.76 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.797 0.808 . . . . 0.0 109.675 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.558 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 5.2 p-10 -63.02 -4.95 2.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.569 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.86 -12.19 15.95 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.706 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.506 HG21 HG21 ' A' ' 39' ' ' THR . 2.4 pp -141.24 10.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.018 0.437 . . . . 0.0 112.11 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.32 129.36 70.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.487 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 158.1 21.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.189 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.431 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.0 t30 -111.56 114.73 28.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.111 0.481 . . . . 0.0 109.973 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -103.74 87.28 2.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.258 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 1.9 p30 45.24 57.51 4.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.561 0.744 . . . . 0.0 112.46 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.62 36.24 26.66 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.998 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -150.57 115.33 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.53 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.8 m-85 -61.8 135.72 57.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.634 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -129.69 115.06 16.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -69.67 114.89 8.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.0 5.95 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.823 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.526 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.11 -53.41 0.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.685 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.558 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.1 tt0 74.91 144.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.22 0.608 . . . . 0.0 110.961 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.694 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.7 m-20 68.36 36.94 2.86 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.265 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.26 -29.27 47.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.589 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.8 p -63.79 -23.28 67.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.044 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.694 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.9 pt-20 -71.39 -16.12 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 109.843 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.636 HG21 ' HG3' ' A' ' 57' ' ' GLU . 76.8 p -126.04 9.15 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -119.52 142.31 48.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.157 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 169.28 17.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.776 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.6 t70 47.22 54.91 8.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.072 0.463 . . . . 0.0 110.973 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.434 HG21 ' HB1' ' A' ' 78' ' ' ALA . 2.1 mt -88.57 109.45 20.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 124.45 41.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.803 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.62 ' CE1' HD13 ' A' ' 94' ' ' LEU . 14.3 t80 -92.08 137.19 32.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.718 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.705 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 10.5 t60 -123.97 86.71 53.57 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.976 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.561 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 5.7 Cg_endo -53.09 -41.0 75.0 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 124.575 3.517 . . . . 0.0 115.131 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.497 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.27 85.99 2.49 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.302 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.705 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 24.6 tt0 -66.54 115.49 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.217 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.09 -150.84 3.73 Favored Glycine 0 C--N 1.333 0.414 0 O-C-N 124.455 1.097 . . . . 0.0 113.449 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.84 -5.77 56.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 109.813 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -22.68 59.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.486 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 57.51 42.88 23.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.374 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -109.92 125.38 31.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.871 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.528 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.9 Cg_endo -73.22 112.93 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.754 2.303 . . . . 0.0 112.206 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 pp -134.45 140.71 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.522 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -110.78 125.02 53.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.497 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -119.31 139.86 51.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.652 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB1' HG21 ' A' ' 62' ' ' ILE . . . -161.77 168.36 23.33 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.043 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.555 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 4.2 mmt85 -85.82 114.86 23.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.613 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.3 131.73 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.897 0.38 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.66 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -77.0 137.45 39.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.85 168.94 10.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.418 ' SG ' ' HB3' ' A' ' 45' ' ' ASP . 72.2 m -54.17 -28.32 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.862 0.363 . . . . 0.0 111.602 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -67.19 -25.11 65.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 111.558 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.29 33.51 5.67 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.66 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -118.07 -160.37 0.78 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.974 -0.613 . . . . 0.0 109.611 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -142.61 137.56 30.13 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.815 0.817 . . . . 0.0 111.204 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.56 117.45 13.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.499 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.0 p-10 -66.11 113.28 4.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.572 ' HB2' HD23 ' A' ' 80' ' ' LEU . 33.6 mmt180 -115.05 172.23 7.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.86 151.61 47.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.53 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.8 p -139.68 144.68 28.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.38 0.61 . . . . 0.0 110.755 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.474 ' HB3' HD21 ' A' ' 95' ' ' ASN . 31.0 m-80 -81.69 110.31 16.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.756 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.62 HD13 ' CE1' ' A' ' 64' ' ' PHE . 4.7 mt -79.33 3.02 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.115 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.474 HD21 ' HB3' ' A' ' 93' ' ' ASN . 25.8 m-80 -62.86 -18.29 62.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.405 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.55 -28.36 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.908 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -77.75 130.19 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.494 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -125.96 166.28 17.23 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.553 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.3 t30 -109.06 123.9 49.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.41 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.69 94.04 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.0 t30 58.82 27.15 15.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.916 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 20.96 7.97 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.814 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 12.7 ptp180 -131.25 139.6 49.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.356 0.578 . . . . 0.0 110.612 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.467 HD12 ' HB2' ' A' ' 33' ' ' SER . 1.8 mp -90.29 124.9 35.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.792 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.23 130.65 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.435 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.447 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 3.3 p90 -79.97 145.16 32.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.475 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.489 0.493 . . . . 0.0 111.114 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.723 0.297 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -153.44 -177.42 6.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -64.13 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.712 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.13 -23.25 54.41 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.798 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.93 -23.37 63.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 111.038 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.0 m -148.6 38.03 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.712 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.8 p -116.74 153.29 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.421 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.467 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 9.6 t-20 54.23 30.64 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.534 0.522 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -75.12 113.54 12.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -143.38 149.17 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.934 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.79 HD12 HD13 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -84.04 144.56 29.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.7 m -131.33 161.36 32.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.655 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.534 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.54 10.44 5.68 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 123.559 0.537 . . . . 0.0 111.237 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.13 24.84 23.61 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.453 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.507 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 96.86 22.02 19.31 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.851 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.558 ' HG2' HG22 ' A' ' 56' ' ' THR . 30.6 mtp180 -104.85 -19.03 14.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.626 0.251 . . . . 0.0 110.407 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 34.5 m -130.44 126.75 37.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.779 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.454 ' CD2' HD13 ' A' ' 97' ' ' ILE . 61.0 tp -96.97 109.55 22.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.517 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.431 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.1 tmm_? -109.08 124.24 50.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.52 149.91 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.0 mt-10 -104.67 112.2 25.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.9 p -124.21 147.51 47.98 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 111.844 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.418 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.29 144.52 36.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.575 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 8.5 p30 -86.07 -175.0 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.52 69.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.84 -23.51 59.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.56 3.2 30.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.959 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.445 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 5.2 t30 -86.07 145.57 27.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.113 0.456 . . . . 0.0 110.078 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -74.14 126.03 29.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.718 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.2 t -126.99 128.97 71.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -86.7 112.99 22.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 t -112.1 151.81 28.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.039 0.447 . . . . 0.0 110.749 -178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.431 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -139.05 132.0 29.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.196 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.585 HD11 HG12 ' A' ' 40' ' ' ILE . 12.8 tp -133.76 123.99 25.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.01 0.433 . . . . 0.0 110.122 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' HG23 ' A' ' 39' ' ' THR . 38.9 m-20 -72.21 108.36 5.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.79 HD13 HD12 ' A' ' 12' ' ' LEU . 24.8 mt -59.53 -45.88 90.49 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.087 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.433 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -63.97 -5.08 3.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.674 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.513 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.73 -9.79 20.54 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.056 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.585 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.23 11.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 111.669 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.64 132.55 68.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.463 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.03 157.97 21.32 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.774 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.3 t30 -110.13 106.31 15.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.48 80.99 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.189 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 51.15 56.64 7.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.143 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.53 39.32 18.52 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.273 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -157.41 117.78 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 0.0 110.366 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.4 m-85 -61.95 137.76 58.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.315 0.578 . . . . 0.0 111.701 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -133.36 118.47 18.51 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.03 115.22 10.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 29.21 6.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.13 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.463 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.99 -53.26 1.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.086 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.501 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 35.1 tt0 72.13 141.93 0.06 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.309 0.644 . . . . 0.0 111.136 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.564 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 79.9 m-20 76.83 30.63 0.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.937 0.895 . . . . 0.0 110.997 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.5 p90 -78.0 -29.28 49.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.374 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.558 HG22 ' HG2' ' A' ' 17' ' ' ARG . 53.8 p -66.02 -25.16 66.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.558 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.564 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 4.7 pt-20 -70.63 -19.3 62.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.273 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.547 HG22 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -122.68 15.74 10.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.332 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.92 151.22 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.59 173.09 11.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.251 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 5.6 t70 47.53 52.41 12.47 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.563 0.54 . . . . 0.0 110.449 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.39 108.75 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.333 0.587 . . . . 0.0 111.74 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.52 123.16 39.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.561 178.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.634 ' CE1' HD13 ' A' ' 94' ' ' LEU . 9.8 t80 -91.77 133.81 35.28 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.015 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.764 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 2.1 t60 -121.67 86.54 45.15 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.491 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.2 Cg_endo -56.34 -38.6 94.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.754 2.969 . . . . 0.0 113.727 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.596 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -130.48 88.22 2.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.46 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.764 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 16.9 tt0 -69.66 115.72 9.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.949 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.21 -146.47 14.97 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.536 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.75 -14.38 59.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.13 -27.21 62.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 52.0 46.95 25.72 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.178 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -99.47 122.74 50.64 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.631 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.438 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.8 Cg_endo -72.75 109.03 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.365 2.043 . . . . 0.0 112.0 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -135.26 141.61 42.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.531 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.3 tm? -112.04 123.41 50.19 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.91 138.75 53.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.609 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.35 168.19 27.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.006 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.9 mmt180 -85.79 115.0 23.18 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.591 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -98.45 124.36 43.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -79.48 142.18 36.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.541 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 2.6 p-10 -97.71 175.98 5.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.8 m -61.4 -22.44 65.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.99 -27.78 43.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.436 . . . . 0.0 110.574 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.8 33.21 2.68 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.829 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 -109.47 -162.46 0.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.66 130.2 16.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.268 0.556 . . . . 0.0 110.294 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.19 117.76 13.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.157 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.9 p-10 -66.68 120.07 12.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.438 0.637 . . . . 0.0 112.209 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.53 ' HB2' HD23 ' A' ' 80' ' ' LEU . 32.3 mmt180 -116.42 177.67 4.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -143.91 147.51 34.09 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.2 p -135.3 144.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.791 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.439 ' HB3' HD21 ' A' ' 95' ' ' ASN . 60.7 m-20 -81.53 110.12 16.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.634 HD13 ' CE1' ' A' ' 64' ' ' PHE . 5.9 mt -78.24 2.45 18.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.439 HD21 ' HB3' ' A' ' 93' ' ' ASN . 19.6 m-80 -63.61 -16.19 60.23 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -25.05 67.45 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.538 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.625 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.9 mt -80.11 121.47 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.783 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -113.7 164.01 14.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.019 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.0 t30 -107.13 116.38 31.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.71 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.587 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 60.6 t -112.16 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.06 0.457 . . . . 0.0 110.279 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.18 24.73 14.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.762 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.4 19.14 9.57 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.509 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -130.59 142.81 50.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.039 0.42 . . . . 0.0 110.606 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 2.0 mp -85.01 119.24 25.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.0 179.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.31 123.59 70.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.885 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -81.69 145.17 30.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.452 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.596 178.369 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.516 ' HE3' ' HA ' ' A' ' 5' ' ' ASP . 3.1 ptt? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.443 ' H ' ' HG3' ' A' ' 1' ' ' MET . 3.3 m -138.58 -165.37 1.81 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -54.5 -36.34 64.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.506 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.17 -25.89 35.39 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.787 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . 0.516 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 20.4 t70 -57.54 -31.8 66.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.209 0.528 . . . . 0.0 110.631 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.1 m -130.15 34.96 4.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.971 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.1 m -117.32 158.54 24.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 0.0 112.027 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -155.97 166.22 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.966 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.43 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.8 t-20 54.71 33.97 20.63 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.619 0.574 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.549 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.87 113.85 16.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.217 0.532 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.71 155.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.735 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.576 HD13 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -94.79 135.29 36.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.419 HG23 ' N ' ' A' ' 14' ' ' ASN . 11.2 m -120.31 165.36 14.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.691 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.0 t-20 74.12 5.98 4.72 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.575 0.547 . . . . 0.0 111.067 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.94 16.16 39.67 Favored Glycine 0 CA--C 1.506 -0.48 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 105.3 27.03 5.99 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.571 ' HG2' HG22 ' A' ' 56' ' ' THR . 28.1 mtp180 -110.86 -18.16 13.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.645 0.26 . . . . 0.0 110.455 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 63.1 m -129.6 128.46 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.369 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.446 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.9 tp -97.85 110.05 22.69 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.627 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.539 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.3 tmm_? -108.47 124.16 49.99 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.71 151.32 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.949 0.404 . . . . 0.0 110.191 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.2 mt-10 -106.94 113.17 26.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' SER . 7.8 p -124.22 146.78 48.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.184 0.516 . . . . 0.0 112.228 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.58 144.88 39.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.02 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -86.25 -173.17 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.804 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.19 73.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.149 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.58 -24.19 63.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.726 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.7 44.23 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.463 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.3 t-20 -84.35 144.89 28.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.169 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -76.25 121.19 22.56 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 t -120.67 154.99 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.374 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -107.53 112.96 25.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.468 ' HB2' HD12 ' A' ' 104' ' ' LEU . 11.6 m -112.97 144.23 42.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.237 0.541 . . . . 0.0 111.386 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.539 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.2 mt-10 -132.8 131.52 41.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.623 HD12 HG12 ' A' ' 40' ' ' ILE . 12.1 tp -131.49 120.53 23.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.191 0.519 . . . . 0.0 109.907 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.586 ' O ' HG21 ' A' ' 39' ' ' THR . 36.0 m-20 -70.04 110.01 4.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.179 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.576 HD11 HD13 ' A' ' 12' ' ' LEU . 37.7 mt -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.874 0.845 . . . . 0.0 109.151 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.5 OUTLIER -63.22 -3.66 2.0 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.548 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.586 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.89 -14.62 15.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.326 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.623 HG12 HD12 ' A' ' 35' ' ' LEU . 2.6 pp -141.7 13.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.561 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.53 131.89 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.21 158.12 21.46 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.569 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.432 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.8 t30 -110.35 106.79 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.05 84.13 3.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 53.09 59.32 4.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.258 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.56 40.27 39.21 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.729 -1.225 . . . . 0.0 111.969 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -160.32 121.15 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 49.4 m-85 -63.69 138.83 58.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 111.228 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -134.48 117.08 15.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -69.51 115.79 9.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.883 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.7 36.79 3.89 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.219 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.543 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.25 -52.12 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.615 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.475 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.7 tt0 73.57 143.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.56 0.695 . . . . 0.0 111.976 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t30 66.64 31.76 7.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.421 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.561 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -69.46 -27.38 65.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.571 HG22 ' HG2' ' A' ' 17' ' ' ARG . 17.0 p -64.38 -17.6 63.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.513 ' HG3' HG22 ' A' ' 58' ' ' THR . 5.5 pt-20 -72.7 -21.78 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.513 HG22 ' HG3' ' A' ' 57' ' ' GLU . 66.6 p -122.91 12.91 9.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -121.86 145.7 47.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.223 0.535 . . . . 0.0 111.311 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.59 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.5 171.27 14.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.222 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.417 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.1 t70 45.45 56.1 6.0 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.538 0.524 . . . . 0.0 110.963 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.487 HG21 ' HB2' ' A' ' 78' ' ' ALA . 2.3 mt -88.42 111.28 22.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.051 0.453 . . . . 0.0 112.03 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 125.25 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.91 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.561 ' CE1' HD12 ' A' ' 94' ' ' LEU . 25.3 t80 -91.09 137.05 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.297 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.639 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.6 t-160 -121.27 86.76 43.68 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.316 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.549 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 8.5 Cg_endo -57.4 -44.58 41.31 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.442 2.761 . . . . 0.0 113.921 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -123.43 84.12 2.23 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.802 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.639 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 2.2 tt0 -66.92 120.17 13.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.24 -140.73 2.55 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 124.574 1.172 . . . . 0.0 114.096 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.82 -11.71 58.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.6 -27.29 63.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.65 46.17 23.24 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.2 129.18 25.07 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.364 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HG3' ' HB3' ' A' ' 4' ' ' ALA . 56.5 Cg_endo -73.21 110.0 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.737 2.291 . . . . 0.0 112.141 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 pp -136.5 141.98 39.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.508 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.5 124.96 53.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.333 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.495 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.93 145.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.006 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.487 ' HB2' HG21 ' A' ' 62' ' ' ILE . . . -162.14 169.7 20.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.59 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.1 mmt180 -86.89 115.33 24.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.579 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.6 mp -99.35 123.0 43.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.025 0.44 . . . . 0.0 110.762 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.62 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.36 137.55 39.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.359 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -96.83 170.48 9.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.2 m -58.05 -25.17 60.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -71.96 -18.89 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.931 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.76 36.9 5.41 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.994 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.62 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.8 pt-20 -118.7 -161.7 0.86 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -141.38 135.13 30.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.968 0.89 . . . . 0.0 111.133 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -130.68 108.13 9.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.551 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.7 p-10 -67.1 112.37 4.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.371 0.605 . . . . 0.0 110.61 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HB2' HD23 ' A' ' 80' ' ' LEU . 35.9 mmt180 -113.62 177.41 4.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.726 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.17 148.9 39.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.1 p -136.81 145.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.375 0.607 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' HB3' HD21 ' A' ' 95' ' ' ASN . 13.5 m120 -83.11 114.03 21.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.153 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.561 HD12 ' CE1' ' A' ' 64' ' ' PHE . 2.2 mt -82.02 2.11 32.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 111.106 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.428 HD21 ' HB3' ' A' ' 93' ' ' ASN . 25.2 m-80 -63.45 -10.48 17.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.299 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.587 ' HD2' ' N ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -70.27 -20.13 63.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.017 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.514 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.3 mt -85.18 131.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.63 159.19 27.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.231 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.9 t30 -106.28 118.97 38.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.536 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 39.4 t -113.0 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.035 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 60.07 21.87 11.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.825 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.43 23.39 6.32 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.55 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.5 ptp180 -132.57 141.07 48.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.122 0.461 . . . . 0.0 110.594 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.468 HD12 ' HB2' ' A' ' 33' ' ' SER . 1.2 mp -89.9 118.17 29.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.653 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.75 127.3 68.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.321 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -82.75 144.91 29.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.583 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.317 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.581 0.229 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -152.39 -178.14 6.64 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -63.96 -38.44 91.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.049 0.452 . . . . 0.0 109.783 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.63 -24.5 21.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.52 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.51 -29.9 59.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -138.78 35.04 2.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.7 m -115.92 155.67 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 111.825 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.76 164.5 36.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.552 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 53.3 36.34 22.54 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.615 0.572 . . . . 0.0 111.484 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.528 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -77.44 113.43 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.691 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 t -142.28 150.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.87 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.546 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.1 tp -85.91 143.98 27.91 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 14' ' ' ASN . 12.9 m -130.37 162.44 29.08 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.5 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.4 t-20 73.76 9.14 4.88 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 0.0 111.216 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.95 19.45 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 96.79 21.0 22.56 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.074 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.551 ' HG2' HG23 ' A' ' 56' ' ' THR . 31.5 mtp180 -102.74 -18.16 15.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.728 0.299 . . . . 0.0 110.697 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 92.9 m -130.49 129.24 42.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.098 0.475 . . . . 0.0 111.773 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 37' ' ' LEU . 56.9 tp -95.6 110.86 22.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.278 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.7 tmm_? -109.05 123.75 49.66 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.44 145.17 29.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.417 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.0 mt-10 -102.05 110.69 22.73 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.449 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.4 t -125.9 147.84 49.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 111.754 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.517 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.68 145.64 38.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.37 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -87.16 -172.85 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.459 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.02 -14.29 62.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.256 0.55 . . . . 0.0 111.773 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.23 -17.22 31.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.252 0.549 . . . . 0.0 110.141 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.03 56.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.547 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.517 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 63.2 t30 -90.47 145.99 24.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -79.8 126.66 31.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.029 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.862 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -91.06 113.38 25.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.471 ' HB2' HD12 ' A' ' 104' ' ' LEU . 2.3 m -110.75 142.6 42.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.094 0.473 . . . . 0.0 111.89 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.83 131.5 42.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.051 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.19 122.89 24.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.092 0.472 . . . . 0.0 110.128 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.448 ' O ' HG22 ' A' ' 39' ' ' THR . 74.1 m-20 -69.37 109.45 4.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.323 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.529 HD11 HD13 ' A' ' 12' ' ' LEU . 18.9 mt -61.89 -43.17 99.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.742 0.782 . . . . 0.0 109.655 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.428 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.23 -4.65 1.86 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.516 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.455 HG21 HG21 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -102.35 -15.06 16.67 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.355 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.472 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.6 pp -141.54 13.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.54 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -128.08 129.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.08 154.84 20.02 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.617 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.452 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -111.06 111.42 22.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.381 . . . . 0.0 110.154 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.09 85.25 2.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.984 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 6.7 m-20 50.0 58.73 5.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.623 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 80.57 34.31 28.75 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.746 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -153.28 119.58 5.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.577 0.227 . . . . 0.0 111.148 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.481 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 48.8 m-85 -67.19 137.59 56.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.226 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -133.2 117.14 17.08 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -68.61 116.15 8.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.776 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.33 25.98 8.5 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.946 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.54 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.42 -52.63 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.917 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 2.8 tt0 74.59 143.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.52 0.676 . . . . 0.0 111.883 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 t30 68.52 35.41 3.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.357 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.54 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.6 p90 -76.9 -24.35 52.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.611 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.551 HG23 ' HG2' ' A' ' 17' ' ' ARG . 13.1 p -67.58 -21.57 65.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.925 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.543 ' HG3' HG21 ' A' ' 58' ' ' THR . 0.1 OUTLIER -74.85 -15.8 60.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.254 0.549 . . . . 0.0 109.713 179.568 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.543 HG21 ' HG3' ' A' ' 57' ' ' GLU . 77.9 p -126.14 14.18 7.82 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.061 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.47 141.33 52.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.755 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.679 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -135.52 168.97 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.501 -179.228 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.463 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 48.65 50.99 16.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.105 0.479 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.4 HG22 ' HB2' ' A' ' 78' ' ' ALA . 2.6 mt -83.58 112.41 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.43 123.07 37.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.684 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.3 t80 -92.09 131.18 37.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.684 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.507 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 20.8 t60 -120.19 87.15 39.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.528 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 9.9 Cg_endo -55.21 -33.18 83.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 124.387 3.391 . . . . 0.0 115.279 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -131.82 91.64 3.01 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.502 -178.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.507 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 33.7 tt0 -65.24 114.12 4.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.086 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.61 -147.18 6.77 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.595 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.91 -0.58 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.159 0.504 . . . . 0.0 110.086 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.69 -19.66 37.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.418 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 23.5 mm-40 57.26 42.27 25.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.107 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -101.8 118.73 58.88 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.525 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 57.2 Cg_endo -71.07 114.02 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.508 2.139 . . . . 0.0 112.898 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.414 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 141.59 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.53 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -113.3 127.97 56.32 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.298 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.498 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.48 141.35 51.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 110.315 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.497 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.43 168.17 25.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.003 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.679 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.8 mmt180 -85.25 115.44 23.03 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.605 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -98.13 120.9 39.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 111.627 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.14 141.56 30.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.583 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.04 173.58 6.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.183 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.409 ' HG ' ' CG ' ' A' ' 45' ' ' ASP . 78.1 m -59.25 -25.1 63.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -75.03 -27.37 60.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 110.413 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.37 38.39 2.11 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.497 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 pt-20 -109.84 -167.19 1.17 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.78 128.94 15.64 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.381 0.61 . . . . 0.0 109.78 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.58 110.79 6.96 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.578 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.0 p-10 -58.8 120.2 8.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.999 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.605 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.5 mmt180 -120.87 173.43 7.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.065 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.42 144.33 33.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.481 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 p -131.03 148.8 33.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.362 0.601 . . . . 0.0 111.389 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.412 ' HB3' HD21 ' A' ' 95' ' ' ASN . 0.8 OUTLIER -82.04 107.28 14.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.751 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.673 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.3 mt -79.85 5.57 13.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.525 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 16.1 m-80 -65.28 -17.18 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.041 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.94 -25.31 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.386 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.529 HD11 ' HB3' ' A' ' 94' ' ' LEU . 12.2 mt -79.13 129.87 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.207 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -124.09 163.39 21.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.59 122.06 45.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.954 0.407 . . . . 0.0 110.733 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.409 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 60.9 t -112.63 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.521 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 60.79 19.19 9.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 111.523 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.47 20.55 8.51 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.068 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.409 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 15.8 ptp180 -130.14 138.01 50.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.471 HD12 ' HB2' ' A' ' 33' ' ' SER . 2.1 mp -84.14 123.73 30.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.64 127.65 56.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -79.16 145.6 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.404 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -165.4 176.3 8.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -59.54 -35.9 75.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.788 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.97 -24.56 54.02 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.733 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.51 -33.16 67.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.71 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -129.09 31.42 4.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.788 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 37.5 p -121.14 155.92 33.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -151.21 170.49 19.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.528 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.2 m120 54.79 30.92 14.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.533 0.521 . . . . 0.0 111.34 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -75.7 114.23 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.602 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.4 t -142.39 149.64 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.858 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.556 HD12 HD13 ' A' ' 37' ' ' LEU . 1.2 tp -86.35 138.36 31.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.453 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 14.1 m -123.24 164.0 19.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.629 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.5 t-20 71.33 9.58 6.55 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.552 0.533 . . . . 0.0 111.259 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.63 17.19 46.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 107.4 19.43 9.35 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.069 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG2' HG23 ' A' ' 56' ' ' THR . 25.1 mtp180 -102.77 -20.0 14.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 110.675 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.453 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.6 m -128.45 126.75 41.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 0.0 111.811 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.448 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -96.66 105.55 17.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.96 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 tmm_? -101.38 123.61 45.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.53 140.94 22.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.642 0.258 . . . . 0.0 110.552 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.528 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 4.0 mt-10 -98.55 109.48 22.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.1 p -118.1 142.29 47.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.19 0.519 . . . . 0.0 111.42 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.93 143.13 47.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.889 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -91.17 -174.05 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.56 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.27 -26.74 63.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.1 -24.0 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.951 0.405 . . . . 0.0 111.258 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.64 4.83 42.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.637 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.9 t-20 -91.03 144.57 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.44 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.9 m0 -77.21 126.52 31.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.963 0.411 . . . . 0.0 110.815 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -120.49 125.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 m -74.93 107.28 6.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.523 ' CB ' ' HG ' ' A' ' 104' ' ' LEU . 13.8 m -111.22 143.42 42.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.177 0.513 . . . . 0.0 111.365 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 10.2 mt-10 -130.19 131.78 45.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.565 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 113.77 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 39' ' ' THR . 26.9 m-20 -67.43 108.72 2.91 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.782 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.556 HD13 HD12 ' A' ' 12' ' ' LEU . 26.5 mt -60.71 -39.46 88.66 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.797 0.808 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.631 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -64.12 -3.82 3.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.666 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.68 -14.51 15.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.254 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.528 HG21 HG22 ' A' ' 39' ' ' THR . 2.5 pp -140.43 13.95 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.56 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -129.29 131.45 67.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.86 157.81 22.02 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.353 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -111.8 112.73 24.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.847 0.355 . . . . 0.0 110.472 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -106.9 86.46 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 22.1 m-20 53.68 52.25 13.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.153 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.613 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.31 37.95 23.05 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.746 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.59 120.98 7.35 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.463 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.5 m-85 -67.24 132.72 48.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.038 0.447 . . . . 0.0 110.98 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -125.18 117.61 24.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.218 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.46 115.36 10.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.584 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 22.03 11.63 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.347 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.521 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -90.18 -51.18 2.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.987 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.631 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.8 tt0 72.57 142.14 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.414 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 6.6 t-20 67.04 38.83 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.987 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.56 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.27 -26.7 47.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.709 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.576 HG23 ' HG2' ' A' ' 17' ' ' ARG . 41.6 p -64.01 -21.95 66.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.627 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.576 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.9 pt-20 -74.65 -14.05 60.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.114 0.483 . . . . 0.0 109.998 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.576 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.8 p -128.35 15.93 6.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.86 148.91 52.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.904 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.549 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -142.59 172.7 12.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.888 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.455 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 2.0 t70 46.7 53.35 10.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.556 0.535 . . . . 0.0 110.778 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.427 HG23 ' HB1' ' A' ' 78' ' ' ALA . 2.3 mt -85.31 114.17 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.42 0.629 . . . . 0.0 111.707 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.508 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.91 120.47 29.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.129 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.605 ' CE1' HD11 ' A' ' 94' ' ' LEU . 12.0 t80 -92.22 132.27 36.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.717 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.416 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 3.0 t60 -123.55 89.31 51.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.428 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 11.9 Cg_endo -59.04 -38.4 87.74 Favored 'Trans proline' 0 N--CA 1.479 0.662 0 C-N-CA 124.106 3.204 . . . . 0.0 115.085 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.87 83.52 2.08 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.885 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.06 110.42 1.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.984 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.29 -141.71 16.03 Favored Glycine 0 C--N 1.332 0.324 0 O-C-N 123.944 0.777 . . . . 0.0 113.968 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.38 -5.66 59.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.382 0.61 . . . . 0.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.99 -20.6 38.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 52.8 42.49 31.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -94.4 119.35 66.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.94 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.2 Cg_endo -71.71 110.46 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.16 1.907 . . . . 0.0 112.24 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.463 HD13 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.43 141.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.515 HD22 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.84 125.31 53.93 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.136 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.508 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.24 140.76 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 110.235 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.53 168.51 25.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.549 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -86.23 115.07 23.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.613 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 2.3 mp -99.15 126.51 44.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -81.96 142.25 32.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.798 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.632 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -100.66 174.19 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.063 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.95 -24.27 62.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -77.13 -28.21 54.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.28 0.562 . . . . 0.0 110.103 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.11 40.05 1.73 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.945 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.1 pt-20 -111.35 -167.18 1.15 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -142.75 127.81 18.51 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 113.89 12.34 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.521 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 6.6 p-10 -65.87 114.65 5.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.486 0.66 . . . . 0.0 111.507 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.575 ' HB2' HD23 ' A' ' 80' ' ' LEU . 38.4 mmt180 -114.27 179.56 3.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.938 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.12 148.87 39.03 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.463 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -133.05 140.05 48.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.806 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.484 ' HB3' HD21 ' A' ' 95' ' ' ASN . 5.8 m-20 -82.76 104.99 13.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.174 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.605 HD11 ' CE1' ' A' ' 64' ' ' PHE . 7.1 mt -74.0 1.41 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.586 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.484 HD21 ' HB3' ' A' ' 93' ' ' ASN . 28.9 m-80 -61.28 -17.53 53.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.322 0.582 . . . . 0.0 109.779 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -25.58 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.149 178.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.572 HD13 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -80.81 126.84 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.752 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -117.46 163.09 16.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.809 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.7 t30 -107.88 120.31 41.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.127 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.494 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.3 t -114.02 94.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.503 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.27 27.97 17.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.222 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.04 26.34 7.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.617 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.8 ptp180 -133.15 137.08 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.991 0.395 . . . . 0.0 110.297 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.523 ' HG ' ' CB ' ' A' ' 33' ' ' SER . 74.6 mt -85.6 122.66 30.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.774 0.321 . . . . 0.0 110.188 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.4 t -132.85 128.04 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.523 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -79.24 146.02 33.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 -179.737 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.616 0.246 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.612 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 41.5 p 174.56 -179.38 0.11 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -56.33 -30.3 62.4 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.329 0.585 . . . . 0.0 109.639 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.715 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.86 -21.74 63.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.735 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.21 -30.67 68.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 m -139.18 39.43 2.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.749 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.715 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 89.3 p -113.64 156.98 22.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -149.03 163.28 37.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.427 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 92.5 m-20 51.42 35.48 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.909 0.756 . . . . 0.0 111.429 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -76.59 112.61 13.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.755 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 t -142.99 155.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.808 HD11 HD12 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -89.02 148.43 23.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.3 m -131.89 162.01 31.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.362 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 3.7 t-20 70.62 12.76 7.33 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 123.699 0.625 . . . . 0.0 111.327 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.47 19.2 33.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.565 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.427 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 100.69 24.04 9.6 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.563 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.5 mtp180 -105.56 -19.44 13.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.545 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.0 m -129.79 125.84 36.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.295 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.474 ' HA ' HD12 ' A' ' 12' ' ' LEU . 48.5 tp -94.08 107.36 19.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.426 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.527 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 tmm_? -102.03 123.12 45.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.452 ' HB2' HD13 ' A' ' 104' ' ' LEU . . . -148.19 138.86 22.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.926 0.394 . . . . 0.0 110.655 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.447 ' HG2' HG22 ' A' ' 32' ' ' THR . 4.3 mt-10 -103.24 110.76 22.85 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.7 t -124.12 146.86 48.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 111.085 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.477 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.84 145.28 45.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.732 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -83.41 -172.08 3.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -33.6 74.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.951 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.34 -24.41 59.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.212 0.53 . . . . 0.0 110.776 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.83 8.47 27.97 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.855 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 59.0 t30 -86.15 145.08 27.16 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -77.64 117.8 19.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.066 0.46 . . . . 0.0 111.1 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.92 153.15 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.6 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.447 HG22 ' HG2' ' A' ' 22' ' ' GLU . 47.4 m -114.68 122.3 46.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.903 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t -124.52 151.15 45.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 0.0 110.493 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.527 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -133.62 131.23 39.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.627 HD13 HG12 ' A' ' 40' ' ' ILE . 14.2 tp -127.47 120.29 28.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 0.0 110.278 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.557 ' O ' HG21 ' A' ' 39' ' ' THR . 32.3 m-20 -68.41 107.5 2.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.737 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.808 HD12 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -62.2 -40.47 96.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.724 0.773 . . . . 0.0 109.227 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.1 p-10 -64.31 -4.95 4.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.528 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.557 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -106.21 -12.06 15.85 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.414 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.627 HG12 HD13 ' A' ' 35' ' ' LEU . 2.6 pp -141.71 11.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 112.083 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.536 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.3 mt -128.1 131.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.52 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.48 157.64 20.94 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.782 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -111.62 108.4 17.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.998 0.428 . . . . 0.0 110.094 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -96.5 78.1 2.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.628 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . 72.6 m-20 48.97 63.77 1.99 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.057 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.549 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.11 34.69 36.68 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.542 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -155.41 114.74 3.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.762 -0.257 . . . . 0.0 110.576 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.487 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.0 m-85 -60.75 140.99 57.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 111.389 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.66 117.33 16.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.502 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -71.66 115.11 10.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.8 28.15 7.56 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.843 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.52 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -97.41 -52.48 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.452 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.7 tt0 73.26 141.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.263 0.625 . . . . 0.0 111.475 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.6 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 7.4 m-20 71.0 34.56 1.84 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.631 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.536 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.9 p90 -77.5 -31.11 53.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.563 HG21 ' HG2' ' A' ' 17' ' ' ARG . 26.8 p -62.54 -26.65 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.931 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 17.7 pt-20 -70.31 -14.85 62.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.325 0.583 . . . . 0.0 109.955 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.546 HG22 ' HG3' ' A' ' 57' ' ' GLU . 70.1 p -127.03 13.97 7.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.3 145.09 51.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.144 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.543 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.16 172.63 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.606 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.459 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 49.14 48.36 20.99 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.059 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.37 108.2 15.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.0 111.43 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -125.08 125.63 44.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.66 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.674 ' CE1' HD11 ' A' ' 94' ' ' LEU . 8.9 t80 -92.28 134.78 34.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.351 0.596 . . . . 0.0 111.879 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.497 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 1.6 t60 -121.65 85.3 43.82 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.156 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.498 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -53.91 -35.5 80.31 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.15 3.233 . . . . 0.0 114.472 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.498 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -131.69 86.2 2.32 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.436 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 27.3 tt0 -63.36 116.55 5.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.92 -144.18 10.28 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 124.415 1.072 . . . . 0.0 113.83 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.76 -16.01 52.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.46 0.648 . . . . 0.0 109.55 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.96 -24.08 65.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.357 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 52.24 52.47 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.71 0.631 . . . . 0.0 110.56 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -110.89 122.14 38.9 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.802 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.452 ' HG3' ' HB1' ' A' ' 4' ' ' ALA . 59.0 Cg_endo -71.51 110.65 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.302 2.002 . . . . 0.0 112.033 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.666 HD12 HH21 ' A' ' 77' ' ' ARG . 1.3 pp -135.76 141.54 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.8 tm? -111.84 124.14 51.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.666 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.98 142.66 47.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.4 167.83 26.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.543 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.2 mmt180 -86.27 114.55 23.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.549 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.5 mp -99.19 126.97 45.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.368 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.661 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -82.92 143.34 30.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.1 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 45' ' ' ASP . 9.9 t70 -105.76 167.24 9.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.987 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.401 ' HG ' ' CG ' ' A' ' 45' ' ' ASP . 98.6 m -51.26 -31.25 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.359 0.412 . . . . 0.0 111.784 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.06 -26.71 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.357 0.599 . . . . 0.0 110.908 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.87 38.8 3.76 Favored Glycine 0 CA--C 1.504 -0.616 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.59 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.661 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 24.4 pt-20 -118.34 -169.45 1.71 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.16 137.55 32.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.673 0.749 . . . . 0.0 111.011 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.16 112.78 8.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.207 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.479 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -63.32 110.35 1.88 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.635 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.488 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.7 mmt180 -115.09 170.45 8.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.456 ' HB2' HD11 ' A' ' 75' ' ' ILE . 3.4 p30 -135.98 153.96 51.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.487 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -138.73 144.74 29.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.398 0.618 . . . . 0.0 110.685 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.442 ' HB3' HD21 ' A' ' 95' ' ' ASN . 1.0 OUTLIER -80.2 111.39 16.52 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.854 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.674 HD11 ' CE1' ' A' ' 64' ' ' PHE . 6.6 mt -82.32 4.59 23.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.489 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.442 HD21 ' HB3' ' A' ' 93' ' ' ASN . 25.4 m-80 -63.35 -18.65 63.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.153 0.502 . . . . 0.0 109.799 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.421 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.98 -24.48 67.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.075 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.636 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.2 mt -80.36 127.49 39.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.358 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.612 ' NE2' ' HA ' ' A' ' 2' ' ' SER . 44.6 mm-40 -117.66 166.69 12.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.345 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.408 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -110.21 118.31 36.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.52 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.486 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -108.61 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 59.91 22.84 11.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.269 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.55 19.04 8.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.772 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.486 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -130.36 141.06 50.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.277 0.538 . . . . 0.0 110.55 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.903 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 82.0 mt -83.95 120.46 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.017 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 60.0 t -125.31 124.29 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.298 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.82 143.9 32.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.619 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.691 ' HA ' HE21 ' A' ' 107' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.547 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.637 0.256 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -161.73 178.55 8.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -62.97 -34.91 78.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.778 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.85 -19.49 29.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.74 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.38 -24.32 67.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.323 0.582 . . . . 0.0 109.909 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.471 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.6 m -142.11 36.86 1.56 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.705 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.778 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 60.5 p -125.68 153.36 43.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 110.681 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -149.57 171.8 16.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.449 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.3 m-20 55.02 30.97 15.17 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.686 0.617 . . . . 0.0 110.984 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -73.8 114.59 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.758 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 t -144.22 149.72 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.512 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.776 HD12 HD13 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -85.48 139.08 31.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 179.309 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.7 m -121.08 165.57 15.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.401 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 69.46 8.18 6.63 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.397 0.436 . . . . 0.0 111.34 178.012 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.48 23.92 27.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.721 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 101.88 23.4 9.3 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.057 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.579 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.6 mtp180 -109.89 -15.65 14.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.64 0.257 . . . . 0.0 110.524 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.615 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 31.3 m -130.3 126.99 38.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.615 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.485 ' HB2' HD22 ' A' ' 37' ' ' LEU . 58.0 tp -97.54 107.1 19.53 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.549 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.1 tmm_? -104.35 125.22 50.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.127 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.05 138.0 20.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.398 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.2 mt-10 -94.8 109.24 21.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.5 p -114.68 142.82 45.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.423 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.33 141.99 43.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.538 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' HB3' HG23 ' A' ' 31' ' ' VAL . 30.9 p-10 -88.09 -178.79 6.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.265 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.02 62.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.9 0.381 . . . . 0.0 111.715 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.26 -23.91 60.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 0.0 111.545 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.46 36.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.9 t-20 -95.99 144.82 25.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.414 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.6 m0 -76.18 123.0 25.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.934 0.397 . . . . 0.0 110.988 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG23 ' HB3' ' A' ' 25' ' ' ASN . 5.2 t -119.47 124.2 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.437 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 m -78.05 107.73 10.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 t -110.83 149.64 30.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.317 0.58 . . . . 0.0 110.524 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 8.1 mt-10 -135.25 131.25 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.403 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.77 114.86 17.82 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.701 ' O ' HG23 ' A' ' 39' ' ' THR . 29.7 m-20 -67.87 109.42 3.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.139 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.776 HD13 HD12 ' A' ' 12' ' ' LEU . 25.3 mt -60.77 -40.08 91.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.259 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.562 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.6 OUTLIER -64.01 -4.61 3.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.701 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -105.17 -13.69 15.63 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.525 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.518 HG23 HG22 ' A' ' 39' ' ' THR . 2.6 pp -141.14 12.64 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.85 130.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.2 158.49 21.59 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.404 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -111.33 110.35 20.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.93 77.2 2.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.145 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.444 ' CG ' ' HG ' ' A' ' 83' ' ' CYS . 69.1 m-20 53.02 59.39 4.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.514 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.579 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.21 34.55 36.65 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.69 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -149.67 110.7 4.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.459 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.2 m-85 -59.09 137.09 58.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.074 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.441 HE21 ' HB2' ' A' ' 49' ' ' GLN . 2.7 tt0 -132.25 117.39 18.15 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.902 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -70.79 114.71 9.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.62 27.02 7.34 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.295 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.547 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.86 -52.53 1.5 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.247 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.562 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.7 tt0 73.69 142.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.496 0.665 . . . . 0.0 111.45 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.65 38.54 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.377 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.558 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.23 -27.21 47.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.579 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.2 p -62.63 -28.21 69.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.956 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.551 ' HG3' HG22 ' A' ' 58' ' ' THR . 2.3 pt-20 -70.39 -18.16 63.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.373 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.551 HG22 ' HG3' ' A' ' 57' ' ' GLU . 70.6 p -122.56 14.78 10.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.16 149.49 46.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -135.15 170.64 15.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.4 t70 43.17 57.64 3.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.475 0.484 . . . . 0.0 111.56 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.53 109.03 19.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.277 0.561 . . . . 0.0 112.077 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 126.22 42.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.324 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.632 ' CE1' HD12 ' A' ' 94' ' ' LEU . 19.4 t80 -91.35 136.73 32.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.277 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.684 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.5 t-160 -118.36 83.03 19.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.367 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.538 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.6 Cg_endo -57.35 -43.64 50.17 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.345 2.697 . . . . 0.0 113.702 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -118.48 82.04 1.78 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.669 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.684 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -63.41 109.81 1.73 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.432 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.53 -140.11 11.05 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.435 1.084 . . . . 0.0 113.623 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.61 -10.98 59.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.345 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.23 53.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.54 39.4 31.02 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.266 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -99.25 120.38 58.24 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.488 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.478 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 44.7 Cg_endo -69.39 108.32 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.28 1.987 . . . . 0.0 111.196 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.2 pp -134.53 142.48 40.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -112.02 126.62 55.35 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.487 ' N ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.83 141.45 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.488 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.35 168.6 21.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.757 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.7 mmt180 -86.07 115.15 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.579 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.87 131.85 45.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.875 0.369 . . . . 0.0 111.096 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.648 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -78.22 140.02 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.245 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -106.94 171.51 7.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.438 179.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.444 ' HG ' ' CG ' ' A' ' 45' ' ' ASP . 74.1 m -55.33 -27.23 45.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.0 0.429 . . . . 0.0 111.297 179.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . 0.413 HD21 ' HB3' ' A' ' 86' ' ' GLU . 9.8 t30 -66.7 -20.28 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.359 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.7 39.69 7.03 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.648 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.4 pt-20 -117.19 -163.47 0.92 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.645 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.9 p90 -144.65 128.74 17.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.87 118.9 16.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.485 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.488 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 8.8 p-10 -60.22 115.06 3.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.544 0.687 . . . . 0.0 112.561 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.548 ' HB2' HD23 ' A' ' 80' ' ' LEU . 28.9 mmt180 -115.3 175.11 5.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.33 146.09 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.459 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.6 p -136.22 143.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.905 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.463 ' HB3' HD21 ' A' ' 95' ' ' ASN . 23.0 m-80 -81.91 110.89 17.6 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.327 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.632 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.0 mt -79.26 0.88 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.478 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.4 m-80 -61.32 -16.29 44.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.426 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.413 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.4 -29.95 71.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 109.715 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.517 HD13 ' HB3' ' A' ' 94' ' ' LEU . 15.0 mt -74.9 130.93 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.871 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.456 ' HG3' HG12 ' A' ' 105' ' ' VAL . 10.9 pt20 -122.9 167.9 12.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.64 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.2 t30 -112.25 121.91 46.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.306 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.505 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.1 t -113.15 94.13 2.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.341 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.43 26.32 12.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.104 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.79 19.38 8.25 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.885 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.7 ptp180 -130.55 135.03 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.22 0.51 . . . . 0.0 110.863 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.06 124.66 32.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.456 HG12 ' HG3' ' A' ' 98' ' ' GLN . 6.9 p -135.04 132.22 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -78.86 140.01 38.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.403 1.081 . . . . 0.0 112.921 -178.671 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.548 0.214 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m -156.67 -176.18 5.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -68.8 -36.95 78.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.444 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.77 -23.92 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.57 -32.81 63.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.466 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.7 m -137.64 38.61 2.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.45 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 66.7 m -117.31 154.6 30.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.366 0.603 . . . . 0.0 112.033 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.35 164.44 34.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.596 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.505 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 85.3 m-20 54.93 32.64 18.37 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.525 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -74.72 113.4 11.95 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.4 147.85 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.88 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.635 HD12 HD13 ' A' ' 37' ' ' LEU . 1.5 tp -85.37 132.69 34.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.243 0.544 . . . . 0.0 109.725 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.483 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.4 m -118.87 165.21 14.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.667 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.518 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.0 t-20 70.65 8.7 6.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.049 0.54 . . . . 0.0 111.659 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.0 13.5 52.69 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.696 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.487 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 109.85 19.65 8.07 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.555 ' HG2' HG22 ' A' ' 56' ' ' THR . 18.5 mtp180 -105.92 -16.73 14.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.648 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 24.7 m -130.27 121.49 26.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.353 . . . . 0.0 111.78 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' CD2' HD11 ' A' ' 97' ' ' ILE . 63.1 tp -92.56 105.28 17.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 tmm_? -100.95 124.1 46.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.65 139.22 25.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.505 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.9 mt-10 -97.96 113.12 24.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.7 p -125.03 145.6 49.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.449 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -76.6 144.17 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.498 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.46 -171.8 2.89 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.188 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -32.17 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 111.74 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.03 -24.52 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.198 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.24 53.1 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -88.81 142.46 27.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.449 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.0 m0 -74.91 125.64 29.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 t -124.64 137.45 57.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.539 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 26.4 m -94.81 109.91 21.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB3' HD12 ' A' ' 104' ' ' LEU . 9.7 t -111.38 151.92 27.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 110.672 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.22 132.35 35.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.91 116.34 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 11.0 m-20 -67.22 108.54 2.74 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.194 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.635 HD13 HD12 ' A' ' 12' ' ' LEU . 42.7 mt -59.34 -46.44 88.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -61.98 -4.84 1.78 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.895 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.534 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.72 -12.16 19.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.463 HG21 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.55 12.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.596 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.34 132.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.8 158.82 20.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.751 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -112.96 109.44 18.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.51 179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -99.42 84.12 2.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.585 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.0 m-20 50.23 46.91 24.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.422 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.589 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.74 43.11 5.85 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.679 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -160.47 114.06 2.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.489 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.7 m-85 -59.91 138.49 57.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.045 0.45 . . . . 0.0 111.272 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -131.07 116.21 17.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -69.33 115.13 8.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.939 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.16 31.45 6.2 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.236 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.54 -51.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.176 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.472 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.9 tt0 72.84 146.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.218 0.607 . . . . 0.0 111.172 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.563 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.3 m-20 73.08 30.07 1.67 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.596 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.0 p90 -76.29 -31.43 58.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.555 HG22 ' HG2' ' A' ' 17' ' ' ARG . 20.0 p -62.45 -30.5 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.882 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.578 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.5 pt-20 -67.79 -15.59 63.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 110.477 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.578 HG23 ' HG3' ' A' ' 57' ' ' GLU . 67.2 p -124.1 10.74 8.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.426 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.63 147.3 47.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.05 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.91 166.11 24.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.329 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.418 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.5 t70 49.08 56.03 8.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.022 0.439 . . . . 0.0 110.639 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.486 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.39 109.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.213 0.53 . . . . 0.0 111.603 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.441 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.91 123.72 41.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.812 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.677 ' CE1' HD12 ' A' ' 94' ' ' LEU . 13.6 t80 -92.51 135.49 34.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.691 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.59 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 13.7 t60 -123.2 86.61 51.5 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.525 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 11.5 Cg_endo -57.06 -37.68 97.74 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 124.213 3.276 . . . . 0.0 114.839 -177.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -128.15 87.77 2.65 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.155 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.59 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 27.3 tt0 -66.51 107.06 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.852 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.1 -150.91 23.04 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.538 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.3 -18.16 60.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 110.051 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.24 62.92 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.875 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 67' ' ' LYS . 40.2 mt-10 50.2 57.13 6.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.687 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -102.83 117.99 59.36 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.16 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.463 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 56.4 Cg_endo -71.74 109.51 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.076 1.851 . . . . 0.0 112.087 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.69 141.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.71 126.28 55.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.504 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.65 139.83 53.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.035 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.626 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.95 167.72 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.959 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.577 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.2 mmt180 -84.78 115.59 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.589 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -100.61 126.57 47.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.82 0.343 . . . . 0.0 111.445 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.633 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -85.0 141.98 29.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.604 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.594 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 4.1 p-10 -101.33 175.34 5.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.714 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.456 ' HG ' ' CG ' ' A' ' 45' ' ' ASP . 72.6 m -60.36 -24.41 65.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -74.54 -28.32 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.58 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.96 37.31 2.37 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.194 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.9 pt-20 -113.26 -168.43 1.33 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.06 129.42 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -139.59 117.46 11.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.626 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 5.6 p-10 -63.3 122.89 17.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.302 0.572 . . . . 0.0 111.353 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.567 ' HB2' HD21 ' A' ' 80' ' ' LEU . 38.1 mmt180 -115.94 179.49 3.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.5 146.63 32.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.0 p -136.24 146.93 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-O 121.325 0.583 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.418 ' HB3' HD21 ' A' ' 95' ' ' ASN . 10.2 m120 -81.83 109.64 16.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.191 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.677 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.2 mt -80.14 4.45 17.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.384 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.463 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 17.4 m-80 -65.14 -10.82 33.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.271 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.38 -18.78 63.05 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 109.653 178.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.505 HD13 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.049 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -122.25 161.78 22.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.927 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -105.69 117.66 34.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.569 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.514 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 53.4 t -113.73 96.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.78 23.15 13.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.78 21.59 9.01 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.38 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.514 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.2 ptp180 -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 110.857 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.498 HD12 ' HB3' ' A' ' 33' ' ' SER . 3.0 mp -84.34 129.21 34.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 131.54 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.22 145.53 27.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.231 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 86.5 mm-40 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.468 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 19.9 m -157.0 -177.37 6.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -68.14 -38.5 82.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -23.63 13.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.688 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.84 -34.52 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.671 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.494 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.7 m -134.96 36.2 3.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 70.4 m -119.95 153.43 35.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 111.458 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -150.02 169.75 20.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.578 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t-20 56.89 28.21 14.23 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.438 0.461 . . . . 0.0 110.692 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -74.45 113.78 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.87 153.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.801 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.696 HD13 HD12 ' A' ' 37' ' ' LEU . 1.1 tp -88.82 136.01 33.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.648 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 23.9 m -116.77 163.06 16.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.541 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.5 t-20 71.26 6.57 5.84 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.491 0.494 . . . . 0.0 111.554 177.695 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.4 22.95 27.9 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.634 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.548 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 103.26 21.07 10.28 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.154 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG2' HG23 ' A' ' 56' ' ' THR . 24.5 mtp180 -107.27 -16.42 14.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.514 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.648 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.0 m -131.72 130.48 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 111.624 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.484 ' HB2' HD23 ' A' ' 37' ' ' LEU . 54.4 tp -99.91 108.7 21.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -110.7 125.13 53.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.088 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.417 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -146.84 155.09 42.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.639 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -107.85 112.87 25.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.537 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 5.1 p -123.97 146.22 48.64 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.606 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.442 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -78.94 143.86 35.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.636 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -90.23 -171.99 3.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.9 -27.37 69.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 0.0 111.214 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -73.54 -20.88 60.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.555 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.42 10.22 54.11 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.6 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.438 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.8 t-20 -96.31 145.06 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.442 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 43.8 m0 -77.21 125.53 29.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.47 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 140.85 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 m -91.77 112.88 24.99 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.473 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.5 m -111.21 146.96 36.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 0.0 111.187 -178.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.6 mt-10 -133.39 139.72 46.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.06 113.85 8.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.632 ' O ' HG23 ' A' ' 39' ' ' THR . 20.8 m-20 -67.57 110.99 3.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.142 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.696 HD12 HD13 ' A' ' 12' ' ' LEU . 80.4 mt -61.23 -43.13 99.37 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.678 0.751 . . . . 0.0 109.778 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.5 -3.79 2.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.796 -179.902 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.632 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.32 -9.59 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.291 179.45 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.51 HG22 HG22 ' A' ' 39' ' ' THR . 2.5 pp -144.08 10.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.51 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 132.59 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.481 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -128.92 159.05 22.15 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.87 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.47 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.3 t30 -111.43 113.34 25.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -97.76 78.57 2.61 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.07 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.48 ' HB2' ' H ' ' A' ' 83' ' ' CYS . 4.4 p-10 40.4 63.5 1.1 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.143 0.902 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 83.87 38.21 10.69 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -159.27 115.86 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.705 -0.291 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.51 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 40.4 m-85 -60.96 138.0 58.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -128.06 115.23 18.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.483 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -73.98 113.68 11.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.12 41.27 3.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -112.53 -50.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.601 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 20.0 tt0 73.32 141.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.309 0.643 . . . . 0.0 112.033 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 5.8 t-20 68.58 38.56 2.28 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.078 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.51 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.2 p90 -77.13 -26.6 53.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.529 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.58 HG23 ' HG2' ' A' ' 17' ' ' ARG . 38.4 p -64.14 -19.78 65.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.634 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.519 ' HG3' HG22 ' A' ' 58' ' ' THR . 6.1 pt-20 -74.76 -19.68 60.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.148 0.499 . . . . 0.0 109.848 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.519 HG22 ' HG3' ' A' ' 57' ' ' GLU . 72.6 p -123.34 18.12 9.8 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.936 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -133.56 150.35 51.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.88 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.733 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.82 172.86 12.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.209 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.407 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 3.5 t70 44.91 55.1 6.34 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.786 0.679 . . . . 0.0 110.997 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.411 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.03 109.13 17.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 112.033 -178.035 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.423 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -120.11 123.24 42.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.122 179.18 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.592 ' CE1' HD11 ' A' ' 94' ' ' LEU . 11.3 t80 -93.38 133.49 36.58 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.671 -178.537 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.724 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 2.5 t60 -124.81 87.41 55.02 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.378 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.5 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.7 Cg_endo -55.99 -34.5 92.39 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.157 3.238 . . . . 0.0 114.14 -178.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.5 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -129.18 85.82 2.36 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.962 179.583 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.724 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 32.8 tt0 -68.46 113.92 6.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.559 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.61 -147.43 10.94 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 124.322 1.014 . . . . 0.0 113.695 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -13.72 59.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.55 0.69 . . . . 0.0 109.356 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.5 65.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 56.45 42.36 27.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.89 128.27 26.12 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.535 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.424 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.2 Cg_endo -73.63 109.2 2.81 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.524 2.149 . . . . 0.0 111.584 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.561 HD13 HH21 ' A' ' 77' ' ' ARG . 1.2 pp -134.43 142.25 41.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.516 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -113.41 123.97 51.33 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.284 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.561 HH21 HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.5 139.45 52.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.909 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.15 169.44 24.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.733 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.9 mmt85 -85.1 115.12 22.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.521 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -101.63 130.54 48.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.698 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.739 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -74.23 135.86 42.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.211 179.211 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -96.13 172.76 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.438 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.48 ' H ' ' HB2' ' A' ' 45' ' ' ASP . 12.1 p -56.78 -27.95 60.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -74.26 -18.67 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.04 0.448 . . . . 0.0 111.526 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.17 36.7 5.11 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.739 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 16.3 pt-20 -119.24 -167.46 1.4 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.57 133.4 34.41 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.962 0.887 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -138.67 118.45 13.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.594 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.579 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.8 p-10 -66.57 118.42 10.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.542 0.686 . . . . 0.0 111.009 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.521 ' HB2' HD21 ' A' ' 80' ' ' LEU . 32.4 mmt180 -114.06 175.0 5.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.7 148.34 40.62 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.51 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.4 p -136.8 144.11 33.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.588 0.709 . . . . 0.0 111.402 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.43 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -78.62 107.48 11.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.576 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.592 HD11 ' CE1' ' A' ' 64' ' ' PHE . 7.6 mt -79.97 3.43 20.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.265 0.555 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -61.5 -19.08 61.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.915 178.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -64.67 -21.94 66.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.512 179.279 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.58 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 10.6 mt -85.38 126.96 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.423 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 92.1 mt-30 -125.09 151.65 45.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.206 -179.193 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 1.5 t30 -92.17 117.67 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.586 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.568 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 58.3 t -113.65 97.13 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.595 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.75 25.9 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.719 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.54 20.74 9.84 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.527 178.045 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.568 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -131.09 140.76 50.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.931 0.366 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.473 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.7 mp -86.07 115.69 23.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.58 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.9 t -115.04 121.92 68.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.688 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -83.33 144.82 29.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.529 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.468 179.26 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.447 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 39.7 m -159.33 -178.76 7.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -64.54 -39.56 93.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.945 0.402 . . . . 0.0 110.177 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.543 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.79 -25.33 27.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.595 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -53.94 -32.48 53.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.068 0.461 . . . . 0.0 110.973 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.499 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.6 m -134.82 33.38 3.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.543 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.3 m -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 112.355 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -154.02 169.22 24.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.575 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.3 t30 56.13 32.43 20.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.423 0.63 . . . . 0.0 110.476 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -78.89 113.7 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.446 -179.495 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 t -143.43 146.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.647 HD12 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -80.88 143.26 32.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.01 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.416 HG23 ' N ' ' A' ' 14' ' ' ASN . 8.8 m -128.5 163.31 25.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.416 ' N ' HG23 ' A' ' 13' ' ' THR . 0.2 OUTLIER 72.12 6.15 5.49 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.676 0.61 . . . . 0.0 111.472 178.437 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.6 23.8 17.66 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.178 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 100.55 14.95 30.94 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.193 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.614 ' HG2' HG22 ' A' ' 56' ' ' THR . 24.5 mtp180 -98.75 -16.76 18.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.82 -0.224 . . . . 0.0 111.034 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 31.7 m -133.27 129.97 38.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.0 111.873 -178.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.432 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.99 108.39 21.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 tmm_? -106.61 124.45 49.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.152 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.93 159.9 44.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.575 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 5.1 mt-10 -114.91 110.4 19.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 6' ' ' SER . 48.2 t -119.7 144.67 47.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.15 144.34 48.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.614 179.385 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.447 ' HB3' HG23 ' A' ' 31' ' ' VAL . 7.1 p30 -90.89 -171.74 3.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.29 68.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 0.0 111.7 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.19 -24.47 60.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.444 . . . . 0.0 111.123 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.18 -0.95 33.21 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.709 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.5 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.6 t30 -83.63 144.95 29.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -75.3 125.23 28.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.509 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.447 HG23 ' HB3' ' A' ' 25' ' ' ASN . 4.2 t -120.73 130.62 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 m -80.22 106.94 12.61 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.598 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.4 m -110.08 135.75 50.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.434 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.4 mt-10 -126.87 131.95 51.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.539 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.78 116.21 19.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.577 ' O ' HG22 ' A' ' 39' ' ' THR . 16.2 m-20 -67.3 109.41 3.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.647 HD11 HD12 ' A' ' 12' ' ' LEU . 34.6 mt -59.59 -46.56 88.57 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.652 0.739 . . . . 0.0 110.052 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.642 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 10.3 t70 -63.79 -4.41 3.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.577 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.09 -11.67 20.32 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.571 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.482 HG21 HG21 ' A' ' 39' ' ' THR . 2.6 pp -145.82 13.41 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 121.066 0.46 . . . . 0.0 112.053 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.55 130.85 70.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.36 159.03 21.85 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.509 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.2 t30 -111.19 111.43 22.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -105.74 85.96 2.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.735 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 6.6 m-20 51.59 50.97 17.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.306 178.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.17 41.19 10.48 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.193 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -158.18 118.27 3.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.0 m-85 -63.71 136.37 57.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.119 0.485 . . . . 0.0 110.607 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -128.78 115.64 18.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.151 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -69.49 115.04 8.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.13 22.63 8.16 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.41 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.538 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -92.99 -54.37 1.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.382 -0.914 . . . . 0.0 114.002 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.5 tt0 72.59 139.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.188 0.595 . . . . 0.0 110.803 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.632 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.7 m120 74.1 39.78 0.48 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.615 0.721 . . . . 0.0 110.516 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.3 p90 -84.79 -26.33 27.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.282 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.614 HG22 ' HG2' ' A' ' 17' ' ' ARG . 71.2 p -68.4 -17.95 64.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.393 -179.238 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.632 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 9.5 pt-20 -78.03 -13.13 59.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.235 0.54 . . . . 0.0 109.857 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.594 HG22 ' HG3' ' A' ' 57' ' ' GLU . 73.5 p -127.67 14.97 7.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.772 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.46 149.95 49.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.848 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.593 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -140.79 171.01 14.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.82 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.512 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 49.02 54.69 10.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.952 0.406 . . . . 0.0 110.393 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.66 108.91 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.306 0.574 . . . . 0.0 112.326 -177.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 123.63 40.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.551 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE1' HD13 ' A' ' 94' ' ' LEU . 15.3 t80 -91.67 133.28 35.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.781 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.82 87.94 43.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.143 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -36.8 79.67 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 123.633 2.889 . . . . 0.0 113.623 -178.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.37 83.48 2.14 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.745 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -67.17 113.92 5.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.317 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.74 -143.95 12.85 Favored Glycine 0 C--N 1.335 0.491 0 O-C-N 124.335 1.022 . . . . 0.0 113.807 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.83 -11.43 58.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 109.956 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.15 -26.05 61.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 57.25 42.66 24.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.284 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.98 125.18 36.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.223 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.47 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -72.23 110.48 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.762 2.308 . . . . 0.0 112.467 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.696 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.38 141.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.506 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.31 128.44 56.47 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.696 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.94 144.57 49.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.059 0.457 . . . . 0.0 110.21 178.878 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.37 170.05 18.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.93 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.593 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -85.91 115.71 23.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.688 HD23 ' HB2' ' A' ' 90' ' ' ARG . 3.2 mp -98.52 127.15 44.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.096 0.474 . . . . 0.0 111.629 -178.494 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -87.79 142.11 28.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.806 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.662 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -97.94 173.74 6.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.672 -179.603 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.469 ' HG ' ' CG ' ' A' ' 45' ' ' ASP . 74.8 m -60.4 -23.41 64.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -77.12 -28.64 54.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.964 0.411 . . . . 0.0 110.623 -179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.09 38.04 1.74 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.294 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.662 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 15.9 pt-20 -113.65 -168.92 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -147.19 132.98 18.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.847 0.832 . . . . 0.0 111.034 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -140.19 120.45 13.89 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.752 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.8 p-10 -67.13 116.4 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.184 0.516 . . . . 0.0 111.585 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.688 ' HB2' HD23 ' A' ' 80' ' ' LEU . 32.1 mmt180 -116.79 177.51 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.94 147.15 32.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.484 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -134.37 143.38 38.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.389 0.614 . . . . 0.0 110.86 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.495 ' HB3' HD21 ' A' ' 95' ' ' ASN . 31.1 m-80 -82.83 110.7 18.07 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.817 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD13 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -80.61 3.15 22.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.495 HD21 ' HB3' ' A' ' 93' ' ' ASN . 18.9 m-80 -61.47 -15.47 37.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.015 178.392 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -64.29 -23.5 67.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.139 178.703 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.577 HD13 ' HB3' ' A' ' 94' ' ' LEU . 10.6 mt -84.54 124.19 39.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.005 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.447 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 77.3 mt-30 -119.65 163.79 16.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.447 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.9 t30 -106.22 120.19 41.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.061 0.458 . . . . 0.0 111.635 -178.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.513 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.8 t -112.61 94.14 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.349 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.22 23.43 13.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.929 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 20.85 7.95 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.549 178.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.513 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.8 ptp180 -130.29 138.96 50.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.996 0.398 . . . . 0.0 110.477 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.598 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 64.1 mt -85.47 117.48 24.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.461 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 61.7 t -121.56 123.45 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -85.89 145.75 27.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 77.5 mt-30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.584 178.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.764 0.316 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -150.46 -176.58 5.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -67.07 -36.2 81.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.749 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.06 -29.13 63.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.643 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.43 -33.55 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.168 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 58.7 m -134.13 35.83 3.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.749 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.7 p -117.21 155.88 28.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.443 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.31 167.62 28.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.493 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 55.01 32.53 18.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.63 0.581 . . . . 0.0 111.17 -179.056 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.478 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -77.08 113.76 15.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.56 151.61 19.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.298 -178.57 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.621 HD13 HD12 ' A' ' 37' ' ' LEU . 1.2 tp -87.58 142.37 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.434 HG21 ' N ' ' A' ' 14' ' ' ASN . 11.7 m -129.68 163.58 25.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.934 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.6 t-20 73.12 9.12 5.34 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.165 0.586 . . . . 0.0 111.441 178.258 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.8 25.92 16.33 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 94.92 22.18 23.86 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.606 ' HG2' HG22 ' A' ' 56' ' ' THR . 32.9 mtp180 -106.32 -18.74 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.607 0.242 . . . . 0.0 110.641 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.4 m -128.37 125.64 39.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 111.846 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.479 ' HB2' HD23 ' A' ' 37' ' ' LEU . 65.4 tp -96.17 106.73 18.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.853 178.2 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.533 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -103.02 124.28 48.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.1 142.71 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 111.114 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.3 mt-10 -98.94 110.03 22.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 6' ' ' SER . 15.4 t -122.36 139.52 53.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.32 144.07 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.892 179.85 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' HB3' HG22 ' A' ' 31' ' ' VAL . 8.9 p30 -91.42 -170.25 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -33.83 66.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -76.29 -22.53 54.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 110.992 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.95 33.82 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.694 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.44 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 m-80 -84.84 141.63 30.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.561 0.18 . . . . 0.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 54.0 m0 -72.51 124.33 24.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 111.149 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.455 HG22 ' HB3' ' A' ' 25' ' ' ASN . 6.3 t -116.57 119.77 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.924 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.7 m -78.43 104.34 8.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.478 ' HB3' HD11 ' A' ' 104' ' ' LEU . 8.7 t -111.52 152.94 26.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.149 0.5 . . . . 0.0 110.425 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.533 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.0 mt-10 -134.74 131.37 37.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.486 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.584 HD12 HG12 ' A' ' 40' ' ' ILE . 12.0 tp -125.52 115.09 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.775 178.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.568 ' O ' HG21 ' A' ' 39' ' ' THR . 27.6 m-20 -66.28 109.13 2.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.914 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.621 HD12 HD13 ' A' ' 12' ' ' LEU . 37.2 mt -60.8 -43.44 98.13 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.702 0.763 . . . . 0.0 109.499 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.35 -5.43 3.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.487 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.568 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.16 -14.59 17.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.426 -179.263 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.584 HG12 HD12 ' A' ' 35' ' ' LEU . 2.6 pp -144.51 13.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.546 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.52 130.3 70.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.52 160.89 21.62 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.221 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.18 112.8 24.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -109.52 87.16 2.44 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.299 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.448 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 33.1 t70 53.27 58.62 5.07 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.6 179.046 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 69.72 42.53 70.81 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.992 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -158.3 117.17 3.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.492 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 57.4 m-85 -61.9 138.56 58.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.227 0.537 . . . . 0.0 110.79 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.45 116.68 20.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.303 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.24 115.02 8.95 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.42 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.3 28.75 7.04 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.477 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.15 -52.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.878 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 27.9 tt0 73.05 143.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 0.0 111.021 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.59 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 80.4 m-20 69.14 36.66 2.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.576 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.546 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -77.28 -30.08 54.14 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.606 HG22 ' HG2' ' A' ' 17' ' ' ARG . 21.4 p -63.9 -23.98 67.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.187 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.59 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.1 pt-20 -73.69 -15.75 61.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.211 0.529 . . . . 0.0 109.929 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.579 HG21 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -123.86 14.26 9.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.996 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.58 154.43 47.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.546 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.95 173.65 11.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.042 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.539 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 13.4 t70 50.45 53.31 13.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.11 0.481 . . . . 0.0 110.211 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.52 109.24 19.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.513 . . . . 0.0 111.947 -178.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.425 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.7 123.93 38.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.762 178.8 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.664 ' CE1' HD13 ' A' ' 94' ' ' LEU . 24.2 t80 -92.58 136.04 33.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.27 0.557 . . . . 0.0 112.01 -178.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.595 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 4.7 t60 -123.32 89.75 50.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.987 178.316 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 12.7 Cg_endo -60.63 -41.01 50.84 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.836 3.024 . . . . 0.0 114.519 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.84 88.29 2.86 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.891 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.595 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 15.6 tt0 -73.26 108.64 6.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.528 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.51 -149.02 14.56 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.713 178.337 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.52 -18.85 61.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 110.001 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.74 -25.82 63.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.163 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 48.6 49.62 18.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.622 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -102.3 122.42 46.72 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.487 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.552 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 52.7 Cg_endo -71.49 108.12 2.31 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.287 1.991 . . . . 0.0 111.331 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.449 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -131.87 140.74 47.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -112.41 125.0 53.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.085 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.487 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.58 139.56 52.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 179.285 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.16 169.55 23.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.792 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 5.0 mmt85 -84.96 115.67 22.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.622 HD23 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -101.26 132.11 46.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.56 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.785 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -77.4 140.41 39.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.055 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.621 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -102.94 174.97 5.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.478 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 57.5 m -59.56 -24.37 63.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.554 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.65 -28.08 61.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.833 179.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.71 37.62 2.95 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.156 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.785 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.0 pt-20 -119.46 -170.2 1.89 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.614 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 85.4 m-85 -138.7 130.45 27.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.064 0.459 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -138.88 123.31 18.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.436 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.9 p-10 -61.81 116.89 5.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.357 0.598 . . . . 0.0 112.423 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.622 ' HB2' HD23 ' A' ' 80' ' ' LEU . 37.8 mmt180 -114.69 179.29 3.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -143.51 151.0 39.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.903 0.382 . . . . 0.0 110.023 -179.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.492 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.5 p -138.85 145.24 28.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.362 0.601 . . . . 0.0 110.918 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HB3' HD21 ' A' ' 95' ' ' ASN . 29.8 m-80 -82.66 109.95 17.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.572 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.664 HD13 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -81.0 3.72 22.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.011 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.552 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -63.11 -17.87 62.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.726 178.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -29.24 69.71 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.944 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.536 HD13 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -77.24 127.3 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.403 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -121.19 165.97 14.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -110.77 117.95 34.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 -179.961 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.2 t -113.14 96.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.337 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.43 22.21 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.051 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 22.67 8.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.592 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -130.21 136.38 49.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.177 0.488 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.478 HD11 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -80.65 116.76 20.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 0.0 110.888 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.89 123.96 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.48 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -82.06 145.69 30.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.868 0.366 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.994 178.875 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.491 ' HG3' ' H ' ' A' ' 2' ' ' SER . 6.5 tpt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.491 ' H ' ' HG3' ' A' ' 1' ' ' MET . 15.7 m -102.26 -179.75 4.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.535 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -62.5 -37.68 86.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.923 0.392 . . . . 0.0 110.092 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.748 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -24.74 63.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.73 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.13 -33.64 67.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.106 0.479 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.2 m -133.42 36.86 3.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.362 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.5 p -117.28 155.82 28.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.162 0.505 . . . . 0.0 111.815 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -148.09 168.4 22.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.064 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.414 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.8 m-20 52.23 33.95 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.386 0.613 . . . . 0.0 110.701 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.496 ' HB1' ' HB3' ' A' ' 66' ' ' PRO . . . -84.55 114.43 21.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.331 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.416 ' HA ' ' HD2' ' A' ' 64' ' ' PHE . 5.9 m -147.27 177.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.22 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.497 HD11 HD12 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.9 139.42 39.66 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.055 179.247 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.412 HG23 ' N ' ' A' ' 14' ' ' ASN . 26.0 m -123.98 162.98 22.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.482 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.454 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.9 t-20 74.03 7.64 4.78 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.671 0.607 . . . . 0.0 111.009 178.216 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.28 22.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.455 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.95 21.54 13.71 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.924 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' HG2' HG23 ' A' ' 56' ' ' THR . 32.9 mtp180 -104.42 -19.09 14.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 37.4 m -127.54 126.53 42.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.006 0.432 . . . . 0.0 111.362 -178.855 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.463 ' CD2' HD13 ' A' ' 97' ' ' ILE . 54.7 tp -95.56 106.82 18.95 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.584 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -106.21 123.9 48.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.887 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.93 137.35 19.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.381 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.414 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.9 mt-10 -96.24 109.27 21.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 6' ' ' SER . 16.5 t -118.57 143.7 46.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.963 0.411 . . . . 0.0 110.139 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.526 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 143.48 50.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.835 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.472 ' HB3' HG23 ' A' ' 31' ' ' VAL . 24.7 p-10 -85.28 -172.4 4.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.68 -21.5 65.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.47 -22.08 26.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.94 3.59 34.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.526 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.4 t30 -88.29 146.65 25.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -75.62 126.68 31.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.472 HG23 ' HB3' ' A' ' 25' ' ' ASN . 10.8 t -124.46 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 m -80.06 109.02 14.11 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.458 ' HB2' HD13 ' A' ' 104' ' ' LEU . 1.9 m -109.78 139.04 45.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.909 0.385 . . . . 0.0 110.376 -178.563 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.49 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.69 130.99 42.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.91 117.6 21.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' HG23 ' A' ' 39' ' ' THR . 27.0 m-20 -68.59 107.72 3.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.967 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.497 HD12 HD11 ' A' ' 12' ' ' LEU . 24.6 mt -60.59 -40.27 91.13 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.592 0.71 . . . . 0.0 110.569 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.66 -5.28 2.56 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -104.93 -14.37 15.48 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.481 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.522 HG22 HG22 ' A' ' 39' ' ' THR . 2.6 pp -141.28 11.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.512 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.53 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.32 156.74 21.01 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.802 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -110.19 108.71 18.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.283 0.563 . . . . 0.0 109.547 178.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -100.19 82.53 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.1 60.88 3.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.298 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.22 35.86 36.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.693 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -154.97 121.33 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.842 -0.21 . . . . 0.0 110.649 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.467 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.4 m-85 -65.41 138.46 58.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.084 0.468 . . . . 0.0 111.07 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -130.45 116.85 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.744 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.51 114.31 9.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.91 29.15 7.41 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.828 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.543 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.79 -53.06 1.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.43 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.543 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 2.4 tt0 76.96 142.54 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.303 0.641 . . . . 0.0 111.333 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.66 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.1 m-20 66.72 38.84 3.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.024 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.512 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.5 p90 -79.43 -28.1 41.71 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.544 HG23 ' HG2' ' A' ' 17' ' ' ARG . 34.8 p -65.51 -25.17 67.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.601 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.66 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 5.4 pt-20 -72.59 -12.36 61.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.328 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.618 HG22 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -130.37 15.93 5.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.31 0.576 . . . . 0.0 109.805 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.15 144.53 51.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.642 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -134.46 173.08 12.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.285 -179.683 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.444 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER 46.01 54.38 8.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.684 0.615 . . . . 0.0 111.046 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.415 HG22 HD22 ' A' ' 12' ' ' LEU . 2.2 mt -89.33 112.77 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.778 -178.212 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.86 125.23 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.847 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.603 ' CE1' HD11 ' A' ' 94' ' ' LEU . 21.5 t80 -92.61 133.75 35.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.516 0.674 . . . . 0.0 112.435 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.686 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 17.0 t-160 -117.57 87.71 26.8 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.525 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 Cg_endo -58.42 -42.95 50.25 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 124.067 3.178 . . . . 0.0 114.637 -177.814 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 87.29 2.71 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.633 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.686 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 25.2 tt0 -68.39 106.83 2.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.258 178.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.35 -152.78 10.8 Favored Glycine 0 C--N 1.332 0.322 0 O-C-N 124.029 0.831 . . . . 0.0 113.71 178.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.85 -9.18 58.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.18 -21.4 43.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.83 178.694 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 46.52 54.39 8.76 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.881 0.738 . . . . 0.0 110.546 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -103.22 118.45 57.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.182 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.554 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.2 Cg_endo -72.38 109.63 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.327 2.018 . . . . 0.0 111.977 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.627 HD13 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -133.04 140.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.534 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.93 126.57 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.465 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.627 HH21 HD13 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.01 143.45 49.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.184 179.028 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.65 168.01 22.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.99 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.642 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.5 mmt180 -86.32 114.66 23.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.603 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.0 mp -97.43 127.27 43.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 110.465 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.1 tmt_? -80.16 139.69 36.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.743 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.16 162.36 12.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.739 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.9 t -47.95 -29.34 3.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -66.4 -26.92 67.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.105 0.479 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.554 ' HA2' ' HE ' ' A' ' 81' ' ' ARG . . . 100.53 33.97 4.9 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.647 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.8 pt-20 -116.02 -167.23 1.23 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.49 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.3 p90 -142.28 138.18 31.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.98 0.895 . . . . 0.0 111.488 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -133.86 111.24 10.32 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.221 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.535 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.2 p-10 -64.21 114.97 4.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.018 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -114.18 176.72 4.92 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -145.76 142.46 28.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.467 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.68 144.3 37.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.063 -178.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.422 ' HB3' HD21 ' A' ' 95' ' ' ASN . 43.7 m-20 -81.35 111.66 17.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.696 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.603 HD11 ' CE1' ' A' ' 64' ' ' PHE . 3.7 mt -81.35 3.72 23.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.681 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.554 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 25.6 m-80 -63.47 -18.03 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.102 0.477 . . . . 0.0 109.773 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -61.87 -28.15 69.29 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.798 178.672 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.0 mt -78.09 124.55 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.167 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -114.99 163.29 15.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.359 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.8 t30 -111.99 119.99 40.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.3 t -113.57 95.03 3.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.727 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.8 25.54 15.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.56 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.97 23.38 7.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.391 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.28 137.54 50.03 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 122.458 -0.436 . . . . 0.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.0 mp -90.31 128.74 36.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.607 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.495 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.3 p -142.44 132.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -79.07 145.32 33.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.961 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.333 -179.075 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.91 0.385 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -161.23 174.76 13.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -59.51 -35.6 74.47 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.735 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.17 -25.61 61.72 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.823 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.28 -20.8 63.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.089 -179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 32.3 m -145.14 35.51 1.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.835 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.735 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.7 p -116.61 158.13 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.49 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.1 ptp180 -152.58 167.82 27.62 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.2 m120 50.21 36.38 12.4 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.942 0.776 . . . . 0.0 111.566 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -78.07 113.7 16.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.04 148.89 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.015 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.804 HD13 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -82.59 147.68 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.836 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.3 m -132.12 163.05 29.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.07 4.5 5.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.615 0.572 . . . . 0.0 111.543 178.142 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.65 23.22 19.15 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 100.97 22.82 10.36 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.979 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.565 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.4 mtp180 -106.59 -18.28 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.671 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 67.7 m -132.37 128.03 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.927 0.394 . . . . 0.0 111.355 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.43 ' HB2' HD22 ' A' ' 37' ' ' LEU . 42.9 tp -96.72 108.77 21.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.021 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.424 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.5 tmm_? -103.28 124.37 48.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.9 138.47 20.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.568 0.223 . . . . 0.0 110.628 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.49 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 5.9 mt-10 -97.82 108.87 21.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 6' ' ' SER . 2.2 p -119.13 141.43 48.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.086 0.469 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.6 143.46 44.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -85.15 -173.61 4.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.414 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.84 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.797 0.332 . . . . 0.0 111.449 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 111.231 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.65 3.38 34.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.78 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.1 m-80 -89.75 144.18 26.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.335 0.112 . . . . 0.0 110.819 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -72.79 128.85 36.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 0.0 111.533 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.11 119.63 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.352 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 m -75.09 106.5 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.588 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.0 m -110.74 144.01 40.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.204 0.526 . . . . 0.0 111.259 -178.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.424 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.6 mt-10 -133.39 134.97 44.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.648 HD13 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -132.32 118.1 19.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.626 ' O ' HG21 ' A' ' 39' ' ' THR . 42.6 m-20 -67.42 107.43 2.43 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.391 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.804 HD11 HD13 ' A' ' 12' ' ' LEU . 46.9 mt -60.67 -42.46 97.11 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.598 0.713 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -63.8 -5.78 4.78 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.672 179.887 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.626 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.36 -10.61 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.207 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.648 HG12 HD13 ' A' ' 35' ' ' LEU . 2.5 pp -145.01 11.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.05 0.453 . . . . 0.0 112.07 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.558 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 131.16 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 157.16 20.76 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . 0.4 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 11.0 t30 -111.1 109.97 20.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.179 0.514 . . . . 0.0 110.38 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -89.63 78.8 6.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.261 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 39.63 48.63 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.003 0.921 . . . . 0.0 113.109 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.535 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 103.45 36.07 3.41 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.851 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -162.26 120.19 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.476 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.3 m-85 -65.29 135.1 54.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -125.78 117.14 22.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.638 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.61 114.05 10.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 29.04 5.93 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.398 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.461 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.3 -51.6 1.13 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.687 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.459 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 28.9 tt0 72.56 143.53 0.06 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.049 0.54 . . . . 0.0 110.915 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 73.0 31.31 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.652 0.781 . . . . 0.0 111.501 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.558 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.3 p90 -77.56 -27.7 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.565 HG21 ' HG2' ' A' ' 17' ' ' ARG . 28.9 p -64.92 -22.53 67.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.826 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.51 ' HG3' HG23 ' A' ' 58' ' ' THR . 3.9 pt-20 -73.86 -18.47 60.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.045 0.45 . . . . 0.0 110.087 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.51 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.9 p -123.34 15.46 9.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.194 0.521 . . . . 0.0 110.064 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.45 153.15 45.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.617 -179.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.579 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -146.22 170.43 16.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.162 -179.942 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.457 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 4.3 t70 46.11 56.06 6.54 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.946 0.403 . . . . 0.0 110.436 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.46 HG21 HD23 ' A' ' 76' ' ' LEU . 2.6 mt -85.03 106.38 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.274 0.559 . . . . 0.0 111.333 -177.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.544 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.63 118.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.902 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CE1' HD11 ' A' ' 94' ' ' LEU . 8.5 t80 -92.82 127.53 38.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.0 110.924 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.41 86.31 38.77 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.424 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.681 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 14.6 Cg_endo -58.8 -38.3 89.42 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 123.414 2.743 . . . . 0.0 112.618 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.681 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -123.58 82.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.397 179.303 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.0 118.75 9.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.3 -138.31 2.74 Favored Glycine 0 C--N 1.333 0.369 0 O-C-N 124.643 1.214 . . . . 0.0 114.776 177.293 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.39 -5.83 59.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.436 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.16 -23.84 37.98 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.913 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 53.02 46.48 26.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.282 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.7 129.96 24.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.6 Cg_endo -73.61 108.38 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.776 2.318 . . . . 0.0 112.4 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.578 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.13 140.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.523 HD22 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.245 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.578 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.84 140.64 49.64 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.966 0.413 . . . . 0.0 109.898 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.444 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.64 169.11 25.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.579 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.1 mmt180 -85.87 114.56 22.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.728 HD21 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -99.65 121.4 41.17 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.296 0.57 . . . . 0.0 111.099 -178.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.764 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.04 141.25 43.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.022 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.569 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.6 p-10 -98.29 177.34 5.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.6 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.4 t -62.94 -22.54 66.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.083 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -77.39 -28.58 52.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.04 30.46 3.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 178.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.764 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.2 pt-20 -115.7 -169.58 1.61 Allowed 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 44.4 p90 -138.47 140.7 39.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.682 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -137.79 120.64 16.43 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.421 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -64.05 112.93 3.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.482 0.658 . . . . 0.0 111.202 -179.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.728 ' HB2' HD21 ' A' ' 80' ' ' LEU . 26.5 mmt180 -114.93 172.6 6.95 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.309 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -140.74 151.44 44.48 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.511 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.476 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -136.1 142.05 39.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.398 0.618 . . . . 0.0 110.34 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 26.7 m-80 -81.24 109.19 15.52 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.569 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.586 HD11 ' CE1' ' A' ' 64' ' ' PHE . 8.2 mt -79.62 0.75 28.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.952 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.406 HD21 ' HB3' ' A' ' 93' ' ' ASN . 22.8 m-80 -62.82 -13.63 35.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 0.0 109.504 177.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -67.13 -24.38 65.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.046 178.697 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.512 HD11 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -83.11 125.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.147 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.62 159.37 24.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.6 t30 -102.87 117.95 35.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.46 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.512 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -111.97 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.824 0.345 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.54 21.64 12.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.27 25.87 5.91 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.53 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.512 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -132.66 139.68 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.094 0.447 . . . . 0.0 110.798 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.588 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 75.0 mt -87.12 116.31 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 110.534 178.853 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.6 p -125.6 130.42 72.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.865 0.364 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -86.71 143.66 27.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.292 179.844 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.465 0.174 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.44 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 7.2 m -157.31 177.07 11.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.589 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -62.62 -37.25 85.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.506 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -25.37 19.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.453 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.43 -34.41 57.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.578 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.502 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.4 m -136.04 36.03 2.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.348 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.506 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 67.6 m -116.05 157.1 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.336 0.589 . . . . 0.0 112.19 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.0 ptp180 -154.59 166.63 32.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.442 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 10.0 m120 51.92 38.18 22.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.648 0.593 . . . . 0.0 111.336 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -81.93 114.0 20.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.66 159.03 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.78 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.78 HD13 HD12 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -95.38 138.52 32.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.3 m -122.53 165.38 16.49 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.566 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.553 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 71.59 6.22 5.64 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.525 0.516 . . . . 0.0 111.484 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.06 21.4 23.11 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.535 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 99.75 24.27 10.11 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.786 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.569 ' HG2' HG23 ' A' ' 56' ' ' THR . 27.1 mtp180 -107.29 -18.47 13.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.797 0.332 . . . . 0.0 110.486 -179.25 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 61.3 m -129.13 126.06 38.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.073 0.463 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.472 ' CD2' HD11 ' A' ' 97' ' ' ILE . 47.4 tp -94.42 107.62 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.274 178.594 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.52 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -101.69 124.5 47.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.873 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.26 140.4 22.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.586 0.232 . . . . 0.0 110.873 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' SER . 6.9 mt-10 -99.07 109.69 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.502 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -122.01 145.2 48.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.329 0.585 . . . . 0.0 111.209 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.513 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.4 144.43 40.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.401 179.109 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -89.05 -171.21 3.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.645 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.73 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.149 0.499 . . . . 0.0 111.234 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.47 -23.7 53.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.2 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.56 1.67 43.5 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.841 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.5 t-20 -85.2 145.34 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -77.07 126.56 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.895 0.379 . . . . 0.0 110.634 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.27 126.55 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.304 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.8 m -79.69 106.18 11.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.549 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 4.4 m -110.43 144.98 38.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.083 0.468 . . . . 0.0 111.446 -177.696 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 14.6 mt-10 -135.23 133.31 38.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.8 120.02 26.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.5 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -68.2 107.01 2.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.663 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.78 HD12 HD13 ' A' ' 12' ' ' LEU . 53.5 mt -61.69 -45.66 93.06 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.461 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.74 -5.53 2.83 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.5 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -102.05 -11.5 18.84 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.21 -179.611 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.448 HD11 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -143.89 11.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.002 0.429 . . . . 0.0 112.113 -179.57 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 132.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.47 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.75 159.99 21.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.75 -179.134 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.78 111.74 23.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.23 0.538 . . . . 0.0 109.732 179.164 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -105.93 87.53 2.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.373 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.08 57.93 6.11 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.624 0.578 . . . . 0.0 112.161 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.582 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.78 42.85 52.6 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.982 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -161.07 120.67 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.505 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 59.0 m-85 -62.66 142.17 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.81 115.95 15.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -70.09 116.11 10.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.232 0.539 . . . . 0.0 109.681 178.806 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.06 31.45 6.58 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.752 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.47 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.45 -51.6 1.11 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.084 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.459 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 3.6 tt0 70.75 143.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.016 0.526 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.628 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 92.0 m-20 76.36 29.19 0.73 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.526 0.73 . . . . 0.0 111.189 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -77.5 -32.15 54.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.753 0.311 . . . . 0.0 110.591 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.569 HG23 ' HG2' ' A' ' 17' ' ' ARG . 24.6 p -63.56 -26.67 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.628 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.6 pt-20 -70.74 -16.37 62.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.728 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.56 HG21 ' HG3' ' A' ' 57' ' ' GLU . 60.2 p -124.31 12.97 8.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.268 0.556 . . . . 0.0 110.351 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.527 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.97 152.8 43.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.188 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.691 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.71 173.7 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.522 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 11.3 t70 47.92 52.88 12.3 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.321 0.581 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.4 mt -85.93 110.25 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.011 -177.911 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.1 120.5 33.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.232 178.928 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.595 ' CE1' HD13 ' A' ' 94' ' ' LEU . 10.0 t80 -91.58 128.47 37.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.78 -178.676 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 m170 -120.18 87.7 40.11 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.027 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 10.3 Cg_endo -56.29 -32.66 88.81 Favored 'Trans proline' 0 CA--C 1.505 -0.959 0 C-N-CA 124.086 3.191 . . . . 0.0 113.752 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.408 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -133.68 88.94 2.53 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.949 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -66.43 116.56 7.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.277 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.86 -145.17 8.9 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 124.403 1.065 . . . . 0.0 113.829 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.73 -8.2 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.2 -23.88 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.552 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.408 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 36.9 mm-40 56.54 44.4 24.16 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -106.44 125.9 31.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.074 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.423 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 67.4 Cg_endo -74.84 108.66 2.76 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.65 2.233 . . . . 0.0 112.468 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.672 HD12 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.64 141.09 41.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.384 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -112.69 125.85 54.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.243 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.672 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.1 139.75 52.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.078 0.466 . . . . 0.0 110.302 178.828 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.72 168.34 27.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.13 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.691 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.3 mmt85 -85.29 116.0 23.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.582 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -101.1 133.43 45.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.37 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.717 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -83.72 138.68 33.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.572 -179.895 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.562 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 1.7 m-20 -98.12 164.42 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.826 178.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.4 m -57.35 -23.42 48.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.136 0.426 . . . . 0.0 111.696 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -68.9 -20.6 64.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.196 178.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.68 39.4 5.28 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.717 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -121.6 -177.06 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.647 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 93.2 m-85 -137.04 137.2 39.12 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.002 0.906 . . . . 0.0 111.672 -178.64 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -139.72 119.8 13.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.597 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 p-10 -66.11 114.05 4.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.573 ' HB2' HD21 ' A' ' 80' ' ' LEU . 35.6 mmt180 -114.44 172.31 7.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -137.02 149.07 47.23 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.837 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.505 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -134.5 146.46 30.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.306 0.574 . . . . 0.0 110.891 -179.612 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.459 ' HB3' HD21 ' A' ' 95' ' ' ASN . 34.8 m-80 -82.12 109.71 16.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.454 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.595 HD13 ' CE1' ' A' ' 64' ' ' PHE . 6.7 mt -80.05 2.46 23.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.932 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.459 HD21 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.45 -12.08 28.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.428 0.632 . . . . 0.0 109.842 178.004 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.606 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.7 -21.53 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.657 178.658 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 94' ' ' LEU . 10.7 mt -85.98 124.29 40.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.315 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 80.5 mt-30 -120.05 167.09 12.55 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.432 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.82 122.07 46.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.4 t -112.4 93.89 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.22 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.4 t30 58.29 25.65 12.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.064 179.269 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.5 18.78 8.77 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.849 178.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.438 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.9 ptp180 -130.78 136.46 48.74 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.314 -0.521 . . . . 0.0 110.42 179.258 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 69.8 mt -83.19 126.22 32.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -134.82 128.1 49.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.179 0.514 . . . . 0.0 111.265 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.83 146.06 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.811 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 24.4 mm-40 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.353 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.559 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 49.6 m -162.07 177.31 9.84 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -60.43 -38.08 82.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -55.03 -23.73 21.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.798 -179.141 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.62 -30.39 68.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.866 179.442 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.4 m -133.57 32.49 3.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.481 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 66.4 m -121.33 156.62 32.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 112.248 -179.05 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.437 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -154.86 170.74 20.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.491 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 81.7 m-20 55.01 32.33 17.93 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.622 0.576 . . . . 0.0 110.918 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.419 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -77.23 113.76 15.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -142.5 151.76 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.692 HD12 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.35 135.43 33.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.129 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.426 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.8 m -121.8 167.14 13.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.892 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.539 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.7 t-20 70.15 6.87 5.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.993 0.517 . . . . 0.0 111.589 178.446 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 22.82 24.76 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA2' HD22 ' A' ' 12' ' ' LEU . . . 100.45 16.77 26.09 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.584 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' HB2' ' HB3' ' A' ' 14' ' ' ASN . 26.1 mtp180 -102.51 -15.51 16.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.677 0.275 . . . . 0.0 110.377 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 25.0 m -130.86 129.46 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.824 0.345 . . . . 0.0 111.714 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.486 ' HB2' HD22 ' A' ' 37' ' ' LEU . 57.3 tp -100.7 107.94 19.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.652 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.9 tmm_? -105.17 123.37 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.469 ' HB1' HD12 ' A' ' 104' ' ' LEU . . . -149.14 146.88 27.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.491 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.7 mt-10 -103.3 109.55 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 6' ' ' SER . 6.5 p -115.13 140.84 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.339 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.453 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -74.72 143.2 44.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.341 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' HB3' HG23 ' A' ' 31' ' ' VAL . 24.4 p-10 -85.94 -177.16 6.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.661 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.64 -15.92 61.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -86.33 -24.34 25.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.42 7.21 30.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.541 -179.533 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 14.5 t-20 -97.27 147.33 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.453 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 51.9 m0 -78.06 128.84 34.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.962 0.411 . . . . 0.0 110.584 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 25' ' ' ASN . 6.5 t -123.58 128.64 74.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.45 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 m -82.32 110.38 17.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.832 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.1 t -111.57 148.72 32.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.545 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -135.43 132.12 37.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.648 HD11 HG12 ' A' ' 40' ' ' ILE . 13.7 tp -133.88 116.71 15.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.44 178.168 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.6 ' O ' HG22 ' A' ' 39' ' ' THR . 19.3 m-20 -68.01 107.77 2.82 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.649 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.692 HD11 HD12 ' A' ' 12' ' ' LEU . 53.7 mt -57.54 -45.21 85.34 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.475 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.54 ' HB2' ' HG1' ' A' ' 56' ' ' THR . 0.4 OUTLIER -62.94 -5.04 2.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.973 -179.42 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.6 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -103.09 -10.76 18.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.819 -179.846 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.648 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.97 12.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.867 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.541 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -128.29 131.68 68.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -127.41 159.31 21.38 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 -178.767 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -112.49 108.15 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 19.4 t-20 -101.16 79.91 2.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.855 0.36 . . . . 0.0 110.131 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.511 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 70.1 m-20 53.15 57.74 5.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.575 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.19 36.45 35.02 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.739 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.422 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 61.7 m-70 -147.89 111.88 5.14 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.027 0.131 . . . . 0.0 110.82 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.469 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.6 m-85 -60.96 132.01 52.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.864 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -124.78 117.44 24.18 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.161 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -72.76 114.7 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.54 26.78 7.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.106 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.26 -52.48 1.46 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.602 -179.136 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.497 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.3 tt0 75.12 145.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.377 0.671 . . . . 0.0 110.884 -178.806 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.478 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.9 m-20 72.92 29.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.406 0.683 . . . . 0.0 111.939 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.541 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -77.04 -27.57 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.54 ' HG1' ' HB2' ' A' ' 38' ' ' ASP . 14.9 p -66.95 -28.11 68.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -178.839 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.541 ' HG3' HG22 ' A' ' 58' ' ' THR . 4.6 pt-20 -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.541 HG22 ' HG3' ' A' ' 57' ' ' GLU . 69.9 p -121.79 13.74 10.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -122.84 151.89 41.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.903 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.52 167.9 21.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.449 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 1.6 t70 49.39 51.98 15.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.101 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.58 110.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.262 0.553 . . . . 0.0 111.384 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.48 122.18 32.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.643 179.534 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.634 ' CE1' HD11 ' A' ' 94' ' ' LEU . 9.4 t80 -91.97 131.84 36.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.358 0.599 . . . . 0.0 111.483 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.491 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 4.8 t-160 -121.84 87.65 46.78 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.908 178.457 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.8 Cg_endo -58.61 -35.21 98.97 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.748 2.965 . . . . 0.0 113.872 -178.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.442 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -124.1 83.58 2.16 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.169 -179.397 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 16.1 tt0 -64.3 110.29 2.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.224 177.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.42 -152.75 14.73 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.289 179.469 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.16 -0.91 26.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.227 0.537 . . . . 0.0 110.471 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.35 -18.26 32.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HA ' ' CA ' ' A' ' 67' ' ' LYS . 27.5 mt-10 52.3 44.64 29.6 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.439 -178.019 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.513 ' HB3' ' HB3' ' A' ' 68' ' ' GLU . 5.9 tp60 -91.83 113.39 58.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.03 -179.537 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.2 Cg_endo -72.91 106.64 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.32 2.013 . . . . 0.0 112.044 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.753 HD12 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -136.14 141.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -111.64 127.99 55.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.202 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.753 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.84 143.72 49.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.21 166.57 25.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.839 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 5.4 mmt180 -85.63 115.06 23.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.575 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -99.15 124.68 44.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 111.596 -178.544 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.551 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -85.06 142.42 29.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.94 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.637 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -103.14 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.331 179.702 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.5 -25.35 62.27 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -72.34 -24.73 61.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.73 36.66 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.742 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.637 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 7.1 pt-20 -111.16 -166.29 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -144.13 132.39 21.89 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.46 111.45 7.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.702 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.6 p-10 -64.42 114.08 4.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.551 ' HB2' HD22 ' A' ' 80' ' ' LEU . 39.2 mmt180 -115.67 177.39 4.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.08 178.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . 0.481 ' HB2' HD11 ' A' ' 75' ' ' ILE . 3.6 p30 -143.37 148.76 36.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.597 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.469 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -132.07 145.56 34.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.325 0.583 . . . . 0.0 110.746 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' HB3' HD21 ' A' ' 95' ' ' ASN . 9.0 m120 -83.66 109.25 17.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.608 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.634 HD11 ' CE1' ' A' ' 64' ' ' PHE . 6.9 mt -78.06 1.78 19.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.441 -179.18 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.424 HD21 ' HB3' ' A' ' 93' ' ' ASN . 20.3 m-80 -65.6 -8.73 21.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.073 0.463 . . . . 0.0 110.04 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.72 -20.22 61.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.252 178.345 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.528 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.6 mt -84.64 122.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.384 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.559 ' OE1' ' HA ' ' A' ' 2' ' ' SER . 2.5 mp0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.635 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.2 t30 -105.15 119.32 38.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.112 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.569 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.02 93.87 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.394 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.25 25.77 14.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.565 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.5 8.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.482 178.399 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 11.8 ptp180 -130.05 138.64 50.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.14 0.47 . . . . 0.0 110.815 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.832 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.3 mt -85.92 114.26 22.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.79 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.405 HG22 ' HG3' ' A' ' 103' ' ' ARG . 40.0 t -123.0 123.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.546 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -79.37 145.65 33.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.695 0.622 . . . . 0.0 111.829 179.454 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m -163.09 174.34 12.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -68.22 -32.95 73.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.73 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -19.2 44.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.329 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.78 -27.65 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.106 0.479 . . . . 0.0 110.721 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.544 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -143.86 39.57 1.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.73 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.9 p -115.69 155.36 27.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.72 -178.783 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.468 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -151.6 164.77 36.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.799 179.444 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 52.85 35.29 18.53 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.715 0.634 . . . . 0.0 111.239 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -76.65 114.34 15.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.56 154.37 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.85 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.692 HD12 HD13 ' A' ' 37' ' ' LEU . 1.7 tp -91.08 141.15 29.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.4 m -126.25 162.73 24.78 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.2 t-20 72.5 9.39 5.73 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.688 0.618 . . . . 0.0 111.121 178.082 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.68 21.2 34.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.308 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 103.16 20.43 11.23 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.245 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.54 ' HG2' HG22 ' A' ' 56' ' ' THR . 21.5 mtp180 -103.75 -18.97 14.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.864 0.364 . . . . 0.0 110.42 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.452 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 49.3 m -129.45 128.44 42.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 112.114 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.478 ' HB2' HD21 ' A' ' 37' ' ' LEU . 50.6 tp -97.79 110.19 22.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.55 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.1 tmm_? -114.37 124.69 52.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 -178.899 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.59 162.65 40.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.926 0.393 . . . . 0.0 111.053 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.8 mt-10 -110.47 114.61 28.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.544 ' HA ' ' O ' ' A' ' 6' ' ' SER . 30.3 t -131.53 142.74 50.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.732 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 145.32 49.28 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.24 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.498 ' HB3' HG23 ' A' ' 31' ' ' VAL . 32.4 p-10 -85.92 -167.48 1.87 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.677 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.402 ' H ' ' HA ' ' A' ' 101' ' ' ASN . . . -63.41 -34.95 78.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.711 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.8 -23.73 61.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.883 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 10.03 35.43 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.0 t30 -91.0 145.35 24.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.461 ' HB3' HH12 ' A' ' 8' ' ' ARG . 33.9 m0 -73.17 122.92 22.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.047 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 25' ' ' ASN . 4.9 t -126.1 143.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.7 m -99.76 111.28 23.62 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.204 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.541 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.3 143.97 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.204 0.526 . . . . 0.0 111.816 -178.461 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.6 mt-10 -130.37 133.33 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.348 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.586 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -131.07 117.74 19.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.176 178.779 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.667 ' O ' HG23 ' A' ' 39' ' ' THR . 29.9 m-20 -69.0 109.78 4.13 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.81 178.912 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.692 HD13 HD12 ' A' ' 12' ' ' LEU . 40.2 mt -60.61 -40.0 90.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.82 0.819 . . . . 0.0 109.927 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -63.16 -5.35 3.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.78 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.667 HG23 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.45 -12.53 15.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.478 -179.332 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.586 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.36 12.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.8 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.59 159.48 22.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.361 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.14 111.86 23.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.085 0.469 . . . . 0.0 109.827 179.084 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -104.48 87.97 2.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.9 t70 49.3 59.24 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.046 178.744 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.66 40.96 36.51 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.601 179.016 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . 0.414 ' N ' HD22 ' A' ' 80' ' ' LEU . 44.2 t-80 -159.22 127.14 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.862 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.484 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 52.6 m-85 -68.0 139.41 56.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -132.11 116.38 16.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.427 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -70.5 115.12 9.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.109 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 28.23 6.77 Favored Glycine 0 C--N 1.32 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.462 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.19 -50.37 1.46 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.513 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 9.7 tt0 73.92 143.46 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.208 0.603 . . . . 0.0 111.727 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.621 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 95.8 m-20 65.64 38.66 5.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.597 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.29 -30.0 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.608 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.54 HG22 ' HG2' ' A' ' 17' ' ' ARG . 74.3 p -62.91 -23.05 67.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.75 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.621 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 8.0 pt-20 -72.3 -14.98 61.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.276 0.56 . . . . 0.0 110.031 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.569 HG23 ' HG3' ' A' ' 57' ' ' GLU . 68.0 p -126.19 7.02 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.119 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.9 144.76 49.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.33 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -138.27 172.32 13.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.053 -179.317 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.524 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.6 t70 48.15 50.96 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.071 0.462 . . . . 0.0 110.125 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.497 ' C ' ' HE ' ' A' ' 63' ' ' ARG . 2.8 mt -83.11 105.8 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.192 0.52 . . . . 0.0 110.691 -178.584 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.546 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -112.23 118.63 35.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.313 -179.848 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.624 ' CE1' HD11 ' A' ' 94' ' ' LEU . 6.2 t80 -93.04 124.69 37.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.863 0.363 . . . . 0.0 110.709 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -118.44 88.99 35.28 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.2 Cg_endo -57.65 -35.13 98.91 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 123.934 3.089 . . . . 0.0 113.538 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.494 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -129.02 88.14 2.67 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.73 -179.458 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -70.6 114.59 8.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.513 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.63 -152.08 10.11 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 124.16 0.912 . . . . 0.0 112.828 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -5.08 54.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.447 0.642 . . . . 0.0 109.527 178.666 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -23.52 59.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.494 ' OE1' ' HG2' ' A' ' 67' ' ' LYS . 28.6 mm-40 58.65 43.56 18.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.105 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.5 119.79 55.04 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.485 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.7 Cg_endo -74.39 108.16 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.368 2.046 . . . . 0.0 111.897 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.612 HD12 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -131.7 141.53 45.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.46 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.517 HD21 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -112.73 123.43 50.29 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.271 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.612 HH21 HD12 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -119.85 138.16 53.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB2' HG22 ' A' ' 62' ' ' ILE . . . -155.9 166.39 33.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.397 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.57 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.5 mmt180 -85.83 114.5 22.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 90' ' ' ARG . 2.5 mp -99.42 129.22 45.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.056 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.743 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -75.23 136.46 40.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.319 179.857 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -96.13 169.68 9.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.316 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 61.7 m -62.71 -15.2 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.027 0.441 . . . . 0.0 111.114 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.69 -27.01 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.658 0.742 . . . . 0.0 109.681 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.85 44.57 2.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.694 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.743 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.5 pt-20 -133.32 -166.47 1.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 52.8 p90 -134.61 139.36 45.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.655 0.741 . . . . 0.0 111.577 -179.677 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -139.18 119.19 13.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.348 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -66.45 116.81 7.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.576 0.703 . . . . 0.0 112.557 -178.131 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.578 ' HB2' HD21 ' A' ' 80' ' ' LEU . 24.2 mmt180 -116.9 172.61 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.162 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -141.56 147.22 37.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.484 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.1 p -134.0 151.34 32.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.212 0.529 . . . . 0.0 111.126 -178.541 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.444 ' HB3' HD21 ' A' ' 95' ' ' ASN . 37.1 m-80 -83.34 112.5 19.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.887 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.624 HD11 ' CE1' ' A' ' 64' ' ' PHE . 6.3 mt -82.33 3.44 27.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.916 0.389 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.444 HD21 ' HB3' ' A' ' 93' ' ' ASN . 20.7 m-80 -65.2 -16.78 63.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.52 67.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.127 179.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.463 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.9 mt -82.69 126.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.22 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.432 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 49.6 tt0 -120.29 162.94 18.58 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.567 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -106.55 119.96 40.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.023 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.608 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.7 t -109.67 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.481 179.801 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.402 ' HA ' ' H ' ' A' ' 26' ' ' ALA . 63.4 t30 60.06 21.69 10.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.026 179.044 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.44 17.57 7.04 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.995 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.29 146.05 51.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.084 0.442 . . . . 0.0 110.856 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.541 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 73.4 mt -89.5 119.04 29.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.102 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 57.7 t -121.22 123.4 69.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.624 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.12 145.14 32.53 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.469 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.333 179.88 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.424 0.154 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -155.99 -171.48 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -56.81 -38.56 72.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.059 0.457 . . . . 0.0 110.365 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.504 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.26 -26.13 37.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.896 -178.356 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.56 -32.09 64.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.0 m -132.76 32.94 3.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.504 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 62.0 m -115.08 152.76 31.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 111.515 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.445 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -145.78 163.93 33.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.022 -179.312 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.437 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 9.9 m120 52.66 33.28 13.43 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.727 0.642 . . . . 0.0 111.761 179.14 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.517 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -74.89 114.01 12.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.4 t -141.56 152.36 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.057 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.779 HD11 HD13 ' A' ' 37' ' ' LEU . 1.1 tp -87.41 140.71 29.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.418 HG23 ' N ' ' A' ' 14' ' ' ASN . 12.2 m -126.48 163.7 22.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.034 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.546 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.7 t-20 73.23 5.69 5.11 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.687 0.617 . . . . 0.0 111.368 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.85 23.4 15.51 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.52 21.63 16.41 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.942 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HG2' HG23 ' A' ' 56' ' ' THR . 29.8 mtp180 -104.12 -19.1 14.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.652 0.263 . . . . 0.0 110.811 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.7 m -129.26 126.94 40.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.955 0.407 . . . . 0.0 111.703 -178.91 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.484 ' HB2' HD22 ' A' ' 37' ' ' LEU . 58.8 tp -94.68 105.67 17.62 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.014 178.176 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.437 ' NH2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 tmm_? -101.97 123.68 46.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' HB1' HD13 ' A' ' 104' ' ' LEU . . . -147.32 144.13 28.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 111.137 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.427 ' HG2' HG21 ' A' ' 32' ' ' THR . 3.9 mt-10 -105.17 113.02 26.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.476 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 45.4 t -127.17 147.63 50.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.199 0.523 . . . . 0.0 111.674 -178.526 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.72 145.67 40.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.426 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.442 ' HB3' HG23 ' A' ' 31' ' ' VAL . 7.7 p30 -93.05 -173.43 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.521 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -34.38 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 112.204 -178.838 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.26 -20.29 61.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.659 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 4.16 54.67 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.926 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -87.59 143.69 27.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.253 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -73.86 122.23 22.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.442 HG23 ' HB3' ' A' ' 25' ' ' ASN . 8.2 t -120.52 146.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.616 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.427 HG21 ' HG2' ' A' ' 22' ' ' GLU . 37.0 m -114.86 110.15 19.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.899 0.38 . . . . 0.0 110.191 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -118.29 164.18 15.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 112.102 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.404 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.5 mt-10 -136.69 140.04 42.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.229 -179.389 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -132.01 113.88 13.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.291 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' THR . 26.8 m-20 -66.65 108.65 2.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.779 HD13 HD11 ' A' ' 12' ' ' LEU . 54.1 mt -59.92 -47.39 85.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.212 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.592 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -64.2 -4.54 3.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.928 -179.447 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.14 -14.72 20.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.908 179.731 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.476 HG21 HG21 ' A' ' 39' ' ' THR . 2.6 pp -143.96 13.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.575 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 3.0 mt -126.4 131.42 71.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.15 160.1 19.75 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.837 -178.627 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.36 104.41 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -92.77 75.48 4.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.791 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.516 ' CG ' ' HG ' ' A' ' 83' ' ' CYS . 50.1 m-20 48.93 65.8 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.023 178.503 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.5 34.79 34.72 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.778 178.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -159.33 120.61 3.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.519 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 61.9 m-85 -63.25 143.54 57.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 111.271 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -133.82 117.4 16.81 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -72.7 114.58 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 40.58 3.08 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.98 -49.23 0.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.281 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.592 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.2 tt0 71.52 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.328 0.651 . . . . 0.0 111.582 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.68 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 91.5 m-20 71.06 35.19 1.68 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.523 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.575 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.79 -32.08 40.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 17' ' ' ARG . 23.8 p -63.47 -30.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.523 -179.159 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.68 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 20.2 pt-20 -67.19 -17.0 64.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.075 0.464 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.524 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.7 p -122.56 12.71 10.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.69 149.95 48.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.47 169.09 18.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.45 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 49.05 57.93 5.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.446 HG21 HD22 ' A' ' 76' ' ' LEU . 2.6 mt -88.06 111.59 22.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.371 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.574 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -116.66 118.83 33.66 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.882 179.624 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.663 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.8 t80 -92.77 128.06 38.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 178.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.455 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 4.0 t-160 -117.19 84.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 19.5 Cg_endo -58.95 -44.9 31.71 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.613 2.875 . . . . 0.0 114.488 -177.609 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 84.32 2.25 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.864 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.426 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 8.3 tt0 -67.81 113.33 5.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.769 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.61 11.04 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 124.299 0.999 . . . . 0.0 112.72 179.535 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.53 58.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.338 0.59 . . . . 0.0 109.548 178.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.78 -18.04 58.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.046 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 51.4 43.33 29.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.926 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.76 118.54 56.1 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.865 -177.724 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.58 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.3 Cg_endo -75.25 111.46 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.447 2.098 . . . . 0.0 111.766 178.644 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.466 HD12 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -132.48 140.47 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.06 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.65 121.15 43.28 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.243 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.574 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.85 140.12 50.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.904 0.383 . . . . 0.0 110.201 179.261 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.83 169.36 23.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.6 mmt180 -85.12 115.15 22.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.502 HD23 ' HB2' ' A' ' 90' ' ' ARG . 4.2 mp -100.9 130.82 46.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 -178.658 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.721 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -78.32 137.67 38.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.02 -179.533 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -99.08 171.5 7.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.129 179.5 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . 0.516 ' HG ' ' CG ' ' A' ' 45' ' ' ASP . 69.6 m -54.63 -29.91 53.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.611 179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -67.82 -23.05 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.689 -178.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.62 36.68 5.26 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.721 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.6 pt-20 -122.09 -166.85 1.45 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.931 -0.634 . . . . 0.0 109.482 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -134.58 141.25 46.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.808 0.813 . . . . 0.0 111.725 -179.024 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -140.18 112.71 7.92 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -68.28 115.49 7.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.376 0.608 . . . . 0.0 111.169 -179.064 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.502 ' HB2' HD23 ' A' ' 80' ' ' LEU . 34.9 mmt180 -116.16 177.28 4.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.414 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -140.32 148.73 41.81 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.519 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.8 p -132.74 148.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.549 -179.473 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.472 ' HB3' HD21 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -86.11 109.01 18.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.995 -179.064 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.663 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.2 mt -78.98 4.04 15.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.472 HD21 ' HB3' ' A' ' 93' ' ' ASN . 15.4 m-80 -64.63 -12.58 47.31 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.043 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.7 -16.69 63.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.183 179.096 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.534 HD11 ' HB3' ' A' ' 94' ' ' LEU . 10.8 mt -88.28 122.59 40.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.618 0.723 . . . . 0.0 111.362 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -110.71 166.42 11.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.592 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . 0.416 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.7 t30 -114.94 115.71 27.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.566 178.846 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 56.2 t -112.69 101.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.36 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t30 60.33 21.68 11.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.006 179.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.58 11.27 27.32 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.597 178.336 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.4 ptp180 -118.16 141.48 48.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 0.0 110.506 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.434 HD13 ' HB1' ' A' ' 21' ' ' ALA . 79.1 mt -89.63 126.45 35.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.769 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.8 p -134.41 134.67 54.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.248 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -88.79 144.86 25.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.815 0.697 . . . . 0.0 111.506 178.885 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.544 0.211 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -154.21 -178.63 7.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -64.95 -35.43 81.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.032 0.444 . . . . 0.0 109.835 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.647 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.61 -24.07 45.28 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.384 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.54 -31.67 64.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.4 m -144.85 42.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.647 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.3 p -115.54 149.4 38.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.022 0.439 . . . . 0.0 111.253 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.15 166.19 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . 0.406 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.1 m-20 52.05 33.25 11.65 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.677 0.61 . . . . 0.0 111.734 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.531 ' HB2' ' HB3' ' A' ' 66' ' ' PRO . . . -77.05 114.54 15.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.086 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.18 155.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.891 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.824 HD13 HD13 ' A' ' 37' ' ' LEU . 1.4 tp -91.66 143.31 26.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.0 110.135 179.394 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.48 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.9 m -129.67 165.23 22.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.765 -179.243 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.1 t-20 72.06 9.82 6.05 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.512 0.507 . . . . 0.0 110.947 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 8.8 57.99 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' HA2' HD21 ' A' ' 12' ' ' LEU . . . 112.36 25.75 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.099 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HG2' HG23 ' A' ' 56' ' ' THR . 21.6 mtp180 -108.45 -18.56 13.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 0.0 110.521 -178.903 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.48 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 46.7 m -127.68 126.57 42.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -178.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' CD2' HD12 ' A' ' 97' ' ' ILE . 45.6 tp -98.01 108.84 21.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.158 178.396 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.521 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -104.14 122.52 45.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' HB3' HD13 ' A' ' 104' ' ' LEU . . . -146.89 137.61 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.743 0.306 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.406 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.6 mt-10 -98.25 110.84 23.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.761 0.315 . . . . 0.0 110.285 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 6' ' ' SER . 49.6 t -125.83 147.88 49.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.853 0.359 . . . . 0.0 110.814 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.447 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.2 145.72 43.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.274 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -85.58 -168.56 2.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.724 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -32.99 74.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.163 0.506 . . . . 0.0 111.289 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.31 -24.31 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.32 4.25 40.88 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.398 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 m-80 -83.78 139.06 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.262 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.8 m0 -72.51 121.95 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.984 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.0 t -123.26 150.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -99.32 109.63 22.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.592 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.5 m -109.38 139.44 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.256 0.55 . . . . 0.0 111.43 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.521 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.0 mt-10 -130.39 131.79 45.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.041 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.507 HD11 HG12 ' A' ' 40' ' ' ILE . 13.3 tp -131.96 124.01 28.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 178.603 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.533 ' O ' HG21 ' A' ' 39' ' ' THR . 39.0 m-20 -72.25 108.64 5.5 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.123 179.179 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.824 HD13 HD13 ' A' ' 12' ' ' LEU . 34.8 mt -61.1 -41.24 96.31 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.618 0.723 . . . . 0.0 109.718 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.36 -5.91 4.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.471 179.639 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.533 HG21 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -103.91 -12.05 17.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.401 -179.231 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.507 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.0 12.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.536 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.545 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.53 132.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.445 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.34 157.32 21.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.567 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -110.88 110.31 20.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.102 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -103.17 87.05 2.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 1.1 m-20 48.34 54.8 9.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.551 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.67 41.99 12.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.997 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 80.4 t60 -158.72 118.26 3.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.365 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.474 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 53.3 m-85 -64.56 137.29 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.78 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.433 HE21 ' HB2' ' A' ' 49' ' ' GLN . 1.8 tt0 -131.26 115.83 16.82 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.281 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -69.13 116.08 9.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.439 178.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.7 33.28 5.37 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.168 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -104.1 -52.66 0.88 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.15 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 35.4 tt0 73.65 142.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 111.213 -179.254 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.545 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.2 m-20 71.92 34.99 1.41 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 111.602 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . 0.545 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.4 p90 -78.84 -27.91 44.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.57 HG23 ' HG2' ' A' ' 17' ' ' ARG . 62.1 p -66.31 -24.0 66.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.615 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.591 ' HG3' HG22 ' A' ' 58' ' ' THR . 4.3 pt-20 -74.91 -11.27 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.591 HG22 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -129.29 14.97 6.16 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.443 0.639 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.4 153.48 47.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.627 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.33 171.57 14.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.204 -179.673 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.571 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 12.7 t70 46.51 55.11 7.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.401 0.438 . . . . 0.0 110.541 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.459 HG22 HD22 ' A' ' 76' ' ' LEU . 2.6 mt -84.72 107.35 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.261 0.553 . . . . 0.0 111.664 -178.026 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.546 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -114.34 118.2 33.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.23 179.728 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.628 ' CE1' HD11 ' A' ' 94' ' ' LEU . 8.1 t80 -92.99 128.76 38.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 111.302 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.416 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -120.49 87.86 41.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.744 177.794 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.643 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -58.86 -35.73 98.13 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.678 2.919 . . . . 0.0 112.693 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.643 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -131.52 85.56 2.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.437 178.995 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.14 121.77 16.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.299 -179.643 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.27 -136.08 1.03 Allowed Glycine 0 C--N 1.333 0.403 0 O-C-N 124.929 1.393 . . . . 0.0 114.818 177.122 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.23 -9.91 58.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.105 -0.548 . . . . 0.0 110.022 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -26.14 59.79 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.284 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 54.48 43.67 29.99 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.747 0.654 . . . . 0.0 109.892 -178.869 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -114.57 131.02 23.57 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.164 -178.813 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.516 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 66.2 Cg_endo -75.46 108.74 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.82 2.347 . . . . 0.0 112.032 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.658 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.8 141.19 43.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.254 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.502 HD21 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -112.59 123.87 51.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.395 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.658 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.28 139.21 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -157.26 166.63 32.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.426 -179.805 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.627 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.0 mmt85 -85.9 115.04 23.28 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.309 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.616 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.8 mp -98.73 126.48 44.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.248 -178.732 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.612 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.51 141.19 30.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.067 -179.628 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.52 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 2.2 p-10 -100.39 174.1 6.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.27 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.8 p -57.7 -29.26 64.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -69.15 -28.36 66.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.848 -179.174 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.17 33.74 3.36 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.605 178.202 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.612 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 8.4 pt-20 -113.68 -164.08 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -146.78 132.3 18.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 0.0 110.623 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -133.68 119.61 19.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.024 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.8 p-10 -65.65 112.02 3.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 111.454 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.616 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -115.08 171.29 7.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.188 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -141.42 147.01 37.27 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.17 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.474 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.7 p -132.82 147.95 31.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.902 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' HB3' HD21 ' A' ' 95' ' ' ASN . 41.6 m-80 -83.2 111.94 19.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.628 HD11 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.35 3.3 21.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.171 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.448 HD21 ' HB3' ' A' ' 93' ' ' ASN . 31.3 m-80 -63.23 -16.5 60.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.089 0.471 . . . . 0.0 109.863 178.514 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.84 -28.68 70.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.553 0.692 . . . . 0.0 109.978 178.76 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 94' ' ' LEU . 13.5 mt -76.44 123.65 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.212 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -116.06 164.02 15.07 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -111.31 118.26 35.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.133 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.9 t -109.85 94.44 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.19 25.16 13.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.045 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.13 17.22 9.67 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.887 177.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.1 ptp180 -130.37 135.99 48.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.133 0.467 . . . . 0.0 110.612 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.592 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 71.1 mt -84.48 125.04 32.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -133.66 132.32 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.21 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.41 144.82 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.371 179.015 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.709 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.85 -27.87 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.675 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -33.29 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.3 m -134.94 37.32 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.709 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 69.6 p -119.43 152.37 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.492 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.2 ptp180 -151.42 168.93 23.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.6 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.0 t30 56.2 30.87 17.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.662 0.744 . . . . 0.0 110.135 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.34 113.52 16.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.178 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.96 146.47 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.4 tp -82.37 141.98 32.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -131.9 165.93 22.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.986 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.7 OUTLIER 71.42 7.17 5.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.574 . . . . 0.0 111.584 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.4 9.9 Favored Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 91.75 18.66 43.49 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.946 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.3 mtp180 -103.43 -16.92 15.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.729 0.3 . . . . 0.0 110.3 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -128.58 129.39 45.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' CD2' HD13 ' A' ' 97' ' ' ILE . 52.8 tp -100.71 104.98 16.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.358 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.4 tmm_? -104.35 124.73 49.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.414 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.92 153.25 32.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 32.7 mt-10 -103.4 110.34 22.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.6 p -119.74 139.6 52.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.087 0.47 . . . . 0.0 111.415 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.49 144.11 44.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.222 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -89.25 -171.57 3.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.279 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.2 -21.53 65.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.64 -19.0 29.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.285 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.11 0.62 41.46 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 66.1 m-20 -80.83 136.3 36.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.447 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 49.5 m0 -77.98 119.48 21.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.005 0.431 . . . . 0.0 110.077 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.32 132.31 65.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -83.08 107.89 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.678 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 21.0 m -110.89 146.1 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.551 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.8 mt-10 -133.15 130.68 39.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.392 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.583 HD11 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -123.04 120.09 32.27 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.246 0.546 . . . . 0.0 110.101 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 39' ' ' THR . 9.3 m-20 -69.32 106.23 2.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.623 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 12' ' ' LEU . 21.2 mt -62.71 -40.23 96.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.929 0.871 . . . . 0.0 109.75 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.6 p-10 -64.27 -5.04 4.33 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.639 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.58 -16.14 16.18 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.556 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.583 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.08 14.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.29 130.75 70.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.97 157.54 21.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.335 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.3 t30 -111.97 113.94 26.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.044 0.45 . . . . 0.0 110.527 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -101.51 81.44 2.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.639 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 49.93 47.92 22.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.384 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 90.64 39.09 5.98 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.863 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -158.09 113.57 2.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 58.0 m-85 -60.27 136.64 58.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 0.0 111.007 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -127.22 114.49 17.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.168 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -71.22 114.53 9.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.8 28.64 6.89 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.705 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -98.5 -52.08 1.36 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.927 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 25.6 tt0 72.85 141.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.134 0.573 . . . . 0.0 111.213 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.655 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 94.6 m-20 70.48 37.87 1.43 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.544 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.7 p90 -81.4 -27.26 34.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.691 HG21 ' HG2' ' A' ' 17' ' ' ARG . 11.9 p -65.16 -19.54 66.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.699 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HG3' HG23 ' A' ' 58' ' ' THR . 8.3 pt-20 -77.32 -14.82 59.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.197 0.522 . . . . 0.0 110.136 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -125.89 12.89 7.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.664 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.27 145.71 47.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.554 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -139.3 169.22 18.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.476 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.2 t70 47.39 54.57 9.39 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.353 0.408 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.34 114.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 112.153 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -128.45 121.97 30.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.124 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.4 t80 -92.04 134.73 34.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -123.22 85.44 51.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.927 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 25.8 Cg_endo -62.22 -45.13 16.39 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 123.622 2.882 . . . . 0.0 113.89 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.809 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.55 0.214 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 64.2 Cg_endo -74.04 106.58 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.465 2.11 . . . . 0.0 111.678 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.494 HD11 HH21 ' A' ' 77' ' ' ARG . 0.8 OUTLIER -132.35 140.92 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.975 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -114.15 124.02 51.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.148 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.494 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.08 142.71 48.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 110.434 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.56 167.66 26.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.709 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.71 115.13 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.0 mp -97.87 121.44 39.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.462 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.549 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.1 pt-20 . . . . . 0 C--O 1.217 -0.647 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -147.73 134.59 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.465 0.65 . . . . 0.0 111.492 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.72 118.82 11.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.052 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 p-10 -64.37 114.73 4.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.469 0.652 . . . . 0.0 111.659 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.695 ' HB2' HD22 ' A' ' 80' ' ' LEU . 30.0 mmt180 -115.84 174.21 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -144.04 144.93 31.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -129.45 145.66 35.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.393 0.616 . . . . 0.0 111.082 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.495 ' HB3' HD22 ' A' ' 95' ' ' ASN . 5.1 m-20 -81.57 107.17 14.11 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.61 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.702 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.3 mt -78.75 4.2 14.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.355 . . . . 0.0 110.995 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.34 -18.99 64.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 109.814 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.73 -24.46 67.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.003 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.7 mt -81.28 124.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -121.0 167.5 12.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.946 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.0 t30 -109.71 121.26 44.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.8 t -112.77 94.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.24 22.98 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.827 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.26 22.15 6.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.082 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 14.9 ptp180 -132.39 143.01 49.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.374 0.587 . . . . 0.0 111.15 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.678 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 67.3 mt -92.22 122.69 34.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.25 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.9 p -138.91 135.86 42.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -82.29 146.27 29.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.198 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.258 -179.799 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.732 0.301 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.2 -25.72 24.42 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.91 -33.76 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.24 0.543 . . . . 0.0 110.676 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 22.5 m -130.04 30.51 4.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.367 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 68.7 m -115.99 154.76 29.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 0.0 112.103 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -155.45 171.76 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.322 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.574 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.6 t-20 55.38 31.12 16.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.559 0.537 . . . . 0.0 110.694 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.51 113.86 16.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.425 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.48 151.34 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.825 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -90.78 134.52 34.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.529 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.2 m -120.69 164.39 16.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.63 5.07 4.87 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.69 0.619 . . . . 0.0 111.342 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.94 13.89 41.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 109.68 20.68 7.56 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.64 ' HG2' HG21 ' A' ' 56' ' ' THR . 22.5 mtp180 -104.27 -21.34 13.54 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.529 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 8.9 m -123.75 131.14 53.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.066 0.46 . . . . 0.0 111.723 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -103.62 105.51 15.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.263 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.6 tmm_? -103.81 124.35 48.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.219 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -147.27 150.25 34.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.801 0.334 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 11.4 mt-10 -107.35 112.41 25.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.7 t -125.67 147.9 49.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.232 0.539 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.89 145.17 40.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 178.868 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 31' ' ' VAL . 31.5 p-10 -87.8 -171.38 3.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.07 68.32 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.45 -24.55 50.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.431 . . . . 0.0 110.923 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.89 11.51 32.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.2 t30 -94.77 146.12 24.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -72.87 125.64 28.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.654 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.0 t -129.33 126.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -81.49 122.94 28.17 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.816 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 1.4 t -125.21 151.33 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.688 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.507 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.02 136.46 40.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.517 HD11 HG12 ' A' ' 40' ' ' ILE . 13.1 tp -130.63 126.11 35.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 39' ' ' THR . 5.5 m-20 -72.33 107.02 4.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 12' ' ' LEU . 47.7 mt -63.61 -41.4 98.31 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.874 0.845 . . . . 0.0 108.97 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -62.59 -4.77 2.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.527 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -104.54 -15.76 15.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.55 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.567 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -140.54 13.25 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.26 130.78 70.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.42 160.52 22.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.298 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -111.81 116.83 31.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 110.173 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -102.93 84.12 2.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.916 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 p30 46.01 43.15 10.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.322 1.049 . . . . 0.0 112.953 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 98.82 37.13 4.28 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.911 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -157.3 117.06 3.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -60.85 136.51 58.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -129.29 114.26 16.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -67.84 115.32 7.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 39.71 3.52 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.993 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -109.83 -55.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.591 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.0 tt0 76.02 138.48 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.564 0.746 . . . . 0.0 111.875 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.4 t30 68.29 40.17 2.14 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.93 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 11.2 p90 -76.19 -30.37 58.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.758 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.64 HG21 ' HG2' ' A' ' 17' ' ' ARG . 42.5 p -61.85 -21.45 64.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.018 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.75 ' HG3' HG23 ' A' ' 58' ' ' THR . 1.1 pt-20 -72.16 -15.68 61.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.336 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.75 HG23 ' HG3' ' A' ' 57' ' ' GLU . 60.7 p -125.42 2.79 7.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -115.92 149.31 38.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.24 172.43 12.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.28 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.56 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 48.78 52.31 14.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.068 0.461 . . . . 0.0 110.202 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 76' ' ' LEU . 2.2 mt -86.44 109.18 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.45 0.643 . . . . 0.0 111.754 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.9 122.96 39.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.62 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.644 ' CE1' HD12 ' A' ' 94' ' ' LEU . 10.2 t80 -91.6 135.11 34.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.736 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -123.66 87.07 52.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.083 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 9.4 Cg_endo -58.13 -38.27 92.11 Favored 'Trans proline' 0 CA--C 1.514 -0.515 0 C-N-CA 123.725 2.95 . . . . 0.0 114.836 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.745 ' HD3' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.03 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.875 0.369 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.9 Cg_endo -72.89 109.68 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.52 2.146 . . . . 0.0 112.017 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.678 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 141.1 43.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.357 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -112.68 127.23 56.06 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.976 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.678 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.91 141.81 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.965 0.412 . . . . 0.0 109.904 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.09 169.42 23.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.06 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.56 ' HG2' ' CB ' ' A' ' 61' ' ' ASP . 4.2 mmt180 -85.97 115.19 23.43 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.0 mp -101.86 134.64 44.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.09 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.79 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.1 pt-20 . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -140.66 136.08 32.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.946 0.879 . . . . 0.0 111.725 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -139.8 125.54 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.102 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 3.7 p-10 -67.53 114.59 6.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 112.078 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 29.3 mmt180 -115.34 173.31 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.91 147.85 37.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 9.8 p -133.12 146.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.021 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.588 ' HB3' HD22 ' A' ' 95' ' ' ASN . 75.3 m-20 -82.91 110.58 18.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.728 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.644 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -79.28 3.95 16.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.588 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.3 m-80 -63.19 -14.36 48.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.053 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -24.93 67.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -79.22 126.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.836 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -118.91 160.56 21.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.932 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.27 120.95 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 52.9 t -112.48 93.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.38 25.73 13.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.84 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.96 14.86 15.95 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.646 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 14.4 ptp180 -124.17 134.57 53.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.347 . . . . 0.0 110.212 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.816 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 79.3 mt -85.17 120.31 26.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.4 t -128.46 136.37 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.914 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 2.1 p90 -87.59 143.69 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.893 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.964 179.31 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 p90 . . . . . 0 C--O 1.231 0.094 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.743 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.29 -21.25 48.24 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.929 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.66 -35.41 70.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.377 0.608 . . . . 0.0 110.186 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -140.29 46.56 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.951 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.743 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 88.9 p -116.1 155.79 27.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 111.29 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -149.33 163.99 36.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 91.3 m-20 51.24 35.96 14.82 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.506 0.504 . . . . 0.0 111.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -79.11 113.81 17.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.411 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -144.67 149.72 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -83.99 142.46 30.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 m -127.87 164.96 21.1 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 7.2 t-20 73.29 9.23 5.2 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 123.575 0.547 . . . . 0.0 110.861 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.12 13.92 50.67 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 108.47 15.94 12.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.056 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HG2' HG21 ' A' ' 56' ' ' THR . 23.6 mtp180 -99.51 -16.98 18.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.583 0.23 . . . . 0.0 111.035 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -131.3 131.0 43.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.026 0.441 . . . . 0.0 111.67 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 37' ' ' LEU . 59.4 tp -98.55 105.09 17.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.796 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -104.91 123.87 48.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.47 41.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -112.4 113.08 25.09 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -126.49 141.07 52.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.095 0.474 . . . . 0.0 111.589 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -67.79 144.06 55.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.448 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.6 p-10 -85.9 -173.85 4.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.509 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.86 75.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.741 0.305 . . . . 0.0 111.527 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.53 -24.24 63.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.082 0.468 . . . . 0.0 111.096 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.84 35.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.721 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 t30 -91.69 146.44 23.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -75.0 124.1 26.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.293 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -127.54 154.59 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.3 m -104.73 114.16 28.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.897 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.0 p -110.7 134.08 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.495 0.664 . . . . 0.0 111.413 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.45 131.83 50.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.647 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.546 HD11 HG12 ' A' ' 40' ' ' ILE . 12.9 tp -131.44 119.59 21.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.955 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 39' ' ' THR . 9.6 t70 -68.88 111.32 4.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 12' ' ' LEU . 33.8 mt -61.73 -45.16 95.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.683 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -63.5 -3.8 2.37 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -101.3 -13.13 18.17 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.823 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.546 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.53 11.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.46 129.54 70.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.46 160.3 22.11 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.312 -0.946 . . . . 0.0 112.518 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.6 t30 -110.88 109.61 19.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.52 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.53 76.56 6.57 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.002 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 39.3 62.07 1.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.802 0.841 . . . . 0.0 112.14 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 88.89 36.89 7.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.794 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -163.24 118.13 1.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.77 0.285 . . . . 0.0 110.483 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CG ' ' HB ' ' A' ' 92' ' ' VAL . 41.5 m-85 -61.57 138.51 58.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.959 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.52 116.14 15.59 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.648 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.24 115.02 8.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.04 38.87 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -110.66 -50.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.258 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 14.5 tt0 74.76 144.32 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.218 0.607 . . . . 0.0 111.527 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 94.0 m-20 64.02 46.03 3.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.749 0.785 . . . . 0.0 111.117 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -85.16 -28.56 25.42 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.39 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 17' ' ' ARG . 77.7 p -68.58 -19.58 64.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.559 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 58' ' ' THR . 12.2 pt-20 -71.37 -17.52 62.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.797 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 57' ' ' GLU . 62.8 p -124.33 9.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.905 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 56' ' ' THR . . . -115.69 150.37 36.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.093 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -137.04 170.09 16.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 7.3 t70 43.54 57.21 4.04 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.594 0.558 . . . . 0.0 111.33 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.442 HG22 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -87.94 113.39 25.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.187 0.518 . . . . 0.0 112.241 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 121.86 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.866 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 94' ' ' LEU . 12.8 t80 -91.47 132.1 36.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.292 0.567 . . . . 0.0 111.679 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -120.18 87.74 40.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 11.2 Cg_endo -57.63 -37.24 97.56 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 123.951 3.101 . . . . 0.0 114.105 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 C--N 1.295 -1.775 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.059 0.456 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 60.2 Cg_endo -73.62 109.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.941 2.428 . . . . 0.0 111.882 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.497 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 140.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.77 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.07 124.63 52.83 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.105 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.501 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.89 141.48 50.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.856 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.23 170.56 20.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.276 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.47 115.14 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -100.63 125.98 47.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.913 0.387 . . . . 0.0 111.575 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.5 pt-20 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -136.11 139.87 43.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.63 0.729 . . . . 0.0 111.424 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -139.48 109.75 6.52 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.1 p-10 -62.83 114.09 3.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.393 0.616 . . . . 0.0 111.374 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.646 ' HB2' HD22 ' A' ' 80' ' ' LEU . 31.2 mmt180 -115.06 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.519 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.84 148.34 32.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CG ' ' A' ' 48' ' ' PHE . 12.7 p -135.31 143.56 36.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.375 0.607 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -84.02 106.22 15.51 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.887 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.611 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.0 mt -75.67 2.17 12.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.504 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 13.2 m120 -62.32 -17.22 58.21 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.697 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -21.55 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.155 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.8 mt -86.74 125.2 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -118.25 159.9 22.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -102.04 119.04 38.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.202 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 41.0 t -111.84 96.62 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.317 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 61.69 20.74 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.466 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 33' ' ' SER . . . 108.62 18.41 9.58 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.33 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 5.5 ptp180 -125.86 150.63 47.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.897 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 78.6 mt -97.78 118.1 33.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.5 p -118.42 126.19 74.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -86.78 144.38 27.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.763 178.4 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 4.9 p90 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.682 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.18 -30.08 59.16 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.003 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.87 -32.55 65.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.306 0.574 . . . . 0.0 111.196 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 56.2 m -136.69 41.12 2.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.209 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.8 p -115.96 145.15 43.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 111.419 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.88 166.03 27.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.016 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.22 31.07 13.4 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.641 0.588 . . . . 0.0 111.309 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.575 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.59 114.85 16.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.601 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.14 149.58 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.147 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -86.93 134.5 33.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.708 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 m -123.32 165.36 17.11 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.118 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.7 OUTLIER 71.24 8.79 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.229 0.612 . . . . 0.0 111.325 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 22.17 22.3 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.532 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.01 14.11 37.51 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.576 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.631 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.3 mtp180 -98.08 -17.11 19.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.402 0.144 . . . . 0.0 111.02 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 26.5 m -130.6 124.52 31.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 37' ' ' LEU . 60.6 tp -95.7 105.92 17.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -103.32 124.15 48.12 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 104' ' ' LEU . . . -147.42 145.06 29.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.027 0.441 . . . . 0.0 111.153 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' A' ' 32' ' ' THR . 10.2 mt-10 -100.25 113.46 26.16 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 6' ' ' SER . 20.1 t -128.02 143.85 51.09 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.949 0.404 . . . . 0.0 110.441 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.08 144.46 48.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.729 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -84.42 -171.44 3.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.704 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.1 72.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.513 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.68 -24.44 63.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.32 38.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.498 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.0 m-80 -96.49 143.85 27.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -73.66 122.72 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 112.026 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 153.76 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.94 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 22' ' ' GLU . 20.2 m -108.55 111.0 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.506 ' HB3' HD13 ' A' ' 104' ' ' LEU . 9.3 t -112.62 155.97 23.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.135 0.493 . . . . 0.0 111.184 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.536 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.2 mt-10 -137.87 131.96 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.868 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.84 117.45 20.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.532 ' O ' HG22 ' A' ' 39' ' ' THR . 21.5 m-20 -68.15 107.04 2.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 109.579 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -59.19 -45.89 89.87 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.504 0.668 . . . . 0.0 110.536 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -62.7 -5.26 2.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.818 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.56 -14.23 18.29 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.992 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.11 10.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.499 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.08 129.94 71.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.77 158.65 20.86 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.883 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 12.1 t30 -110.7 111.48 22.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -93.07 79.29 4.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.537 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.4 49.84 4.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.174 0.921 . . . . 0.0 112.811 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 102.33 33.09 4.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.233 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -162.38 123.5 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.118 0.459 . . . . 0.0 111.061 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -64.08 139.79 58.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.18 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -133.02 117.49 17.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.65 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.17 114.59 8.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.26 34.86 5.2 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.759 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -107.7 -49.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.06 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.5 tt0 72.07 145.46 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.3 m-20 69.91 34.89 2.42 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.486 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.5 p90 -77.77 -28.46 50.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.631 HG21 ' HG2' ' A' ' 17' ' ' ARG . 40.0 p -68.86 -28.52 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.293 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.625 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.3 pt-20 -70.82 -13.83 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 109.979 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.0 p -126.09 17.51 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.04 163.5 26.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.09 166.39 29.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.35 61.43 3.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 110.749 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 78' ' ' ALA . 1.8 mt -93.61 116.76 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.704 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.48 126.77 30.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.28 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.668 ' CE1' HD12 ' A' ' 94' ' ' LEU . 16.5 t80 -92.2 137.93 31.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.349 0.595 . . . . 0.0 112.206 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -119.44 84.56 29.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.567 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.756 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 Cg_endo -58.72 -39.15 84.83 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.566 2.844 . . . . 0.0 114.177 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.244 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.611 0.244 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 59.7 Cg_endo -74.57 107.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.21 1.94 . . . . 0.0 111.452 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.73 141.61 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.9 124.94 53.76 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.222 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HD3' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.62 141.11 50.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.23 179.147 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.27 166.17 30.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.628 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 11.8 mmt180 -85.69 115.18 23.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -98.05 129.83 44.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.232 0.539 . . . . 0.0 112.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.051 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.7 pt-20 . . . . . 0 C--O 1.223 -0.303 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -147.76 128.2 14.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.0 110.135 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -137.42 120.94 17.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.7 p-10 -64.62 125.53 25.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.587 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -120.57 178.09 4.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.752 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -144.73 147.69 33.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 p -136.22 140.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.582 0.706 . . . . 0.0 110.999 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.516 ' HB3' HD22 ' A' ' 95' ' ' ASN . 26.0 m-80 -79.2 108.42 12.69 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.641 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.668 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -78.97 5.82 10.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.331 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 93' ' ' ASN . 18.8 m-80 -67.23 -8.61 33.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 110.281 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -72.84 -15.61 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.932 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.0 mt -89.05 126.13 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -115.87 169.93 8.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.508 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -115.2 118.77 34.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.226 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.444 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -113.75 100.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.57 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.73 24.64 13.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.37 0.605 . . . . 0.0 110.801 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.99 23.0 10.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.304 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.5 ptp180 -129.92 134.76 47.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.951 0.376 . . . . 0.0 110.069 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.1 mp -83.67 128.41 34.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.2 130.29 21.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.99 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -82.04 145.92 29.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.249 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.738 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.415 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 11.7 p90 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -52.4 -26.39 12.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.465 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.65 -29.63 27.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.011 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 25.5 m -141.47 34.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 66.7 m -115.64 152.92 32.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.389 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 167.64 26.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.96 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 74.0 m-20 55.6 31.71 17.77 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.524 0.515 . . . . 0.0 111.457 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -73.41 114.47 11.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.314 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.8 t -142.3 150.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.083 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.1 138.35 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -125.81 165.3 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 9.3 t30 72.49 6.36 5.44 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.57 0.544 . . . . 0.0 111.531 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.71 28.74 11.81 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 93.28 20.92 31.2 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.686 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.5 mtp180 -106.78 -13.99 15.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.687 0.28 . . . . 0.0 110.275 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 28.7 m -133.15 129.24 37.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.913 0.387 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' HD13 ' A' ' 97' ' ' ILE . 55.5 tp -100.33 108.7 20.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.609 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.7 tmm_? -103.96 123.54 47.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.75 151.0 36.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.006 0.431 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.7 mt-10 -106.44 114.47 28.61 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 6' ' ' SER . 12.6 t -130.32 147.93 52.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.307 0.575 . . . . 0.0 111.677 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.74 144.72 36.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.829 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -87.72 -168.6 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.791 0.329 . . . . 0.0 111.645 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.81 75.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.44 -24.24 61.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.147 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.8 5.84 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -86.48 144.69 27.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -77.47 125.34 29.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.482 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.15 131.75 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.869 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -83.58 110.05 17.92 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.531 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.8 p -111.36 143.43 42.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.321 0.581 . . . . 0.0 111.642 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -130.7 133.15 45.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.34 119.17 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.5 m-20 -68.88 108.48 3.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 12' ' ' LEU . 55.3 mt -59.28 -46.76 87.66 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.108 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -62.77 -4.91 2.33 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.85 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.12 -13.97 20.68 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.872 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -143.99 12.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.008 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.577 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -126.63 130.83 71.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.22 163.06 19.36 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.819 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.14 108.75 17.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 0.0 110.328 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -101.67 82.93 2.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.301 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 48.99 57.21 6.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.124 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.14 41.86 20.84 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -159.39 113.0 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.557 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.0 m-85 -58.76 136.28 57.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.244 0.545 . . . . 0.0 111.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -123.74 114.77 20.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.51 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.78 114.47 8.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.62 35.4 4.92 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.647 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.18 -49.54 0.82 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.148 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 28.9 tt0 70.15 145.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.026 0.53 . . . . 0.0 111.123 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.651 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 90.7 m-20 72.35 31.78 1.77 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.215 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.577 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.1 p90 -76.57 -31.51 57.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.686 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.1 p -64.12 -27.18 68.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.876 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.3 pt-20 -72.04 -14.41 61.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.199 0.523 . . . . 0.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -125.09 14.05 8.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.922 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.8 157.32 37.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.654 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -148.93 170.66 17.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.322 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.438 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.2 t70 49.07 52.44 14.37 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.385 0.428 . . . . 0.0 110.74 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.429 HG22 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -84.79 112.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -126.54 124.89 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.643 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.65 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.8 t80 -91.6 137.65 32.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.352 0.596 . . . . 0.0 111.486 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -122.89 82.3 49.92 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 6.9 Cg_endo -56.94 -43.07 57.68 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.384 2.723 . . . . 0.0 113.947 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 3.3 mptt . . . . . 0 C--N 1.295 -1.791 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.438 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 42.8 Cg_endo -70.01 108.94 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.568 2.179 . . . . 0.0 112.072 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -136.34 142.19 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.532 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.06 126.96 56.05 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.964 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.75 142.39 50.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.099 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.16 171.1 19.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.734 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.3 mmt180 -85.12 115.87 23.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -101.74 124.71 47.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.941 0.4 . . . . 0.0 111.666 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.469 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.3 pt-20 . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -140.43 139.71 35.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.036 0.922 . . . . 0.0 111.503 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -138.79 112.73 8.5 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.682 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.569 ' HB3' ' CD ' ' A' ' 79' ' ' ARG . 5.4 p-10 -64.43 113.15 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.518 0.675 . . . . 0.0 111.341 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.627 ' HB2' HD22 ' A' ' 80' ' ' LEU . 25.7 mmt180 -114.39 177.11 4.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HB2' HD13 ' A' ' 75' ' ' ILE . 7.7 p-10 -142.57 148.74 38.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.557 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -134.31 147.59 30.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.493 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.558 ' HB3' HD22 ' A' ' 95' ' ' ASN . 4.6 m-20 -85.42 110.09 18.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.709 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.65 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.5 mt -77.5 2.48 16.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.293 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.558 HD22 ' HB3' ' A' ' 93' ' ' ASN . 16.6 m-80 -62.73 -12.75 25.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 109.91 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.7 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -69.51 -18.06 63.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.692 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.593 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.9 mt -87.06 123.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.443 0.64 . . . . 0.0 110.626 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -116.96 164.6 14.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.217 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.6 t30 -108.27 121.06 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 61.4 t -113.01 94.62 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.69 22.56 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.985 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.62 16.73 9.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.594 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.2 ptp180 -129.22 143.71 50.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 82.7 mt -89.37 133.23 34.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.71 131.4 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -82.48 145.78 29.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 57.6 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.47 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 p90 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.761 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.15 -24.1 51.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.422 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -59.16 -24.24 62.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.5 m -148.01 39.32 0.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.761 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.7 p -116.22 158.27 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.938 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -155.32 166.8 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.517 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.511 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.8 m-20 52.89 35.47 19.12 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.788 0.68 . . . . 0.0 111.332 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -79.31 114.36 18.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.427 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 t -143.84 151.58 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -85.17 145.22 27.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 m -131.99 164.73 25.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 73.77 5.22 4.83 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.602 0.564 . . . . 0.0 111.234 177.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.06 23.58 19.65 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 99.1 16.86 29.07 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.824 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.721 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.7 mtp180 -100.75 -18.38 16.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.581 0.229 . . . . 0.0 110.783 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 50.5 m -130.22 128.42 41.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 0.0 111.54 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD2' HD13 ' A' ' 97' ' ' ILE . 58.8 tp -97.59 108.8 21.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.72 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.2 tmm_? -103.4 124.94 49.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.25 138.95 20.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -98.83 109.85 22.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD11 ' A' ' 104' ' ' LEU . 3.3 m -121.29 144.28 48.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.028 0.442 . . . . 0.0 111.035 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.29 143.32 47.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.94 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HB3' HG21 ' A' ' 31' ' ' VAL . 25.2 p-10 -90.26 -172.77 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.595 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.51 66.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.721 0.296 . . . . 0.0 111.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.18 -25.03 59.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.114 0.483 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.21 39.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.515 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.7 t-20 -88.94 146.32 24.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -78.55 119.63 22.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.057 0.456 . . . . 0.0 110.99 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -115.9 125.18 72.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.801 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.5 m -80.36 107.3 13.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.4 t -112.52 149.23 32.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.325 0.583 . . . . 0.0 110.584 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.9 mt-10 -134.96 131.77 37.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.85 119.18 23.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 39' ' ' THR . 47.4 m-20 -68.41 108.73 3.37 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.028 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 12' ' ' LEU . 68.3 mt -61.86 -42.35 98.95 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.55 -5.21 2.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.09 -12.08 16.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.439 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.538 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.94 10.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 130.44 70.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.59 160.79 20.95 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.966 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -110.94 107.85 17.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.505 0.669 . . . . 0.0 110.214 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -87.83 75.73 8.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.107 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 39.16 59.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 112.588 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 91.36 36.29 6.64 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.551 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -165.5 121.72 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.542 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.7 m-85 -60.93 143.78 54.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.346 0.593 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -132.91 115.81 15.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.422 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -73.01 115.08 11.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 31.91 6.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.784 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -102.03 -50.8 1.13 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.194 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.7 tt0 72.61 144.96 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.901 0.48 . . . . 0.0 111.422 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 2.6 t-20 68.74 34.71 3.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.244 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.2 p90 -77.27 -28.49 53.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.95 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.721 HG21 ' HG2' ' A' ' 17' ' ' ARG . 33.0 p -64.63 -22.23 66.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.555 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.674 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.6 pt-20 -73.16 -15.32 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.038 0.446 . . . . 0.0 110.371 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.8 p -128.19 16.32 6.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.271 0.558 . . . . 0.0 110.031 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.21 150.27 50.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.144 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.32 173.07 11.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.503 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.491 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 48.43 50.86 16.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.545 0.528 . . . . 0.0 110.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.05 108.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.337 0.589 . . . . 0.0 111.536 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.52 123.16 37.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.68 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.629 ' CE1' HD12 ' A' ' 94' ' ' LEU . 18.3 t80 -92.15 135.32 34.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.247 0.546 . . . . 0.0 111.895 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 16.5 t60 -124.5 89.33 52.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.04 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.2 Cg_endo -57.11 -36.86 99.31 Favored 'Trans proline' 0 CA--C 1.51 -0.712 0 C-N-CA 124.11 3.207 . . . . 0.0 114.633 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.656 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 56.9 Cg_endo -71.37 110.43 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.779 2.32 . . . . 0.0 112.642 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.703 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 140.24 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -111.66 126.83 55.45 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.081 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.703 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.0 142.53 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.84 24.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.675 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.588 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.4 mmt180 -86.3 115.09 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.32 124.06 45.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.365 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.4 pt-20 . . . . . 0 C--O 1.22 -0.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.12 142.61 36.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.784 0.802 . . . . 0.0 111.417 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -140.99 112.04 7.2 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.073 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.2 p-10 -62.02 115.27 3.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.31 0.576 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -116.44 175.44 5.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.953 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.39 149.08 38.88 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.542 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -137.52 143.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.459 0.647 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HB3' HD22 ' A' ' 95' ' ' ASN . 36.5 m-20 -79.36 110.04 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.551 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.629 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.5 mt -79.04 1.11 25.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.798 0.332 . . . . 0.0 111.238 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.475 HD22 ' HB3' ' A' ' 93' ' ' ASN . 14.9 m-80 -61.93 -13.87 29.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -26.5 67.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.447 0.641 . . . . 0.0 109.39 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.2 mt -80.13 127.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.415 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -121.01 161.99 20.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -104.88 120.6 41.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.024 0.44 . . . . 0.0 110.63 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 60.2 t -113.1 94.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.32 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.94 24.91 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.714 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 23.14 8.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.0 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.587 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 7.6 ptp180 -130.6 134.15 46.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.95 0.375 . . . . 0.0 110.271 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.2 mp -80.89 119.46 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' A' ' 103' ' ' ARG . 48.3 t -127.14 125.37 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.226 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.56 144.02 34.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.205 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.909 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.7 p90 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.717 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.3 -27.68 37.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.62 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.38 -31.83 66.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 110.976 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.9 m -138.11 41.31 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.717 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.2 p -122.67 154.55 37.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.597 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -151.37 167.51 27.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 84.9 m-20 53.69 34.43 18.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.659 0.599 . . . . 0.0 111.214 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.588 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -80.03 112.96 17.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.91 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.25 153.64 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.043 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.58 142.78 27.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 14' ' ' ASN . 20.4 m -130.37 163.53 26.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.4 t30 72.67 9.06 5.63 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.725 0.641 . . . . 0.0 111.657 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 25.27 15.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.037 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 93.08 26.18 17.16 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.611 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.588 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.7 mtp180 -108.09 -18.3 13.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.835 0.35 . . . . 0.0 110.196 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 42.1 m -128.73 129.91 46.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.768 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.1 tp -102.77 111.99 24.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.578 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -110.4 126.05 53.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.043 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -150.16 138.46 20.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 110.6 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.6 mt-10 -96.09 110.04 22.36 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' SER . 5.1 p -117.5 141.16 48.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.133 0.492 . . . . 0.0 111.643 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.16 143.89 40.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.771 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 p30 -90.58 -172.98 3.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.74 -34.07 70.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.627 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.64 -17.9 61.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.277 0.56 . . . . 0.0 110.83 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.45 6.71 56.41 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.6 t-20 -86.9 142.26 28.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.499 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.1 m0 -77.63 116.73 18.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.025 0.44 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.57 122.57 67.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 m -76.4 109.75 10.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.752 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 24.0 m -109.93 143.46 39.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.0 mt-10 -135.5 132.72 37.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.556 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.61 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -136.74 119.58 16.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.661 ' O ' HG22 ' A' ' 39' ' ' THR . 18.2 m-20 -69.67 110.34 4.82 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.722 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 12' ' ' LEU . 11.1 mt -60.6 -39.96 90.03 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.836 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -64.45 -5.93 6.3 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.492 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.56 -9.77 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.658 -178.999 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.61 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.16 10.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.71 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.43 131.16 70.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.12 158.03 20.2 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.755 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -111.45 108.53 18.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.15 0.5 . . . . 0.0 110.319 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -93.58 78.99 4.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.317 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 41.24 60.73 1.98 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.817 0.847 . . . . 0.0 112.432 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.23 35.5 9.59 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.771 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -158.5 117.35 3.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.801 -0.235 . . . . 0.0 110.736 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -62.93 139.48 58.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -133.5 116.78 16.37 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.43 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.419 ' HH2' HD22 ' A' ' 94' ' ' LEU . 90.6 m95 -69.67 115.62 9.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 39.14 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.873 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -111.58 -51.21 0.58 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.375 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.5 tt0 72.98 144.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.23 0.612 . . . . 0.0 111.344 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.7 m-20 72.47 28.99 2.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.82 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -74.1 -29.16 61.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.588 HG21 ' HG2' ' A' ' 17' ' ' ARG . 17.8 p -67.7 -20.43 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.004 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.2 pt-20 -76.49 -12.91 60.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.8 p -127.1 13.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.974 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.31 150.91 51.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.589 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.06 173.42 11.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.998 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 47.5 58.79 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 110.423 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.503 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 1.8 mt -94.9 110.7 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.4 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 126.41 39.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.413 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.0 t80 -91.38 134.99 34.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.363 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -120.34 84.66 35.45 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.336 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -56.77 -41.11 79.07 Favored 'Trans proline' 0 CA--C 1.512 -0.607 0 C-N-CA 123.254 2.636 . . . . 0.0 113.89 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.595 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.774 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.743 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.567 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -71.99 111.08 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.592 2.194 . . . . 0.0 112.669 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.411 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -134.37 141.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.24 125.43 54.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.517 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.05 142.5 49.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.147 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -161.71 169.72 20.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.223 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.605 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -86.0 115.0 23.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.6 mp -101.4 131.51 47.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.824 0.345 . . . . 0.0 111.303 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.022 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 98.4 m-85 -135.95 136.36 40.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.707 0.765 . . . . 0.0 111.332 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -138.29 119.14 14.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.701 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 12.6 p-10 -64.49 113.26 3.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.433 0.635 . . . . 0.0 111.332 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD22 ' A' ' 80' ' ' LEU . 31.0 mmt180 -115.0 176.47 5.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -144.44 151.95 39.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.49 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.9 p -139.6 146.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.209 0.528 . . . . 0.0 110.78 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.412 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 14.1 m120 -81.73 111.73 18.25 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.775 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.688 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.3 mt -80.55 -0.75 39.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.306 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.567 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.5 m120 -62.08 -14.22 34.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -68.05 -24.2 65.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -80.85 126.9 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.319 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -120.66 162.69 19.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.07 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -105.77 118.44 36.59 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.215 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.546 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.5 t -113.52 96.95 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.563 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.8 t30 59.87 24.7 13.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 111.482 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.94 24.32 7.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.998 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -132.9 139.25 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.322 0.561 . . . . 0.0 110.978 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.752 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 53.8 mt -84.99 117.29 23.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 47.3 t -122.78 122.47 65.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.818 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.84 143.85 34.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--O 1.249 1.074 0 O-C-N 123.722 0.639 . . . . 0.0 111.659 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.46 -25.85 38.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.156 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.61 -30.56 55.09 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -136.64 33.09 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.417 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 69.4 m -120.22 156.45 31.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.022 0.439 . . . . 0.0 112.041 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.98 170.79 19.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.545 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 95.6 m-20 53.02 33.56 15.09 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.683 0.614 . . . . 0.0 111.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.45 114.14 13.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.95 157.02 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.551 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.81 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -94.34 134.54 36.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 109.882 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -119.42 163.32 17.4 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.091 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.0 t30 70.27 9.61 7.05 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.712 0.632 . . . . 0.0 111.561 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.2 26.72 17.75 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.902 -0.665 . . . . 0.0 111.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.33 22.8 21.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.969 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.9 mtp180 -106.33 -18.0 14.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.845 0.355 . . . . 0.0 110.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -132.52 127.76 35.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.094 0.473 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.444 ' HB2' HD21 ' A' ' 37' ' ' LEU . 55.5 tp -95.69 105.18 17.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.611 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -102.09 124.17 47.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.039 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.73 29.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.2 mt-10 -99.59 109.14 21.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 6.3 p -116.43 140.23 49.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.3 143.38 40.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' HB3' HG21 ' A' ' 31' ' ' VAL . 23.9 p-10 -87.26 -176.45 5.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.363 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.94 -30.55 66.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.533 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.68 -24.57 59.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.18 5.35 40.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.835 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.2 t-20 -89.01 144.77 25.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.432 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.5 m0 -77.65 121.1 23.51 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.978 0.418 . . . . 0.0 110.968 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -118.95 125.12 74.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.791 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -80.16 110.23 15.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.474 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.2 t -111.75 150.03 30.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 110.555 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.2 mt-10 -134.93 131.56 37.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.383 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.9 116.24 19.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 39' ' ' THR . 12.8 m-20 -67.61 107.68 2.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.509 0.671 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.81 HD11 HD11 ' A' ' 12' ' ' LEU . 38.0 mt -59.92 -42.5 94.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.453 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 2.4 p-10 -63.43 -5.67 3.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.8 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -105.66 -10.29 16.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.575 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.508 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -142.78 10.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 111.769 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -127.57 131.22 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.68 159.14 20.91 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.071 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -111.06 112.55 24.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -99.36 76.82 2.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 52.25 58.22 5.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.563 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.99 32.47 29.26 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.358 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -149.44 122.06 8.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.9 m-85 -66.3 135.18 54.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.809 0.337 . . . . 0.0 110.837 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -128.34 117.17 20.97 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -71.34 115.51 10.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.33 33.27 5.74 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.107 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -103.95 -51.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.107 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 23.3 tt0 70.69 143.31 0.05 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.089 0.556 . . . . 0.0 110.689 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.663 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 11.7 m120 76.89 31.23 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.322 0.649 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.4 p90 -80.69 -29.7 36.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.246 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.648 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.1 p -65.64 -17.36 64.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.007 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 12.4 pt-20 -80.25 -15.55 56.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.148 0.499 . . . . 0.0 109.996 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -124.6 14.66 8.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.23 150.1 49.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.682 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.768 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -141.03 172.81 12.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 1.1 t70 43.67 58.17 3.65 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.859 0.724 . . . . 0.0 111.129 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.4 mt -88.75 111.39 22.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.203 0.525 . . . . 0.0 112.139 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.55 123.21 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.069 179.189 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.68 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.2 t80 -92.88 134.6 34.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.14 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 8.1 t-160 -126.19 89.42 52.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 65' ' ' HIS . 20.7 Cg_endo -62.42 -36.58 65.61 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.886 3.058 . . . . 0.0 114.144 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.308 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.654 0.264 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 53.0 Cg_endo -71.47 110.42 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.833 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.752 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.42 141.36 42.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -114.13 127.91 56.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.369 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.752 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.01 141.8 51.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.203 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.54 168.94 23.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.812 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.768 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.1 mmt85 -85.54 114.9 22.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -100.26 129.18 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.65 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.963 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.4 pt-20 . . . . . 0 C--O 1.221 -0.399 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -140.57 132.99 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.863 0.839 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -137.8 112.95 9.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.211 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.5 p-10 -64.02 116.08 5.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.291 0.567 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.585 ' HB2' HD22 ' A' ' 80' ' ' LEU . 36.4 mmt180 -115.84 174.54 5.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -141.46 142.97 33.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.6 p -130.33 148.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.571 ' HB3' HD22 ' A' ' 95' ' ' ASN . 93.8 m-20 -83.45 110.59 18.31 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.04 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.68 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.99 1.18 32.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.562 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.571 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.6 m-80 -60.73 -17.29 47.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.429 . . . . 0.0 110.486 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.04 66.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.256 0.55 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -81.75 132.86 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -124.29 167.36 14.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -113.05 123.42 50.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.097 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.557 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 39.2 t -114.07 93.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.97 27.69 13.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.827 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.34 19.27 8.06 Favored Glycine 0 C--N 1.32 -0.353 0 C-N-CA 120.293 -0.956 . . . . 0.0 114.133 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 6.6 ptp180 -130.55 141.79 50.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.388 0.594 . . . . 0.0 111.116 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.3 mp -90.58 124.02 34.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.621 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.1 p -132.56 128.24 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -84.98 145.49 27.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.491 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.743 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.0 p90 . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -58.67 -19.29 38.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.081 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.88 -38.35 70.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.443 0.64 . . . . 0.0 109.945 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 61.0 m -130.01 33.83 4.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.517 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.0 m -120.02 155.23 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.0 ptp180 -151.78 170.77 18.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.5 m-20 54.18 32.52 16.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.14 0.495 . . . . 0.0 110.906 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.33 113.36 12.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.961 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.98 155.29 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.555 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -92.15 138.05 31.85 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.478 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.9 m -123.91 163.59 20.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.128 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 71.0 6.53 5.9 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.665 0.603 . . . . 0.0 111.666 178.04 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.38 23.63 14.0 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.543 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.36 17.77 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.812 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.702 ' HG2' HG21 ' A' ' 56' ' ' THR . 29.8 mtp180 -100.07 -18.11 17.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.592 0.234 . . . . 0.0 110.922 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.8 m -131.39 124.76 30.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.075 0.464 . . . . 0.0 111.52 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD2' HD13 ' A' ' 97' ' ' ILE . 60.4 tp -92.77 104.95 17.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.489 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.8 tmm_? -101.78 125.46 48.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.091 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.37 144.47 25.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 6.8 mt-10 -98.6 108.84 21.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.7 p -115.87 141.25 48.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.584 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.12 141.09 42.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.492 ' HB3' HG21 ' A' ' 31' ' ' VAL . 29.0 p-10 -86.87 -175.33 5.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.311 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.09 68.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.74 -23.87 61.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.067 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.11 8.58 44.28 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.262 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.5 t-20 -93.72 147.25 23.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -77.61 117.87 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.508 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 25' ' ' ASN . 9.8 t -113.25 122.95 68.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.2 m -78.58 105.22 9.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -111.1 154.04 24.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.2 mt-10 -139.57 132.47 29.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.42 114.88 18.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 39' ' ' THR . 21.3 m-20 -65.4 107.34 1.62 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.104 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 12' ' ' LEU . 85.6 mt -60.32 -45.59 92.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.652 0.739 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -62.62 -5.23 2.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.79 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.07 -13.15 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.036 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.523 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -142.95 12.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 111.923 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.64 131.45 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.85 156.85 19.67 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.442 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.467 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.2 t30 -111.58 107.19 16.26 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.52 82.16 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 40.6 51.98 3.02 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.319 1.012 . . . . 0.0 113.329 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 99.44 35.08 4.81 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.145 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -163.2 122.07 2.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.774 0.287 . . . . 0.0 110.628 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 47.1 m-85 -65.17 141.09 58.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 111.325 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.21 117.87 19.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.411 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -73.01 114.44 11.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.77 29.3 6.99 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.67 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.86 -53.76 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.978 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 31.5 tt0 73.07 143.89 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.387 0.675 . . . . 0.0 111.474 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 83.6 m-20 74.25 29.03 1.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.383 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -75.75 -33.44 60.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.517 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.702 HG21 ' HG2' ' A' ' 17' ' ' ARG . 22.6 p -61.71 -30.38 70.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.8 pt-20 -68.3 -13.58 62.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.837 0.351 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.549 HG23 ' HG3' ' A' ' 57' ' ' GLU . 76.6 p -126.22 13.63 7.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 109.924 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.51 146.11 50.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.625 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -136.91 172.86 12.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.637 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER 46.79 52.39 11.44 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.828 0.705 . . . . 0.0 110.473 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.62 112.01 21.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.0 111.659 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.48 124.61 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.548 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.704 ' CE1' HD12 ' A' ' 94' ' ' LEU . 21.5 t80 -92.37 136.66 33.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.363 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -122.72 85.65 49.48 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 18.7 Cg_endo -62.32 -43.7 21.97 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 123.228 2.619 . . . . 0.0 113.671 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.729 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.58 109.83 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.662 2.241 . . . . 0.0 112.369 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -133.51 141.58 43.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.1 tm? -114.29 125.79 54.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.176 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.488 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.21 141.39 51.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.87 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.55 167.53 26.95 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.042 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.2 mmt180 -85.16 114.59 22.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -98.22 121.56 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.923 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.8 pt-20 . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -143.28 128.92 19.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.04 111.63 8.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.224 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.4 p-10 -65.65 120.29 12.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 112.445 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.69 ' HB2' HD22 ' A' ' 80' ' ' LEU . 36.3 mmt180 -115.94 174.88 5.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.979 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -139.42 150.62 45.47 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -140.54 144.66 26.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.391 0.615 . . . . 0.0 110.912 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.568 ' HB3' HD22 ' A' ' 95' ' ' ASN . 38.0 m-80 -80.87 109.0 15.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 64' ' ' PHE . 3.8 mt -79.01 1.12 25.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.453 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.568 HD22 ' HB3' ' A' ' 93' ' ' ASN . 15.6 m-80 -60.8 -16.63 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.273 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -23.52 67.42 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.941 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -82.22 125.61 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -117.0 163.34 16.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.219 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.65 117.66 34.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.533 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 48.5 t -113.11 94.22 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 57.75 27.32 14.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.598 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.98 23.69 8.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.485 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -131.61 134.48 46.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.079 0.439 . . . . 0.0 110.38 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 mp -85.92 124.36 32.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.3 p -137.1 131.62 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.593 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.52 145.91 29.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.978 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.196 -179.82 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.3 p90 . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.16 -24.55 41.99 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.635 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.19 -33.35 65.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.006 0.432 . . . . 0.0 110.926 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.4 m -132.38 33.24 3.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.167 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 71.8 m -119.38 156.6 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.433 . . . . 0.0 111.699 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -153.09 169.94 21.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.0 m120 52.92 33.88 15.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.686 0.617 . . . . 0.0 111.176 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.77 113.38 16.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.749 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 t -143.44 156.3 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.836 HD11 HD11 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -91.39 141.61 28.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 7.9 m -125.39 165.05 19.09 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.2 t-20 71.1 8.85 6.58 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.623 0.577 . . . . 0.0 111.657 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.02 26.3 16.89 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.05 27.09 11.35 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.054 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.719 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.7 mtp180 -111.37 -17.09 13.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.704 0.288 . . . . 0.0 110.497 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 40.4 m -128.76 126.44 39.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD2' HD13 ' A' ' 97' ' ' ILE . 39.6 tp -94.97 107.54 19.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.578 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -107.62 124.83 50.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.26 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -150.72 148.48 28.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.671 0.272 . . . . 0.0 111.12 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.9 mt-10 -103.67 109.47 21.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -118.59 148.17 42.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -79.86 141.99 35.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.461 ' HB3' HG11 ' A' ' 31' ' ' VAL . 34.3 p30 -89.46 -175.03 4.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.602 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.46 -28.86 69.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 111.04 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.04 -24.57 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.09 5.84 46.28 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.571 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.7 m-80 -95.18 149.28 21.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.424 0.29 . . . . 0.0 111.069 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.507 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 54.3 m0 -81.4 110.43 16.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 109.922 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -112.17 121.81 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.048 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -74.78 114.71 13.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.822 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.0 t -112.87 149.94 32.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -136.11 131.68 35.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.14 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 HG12 ' A' ' 40' ' ' ILE . 15.8 tp -129.05 118.75 23.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.0 0.429 . . . . 0.0 110.611 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 39' ' ' THR . 2.9 m-20 -68.07 110.02 3.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.755 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.836 HD11 HD11 ' A' ' 12' ' ' LEU . 23.8 mt -62.06 -39.16 91.43 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.491 0.662 . . . . 0.0 109.604 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -63.53 -6.12 4.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.227 178.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -101.89 -15.2 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.243 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.505 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.36 10.8 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -127.25 129.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.06 158.32 21.46 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.11 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.429 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.0 t30 -110.89 114.17 27.29 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.18 82.35 1.66 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.288 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 53.29 65.1 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.247 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.86 34.72 62.13 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.816 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -156.26 120.36 4.46 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.629 -0.336 . . . . 0.0 110.182 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 46.6 m-85 -62.08 142.98 57.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.148 0.499 . . . . 0.0 111.198 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -132.13 117.07 17.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.461 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -74.08 114.05 11.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.55 31.44 6.1 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.581 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.39 -51.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.084 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 25.8 tt0 73.26 143.09 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.188 0.595 . . . . 0.0 112.063 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 t30 68.78 31.78 4.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.694 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.0 p90 -72.31 -27.96 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.719 HG21 ' HG2' ' A' ' 17' ' ' ARG . 20.1 p -63.81 -19.6 65.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.111 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.678 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -74.58 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.134 0.493 . . . . 0.0 110.371 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -126.83 14.08 7.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.75 143.91 51.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.856 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.62 173.96 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.338 179.295 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.561 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 17.6 t0 48.17 50.61 16.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.234 0.54 . . . . 0.0 110.315 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.75 108.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.049 0.452 . . . . 0.0 111.738 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -125.46 123.95 40.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.047 178.851 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 94' ' ' LEU . 4.5 t80 -91.28 130.61 37.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.927 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 11.1 t-80 -121.11 85.46 41.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.538 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 65' ' ' HIS . 9.2 Cg_endo -56.3 -36.37 96.89 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 123.933 3.088 . . . . 0.0 114.677 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.264 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.919 0.39 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 41.7 Cg_endo -68.07 112.1 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.681 2.254 . . . . 0.0 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.462 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -134.12 141.5 43.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -112.75 124.21 52.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.303 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.502 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.05 140.73 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.958 0.408 . . . . 0.0 109.961 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.0 169.83 22.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.839 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.4 mmt85 -86.34 115.59 23.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.9 mp -101.5 128.8 47.58 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 123.463 0.477 . . . . 0.0 111.074 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.742 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.9 pt-20 . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 90.5 m-85 -134.5 138.59 44.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.761 0.791 . . . . 0.0 111.575 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -139.64 118.12 12.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.649 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.4 p-10 -65.02 112.37 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.344 0.592 . . . . 0.0 111.283 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.646 ' HB2' HD22 ' A' ' 80' ' ' LEU . 28.2 mmt180 -115.41 174.56 5.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -141.9 152.44 43.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -138.67 144.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -82.62 110.37 17.63 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.672 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.647 ' HB3' HD12 ' A' ' 97' ' ' ILE . 8.5 mt -79.49 3.05 19.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.308 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.451 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 18.0 m120 -62.19 -14.07 34.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.199 0.523 . . . . 0.0 109.819 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -21.21 66.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.186 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.647 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -83.6 127.94 39.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 0.0 111.505 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -121.45 160.91 23.17 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.125 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -108.43 120.73 43.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.071 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 48.3 t -113.72 94.38 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.001 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.48 23.48 12.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.451 ' CA ' HG11 ' A' ' 31' ' ' VAL . . . 114.15 14.34 9.23 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 119.287 -1.435 . . . . 0.0 113.695 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.8 ptp180 -130.18 135.57 48.31 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.425 -0.456 . . . . 0.0 111.161 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.822 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.8 mt -87.84 125.45 34.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.101 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.3 p -137.99 136.37 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.652 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -85.83 145.73 27.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.091 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.8 p90 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.55 -27.31 37.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.942 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.13 -31.37 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 m -130.16 31.0 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 73.4 m -116.83 156.8 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.455 0.645 . . . . 0.0 112.204 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.1 ptp180 -152.33 170.87 19.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.084 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.577 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.9 t-20 56.11 30.4 16.32 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.624 0.578 . . . . 0.0 110.266 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -76.98 113.04 14.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.64 147.13 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.648 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.5 tp -84.46 140.82 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 14' ' ' ASN . 10.8 m -126.26 163.24 23.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.025 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.1 t-20 72.05 8.97 6.03 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.619 0.574 . . . . 0.0 111.607 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.6 23.25 24.21 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 97.49 24.92 11.47 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.101 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.2 mtp180 -107.59 -18.15 13.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.864 0.364 . . . . 0.0 110.288 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 m -130.1 128.51 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.358 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 37' ' ' LEU . 49.5 tp -97.32 108.65 21.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.648 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.2 tmm_? -105.42 123.98 48.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.309 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.08 26.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -106.09 110.05 22.18 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 41.8 t -121.69 145.6 47.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.87 144.01 52.64 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.277 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.542 ' HB3' HG21 ' A' ' 31' ' ' VAL . 22.6 p-10 -88.13 -167.52 1.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.952 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.24 68.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.599 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.34 -23.56 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.209 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.68 0.59 32.4 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.888 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 56.5 t30 -83.53 143.01 30.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -75.41 119.85 20.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.134 0.492 . . . . 0.0 110.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.1 t -117.92 124.42 73.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.317 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 22' ' ' GLU . 7.8 m -77.18 107.15 9.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.431 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.09 141.32 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.243 0.544 . . . . 0.0 111.088 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.0 mt-10 -130.14 131.01 45.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.664 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.579 HD11 HG12 ' A' ' 40' ' ' ILE . 15.2 tp -125.15 120.35 31.12 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.619 ' O ' HG22 ' A' ' 39' ' ' THR . 53.6 m-20 -68.61 107.77 3.09 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.369 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 12' ' ' LEU . 37.8 mt -60.36 -39.79 88.45 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.873 0.844 . . . . 0.0 109.621 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.672 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.5 p-10 -63.35 -5.04 3.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.758 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -107.63 -9.16 15.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.786 -179.338 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.579 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.62 10.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.91 132.4 68.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.7 158.18 22.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.426 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -112.02 114.2 26.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.777 0.322 . . . . 0.0 110.214 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -105.5 82.94 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.545 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.04 52.8 12.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.908 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.54 35.69 22.06 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -148.53 118.05 6.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.7 m-85 -63.97 134.99 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.165 0.507 . . . . 0.0 110.571 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -126.58 116.51 21.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.456 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -72.88 114.13 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.47 30.47 6.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.923 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.58 -50.44 1.2 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.895 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 23.4 tt0 70.68 144.97 0.06 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.127 0.571 . . . . 0.0 111.345 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.559 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 6.3 m-20 71.08 33.65 2.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.343 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.91 -27.46 39.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.933 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.618 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.9 p -65.72 -17.29 64.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.977 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 58' ' ' THR . 7.9 pt-20 -76.8 -18.19 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 109.852 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -123.31 9.79 9.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.473 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -118.85 144.05 46.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.24 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -136.02 166.93 22.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.095 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 45.74 55.86 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.584 HG22 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -83.18 106.61 14.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.308 0.575 . . . . 0.0 110.806 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.55 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -109.86 118.43 36.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.607 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.1 t80 -93.1 128.59 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.065 0.459 . . . . 0.0 111.103 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 39.7 t60 -124.38 88.77 52.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.151 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 19.7 Cg_endo -59.99 -35.94 91.47 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 124.156 3.237 . . . . 0.0 115.163 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.894 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.587 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 CA--C 1.522 -0.105 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 60.2 Cg_endo -72.87 112.36 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.154 1.903 . . . . 0.0 112.21 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -132.14 141.72 44.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.584 HD21 HG22 ' A' ' 62' ' ' ILE . 1.8 tm? -114.93 122.57 46.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.93 140.42 50.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.345 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -156.63 166.67 32.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.298 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.2 mmt180 -85.58 114.75 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.617 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.4 mp -99.35 127.75 45.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.199 0.523 . . . . 0.0 111.164 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.6 pt-20 . . . . . 0 C--O 1.22 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -145.9 129.38 16.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.47 117.98 12.17 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.971 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.7 p-10 -66.61 114.01 5.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.0 111.706 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.575 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -115.78 172.21 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.69 146.45 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.0 p -128.2 150.64 34.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.74 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 78.2 m-20 -87.07 103.98 15.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.892 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' HB3' HD12 ' A' ' 97' ' ' ILE . 7.9 mt -75.43 0.53 16.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.81 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.642 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.7 m120 -60.9 -19.94 61.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.7 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -65.73 -22.01 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.783 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.6 mt -82.95 128.39 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.184 0.516 . . . . 0.0 111.267 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -119.1 168.29 10.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.81 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -112.59 121.05 43.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.499 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -112.25 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.401 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.89 24.73 13.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.556 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.78 20.58 8.37 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.699 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.499 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.5 ptp180 -129.8 139.98 51.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.152 0.476 . . . . 0.0 110.037 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 76.0 mt -87.08 124.05 32.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 0.0 110.992 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.6 p -127.98 128.78 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -84.12 146.73 27.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.551 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.947 0.78 . . . . 0.0 111.266 178.492 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 p90 . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.306 0.574 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.763 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.3 -25.47 34.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.196 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -53.84 -33.07 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.037 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.14 37.39 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.987 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.763 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.3 p -115.28 157.26 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 111.466 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -147.91 169.73 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 8.0 m120 50.45 34.44 9.29 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.748 0.655 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -85.74 112.42 21.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.39 178.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.306 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.9 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.15 146.54 28.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.0 m -132.12 161.5 33.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.4 t-20 74.04 9.48 4.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.692 0.62 . . . . 0.0 111.178 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.74 24.85 22.22 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 97.07 23.16 15.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.98 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.68 ' HG2' HG21 ' A' ' 56' ' ' THR . 31.0 mtp180 -107.99 -17.07 14.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.588 0.232 . . . . 0.0 110.525 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.6 m -129.99 127.95 41.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.585 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.69 107.39 19.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmm_? -104.54 124.64 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.079 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.43 151.28 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.63 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.771 ' HG2' HG23 ' A' ' 32' ' ' THR . 13.8 mt-10 -113.06 110.96 21.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.1 t -123.17 147.5 46.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.77 143.68 43.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.922 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.535 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.5 p-10 -91.31 -175.09 4.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.809 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.37 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 111.463 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.76 -24.85 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.828 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.75 10.38 37.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.648 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.6 t-20 -96.13 146.79 24.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.454 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.8 m0 -77.07 121.43 23.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -120.5 120.89 64.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.724 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 22' ' ' GLU . 11.2 m -81.73 109.47 16.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -113.26 150.74 32.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.137 0.494 . . . . 0.0 111.585 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.0 mt-10 -132.7 135.03 45.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.71 116.24 18.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' THR . 16.0 m-20 -68.32 109.81 3.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.526 0.679 . . . . 0.0 110.196 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.9 HD11 HD11 ' A' ' 12' ' ' LEU . 15.9 mt -61.42 -41.02 96.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.531 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -65.02 -4.91 5.19 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.192 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -104.66 -14.15 15.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.455 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.517 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -141.28 10.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.13 132.09 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.216 -0.303 . . . . 0.0 110.23 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.87 159.74 22.24 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.256 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.8 t30 -111.51 116.65 31.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 0.0 110.198 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -104.29 85.15 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 40.66 59.41 2.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.0 112.943 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 86.43 38.6 8.2 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.997 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.416 ' N ' HD23 ' A' ' 80' ' ' LEU . 50.6 t-80 -162.11 124.23 2.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -67.07 138.81 57.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.109 0.48 . . . . 0.0 110.633 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -130.1 116.94 19.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.607 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.4 ' HH2' HD22 ' A' ' 94' ' ' LEU . 91.9 m95 -69.42 115.64 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 30.13 6.35 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.199 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -100.5 -53.59 1.05 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.071 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.5 tt0 73.55 139.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.377 0.608 . . . . 0.0 111.738 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 t30 70.35 36.69 1.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.133 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -76.1 -26.93 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.041 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.68 HG21 ' HG2' ' A' ' 17' ' ' ARG . 36.3 p -63.66 -24.31 67.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 58' ' ' THR . 1.7 pt-20 -70.24 -17.1 63.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.269 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.7 p -125.78 16.0 8.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.503 0.668 . . . . 0.0 109.984 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.94 150.1 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.636 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -143.4 172.5 12.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.479 -179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.3 t70 48.22 57.22 6.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.082 0.467 . . . . 0.0 110.012 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -91.93 113.86 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.498 -177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.421 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -132.69 129.67 39.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 178.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.5 t80 -92.29 139.63 30.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 112.223 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -120.38 82.06 31.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.75 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.808 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.8 Cg_endo -55.88 -45.84 35.81 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 123.908 3.072 . . . . 0.0 114.539 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.808 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.879 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.107 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.655 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 59.4 Cg_endo -72.5 110.85 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.476 2.118 . . . . 0.0 111.533 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -134.73 141.97 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.57 124.73 53.06 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.918 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.541 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.06 144.36 48.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.496 . . . . 0.0 110.498 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.04 170.55 19.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.87 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.636 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -85.48 114.86 22.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.15 126.37 46.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.261 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.8 pt-20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -138.36 139.28 38.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.769 0.795 . . . . 0.0 111.257 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -138.7 111.64 7.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.281 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.2 p-10 -63.4 111.92 2.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.692 0.758 . . . . 0.0 111.777 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 33.2 mmt180 -114.56 175.22 5.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.447 ' HB2' HD13 ' A' ' 75' ' ' ILE . 5.9 p-10 -143.55 146.12 33.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.4 p -128.86 144.23 38.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.616 0.722 . . . . 0.0 111.096 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.446 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 36.9 m-20 -79.87 106.11 11.65 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.732 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.679 ' HB3' HD12 ' A' ' 97' ' ' ILE . 3.8 mt -78.57 1.83 21.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.655 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 13.7 m120 -59.92 -19.95 54.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.426 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -62.92 -22.95 67.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.188 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.2 mt -83.8 128.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.011 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 38.6 tt0 -122.4 162.34 21.79 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.944 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.475 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 4.8 t30 -102.01 117.91 35.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.179 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 51.3 t -113.0 95.82 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.343 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.29 23.36 13.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.239 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.06 8.23 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.428 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 17.9 ptp180 -130.39 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.807 0.304 . . . . 0.0 110.259 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.05 115.6 23.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.8 t -117.93 121.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -81.49 146.47 30.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.166 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.427 ' H ' ' HB3' ' A' ' 96' ' ' ARG . 36.6 tt0 . . . . . 0 C--O 1.247 0.957 0 O-C-N 123.67 0.607 . . . . 0.0 111.372 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.73 -25.36 54.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -55.61 -32.51 63.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 110.923 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.0 m -133.04 32.3 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 65.8 m -116.53 156.51 26.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.593 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.6 ptp180 -153.41 168.79 24.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.616 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.57 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 55.6 t30 55.44 31.25 16.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.431 0.634 . . . . 0.0 110.806 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.563 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.24 114.73 17.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.904 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 153.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -89.23 146.0 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.4 m -131.68 165.47 23.63 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.4 t-20 71.81 8.31 6.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 111.638 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.21 25.08 14.88 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.552 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.33 27.96 10.25 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.783 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.742 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -112.71 -15.49 12.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.815 0.34 . . . . 0.0 110.413 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.2 m -129.85 130.23 44.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 0.0 111.717 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.1 tp -99.28 111.47 23.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.508 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -113.07 124.29 52.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.55 153.53 33.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 9.0 mt-10 -106.05 109.92 22.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -117.98 143.61 46.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.56 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.84 144.27 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.682 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -88.42 -173.7 4.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.952 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.35 67.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.99 -24.48 55.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.945 0.402 . . . . 0.0 111.294 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.46 0.76 32.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.512 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.5 t30 -82.8 143.56 30.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -77.5 129.14 35.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.38 123.72 65.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.558 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -77.29 107.79 9.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.503 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.8 m -110.3 143.44 40.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.305 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -128.06 143.51 51.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -141.82 120.53 12.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 39' ' ' THR . 14.4 m-20 -70.45 107.16 3.7 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 110.004 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 12' ' ' LEU . 52.6 mt -60.69 -40.59 92.76 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.797 0.808 . . . . 0.0 109.675 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.57 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 5.2 p-10 -63.02 -4.95 2.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.86 -12.19 15.95 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.706 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.539 HG23 HG23 ' A' ' 39' ' ' THR . 2.4 pp -141.24 10.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.018 0.437 . . . . 0.0 112.11 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.32 129.36 70.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 158.1 21.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.189 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.0 t30 -111.56 114.73 28.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.111 0.481 . . . . 0.0 109.973 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -103.74 87.28 2.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.258 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.9 p30 45.24 57.51 4.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.561 0.744 . . . . 0.0 112.46 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.646 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.62 36.24 26.66 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.998 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -150.57 115.33 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.8 m-85 -61.8 135.72 57.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.634 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -129.69 115.06 16.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -69.67 114.89 8.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.0 5.95 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.823 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.11 -53.41 0.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.685 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.1 tt0 74.91 144.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.22 0.608 . . . . 0.0 110.961 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.7 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.7 m-20 68.36 36.94 2.86 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.265 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.26 -29.27 47.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.742 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.8 p -63.79 -23.28 67.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.044 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.791 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.9 pt-20 -71.39 -16.12 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 109.843 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.791 HG23 ' HG3' ' A' ' 57' ' ' GLU . 76.8 p -126.04 9.15 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -119.52 142.31 48.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.157 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 169.28 17.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.776 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.6 t70 47.22 54.91 8.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.072 0.463 . . . . 0.0 110.973 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.57 109.45 20.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 124.45 41.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.803 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.3 t80 -92.08 137.19 32.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.718 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t60 -123.97 86.71 53.57 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.976 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 5.7 Cg_endo -53.09 -41.0 75.0 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 124.575 3.517 . . . . 0.0 115.131 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.302 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 CA--C 1.518 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.61 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -73.22 112.93 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.754 2.303 . . . . 0.0 112.206 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.508 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.3 pp -134.45 140.71 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -110.78 125.02 53.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -119.31 139.86 51.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.652 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -161.77 168.36 23.33 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.043 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 4.2 mmt85 -85.82 114.86 23.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.646 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.3 131.73 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.897 0.38 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.751 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.679 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 C--O 1.221 -0.414 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -142.61 137.56 30.13 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.815 0.817 . . . . 0.0 111.204 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.56 117.45 13.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.499 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.0 p-10 -66.11 113.28 4.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.614 ' HB2' HD22 ' A' ' 80' ' ' LEU . 33.6 mmt180 -115.05 172.23 7.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.86 151.61 47.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.552 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.8 p -139.68 144.68 28.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.38 0.61 . . . . 0.0 110.755 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 10.3 m120 -81.69 110.31 16.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.756 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.7 mt -79.33 3.02 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.115 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.61 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 15.6 m120 -62.86 -18.29 62.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.55 -28.36 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.908 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -77.75 130.19 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.494 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -125.96 166.28 17.23 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.3 t30 -109.06 123.9 49.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.69 94.04 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.0 t30 58.82 27.15 15.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.916 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 20.96 7.97 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.814 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 12.7 ptp180 -131.25 139.6 49.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.356 0.578 . . . . 0.0 110.612 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.8 mp -90.29 124.9 35.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.792 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.23 130.65 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.435 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 3.3 p90 -79.97 145.16 32.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.475 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.489 0.493 . . . . 0.0 111.114 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.734 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.13 -23.25 54.41 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.798 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.93 -23.37 63.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 111.038 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.0 m -148.6 38.03 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.734 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.8 p -116.74 153.29 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.496 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 9.6 t-20 54.23 30.64 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.534 0.522 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.12 113.54 12.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -143.38 149.17 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.934 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -84.04 144.56 29.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 12.7 m -131.33 161.36 32.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.655 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.54 10.44 5.68 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 123.559 0.537 . . . . 0.0 111.237 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.13 24.84 23.61 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.453 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 96.86 22.02 19.31 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.851 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.644 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -104.85 -19.03 14.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.626 0.251 . . . . 0.0 110.407 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 34.5 m -130.44 126.75 37.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.779 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' CD2' HD13 ' A' ' 97' ' ' ILE . 61.0 tp -96.97 109.55 22.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.517 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.1 tmm_? -109.08 124.24 50.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.52 149.91 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.0 mt-10 -104.67 112.2 25.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.9 p -124.21 147.51 47.98 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 111.844 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.29 144.52 36.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.575 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 8.5 p30 -86.07 -175.0 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.52 69.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.84 -23.51 59.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.56 3.2 30.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.959 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.477 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 5.2 t30 -86.07 145.57 27.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.113 0.456 . . . . 0.0 110.078 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -74.14 126.03 29.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.718 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -126.99 128.97 71.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -86.7 112.99 22.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.403 ' HB3' HD13 ' A' ' 104' ' ' LEU . 4.1 t -112.1 151.81 28.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.039 0.447 . . . . 0.0 110.749 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.444 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -139.05 132.0 29.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.196 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.614 HD11 HG12 ' A' ' 40' ' ' ILE . 12.8 tp -133.76 123.99 25.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.01 0.433 . . . . 0.0 110.122 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 39' ' ' THR . 38.9 m-20 -72.21 108.36 5.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 12' ' ' LEU . 24.8 mt -59.53 -45.88 90.49 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.087 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -63.97 -5.08 3.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.674 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.73 -9.79 20.54 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.056 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.614 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.23 11.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 111.669 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.64 132.55 68.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.03 157.97 21.32 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.774 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.3 t30 -110.13 106.31 15.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.48 80.99 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.189 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 51.15 56.64 7.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.143 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.53 39.32 18.52 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.273 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -157.41 117.78 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 0.0 110.366 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.4 m-85 -61.95 137.76 58.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.315 0.578 . . . . 0.0 111.701 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -133.36 118.47 18.51 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.03 115.22 10.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 29.21 6.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.13 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.99 -53.26 1.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.086 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 35.1 tt0 72.13 141.93 0.06 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.309 0.644 . . . . 0.0 111.136 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.57 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 79.9 m-20 76.83 30.63 0.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.937 0.895 . . . . 0.0 110.997 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.5 p90 -78.0 -29.28 49.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.374 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.644 HG21 ' HG2' ' A' ' 17' ' ' ARG . 53.8 p -66.02 -25.16 66.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.558 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.666 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.7 pt-20 -70.63 -19.3 62.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.273 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.666 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -122.68 15.74 10.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.332 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.92 151.22 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.59 173.09 11.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.251 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 5.6 t70 47.53 52.41 12.47 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.563 0.54 . . . . 0.0 110.449 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.39 108.75 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.333 0.587 . . . . 0.0 111.74 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.428 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -123.52 123.16 39.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.561 178.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.8 t80 -91.77 133.81 35.28 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.015 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -121.67 86.54 45.15 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.491 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.614 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.2 Cg_endo -56.34 -38.6 94.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.754 2.969 . . . . 0.0 113.727 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.614 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.65 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.46 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.8 Cg_endo -72.75 109.03 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.365 2.043 . . . . 0.0 112.0 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.449 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -135.26 141.61 42.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.3 tm? -112.04 123.41 50.19 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.47 ' H ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -119.91 138.75 53.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.609 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.35 168.19 27.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.006 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.62 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.9 mmt180 -85.79 115.0 23.18 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.623 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -98.45 124.36 43.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 . . . . . 0 C--O 1.223 -0.34 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.66 130.2 16.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.268 0.556 . . . . 0.0 110.294 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.19 117.76 13.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.157 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.9 p-10 -66.68 120.07 12.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.438 0.637 . . . . 0.0 112.209 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.564 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.3 mmt180 -116.42 177.67 4.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -143.91 147.51 34.09 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.2 p -135.3 144.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.791 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HB3' HD22 ' A' ' 95' ' ' ASN . 60.7 m-20 -81.53 110.12 16.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.9 mt -78.24 2.45 18.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.505 HD22 ' HB3' ' A' ' 93' ' ' ASN . 19.6 m-80 -63.61 -16.19 60.23 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -25.05 67.45 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.538 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.629 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.9 mt -80.11 121.47 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.783 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -113.7 164.01 14.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.019 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.0 t30 -107.13 116.38 31.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.71 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 60.6 t -112.16 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.06 0.457 . . . . 0.0 110.279 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.18 24.73 14.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.762 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.4 19.14 9.57 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.509 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -130.59 142.81 50.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.039 0.42 . . . . 0.0 110.606 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.403 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.0 mp -85.01 119.24 25.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.0 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.31 123.59 70.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.885 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -81.69 145.17 30.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.452 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.596 178.369 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.2 p90 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.17 -25.89 35.39 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.787 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.54 -31.8 66.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.209 0.528 . . . . 0.0 110.631 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.1 m -130.15 34.96 4.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.971 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.1 m -117.32 158.54 24.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 0.0 112.027 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -155.97 166.22 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.966 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.452 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.8 t-20 54.71 33.97 20.63 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.619 0.574 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.87 113.85 16.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.217 0.532 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.71 155.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.735 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -94.79 135.29 36.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 14' ' ' ASN . 11.2 m -120.31 165.36 14.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.691 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.0 t-20 74.12 5.98 4.72 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.575 0.547 . . . . 0.0 111.067 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.94 16.16 39.67 Favored Glycine 0 CA--C 1.506 -0.48 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 105.3 27.03 5.99 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.735 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.1 mtp180 -110.86 -18.16 13.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.645 0.26 . . . . 0.0 110.455 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 63.1 m -129.6 128.46 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.369 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.9 tp -97.85 110.05 22.69 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.627 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.3 tmm_? -108.47 124.16 49.99 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.71 151.32 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.949 0.404 . . . . 0.0 110.191 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.2 mt-10 -106.94 113.17 26.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 6' ' ' SER . 7.8 p -124.22 146.78 48.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.184 0.516 . . . . 0.0 112.228 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.58 144.88 39.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.02 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -86.25 -173.17 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.804 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.19 73.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.149 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.58 -24.19 63.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.726 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.7 44.23 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.463 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.3 t-20 -84.35 144.89 28.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.169 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -76.25 121.19 22.56 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 t -120.67 154.99 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.374 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -107.53 112.96 25.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' LEU . 11.6 m -112.97 144.23 42.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.237 0.541 . . . . 0.0 111.386 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.2 mt-10 -132.8 131.52 41.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.653 HD11 HG12 ' A' ' 40' ' ' ILE . 12.1 tp -131.49 120.53 23.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.191 0.519 . . . . 0.0 109.907 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 39' ' ' THR . 36.0 m-20 -70.04 110.01 4.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.179 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 12' ' ' LEU . 37.7 mt -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.874 0.845 . . . . 0.0 109.151 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.5 OUTLIER -63.22 -3.66 2.0 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.548 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.89 -14.62 15.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.326 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.653 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -141.7 13.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.53 131.89 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.21 158.12 21.46 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.569 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.8 t30 -110.35 106.79 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.05 84.13 3.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 53.09 59.32 4.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.258 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.605 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.56 40.27 39.21 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.729 -1.225 . . . . 0.0 111.969 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -160.32 121.15 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.499 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 49.4 m-85 -63.69 138.83 58.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 111.228 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -134.48 117.08 15.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -69.51 115.79 9.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.883 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.7 36.79 3.89 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.219 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.25 -52.12 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.615 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.7 tt0 73.57 143.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.56 0.695 . . . . 0.0 111.976 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t30 66.64 31.76 7.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.421 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -69.46 -27.38 65.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.735 HG21 ' HG2' ' A' ' 17' ' ' ARG . 17.0 p -64.38 -17.6 63.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.701 ' HG3' HG23 ' A' ' 58' ' ' THR . 5.5 pt-20 -72.7 -21.78 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.6 p -122.91 12.91 9.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -121.86 145.7 47.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.223 0.535 . . . . 0.0 111.311 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.5 171.27 14.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.222 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.1 t70 45.45 56.1 6.0 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.538 0.524 . . . . 0.0 110.963 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.3 mt -88.42 111.28 22.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.051 0.453 . . . . 0.0 112.03 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 125.25 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.91 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.599 ' CE1' HD12 ' A' ' 94' ' ' LEU . 25.3 t80 -91.09 137.05 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.297 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -121.27 86.76 43.68 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.316 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 8.5 Cg_endo -57.4 -44.58 41.31 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.442 2.761 . . . . 0.0 113.921 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? . . . . . 0 C--N 1.295 -1.768 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.802 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.639 0.257 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.5 Cg_endo -73.21 110.0 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.737 2.291 . . . . 0.0 112.141 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.2 pp -136.5 141.98 39.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.5 124.96 53.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.333 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.509 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.93 145.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.006 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -162.14 169.7 20.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.1 mmt180 -86.89 115.33 24.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.605 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.6 mp -99.35 123.0 43.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.025 0.44 . . . . 0.0 110.762 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.359 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.629 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.8 pt-20 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -141.38 135.13 30.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.968 0.89 . . . . 0.0 111.133 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -130.68 108.13 9.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.7 p-10 -67.1 112.37 4.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.371 0.605 . . . . 0.0 110.61 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.522 ' HB2' HD22 ' A' ' 80' ' ' LEU . 35.9 mmt180 -113.62 177.41 4.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.726 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.17 148.9 39.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.499 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.1 p -136.81 145.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.375 0.607 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HB3' HD22 ' A' ' 95' ' ' ASN . 13.5 m120 -83.11 114.03 21.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.153 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.599 HD12 ' CE1' ' A' ' 64' ' ' PHE . 2.2 mt -82.02 2.11 32.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 111.106 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.2 m-80 -63.45 -10.48 17.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.299 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' HD2' ' N ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -70.27 -20.13 63.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.017 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.3 mt -85.18 131.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.63 159.19 27.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.231 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.9 t30 -106.28 118.97 38.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 39.4 t -113.0 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.035 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 60.07 21.87 11.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.825 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.43 23.39 6.32 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.55 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.5 ptp180 -132.57 141.07 48.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.122 0.461 . . . . 0.0 110.594 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.2 mp -89.9 118.17 29.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.653 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.75 127.3 68.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.321 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -82.75 144.91 29.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.583 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.317 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.7 p90 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.63 -24.5 21.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.52 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.51 -29.9 59.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -138.78 35.04 2.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.7 m -115.92 155.67 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 111.825 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.76 164.5 36.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.552 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 94.5 m-20 53.3 36.34 22.54 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.615 0.572 . . . . 0.0 111.484 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.44 113.43 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.691 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 t -142.28 150.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.87 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.1 tp -85.91 143.98 27.91 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 m -130.37 162.44 29.08 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.4 t-20 73.76 9.14 4.88 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 0.0 111.216 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.95 19.45 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 96.79 21.0 22.56 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.074 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 56' ' ' THR . 31.5 mtp180 -102.74 -18.16 15.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.728 0.299 . . . . 0.0 110.697 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 92.9 m -130.49 129.24 42.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.098 0.475 . . . . 0.0 111.773 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 97' ' ' ILE . 56.9 tp -95.6 110.86 22.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.278 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.7 tmm_? -109.05 123.75 49.66 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.44 145.17 29.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.0 mt-10 -102.05 110.69 22.73 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.4 t -125.9 147.84 49.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 111.754 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.68 145.64 38.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.37 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -87.16 -172.85 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.459 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.02 -14.29 62.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.256 0.55 . . . . 0.0 111.773 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.23 -17.22 31.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.252 0.549 . . . . 0.0 110.141 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.03 56.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.547 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 63.2 t30 -90.47 145.99 24.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -79.8 126.66 31.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.029 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.862 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -91.06 113.38 25.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 104' ' ' LEU . 2.3 m -110.75 142.6 42.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.094 0.473 . . . . 0.0 111.89 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.83 131.5 42.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.051 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.19 122.89 24.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.092 0.472 . . . . 0.0 110.128 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 39' ' ' THR . 74.1 m-20 -69.37 109.45 4.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.323 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD11 HD11 ' A' ' 12' ' ' LEU . 18.9 mt -61.89 -43.17 99.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.742 0.782 . . . . 0.0 109.655 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.23 -4.65 1.86 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.516 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -102.35 -15.06 16.67 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.355 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.5 HD12 HG13 ' A' ' 41' ' ' ILE . 2.6 pp -141.54 13.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -128.08 129.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.08 154.84 20.02 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.617 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.473 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -111.06 111.42 22.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.381 . . . . 0.0 110.154 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.09 85.25 2.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.984 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.0 58.73 5.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.623 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 80.57 34.31 28.75 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.746 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -153.28 119.58 5.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.577 0.227 . . . . 0.0 111.148 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.498 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 48.8 m-85 -67.19 137.59 56.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.226 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -133.2 117.14 17.08 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -68.61 116.15 8.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.776 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.33 25.98 8.5 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.946 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.42 -52.63 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.917 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 22.4 tt0 74.59 143.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.52 0.676 . . . . 0.0 111.883 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 t30 68.52 35.41 3.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.357 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.6 p90 -76.9 -24.35 52.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.611 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.675 HG21 ' HG2' ' A' ' 17' ' ' ARG . 13.1 p -67.58 -21.57 65.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.925 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.669 ' HG3' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -74.85 -15.8 60.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.254 0.549 . . . . 0.0 109.713 179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.669 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.9 p -126.14 14.18 7.82 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.061 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.47 141.33 52.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.755 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -135.52 168.97 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.501 -179.228 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 48.65 50.99 16.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.105 0.479 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.6 mt -83.58 112.41 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.43 123.07 37.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.684 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.679 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.3 t80 -92.09 131.18 37.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.684 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 20.8 t60 -120.19 87.15 39.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.9 Cg_endo -55.21 -33.18 83.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 124.387 3.391 . . . . 0.0 115.279 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.882 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.502 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 . . . . . 0 C--O 1.226 -0.156 0 CA-C-O 120.902 0.382 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 57.2 Cg_endo -71.07 114.02 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.508 2.139 . . . . 0.0 112.898 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.442 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 141.59 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.3 127.97 56.32 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.298 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.511 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.48 141.35 51.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 110.315 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.43 168.17 25.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.003 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.693 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.8 mmt180 -85.25 115.44 23.03 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.641 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -98.13 120.9 39.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 111.627 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.78 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 pt-20 . . . . . 0 C--O 1.222 -0.352 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.78 128.94 15.64 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.381 0.61 . . . . 0.0 109.78 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.58 110.79 6.96 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.0 p-10 -58.8 120.2 8.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.999 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.641 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.5 mmt180 -120.87 173.43 7.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.065 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.42 144.33 33.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 p -131.03 148.8 33.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.362 0.601 . . . . 0.0 111.389 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.471 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.8 OUTLIER -82.04 107.28 14.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.751 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.679 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.3 mt -79.85 5.57 13.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 16.1 m-80 -65.28 -17.18 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.041 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.94 -25.31 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.386 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.2 mt -79.13 129.87 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.207 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -124.09 163.39 21.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.59 122.06 45.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.954 0.407 . . . . 0.0 110.733 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.63 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.521 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 60.79 19.19 9.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 111.523 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.47 20.55 8.51 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.068 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.14 138.01 50.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.1 mp -84.14 123.73 30.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.64 127.65 56.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -79.16 145.6 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.404 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.1 p90 . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.797 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.97 -24.56 54.02 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.733 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.51 -33.16 67.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.71 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -129.09 31.42 4.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.797 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 37.5 p -121.14 155.92 33.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -151.21 170.49 19.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.2 m120 54.79 30.92 14.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.533 0.521 . . . . 0.0 111.34 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.7 114.23 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.602 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.4 t -142.39 149.64 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.858 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.584 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.2 tp -86.35 138.36 31.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 14.1 m -123.24 164.0 19.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.629 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.5 t-20 71.33 9.58 6.55 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.552 0.533 . . . . 0.0 111.259 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.63 17.19 46.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 107.4 19.43 9.35 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.069 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.663 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.1 mtp180 -102.77 -20.0 14.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 110.675 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.6 m -128.45 126.75 41.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 0.0 111.811 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -96.66 105.55 17.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.96 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 tmm_? -101.38 123.61 45.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.53 140.94 22.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.642 0.258 . . . . 0.0 110.552 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 4.0 mt-10 -98.55 109.48 22.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.1 p -118.1 142.29 47.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.19 0.519 . . . . 0.0 111.42 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.93 143.13 47.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.889 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.42 ' HB3' HG21 ' A' ' 31' ' ' VAL . 22.4 p-10 -91.17 -174.05 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.56 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.27 -26.74 63.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.1 -24.0 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.951 0.405 . . . . 0.0 111.258 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.64 4.83 42.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.637 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.9 t-20 -91.03 144.57 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.466 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.9 m0 -77.21 126.52 31.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.963 0.411 . . . . 0.0 110.815 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -120.49 125.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 m -74.93 107.28 6.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.549 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.8 m -111.22 143.42 42.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.177 0.513 . . . . 0.0 111.365 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 10.2 mt-10 -130.19 131.78 45.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.565 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 113.77 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 39' ' ' THR . 26.9 m-20 -67.43 108.72 2.91 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.782 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 12' ' ' LEU . 26.5 mt -60.71 -39.46 88.66 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.797 0.808 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -64.12 -3.82 3.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.68 -14.51 15.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.254 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.551 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -140.43 13.95 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -129.29 131.45 67.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.86 157.81 22.02 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.353 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -111.8 112.73 24.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.847 0.355 . . . . 0.0 110.472 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -106.9 86.46 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 53.68 52.25 13.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.153 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.31 37.95 23.05 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.746 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.59 120.98 7.35 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.5 m-85 -67.24 132.72 48.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.038 0.447 . . . . 0.0 110.98 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -125.18 117.61 24.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.218 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.46 115.36 10.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.584 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 22.03 11.63 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.347 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -90.18 -51.18 2.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.987 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.8 tt0 72.57 142.14 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 6.6 t-20 67.04 38.83 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.987 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.27 -26.7 47.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.709 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.663 HG21 ' HG2' ' A' ' 17' ' ' ARG . 41.6 p -64.01 -21.95 66.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.627 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.689 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.9 pt-20 -74.65 -14.05 60.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.114 0.483 . . . . 0.0 109.998 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.8 p -128.35 15.93 6.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.86 148.91 52.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.904 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -142.59 172.7 12.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.888 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 2.0 t70 46.7 53.35 10.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.556 0.535 . . . . 0.0 110.778 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.431 HG22 HD21 ' A' ' 76' ' ' LEU . 2.3 mt -85.31 114.17 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.42 0.629 . . . . 0.0 111.707 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.532 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.91 120.47 29.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.129 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' CE1' HD12 ' A' ' 94' ' ' LEU . 12.0 t80 -92.22 132.27 36.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.717 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 30.1 t-80 -123.55 89.31 51.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -59.04 -38.4 87.74 Favored 'Trans proline' 0 N--CA 1.479 0.662 0 C-N-CA 124.106 3.204 . . . . 0.0 115.085 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.885 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.677 0.275 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.2 Cg_endo -71.71 110.46 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.16 1.907 . . . . 0.0 112.24 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.485 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.43 141.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.84 125.31 53.93 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.136 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.24 140.76 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 110.235 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.53 168.51 25.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.564 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -86.23 115.07 23.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 2.3 mp -99.15 126.51 44.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.798 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.665 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.1 pt-20 . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -142.75 127.81 18.51 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 113.89 12.34 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 6.6 p-10 -65.87 114.65 5.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.486 0.66 . . . . 0.0 111.507 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.617 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.4 mmt180 -114.27 179.56 3.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.938 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.12 148.87 39.03 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -133.05 140.05 48.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.806 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.564 ' HB3' HD22 ' A' ' 95' ' ' ASN . 5.8 m-20 -82.76 104.99 13.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.174 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.625 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.1 mt -74.0 1.41 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.586 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.564 HD22 ' HB3' ' A' ' 93' ' ' ASN . 28.9 m-80 -61.28 -17.53 53.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.322 0.582 . . . . 0.0 109.779 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.06 -25.58 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.149 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.58 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -80.81 126.84 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.752 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 79.0 mm-40 -117.46 163.09 16.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.809 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.7 t30 -107.88 120.31 41.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.127 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.3 t -114.02 94.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.503 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.27 27.97 17.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.222 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.04 26.34 7.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.617 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.8 ptp180 -133.15 137.08 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.991 0.395 . . . . 0.0 110.297 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 74.6 mt -85.6 122.66 30.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.774 0.321 . . . . 0.0 110.188 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.4 t -132.85 128.04 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.523 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -79.24 146.02 33.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 -179.737 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.329 0.585 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.731 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.86 -21.74 63.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.735 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.21 -30.67 68.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 m -139.18 39.43 2.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.749 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 89.3 p -113.64 156.98 22.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -149.03 163.28 37.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.444 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 92.5 m-20 51.42 35.48 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.909 0.756 . . . . 0.0 111.429 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.695 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -76.59 112.61 13.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.755 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 t -142.99 155.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.851 HD11 HD11 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -89.02 148.43 23.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.3 m -131.89 162.01 31.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.362 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 3.7 t-20 70.62 12.76 7.33 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 123.699 0.625 . . . . 0.0 111.327 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.47 19.2 33.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.565 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 100.69 24.04 9.6 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.5 mtp180 -105.56 -19.44 13.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.545 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.0 m -129.79 125.84 36.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.295 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 12' ' ' LEU . 48.5 tp -94.08 107.36 19.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.426 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.53 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 tmm_? -102.03 123.12 45.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -148.19 138.86 22.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.926 0.394 . . . . 0.0 110.655 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 4.3 mt-10 -103.24 110.76 22.85 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.7 t -124.12 146.86 48.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 111.085 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.84 145.28 45.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.732 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -83.41 -172.08 3.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -33.6 74.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.951 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.34 -24.41 59.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.212 0.53 . . . . 0.0 110.776 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.83 8.47 27.97 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.855 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 59.0 t30 -86.15 145.08 27.16 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -77.64 117.8 19.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.066 0.46 . . . . 0.0 111.1 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.92 153.15 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.6 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 47.4 m -114.68 122.3 46.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.914 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t -124.52 151.15 45.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 0.0 110.493 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -133.62 131.23 39.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.656 HD11 HG12 ' A' ' 40' ' ' ILE . 14.2 tp -127.47 120.29 28.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 0.0 110.278 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 39' ' ' THR . 32.3 m-20 -68.41 107.5 2.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.737 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.851 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -62.2 -40.47 96.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.724 0.773 . . . . 0.0 109.227 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.1 p-10 -64.31 -4.95 4.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.528 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -106.21 -12.06 15.85 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.414 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.656 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -141.71 11.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 112.083 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.3 mt -128.1 131.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.535 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.48 157.64 20.94 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.782 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.9 t30 -111.62 108.4 17.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.998 0.428 . . . . 0.0 110.094 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -96.5 78.1 2.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.628 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 48.97 63.77 1.99 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.057 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.11 34.69 36.68 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.542 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -155.41 114.74 3.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.762 -0.257 . . . . 0.0 110.576 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.0 m-85 -60.75 140.99 57.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 111.389 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.66 117.33 16.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.502 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -71.66 115.11 10.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.8 28.15 7.56 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.843 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.535 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -97.41 -52.48 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.452 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.7 tt0 73.26 141.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.263 0.625 . . . . 0.0 111.475 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.601 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 7.4 m-20 71.0 34.56 1.84 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.631 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.9 p90 -77.5 -31.11 53.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.629 HG21 ' HG2' ' A' ' 17' ' ' ARG . 26.8 p -62.54 -26.65 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.931 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 58' ' ' THR . 17.7 pt-20 -70.31 -14.85 62.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.325 0.583 . . . . 0.0 109.955 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.617 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.1 p -127.03 13.97 7.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.3 145.09 51.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.144 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.16 172.63 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.606 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.472 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 49.14 48.36 20.99 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.059 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.37 108.2 15.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.0 111.43 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -125.08 125.63 44.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.66 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.695 ' HE2' ' HB1' ' A' ' 10' ' ' ALA . 8.9 t80 -92.28 134.78 34.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.351 0.596 . . . . 0.0 111.879 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -121.65 85.3 43.82 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.156 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -53.91 -35.5 80.31 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.15 3.233 . . . . 0.0 114.472 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.436 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.0 Cg_endo -71.51 110.65 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.302 2.002 . . . . 0.0 112.033 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.678 HD11 HH21 ' A' ' 77' ' ' ARG . 1.3 pp -135.76 141.54 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -111.84 124.14 51.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.678 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.98 142.66 47.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.4 167.83 26.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.2 mmt180 -86.27 114.55 23.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.5 mp -99.19 126.97 45.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.368 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.1 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.669 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 24.4 pt-20 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.16 137.55 32.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.673 0.749 . . . . 0.0 111.011 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.16 112.78 8.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.207 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -63.32 110.35 1.88 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.635 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.529 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.7 mmt180 -115.09 170.45 8.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.495 ' HB2' HD13 ' A' ' 75' ' ' ILE . 3.4 p30 -135.98 153.96 51.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.509 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -138.73 144.74 29.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.398 0.618 . . . . 0.0 110.685 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.507 ' HB3' HD22 ' A' ' 95' ' ' ASN . 4.0 m-20 -80.2 111.39 16.52 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.854 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.675 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.6 mt -82.32 4.59 23.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.489 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.507 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.4 m-80 -63.35 -18.65 63.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.153 0.502 . . . . 0.0 109.799 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.98 -24.48 67.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.075 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.2 mt -80.36 127.49 39.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.358 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -117.66 166.69 12.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.345 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -110.21 118.31 36.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.52 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -108.61 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 59.91 22.84 11.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.269 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.55 19.04 8.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.772 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -130.36 141.06 50.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.277 0.538 . . . . 0.0 110.55 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.914 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 82.0 mt -83.95 120.46 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.017 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 60.0 t -125.31 124.29 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.298 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.82 143.9 32.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.619 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.547 179.82 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.795 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.85 -19.49 29.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.74 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.38 -24.32 67.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.323 0.582 . . . . 0.0 109.909 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.6 m -142.11 36.86 1.56 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.705 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.795 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 60.5 p -125.68 153.36 43.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 110.681 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -149.57 171.8 16.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.3 m-20 55.02 30.97 15.17 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.686 0.617 . . . . 0.0 110.984 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.578 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -73.8 114.59 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.758 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 t -144.22 149.72 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.512 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -85.48 139.08 31.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 179.309 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.638 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.7 m -121.08 165.57 15.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.401 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 69.46 8.18 6.63 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.397 0.436 . . . . 0.0 111.34 178.012 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.48 23.92 27.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.721 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 101.88 23.4 9.3 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.057 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.682 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.6 mtp180 -109.89 -15.65 14.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.64 0.257 . . . . 0.0 110.524 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.638 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 31.3 m -130.3 126.99 38.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.615 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.0 tp -97.54 107.1 19.53 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.1 tmm_? -104.35 125.22 50.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.127 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.05 138.0 20.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.398 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.2 mt-10 -94.8 109.24 21.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.5 p -114.68 142.82 45.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.423 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.33 141.99 43.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.538 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.484 ' HB3' HG21 ' A' ' 31' ' ' VAL . 30.9 p-10 -88.09 -178.79 6.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.265 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.02 62.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.9 0.381 . . . . 0.0 111.715 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.26 -23.91 60.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 0.0 111.545 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.46 36.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.9 t-20 -95.99 144.82 25.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.6 m0 -76.18 123.0 25.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.934 0.397 . . . . 0.0 110.988 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 25' ' ' ASN . 5.2 t -119.47 124.2 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.437 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 m -78.05 107.73 10.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 t -110.83 149.64 30.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.317 0.58 . . . . 0.0 110.524 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 8.1 mt-10 -135.25 131.25 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.403 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.77 114.86 17.82 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.712 ' O ' HG22 ' A' ' 39' ' ' THR . 29.7 m-20 -67.87 109.42 3.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.139 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 12' ' ' LEU . 25.3 mt -60.77 -40.08 91.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.259 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.6 OUTLIER -64.01 -4.61 3.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -105.17 -13.69 15.63 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.525 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.14 12.64 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.85 130.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.2 158.49 21.59 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.404 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -111.33 110.35 20.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -98.93 77.2 2.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.145 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 53.02 59.39 4.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.514 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.21 34.55 36.65 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.69 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -149.67 110.7 4.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.2 m-85 -59.09 137.09 58.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.074 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -132.25 117.39 18.15 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.902 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.439 ' HH2' HD22 ' A' ' 94' ' ' LEU . 92.1 m95 -70.79 114.71 9.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.62 27.02 7.34 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.295 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.86 -52.53 1.5 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.247 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 19.8 tt0 73.69 142.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.496 0.665 . . . . 0.0 111.45 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.65 38.54 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.377 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.23 -27.21 47.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.682 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.2 p -62.63 -28.21 69.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.956 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.619 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -70.39 -18.16 63.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.373 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.619 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.6 p -122.56 14.78 10.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.16 149.49 46.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -135.15 170.64 15.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.4 t70 43.17 57.64 3.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.475 0.484 . . . . 0.0 111.56 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.53 109.03 19.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.277 0.561 . . . . 0.0 112.077 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 126.22 42.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.324 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.638 ' CE1' HD12 ' A' ' 94' ' ' LEU . 19.4 t80 -91.35 136.73 32.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.277 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -118.36 83.03 19.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.367 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.6 Cg_endo -57.35 -43.64 50.17 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.345 2.697 . . . . 0.0 113.702 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mptt . . . . . 0 C--N 1.297 -1.692 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.669 179.771 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 78.3 mt-30 . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 120.59 0.233 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.621 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 44.7 Cg_endo -69.39 108.32 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.28 1.987 . . . . 0.0 111.196 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.469 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.2 pp -134.53 142.48 40.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.1 tm? -112.02 126.62 55.35 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.497 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.83 141.45 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.35 168.6 21.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.757 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.7 mmt180 -86.07 115.15 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.607 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.87 131.85 45.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.875 0.369 . . . . 0.0 111.096 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.245 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.4 pt-20 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.9 p90 -144.65 128.74 17.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.87 118.9 16.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.485 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 8.8 p-10 -60.22 115.06 3.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.544 0.687 . . . . 0.0 112.561 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.607 ' HB2' HD22 ' A' ' 80' ' ' LEU . 28.9 mmt180 -115.3 175.11 5.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.33 146.09 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.6 p -136.22 143.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.905 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.43 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 7.4 m120 -81.91 110.89 17.6 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.327 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.638 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.0 mt -79.26 0.88 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.621 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 m120 -61.32 -16.29 44.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.426 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.4 -29.95 71.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 109.715 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 94' ' ' LEU . 15.0 mt -74.9 130.93 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.871 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.485 ' HG3' HG13 ' A' ' 105' ' ' VAL . 10.9 pt20 -122.9 167.9 12.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.64 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.2 t30 -112.25 121.91 46.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.306 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.1 t -113.15 94.13 2.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.341 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.43 26.32 12.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.104 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.79 19.38 8.25 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.885 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.7 ptp180 -130.55 135.03 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.22 0.51 . . . . 0.0 110.863 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.06 124.66 32.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG13 ' HG3' ' A' ' 98' ' ' GLN . 6.9 p -135.04 132.22 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -78.86 140.01 38.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.403 1.081 . . . . 0.0 112.921 -178.671 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.77 -23.92 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.57 -32.81 63.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.7 m -137.64 38.61 2.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 66.7 m -117.31 154.6 30.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.366 0.603 . . . . 0.0 112.033 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.35 164.44 34.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.596 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 85.3 m-20 54.93 32.64 18.37 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.594 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -74.72 113.4 11.95 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.4 147.85 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.88 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 37' ' ' LEU . 1.5 tp -85.37 132.69 34.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.243 0.544 . . . . 0.0 109.725 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.4 m -118.87 165.21 14.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.667 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.0 t-20 70.65 8.7 6.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.049 0.54 . . . . 0.0 111.659 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.0 13.5 52.69 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.696 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.485 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 109.85 19.65 8.07 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.692 ' HG2' HG21 ' A' ' 56' ' ' THR . 18.5 mtp180 -105.92 -16.73 14.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.648 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 24.7 m -130.27 121.49 26.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.353 . . . . 0.0 111.78 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.493 ' CD2' HD13 ' A' ' 97' ' ' ILE . 63.1 tp -92.56 105.28 17.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 tmm_? -100.95 124.1 46.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.65 139.22 25.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.9 mt-10 -97.96 113.12 24.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.7 p -125.03 145.6 49.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -76.6 144.17 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.498 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.46 -171.8 2.89 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.188 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -32.17 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 111.74 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.03 -24.52 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.198 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.24 53.1 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.1 m-80 -88.81 142.46 27.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.473 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.0 m0 -74.91 125.64 29.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 t -124.64 137.45 57.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.539 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 26.4 m -94.81 109.91 21.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 104' ' ' LEU . 9.7 t -111.38 151.92 27.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 110.672 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.22 132.35 35.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.91 116.34 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 11.0 m-20 -67.22 108.54 2.74 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.194 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 12' ' ' LEU . 42.7 mt -59.34 -46.44 88.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -61.98 -4.84 1.78 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.895 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.72 -12.16 19.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.487 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.55 12.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.34 132.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.8 158.82 20.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.751 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -112.96 109.44 18.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -99.42 84.12 2.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.585 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.23 46.91 24.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.422 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.616 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.74 43.11 5.85 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.679 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -160.47 114.06 2.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.7 m-85 -59.91 138.49 57.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.045 0.45 . . . . 0.0 111.272 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -131.07 116.21 17.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -69.33 115.13 8.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.939 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.16 31.45 6.2 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.236 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.54 -51.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.176 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.9 tt0 72.84 146.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.218 0.607 . . . . 0.0 111.172 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.3 m-20 73.08 30.07 1.67 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.0 p90 -76.29 -31.43 58.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.692 HG21 ' HG2' ' A' ' 17' ' ' ARG . 20.0 p -62.45 -30.5 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.882 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.623 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.5 pt-20 -67.79 -15.59 63.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 110.477 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.623 HG23 ' HG3' ' A' ' 57' ' ' GLU . 67.2 p -124.1 10.74 8.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.426 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.63 147.3 47.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.05 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.91 166.11 24.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.329 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.5 t70 49.08 56.03 8.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.022 0.439 . . . . 0.0 110.639 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.39 109.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.213 0.53 . . . . 0.0 111.603 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.91 123.72 41.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.812 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CE1' HD12 ' A' ' 94' ' ' LEU . 13.6 t80 -92.51 135.49 34.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.691 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 13.7 t60 -123.2 86.61 51.5 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 11.5 Cg_endo -57.06 -37.68 97.74 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 124.213 3.276 . . . . 0.0 114.839 -177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.74 109.51 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.076 1.851 . . . . 0.0 112.087 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.407 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -133.69 141.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.71 126.28 55.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.512 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.65 139.83 53.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.035 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.95 167.72 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.959 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.2 mmt180 -84.78 115.59 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.616 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -100.61 126.57 47.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.82 0.343 . . . . 0.0 111.445 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.604 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.9 pt-20 . . . . . 0 C--O 1.22 -0.491 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.06 129.42 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -139.59 117.46 11.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.631 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 5.6 p-10 -63.3 122.89 17.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.302 0.572 . . . . 0.0 111.353 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.605 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.1 mmt180 -115.94 179.49 3.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.5 146.63 32.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.0 p -136.24 146.93 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-O 121.325 0.583 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.5 ' HB3' HD22 ' A' ' 95' ' ' ASN . 86.6 m-20 -81.83 109.64 16.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.191 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.2 mt -80.14 4.45 17.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.384 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.5 HD22 ' HB3' ' A' ' 93' ' ' ASN . 17.4 m-80 -65.14 -10.82 33.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.271 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.38 -18.78 63.05 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 109.653 178.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.049 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -122.25 161.78 22.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.927 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -105.69 117.66 34.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.569 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 53.4 t -113.73 96.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.78 23.15 13.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.78 21.59 9.01 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.38 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.2 ptp180 -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 110.857 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 33' ' ' SER . 3.0 mp -84.34 129.21 34.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 131.54 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.22 145.53 27.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.231 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 86.5 mm-40 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.468 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.3 p90 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -23.63 13.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.688 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.84 -34.52 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.671 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.7 m -134.96 36.2 3.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.579 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 70.4 m -119.95 153.43 35.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 111.458 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -150.02 169.75 20.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.578 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.557 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t-20 56.89 28.21 14.23 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.438 0.461 . . . . 0.0 110.692 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.562 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -74.45 113.78 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.87 153.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.801 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.82 136.01 33.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 23.9 m -116.77 163.06 16.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.5 t-20 71.26 6.57 5.84 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.491 0.494 . . . . 0.0 111.554 177.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.4 22.95 27.9 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.634 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 103.26 21.07 10.28 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.154 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.5 mtp180 -107.27 -16.42 14.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.514 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.0 m -131.72 130.48 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 111.624 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HB2' HD21 ' A' ' 37' ' ' LEU . 54.4 tp -99.91 108.7 21.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -110.7 125.13 53.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.088 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.414 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -146.84 155.09 42.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.639 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -107.85 112.87 25.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 5.1 p -123.97 146.22 48.64 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.606 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.94 143.86 35.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.636 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -90.23 -171.99 3.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.9 -27.37 69.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 0.0 111.214 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -73.54 -20.88 60.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.555 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.42 10.22 54.11 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.6 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.8 t-20 -96.31 145.06 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.467 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 43.8 m0 -77.21 125.53 29.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.47 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 140.85 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 m -91.77 112.88 24.99 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.328 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.493 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.5 m -111.21 146.96 36.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 0.0 111.187 -178.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.6 mt-10 -133.39 139.72 46.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.06 113.85 8.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' THR . 20.8 m-20 -67.57 110.99 3.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.142 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 12' ' ' LEU . 80.4 mt -61.23 -43.13 99.37 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.678 0.751 . . . . 0.0 109.778 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.5 -3.79 2.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.796 -179.902 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.32 -9.59 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.291 179.45 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -144.08 10.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 132.59 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -128.92 159.05 22.15 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.87 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.477 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.3 t30 -111.43 113.34 25.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -97.76 78.57 2.61 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.07 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 40.4 63.5 1.1 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.143 0.902 . . . . 0.0 112.48 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 83.87 38.21 10.69 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -159.27 115.86 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.705 -0.291 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.532 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 40.4 m-85 -60.96 138.0 58.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -128.06 115.23 18.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.483 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -73.98 113.68 11.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.12 41.27 3.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -112.53 -50.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.601 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 20.0 tt0 73.32 141.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.309 0.643 . . . . 0.0 112.033 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 5.8 t-20 68.58 38.56 2.28 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.078 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.2 p90 -77.13 -26.6 53.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.529 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.684 HG21 ' HG2' ' A' ' 17' ' ' ARG . 38.4 p -64.14 -19.78 65.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.634 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.676 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.1 pt-20 -74.76 -19.68 60.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.148 0.499 . . . . 0.0 109.848 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.676 HG23 ' HG3' ' A' ' 57' ' ' GLU . 72.6 p -123.34 18.12 9.8 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.936 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -133.56 150.35 51.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.88 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.741 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.82 172.86 12.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.209 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 3.5 t70 44.91 55.1 6.34 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.786 0.679 . . . . 0.0 110.997 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.03 109.13 17.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 112.033 -178.035 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -120.11 123.24 42.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.122 179.18 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' HD12 ' A' ' 94' ' ' LEU . 11.3 t80 -93.38 133.49 36.58 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.671 -178.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t60 -124.81 87.41 55.02 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.378 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.7 Cg_endo -55.99 -34.5 92.39 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.157 3.238 . . . . 0.0 114.14 -178.664 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.962 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 120.925 0.393 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.2 Cg_endo -73.63 109.2 2.81 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.524 2.149 . . . . 0.0 111.584 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.594 HD11 HH21 ' A' ' 77' ' ' ARG . 1.2 pp -134.43 142.25 41.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -113.41 123.97 51.33 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.284 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.594 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.5 139.45 52.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.909 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.15 169.44 24.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.741 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.9 mmt85 -85.1 115.12 22.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -101.63 130.54 48.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.698 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.759 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.211 179.211 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 16.3 pt-20 . . . . . 0 C--O 1.22 -0.491 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.57 133.4 34.41 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.962 0.887 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -138.67 118.45 13.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.594 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.8 p-10 -66.57 118.42 10.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.542 0.686 . . . . 0.0 111.009 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.544 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.4 mmt180 -114.06 175.0 5.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.7 148.34 40.62 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.532 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.4 p -136.8 144.11 33.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.588 0.709 . . . . 0.0 111.402 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.448 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -78.62 107.48 11.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.576 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.612 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.6 mt -79.97 3.43 20.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.265 0.555 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.426 HD22 ' HB3' ' A' ' 93' ' ' ASN . 24.0 m-80 -61.5 -19.08 61.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.915 178.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -64.67 -21.94 66.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.512 179.279 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 10.6 mt -85.38 126.96 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -125.09 151.65 45.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.206 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 1.5 t30 -92.17 117.67 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.586 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 58.3 t -113.65 97.13 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.595 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.75 25.9 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.719 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.54 20.74 9.84 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.527 178.045 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -131.09 140.76 50.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.931 0.366 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.7 mp -86.07 115.69 23.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.9 t -115.04 121.92 68.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.688 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -83.33 144.82 29.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.529 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.468 179.26 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.9 p90 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.79 -25.33 27.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.595 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -53.94 -32.48 53.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.068 0.461 . . . . 0.0 110.973 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.6 m -134.82 33.38 3.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.3 m -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 112.355 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.8 ptp180 -154.02 169.22 24.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.223 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.615 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.3 t30 56.13 32.43 20.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.423 0.63 . . . . 0.0 110.476 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.89 113.7 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.446 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 t -143.43 146.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -80.88 143.26 32.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.01 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -128.5 163.31 25.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.12 6.15 5.49 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.676 0.61 . . . . 0.0 111.472 178.437 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.6 23.8 17.66 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.178 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.524 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 100.55 14.95 30.94 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.193 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.5 mtp180 -98.75 -16.76 18.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.82 -0.224 . . . . 0.0 111.034 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 31.7 m -133.27 129.97 38.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.0 111.873 -178.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.99 108.39 21.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 tmm_? -106.61 124.45 49.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.152 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.93 159.9 44.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 5.1 mt-10 -114.91 110.4 19.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 6' ' ' SER . 48.2 t -119.7 144.67 47.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.15 144.34 48.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.614 179.385 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.1 p30 -90.89 -171.74 3.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.29 68.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 0.0 111.7 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.19 -24.47 60.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.444 . . . . 0.0 111.123 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.18 -0.95 33.21 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.709 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.6 t30 -83.63 144.95 29.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -75.3 125.23 28.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.509 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.2 t -120.73 130.62 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 m -80.22 106.94 12.61 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.062 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.622 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.4 m -110.08 135.75 50.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.434 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.4 mt-10 -126.87 131.95 51.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.539 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.78 116.21 19.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 39' ' ' THR . 16.2 m-20 -67.3 109.41 3.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 12' ' ' LEU . 34.6 mt -59.59 -46.56 88.57 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.652 0.739 . . . . 0.0 110.052 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.648 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 10.3 t70 -63.79 -4.41 3.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.09 -11.67 20.32 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.571 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -145.82 13.41 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 121.066 0.46 . . . . 0.0 112.053 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.55 130.85 70.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.36 159.03 21.85 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.509 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.423 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 9.2 t30 -111.19 111.43 22.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -105.74 85.96 2.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.735 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 51.59 50.97 17.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.306 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.17 41.19 10.48 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.193 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -158.18 118.27 3.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.0 m-85 -63.71 136.37 57.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.119 0.485 . . . . 0.0 110.607 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -128.78 115.64 18.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.151 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -69.49 115.04 8.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.13 22.63 8.16 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.41 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -92.99 -54.37 1.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.382 -0.914 . . . . 0.0 114.002 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.5 tt0 72.59 139.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.188 0.595 . . . . 0.0 110.803 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.641 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.7 m120 74.1 39.78 0.48 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.615 0.721 . . . . 0.0 110.516 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.3 p90 -84.79 -26.33 27.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.282 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.667 HG21 ' HG2' ' A' ' 17' ' ' ARG . 71.2 p -68.4 -17.95 64.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.393 -179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 58' ' ' THR . 9.5 pt-20 -78.03 -13.13 59.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.235 0.54 . . . . 0.0 109.857 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.711 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.5 p -127.67 14.97 7.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.772 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.46 149.95 49.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.848 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -140.79 171.01 14.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.82 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 49.02 54.69 10.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.952 0.406 . . . . 0.0 110.393 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.66 108.91 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.306 0.574 . . . . 0.0 112.326 -177.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 123.63 40.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.551 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.656 ' CE1' HD12 ' A' ' 94' ' ' LEU . 15.3 t80 -91.67 133.28 35.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.781 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.82 87.94 43.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.143 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -36.8 79.67 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 123.633 2.889 . . . . 0.0 113.623 -178.376 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.745 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.614 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -72.23 110.48 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.762 2.308 . . . . 0.0 112.467 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.724 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.38 141.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.31 128.44 56.47 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.724 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.94 144.57 49.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.059 0.457 . . . . 0.0 110.21 178.878 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.37 170.05 18.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.93 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.603 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -85.91 115.71 23.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.2 mp -98.52 127.15 44.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.096 0.474 . . . . 0.0 111.629 -178.494 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.806 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.9 pt-20 . . . . . 0 C--O 1.22 -0.479 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -147.19 132.98 18.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.847 0.832 . . . . 0.0 111.034 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -140.19 120.45 13.89 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.752 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.8 p-10 -67.13 116.4 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.184 0.516 . . . . 0.0 111.585 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.731 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.1 mmt180 -116.79 177.51 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.94 147.15 32.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -134.37 143.38 38.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.389 0.614 . . . . 0.0 110.86 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -82.83 110.7 18.07 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.817 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.656 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -80.61 3.15 22.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.614 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.3 m120 -61.47 -15.47 37.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.015 178.392 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -23.5 67.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.139 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.596 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.6 mt -84.54 124.19 39.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.005 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -119.65 163.79 16.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.714 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.9 t30 -106.22 120.19 41.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.061 0.458 . . . . 0.0 111.635 -178.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.8 t -112.61 94.14 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.349 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.22 23.43 13.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.929 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 20.85 7.95 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.549 178.533 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.8 ptp180 -130.29 138.96 50.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.996 0.398 . . . . 0.0 110.477 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 64.1 mt -85.47 117.48 24.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.461 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 61.7 t -121.56 123.45 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -85.89 145.75 27.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.584 178.724 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.774 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.06 -29.13 63.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.643 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.43 -33.55 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.168 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 58.7 m -134.13 35.83 3.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.774 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.7 p -117.21 155.88 28.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.443 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.31 167.62 28.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.493 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 55.01 32.53 18.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.63 0.581 . . . . 0.0 111.17 -179.056 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.529 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.08 113.76 15.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.56 151.61 19.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.298 -178.57 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -87.58 142.37 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.415 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 11.7 m -129.68 163.58 25.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.934 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.6 t-20 73.12 9.12 5.34 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.165 0.586 . . . . 0.0 111.441 178.258 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.8 25.92 16.33 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 94.92 22.18 23.86 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.71 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.9 mtp180 -106.32 -18.74 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.607 0.242 . . . . 0.0 110.641 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.4 m -128.37 125.64 39.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 111.846 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.17 106.73 18.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.853 178.2 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -103.02 124.28 48.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.1 142.71 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 111.114 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.3 mt-10 -98.94 110.03 22.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' SER . 15.4 t -122.36 139.52 53.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.32 144.07 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.892 179.85 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.481 ' HB3' HG21 ' A' ' 31' ' ' VAL . 8.9 p30 -91.42 -170.25 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -33.83 66.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -76.29 -22.53 54.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 110.992 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.95 33.82 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.694 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 m-80 -84.84 141.63 30.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.561 0.18 . . . . 0.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 54.0 m0 -72.51 124.33 24.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 111.149 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 25' ' ' ASN . 6.3 t -116.57 119.77 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.924 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.7 m -78.43 104.34 8.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.7 t -111.52 152.94 26.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.149 0.5 . . . . 0.0 110.425 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.0 mt-10 -134.74 131.37 37.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.486 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.613 HD11 HG12 ' A' ' 40' ' ' ILE . 12.0 tp -125.52 115.09 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.775 178.581 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -66.28 109.13 2.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.914 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 12' ' ' LEU . 37.2 mt -60.8 -43.44 98.13 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.702 0.763 . . . . 0.0 109.499 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.35 -5.43 3.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.487 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.16 -14.59 17.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.426 -179.263 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.613 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.51 13.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.52 130.3 70.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.52 160.89 21.62 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.221 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.18 112.8 24.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -109.52 87.16 2.44 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.299 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.27 58.62 5.07 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.6 179.046 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 69.72 42.53 70.81 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.992 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -158.3 117.17 3.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 57.4 m-85 -61.9 138.56 58.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.227 0.537 . . . . 0.0 110.79 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.45 116.68 20.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.303 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.24 115.02 8.95 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.42 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.3 28.75 7.04 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.15 -52.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.878 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 27.9 tt0 73.05 143.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 0.0 111.021 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.599 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 80.4 m-20 69.14 36.66 2.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.576 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -77.28 -30.08 54.14 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.71 HG21 ' HG2' ' A' ' 17' ' ' ARG . 21.4 p -63.9 -23.98 67.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.187 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.645 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.1 pt-20 -73.69 -15.75 61.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.211 0.529 . . . . 0.0 109.929 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.645 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -123.86 14.26 9.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.996 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.58 154.43 47.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.95 173.65 11.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.042 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 13.4 t70 50.45 53.31 13.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.11 0.481 . . . . 0.0 110.211 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.9 mt -88.52 109.24 19.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.513 . . . . 0.0 111.947 -178.025 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.452 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.7 123.93 38.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.762 178.8 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.664 ' CE1' HD12 ' A' ' 94' ' ' LEU . 24.2 t80 -92.58 136.04 33.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.27 0.557 . . . . 0.0 112.01 -178.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -123.32 89.75 50.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.987 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.7 Cg_endo -60.63 -41.01 50.84 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.836 3.024 . . . . 0.0 114.519 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.671 0.272 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.708 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 52.7 Cg_endo -71.49 108.12 2.31 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.287 1.991 . . . . 0.0 111.331 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.465 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -131.87 140.74 47.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -112.41 125.0 53.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.085 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.494 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.58 139.56 52.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 179.285 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.16 169.55 23.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.792 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 5.0 mmt85 -84.96 115.67 22.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -101.26 132.11 46.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.56 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.803 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.055 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.803 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.0 pt-20 . . . . . 0 C--O 1.22 -0.475 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 85.4 m-85 -138.7 130.45 27.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.064 0.459 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -138.88 123.31 18.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.436 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.9 p-10 -61.81 116.89 5.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.357 0.598 . . . . 0.0 112.423 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.654 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.8 mmt180 -114.69 179.29 3.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.56 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -143.51 151.0 39.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.903 0.382 . . . . 0.0 110.023 -179.057 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.515 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.5 p -138.85 145.24 28.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.362 0.601 . . . . 0.0 110.918 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -82.66 109.95 17.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.572 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.664 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -81.0 3.72 22.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.011 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.708 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 15.2 m120 -63.11 -17.87 62.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.726 178.732 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -29.24 69.71 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.944 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -77.24 127.3 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.403 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -121.19 165.97 14.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 7.1 t30 -110.77 117.95 34.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.2 t -113.14 96.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.337 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.43 22.21 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.051 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 22.67 8.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.592 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -130.21 136.38 49.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.177 0.488 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -80.65 116.76 20.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 0.0 110.888 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.89 123.96 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.48 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -82.06 145.69 30.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.868 0.366 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.994 178.875 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.766 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -24.74 63.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.73 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.13 -33.64 67.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.106 0.479 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.2 m -133.42 36.86 3.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.362 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.766 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.5 p -117.28 155.82 28.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.162 0.505 . . . . 0.0 111.815 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -148.09 168.4 22.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.064 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.428 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.8 m-20 52.23 33.95 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.386 0.613 . . . . 0.0 110.701 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -84.55 114.43 21.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.331 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 64' ' ' PHE . 5.9 m -147.27 177.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.22 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.9 139.42 39.66 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.055 179.247 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 14' ' ' ASN . 26.0 m -123.98 162.98 22.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.482 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.9 t-20 74.03 7.64 4.78 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.671 0.607 . . . . 0.0 111.009 178.216 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.28 22.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.95 21.54 13.71 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.924 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.9 mtp180 -104.42 -19.09 14.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 37.4 m -127.54 126.53 42.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.006 0.432 . . . . 0.0 111.362 -178.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.476 ' CD2' HD13 ' A' ' 97' ' ' ILE . 54.7 tp -95.56 106.82 18.95 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.584 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -106.21 123.9 48.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.887 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.93 137.35 19.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.381 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.9 mt-10 -96.24 109.27 21.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' SER . 16.5 t -118.57 143.7 46.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.963 0.411 . . . . 0.0 110.139 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 143.48 50.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.835 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 31' ' ' VAL . 24.7 p-10 -85.28 -172.4 4.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.68 -21.5 65.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.47 -22.08 26.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.94 3.59 34.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.4 t30 -88.29 146.65 25.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -75.62 126.68 31.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 25' ' ' ASN . 10.8 t -124.46 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 m -80.06 109.02 14.11 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.598 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.514 ' HB2' HD13 ' A' ' 104' ' ' LEU . 1.9 m -109.78 139.04 45.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.909 0.385 . . . . 0.0 110.376 -178.563 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.69 130.99 42.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.91 117.6 21.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 39' ' ' THR . 27.0 m-20 -68.59 107.72 3.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.967 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 12' ' ' LEU . 24.6 mt -60.59 -40.27 91.13 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.592 0.71 . . . . 0.0 110.569 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.66 -5.28 2.56 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -104.93 -14.37 15.48 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.481 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.546 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.28 11.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.32 156.74 21.01 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.802 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.9 t30 -110.19 108.71 18.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.283 0.563 . . . . 0.0 109.547 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -100.19 82.53 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.1 60.88 3.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.298 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.22 35.86 36.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.693 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -154.97 121.33 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.842 -0.21 . . . . 0.0 110.649 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.4 m-85 -65.41 138.46 58.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.084 0.468 . . . . 0.0 111.07 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -130.45 116.85 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.744 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.51 114.31 9.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.91 29.15 7.41 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.828 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.79 -53.06 1.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.43 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 17.4 tt0 76.96 142.54 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.303 0.641 . . . . 0.0 111.333 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.671 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.1 m-20 66.72 38.84 3.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.024 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.5 p90 -79.43 -28.1 41.71 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.629 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.8 p -65.51 -25.17 67.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.601 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.79 ' HG3' HG23 ' A' ' 58' ' ' THR . 5.4 pt-20 -72.59 -12.36 61.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.328 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.79 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -130.37 15.93 5.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.31 0.576 . . . . 0.0 109.805 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.15 144.53 51.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -134.46 173.08 12.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.285 -179.683 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER 46.01 54.38 8.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.684 0.615 . . . . 0.0 111.046 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.43 HG22 HD23 ' A' ' 12' ' ' LEU . 2.2 mt -89.33 112.77 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.778 -178.212 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -130.86 125.23 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.847 179.283 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.618 ' CE1' HD12 ' A' ' 94' ' ' LEU . 21.5 t80 -92.61 133.75 35.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.516 0.674 . . . . 0.0 112.435 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -117.57 87.71 26.8 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.525 177.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 Cg_endo -58.42 -42.95 50.25 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 124.067 3.178 . . . . 0.0 114.637 -177.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.633 -178.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.2 Cg_endo -72.38 109.63 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.327 2.018 . . . . 0.0 111.977 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.642 HD11 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -133.04 140.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.93 126.57 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.465 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.642 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.01 143.45 49.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.184 179.028 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.65 168.01 22.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.99 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.5 mmt180 -86.32 114.66 23.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.0 mp -97.43 127.27 43.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 110.465 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.1 tmt_? . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.743 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.8 pt-20 . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.3 p90 -142.28 138.18 31.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.98 0.895 . . . . 0.0 111.488 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -133.86 111.24 10.32 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.221 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.2 p-10 -64.21 114.97 4.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.018 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.545 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -114.18 176.72 4.92 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -145.76 142.46 28.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.68 144.3 37.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.063 -178.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.478 ' HB3' HD22 ' A' ' 95' ' ' ASN . 43.7 m-20 -81.35 111.66 17.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.696 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.618 HD12 ' CE1' ' A' ' 64' ' ' PHE . 3.7 mt -81.35 3.72 23.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.681 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.56 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 25.6 m-80 -63.47 -18.03 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.102 0.477 . . . . 0.0 109.773 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -61.87 -28.15 69.29 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.798 178.672 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.532 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.0 mt -78.09 124.55 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.167 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -114.99 163.29 15.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.359 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.8 t30 -111.99 119.99 40.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.579 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.3 t -113.57 95.03 3.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.727 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.8 25.54 15.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.56 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.97 23.38 7.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.391 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.28 137.54 50.03 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 122.458 -0.436 . . . . 0.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.0 mp -90.31 128.74 36.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.607 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.3 p -142.44 132.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -79.07 145.32 33.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.961 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.333 -179.075 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 p90 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.751 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.17 -25.61 61.72 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.823 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.28 -20.8 63.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.089 -179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 32.3 m -145.14 35.51 1.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.835 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.751 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.7 p -116.61 158.13 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.1 ptp180 -152.58 167.82 27.62 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.405 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 85.7 m-20 50.21 36.38 12.4 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.942 0.776 . . . . 0.0 111.566 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -78.07 113.7 16.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.04 148.89 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.015 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -82.59 147.68 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.836 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.3 m -132.12 163.05 29.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.07 4.5 5.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.615 0.572 . . . . 0.0 111.543 178.142 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.65 23.22 19.15 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 100.97 22.82 10.36 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.979 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.673 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.4 mtp180 -106.59 -18.28 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.671 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 67.7 m -132.37 128.03 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.927 0.394 . . . . 0.0 111.355 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 37' ' ' LEU . 42.9 tp -96.72 108.77 21.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.021 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.5 tmm_? -103.28 124.37 48.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.9 138.47 20.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.568 0.223 . . . . 0.0 110.628 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 5.9 mt-10 -97.82 108.87 21.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 6' ' ' SER . 2.2 p -119.13 141.43 48.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.086 0.469 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.6 143.46 44.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -85.15 -173.61 4.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.414 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.84 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.797 0.332 . . . . 0.0 111.449 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 111.231 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.65 3.38 34.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.78 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.1 m-80 -89.75 144.18 26.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.335 0.112 . . . . 0.0 110.819 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -72.79 128.85 36.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 0.0 111.533 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.11 119.63 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.352 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 m -75.09 106.5 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.607 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.0 m -110.74 144.01 40.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.204 0.526 . . . . 0.0 111.259 -178.209 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.6 mt-10 -133.39 134.97 44.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -132.32 118.1 19.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' THR . 42.6 m-20 -67.42 107.43 2.43 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.391 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 12' ' ' LEU . 46.9 mt -60.67 -42.46 97.11 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.598 0.713 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -63.8 -5.78 4.78 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.672 179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.36 -10.61 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.207 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.67 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -145.01 11.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.05 0.453 . . . . 0.0 112.07 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 131.16 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 157.16 20.76 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.42 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.0 t30 -111.1 109.97 20.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.179 0.514 . . . . 0.0 110.38 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -89.63 78.8 6.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.261 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 39.63 48.63 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.003 0.921 . . . . 0.0 113.109 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 103.45 36.07 3.41 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.851 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -162.26 120.19 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.498 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.3 m-85 -65.29 135.1 54.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -125.78 117.14 22.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.638 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.61 114.05 10.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 29.04 5.93 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.398 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.478 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.3 -51.6 1.13 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.687 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 28.9 tt0 72.56 143.53 0.06 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.049 0.54 . . . . 0.0 110.915 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 73.0 31.31 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.652 0.781 . . . . 0.0 111.501 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.3 p90 -77.56 -27.7 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.673 HG21 ' HG2' ' A' ' 17' ' ' ARG . 28.9 p -64.92 -22.53 67.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.826 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 58' ' ' THR . 3.9 pt-20 -73.86 -18.47 60.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.045 0.45 . . . . 0.0 110.087 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.9 p -123.34 15.46 9.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.194 0.521 . . . . 0.0 110.064 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.45 153.15 45.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.617 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -146.22 170.43 16.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.162 -179.942 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.3 t70 46.11 56.06 6.54 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.946 0.403 . . . . 0.0 110.436 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.551 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -85.03 106.38 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.274 0.559 . . . . 0.0 111.333 -177.976 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.63 118.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.902 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' HB2' HD22 ' A' ' 12' ' ' LEU . 8.5 t80 -92.82 127.53 38.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.0 110.924 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.41 86.31 38.77 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.424 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.672 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 14.6 Cg_endo -58.8 -38.3 89.42 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 123.414 2.743 . . . . 0.0 112.618 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.397 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.863 0.363 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.486 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 61.6 Cg_endo -73.61 108.38 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.776 2.318 . . . . 0.0 112.4 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.579 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.13 140.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.551 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.245 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.579 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.84 140.64 49.64 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.966 0.413 . . . . 0.0 109.898 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.64 169.11 25.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.1 mmt180 -85.87 114.56 22.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.763 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -99.65 121.4 41.17 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.296 0.57 . . . . 0.0 111.099 -178.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.022 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.788 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.2 pt-20 . . . . . 0 C--O 1.218 -0.605 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 44.4 p90 -138.47 140.7 39.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.682 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -137.79 120.64 16.43 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.421 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -64.05 112.93 3.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.482 0.658 . . . . 0.0 111.202 -179.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.763 ' HB2' HD22 ' A' ' 80' ' ' LEU . 26.5 mmt180 -114.93 172.6 6.95 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.309 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -140.74 151.44 44.48 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.511 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -136.1 142.05 39.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.398 0.618 . . . . 0.0 110.34 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.442 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 10.3 m120 -81.24 109.19 15.52 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.569 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.616 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.2 mt -79.62 0.75 28.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.952 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.486 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 m120 -62.82 -13.63 35.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 0.0 109.504 177.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -67.13 -24.38 65.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.046 178.697 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -83.11 125.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.147 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.62 159.37 24.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.6 t30 -102.87 117.95 35.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.46 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.51 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -111.97 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.824 0.345 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.54 21.64 12.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.27 25.87 5.91 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.53 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -132.66 139.68 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.094 0.447 . . . . 0.0 110.798 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 75.0 mt -87.12 116.31 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 110.534 178.853 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.6 p -125.6 130.42 72.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.865 0.364 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -86.71 143.66 27.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.292 179.844 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 p90 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -25.37 19.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.453 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.43 -34.41 57.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.578 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.4 m -136.04 36.03 2.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.348 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 67.6 m -116.05 157.1 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.336 0.589 . . . . 0.0 112.19 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.0 ptp180 -154.59 166.63 32.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 10.0 m120 51.92 38.18 22.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.648 0.593 . . . . 0.0 111.336 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -81.93 114.0 20.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.66 159.03 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.78 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.817 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -95.38 138.52 32.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.3 m -122.53 165.38 16.49 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.566 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 71.59 6.22 5.64 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.525 0.516 . . . . 0.0 111.484 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.06 21.4 23.11 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.535 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 99.75 24.27 10.11 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.786 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.1 mtp180 -107.29 -18.47 13.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.797 0.332 . . . . 0.0 110.486 -179.25 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 61.3 m -129.13 126.06 38.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.073 0.463 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' A' ' 97' ' ' ILE . 47.4 tp -94.42 107.62 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.274 178.594 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -101.69 124.5 47.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.873 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.26 140.4 22.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.586 0.232 . . . . 0.0 110.873 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' SER . 6.9 mt-10 -99.07 109.69 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -122.01 145.2 48.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.329 0.585 . . . . 0.0 111.209 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.4 144.43 40.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.401 179.109 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -89.05 -171.21 3.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.645 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.73 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.149 0.499 . . . . 0.0 111.234 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.47 -23.7 53.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.2 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.56 1.67 43.5 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.841 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.5 t-20 -85.2 145.34 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -77.07 126.56 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.895 0.379 . . . . 0.0 110.634 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.27 126.55 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.304 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.8 m -79.69 106.18 11.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.514 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.574 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 4.4 m -110.43 144.98 38.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.083 0.468 . . . . 0.0 111.446 -177.696 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 14.6 mt-10 -135.23 133.31 38.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.8 120.02 26.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -68.2 107.01 2.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.663 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.817 HD11 HD11 ' A' ' 12' ' ' LEU . 53.5 mt -61.69 -45.66 93.06 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.461 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.74 -5.53 2.83 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -102.05 -11.5 18.84 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.21 -179.611 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.464 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -143.89 11.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.002 0.429 . . . . 0.0 112.113 -179.57 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 132.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.75 159.99 21.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.75 -179.134 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.78 111.74 23.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.23 0.538 . . . . 0.0 109.732 179.164 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -105.93 87.53 2.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.373 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.08 57.93 6.11 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.624 0.578 . . . . 0.0 112.161 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.78 42.85 52.6 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.982 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -161.07 120.67 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.527 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 59.0 m-85 -62.66 142.17 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.81 115.95 15.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -70.09 116.11 10.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.232 0.539 . . . . 0.0 109.681 178.806 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.06 31.45 6.58 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.752 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.45 -51.6 1.11 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.084 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 25.0 tt0 70.75 143.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.016 0.526 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.634 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 92.0 m-20 76.36 29.19 0.73 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.526 0.73 . . . . 0.0 111.189 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -77.5 -32.15 54.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.753 0.311 . . . . 0.0 110.591 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.703 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.6 p -63.56 -26.67 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.6 pt-20 -70.74 -16.37 62.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.728 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.632 HG23 ' HG3' ' A' ' 57' ' ' GLU . 60.2 p -124.31 12.97 8.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.268 0.556 . . . . 0.0 110.351 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.97 152.8 43.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.188 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.71 173.7 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 11.3 t70 47.92 52.88 12.3 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.321 0.581 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.415 HG22 HD21 ' A' ' 76' ' ' LEU . 2.4 mt -85.93 110.25 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -123.1 120.5 33.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.232 178.928 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.623 ' HB2' HD22 ' A' ' 12' ' ' LEU . 10.0 t80 -91.58 128.47 37.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.78 -178.676 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -120.18 87.7 40.11 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.027 178.737 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 10.3 Cg_endo -56.29 -32.66 88.81 Favored 'Trans proline' 0 CA--C 1.505 -0.959 0 C-N-CA 124.086 3.191 . . . . 0.0 113.752 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.949 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.469 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 67.4 Cg_endo -74.84 108.66 2.76 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.65 2.233 . . . . 0.0 112.468 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.708 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.64 141.09 41.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.384 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -112.69 125.85 54.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.243 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.708 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.1 139.75 52.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.078 0.466 . . . . 0.0 110.302 178.828 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.72 168.34 27.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.13 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.708 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.3 mmt85 -85.29 116.0 23.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.608 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -101.1 133.43 45.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 93.2 m-85 -137.04 137.2 39.12 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.002 0.906 . . . . 0.0 111.672 -178.64 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -139.72 119.8 13.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.597 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 p-10 -66.11 114.05 4.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.593 ' HB2' HD22 ' A' ' 80' ' ' LEU . 35.6 mmt180 -114.44 172.31 7.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HB2' HD13 ' A' ' 75' ' ' ILE . 10.0 p-10 -137.02 149.07 47.23 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.837 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.527 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -134.5 146.46 30.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.306 0.574 . . . . 0.0 110.891 -179.612 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -82.12 109.71 16.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.454 -179.48 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.619 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.7 mt -80.05 2.46 23.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.932 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.469 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 13.6 m120 -63.45 -12.08 28.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.428 0.632 . . . . 0.0 109.842 178.004 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.606 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.7 -21.53 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.657 178.658 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.7 mt -85.98 124.29 40.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.315 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -120.05 167.09 12.55 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.432 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.82 122.07 46.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.4 t -112.4 93.89 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.22 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.4 t30 58.29 25.65 12.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.064 179.269 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.5 18.78 8.77 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.849 178.08 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.443 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 16.9 ptp180 -130.78 136.46 48.74 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.314 -0.521 . . . . 0.0 110.42 179.258 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 69.8 mt -83.19 126.22 32.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -134.82 128.1 49.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.179 0.514 . . . . 0.0 111.265 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.83 146.06 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.811 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 107' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 24.4 mm-40 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.353 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.03 -23.73 21.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.798 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.62 -30.39 68.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.866 179.442 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.4 m -133.57 32.49 3.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 66.4 m -121.33 156.62 32.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 112.248 -179.05 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -154.86 170.74 20.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.504 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 81.7 m-20 55.01 32.33 17.93 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.622 0.576 . . . . 0.0 110.918 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.23 113.76 15.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -142.5 151.76 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.35 135.43 33.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.129 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.8 m -121.8 167.14 13.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.892 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.7 t-20 70.15 6.87 5.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.993 0.517 . . . . 0.0 111.589 178.446 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 22.82 24.76 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 100.45 16.77 26.09 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.584 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.627 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.1 mtp180 -102.51 -15.51 16.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.677 0.275 . . . . 0.0 110.377 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 25.0 m -130.86 129.46 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.824 0.345 . . . . 0.0 111.714 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.3 tp -100.7 107.94 19.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.652 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.9 tmm_? -105.17 123.37 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -149.14 146.88 27.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.7 mt-10 -103.3 109.55 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' SER . 6.5 p -115.13 140.84 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.339 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -74.72 143.2 44.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.341 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.45 ' HB3' HG21 ' A' ' 31' ' ' VAL . 24.4 p-10 -85.94 -177.16 6.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.661 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.64 -15.92 61.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -86.33 -24.34 25.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.42 7.21 30.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.541 -179.533 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 14.5 t-20 -97.27 147.33 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.479 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 51.9 m0 -78.06 128.84 34.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.962 0.411 . . . . 0.0 110.584 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 25' ' ' ASN . 6.5 t -123.58 128.64 74.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.45 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 m -82.32 110.38 17.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.846 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.1 t -111.57 148.72 32.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.545 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -135.43 132.12 37.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.679 HD11 HG12 ' A' ' 40' ' ' ILE . 13.7 tp -133.88 116.71 15.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.44 178.168 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 39' ' ' THR . 19.3 m-20 -68.01 107.77 2.82 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.649 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 12' ' ' LEU . 53.7 mt -57.54 -45.21 85.34 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.475 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.94 -5.04 2.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.973 -179.42 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -103.09 -10.76 18.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.819 -179.846 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.679 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.97 12.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.867 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -128.29 131.68 68.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -127.41 159.31 21.38 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 -178.767 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -112.49 108.15 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 19.4 t-20 -101.16 79.91 2.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.855 0.36 . . . . 0.0 110.131 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 53.15 57.74 5.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.19 36.45 35.02 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.739 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 61.7 m-70 -147.89 111.88 5.14 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.027 0.131 . . . . 0.0 110.82 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.489 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.6 m-85 -60.96 132.01 52.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.864 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -124.78 117.44 24.18 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.161 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -72.76 114.7 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.54 26.78 7.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.106 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.26 -52.48 1.46 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.602 -179.136 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.3 tt0 75.12 145.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.377 0.671 . . . . 0.0 110.884 -178.806 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.9 m-20 72.92 29.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.406 0.683 . . . . 0.0 111.939 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -77.04 -27.57 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.9 p -66.95 -28.11 68.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -178.839 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.609 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.6 pt-20 -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.609 HG23 ' HG3' ' A' ' 57' ' ' GLU . 69.9 p -121.79 13.74 10.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -122.84 151.89 41.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.903 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.52 167.9 21.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.488 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 1.6 t70 49.39 51.98 15.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.101 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.58 110.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.262 0.553 . . . . 0.0 111.384 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.451 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -127.48 122.18 32.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.643 179.534 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.4 t80 -91.97 131.84 36.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.358 0.599 . . . . 0.0 111.483 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -121.84 87.65 46.78 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.908 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.8 Cg_endo -58.61 -35.21 98.97 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.748 2.965 . . . . 0.0 113.872 -178.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.835 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.169 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 73' ' ' GLN . 5.9 tp60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.2 Cg_endo -72.91 106.64 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.32 2.013 . . . . 0.0 112.044 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.769 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -136.14 141.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -111.64 127.99 55.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.202 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.769 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.84 143.72 49.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.21 166.57 25.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.839 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 5.4 mmt180 -85.63 115.06 23.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.601 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -99.15 124.68 44.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 111.596 -178.544 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.94 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -144.13 132.39 21.89 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.46 111.45 7.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.702 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.6 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.6 p-10 -64.42 114.08 4.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.585 ' HB2' HD22 ' A' ' 80' ' ' LEU . 39.2 mmt180 -115.67 177.39 4.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.08 178.461 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' HB2' HD13 ' A' ' 75' ' ' ILE . 3.6 p30 -143.37 148.76 36.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.597 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -132.07 145.56 34.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.325 0.583 . . . . 0.0 110.746 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.487 ' HB3' HD22 ' A' ' 95' ' ' ASN . 86.6 m-20 -83.66 109.25 17.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.608 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.9 mt -78.06 1.78 19.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.441 -179.18 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.487 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.3 m-80 -65.6 -8.73 21.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.073 0.463 . . . . 0.0 110.04 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.415 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -72.72 -20.22 61.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.252 178.345 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.6 mt -84.64 122.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.384 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.2 t30 -105.15 119.32 38.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.112 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.02 93.87 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.394 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.25 25.77 14.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.565 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.5 8.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.482 178.399 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 11.8 ptp180 -130.05 138.64 50.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.14 0.47 . . . . 0.0 110.815 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.3 mt -85.92 114.26 22.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.79 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 103' ' ' ARG . 40.0 t -123.0 123.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.546 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -79.37 145.65 33.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.167 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.695 0.622 . . . . 0.0 111.829 179.454 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.748 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -19.2 44.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.329 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.78 -27.65 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.106 0.479 . . . . 0.0 110.721 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -143.86 39.57 1.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.9 p -115.69 155.36 27.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.72 -178.783 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.47 HH12 ' HB3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -151.6 164.77 36.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.799 179.444 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 52.85 35.29 18.53 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.715 0.634 . . . . 0.0 111.239 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -76.65 114.34 15.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.56 154.37 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.85 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.7 tp -91.08 141.15 29.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.47 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.4 m -126.25 162.73 24.78 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.2 t-20 72.5 9.39 5.73 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.688 0.618 . . . . 0.0 111.121 178.082 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.68 21.2 34.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.308 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 103.16 20.43 11.23 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.245 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.627 ' HG2' HG21 ' A' ' 56' ' ' THR . 21.5 mtp180 -103.75 -18.97 14.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.864 0.364 . . . . 0.0 110.42 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 49.3 m -129.45 128.44 42.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 112.114 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.502 ' HB2' HD21 ' A' ' 37' ' ' LEU . 50.6 tp -97.79 110.19 22.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.55 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.1 tmm_? -114.37 124.69 52.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 -178.899 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.59 162.65 40.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.926 0.393 . . . . 0.0 111.053 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.8 mt-10 -110.47 114.61 28.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' SER . 30.3 t -131.53 142.74 50.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.732 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 145.32 49.28 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.24 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.59 ' HB3' HG21 ' A' ' 31' ' ' VAL . 32.4 p-10 -85.92 -167.48 1.87 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.677 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 101' ' ' ASN . . . -63.41 -34.95 78.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.711 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.8 -23.73 61.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.883 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 10.03 35.43 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.0 t30 -91.0 145.35 24.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' TRP . . . . . 0.47 ' HB3' HH12 ' A' ' 8' ' ' ARG . 33.9 m0 -73.17 122.92 22.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.047 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.9 t -126.1 143.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.7 m -99.76 111.28 23.62 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.204 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.3 143.97 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.204 0.526 . . . . 0.0 111.816 -178.461 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.6 mt-10 -130.37 133.33 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.348 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -131.07 117.74 19.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.176 178.779 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.674 ' O ' HG22 ' A' ' 39' ' ' THR . 29.9 m-20 -69.0 109.78 4.13 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.81 178.912 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 12' ' ' LEU . 40.2 mt -60.61 -40.0 90.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.82 0.819 . . . . 0.0 109.927 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -63.16 -5.35 3.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.78 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.45 -12.53 15.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.478 -179.332 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.624 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.36 12.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.8 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.59 159.48 22.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.361 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.14 111.86 23.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.085 0.469 . . . . 0.0 109.827 179.084 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -104.48 87.97 2.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.9 t70 49.3 59.24 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.046 178.744 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.66 40.96 36.51 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.601 179.016 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.455 ' N ' HD23 ' A' ' 80' ' ' LEU . 44.2 t-80 -159.22 127.14 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.862 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 52.6 m-85 -68.0 139.41 56.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -132.11 116.38 16.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.427 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -70.5 115.12 9.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.109 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 28.23 6.77 Favored Glycine 0 C--N 1.32 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.462 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.19 -50.37 1.46 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.513 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 9.7 tt0 73.92 143.46 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.208 0.603 . . . . 0.0 111.727 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.625 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 95.8 m-20 65.64 38.66 5.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.597 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.29 -30.0 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.608 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 17' ' ' ARG . 74.3 p -62.91 -23.05 67.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.75 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 58' ' ' THR . 8.0 pt-20 -72.3 -14.98 61.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.276 0.56 . . . . 0.0 110.031 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 57' ' ' GLU . 68.0 p -126.19 7.02 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.119 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.9 144.76 49.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.33 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -138.27 172.32 13.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.053 -179.317 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.6 t70 48.15 50.96 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.071 0.462 . . . . 0.0 110.125 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.533 ' C ' ' HE ' ' A' ' 63' ' ' ARG . 2.8 mt -83.11 105.8 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.192 0.52 . . . . 0.0 110.691 -178.584 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -112.23 118.63 35.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.313 -179.848 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.627 ' CE1' HD12 ' A' ' 94' ' ' LEU . 6.2 t80 -93.04 124.69 37.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.863 0.363 . . . . 0.0 110.709 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -118.44 88.99 35.28 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.2 Cg_endo -57.65 -35.13 98.91 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 123.934 3.089 . . . . 0.0 113.538 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.73 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.766 0.317 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.534 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 58.7 Cg_endo -74.39 108.16 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.368 2.046 . . . . 0.0 111.897 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.604 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -131.7 141.53 45.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.46 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 62' ' ' ILE . 2.0 tm? -112.73 123.43 50.29 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.271 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.604 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -119.85 138.16 53.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -155.9 166.39 33.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.397 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.5 mmt180 -85.83 114.5 22.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.5 mp -99.42 129.22 45.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.056 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.76 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.5 pt-20 . . . . . 0 C--O 1.22 -0.499 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 52.8 p90 -134.61 139.36 45.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.655 0.741 . . . . 0.0 111.577 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -139.18 119.19 13.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.348 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -66.45 116.81 7.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.576 0.703 . . . . 0.0 112.557 -178.131 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD22 ' A' ' 80' ' ' LEU . 24.2 mmt180 -116.9 172.61 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.162 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -141.56 147.22 37.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.1 p -134.0 151.34 32.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.212 0.529 . . . . 0.0 111.126 -178.541 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -83.34 112.5 19.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.887 -179.334 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.627 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.3 mt -82.33 3.44 27.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.916 0.389 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.534 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 m120 -65.2 -16.78 63.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.52 67.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.127 179.351 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.9 mt -82.69 126.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.22 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 49.6 tt0 -120.29 162.94 18.58 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -106.55 119.96 40.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.023 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.7 t -109.67 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.481 179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.423 ' HA ' ' H ' ' A' ' 26' ' ' ALA . 63.4 t30 60.06 21.69 10.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.026 179.044 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.44 17.57 7.04 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.995 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.29 146.05 51.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.084 0.442 . . . . 0.0 110.856 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 73.4 mt -89.5 119.04 29.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.102 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 57.7 t -121.22 123.4 69.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.624 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.12 145.14 32.53 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.469 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.333 179.88 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 121.059 0.457 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.26 -26.13 37.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.896 -178.356 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.56 -32.09 64.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.0 m -132.76 32.94 3.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 62.0 m -115.08 152.76 31.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 111.515 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -145.78 163.93 33.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.022 -179.312 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.454 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 9.9 m120 52.66 33.28 13.43 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.727 0.642 . . . . 0.0 111.761 179.14 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -74.89 114.01 12.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.4 t -141.56 152.36 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.057 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -87.41 140.71 29.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.433 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 12.2 m -126.48 163.7 22.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.034 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.7 t-20 73.23 5.69 5.11 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.687 0.617 . . . . 0.0 111.368 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.85 23.4 15.51 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.52 21.63 16.41 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.942 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.699 ' HG2' HG21 ' A' ' 56' ' ' THR . 29.8 mtp180 -104.12 -19.1 14.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.652 0.263 . . . . 0.0 110.811 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.7 m -129.26 126.94 40.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.955 0.407 . . . . 0.0 111.703 -178.91 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.504 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.8 tp -94.68 105.67 17.62 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.014 178.176 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' NH2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 tmm_? -101.97 123.68 46.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -147.32 144.13 28.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 111.137 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 32' ' ' THR . 3.9 mt-10 -105.17 113.02 26.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 45.4 t -127.17 147.63 50.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.199 0.523 . . . . 0.0 111.674 -178.526 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.72 145.67 40.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.426 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.48 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.7 p30 -93.05 -173.43 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.521 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -34.38 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 112.204 -178.838 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.26 -20.29 61.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.659 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 4.16 54.67 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.926 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 t-20 -87.59 143.69 27.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -73.86 122.23 22.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 25' ' ' ASN . 8.2 t -120.52 146.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.616 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 22' ' ' GLU . 37.0 m -114.86 110.15 19.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.899 0.38 . . . . 0.0 110.191 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -118.29 164.18 15.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 112.102 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.5 mt-10 -136.69 140.04 42.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.229 -179.389 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.426 HD21 HG12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -132.01 113.88 13.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.291 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 39' ' ' THR . 26.8 m-20 -66.65 108.65 2.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 12' ' ' LEU . 54.1 mt -59.92 -47.39 85.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.212 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -64.2 -4.54 3.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.928 -179.447 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.14 -14.72 20.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.908 179.731 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.96 13.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 3.0 mt -126.4 131.42 71.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.15 160.1 19.75 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.837 -178.627 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.36 104.41 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -92.77 75.48 4.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.791 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 48.93 65.8 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.023 178.503 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.5 34.79 34.72 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.778 178.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -159.33 120.61 3.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 61.9 m-85 -63.25 143.54 57.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 111.271 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -133.82 117.4 16.81 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -72.7 114.58 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 40.58 3.08 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.98 -49.23 0.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.281 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.2 tt0 71.52 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.328 0.651 . . . . 0.0 111.582 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.683 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 91.5 m-20 71.06 35.19 1.68 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.523 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.79 -32.08 40.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.699 HG21 ' HG2' ' A' ' 17' ' ' ARG . 23.8 p -63.47 -30.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.523 -179.159 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 20.2 pt-20 -67.19 -17.0 64.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.075 0.464 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.547 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.7 p -122.56 12.71 10.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.69 149.95 48.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.47 169.09 18.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 49.05 57.93 5.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.471 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -88.06 111.59 22.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.371 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -116.66 118.83 33.66 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.882 179.624 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.8 t80 -92.77 128.06 38.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 178.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 4.0 t-160 -117.19 84.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 19.5 Cg_endo -58.95 -44.9 31.71 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.613 2.875 . . . . 0.0 114.488 -177.609 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.845 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.3 Cg_endo -75.25 111.46 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.447 2.098 . . . . 0.0 111.766 178.644 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.492 HD11 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -132.48 140.47 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.06 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -113.65 121.15 43.28 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.243 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.85 140.12 50.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.904 0.383 . . . . 0.0 110.201 179.261 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.83 169.36 23.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.6 mmt180 -85.12 115.15 22.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.2 mp -100.9 130.82 46.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 -178.658 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.02 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.6 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 45.6 p90 -134.58 141.25 46.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.808 0.813 . . . . 0.0 111.725 -179.024 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -140.18 112.71 7.92 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -68.28 115.49 7.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.376 0.608 . . . . 0.0 111.169 -179.064 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.9 mmt180 -116.16 177.28 4.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.414 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -140.32 148.73 41.81 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.539 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.8 p -132.74 148.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.549 -179.473 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.544 ' HB3' HD22 ' A' ' 95' ' ' ASN . 4.6 m-20 -86.11 109.01 18.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.995 -179.064 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.673 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.2 mt -78.98 4.04 15.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' A' ' 93' ' ' ASN . 15.4 m-80 -64.63 -12.58 47.31 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.043 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -69.7 -16.69 63.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.183 179.096 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.8 mt -88.28 122.59 40.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.618 0.723 . . . . 0.0 111.362 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -110.71 166.42 11.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.592 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.7 t30 -114.94 115.71 27.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.566 178.846 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 56.2 t -112.69 101.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.36 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' HB2' ' A' ' 25' ' ' ASN . 4.6 t30 60.33 21.68 11.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.006 179.422 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.58 11.27 27.32 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.597 178.336 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.4 ptp180 -118.16 141.48 48.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 0.0 110.506 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 21' ' ' ALA . 79.1 mt -89.63 126.45 35.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.769 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.8 p -134.41 134.67 54.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.248 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -88.79 144.86 25.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.815 0.697 . . . . 0.0 111.506 178.885 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 121.032 0.444 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.669 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.61 -24.07 45.28 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.384 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.54 -31.67 64.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.4 m -144.85 42.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.669 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.3 p -115.54 149.4 38.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.022 0.439 . . . . 0.0 111.253 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.15 166.19 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' ASN . . . . . 0.415 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.1 m-20 52.05 33.25 11.65 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.677 0.61 . . . . 0.0 111.734 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.05 114.54 15.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.086 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.18 155.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.891 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -91.66 143.31 26.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.0 110.135 179.394 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.9 m -129.67 165.23 22.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.765 -179.243 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.1 t-20 72.06 9.82 6.05 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.512 0.507 . . . . 0.0 110.947 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 8.8 57.99 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 112.36 25.75 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.099 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.693 ' HG2' HG21 ' A' ' 56' ' ' THR . 21.6 mtp180 -108.45 -18.56 13.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 0.0 110.521 -178.903 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 46.7 m -127.68 126.57 42.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -178.832 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.476 ' CD2' HD13 ' A' ' 97' ' ' ILE . 45.6 tp -98.01 108.84 21.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.158 178.396 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -104.14 122.52 45.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -146.89 137.61 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.743 0.306 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.6 mt-10 -98.25 110.84 23.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.761 0.315 . . . . 0.0 110.285 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' SER . 49.6 t -125.83 147.88 49.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.853 0.359 . . . . 0.0 110.814 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.2 145.72 43.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.274 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -85.58 -168.56 2.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.724 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -32.99 74.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.163 0.506 . . . . 0.0 111.289 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.31 -24.31 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.32 4.25 40.88 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.398 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 m-80 -83.78 139.06 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.262 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.8 m0 -72.51 121.95 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.984 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.0 t -123.26 150.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -99.32 109.63 22.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.613 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.5 m -109.38 139.44 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.256 0.55 . . . . 0.0 111.43 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.0 mt-10 -130.39 131.79 45.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.041 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.542 HD11 HG12 ' A' ' 40' ' ' ILE . 13.3 tp -131.96 124.01 28.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 178.603 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 39' ' ' THR . 39.0 m-20 -72.25 108.64 5.5 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.123 179.179 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 12' ' ' LEU . 34.8 mt -61.1 -41.24 96.31 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.618 0.723 . . . . 0.0 109.718 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.36 -5.91 4.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.471 179.639 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -103.91 -12.05 17.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.401 -179.231 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.542 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.0 12.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.536 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.53 132.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.456 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.34 157.32 21.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.567 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 8.9 t30 -110.88 110.31 20.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.102 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -103.17 87.05 2.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 48.34 54.8 9.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.551 179.201 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.67 41.99 12.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.997 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' HIS . . . . . 0.417 ' N ' HD23 ' A' ' 80' ' ' LEU . 80.4 t60 -158.72 118.26 3.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 53.3 m-85 -64.56 137.29 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.78 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -131.26 115.83 16.82 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.281 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -69.13 116.08 9.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.439 178.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.7 33.28 5.37 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.168 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -104.1 -52.66 0.88 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.15 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 35.4 tt0 73.65 142.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 111.213 -179.254 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.557 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.2 m-20 71.92 34.99 1.41 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 111.602 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.4 p90 -78.84 -27.91 44.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.693 HG21 ' HG2' ' A' ' 17' ' ' ARG . 62.1 p -66.31 -24.0 66.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.615 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.668 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.3 pt-20 -74.91 -11.27 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.668 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -129.29 14.97 6.16 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.443 0.639 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.4 153.48 47.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.639 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.33 171.57 14.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.204 -179.673 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.612 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 12.7 t70 46.51 55.11 7.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.401 0.438 . . . . 0.0 110.541 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.514 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -84.72 107.35 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.261 0.553 . . . . 0.0 111.664 -178.026 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.557 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -114.34 118.2 33.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.23 179.728 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.641 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.1 t80 -92.99 128.76 38.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 111.302 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -120.49 87.86 41.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.744 177.794 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -58.86 -35.73 98.13 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.678 2.919 . . . . 0.0 112.693 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.65 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.437 178.995 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 66.2 Cg_endo -75.46 108.74 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.82 2.347 . . . . 0.0 112.032 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.654 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.8 141.19 43.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.254 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -112.59 123.87 51.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.395 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.654 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.28 139.21 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.26 166.63 32.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.426 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.639 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.0 mmt85 -85.9 115.04 23.28 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.309 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.655 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.8 mp -98.73 126.48 44.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.248 -178.732 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.067 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 8.4 pt-20 . . . . . 0 C--O 1.221 -0.444 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -146.78 132.3 18.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 0.0 110.623 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -133.68 119.61 19.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.024 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.8 p-10 -65.65 112.02 3.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 111.454 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' ARG . . . . . 0.655 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -115.08 171.29 7.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.188 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -141.42 147.01 37.27 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.17 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.7 p -132.82 147.95 31.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.902 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.523 ' HB3' HD22 ' A' ' 95' ' ' ASN . 41.6 m-80 -83.2 111.94 19.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.641 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.35 3.3 21.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.171 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.523 HD22 ' HB3' ' A' ' 93' ' ' ASN . 31.3 m-80 -63.23 -16.5 60.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.089 0.471 . . . . 0.0 109.863 178.514 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.84 -28.68 70.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.553 0.692 . . . . 0.0 109.978 178.76 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.5 mt -76.44 123.65 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.212 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -116.06 164.02 15.07 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -111.31 118.26 35.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.133 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.9 t -109.85 94.44 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.19 25.16 13.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.045 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.13 17.22 9.67 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.887 177.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.1 ptp180 -130.37 135.99 48.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.133 0.467 . . . . 0.0 110.612 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.613 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 71.1 mt -84.48 125.04 32.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -133.66 132.32 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.21 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.41 144.82 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.371 179.015 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.563 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 12.9 m -158.3 179.84 8.78 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -64.9 -33.34 75.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.709 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.85 -27.87 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.675 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -33.29 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.3 m -134.94 37.32 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.709 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 69.6 p -119.43 152.37 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.492 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.2 ptp180 -151.42 168.93 23.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.6 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.0 t30 56.2 30.87 17.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.662 0.744 . . . . 0.0 110.135 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.34 113.52 16.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.178 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.96 146.47 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.4 tp -82.37 141.98 32.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -131.9 165.93 22.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.986 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.7 OUTLIER 71.42 7.17 5.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.574 . . . . 0.0 111.584 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.4 9.9 Favored Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 91.75 18.66 43.49 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.946 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.3 mtp180 -103.43 -16.92 15.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.729 0.3 . . . . 0.0 110.3 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -128.58 129.39 45.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' CD2' HD13 ' A' ' 97' ' ' ILE . 52.8 tp -100.71 104.98 16.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.358 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.4 tmm_? -104.35 124.73 49.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.414 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.92 153.25 32.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 32.7 mt-10 -103.4 110.34 22.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.6 p -119.74 139.6 52.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.087 0.47 . . . . 0.0 111.415 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.49 144.11 44.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.222 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -89.25 -171.57 3.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.279 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.2 -21.53 65.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.64 -19.0 29.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.285 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.11 0.62 41.46 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 66.1 m-20 -80.83 136.3 36.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.447 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 49.5 m0 -77.98 119.48 21.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.005 0.431 . . . . 0.0 110.077 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.32 132.31 65.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -83.08 107.89 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.678 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 21.0 m -110.89 146.1 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.551 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.8 mt-10 -133.15 130.68 39.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.392 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.583 HD11 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -123.04 120.09 32.27 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.246 0.546 . . . . 0.0 110.101 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 39' ' ' THR . 9.3 m-20 -69.32 106.23 2.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.623 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 12' ' ' LEU . 21.2 mt -62.71 -40.23 96.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.929 0.871 . . . . 0.0 109.75 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.6 p-10 -64.27 -5.04 4.33 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.639 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.58 -16.14 16.18 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.556 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.583 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.08 14.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.29 130.75 70.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.97 157.54 21.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.335 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.3 t30 -111.97 113.94 26.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.044 0.45 . . . . 0.0 110.527 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -101.51 81.44 2.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.639 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.0 m-20 49.93 47.92 22.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.384 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 90.64 39.09 5.98 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.863 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -158.09 113.57 2.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 58.0 m-85 -60.27 136.64 58.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 0.0 111.007 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -127.22 114.49 17.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.168 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -71.22 114.53 9.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.8 28.64 6.89 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.705 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -98.5 -52.08 1.36 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.927 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 25.6 tt0 72.85 141.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.134 0.573 . . . . 0.0 111.213 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.655 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 94.6 m-20 70.48 37.87 1.43 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.544 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.7 p90 -81.4 -27.26 34.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.691 HG21 ' HG2' ' A' ' 17' ' ' ARG . 11.9 p -65.16 -19.54 66.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.699 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HG3' HG23 ' A' ' 58' ' ' THR . 8.3 pt-20 -77.32 -14.82 59.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.197 0.522 . . . . 0.0 110.136 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -125.89 12.89 7.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.664 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.27 145.71 47.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.554 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -139.3 169.22 18.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.476 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.2 t70 47.39 54.57 9.39 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.353 0.408 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.34 114.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 112.153 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -128.45 121.97 30.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.124 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.4 t80 -92.04 134.73 34.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 3.3 t-160 -123.22 85.44 51.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 25.8 Cg_endo -62.22 -45.13 16.39 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 123.622 2.882 . . . . 0.0 113.89 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -121.95 81.57 1.84 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.9 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.498 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 3.3 tt0 -65.21 111.78 3.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.404 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.11 -142.03 8.14 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 124.493 1.121 . . . . 0.0 113.94 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -6.88 58.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.082 0.468 . . . . 0.0 110.651 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.78 -20.21 33.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.63 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.92 42.5 24.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.564 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -98.57 120.72 58.5 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.016 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 64.2 Cg_endo -74.04 106.58 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.465 2.11 . . . . 0.0 111.678 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.494 HD11 HH21 ' A' ' 77' ' ' ARG . 0.8 OUTLIER -132.35 140.92 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.975 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -114.15 124.02 51.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.148 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.494 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.08 142.71 48.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 110.434 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.56 167.66 26.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.709 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.71 115.13 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.0 mp -97.87 121.44 39.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.462 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.549 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.07 174.26 6.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.5 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 71.7 m -61.36 -24.56 66.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -73.11 -29.15 62.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.56 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 34.38 2.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.256 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.635 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 11.1 pt-20 -112.08 -168.18 1.28 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -147.73 134.59 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.465 0.65 . . . . 0.0 111.492 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.72 118.82 11.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.052 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 p-10 -64.37 114.73 4.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.469 0.652 . . . . 0.0 111.659 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.695 ' HB2' HD22 ' A' ' 80' ' ' LEU . 30.0 mmt180 -115.84 174.21 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -144.04 144.93 31.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -129.45 145.66 35.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.393 0.616 . . . . 0.0 111.082 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.495 ' HB3' HD22 ' A' ' 95' ' ' ASN . 5.1 m-20 -81.57 107.17 14.11 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.61 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.702 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.3 mt -78.75 4.2 14.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.355 . . . . 0.0 110.995 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.34 -18.99 64.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 109.814 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.73 -24.46 67.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.003 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.7 mt -81.28 124.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.563 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 70.4 mt-30 -121.0 167.5 12.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.946 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.0 t30 -109.71 121.26 44.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.8 t -112.77 94.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.24 22.98 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.827 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.26 22.15 6.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.082 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 14.9 ptp180 -132.39 143.01 49.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.374 0.587 . . . . 0.0 111.15 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.678 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 67.3 mt -92.22 122.69 34.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.25 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.9 p -138.91 135.86 42.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -82.29 146.27 29.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.198 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.258 -179.799 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 16.6 tpp . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.429 ' H ' ' HG3' ' A' ' 1' ' ' MET . 17.5 m -132.83 174.86 9.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -56.16 -37.97 70.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.203 0.314 . . . . 0.0 110.635 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.2 -25.72 24.42 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.507 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 4.1 t70 -56.91 -33.76 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.24 0.543 . . . . 0.0 110.676 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 22.5 m -130.04 30.51 4.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.367 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 68.7 m -115.99 154.76 29.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 0.0 112.103 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -155.45 171.76 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.322 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.574 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.6 t-20 55.38 31.12 16.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.559 0.537 . . . . 0.0 110.694 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.51 113.86 16.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.425 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.48 151.34 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.825 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -90.78 134.52 34.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.529 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.2 m -120.69 164.39 16.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.63 5.07 4.87 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.69 0.619 . . . . 0.0 111.342 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.94 13.89 41.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 109.68 20.68 7.56 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.64 ' HG2' HG21 ' A' ' 56' ' ' THR . 22.5 mtp180 -104.27 -21.34 13.54 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.529 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 8.9 m -123.75 131.14 53.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.066 0.46 . . . . 0.0 111.723 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -103.62 105.51 15.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.263 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.6 tmm_? -103.81 124.35 48.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.219 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -147.27 150.25 34.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.801 0.334 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 11.4 mt-10 -107.35 112.41 25.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.7 t -125.67 147.9 49.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.232 0.539 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.89 145.17 40.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 178.868 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 31' ' ' VAL . 31.5 p-10 -87.8 -171.38 3.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.07 68.32 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.45 -24.55 50.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.431 . . . . 0.0 110.923 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.89 11.51 32.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.2 t30 -94.77 146.12 24.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -72.87 125.64 28.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.654 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.0 t -129.33 126.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -81.49 122.94 28.17 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.816 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 1.4 t -125.21 151.33 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.688 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.507 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.02 136.46 40.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.517 HD11 HG12 ' A' ' 40' ' ' ILE . 13.1 tp -130.63 126.11 35.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 39' ' ' THR . 5.5 m-20 -72.33 107.02 4.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 12' ' ' LEU . 47.7 mt -63.61 -41.4 98.31 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.874 0.845 . . . . 0.0 108.97 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -62.59 -4.77 2.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.527 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -104.54 -15.76 15.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.55 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.567 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -140.54 13.25 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.26 130.78 70.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.42 160.52 22.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.298 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -111.81 116.83 31.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 110.173 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -102.93 84.12 2.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.916 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 83' ' ' CYS . 3.5 p30 46.01 43.15 10.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.322 1.049 . . . . 0.0 112.953 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 98.82 37.13 4.28 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.911 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -157.3 117.06 3.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -60.85 136.51 58.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -129.29 114.26 16.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -67.84 115.32 7.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 39.71 3.52 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.993 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -109.83 -55.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.591 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.0 tt0 76.02 138.48 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.564 0.746 . . . . 0.0 111.875 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.4 t30 68.29 40.17 2.14 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.93 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 11.2 p90 -76.19 -30.37 58.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.758 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.64 HG21 ' HG2' ' A' ' 17' ' ' ARG . 42.5 p -61.85 -21.45 64.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.018 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.75 ' HG3' HG23 ' A' ' 58' ' ' THR . 1.1 pt-20 -72.16 -15.68 61.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.336 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.75 HG23 ' HG3' ' A' ' 57' ' ' GLU . 60.7 p -125.42 2.79 7.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -115.92 149.31 38.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.24 172.43 12.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.28 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.56 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 48.78 52.31 14.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.068 0.461 . . . . 0.0 110.202 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 76' ' ' LEU . 2.2 mt -86.44 109.18 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.45 0.643 . . . . 0.0 111.754 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.9 122.96 39.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.62 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.644 ' CE1' HD12 ' A' ' 94' ' ' LEU . 10.2 t80 -91.6 135.11 34.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.736 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.6 t-80 -123.66 87.07 52.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.083 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 9.4 Cg_endo -58.13 -38.27 92.11 Favored 'Trans proline' 0 CA--C 1.514 -0.515 0 C-N-CA 123.725 2.95 . . . . 0.0 114.836 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.745 ' HD3' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.2 85.13 2.36 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.03 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -67.2 116.4 7.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.329 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.26 -148.89 8.13 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 124.305 1.003 . . . . 0.0 113.239 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.77 -2.72 55.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.455 0.645 . . . . 0.0 109.57 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.42 -22.51 51.43 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.831 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 57.22 42.5 25.29 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 124.104 0.877 . . . . 0.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -102.12 119.49 56.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.9 Cg_endo -72.89 109.68 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.52 2.146 . . . . 0.0 112.017 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.678 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 141.1 43.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.357 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -112.68 127.23 56.06 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.976 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.678 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.91 141.81 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.965 0.412 . . . . 0.0 109.904 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.09 169.42 23.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.06 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.56 ' HG2' ' CB ' ' A' ' 61' ' ' ASP . 4.2 mmt180 -85.97 115.19 23.43 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.0 mp -101.86 134.64 44.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.09 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.2 135.72 39.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.79 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 3.9 m-20 -90.96 172.27 8.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.756 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 45' ' ' ASP . 29.9 t -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.22 0.533 . . . . 0.0 110.743 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -72.32 -26.35 61.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.035 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.68 40.07 2.81 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.1 pt-20 -125.98 -165.45 1.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -140.66 136.08 32.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.946 0.879 . . . . 0.0 111.725 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -139.8 125.54 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.102 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 3.7 p-10 -67.53 114.59 6.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 112.078 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 29.3 mmt180 -115.34 173.31 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.91 147.85 37.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 9.8 p -133.12 146.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.021 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.588 ' HB3' HD22 ' A' ' 95' ' ' ASN . 75.3 m-20 -82.91 110.58 18.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.728 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.644 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -79.28 3.95 16.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.588 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.3 m-80 -63.19 -14.36 48.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.053 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -24.93 67.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -79.22 126.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.836 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -118.91 160.56 21.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.932 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.27 120.95 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 52.9 t -112.48 93.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.38 25.73 13.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.84 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.96 14.86 15.95 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.646 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 14.4 ptp180 -124.17 134.57 53.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.347 . . . . 0.0 110.212 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.816 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 79.3 mt -85.17 120.31 26.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.4 t -128.46 136.37 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.914 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 2.1 p90 -87.59 143.69 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.893 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.964 179.31 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 6.2 ptt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -99.7 -166.08 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -62.91 -35.4 79.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.743 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.29 -21.25 48.24 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.929 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.554 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 9.2 t70 -57.66 -35.41 70.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.377 0.608 . . . . 0.0 110.186 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -140.29 46.56 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.951 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.743 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 88.9 p -116.1 155.79 27.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 111.29 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -149.33 163.99 36.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 91.3 m-20 51.24 35.96 14.82 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.506 0.504 . . . . 0.0 111.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -79.11 113.81 17.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.411 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -144.67 149.72 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -83.99 142.46 30.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 m -127.87 164.96 21.1 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 7.2 t-20 73.29 9.23 5.2 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 123.575 0.547 . . . . 0.0 110.861 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.12 13.92 50.67 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 108.47 15.94 12.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.056 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HG2' HG21 ' A' ' 56' ' ' THR . 23.6 mtp180 -99.51 -16.98 18.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.583 0.23 . . . . 0.0 111.035 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -131.3 131.0 43.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.026 0.441 . . . . 0.0 111.67 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 37' ' ' LEU . 59.4 tp -98.55 105.09 17.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.796 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -104.91 123.87 48.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.47 41.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -112.4 113.08 25.09 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -126.49 141.07 52.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.095 0.474 . . . . 0.0 111.589 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -67.79 144.06 55.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.448 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.6 p-10 -85.9 -173.85 4.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.509 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.86 75.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.741 0.305 . . . . 0.0 111.527 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.53 -24.24 63.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.082 0.468 . . . . 0.0 111.096 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.84 35.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.721 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 t30 -91.69 146.44 23.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -75.0 124.1 26.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.293 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -127.54 154.59 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.3 m -104.73 114.16 28.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.897 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.0 p -110.7 134.08 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.495 0.664 . . . . 0.0 111.413 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.45 131.83 50.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.647 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD11 HG12 ' A' ' 40' ' ' ILE . 12.9 tp -131.44 119.59 21.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.955 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 39' ' ' THR . 9.6 t70 -68.88 111.32 4.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 12' ' ' LEU . 33.8 mt -61.73 -45.16 95.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.683 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -63.5 -3.8 2.37 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -101.3 -13.13 18.17 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.823 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.546 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.53 11.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.46 129.54 70.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.46 160.3 22.11 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.312 -0.946 . . . . 0.0 112.518 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.6 t30 -110.88 109.61 19.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.52 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.53 76.56 6.57 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.002 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 39.3 62.07 1.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.802 0.841 . . . . 0.0 112.14 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 88.89 36.89 7.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.794 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -163.24 118.13 1.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.77 0.285 . . . . 0.0 110.483 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CG ' ' HB ' ' A' ' 92' ' ' VAL . 41.5 m-85 -61.57 138.51 58.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.959 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.52 116.14 15.59 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.648 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.24 115.02 8.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.04 38.87 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -110.66 -50.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.258 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 14.5 tt0 74.76 144.32 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.218 0.607 . . . . 0.0 111.527 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 94.0 m-20 64.02 46.03 3.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.749 0.785 . . . . 0.0 111.117 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -85.16 -28.56 25.42 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.39 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 17' ' ' ARG . 77.7 p -68.58 -19.58 64.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.559 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 58' ' ' THR . 12.2 pt-20 -71.37 -17.52 62.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.797 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 57' ' ' GLU . 62.8 p -124.33 9.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.905 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 56' ' ' THR . . . -115.69 150.37 36.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.093 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -137.04 170.09 16.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 7.3 t70 43.54 57.21 4.04 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.594 0.558 . . . . 0.0 111.33 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.442 HG22 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -87.94 113.39 25.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.187 0.518 . . . . 0.0 112.241 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 121.86 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.866 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 94' ' ' LEU . 12.8 t80 -91.47 132.1 36.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.292 0.567 . . . . 0.0 111.679 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.9 t-80 -120.18 87.74 40.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 11.2 Cg_endo -57.63 -37.24 97.56 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 123.951 3.101 . . . . 0.0 114.105 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.31 83.64 2.18 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -68.63 115.5 8.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.842 179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.52 -149.81 4.9 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.001 -0.999 . . . . 0.0 113.921 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -9.44 58.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.402 0.62 . . . . 0.0 109.706 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.59 -27.55 61.36 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.785 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 54.47 43.12 30.84 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.474 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -107.31 129.92 23.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.377 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 60.2 Cg_endo -73.62 109.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.941 2.428 . . . . 0.0 111.882 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.497 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 140.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.77 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.07 124.63 52.83 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.105 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.501 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.89 141.48 50.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.856 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.23 170.56 20.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.276 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.47 115.14 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -100.63 125.98 47.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.913 0.387 . . . . 0.0 111.575 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -74.26 139.64 44.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.49 171.27 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.4 m -60.06 -23.94 64.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.88 -25.7 62.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.35 0.595 . . . . 0.0 110.235 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.06 40.83 3.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.703 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.5 pt-20 -123.33 -163.44 1.12 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -136.11 139.87 43.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.63 0.729 . . . . 0.0 111.424 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -139.48 109.75 6.52 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.1 p-10 -62.83 114.09 3.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.393 0.616 . . . . 0.0 111.374 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.646 ' HB2' HD22 ' A' ' 80' ' ' LEU . 31.2 mmt180 -115.06 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.519 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.84 148.34 32.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CG ' ' A' ' 48' ' ' PHE . 12.7 p -135.31 143.56 36.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.375 0.607 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -84.02 106.22 15.51 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.887 -179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.611 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.0 mt -75.67 2.17 12.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.504 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 13.2 m120 -62.32 -17.22 58.21 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.697 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -21.55 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.155 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.8 mt -86.74 125.2 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -118.25 159.9 22.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -102.04 119.04 38.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.202 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 41.0 t -111.84 96.62 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.317 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 61.69 20.74 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.466 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 33' ' ' SER . . . 108.62 18.41 9.58 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.33 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 5.5 ptp180 -125.86 150.63 47.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.897 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 78.6 mt -97.78 118.1 33.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.5 p -118.42 126.19 74.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -86.78 144.38 27.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.763 178.4 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 4.7 tpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HA ' ' HG3' ' A' ' 98' ' ' GLN . 11.6 m -129.02 -177.28 4.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.635 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 4.9 p90 -63.35 -30.42 71.55 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.682 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.18 -30.08 59.16 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.003 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.548 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 8.8 t70 -56.87 -32.55 65.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.306 0.574 . . . . 0.0 111.196 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 56.2 m -136.69 41.12 2.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.209 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.8 p -115.96 145.15 43.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 111.419 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.88 166.03 27.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.016 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.22 31.07 13.4 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.641 0.588 . . . . 0.0 111.309 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.575 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.59 114.85 16.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.601 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.14 149.58 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.147 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -86.93 134.5 33.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.708 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 m -123.32 165.36 17.11 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.118 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.7 OUTLIER 71.24 8.79 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.229 0.612 . . . . 0.0 111.325 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 22.17 22.3 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.532 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.01 14.11 37.51 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.576 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.631 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.3 mtp180 -98.08 -17.11 19.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.402 0.144 . . . . 0.0 111.02 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 26.5 m -130.6 124.52 31.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 37' ' ' LEU . 60.6 tp -95.7 105.92 17.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -103.32 124.15 48.12 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 104' ' ' LEU . . . -147.42 145.06 29.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.027 0.441 . . . . 0.0 111.153 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' HG2' HG23 ' A' ' 32' ' ' THR . 10.2 mt-10 -100.25 113.46 26.16 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 6' ' ' SER . 20.1 t -128.02 143.85 51.09 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.949 0.404 . . . . 0.0 110.441 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.08 144.46 48.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.729 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -84.42 -171.44 3.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.704 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.1 72.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.513 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.68 -24.44 63.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.32 38.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.498 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.0 m-80 -96.49 143.85 27.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -73.66 122.72 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 112.026 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 153.76 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.94 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 22' ' ' GLU . 20.2 m -108.55 111.0 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.506 ' HB3' HD13 ' A' ' 104' ' ' LEU . 9.3 t -112.62 155.97 23.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.135 0.493 . . . . 0.0 111.184 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.536 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.2 mt-10 -137.87 131.96 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.868 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.84 117.45 20.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' O ' HG22 ' A' ' 39' ' ' THR . 21.5 m-20 -68.15 107.04 2.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 109.579 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -59.19 -45.89 89.87 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.504 0.668 . . . . 0.0 110.536 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -62.7 -5.26 2.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.818 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.56 -14.23 18.29 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.992 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.11 10.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.499 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.08 129.94 71.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.77 158.65 20.86 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.883 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 12.1 t30 -110.7 111.48 22.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -93.07 79.29 4.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.537 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.4 49.84 4.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.174 0.921 . . . . 0.0 112.811 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 102.33 33.09 4.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.233 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -162.38 123.5 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.118 0.459 . . . . 0.0 111.061 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -64.08 139.79 58.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.18 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -133.02 117.49 17.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.65 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.17 114.59 8.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.26 34.86 5.2 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.759 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -107.7 -49.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.06 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.5 tt0 72.07 145.46 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.3 m-20 69.91 34.89 2.42 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.486 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.5 p90 -77.77 -28.46 50.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.631 HG21 ' HG2' ' A' ' 17' ' ' ARG . 40.0 p -68.86 -28.52 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.293 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.625 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.3 pt-20 -70.82 -13.83 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 109.979 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.0 p -126.09 17.51 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.04 163.5 26.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.09 166.39 29.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.35 61.43 3.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 110.749 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 78' ' ' ALA . 1.8 mt -93.61 116.76 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.704 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.48 126.77 30.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.28 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.668 ' CE1' HD12 ' A' ' 94' ' ' LEU . 16.5 t80 -92.2 137.93 31.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.349 0.595 . . . . 0.0 112.206 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.75 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 11.0 t-160 -119.44 84.56 29.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.567 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.756 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 Cg_endo -58.72 -39.15 84.83 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.566 2.844 . . . . 0.0 114.177 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -127.64 87.07 2.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.244 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.75 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 4.4 tt0 -70.55 113.76 7.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.603 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.17 -145.85 8.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.305 1.003 . . . . 0.0 113.148 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.47 -1.76 51.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.62 -21.92 47.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.699 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 55.45 40.02 31.22 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -99.46 115.81 65.4 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.522 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 59.7 Cg_endo -74.57 107.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.21 1.94 . . . . 0.0 111.452 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.73 141.61 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.9 124.94 53.76 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.222 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HD3' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.62 141.11 50.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.23 179.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.27 166.17 30.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.628 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 11.8 mmt180 -85.69 115.18 23.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -98.05 129.83 44.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.232 0.539 . . . . 0.0 112.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -80.55 143.39 33.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.051 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.569 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 2.3 p-10 -98.56 177.84 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.87 -24.07 67.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -79.4 -28.49 41.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.799 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.28 40.63 1.36 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.073 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.7 pt-20 -112.6 -163.99 0.89 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -147.76 128.2 14.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.0 110.135 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -137.42 120.94 17.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.7 p-10 -64.62 125.53 25.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.587 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -120.57 178.09 4.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.752 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -144.73 147.69 33.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 p -136.22 140.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.582 0.706 . . . . 0.0 110.999 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.516 ' HB3' HD22 ' A' ' 95' ' ' ASN . 26.0 m-80 -79.2 108.42 12.69 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.641 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.668 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -78.97 5.82 10.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.331 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 93' ' ' ASN . 18.8 m-80 -67.23 -8.61 33.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 110.281 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -72.84 -15.61 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.932 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.0 mt -89.05 126.13 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' A' ' 2' ' ' SER . 2.1 mp0 -115.87 169.93 8.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.508 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -115.2 118.77 34.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.226 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.444 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -113.75 100.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.57 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.73 24.64 13.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.37 0.605 . . . . 0.0 110.801 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.99 23.0 10.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.304 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.5 ptp180 -129.92 134.76 47.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.951 0.376 . . . . 0.0 110.069 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.1 mp -83.67 128.41 34.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.2 130.29 21.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.99 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -82.04 145.92 29.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.249 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.738 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.2 tpp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.806 0.336 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -151.35 -169.29 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.415 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 11.7 p90 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -52.4 -26.39 12.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.465 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.65 -29.63 27.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.011 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 25.5 m -141.47 34.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 66.7 m -115.64 152.92 32.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.389 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 167.64 26.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.96 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 74.0 m-20 55.6 31.71 17.77 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.524 0.515 . . . . 0.0 111.457 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -73.41 114.47 11.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.314 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.8 t -142.3 150.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.083 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.1 138.35 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -125.81 165.3 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 9.3 t30 72.49 6.36 5.44 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.57 0.544 . . . . 0.0 111.531 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.71 28.74 11.81 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 93.28 20.92 31.2 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.686 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.5 mtp180 -106.78 -13.99 15.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.687 0.28 . . . . 0.0 110.275 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 28.7 m -133.15 129.24 37.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.913 0.387 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' HD13 ' A' ' 97' ' ' ILE . 55.5 tp -100.33 108.7 20.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.609 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.7 tmm_? -103.96 123.54 47.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.75 151.0 36.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.006 0.431 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.7 mt-10 -106.44 114.47 28.61 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 6' ' ' SER . 12.6 t -130.32 147.93 52.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.307 0.575 . . . . 0.0 111.677 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.74 144.72 36.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.829 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -87.72 -168.6 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.791 0.329 . . . . 0.0 111.645 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.81 75.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.44 -24.24 61.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.147 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.8 5.84 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -86.48 144.69 27.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -77.47 125.34 29.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.482 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.15 131.75 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.869 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -83.58 110.05 17.92 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.531 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.8 p -111.36 143.43 42.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.321 0.581 . . . . 0.0 111.642 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -130.7 133.15 45.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.34 119.17 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.5 m-20 -68.88 108.48 3.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 12' ' ' LEU . 55.3 mt -59.28 -46.76 87.66 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.108 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -62.77 -4.91 2.33 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.85 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.12 -13.97 20.68 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.872 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -143.99 12.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.008 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.577 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -126.63 130.83 71.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.22 163.06 19.36 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.819 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.14 108.75 17.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 0.0 110.328 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -101.67 82.93 2.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.301 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.4 m-20 48.99 57.21 6.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.124 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.14 41.86 20.84 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -159.39 113.0 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.557 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.0 m-85 -58.76 136.28 57.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.244 0.545 . . . . 0.0 111.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -123.74 114.77 20.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.51 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.78 114.47 8.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.62 35.4 4.92 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.647 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.18 -49.54 0.82 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.148 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 28.9 tt0 70.15 145.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.026 0.53 . . . . 0.0 111.123 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.651 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 90.7 m-20 72.35 31.78 1.77 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.215 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.577 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.1 p90 -76.57 -31.51 57.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.686 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.1 p -64.12 -27.18 68.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.876 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.3 pt-20 -72.04 -14.41 61.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.199 0.523 . . . . 0.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -125.09 14.05 8.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.922 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.8 157.32 37.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.654 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -148.93 170.66 17.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.322 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.2 t70 49.07 52.44 14.37 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.385 0.428 . . . . 0.0 110.74 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.429 HG22 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -84.79 112.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -126.54 124.89 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.643 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.65 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.8 t80 -91.6 137.65 32.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.352 0.596 . . . . 0.0 111.486 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.684 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 7.6 t-160 -122.89 82.3 49.92 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 6.9 Cg_endo -56.94 -43.07 57.68 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.384 2.723 . . . . 0.0 113.947 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 3.3 mptt -120.2 83.71 2.1 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.684 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 1.8 tt0 -66.84 109.04 2.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.421 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.29 -140.74 12.74 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 124.376 1.047 . . . . 0.0 114.129 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.13 -9.46 59.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.886 0.374 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.91 44.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.111 0.481 . . . . 0.0 109.787 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.71 41.15 31.39 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.477 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 123.05 48.33 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.833 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 42.8 Cg_endo -70.01 108.94 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.568 2.179 . . . . 0.0 112.072 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -136.34 142.19 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.532 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.06 126.96 56.05 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.964 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.75 142.39 50.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.099 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.16 171.1 19.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.734 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.3 mmt180 -85.12 115.87 23.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -101.74 124.71 47.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.941 0.4 . . . . 0.0 111.666 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -79.29 142.95 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.469 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.687 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -105.93 171.8 7.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 75.9 m -56.14 -27.28 53.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -69.27 -27.3 65.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.351 0.596 . . . . 0.0 109.924 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.4 ' HA2' ' HE ' ' A' ' 81' ' ' ARG . . . 102.08 38.27 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.146 177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.3 pt-20 -122.03 -165.86 1.32 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -140.43 139.71 35.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.036 0.922 . . . . 0.0 111.503 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -138.79 112.73 8.5 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.682 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.569 ' HB3' ' CD ' ' A' ' 79' ' ' ARG . 5.4 p-10 -64.43 113.15 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.518 0.675 . . . . 0.0 111.341 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.627 ' HB2' HD22 ' A' ' 80' ' ' LEU . 25.7 mmt180 -114.39 177.11 4.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HB2' HD13 ' A' ' 75' ' ' ILE . 7.7 p-10 -142.57 148.74 38.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.557 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -134.31 147.59 30.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.493 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.558 ' HB3' HD22 ' A' ' 95' ' ' ASN . 4.6 m-20 -85.42 110.09 18.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.709 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.65 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.5 mt -77.5 2.48 16.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.293 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.558 HD22 ' HB3' ' A' ' 93' ' ' ASN . 16.6 m-80 -62.73 -12.75 25.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 109.91 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.7 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -69.51 -18.06 63.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.692 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.593 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.9 mt -87.06 123.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.443 0.64 . . . . 0.0 110.626 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -116.96 164.6 14.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.217 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.6 t30 -108.27 121.06 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 61.4 t -113.01 94.62 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.69 22.56 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.985 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.62 16.73 9.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.594 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.2 ptp180 -129.22 143.71 50.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 82.7 mt -89.37 133.23 34.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.71 131.4 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -82.48 145.78 29.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 57.6 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.47 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HB3' ' HB2' ' A' ' 5' ' ' ASP . 15.3 tpt . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.738 0.304 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -155.17 -172.16 4.07 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -66.24 -33.95 76.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.761 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.15 -24.1 51.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.422 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 17.3 t0 -59.16 -24.24 62.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.5 m -148.01 39.32 0.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.761 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.7 p -116.22 158.27 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.938 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -155.32 166.8 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.517 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.511 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.8 m-20 52.89 35.47 19.12 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.788 0.68 . . . . 0.0 111.332 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -79.31 114.36 18.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.427 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 t -143.84 151.58 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -85.17 145.22 27.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 m -131.99 164.73 25.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 73.77 5.22 4.83 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.602 0.564 . . . . 0.0 111.234 177.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.06 23.58 19.65 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 99.1 16.86 29.07 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.824 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.721 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.7 mtp180 -100.75 -18.38 16.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.581 0.229 . . . . 0.0 110.783 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 50.5 m -130.22 128.42 41.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 0.0 111.54 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD2' HD13 ' A' ' 97' ' ' ILE . 58.8 tp -97.59 108.8 21.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.72 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.2 tmm_? -103.4 124.94 49.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.25 138.95 20.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -98.83 109.85 22.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD11 ' A' ' 104' ' ' LEU . 3.3 m -121.29 144.28 48.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.028 0.442 . . . . 0.0 111.035 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.29 143.32 47.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.94 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HB3' HG21 ' A' ' 31' ' ' VAL . 25.2 p-10 -90.26 -172.77 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.595 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.51 66.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.721 0.296 . . . . 0.0 111.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.18 -25.03 59.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.114 0.483 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.21 39.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.515 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.7 t-20 -88.94 146.32 24.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -78.55 119.63 22.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.057 0.456 . . . . 0.0 110.99 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -115.9 125.18 72.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.801 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.5 m -80.36 107.3 13.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.4 t -112.52 149.23 32.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.325 0.583 . . . . 0.0 110.584 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.9 mt-10 -134.96 131.77 37.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.85 119.18 23.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 39' ' ' THR . 47.4 m-20 -68.41 108.73 3.37 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.028 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 12' ' ' LEU . 68.3 mt -61.86 -42.35 98.95 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.55 -5.21 2.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.09 -12.08 16.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.439 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.538 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.94 10.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 130.44 70.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.59 160.79 20.95 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.966 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -110.94 107.85 17.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.505 0.669 . . . . 0.0 110.214 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -87.83 75.73 8.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.107 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 7.1 p-10 39.16 59.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 112.588 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 91.36 36.29 6.64 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.551 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -165.5 121.72 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.542 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.7 m-85 -60.93 143.78 54.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.346 0.593 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -132.91 115.81 15.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.422 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -73.01 115.08 11.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 31.91 6.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.784 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -102.03 -50.8 1.13 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.194 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.7 tt0 72.61 144.96 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.901 0.48 . . . . 0.0 111.422 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 2.6 t-20 68.74 34.71 3.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.244 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.2 p90 -77.27 -28.49 53.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.95 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.721 HG21 ' HG2' ' A' ' 17' ' ' ARG . 33.0 p -64.63 -22.23 66.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.555 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.674 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.6 pt-20 -73.16 -15.32 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.038 0.446 . . . . 0.0 110.371 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.8 p -128.19 16.32 6.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.271 0.558 . . . . 0.0 110.031 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.21 150.27 50.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.144 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.32 173.07 11.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.503 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 48.43 50.86 16.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.545 0.528 . . . . 0.0 110.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.05 108.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.337 0.589 . . . . 0.0 111.536 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.52 123.16 37.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.68 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.629 ' CE1' HD12 ' A' ' 94' ' ' LEU . 18.3 t80 -92.15 135.32 34.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.247 0.546 . . . . 0.0 111.895 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 4.6 t-80 -124.5 89.33 52.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.04 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.2 Cg_endo -57.11 -36.86 99.31 Favored 'Trans proline' 0 CA--C 1.51 -0.712 0 C-N-CA 124.11 3.207 . . . . 0.0 114.633 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.08 88.78 2.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.656 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -70.42 114.25 8.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.095 178.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -153.01 7.33 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.025 0.828 . . . . 0.0 113.714 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.76 -13.37 60.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.224 0.535 . . . . 0.0 109.694 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.15 59.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 49.3 52.56 14.21 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.879 0.737 . . . . 0.0 110.764 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -104.97 124.51 36.44 Favored Pre-proline 0 N--CA 1.447 -0.59 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.522 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 56.9 Cg_endo -71.37 110.43 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.779 2.32 . . . . 0.0 112.642 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.703 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 140.24 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -111.66 126.83 55.45 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.081 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.703 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.0 142.53 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.84 24.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.675 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.588 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.4 mmt180 -86.3 115.09 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.32 124.06 45.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.365 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.78 137.37 40.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.872 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.37 166.27 12.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 45' ' ' ASP . 95.9 m -58.57 -20.93 51.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.418 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.06 -26.83 63.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.282 0.563 . . . . 0.0 110.56 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.92 41.14 2.93 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.4 pt-20 -126.97 -163.72 1.28 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.12 142.61 36.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.784 0.802 . . . . 0.0 111.417 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -140.99 112.04 7.2 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.073 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.2 p-10 -62.02 115.27 3.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.31 0.576 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -116.44 175.44 5.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.953 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.39 149.08 38.88 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.542 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -137.52 143.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.459 0.647 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HB3' HD22 ' A' ' 95' ' ' ASN . 36.5 m-20 -79.36 110.04 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.551 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.629 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.5 mt -79.04 1.11 25.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.798 0.332 . . . . 0.0 111.238 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.475 HD22 ' HB3' ' A' ' 93' ' ' ASN . 14.9 m-80 -61.93 -13.87 29.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -26.5 67.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.447 0.641 . . . . 0.0 109.39 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.2 mt -80.13 127.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.415 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.8 tt0 -121.01 161.99 20.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -104.88 120.6 41.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.024 0.44 . . . . 0.0 110.63 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 60.2 t -113.1 94.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.32 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.94 24.91 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.714 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 23.14 8.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.0 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.587 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 7.6 ptp180 -130.6 134.15 46.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.95 0.375 . . . . 0.0 110.271 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.2 mp -80.89 119.46 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' A' ' 103' ' ' ARG . 48.3 t -127.14 125.37 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.226 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.56 144.02 34.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.205 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.909 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 p 177.48 -178.88 0.21 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -63.6 -31.17 72.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.717 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.3 -27.68 37.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.62 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.38 -31.83 66.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 110.976 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.9 m -138.11 41.31 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.717 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.2 p -122.67 154.55 37.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.597 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -151.37 167.51 27.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 84.9 m-20 53.69 34.43 18.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.659 0.599 . . . . 0.0 111.214 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.588 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -80.03 112.96 17.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.91 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.25 153.64 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.043 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.58 142.78 27.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 14' ' ' ASN . 20.4 m -130.37 163.53 26.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.4 t30 72.67 9.06 5.63 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.725 0.641 . . . . 0.0 111.657 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 25.27 15.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.037 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 93.08 26.18 17.16 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.611 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.588 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.7 mtp180 -108.09 -18.3 13.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.835 0.35 . . . . 0.0 110.196 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 42.1 m -128.73 129.91 46.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.768 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.1 tp -102.77 111.99 24.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.578 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -110.4 126.05 53.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.043 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -150.16 138.46 20.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 110.6 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.6 mt-10 -96.09 110.04 22.36 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' SER . 5.1 p -117.5 141.16 48.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.133 0.492 . . . . 0.0 111.643 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.16 143.89 40.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.771 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 p30 -90.58 -172.98 3.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.74 -34.07 70.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.627 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.64 -17.9 61.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.277 0.56 . . . . 0.0 110.83 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.45 6.71 56.41 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.6 t-20 -86.9 142.26 28.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.499 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.1 m0 -77.63 116.73 18.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.025 0.44 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.57 122.57 67.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 m -76.4 109.75 10.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.752 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 24.0 m -109.93 143.46 39.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.0 mt-10 -135.5 132.72 37.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.556 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.61 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -136.74 119.58 16.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.661 ' O ' HG22 ' A' ' 39' ' ' THR . 18.2 m-20 -69.67 110.34 4.82 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.722 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 12' ' ' LEU . 11.1 mt -60.6 -39.96 90.03 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.836 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -64.45 -5.93 6.3 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.492 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.56 -9.77 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.658 -178.999 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.61 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.16 10.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.71 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.43 131.16 70.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.12 158.03 20.2 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.755 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -111.45 108.53 18.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.15 0.5 . . . . 0.0 110.319 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -93.58 78.99 4.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.317 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 41.24 60.73 1.98 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.817 0.847 . . . . 0.0 112.432 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.23 35.5 9.59 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.771 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -158.5 117.35 3.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.801 -0.235 . . . . 0.0 110.736 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -62.93 139.48 58.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -133.5 116.78 16.37 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.43 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.419 ' HH2' HD22 ' A' ' 94' ' ' LEU . 90.6 m95 -69.67 115.62 9.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 39.14 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.873 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -111.58 -51.21 0.58 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.375 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.5 tt0 72.98 144.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.23 0.612 . . . . 0.0 111.344 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.7 m-20 72.47 28.99 2.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.82 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -74.1 -29.16 61.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.588 HG21 ' HG2' ' A' ' 17' ' ' ARG . 17.8 p -67.7 -20.43 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.004 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.2 pt-20 -76.49 -12.91 60.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.8 p -127.1 13.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.974 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.31 150.91 51.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.589 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.06 173.42 11.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.998 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 47.5 58.79 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 110.423 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.503 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 1.8 mt -94.9 110.7 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.4 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 126.41 39.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.413 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.0 t80 -91.38 134.99 34.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.363 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.566 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 8.8 t-160 -120.34 84.66 35.45 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.336 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -56.77 -41.11 79.07 Favored 'Trans proline' 0 CA--C 1.512 -0.607 0 C-N-CA 123.254 2.636 . . . . 0.0 113.89 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.595 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -121.46 82.54 1.95 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.743 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.566 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 13.1 tt0 -69.68 113.64 7.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.88 -151.16 7.25 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.4 1.062 . . . . 0.0 114.138 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.88 -9.07 58.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.99 -25.1 47.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 47.61 55.06 8.89 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.929 0.768 . . . . 0.0 110.47 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -118.09 127.22 26.74 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.058 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.567 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -71.99 111.08 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.592 2.194 . . . . 0.0 112.669 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.411 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -134.37 141.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.24 125.43 54.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.05 142.5 49.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.147 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -161.71 169.72 20.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.223 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.605 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -86.0 115.0 23.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.6 mp -101.4 131.51 47.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.824 0.345 . . . . 0.0 111.303 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -75.87 136.17 40.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.022 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.535 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 4.1 m-20 -94.72 172.6 8.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.54 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.8 t -61.18 -25.85 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -69.51 -19.32 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.76 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.85 37.66 6.33 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -122.64 -169.1 1.85 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 98.4 m-85 -135.95 136.36 40.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.707 0.765 . . . . 0.0 111.332 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -138.29 119.14 14.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.701 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 12.6 p-10 -64.49 113.26 3.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.433 0.635 . . . . 0.0 111.332 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD22 ' A' ' 80' ' ' LEU . 31.0 mmt180 -115.0 176.47 5.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -144.44 151.95 39.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.49 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.9 p -139.6 146.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.209 0.528 . . . . 0.0 110.78 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.412 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 14.1 m120 -81.73 111.73 18.25 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.775 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.688 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.3 mt -80.55 -0.75 39.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.306 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.567 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.5 m120 -62.08 -14.22 34.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -68.05 -24.2 65.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -80.85 126.9 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.319 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -120.66 162.69 19.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.07 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -105.77 118.44 36.59 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.215 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.546 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.5 t -113.52 96.95 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.563 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.8 t30 59.87 24.7 13.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 111.482 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.94 24.32 7.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.998 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -132.9 139.25 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.322 0.561 . . . . 0.0 110.978 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.752 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 53.8 mt -84.99 117.29 23.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 47.3 t -122.78 122.47 65.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.818 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.84 143.85 34.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--O 1.249 1.074 0 O-C-N 123.722 0.639 . . . . 0.0 111.659 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.3 tpp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.678 0.275 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -142.89 -172.44 3.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.96 -38.05 89.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.46 -25.85 38.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.156 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.61 -30.56 55.09 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -136.64 33.09 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.417 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 69.4 m -120.22 156.45 31.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.022 0.439 . . . . 0.0 112.041 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.98 170.79 19.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.545 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 95.6 m-20 53.02 33.56 15.09 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.683 0.614 . . . . 0.0 111.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.45 114.14 13.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.95 157.02 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.551 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.81 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -94.34 134.54 36.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 109.882 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -119.42 163.32 17.4 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.091 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.0 t30 70.27 9.61 7.05 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.712 0.632 . . . . 0.0 111.561 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.2 26.72 17.75 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.902 -0.665 . . . . 0.0 111.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.33 22.8 21.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.969 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.9 mtp180 -106.33 -18.0 14.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.845 0.355 . . . . 0.0 110.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -132.52 127.76 35.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.094 0.473 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.444 ' HB2' HD21 ' A' ' 37' ' ' LEU . 55.5 tp -95.69 105.18 17.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.611 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -102.09 124.17 47.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.039 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.73 29.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.2 mt-10 -99.59 109.14 21.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 6.3 p -116.43 140.23 49.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.3 143.38 40.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' HB3' HG21 ' A' ' 31' ' ' VAL . 23.9 p-10 -87.26 -176.45 5.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.363 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.94 -30.55 66.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.533 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.68 -24.57 59.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.18 5.35 40.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.835 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.2 t-20 -89.01 144.77 25.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.432 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.5 m0 -77.65 121.1 23.51 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.978 0.418 . . . . 0.0 110.968 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -118.95 125.12 74.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.791 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -80.16 110.23 15.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.474 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.2 t -111.75 150.03 30.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 110.555 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.2 mt-10 -134.93 131.56 37.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.383 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.9 116.24 19.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 39' ' ' THR . 12.8 m-20 -67.61 107.68 2.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.509 0.671 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.81 HD11 HD11 ' A' ' 12' ' ' LEU . 38.0 mt -59.92 -42.5 94.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.453 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 2.4 p-10 -63.43 -5.67 3.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.8 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -105.66 -10.29 16.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.575 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.508 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -142.78 10.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 111.769 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -127.57 131.22 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.68 159.14 20.91 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.071 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -111.06 112.55 24.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -99.36 76.82 2.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 52.25 58.22 5.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.563 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.99 32.47 29.26 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.358 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -149.44 122.06 8.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.9 m-85 -66.3 135.18 54.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.809 0.337 . . . . 0.0 110.837 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -128.34 117.17 20.97 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -71.34 115.51 10.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.33 33.27 5.74 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.107 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -103.95 -51.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.107 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 23.3 tt0 70.69 143.31 0.05 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.089 0.556 . . . . 0.0 110.689 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.663 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 11.7 m120 76.89 31.23 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.322 0.649 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.4 p90 -80.69 -29.7 36.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.246 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.648 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.1 p -65.64 -17.36 64.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.007 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 12.4 pt-20 -80.25 -15.55 56.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.148 0.499 . . . . 0.0 109.996 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -124.6 14.66 8.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.23 150.1 49.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.682 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.768 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -141.03 172.81 12.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 1.1 t70 43.67 58.17 3.65 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.859 0.724 . . . . 0.0 111.129 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.4 mt -88.75 111.39 22.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.203 0.525 . . . . 0.0 112.139 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.55 123.21 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.069 179.189 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.68 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.2 t80 -92.88 134.6 34.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.14 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 8.1 t-160 -126.19 89.42 52.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 65' ' ' HIS . 20.7 Cg_endo -62.42 -36.58 65.61 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.886 3.058 . . . . 0.0 114.144 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.89 84.6 2.26 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.308 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 8.8 tt0 -71.04 117.05 12.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.625 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.13 -147.45 21.6 Favored Glycine 0 C--N 1.334 0.456 0 O-C-N 123.9 0.75 . . . . 0.0 113.509 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.88 -9.45 58.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.45 0.643 . . . . 0.0 109.557 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.19 -27.64 59.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.347 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 55.41 51.11 13.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.988 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -104.17 124.31 37.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.459 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 53.0 Cg_endo -71.47 110.42 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.833 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.752 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.42 141.36 42.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -114.13 127.91 56.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.369 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.752 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.01 141.8 51.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.203 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.54 168.94 23.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.812 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.768 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.1 mmt85 -85.54 114.9 22.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -100.26 129.18 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.65 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.47 137.13 40.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.963 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.671 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 1.1 m-20 -91.17 174.45 7.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 35.4 t -64.66 -25.1 67.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -73.58 -18.87 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.823 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.98 41.77 3.97 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.4 pt-20 -123.37 -162.63 1.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -140.57 132.99 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.863 0.839 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -137.8 112.95 9.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.211 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.5 p-10 -64.02 116.08 5.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.291 0.567 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.585 ' HB2' HD22 ' A' ' 80' ' ' LEU . 36.4 mmt180 -115.84 174.54 5.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -141.46 142.97 33.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.6 p -130.33 148.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.571 ' HB3' HD22 ' A' ' 95' ' ' ASN . 93.8 m-20 -83.45 110.59 18.31 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.04 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.68 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.99 1.18 32.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.562 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.571 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.6 m-80 -60.73 -17.29 47.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.429 . . . . 0.0 110.486 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.04 66.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.256 0.55 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -81.75 132.86 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -124.29 167.36 14.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -113.05 123.42 50.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.097 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.557 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 39.2 t -114.07 93.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.97 27.69 13.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.827 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.34 19.27 8.06 Favored Glycine 0 C--N 1.32 -0.353 0 C-N-CA 120.293 -0.956 . . . . 0.0 114.133 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 6.6 ptp180 -130.55 141.79 50.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.388 0.594 . . . . 0.0 111.116 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.3 mp -90.58 124.02 34.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.621 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.1 p -132.56 128.24 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -84.98 145.49 27.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.491 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.743 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 7.5 ptt? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -104.99 -165.74 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -58.2 -37.38 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -58.67 -19.29 38.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.081 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.603 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 5.7 t70 -55.88 -38.35 70.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.443 0.64 . . . . 0.0 109.945 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 61.0 m -130.01 33.83 4.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.517 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.0 m -120.02 155.23 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.0 ptp180 -151.78 170.77 18.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.5 m-20 54.18 32.52 16.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.14 0.495 . . . . 0.0 110.906 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.33 113.36 12.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.961 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.98 155.29 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.555 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -92.15 138.05 31.85 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.478 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.9 m -123.91 163.59 20.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.128 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 71.0 6.53 5.9 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.665 0.603 . . . . 0.0 111.666 178.04 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.38 23.63 14.0 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.36 17.77 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.812 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.702 ' HG2' HG21 ' A' ' 56' ' ' THR . 29.8 mtp180 -100.07 -18.11 17.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.592 0.234 . . . . 0.0 110.922 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.8 m -131.39 124.76 30.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.075 0.464 . . . . 0.0 111.52 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD2' HD13 ' A' ' 97' ' ' ILE . 60.4 tp -92.77 104.95 17.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.489 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.8 tmm_? -101.78 125.46 48.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.091 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.37 144.47 25.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 6.8 mt-10 -98.6 108.84 21.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.7 p -115.87 141.25 48.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.584 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.12 141.09 42.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.492 ' HB3' HG21 ' A' ' 31' ' ' VAL . 29.0 p-10 -86.87 -175.33 5.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.311 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.09 68.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.74 -23.87 61.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.067 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.11 8.58 44.28 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.262 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.5 t-20 -93.72 147.25 23.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -77.61 117.87 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.508 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 25' ' ' ASN . 9.8 t -113.25 122.95 68.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.2 m -78.58 105.22 9.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -111.1 154.04 24.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.2 mt-10 -139.57 132.47 29.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.42 114.88 18.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 39' ' ' THR . 21.3 m-20 -65.4 107.34 1.62 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.104 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 12' ' ' LEU . 85.6 mt -60.32 -45.59 92.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.652 0.739 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -62.62 -5.23 2.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.79 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.07 -13.15 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.036 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.523 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -142.95 12.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 111.923 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.64 131.45 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.85 156.85 19.67 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.442 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.467 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.2 t30 -111.58 107.19 16.26 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.52 82.16 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 5.2 p-10 40.6 51.98 3.02 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.319 1.012 . . . . 0.0 113.329 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 99.44 35.08 4.81 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.145 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -163.2 122.07 2.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.774 0.287 . . . . 0.0 110.628 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 47.1 m-85 -65.17 141.09 58.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 111.325 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.21 117.87 19.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.411 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -73.01 114.44 11.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.77 29.3 6.99 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.67 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.86 -53.76 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.978 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 31.5 tt0 73.07 143.89 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.387 0.675 . . . . 0.0 111.474 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 83.6 m-20 74.25 29.03 1.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.383 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -75.75 -33.44 60.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.517 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.702 HG21 ' HG2' ' A' ' 17' ' ' ARG . 22.6 p -61.71 -30.38 70.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.8 pt-20 -68.3 -13.58 62.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.837 0.351 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.549 HG23 ' HG3' ' A' ' 57' ' ' GLU . 76.6 p -126.22 13.63 7.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 109.924 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.51 146.11 50.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.625 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -136.91 172.86 12.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.637 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER 46.79 52.39 11.44 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.828 0.705 . . . . 0.0 110.473 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.62 112.01 21.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.0 111.659 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.48 124.61 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.548 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.704 ' CE1' HD12 ' A' ' 94' ' ' LEU . 21.5 t80 -92.37 136.66 33.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.363 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.703 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.9 t-160 -122.72 85.65 49.48 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 18.7 Cg_endo -62.32 -43.7 21.97 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 123.228 2.619 . . . . 0.0 113.671 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -118.65 82.42 1.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.729 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.703 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 2.4 tt0 -66.85 113.69 5.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.521 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.21 -142.43 10.15 Favored Glycine 0 C--N 1.335 0.525 0 O-C-N 124.407 1.067 . . . . 0.0 113.374 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.77 -9.75 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.982 0.42 . . . . 0.0 109.918 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.33 57.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.795 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 54.16 46.52 25.16 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.469 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.27 124.1 36.21 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.58 109.83 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.662 2.241 . . . . 0.0 112.369 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -133.51 141.58 43.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.1 tm? -114.29 125.79 54.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.176 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.488 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.21 141.39 51.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.87 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.55 167.53 26.95 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.042 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.2 mmt180 -85.16 114.59 22.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -98.22 121.56 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -77.68 142.18 38.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.923 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.589 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.7 p-10 -96.69 178.8 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.222 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -63.15 -21.91 66.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -79.48 -28.19 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.128 0.489 . . . . 0.0 110.77 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.58 32.41 2.94 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.026 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.8 pt-20 -104.25 -166.12 1.22 Allowed 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -143.28 128.92 19.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.04 111.63 8.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.224 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.4 p-10 -65.65 120.29 12.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 112.445 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.69 ' HB2' HD22 ' A' ' 80' ' ' LEU . 36.3 mmt180 -115.94 174.88 5.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.979 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -139.42 150.62 45.47 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -140.54 144.66 26.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.391 0.615 . . . . 0.0 110.912 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.568 ' HB3' HD22 ' A' ' 95' ' ' ASN . 38.0 m-80 -80.87 109.0 15.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 64' ' ' PHE . 3.8 mt -79.01 1.12 25.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.453 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.568 HD22 ' HB3' ' A' ' 93' ' ' ASN . 15.6 m-80 -60.8 -16.63 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.273 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -23.52 67.42 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.941 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -82.22 125.61 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -117.0 163.34 16.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.219 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.65 117.66 34.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.533 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 48.5 t -113.11 94.22 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 57.75 27.32 14.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.598 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.98 23.69 8.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.485 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -131.61 134.48 46.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.079 0.439 . . . . 0.0 110.38 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 mp -85.92 124.36 32.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.3 p -137.1 131.62 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.593 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.52 145.91 29.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.978 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 57.8 tp60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.196 -179.82 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 tpp . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.837 0.351 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.9 m -153.97 -164.49 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -55.93 -37.26 68.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.147 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.16 -24.55 41.99 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.635 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.19 -33.35 65.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.006 0.432 . . . . 0.0 110.926 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.4 m -132.38 33.24 3.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.167 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 71.8 m -119.38 156.6 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.433 . . . . 0.0 111.699 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -153.09 169.94 21.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.0 m120 52.92 33.88 15.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.686 0.617 . . . . 0.0 111.176 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.77 113.38 16.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.749 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 t -143.44 156.3 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.836 HD11 HD11 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -91.39 141.61 28.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 7.9 m -125.39 165.05 19.09 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.2 t-20 71.1 8.85 6.58 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.623 0.577 . . . . 0.0 111.657 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.02 26.3 16.89 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.05 27.09 11.35 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.054 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.719 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.7 mtp180 -111.37 -17.09 13.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.704 0.288 . . . . 0.0 110.497 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 40.4 m -128.76 126.44 39.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD2' HD13 ' A' ' 97' ' ' ILE . 39.6 tp -94.97 107.54 19.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.578 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -107.62 124.83 50.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.26 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -150.72 148.48 28.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.671 0.272 . . . . 0.0 111.12 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.9 mt-10 -103.67 109.47 21.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -118.59 148.17 42.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -79.86 141.99 35.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.461 ' HB3' HG11 ' A' ' 31' ' ' VAL . 34.3 p30 -89.46 -175.03 4.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.602 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.46 -28.86 69.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 111.04 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.04 -24.57 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.09 5.84 46.28 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.571 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.7 m-80 -95.18 149.28 21.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.424 0.29 . . . . 0.0 111.069 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.507 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 54.3 m0 -81.4 110.43 16.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 109.922 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -112.17 121.81 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.048 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -74.78 114.71 13.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.822 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.0 t -112.87 149.94 32.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -136.11 131.68 35.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.14 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 HG12 ' A' ' 40' ' ' ILE . 15.8 tp -129.05 118.75 23.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.0 0.429 . . . . 0.0 110.611 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 39' ' ' THR . 2.9 m-20 -68.07 110.02 3.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.755 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.836 HD11 HD11 ' A' ' 12' ' ' LEU . 23.8 mt -62.06 -39.16 91.43 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.491 0.662 . . . . 0.0 109.604 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -63.53 -6.12 4.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.227 178.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -101.89 -15.2 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.243 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.36 10.8 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -127.25 129.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.06 158.32 21.46 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.11 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.429 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.0 t30 -110.89 114.17 27.29 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.18 82.35 1.66 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.288 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 53.29 65.1 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.247 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.86 34.72 62.13 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.816 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -156.26 120.36 4.46 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.629 -0.336 . . . . 0.0 110.182 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 46.6 m-85 -62.08 142.98 57.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.148 0.499 . . . . 0.0 111.198 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -132.13 117.07 17.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.461 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -74.08 114.05 11.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.55 31.44 6.1 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.581 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.39 -51.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.084 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 25.8 tt0 73.26 143.09 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.188 0.595 . . . . 0.0 112.063 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 t30 68.78 31.78 4.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.694 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.0 p90 -72.31 -27.96 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.719 HG21 ' HG2' ' A' ' 17' ' ' ARG . 20.1 p -63.81 -19.6 65.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.111 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.678 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -74.58 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.134 0.493 . . . . 0.0 110.371 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -126.83 14.08 7.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.75 143.91 51.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.856 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.62 173.96 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.338 179.295 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.561 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 17.6 t0 48.17 50.61 16.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.234 0.54 . . . . 0.0 110.315 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.75 108.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.049 0.452 . . . . 0.0 111.738 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -125.46 123.95 40.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.047 178.851 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 94' ' ' LEU . 4.5 t80 -91.28 130.61 37.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.927 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 11.1 t-80 -121.11 85.46 41.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.538 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 65' ' ' HIS . 9.2 Cg_endo -56.3 -36.37 96.89 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 123.933 3.088 . . . . 0.0 114.677 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 80.57 1.56 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.264 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -66.15 114.46 5.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.577 0.227 . . . . 0.0 111.321 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.22 -144.16 14.37 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 124.148 0.905 . . . . 0.0 113.76 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.4 -10.04 58.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.22 -25.09 57.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.841 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 54.54 44.01 29.39 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -102.44 124.38 39.63 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.401 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 41.7 Cg_endo -68.07 112.1 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.681 2.254 . . . . 0.0 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.462 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -134.12 141.5 43.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -112.75 124.21 52.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.303 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.502 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.05 140.73 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.958 0.408 . . . . 0.0 109.961 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.0 169.83 22.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.839 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.4 mmt85 -86.34 115.59 23.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.9 mp -101.5 128.8 47.58 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 123.463 0.477 . . . . 0.0 111.074 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -78.8 138.6 38.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.463 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 10.2 m-20 -95.16 169.16 10.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.62 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.63 -25.04 64.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.91 0.386 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.77 -20.89 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.441 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 38.27 4.26 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.81 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.742 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.9 pt-20 -122.44 -172.42 2.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 90.5 m-85 -134.5 138.59 44.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.761 0.791 . . . . 0.0 111.575 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -139.64 118.12 12.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.649 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.4 p-10 -65.02 112.37 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.344 0.592 . . . . 0.0 111.283 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.646 ' HB2' HD22 ' A' ' 80' ' ' LEU . 28.2 mmt180 -115.41 174.56 5.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -141.9 152.44 43.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -138.67 144.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -82.62 110.37 17.63 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.672 -179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.647 ' HB3' HD12 ' A' ' 97' ' ' ILE . 8.5 mt -79.49 3.05 19.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.308 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.451 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 18.0 m120 -62.19 -14.07 34.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.199 0.523 . . . . 0.0 109.819 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -21.21 66.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.186 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.647 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -83.6 127.94 39.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 0.0 111.505 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -121.45 160.91 23.17 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.125 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -108.43 120.73 43.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.071 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 48.3 t -113.72 94.38 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.001 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.48 23.48 12.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.451 ' CA ' HG11 ' A' ' 31' ' ' VAL . . . 114.15 14.34 9.23 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 119.287 -1.435 . . . . 0.0 113.695 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.8 ptp180 -130.18 135.57 48.31 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.425 -0.456 . . . . 0.0 111.161 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.822 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.8 mt -87.84 125.45 34.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.101 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.3 p -137.99 136.37 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.652 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -85.83 145.73 27.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.091 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.58 0.228 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -157.15 174.39 15.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -58.11 -39.17 77.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.157 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.55 -27.31 37.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.942 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.13 -31.37 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 m -130.16 31.0 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 73.4 m -116.83 156.8 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.455 0.645 . . . . 0.0 112.204 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.1 ptp180 -152.33 170.87 19.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.084 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.577 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.9 t-20 56.11 30.4 16.32 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.624 0.578 . . . . 0.0 110.266 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -76.98 113.04 14.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.64 147.13 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.648 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.5 tp -84.46 140.82 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 14' ' ' ASN . 10.8 m -126.26 163.24 23.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.025 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.1 t-20 72.05 8.97 6.03 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.619 0.574 . . . . 0.0 111.607 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.6 23.25 24.21 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 97.49 24.92 11.47 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.101 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.2 mtp180 -107.59 -18.15 13.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.864 0.364 . . . . 0.0 110.288 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 m -130.1 128.51 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.358 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 37' ' ' LEU . 49.5 tp -97.32 108.65 21.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.648 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.2 tmm_? -105.42 123.98 48.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.309 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.08 26.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -106.09 110.05 22.18 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 41.8 t -121.69 145.6 47.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.87 144.01 52.64 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.277 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.542 ' HB3' HG21 ' A' ' 31' ' ' VAL . 22.6 p-10 -88.13 -167.52 1.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.952 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.24 68.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.599 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.34 -23.56 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.209 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.68 0.59 32.4 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.888 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 56.5 t30 -83.53 143.01 30.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -75.41 119.85 20.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.134 0.492 . . . . 0.0 110.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.1 t -117.92 124.42 73.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.317 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 22' ' ' GLU . 7.8 m -77.18 107.15 9.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.431 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.09 141.32 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.243 0.544 . . . . 0.0 111.088 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.0 mt-10 -130.14 131.01 45.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.664 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.579 HD11 HG12 ' A' ' 40' ' ' ILE . 15.2 tp -125.15 120.35 31.12 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.619 ' O ' HG22 ' A' ' 39' ' ' THR . 53.6 m-20 -68.61 107.77 3.09 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.369 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 12' ' ' LEU . 37.8 mt -60.36 -39.79 88.45 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.873 0.844 . . . . 0.0 109.621 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.5 p-10 -63.35 -5.04 3.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.758 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -107.63 -9.16 15.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.786 -179.338 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.579 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.62 10.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.91 132.4 68.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.7 158.18 22.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.426 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -112.02 114.2 26.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.777 0.322 . . . . 0.0 110.214 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -105.5 82.94 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.545 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 5.3 m-20 54.04 52.8 12.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.908 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.54 35.69 22.06 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -148.53 118.05 6.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.7 m-85 -63.97 134.99 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.165 0.507 . . . . 0.0 110.571 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -126.58 116.51 21.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.456 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -72.88 114.13 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.47 30.47 6.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.923 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.58 -50.44 1.2 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.895 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 23.4 tt0 70.68 144.97 0.06 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.127 0.571 . . . . 0.0 111.345 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.559 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 6.3 m-20 71.08 33.65 2.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.343 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.91 -27.46 39.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.933 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.618 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.9 p -65.72 -17.29 64.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.977 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 58' ' ' THR . 7.9 pt-20 -76.8 -18.19 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 109.852 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -123.31 9.79 9.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.473 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -118.85 144.05 46.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.24 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -136.02 166.93 22.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.095 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 45.74 55.86 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.584 HG22 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -83.18 106.61 14.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.308 0.575 . . . . 0.0 110.806 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.55 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -109.86 118.43 36.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.607 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.1 t80 -93.1 128.59 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.065 0.459 . . . . 0.0 111.103 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 11.8 t-80 -124.38 88.77 52.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.151 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 19.7 Cg_endo -59.99 -35.94 91.47 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 124.156 3.237 . . . . 0.0 115.163 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -127.07 90.25 3.12 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.587 -178.504 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.498 ' HB3' ' HB2' ' A' ' 73' ' ' GLN . 17.5 tt0 -69.97 109.54 4.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.52 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.36 -148.77 33.12 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.165 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.67 -1.05 53.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.377 0.608 . . . . 0.0 109.797 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.45 -20.08 30.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.584 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 54.87 43.17 30.4 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.706 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 68' ' ' GLU . 15.6 mm100 -90.5 114.48 61.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.32 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.642 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 60.2 Cg_endo -72.87 112.36 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.154 1.903 . . . . 0.0 112.21 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -132.14 141.72 44.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.584 HD21 HG22 ' A' ' 62' ' ' ILE . 1.8 tm? -114.93 122.57 46.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.93 140.42 50.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.345 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -156.63 166.67 32.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.298 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.2 mmt180 -85.58 114.75 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.617 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.4 mp -99.35 127.75 45.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.199 0.523 . . . . 0.0 111.164 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.38 142.84 29.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -99.62 172.94 6.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.127 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.13 -27.65 62.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.406 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 23.9 t-20 -75.77 -28.19 58.32 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.707 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.63 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 9.6 pt-20 -105.98 -167.36 1.3 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -145.9 129.38 16.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.47 117.98 12.17 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.971 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.7 p-10 -66.61 114.01 5.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.0 111.706 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.575 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -115.78 172.21 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.69 146.45 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.0 p -128.2 150.64 34.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.74 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.422 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 78.2 m-20 -87.07 103.98 15.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.892 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' HB3' HD12 ' A' ' 97' ' ' ILE . 7.9 mt -75.43 0.53 16.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.81 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.642 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.7 m120 -60.9 -19.94 61.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.7 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -65.73 -22.01 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.783 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.6 mt -82.95 128.39 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.184 0.516 . . . . 0.0 111.267 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -119.1 168.29 10.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.81 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -112.59 121.05 43.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.499 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -112.25 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.401 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.89 24.73 13.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.556 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.78 20.58 8.37 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.699 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.499 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.5 ptp180 -129.8 139.98 51.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.152 0.476 . . . . 0.0 110.037 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 76.0 mt -87.08 124.05 32.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 0.0 110.992 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.6 p -127.98 128.78 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -84.12 146.73 27.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.551 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.947 0.78 . . . . 0.0 111.266 178.492 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.869 0.366 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -162.74 -175.27 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -59.45 -34.32 72.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.306 0.574 . . . . 0.0 109.615 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.763 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.3 -25.47 34.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.196 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -53.84 -33.07 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.037 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.14 37.39 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.987 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.763 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.3 p -115.28 157.26 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 111.466 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -147.91 169.73 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 8.0 m120 50.45 34.44 9.29 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.748 0.655 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -85.74 112.42 21.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.39 178.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.306 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.9 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.15 146.54 28.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.0 m -132.12 161.5 33.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.4 t-20 74.04 9.48 4.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.692 0.62 . . . . 0.0 111.178 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.74 24.85 22.22 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 97.07 23.16 15.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.98 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.68 ' HG2' HG21 ' A' ' 56' ' ' THR . 31.0 mtp180 -107.99 -17.07 14.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.588 0.232 . . . . 0.0 110.525 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.6 m -129.99 127.95 41.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.585 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.69 107.39 19.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmm_? -104.54 124.64 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.079 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.43 151.28 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.63 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.771 ' HG2' HG23 ' A' ' 32' ' ' THR . 13.8 mt-10 -113.06 110.96 21.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.1 t -123.17 147.5 46.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.77 143.68 43.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.922 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.535 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.5 p-10 -91.31 -175.09 4.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.809 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.37 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 111.463 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.76 -24.85 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.828 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.75 10.38 37.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.648 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.6 t-20 -96.13 146.79 24.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.454 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.8 m0 -77.07 121.43 23.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -120.5 120.89 64.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.724 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 22' ' ' GLU . 11.2 m -81.73 109.47 16.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -113.26 150.74 32.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.137 0.494 . . . . 0.0 111.585 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.0 mt-10 -132.7 135.03 45.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.71 116.24 18.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' THR . 16.0 m-20 -68.32 109.81 3.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.526 0.679 . . . . 0.0 110.196 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.9 HD11 HD11 ' A' ' 12' ' ' LEU . 15.9 mt -61.42 -41.02 96.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.531 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -65.02 -4.91 5.19 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.192 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -104.66 -14.15 15.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.455 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.517 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -141.28 10.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.13 132.09 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.216 -0.303 . . . . 0.0 110.23 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.87 159.74 22.24 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.256 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.8 t30 -111.51 116.65 31.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 0.0 110.198 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -104.29 85.15 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 40.66 59.41 2.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.0 112.943 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 86.43 38.6 8.2 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.997 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.416 ' N ' HD23 ' A' ' 80' ' ' LEU . 50.6 t-80 -162.11 124.23 2.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -67.07 138.81 57.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.109 0.48 . . . . 0.0 110.633 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -130.1 116.94 19.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.607 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.4 ' HH2' HD22 ' A' ' 94' ' ' LEU . 91.9 m95 -69.42 115.64 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 30.13 6.35 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.199 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -100.5 -53.59 1.05 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.071 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.5 tt0 73.55 139.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.377 0.608 . . . . 0.0 111.738 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 t30 70.35 36.69 1.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.133 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -76.1 -26.93 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.041 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.68 HG21 ' HG2' ' A' ' 17' ' ' ARG . 36.3 p -63.66 -24.31 67.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 58' ' ' THR . 1.7 pt-20 -70.24 -17.1 63.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.269 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.7 p -125.78 16.0 8.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.503 0.668 . . . . 0.0 109.984 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.94 150.1 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.636 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -143.4 172.5 12.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.479 -179.636 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.3 t70 48.22 57.22 6.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.082 0.467 . . . . 0.0 110.012 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -91.93 113.86 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.498 -177.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.421 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -132.69 129.67 39.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 178.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.5 t80 -92.29 139.63 30.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 112.223 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 5.5 t-160 -120.38 82.06 31.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.75 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.808 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.8 Cg_endo -55.88 -45.84 35.81 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 123.908 3.072 . . . . 0.0 114.539 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.808 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -124.52 85.31 2.4 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.107 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 5.1 tt0 -69.73 114.3 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.613 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.35 -145.41 6.09 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 124.596 1.185 . . . . 0.0 113.528 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.33 -5.81 58.84 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.62 -23.59 56.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.32 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 54.57 45.78 26.19 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.216 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 83.9 mt-30 -112.22 122.57 36.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.69 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.4 Cg_endo -72.5 110.85 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.476 2.118 . . . . 0.0 111.533 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -134.73 141.97 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.47 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.57 124.73 53.06 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.918 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.06 144.36 48.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.496 . . . . 0.0 110.498 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.04 170.55 19.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.87 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.636 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -85.48 114.86 22.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.15 126.37 46.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -73.6 136.29 43.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.261 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.08 173.18 7.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.185 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.54 -21.55 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.423 . . . . 0.0 110.729 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -71.68 -19.97 62.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.611 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.27 37.95 6.1 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.8 pt-20 -124.32 -162.92 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -138.36 139.28 38.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.769 0.795 . . . . 0.0 111.257 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -138.7 111.64 7.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.281 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.2 p-10 -63.4 111.92 2.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.692 0.758 . . . . 0.0 111.777 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 33.2 mmt180 -114.56 175.22 5.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.447 ' HB2' HD13 ' A' ' 75' ' ' ILE . 5.9 p-10 -143.55 146.12 33.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.4 p -128.86 144.23 38.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.616 0.722 . . . . 0.0 111.096 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.496 ' HB3' HD22 ' A' ' 95' ' ' ASN . 36.9 m-20 -79.87 106.11 11.65 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.732 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.679 ' HB3' HD12 ' A' ' 97' ' ' ILE . 3.8 mt -78.57 1.83 21.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -59.92 -19.95 54.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.426 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -62.92 -22.95 67.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.188 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.2 mt -83.8 128.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.011 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 38.6 tt0 -122.4 162.34 21.79 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.944 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.475 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 4.8 t30 -102.01 117.91 35.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.179 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 51.3 t -113.0 95.82 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.343 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.29 23.36 13.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.239 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.06 8.23 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.428 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 17.9 ptp180 -130.39 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.807 0.304 . . . . 0.0 110.259 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.05 115.6 23.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.8 t -117.93 121.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -81.49 146.47 30.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.166 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.427 ' H ' ' HB3' ' A' ' 96' ' ' ARG . 36.6 tt0 . . . . . 0 C--O 1.247 0.957 0 O-C-N 123.67 0.607 . . . . 0.0 111.372 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 tpp . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.607 0.241 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 p -174.16 -177.94 1.38 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.276 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -62.66 -32.93 74.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.73 -25.36 54.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -55.61 -32.51 63.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 110.923 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.0 m -133.04 32.3 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 65.8 m -116.53 156.51 26.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.593 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.6 ptp180 -153.41 168.79 24.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.616 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.57 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 55.6 t30 55.44 31.25 16.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.431 0.634 . . . . 0.0 110.806 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.563 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.24 114.73 17.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.904 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 153.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -89.23 146.0 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.4 m -131.68 165.47 23.63 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.4 t-20 71.81 8.31 6.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 111.638 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.21 25.08 14.88 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.552 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.33 27.96 10.25 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.783 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.742 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -112.71 -15.49 12.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.815 0.34 . . . . 0.0 110.413 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.2 m -129.85 130.23 44.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 0.0 111.717 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.1 tp -99.28 111.47 23.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.508 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -113.07 124.29 52.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.55 153.53 33.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 9.0 mt-10 -106.05 109.92 22.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -117.98 143.61 46.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.56 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.84 144.27 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.682 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -88.42 -173.7 4.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.952 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.35 67.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.99 -24.48 55.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.945 0.402 . . . . 0.0 111.294 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.46 0.76 32.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.512 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.5 t30 -82.8 143.56 30.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -77.5 129.14 35.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.38 123.72 65.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.558 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -77.29 107.79 9.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.503 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.8 m -110.3 143.44 40.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.305 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -128.06 143.51 51.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -141.82 120.53 12.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 39' ' ' THR . 14.4 m-20 -70.45 107.16 3.7 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 110.004 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 12' ' ' LEU . 52.6 mt -60.69 -40.59 92.76 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.797 0.808 . . . . 0.0 109.675 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.57 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 5.2 p-10 -63.02 -4.95 2.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.86 -12.19 15.95 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.706 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.539 HG23 HG23 ' A' ' 39' ' ' THR . 2.4 pp -141.24 10.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.018 0.437 . . . . 0.0 112.11 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.32 129.36 70.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 158.1 21.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.189 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.0 t30 -111.56 114.73 28.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.111 0.481 . . . . 0.0 109.973 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -103.74 87.28 2.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.258 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 1.9 p30 45.24 57.51 4.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.561 0.744 . . . . 0.0 112.46 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.646 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.62 36.24 26.66 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.998 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -150.57 115.33 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.8 m-85 -61.8 135.72 57.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.634 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -129.69 115.06 16.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -69.67 114.89 8.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.0 5.95 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.823 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.11 -53.41 0.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.685 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.1 tt0 74.91 144.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.22 0.608 . . . . 0.0 110.961 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.7 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.7 m-20 68.36 36.94 2.86 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.265 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.26 -29.27 47.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.742 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.8 p -63.79 -23.28 67.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.044 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.791 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.9 pt-20 -71.39 -16.12 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 109.843 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.791 HG23 ' HG3' ' A' ' 57' ' ' GLU . 76.8 p -126.04 9.15 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -119.52 142.31 48.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.157 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 169.28 17.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.776 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.6 t70 47.22 54.91 8.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.072 0.463 . . . . 0.0 110.973 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.57 109.45 20.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 124.45 41.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.803 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.3 t80 -92.08 137.19 32.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.718 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 6.0 t-80 -123.97 86.71 53.57 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.976 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 5.7 Cg_endo -53.09 -41.0 75.0 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 124.575 3.517 . . . . 0.0 115.131 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.27 85.99 2.49 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.302 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.404 ' HA ' ' ND1' ' A' ' 65' ' ' HIS . 24.6 tt0 -66.54 115.49 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.217 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.09 -150.84 3.73 Favored Glycine 0 C--N 1.333 0.414 0 O-C-N 124.455 1.097 . . . . 0.0 113.449 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.84 -5.77 56.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 109.813 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -22.68 59.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.486 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 57.51 42.88 23.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.374 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -109.92 125.38 31.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.871 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.61 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -73.22 112.93 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.754 2.303 . . . . 0.0 112.206 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.508 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.3 pp -134.45 140.71 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -110.78 125.02 53.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.522 ' H ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -119.31 139.86 51.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.652 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -161.77 168.36 23.33 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.043 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 4.2 mmt85 -85.82 114.86 23.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.646 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.3 131.73 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.897 0.38 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -77.0 137.45 39.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.85 168.94 10.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 45' ' ' ASP . 72.2 m -54.17 -28.32 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.862 0.363 . . . . 0.0 111.602 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -67.19 -25.11 65.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 111.558 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.29 33.51 5.67 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.679 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -118.07 -160.37 0.78 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.974 -0.613 . . . . 0.0 109.611 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -142.61 137.56 30.13 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.815 0.817 . . . . 0.0 111.204 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.56 117.45 13.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.499 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.0 p-10 -66.11 113.28 4.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.614 ' HB2' HD22 ' A' ' 80' ' ' LEU . 33.6 mmt180 -115.05 172.23 7.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.86 151.61 47.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.552 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.8 p -139.68 144.68 28.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.38 0.61 . . . . 0.0 110.755 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 10.3 m120 -81.69 110.31 16.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.756 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.7 mt -79.33 3.02 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.115 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.61 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 15.6 m120 -62.86 -18.29 62.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.55 -28.36 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.908 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -77.75 130.19 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.494 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -125.96 166.28 17.23 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.3 t30 -109.06 123.9 49.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.69 94.04 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.0 t30 58.82 27.15 15.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.916 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 20.96 7.97 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.814 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 12.7 ptp180 -131.25 139.6 49.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.356 0.578 . . . . 0.0 110.612 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.8 mp -90.29 124.9 35.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.792 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.23 130.65 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.435 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 3.3 p90 -79.97 145.16 32.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.475 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.489 0.493 . . . . 0.0 111.114 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.723 0.297 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -153.44 -177.42 6.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -64.13 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.734 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.13 -23.25 54.41 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.798 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.93 -23.37 63.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 111.038 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.0 m -148.6 38.03 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.734 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.8 p -116.74 153.29 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.496 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 9.6 t-20 54.23 30.64 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.534 0.522 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.12 113.54 12.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -143.38 149.17 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.934 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -84.04 144.56 29.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 12.7 m -131.33 161.36 32.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.655 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.54 10.44 5.68 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 123.559 0.537 . . . . 0.0 111.237 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.13 24.84 23.61 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.453 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 96.86 22.02 19.31 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.851 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.644 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -104.85 -19.03 14.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.626 0.251 . . . . 0.0 110.407 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 34.5 m -130.44 126.75 37.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.779 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' CD2' HD13 ' A' ' 97' ' ' ILE . 61.0 tp -96.97 109.55 22.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.517 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.1 tmm_? -109.08 124.24 50.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.52 149.91 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.0 mt-10 -104.67 112.2 25.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.9 p -124.21 147.51 47.98 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 111.844 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.29 144.52 36.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.575 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 8.5 p30 -86.07 -175.0 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.52 69.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.84 -23.51 59.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.56 3.2 30.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.959 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.477 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 5.2 t30 -86.07 145.57 27.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.113 0.456 . . . . 0.0 110.078 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -74.14 126.03 29.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.718 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -126.99 128.97 71.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -86.7 112.99 22.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.403 ' HB3' HD13 ' A' ' 104' ' ' LEU . 4.1 t -112.1 151.81 28.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.039 0.447 . . . . 0.0 110.749 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -139.05 132.0 29.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.196 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.614 HD11 HG12 ' A' ' 40' ' ' ILE . 12.8 tp -133.76 123.99 25.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.01 0.433 . . . . 0.0 110.122 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 39' ' ' THR . 38.9 m-20 -72.21 108.36 5.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 12' ' ' LEU . 24.8 mt -59.53 -45.88 90.49 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.087 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -63.97 -5.08 3.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.674 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.73 -9.79 20.54 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.056 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.614 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.23 11.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 111.669 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.64 132.55 68.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.03 157.97 21.32 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.774 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.3 t30 -110.13 106.31 15.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.48 80.99 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.189 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 51.15 56.64 7.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.143 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.53 39.32 18.52 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.273 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -157.41 117.78 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 0.0 110.366 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.4 m-85 -61.95 137.76 58.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.315 0.578 . . . . 0.0 111.701 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -133.36 118.47 18.51 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.03 115.22 10.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 29.21 6.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.13 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.99 -53.26 1.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.086 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 35.1 tt0 72.13 141.93 0.06 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.309 0.644 . . . . 0.0 111.136 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.57 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 79.9 m-20 76.83 30.63 0.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.937 0.895 . . . . 0.0 110.997 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.5 p90 -78.0 -29.28 49.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.374 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.644 HG21 ' HG2' ' A' ' 17' ' ' ARG . 53.8 p -66.02 -25.16 66.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.558 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.666 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.7 pt-20 -70.63 -19.3 62.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.273 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.666 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -122.68 15.74 10.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.332 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.92 151.22 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.59 173.09 11.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.251 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 5.6 t70 47.53 52.41 12.47 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.563 0.54 . . . . 0.0 110.449 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.39 108.75 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.333 0.587 . . . . 0.0 111.74 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.428 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -123.52 123.16 39.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.561 178.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.8 t80 -91.77 133.81 35.28 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.015 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.42 ' ND1' ' HA ' ' A' ' 68' ' ' GLU . 1.3 t-80 -121.67 86.54 45.15 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.491 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.614 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.2 Cg_endo -56.34 -38.6 94.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.754 2.969 . . . . 0.0 113.727 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.614 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -130.48 88.22 2.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.46 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.42 ' HA ' ' ND1' ' A' ' 65' ' ' HIS . 16.9 tt0 -69.66 115.72 9.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.949 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.21 -146.47 14.97 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.536 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.75 -14.38 59.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.13 -27.21 62.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 52.0 46.95 25.72 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.178 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -99.47 122.74 50.64 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.631 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.8 Cg_endo -72.75 109.03 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.365 2.043 . . . . 0.0 112.0 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.449 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -135.26 141.61 42.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.3 tm? -112.04 123.41 50.19 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.47 ' H ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -119.91 138.75 53.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.609 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.35 168.19 27.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.006 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.62 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.9 mmt180 -85.79 115.0 23.18 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.623 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -98.45 124.36 43.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -79.48 142.18 36.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.554 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 2.6 p-10 -97.71 175.98 5.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.8 m -61.4 -22.44 65.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.99 -27.78 43.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.436 . . . . 0.0 110.574 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.8 33.21 2.68 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.829 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 -109.47 -162.46 0.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.66 130.2 16.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.268 0.556 . . . . 0.0 110.294 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.19 117.76 13.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.157 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.9 p-10 -66.68 120.07 12.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.438 0.637 . . . . 0.0 112.209 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.564 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.3 mmt180 -116.42 177.67 4.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -143.91 147.51 34.09 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.2 p -135.3 144.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.791 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HB3' HD22 ' A' ' 95' ' ' ASN . 60.7 m-20 -81.53 110.12 16.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.9 mt -78.24 2.45 18.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.505 HD22 ' HB3' ' A' ' 93' ' ' ASN . 19.6 m-80 -63.61 -16.19 60.23 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -25.05 67.45 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.538 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.629 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.9 mt -80.11 121.47 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.783 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -113.7 164.01 14.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.019 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.0 t30 -107.13 116.38 31.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.71 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 60.6 t -112.16 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.06 0.457 . . . . 0.0 110.279 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.18 24.73 14.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.762 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.4 19.14 9.57 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.509 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -130.59 142.81 50.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.039 0.42 . . . . 0.0 110.606 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.403 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.0 mp -85.01 119.24 25.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.0 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.31 123.59 70.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.885 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -81.69 145.17 30.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.452 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.596 178.369 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 3.1 ptt? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.442 ' H ' ' HG3' ' A' ' 1' ' ' MET . 3.3 m -138.58 -165.37 1.81 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -54.5 -36.34 64.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.506 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.17 -25.89 35.39 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.787 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 20.4 t70 -57.54 -31.8 66.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.209 0.528 . . . . 0.0 110.631 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.1 m -130.15 34.96 4.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.971 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.1 m -117.32 158.54 24.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 0.0 112.027 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -155.97 166.22 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.966 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.452 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.8 t-20 54.71 33.97 20.63 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.619 0.574 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.87 113.85 16.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.217 0.532 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.71 155.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.735 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -94.79 135.29 36.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 14' ' ' ASN . 11.2 m -120.31 165.36 14.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.691 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.0 t-20 74.12 5.98 4.72 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.575 0.547 . . . . 0.0 111.067 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.94 16.16 39.67 Favored Glycine 0 CA--C 1.506 -0.48 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 105.3 27.03 5.99 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.735 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.1 mtp180 -110.86 -18.16 13.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.645 0.26 . . . . 0.0 110.455 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 63.1 m -129.6 128.46 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.369 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.9 tp -97.85 110.05 22.69 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.627 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.3 tmm_? -108.47 124.16 49.99 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.71 151.32 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.949 0.404 . . . . 0.0 110.191 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.2 mt-10 -106.94 113.17 26.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 6' ' ' SER . 7.8 p -124.22 146.78 48.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.184 0.516 . . . . 0.0 112.228 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.58 144.88 39.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.02 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -86.25 -173.17 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.804 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.19 73.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.149 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.58 -24.19 63.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.726 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.7 44.23 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.463 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.3 t-20 -84.35 144.89 28.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.169 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -76.25 121.19 22.56 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 t -120.67 154.99 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.374 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -107.53 112.96 25.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' LEU . 11.6 m -112.97 144.23 42.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.237 0.541 . . . . 0.0 111.386 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.2 mt-10 -132.8 131.52 41.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.653 HD11 HG12 ' A' ' 40' ' ' ILE . 12.1 tp -131.49 120.53 23.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.191 0.519 . . . . 0.0 109.907 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 39' ' ' THR . 36.0 m-20 -70.04 110.01 4.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.179 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 12' ' ' LEU . 37.7 mt -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.874 0.845 . . . . 0.0 109.151 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.5 OUTLIER -63.22 -3.66 2.0 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.548 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.89 -14.62 15.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.326 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.653 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -141.7 13.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.53 131.89 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.21 158.12 21.46 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.569 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.8 t30 -110.35 106.79 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.05 84.13 3.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 53.09 59.32 4.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.258 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.605 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.56 40.27 39.21 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.729 -1.225 . . . . 0.0 111.969 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -160.32 121.15 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.499 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 49.4 m-85 -63.69 138.83 58.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 111.228 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -134.48 117.08 15.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -69.51 115.79 9.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.883 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.7 36.79 3.89 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.219 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.25 -52.12 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.615 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.7 tt0 73.57 143.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.56 0.695 . . . . 0.0 111.976 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t30 66.64 31.76 7.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.421 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -69.46 -27.38 65.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.735 HG21 ' HG2' ' A' ' 17' ' ' ARG . 17.0 p -64.38 -17.6 63.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.701 ' HG3' HG23 ' A' ' 58' ' ' THR . 5.5 pt-20 -72.7 -21.78 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.6 p -122.91 12.91 9.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -121.86 145.7 47.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.223 0.535 . . . . 0.0 111.311 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.5 171.27 14.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.222 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.1 t70 45.45 56.1 6.0 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.538 0.524 . . . . 0.0 110.963 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.3 mt -88.42 111.28 22.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.051 0.453 . . . . 0.0 112.03 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 125.25 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.91 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.599 ' CE1' HD12 ' A' ' 94' ' ' LEU . 25.3 t80 -91.09 137.05 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.297 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.647 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.6 t-160 -121.27 86.76 43.68 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.316 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 8.5 Cg_endo -57.4 -44.58 41.31 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.442 2.761 . . . . 0.0 113.921 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -123.43 84.12 2.23 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.802 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.647 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 2.2 tt0 -66.92 120.17 13.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.24 -140.73 2.55 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 124.574 1.172 . . . . 0.0 114.096 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.82 -11.71 58.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.6 -27.29 63.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.65 46.17 23.24 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.2 129.18 25.07 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.364 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.5 Cg_endo -73.21 110.0 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.737 2.291 . . . . 0.0 112.141 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.2 pp -136.5 141.98 39.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.5 124.96 53.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.333 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.509 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.93 145.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.006 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -162.14 169.7 20.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.1 mmt180 -86.89 115.33 24.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.605 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.6 mp -99.35 123.0 43.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.025 0.44 . . . . 0.0 110.762 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.36 137.55 39.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.359 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -96.83 170.48 9.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.2 m -58.05 -25.17 60.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -71.96 -18.89 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.931 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.76 36.9 5.41 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.994 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.629 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.8 pt-20 -118.7 -161.7 0.86 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -141.38 135.13 30.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.968 0.89 . . . . 0.0 111.133 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -130.68 108.13 9.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.7 p-10 -67.1 112.37 4.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.371 0.605 . . . . 0.0 110.61 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.522 ' HB2' HD22 ' A' ' 80' ' ' LEU . 35.9 mmt180 -113.62 177.41 4.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.726 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.17 148.9 39.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.499 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.1 p -136.81 145.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.375 0.607 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HB3' HD22 ' A' ' 95' ' ' ASN . 13.5 m120 -83.11 114.03 21.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.153 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.599 HD12 ' CE1' ' A' ' 64' ' ' PHE . 2.2 mt -82.02 2.11 32.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 111.106 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.2 m-80 -63.45 -10.48 17.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.299 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' HD2' ' N ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -70.27 -20.13 63.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.017 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.3 mt -85.18 131.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.63 159.19 27.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.231 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.9 t30 -106.28 118.97 38.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 39.4 t -113.0 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.035 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 60.07 21.87 11.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.825 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.43 23.39 6.32 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.55 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.5 ptp180 -132.57 141.07 48.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.122 0.461 . . . . 0.0 110.594 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.2 mp -89.9 118.17 29.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.653 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.75 127.3 68.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.321 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -82.75 144.91 29.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.583 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.317 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.581 0.229 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -152.39 -178.14 6.64 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -63.96 -38.44 91.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.049 0.452 . . . . 0.0 109.783 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.63 -24.5 21.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.52 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.51 -29.9 59.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -138.78 35.04 2.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.7 m -115.92 155.67 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 111.825 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.76 164.5 36.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.552 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 94.5 m-20 53.3 36.34 22.54 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.615 0.572 . . . . 0.0 111.484 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.44 113.43 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.691 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 t -142.28 150.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.87 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.1 tp -85.91 143.98 27.91 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 m -130.37 162.44 29.08 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.4 t-20 73.76 9.14 4.88 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 0.0 111.216 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.95 19.45 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 96.79 21.0 22.56 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.074 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 56' ' ' THR . 31.5 mtp180 -102.74 -18.16 15.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.728 0.299 . . . . 0.0 110.697 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 92.9 m -130.49 129.24 42.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.098 0.475 . . . . 0.0 111.773 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 97' ' ' ILE . 56.9 tp -95.6 110.86 22.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.278 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.7 tmm_? -109.05 123.75 49.66 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.44 145.17 29.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.0 mt-10 -102.05 110.69 22.73 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.4 t -125.9 147.84 49.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 111.754 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.68 145.64 38.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.37 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -87.16 -172.85 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.459 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.02 -14.29 62.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.256 0.55 . . . . 0.0 111.773 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.23 -17.22 31.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.252 0.549 . . . . 0.0 110.141 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.03 56.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.547 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 63.2 t30 -90.47 145.99 24.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -79.8 126.66 31.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.029 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.862 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -91.06 113.38 25.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 104' ' ' LEU . 2.3 m -110.75 142.6 42.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.094 0.473 . . . . 0.0 111.89 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.83 131.5 42.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.051 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.19 122.89 24.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.092 0.472 . . . . 0.0 110.128 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 39' ' ' THR . 74.1 m-20 -69.37 109.45 4.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.323 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD11 HD11 ' A' ' 12' ' ' LEU . 18.9 mt -61.89 -43.17 99.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.742 0.782 . . . . 0.0 109.655 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.23 -4.65 1.86 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.516 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -102.35 -15.06 16.67 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.355 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.5 HD12 HG13 ' A' ' 41' ' ' ILE . 2.6 pp -141.54 13.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -128.08 129.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.08 154.84 20.02 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.617 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.473 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -111.06 111.42 22.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.381 . . . . 0.0 110.154 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.09 85.25 2.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.984 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 6.7 m-20 50.0 58.73 5.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.623 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 80.57 34.31 28.75 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.746 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -153.28 119.58 5.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.577 0.227 . . . . 0.0 111.148 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.498 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 48.8 m-85 -67.19 137.59 56.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.226 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -133.2 117.14 17.08 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.226 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -68.61 116.15 8.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.776 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.33 25.98 8.5 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.946 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.42 -52.63 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.917 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 22.4 tt0 74.59 143.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.52 0.676 . . . . 0.0 111.883 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 t30 68.52 35.41 3.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.357 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.6 p90 -76.9 -24.35 52.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.611 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.675 HG21 ' HG2' ' A' ' 17' ' ' ARG . 13.1 p -67.58 -21.57 65.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.925 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.669 ' HG3' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -74.85 -15.8 60.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.254 0.549 . . . . 0.0 109.713 179.568 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.669 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.9 p -126.14 14.18 7.82 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.061 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.47 141.33 52.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.755 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -135.52 168.97 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.501 -179.228 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 48.65 50.99 16.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.105 0.479 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.6 mt -83.58 112.41 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.43 123.07 37.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.684 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.679 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.3 t80 -92.09 131.18 37.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.684 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 7.9 t-80 -120.19 87.15 39.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.9 Cg_endo -55.21 -33.18 83.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 124.387 3.391 . . . . 0.0 115.279 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -131.82 91.64 3.01 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.502 -178.392 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -65.24 114.12 4.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.086 178.158 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.61 -147.18 6.77 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.595 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.91 -0.58 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.159 0.504 . . . . 0.0 110.086 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.69 -19.66 37.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 23.5 mm-40 57.26 42.27 25.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.107 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -101.8 118.73 58.88 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 57.2 Cg_endo -71.07 114.02 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.508 2.139 . . . . 0.0 112.898 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.442 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 141.59 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.3 127.97 56.32 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.298 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.511 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.48 141.35 51.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 110.315 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.43 168.17 25.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.003 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.693 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.8 mmt180 -85.25 115.44 23.03 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.641 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -98.13 120.9 39.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 111.627 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.14 141.56 30.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.04 173.58 6.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.183 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 78.1 m -59.25 -25.1 63.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -75.03 -27.37 60.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 110.413 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.37 38.39 2.11 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.497 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 pt-20 -109.84 -167.19 1.17 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.78 128.94 15.64 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.381 0.61 . . . . 0.0 109.78 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.58 110.79 6.96 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.0 p-10 -58.8 120.2 8.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.999 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.641 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.5 mmt180 -120.87 173.43 7.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.065 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.42 144.33 33.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 p -131.03 148.8 33.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.362 0.601 . . . . 0.0 111.389 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.471 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.8 OUTLIER -82.04 107.28 14.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.751 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.679 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.3 mt -79.85 5.57 13.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 16.1 m-80 -65.28 -17.18 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.041 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.94 -25.31 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.386 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.2 mt -79.13 129.87 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.207 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -124.09 163.39 21.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.59 122.06 45.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.954 0.407 . . . . 0.0 110.733 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.63 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.521 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 60.79 19.19 9.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 111.523 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.47 20.55 8.51 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.068 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.14 138.01 50.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.1 mp -84.14 123.73 30.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.64 127.65 56.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -79.16 145.6 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.404 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.407 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 14.6 m -165.4 176.3 8.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -59.54 -35.9 75.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.797 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.97 -24.56 54.02 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.733 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.51 -33.16 67.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.71 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -129.09 31.42 4.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.797 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 37.5 p -121.14 155.92 33.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -151.21 170.49 19.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.2 m120 54.79 30.92 14.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.533 0.521 . . . . 0.0 111.34 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.7 114.23 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.602 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.4 t -142.39 149.64 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.858 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.584 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.2 tp -86.35 138.36 31.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 14.1 m -123.24 164.0 19.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.629 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.5 t-20 71.33 9.58 6.55 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.552 0.533 . . . . 0.0 111.259 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.63 17.19 46.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 107.4 19.43 9.35 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.069 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.663 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.1 mtp180 -102.77 -20.0 14.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 110.675 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.6 m -128.45 126.75 41.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 0.0 111.811 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -96.66 105.55 17.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.96 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 tmm_? -101.38 123.61 45.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.53 140.94 22.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.642 0.258 . . . . 0.0 110.552 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 4.0 mt-10 -98.55 109.48 22.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.1 p -118.1 142.29 47.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.19 0.519 . . . . 0.0 111.42 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.93 143.13 47.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.889 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.42 ' HB3' HG21 ' A' ' 31' ' ' VAL . 22.4 p-10 -91.17 -174.05 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.56 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.27 -26.74 63.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.1 -24.0 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.951 0.405 . . . . 0.0 111.258 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.64 4.83 42.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.637 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.9 t-20 -91.03 144.57 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.466 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.9 m0 -77.21 126.52 31.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.963 0.411 . . . . 0.0 110.815 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -120.49 125.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 m -74.93 107.28 6.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.549 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.8 m -111.22 143.42 42.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.177 0.513 . . . . 0.0 111.365 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 10.2 mt-10 -130.19 131.78 45.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.565 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 113.77 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 39' ' ' THR . 26.9 m-20 -67.43 108.72 2.91 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.782 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 12' ' ' LEU . 26.5 mt -60.71 -39.46 88.66 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.797 0.808 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -64.12 -3.82 3.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.68 -14.51 15.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.254 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.551 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -140.43 13.95 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -129.29 131.45 67.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.86 157.81 22.02 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.353 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -111.8 112.73 24.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.847 0.355 . . . . 0.0 110.472 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -106.9 86.46 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 22.1 m-20 53.68 52.25 13.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.153 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.31 37.95 23.05 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.746 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.59 120.98 7.35 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.5 m-85 -67.24 132.72 48.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.038 0.447 . . . . 0.0 110.98 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -125.18 117.61 24.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.218 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.46 115.36 10.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.584 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 22.03 11.63 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.347 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -90.18 -51.18 2.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.987 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.8 tt0 72.57 142.14 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 6.6 t-20 67.04 38.83 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.987 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.27 -26.7 47.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.709 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.663 HG21 ' HG2' ' A' ' 17' ' ' ARG . 41.6 p -64.01 -21.95 66.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.627 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.689 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.9 pt-20 -74.65 -14.05 60.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.114 0.483 . . . . 0.0 109.998 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.8 p -128.35 15.93 6.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.86 148.91 52.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.904 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -142.59 172.7 12.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.888 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 2.0 t70 46.7 53.35 10.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.556 0.535 . . . . 0.0 110.778 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG22 HD21 ' A' ' 76' ' ' LEU . 2.3 mt -85.31 114.17 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.42 0.629 . . . . 0.0 111.707 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.532 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.91 120.47 29.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.129 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' CE1' HD12 ' A' ' 94' ' ' LEU . 12.0 t80 -92.22 132.27 36.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.717 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 30.1 t-80 -123.55 89.31 51.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -59.04 -38.4 87.74 Favored 'Trans proline' 0 N--CA 1.479 0.662 0 C-N-CA 124.106 3.204 . . . . 0.0 115.085 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.87 83.52 2.08 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.885 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.06 110.42 1.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.984 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.29 -141.71 16.03 Favored Glycine 0 C--N 1.332 0.324 0 O-C-N 123.944 0.777 . . . . 0.0 113.968 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.38 -5.66 59.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.382 0.61 . . . . 0.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.99 -20.6 38.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 52.8 42.49 31.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -94.4 119.35 66.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.94 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.2 Cg_endo -71.71 110.46 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.16 1.907 . . . . 0.0 112.24 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.485 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.43 141.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.84 125.31 53.93 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.136 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.24 140.76 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 110.235 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.53 168.51 25.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.564 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -86.23 115.07 23.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 2.3 mp -99.15 126.51 44.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -81.96 142.25 32.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.798 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.644 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -100.66 174.19 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.063 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.95 -24.27 62.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -77.13 -28.21 54.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.28 0.562 . . . . 0.0 110.103 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.11 40.05 1.73 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.945 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.665 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.1 pt-20 -111.35 -167.18 1.15 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -142.75 127.81 18.51 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 113.89 12.34 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 6.6 p-10 -65.87 114.65 5.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.486 0.66 . . . . 0.0 111.507 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.617 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.4 mmt180 -114.27 179.56 3.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.938 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.12 148.87 39.03 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -133.05 140.05 48.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.806 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.564 ' HB3' HD22 ' A' ' 95' ' ' ASN . 5.8 m-20 -82.76 104.99 13.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.174 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.625 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.1 mt -74.0 1.41 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.586 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.564 HD22 ' HB3' ' A' ' 93' ' ' ASN . 28.9 m-80 -61.28 -17.53 53.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.322 0.582 . . . . 0.0 109.779 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.06 -25.58 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.149 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.58 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -80.81 126.84 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.752 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.407 ' NE2' ' HA ' ' A' ' 2' ' ' SER . 79.0 mm-40 -117.46 163.09 16.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.809 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.7 t30 -107.88 120.31 41.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.127 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.3 t -114.02 94.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.503 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.27 27.97 17.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.222 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.04 26.34 7.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.617 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.8 ptp180 -133.15 137.08 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.991 0.395 . . . . 0.0 110.297 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 74.6 mt -85.6 122.66 30.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.774 0.321 . . . . 0.0 110.188 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.4 t -132.85 128.04 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.523 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -79.24 146.02 33.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 -179.737 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.616 0.246 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.616 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 41.5 p 174.56 -179.38 0.11 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -56.33 -30.3 62.4 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.329 0.585 . . . . 0.0 109.639 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.731 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.86 -21.74 63.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.735 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.21 -30.67 68.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 m -139.18 39.43 2.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.749 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 89.3 p -113.64 156.98 22.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -149.03 163.28 37.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.444 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 92.5 m-20 51.42 35.48 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.909 0.756 . . . . 0.0 111.429 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.695 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -76.59 112.61 13.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.755 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 t -142.99 155.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.851 HD11 HD11 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -89.02 148.43 23.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.3 m -131.89 162.01 31.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.362 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 3.7 t-20 70.62 12.76 7.33 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 123.699 0.625 . . . . 0.0 111.327 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.47 19.2 33.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.565 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 100.69 24.04 9.6 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.5 mtp180 -105.56 -19.44 13.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.545 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.0 m -129.79 125.84 36.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.295 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 12' ' ' LEU . 48.5 tp -94.08 107.36 19.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.426 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 tmm_? -102.03 123.12 45.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -148.19 138.86 22.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.926 0.394 . . . . 0.0 110.655 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 4.3 mt-10 -103.24 110.76 22.85 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.7 t -124.12 146.86 48.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 111.085 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.84 145.28 45.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.732 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -83.41 -172.08 3.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -33.6 74.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.951 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.34 -24.41 59.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.212 0.53 . . . . 0.0 110.776 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.83 8.47 27.97 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.855 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 59.0 t30 -86.15 145.08 27.16 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -77.64 117.8 19.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.066 0.46 . . . . 0.0 111.1 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.92 153.15 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.6 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 47.4 m -114.68 122.3 46.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.914 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t -124.52 151.15 45.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 0.0 110.493 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -133.62 131.23 39.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.656 HD11 HG12 ' A' ' 40' ' ' ILE . 14.2 tp -127.47 120.29 28.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 0.0 110.278 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 39' ' ' THR . 32.3 m-20 -68.41 107.5 2.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.737 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.851 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -62.2 -40.47 96.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.724 0.773 . . . . 0.0 109.227 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.1 p-10 -64.31 -4.95 4.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.528 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -106.21 -12.06 15.85 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.414 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.656 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -141.71 11.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 112.083 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.3 mt -128.1 131.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.48 157.64 20.94 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.782 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.9 t30 -111.62 108.4 17.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.998 0.428 . . . . 0.0 110.094 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -96.5 78.1 2.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.628 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . 72.6 m-20 48.97 63.77 1.99 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.057 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.11 34.69 36.68 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.542 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -155.41 114.74 3.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.762 -0.257 . . . . 0.0 110.576 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.0 m-85 -60.75 140.99 57.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 111.389 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.66 117.33 16.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.502 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -71.66 115.11 10.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.8 28.15 7.56 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.843 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.535 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -97.41 -52.48 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.452 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.7 tt0 73.26 141.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.263 0.625 . . . . 0.0 111.475 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.601 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 7.4 m-20 71.0 34.56 1.84 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.631 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.9 p90 -77.5 -31.11 53.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.629 HG21 ' HG2' ' A' ' 17' ' ' ARG . 26.8 p -62.54 -26.65 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.931 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 58' ' ' THR . 17.7 pt-20 -70.31 -14.85 62.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.325 0.583 . . . . 0.0 109.955 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.617 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.1 p -127.03 13.97 7.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.3 145.09 51.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.144 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.16 172.63 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.606 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.472 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 49.14 48.36 20.99 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.059 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.37 108.2 15.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.0 111.43 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -125.08 125.63 44.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.66 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.695 ' HE2' ' HB1' ' A' ' 10' ' ' ALA . 8.9 t80 -92.28 134.78 34.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.351 0.596 . . . . 0.0 111.879 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -121.65 85.3 43.82 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.156 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -53.91 -35.5 80.31 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.15 3.233 . . . . 0.0 114.472 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -131.69 86.2 2.32 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.436 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -63.36 116.55 5.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.92 -144.18 10.28 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 124.415 1.072 . . . . 0.0 113.83 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.76 -16.01 52.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.46 0.648 . . . . 0.0 109.55 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.96 -24.08 65.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.357 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 52.24 52.47 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.71 0.631 . . . . 0.0 110.56 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -110.89 122.14 38.9 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.802 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.0 Cg_endo -71.51 110.65 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.302 2.002 . . . . 0.0 112.033 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.678 HD11 HH21 ' A' ' 77' ' ' ARG . 1.3 pp -135.76 141.54 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -111.84 124.14 51.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.678 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.98 142.66 47.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.4 167.83 26.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.2 mmt180 -86.27 114.55 23.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.5 mp -99.19 126.97 45.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.368 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -82.92 143.34 30.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.1 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 45' ' ' ASP . 9.9 t70 -105.76 167.24 9.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.987 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.6 m -51.26 -31.25 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.359 0.412 . . . . 0.0 111.784 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.06 -26.71 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.357 0.599 . . . . 0.0 110.908 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.87 38.8 3.76 Favored Glycine 0 CA--C 1.504 -0.616 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.59 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.669 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 24.4 pt-20 -118.34 -169.45 1.71 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.16 137.55 32.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.673 0.749 . . . . 0.0 111.011 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.16 112.78 8.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.207 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -63.32 110.35 1.88 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.635 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.529 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.7 mmt180 -115.09 170.45 8.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.495 ' HB2' HD13 ' A' ' 75' ' ' ILE . 3.4 p30 -135.98 153.96 51.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.509 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -138.73 144.74 29.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.398 0.618 . . . . 0.0 110.685 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.507 ' HB3' HD22 ' A' ' 95' ' ' ASN . 4.0 m-20 -80.2 111.39 16.52 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.854 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.675 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.6 mt -82.32 4.59 23.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.489 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.507 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.4 m-80 -63.35 -18.65 63.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.153 0.502 . . . . 0.0 109.799 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.98 -24.48 67.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.075 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.2 mt -80.36 127.49 39.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.358 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.616 ' NE2' ' HA ' ' A' ' 2' ' ' SER . 44.6 mm-40 -117.66 166.69 12.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.345 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -110.21 118.31 36.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.52 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -108.61 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 59.91 22.84 11.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.269 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.55 19.04 8.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.772 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -130.36 141.06 50.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.277 0.538 . . . . 0.0 110.55 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.914 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 82.0 mt -83.95 120.46 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.017 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 60.0 t -125.31 124.29 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.298 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.82 143.9 32.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.619 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 . . . . . 0 C--O 1.25 1.102 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.547 179.82 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.637 0.256 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -161.73 178.55 8.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -62.97 -34.91 78.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.795 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.85 -19.49 29.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.74 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.38 -24.32 67.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.323 0.582 . . . . 0.0 109.909 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.6 m -142.11 36.86 1.56 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.705 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.795 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 60.5 p -125.68 153.36 43.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 110.681 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -149.57 171.8 16.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.3 m-20 55.02 30.97 15.17 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.686 0.617 . . . . 0.0 110.984 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.578 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -73.8 114.59 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.758 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 t -144.22 149.72 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.512 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -85.48 139.08 31.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 179.309 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.638 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.7 m -121.08 165.57 15.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.401 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 69.46 8.18 6.63 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.397 0.436 . . . . 0.0 111.34 178.012 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.48 23.92 27.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.721 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 101.88 23.4 9.3 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.057 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.682 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.6 mtp180 -109.89 -15.65 14.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.64 0.257 . . . . 0.0 110.524 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.638 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 31.3 m -130.3 126.99 38.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.615 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.0 tp -97.54 107.1 19.53 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.1 tmm_? -104.35 125.22 50.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.127 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.05 138.0 20.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.398 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.2 mt-10 -94.8 109.24 21.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.5 p -114.68 142.82 45.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.423 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.33 141.99 43.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.538 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.484 ' HB3' HG21 ' A' ' 31' ' ' VAL . 30.9 p-10 -88.09 -178.79 6.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.265 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.02 62.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.9 0.381 . . . . 0.0 111.715 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.26 -23.91 60.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 0.0 111.545 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.46 36.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.9 t-20 -95.99 144.82 25.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.6 m0 -76.18 123.0 25.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.934 0.397 . . . . 0.0 110.988 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 25' ' ' ASN . 5.2 t -119.47 124.2 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.437 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 m -78.05 107.73 10.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 t -110.83 149.64 30.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.317 0.58 . . . . 0.0 110.524 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 8.1 mt-10 -135.25 131.25 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.403 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.77 114.86 17.82 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.712 ' O ' HG22 ' A' ' 39' ' ' THR . 29.7 m-20 -67.87 109.42 3.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.139 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 12' ' ' LEU . 25.3 mt -60.77 -40.08 91.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.259 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.6 OUTLIER -64.01 -4.61 3.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -105.17 -13.69 15.63 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.525 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.14 12.64 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.85 130.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.2 158.49 21.59 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.404 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -111.33 110.35 20.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -98.93 77.2 2.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.145 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . 69.1 m-20 53.02 59.39 4.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.514 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.21 34.55 36.65 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.69 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -149.67 110.7 4.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.2 m-85 -59.09 137.09 58.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.074 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -132.25 117.39 18.15 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.902 -179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.439 ' HH2' HD22 ' A' ' 94' ' ' LEU . 92.1 m95 -70.79 114.71 9.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.62 27.02 7.34 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.295 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.86 -52.53 1.5 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.247 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 19.8 tt0 73.69 142.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.496 0.665 . . . . 0.0 111.45 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.65 38.54 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.377 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.23 -27.21 47.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.682 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.2 p -62.63 -28.21 69.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.956 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.619 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -70.39 -18.16 63.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.373 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.619 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.6 p -122.56 14.78 10.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.16 149.49 46.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -135.15 170.64 15.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.4 t70 43.17 57.64 3.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.475 0.484 . . . . 0.0 111.56 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.53 109.03 19.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.277 0.561 . . . . 0.0 112.077 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 126.22 42.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.324 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.638 ' CE1' HD12 ' A' ' 94' ' ' LEU . 19.4 t80 -91.35 136.73 32.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.277 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.5 t-160 -118.36 83.03 19.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.367 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.6 Cg_endo -57.35 -43.64 50.17 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.345 2.697 . . . . 0.0 113.702 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -118.48 82.04 1.78 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.669 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -63.41 109.81 1.73 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.432 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.53 -140.11 11.05 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.435 1.084 . . . . 0.0 113.623 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.61 -10.98 59.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.345 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.23 53.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.54 39.4 31.02 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.266 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -99.25 120.38 58.24 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.488 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.621 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 44.7 Cg_endo -69.39 108.32 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.28 1.987 . . . . 0.0 111.196 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.469 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.2 pp -134.53 142.48 40.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.1 tm? -112.02 126.62 55.35 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.497 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.83 141.45 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.35 168.6 21.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.757 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.7 mmt180 -86.07 115.15 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.607 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.87 131.85 45.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.875 0.369 . . . . 0.0 111.096 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -78.22 140.02 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.245 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 45' ' ' ASP . 27.4 t70 -106.94 171.51 7.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.438 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 74.1 m -55.33 -27.23 45.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.0 0.429 . . . . 0.0 111.297 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -66.7 -20.28 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.359 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.7 39.69 7.03 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.4 pt-20 -117.19 -163.47 0.92 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.645 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.9 p90 -144.65 128.74 17.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.87 118.9 16.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.485 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 8.8 p-10 -60.22 115.06 3.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.544 0.687 . . . . 0.0 112.561 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.607 ' HB2' HD22 ' A' ' 80' ' ' LEU . 28.9 mmt180 -115.3 175.11 5.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.33 146.09 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.6 p -136.22 143.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.905 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.43 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 7.4 m120 -81.91 110.89 17.6 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.327 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.638 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.0 mt -79.26 0.88 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.621 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 m120 -61.32 -16.29 44.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.426 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.4 -29.95 71.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 109.715 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 94' ' ' LEU . 15.0 mt -74.9 130.93 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.871 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.485 ' HG3' HG13 ' A' ' 105' ' ' VAL . 10.9 pt20 -122.9 167.9 12.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.64 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.2 t30 -112.25 121.91 46.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.306 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.1 t -113.15 94.13 2.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.341 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.43 26.32 12.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.104 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.79 19.38 8.25 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.885 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.7 ptp180 -130.55 135.03 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.22 0.51 . . . . 0.0 110.863 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.06 124.66 32.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG13 ' HG3' ' A' ' 98' ' ' GLN . 6.9 p -135.04 132.22 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -78.86 140.01 38.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.403 1.081 . . . . 0.0 112.921 -178.671 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.548 0.214 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m -156.67 -176.18 5.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -68.8 -36.95 78.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.77 -23.92 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.57 -32.81 63.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.7 m -137.64 38.61 2.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 66.7 m -117.31 154.6 30.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.366 0.603 . . . . 0.0 112.033 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.35 164.44 34.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.596 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 85.3 m-20 54.93 32.64 18.37 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.594 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -74.72 113.4 11.95 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.4 147.85 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.88 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 37' ' ' LEU . 1.5 tp -85.37 132.69 34.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.243 0.544 . . . . 0.0 109.725 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.4 m -118.87 165.21 14.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.667 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.0 t-20 70.65 8.7 6.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.049 0.54 . . . . 0.0 111.659 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.0 13.5 52.69 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.696 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.485 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 109.85 19.65 8.07 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.692 ' HG2' HG21 ' A' ' 56' ' ' THR . 18.5 mtp180 -105.92 -16.73 14.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.648 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 24.7 m -130.27 121.49 26.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.353 . . . . 0.0 111.78 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.493 ' CD2' HD13 ' A' ' 97' ' ' ILE . 63.1 tp -92.56 105.28 17.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 tmm_? -100.95 124.1 46.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.65 139.22 25.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.9 mt-10 -97.96 113.12 24.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.7 p -125.03 145.6 49.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -76.6 144.17 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.498 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.46 -171.8 2.89 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.188 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -32.17 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 111.74 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.03 -24.52 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.198 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.24 53.1 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.1 m-80 -88.81 142.46 27.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.473 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.0 m0 -74.91 125.64 29.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 t -124.64 137.45 57.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.539 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 26.4 m -94.81 109.91 21.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 104' ' ' LEU . 9.7 t -111.38 151.92 27.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 110.672 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.22 132.35 35.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.91 116.34 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 11.0 m-20 -67.22 108.54 2.74 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.194 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 12' ' ' LEU . 42.7 mt -59.34 -46.44 88.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -61.98 -4.84 1.78 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.895 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.72 -12.16 19.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.487 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.55 12.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.34 132.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.8 158.82 20.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.751 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -112.96 109.44 18.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -99.42 84.12 2.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.585 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.0 m-20 50.23 46.91 24.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.422 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.616 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.74 43.11 5.85 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.679 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -160.47 114.06 2.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.7 m-85 -59.91 138.49 57.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.045 0.45 . . . . 0.0 111.272 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -131.07 116.21 17.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -69.33 115.13 8.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.939 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.16 31.45 6.2 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.236 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.54 -51.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.176 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.9 tt0 72.84 146.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.218 0.607 . . . . 0.0 111.172 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.3 m-20 73.08 30.07 1.67 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.0 p90 -76.29 -31.43 58.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.692 HG21 ' HG2' ' A' ' 17' ' ' ARG . 20.0 p -62.45 -30.5 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.882 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.623 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.5 pt-20 -67.79 -15.59 63.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 110.477 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.623 HG23 ' HG3' ' A' ' 57' ' ' GLU . 67.2 p -124.1 10.74 8.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.426 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.63 147.3 47.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.05 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.91 166.11 24.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.329 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.5 t70 49.08 56.03 8.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.022 0.439 . . . . 0.0 110.639 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.39 109.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.213 0.53 . . . . 0.0 111.603 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.91 123.72 41.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.812 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CE1' HD12 ' A' ' 94' ' ' LEU . 13.6 t80 -92.51 135.49 34.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.691 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 7.1 t-80 -123.2 86.61 51.5 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 11.5 Cg_endo -57.06 -37.68 97.74 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 124.213 3.276 . . . . 0.0 114.839 -177.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -128.15 87.77 2.65 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.155 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -66.51 107.06 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.852 178.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.1 -150.91 23.04 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.538 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.3 -18.16 60.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 110.051 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.24 62.92 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.875 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 67' ' ' LYS . 40.2 mt-10 50.2 57.13 6.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.687 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -102.83 117.99 59.36 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.16 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.74 109.51 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.076 1.851 . . . . 0.0 112.087 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.407 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -133.69 141.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.71 126.28 55.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.512 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.65 139.83 53.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.035 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.95 167.72 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.959 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.2 mmt180 -84.78 115.59 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.616 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -100.61 126.57 47.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.82 0.343 . . . . 0.0 111.445 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -85.0 141.98 29.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.604 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 4.1 p-10 -101.33 175.34 5.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.714 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 72.6 m -60.36 -24.41 65.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -74.54 -28.32 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.58 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.96 37.31 2.37 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.194 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.9 pt-20 -113.26 -168.43 1.33 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.06 129.42 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -139.59 117.46 11.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.631 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 5.6 p-10 -63.3 122.89 17.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.302 0.572 . . . . 0.0 111.353 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.605 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.1 mmt180 -115.94 179.49 3.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.5 146.63 32.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.0 p -136.24 146.93 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-O 121.325 0.583 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.5 ' HB3' HD22 ' A' ' 95' ' ' ASN . 86.6 m-20 -81.83 109.64 16.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.191 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.2 mt -80.14 4.45 17.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.384 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.5 HD22 ' HB3' ' A' ' 93' ' ' ASN . 17.4 m-80 -65.14 -10.82 33.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.271 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.38 -18.78 63.05 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 109.653 178.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.049 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -122.25 161.78 22.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.927 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -105.69 117.66 34.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.569 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 53.4 t -113.73 96.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.78 23.15 13.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.78 21.59 9.01 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.38 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.2 ptp180 -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 110.857 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 33' ' ' SER . 3.0 mp -84.34 129.21 34.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 131.54 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.22 145.53 27.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.231 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 86.5 mm-40 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.468 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 19.9 m -157.0 -177.37 6.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -68.14 -38.5 82.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -23.63 13.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.688 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.84 -34.52 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.671 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.7 m -134.96 36.2 3.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.579 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 70.4 m -119.95 153.43 35.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 111.458 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -150.02 169.75 20.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.578 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.557 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t-20 56.89 28.21 14.23 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.438 0.461 . . . . 0.0 110.692 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.562 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -74.45 113.78 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.87 153.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.801 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.82 136.01 33.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 23.9 m -116.77 163.06 16.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.5 t-20 71.26 6.57 5.84 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.491 0.494 . . . . 0.0 111.554 177.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.4 22.95 27.9 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.634 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 103.26 21.07 10.28 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.154 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.5 mtp180 -107.27 -16.42 14.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.514 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.0 m -131.72 130.48 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 111.624 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HB2' HD21 ' A' ' 37' ' ' LEU . 54.4 tp -99.91 108.7 21.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -110.7 125.13 53.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.088 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.414 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -146.84 155.09 42.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.639 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -107.85 112.87 25.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 5.1 p -123.97 146.22 48.64 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.606 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.94 143.86 35.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.636 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -90.23 -171.99 3.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.9 -27.37 69.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 0.0 111.214 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -73.54 -20.88 60.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.555 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.42 10.22 54.11 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.6 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.8 t-20 -96.31 145.06 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.467 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 43.8 m0 -77.21 125.53 29.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.47 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 140.85 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 m -91.77 112.88 24.99 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.328 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.493 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.5 m -111.21 146.96 36.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 0.0 111.187 -178.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.6 mt-10 -133.39 139.72 46.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.06 113.85 8.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' THR . 20.8 m-20 -67.57 110.99 3.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.142 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 12' ' ' LEU . 80.4 mt -61.23 -43.13 99.37 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.678 0.751 . . . . 0.0 109.778 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.5 -3.79 2.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.796 -179.902 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.32 -9.59 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.291 179.45 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -144.08 10.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 132.59 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -128.92 159.05 22.15 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.87 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.477 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.3 t30 -111.43 113.34 25.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -97.76 78.57 2.61 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.07 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 83' ' ' CYS . 4.4 p-10 40.4 63.5 1.1 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.143 0.902 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 83.87 38.21 10.69 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -159.27 115.86 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.705 -0.291 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.532 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 40.4 m-85 -60.96 138.0 58.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -128.06 115.23 18.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.483 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -73.98 113.68 11.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.12 41.27 3.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -112.53 -50.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.601 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 20.0 tt0 73.32 141.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.309 0.643 . . . . 0.0 112.033 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 5.8 t-20 68.58 38.56 2.28 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.078 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.2 p90 -77.13 -26.6 53.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.529 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.684 HG21 ' HG2' ' A' ' 17' ' ' ARG . 38.4 p -64.14 -19.78 65.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.634 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.676 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.1 pt-20 -74.76 -19.68 60.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.148 0.499 . . . . 0.0 109.848 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.676 HG23 ' HG3' ' A' ' 57' ' ' GLU . 72.6 p -123.34 18.12 9.8 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.936 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -133.56 150.35 51.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.88 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.741 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.82 172.86 12.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.209 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 3.5 t70 44.91 55.1 6.34 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.786 0.679 . . . . 0.0 110.997 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.03 109.13 17.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 112.033 -178.035 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -120.11 123.24 42.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.122 179.18 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' HD12 ' A' ' 94' ' ' LEU . 11.3 t80 -93.38 133.49 36.58 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.671 -178.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 1.3 t-80 -124.81 87.41 55.02 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.378 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.7 Cg_endo -55.99 -34.5 92.39 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.157 3.238 . . . . 0.0 114.14 -178.664 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -129.18 85.82 2.36 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.962 179.583 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -68.46 113.92 6.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.559 179.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.61 -147.43 10.94 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 124.322 1.014 . . . . 0.0 113.695 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -13.72 59.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.55 0.69 . . . . 0.0 109.356 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.5 65.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 56.45 42.36 27.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.89 128.27 26.12 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.535 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.2 Cg_endo -73.63 109.2 2.81 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.524 2.149 . . . . 0.0 111.584 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.594 HD11 HH21 ' A' ' 77' ' ' ARG . 1.2 pp -134.43 142.25 41.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -113.41 123.97 51.33 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.284 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.594 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.5 139.45 52.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.909 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.15 169.44 24.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.741 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.9 mmt85 -85.1 115.12 22.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -101.63 130.54 48.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.698 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.759 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -74.23 135.86 42.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.211 179.211 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 3.1 m-20 -96.13 172.76 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.438 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 45' ' ' ASP . 12.1 p -56.78 -27.95 60.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -74.26 -18.67 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.04 0.448 . . . . 0.0 111.526 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.17 36.7 5.11 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 16.3 pt-20 -119.24 -167.46 1.4 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.57 133.4 34.41 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.962 0.887 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -138.67 118.45 13.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.594 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.8 p-10 -66.57 118.42 10.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.542 0.686 . . . . 0.0 111.009 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.544 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.4 mmt180 -114.06 175.0 5.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.7 148.34 40.62 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.532 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.4 p -136.8 144.11 33.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.588 0.709 . . . . 0.0 111.402 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -78.62 107.48 11.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.576 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.612 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.6 mt -79.97 3.43 20.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.265 0.555 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.426 HD22 ' HB3' ' A' ' 93' ' ' ASN . 24.0 m-80 -61.5 -19.08 61.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.915 178.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -64.67 -21.94 66.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.512 179.279 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 10.6 mt -85.38 126.96 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 92.1 mt-30 -125.09 151.65 45.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.206 -179.193 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 1.5 t30 -92.17 117.67 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.586 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 58.3 t -113.65 97.13 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.595 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.75 25.9 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.719 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.54 20.74 9.84 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.527 178.045 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -131.09 140.76 50.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.931 0.366 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.7 mp -86.07 115.69 23.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.9 t -115.04 121.92 68.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.688 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -83.33 144.82 29.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.529 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.468 179.26 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.462 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 39.7 m -159.33 -178.76 7.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -64.54 -39.56 93.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.945 0.402 . . . . 0.0 110.177 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.79 -25.33 27.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.595 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -53.94 -32.48 53.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.068 0.461 . . . . 0.0 110.973 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.6 m -134.82 33.38 3.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.3 m -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 112.355 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.8 ptp180 -154.02 169.22 24.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.223 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.615 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.3 t30 56.13 32.43 20.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.423 0.63 . . . . 0.0 110.476 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.89 113.7 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.446 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 t -143.43 146.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -80.88 143.26 32.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.01 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -128.5 163.31 25.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.12 6.15 5.49 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.676 0.61 . . . . 0.0 111.472 178.437 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.6 23.8 17.66 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.178 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.524 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 100.55 14.95 30.94 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.193 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.5 mtp180 -98.75 -16.76 18.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.82 -0.224 . . . . 0.0 111.034 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 31.7 m -133.27 129.97 38.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.0 111.873 -178.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.99 108.39 21.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 tmm_? -106.61 124.45 49.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.152 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.93 159.9 44.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 5.1 mt-10 -114.91 110.4 19.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 6' ' ' SER . 48.2 t -119.7 144.67 47.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.15 144.34 48.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.614 179.385 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.1 p30 -90.89 -171.74 3.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.29 68.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 0.0 111.7 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.19 -24.47 60.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.444 . . . . 0.0 111.123 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.18 -0.95 33.21 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.709 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.6 t30 -83.63 144.95 29.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -75.3 125.23 28.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.509 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.2 t -120.73 130.62 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 m -80.22 106.94 12.61 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.062 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.622 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.4 m -110.08 135.75 50.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.434 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.4 mt-10 -126.87 131.95 51.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.539 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.78 116.21 19.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 39' ' ' THR . 16.2 m-20 -67.3 109.41 3.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 12' ' ' LEU . 34.6 mt -59.59 -46.56 88.57 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.652 0.739 . . . . 0.0 110.052 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.648 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 10.3 t70 -63.79 -4.41 3.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.09 -11.67 20.32 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.571 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -145.82 13.41 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 121.066 0.46 . . . . 0.0 112.053 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.55 130.85 70.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.36 159.03 21.85 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.509 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 9.2 t30 -111.19 111.43 22.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -105.74 85.96 2.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.735 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 6.6 m-20 51.59 50.97 17.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.306 178.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.17 41.19 10.48 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.193 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -158.18 118.27 3.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.0 m-85 -63.71 136.37 57.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.119 0.485 . . . . 0.0 110.607 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -128.78 115.64 18.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.151 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -69.49 115.04 8.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.13 22.63 8.16 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.41 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -92.99 -54.37 1.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.382 -0.914 . . . . 0.0 114.002 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.5 tt0 72.59 139.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.188 0.595 . . . . 0.0 110.803 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.641 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.7 m120 74.1 39.78 0.48 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.615 0.721 . . . . 0.0 110.516 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.3 p90 -84.79 -26.33 27.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.282 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.667 HG21 ' HG2' ' A' ' 17' ' ' ARG . 71.2 p -68.4 -17.95 64.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.393 -179.238 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 58' ' ' THR . 9.5 pt-20 -78.03 -13.13 59.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.235 0.54 . . . . 0.0 109.857 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.711 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.5 p -127.67 14.97 7.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.772 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.46 149.95 49.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.848 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -140.79 171.01 14.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.82 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 49.02 54.69 10.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.952 0.406 . . . . 0.0 110.393 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.66 108.91 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.306 0.574 . . . . 0.0 112.326 -177.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 123.63 40.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.551 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.656 ' CE1' HD12 ' A' ' 94' ' ' LEU . 15.3 t80 -91.67 133.28 35.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.781 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.82 87.94 43.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.143 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -36.8 79.67 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 123.633 2.889 . . . . 0.0 113.623 -178.376 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.37 83.48 2.14 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.745 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -67.17 113.92 5.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.317 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.74 -143.95 12.85 Favored Glycine 0 C--N 1.335 0.491 0 O-C-N 124.335 1.022 . . . . 0.0 113.807 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.83 -11.43 58.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 109.956 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.15 -26.05 61.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 57.25 42.66 24.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.284 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.98 125.18 36.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.223 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.614 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -72.23 110.48 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.762 2.308 . . . . 0.0 112.467 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.724 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.38 141.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.31 128.44 56.47 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.724 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.94 144.57 49.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.059 0.457 . . . . 0.0 110.21 178.878 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.37 170.05 18.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.93 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.603 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -85.91 115.71 23.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.2 mp -98.52 127.15 44.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.096 0.474 . . . . 0.0 111.629 -178.494 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -87.79 142.11 28.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.806 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.669 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -97.94 173.74 6.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.672 -179.603 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 74.8 m -60.4 -23.41 64.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.433 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 50.0 t30 -77.12 -28.64 54.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.964 0.411 . . . . 0.0 110.623 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.09 38.04 1.74 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.294 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.669 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 15.9 pt-20 -113.65 -168.92 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -147.19 132.98 18.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.847 0.832 . . . . 0.0 111.034 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -140.19 120.45 13.89 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.752 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.8 p-10 -67.13 116.4 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.184 0.516 . . . . 0.0 111.585 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.731 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.1 mmt180 -116.79 177.51 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.94 147.15 32.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -134.37 143.38 38.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.389 0.614 . . . . 0.0 110.86 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.7 m120 -82.83 110.7 18.07 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.817 -179.269 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.656 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -80.61 3.15 22.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.614 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.3 m120 -61.47 -15.47 37.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.015 178.392 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -23.5 67.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.139 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.596 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.6 mt -84.54 124.19 39.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.005 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 77.3 mt-30 -119.65 163.79 16.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.9 t30 -106.22 120.19 41.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.061 0.458 . . . . 0.0 111.635 -178.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.8 t -112.61 94.14 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.349 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.22 23.43 13.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.929 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 20.85 7.95 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.549 178.533 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.8 ptp180 -130.29 138.96 50.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.996 0.398 . . . . 0.0 110.477 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 64.1 mt -85.47 117.48 24.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.461 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 61.7 t -121.56 123.45 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -85.89 145.75 27.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.584 178.724 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.764 0.316 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -150.46 -176.58 5.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -67.07 -36.2 81.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.774 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.06 -29.13 63.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.643 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.43 -33.55 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.168 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 58.7 m -134.13 35.83 3.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.774 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.7 p -117.21 155.88 28.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.443 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.31 167.62 28.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.493 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 55.01 32.53 18.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.63 0.581 . . . . 0.0 111.17 -179.056 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.529 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.08 113.76 15.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.56 151.61 19.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.298 -178.57 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -87.58 142.37 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.415 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 11.7 m -129.68 163.58 25.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.934 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.6 t-20 73.12 9.12 5.34 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.165 0.586 . . . . 0.0 111.441 178.258 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.8 25.92 16.33 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 94.92 22.18 23.86 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.71 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.9 mtp180 -106.32 -18.74 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.607 0.242 . . . . 0.0 110.641 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.4 m -128.37 125.64 39.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 111.846 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.17 106.73 18.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.853 178.2 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -103.02 124.28 48.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.1 142.71 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 111.114 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.3 mt-10 -98.94 110.03 22.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' SER . 15.4 t -122.36 139.52 53.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.32 144.07 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.892 179.85 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.481 ' HB3' HG21 ' A' ' 31' ' ' VAL . 8.9 p30 -91.42 -170.25 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -33.83 66.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -76.29 -22.53 54.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 110.992 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.95 33.82 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.694 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 m-80 -84.84 141.63 30.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.561 0.18 . . . . 0.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 54.0 m0 -72.51 124.33 24.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 111.149 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 25' ' ' ASN . 6.3 t -116.57 119.77 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.924 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.7 m -78.43 104.34 8.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.7 t -111.52 152.94 26.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.149 0.5 . . . . 0.0 110.425 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.0 mt-10 -134.74 131.37 37.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.486 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.613 HD11 HG12 ' A' ' 40' ' ' ILE . 12.0 tp -125.52 115.09 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.775 178.581 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -66.28 109.13 2.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.914 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 12' ' ' LEU . 37.2 mt -60.8 -43.44 98.13 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.702 0.763 . . . . 0.0 109.499 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.35 -5.43 3.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.487 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.16 -14.59 17.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.426 -179.263 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.613 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.51 13.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.52 130.3 70.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.52 160.89 21.62 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.221 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.18 112.8 24.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -109.52 87.16 2.44 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.299 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 33.1 t70 53.27 58.62 5.07 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.6 179.046 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 69.72 42.53 70.81 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.992 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -158.3 117.17 3.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 57.4 m-85 -61.9 138.56 58.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.227 0.537 . . . . 0.0 110.79 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.45 116.68 20.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.303 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.24 115.02 8.95 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.42 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.3 28.75 7.04 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.15 -52.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.878 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 27.9 tt0 73.05 143.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 0.0 111.021 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.599 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 80.4 m-20 69.14 36.66 2.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.576 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -77.28 -30.08 54.14 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.71 HG21 ' HG2' ' A' ' 17' ' ' ARG . 21.4 p -63.9 -23.98 67.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.187 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.645 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.1 pt-20 -73.69 -15.75 61.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.211 0.529 . . . . 0.0 109.929 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.645 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -123.86 14.26 9.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.996 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.58 154.43 47.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.95 173.65 11.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.042 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 13.4 t70 50.45 53.31 13.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.11 0.481 . . . . 0.0 110.211 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.9 mt -88.52 109.24 19.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.513 . . . . 0.0 111.947 -178.025 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.7 123.93 38.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.762 178.8 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.664 ' CE1' HD12 ' A' ' 94' ' ' LEU . 24.2 t80 -92.58 136.04 33.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.27 0.557 . . . . 0.0 112.01 -178.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -123.32 89.75 50.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.987 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.7 Cg_endo -60.63 -41.01 50.84 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.836 3.024 . . . . 0.0 114.519 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.437 ' HB3' ' NZ ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.84 88.29 2.86 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.891 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -73.26 108.64 6.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.528 178.999 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.51 -149.02 14.56 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.713 178.337 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.52 -18.85 61.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 110.001 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.74 -25.82 63.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.163 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 48.6 49.62 18.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.622 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -102.3 122.42 46.72 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.487 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.708 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 52.7 Cg_endo -71.49 108.12 2.31 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.287 1.991 . . . . 0.0 111.331 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.465 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -131.87 140.74 47.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -112.41 125.0 53.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.085 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.58 139.56 52.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 179.285 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.16 169.55 23.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.792 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 5.0 mmt85 -84.96 115.67 22.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -101.26 132.11 46.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.56 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.803 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -77.4 140.41 39.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.055 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -102.94 174.97 5.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.478 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 57.5 m -59.56 -24.37 63.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.554 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' ASN . . . . . 0.42 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 5.2 t30 -73.65 -28.08 61.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.833 179.442 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.71 37.62 2.95 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.156 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.803 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.0 pt-20 -119.46 -170.2 1.89 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 85.4 m-85 -138.7 130.45 27.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.064 0.459 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -138.88 123.31 18.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.436 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.9 p-10 -61.81 116.89 5.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.357 0.598 . . . . 0.0 112.423 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.654 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.8 mmt180 -114.69 179.29 3.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -143.51 151.0 39.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.903 0.382 . . . . 0.0 110.023 -179.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.515 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.5 p -138.85 145.24 28.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.362 0.601 . . . . 0.0 110.918 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -82.66 109.95 17.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.572 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.664 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -81.0 3.72 22.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.011 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.708 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 15.2 m120 -63.11 -17.87 62.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.726 178.732 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -29.24 69.71 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.944 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -77.24 127.3 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.403 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -121.19 165.97 14.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 7.1 t30 -110.77 117.95 34.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.2 t -113.14 96.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.337 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.43 22.21 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.051 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 22.67 8.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.592 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -130.21 136.38 49.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.177 0.488 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -80.65 116.76 20.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 0.0 110.888 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.89 123.96 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.48 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -82.06 145.69 30.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.868 0.366 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.994 178.875 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HG3' ' H ' ' A' ' 2' ' ' SER . 6.5 tpt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.507 ' H ' ' HG3' ' A' ' 1' ' ' MET . 15.7 m -102.26 -179.75 4.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.535 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -62.5 -37.68 86.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.923 0.392 . . . . 0.0 110.092 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.766 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -24.74 63.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.73 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.13 -33.64 67.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.106 0.479 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.2 m -133.42 36.86 3.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.362 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.766 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.5 p -117.28 155.82 28.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.162 0.505 . . . . 0.0 111.815 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -148.09 168.4 22.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.064 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.428 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.8 m-20 52.23 33.95 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.386 0.613 . . . . 0.0 110.701 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -84.55 114.43 21.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.331 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 64' ' ' PHE . 5.9 m -147.27 177.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.22 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.9 139.42 39.66 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.055 179.247 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 14' ' ' ASN . 26.0 m -123.98 162.98 22.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.482 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.9 t-20 74.03 7.64 4.78 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.671 0.607 . . . . 0.0 111.009 178.216 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.28 22.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.95 21.54 13.71 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.924 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.9 mtp180 -104.42 -19.09 14.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 37.4 m -127.54 126.53 42.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.006 0.432 . . . . 0.0 111.362 -178.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.476 ' CD2' HD13 ' A' ' 97' ' ' ILE . 54.7 tp -95.56 106.82 18.95 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.584 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -106.21 123.9 48.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.887 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.93 137.35 19.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.381 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.9 mt-10 -96.24 109.27 21.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' SER . 16.5 t -118.57 143.7 46.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.963 0.411 . . . . 0.0 110.139 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 143.48 50.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.835 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 31' ' ' VAL . 24.7 p-10 -85.28 -172.4 4.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.68 -21.5 65.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.47 -22.08 26.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.94 3.59 34.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.4 t30 -88.29 146.65 25.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -75.62 126.68 31.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 25' ' ' ASN . 10.8 t -124.46 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 m -80.06 109.02 14.11 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.514 ' HB2' HD13 ' A' ' 104' ' ' LEU . 1.9 m -109.78 139.04 45.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.909 0.385 . . . . 0.0 110.376 -178.563 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.69 130.99 42.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.91 117.6 21.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 39' ' ' THR . 27.0 m-20 -68.59 107.72 3.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.967 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 12' ' ' LEU . 24.6 mt -60.59 -40.27 91.13 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.592 0.71 . . . . 0.0 110.569 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.66 -5.28 2.56 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -104.93 -14.37 15.48 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.481 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.546 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.28 11.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.32 156.74 21.01 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.802 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.9 t30 -110.19 108.71 18.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.283 0.563 . . . . 0.0 109.547 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -100.19 82.53 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.1 60.88 3.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.298 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.22 35.86 36.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.693 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -154.97 121.33 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.842 -0.21 . . . . 0.0 110.649 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.4 m-85 -65.41 138.46 58.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.084 0.468 . . . . 0.0 111.07 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -130.45 116.85 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.744 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.51 114.31 9.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.91 29.15 7.41 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.828 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.79 -53.06 1.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.43 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 17.4 tt0 76.96 142.54 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.303 0.641 . . . . 0.0 111.333 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.671 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.1 m-20 66.72 38.84 3.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.024 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.5 p90 -79.43 -28.1 41.71 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.629 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.8 p -65.51 -25.17 67.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.601 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.79 ' HG3' HG23 ' A' ' 58' ' ' THR . 5.4 pt-20 -72.59 -12.36 61.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.328 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.79 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -130.37 15.93 5.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.31 0.576 . . . . 0.0 109.805 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.15 144.53 51.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -134.46 173.08 12.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.285 -179.683 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER 46.01 54.38 8.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.684 0.615 . . . . 0.0 111.046 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.43 HG22 HD23 ' A' ' 12' ' ' LEU . 2.2 mt -89.33 112.77 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.778 -178.212 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -130.86 125.23 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.847 179.283 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.618 ' CE1' HD12 ' A' ' 94' ' ' LEU . 21.5 t80 -92.61 133.75 35.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.516 0.674 . . . . 0.0 112.435 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.487 ' NE2' ' HA ' ' A' ' 68' ' ' GLU . 2.1 t60 -117.57 87.71 26.8 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.525 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 Cg_endo -58.42 -42.95 50.25 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 124.067 3.178 . . . . 0.0 114.637 -177.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 87.29 2.71 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.633 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.487 ' HA ' ' NE2' ' A' ' 65' ' ' HIS . 25.2 tt0 -68.39 106.83 2.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.258 178.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.35 -152.78 10.8 Favored Glycine 0 C--N 1.332 0.322 0 O-C-N 124.029 0.831 . . . . 0.0 113.71 178.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.85 -9.18 58.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.18 -21.4 43.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.83 178.694 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 46.52 54.39 8.76 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.881 0.738 . . . . 0.0 110.546 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -103.22 118.45 57.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.182 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.2 Cg_endo -72.38 109.63 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.327 2.018 . . . . 0.0 111.977 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.642 HD11 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -133.04 140.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.93 126.57 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.465 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.642 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.01 143.45 49.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.184 179.028 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.65 168.01 22.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.99 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.5 mmt180 -86.32 114.66 23.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.0 mp -97.43 127.27 43.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 110.465 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.1 tmt_? -80.16 139.69 36.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.743 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.16 162.36 12.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.739 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.9 t -47.95 -29.34 3.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -66.4 -26.92 67.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.105 0.479 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.589 ' HA2' ' HE ' ' A' ' 81' ' ' ARG . . . 100.53 33.97 4.9 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.8 pt-20 -116.02 -167.23 1.23 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.3 p90 -142.28 138.18 31.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.98 0.895 . . . . 0.0 111.488 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -133.86 111.24 10.32 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.221 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.2 p-10 -64.21 114.97 4.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.018 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.545 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -114.18 176.72 4.92 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -145.76 142.46 28.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.68 144.3 37.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.063 -178.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.478 ' HB3' HD22 ' A' ' 95' ' ' ASN . 43.7 m-20 -81.35 111.66 17.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.696 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.618 HD12 ' CE1' ' A' ' 64' ' ' PHE . 3.7 mt -81.35 3.72 23.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.681 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.56 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 25.6 m-80 -63.47 -18.03 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.102 0.477 . . . . 0.0 109.773 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -61.87 -28.15 69.29 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.798 178.672 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.532 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.0 mt -78.09 124.55 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.167 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -114.99 163.29 15.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.359 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.8 t30 -111.99 119.99 40.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.579 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.3 t -113.57 95.03 3.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.727 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.8 25.54 15.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.56 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.97 23.38 7.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.391 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.28 137.54 50.03 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 122.458 -0.436 . . . . 0.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.0 mp -90.31 128.74 36.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.607 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.3 p -142.44 132.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -79.07 145.32 33.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.961 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.333 -179.075 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.91 0.385 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -161.23 174.76 13.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -59.51 -35.6 74.47 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.751 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.17 -25.61 61.72 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.823 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.28 -20.8 63.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.089 -179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 32.3 m -145.14 35.51 1.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.835 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.751 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.7 p -116.61 158.13 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.1 ptp180 -152.58 167.82 27.62 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.405 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 85.7 m-20 50.21 36.38 12.4 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.942 0.776 . . . . 0.0 111.566 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -78.07 113.7 16.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.04 148.89 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.015 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -82.59 147.68 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.836 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.3 m -132.12 163.05 29.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.07 4.5 5.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.615 0.572 . . . . 0.0 111.543 178.142 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.65 23.22 19.15 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 100.97 22.82 10.36 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.979 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.673 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.4 mtp180 -106.59 -18.28 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.671 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 67.7 m -132.37 128.03 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.927 0.394 . . . . 0.0 111.355 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 37' ' ' LEU . 42.9 tp -96.72 108.77 21.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.021 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.5 tmm_? -103.28 124.37 48.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.9 138.47 20.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.568 0.223 . . . . 0.0 110.628 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 5.9 mt-10 -97.82 108.87 21.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 6' ' ' SER . 2.2 p -119.13 141.43 48.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.086 0.469 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.6 143.46 44.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -85.15 -173.61 4.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.414 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.84 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.797 0.332 . . . . 0.0 111.449 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 111.231 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.65 3.38 34.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.78 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.1 m-80 -89.75 144.18 26.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.335 0.112 . . . . 0.0 110.819 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -72.79 128.85 36.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 0.0 111.533 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.11 119.63 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.352 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 m -75.09 106.5 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.607 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.0 m -110.74 144.01 40.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.204 0.526 . . . . 0.0 111.259 -178.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.6 mt-10 -133.39 134.97 44.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -132.32 118.1 19.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' THR . 42.6 m-20 -67.42 107.43 2.43 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.391 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 12' ' ' LEU . 46.9 mt -60.67 -42.46 97.11 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.598 0.713 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -63.8 -5.78 4.78 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.672 179.887 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.36 -10.61 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.207 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.67 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -145.01 11.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.05 0.453 . . . . 0.0 112.07 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 131.16 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 157.16 20.76 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.42 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.0 t30 -111.1 109.97 20.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.179 0.514 . . . . 0.0 110.38 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -89.63 78.8 6.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.261 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 39.63 48.63 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.003 0.921 . . . . 0.0 113.109 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 103.45 36.07 3.41 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.851 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -162.26 120.19 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.498 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.3 m-85 -65.29 135.1 54.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -125.78 117.14 22.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.638 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.61 114.05 10.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 29.04 5.93 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.398 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.3 -51.6 1.13 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.687 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 28.9 tt0 72.56 143.53 0.06 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.049 0.54 . . . . 0.0 110.915 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 73.0 31.31 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.652 0.781 . . . . 0.0 111.501 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.3 p90 -77.56 -27.7 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.673 HG21 ' HG2' ' A' ' 17' ' ' ARG . 28.9 p -64.92 -22.53 67.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.826 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 58' ' ' THR . 3.9 pt-20 -73.86 -18.47 60.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.045 0.45 . . . . 0.0 110.087 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.9 p -123.34 15.46 9.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.194 0.521 . . . . 0.0 110.064 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.45 153.15 45.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.617 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -146.22 170.43 16.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.162 -179.942 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.3 t70 46.11 56.06 6.54 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.946 0.403 . . . . 0.0 110.436 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.551 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -85.03 106.38 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.274 0.559 . . . . 0.0 111.333 -177.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.63 118.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.902 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' HB2' HD22 ' A' ' 12' ' ' LEU . 8.5 t80 -92.82 127.53 38.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.0 110.924 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.41 86.31 38.77 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.424 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.672 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 14.6 Cg_endo -58.8 -38.3 89.42 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 123.414 2.743 . . . . 0.0 112.618 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -123.58 82.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.397 179.303 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.0 118.75 9.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.3 -138.31 2.74 Favored Glycine 0 C--N 1.333 0.369 0 O-C-N 124.643 1.214 . . . . 0.0 114.776 177.293 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.39 -5.83 59.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.436 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.16 -23.84 37.98 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.913 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 53.02 46.48 26.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.282 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.7 129.96 24.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.486 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 61.6 Cg_endo -73.61 108.38 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.776 2.318 . . . . 0.0 112.4 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.579 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.13 140.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.551 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.245 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.579 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.84 140.64 49.64 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.966 0.413 . . . . 0.0 109.898 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.64 169.11 25.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.1 mmt180 -85.87 114.56 22.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.763 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -99.65 121.4 41.17 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.296 0.57 . . . . 0.0 111.099 -178.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.04 141.25 43.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.022 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.585 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.6 p-10 -98.29 177.34 5.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.6 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.4 t -62.94 -22.54 66.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.083 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -77.39 -28.58 52.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.04 30.46 3.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 178.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.788 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.2 pt-20 -115.7 -169.58 1.61 Allowed 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 44.4 p90 -138.47 140.7 39.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.682 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -137.79 120.64 16.43 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.421 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -64.05 112.93 3.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.482 0.658 . . . . 0.0 111.202 -179.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.763 ' HB2' HD22 ' A' ' 80' ' ' LEU . 26.5 mmt180 -114.93 172.6 6.95 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.309 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -140.74 151.44 44.48 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.511 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -136.1 142.05 39.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.398 0.618 . . . . 0.0 110.34 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.442 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 10.3 m120 -81.24 109.19 15.52 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.569 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.616 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.2 mt -79.62 0.75 28.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.952 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.486 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 m120 -62.82 -13.63 35.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 0.0 109.504 177.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -67.13 -24.38 65.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.046 178.697 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -83.11 125.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.147 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.62 159.37 24.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.6 t30 -102.87 117.95 35.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.46 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.51 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -111.97 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.824 0.345 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.54 21.64 12.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.27 25.87 5.91 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.53 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -132.66 139.68 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.094 0.447 . . . . 0.0 110.798 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 75.0 mt -87.12 116.31 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 110.534 178.853 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.6 p -125.6 130.42 72.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.865 0.364 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -86.71 143.66 27.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.292 179.844 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.465 0.174 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 7.2 m -157.31 177.07 11.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.589 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -62.62 -37.25 85.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -25.37 19.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.453 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.43 -34.41 57.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.578 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.4 m -136.04 36.03 2.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.348 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 67.6 m -116.05 157.1 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.336 0.589 . . . . 0.0 112.19 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.0 ptp180 -154.59 166.63 32.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 10.0 m120 51.92 38.18 22.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.648 0.593 . . . . 0.0 111.336 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -81.93 114.0 20.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.66 159.03 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.78 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.817 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -95.38 138.52 32.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.3 m -122.53 165.38 16.49 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.566 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 71.59 6.22 5.64 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.525 0.516 . . . . 0.0 111.484 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.06 21.4 23.11 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.535 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 99.75 24.27 10.11 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.786 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.1 mtp180 -107.29 -18.47 13.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.797 0.332 . . . . 0.0 110.486 -179.25 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 61.3 m -129.13 126.06 38.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.073 0.463 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' A' ' 97' ' ' ILE . 47.4 tp -94.42 107.62 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.274 178.594 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -101.69 124.5 47.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.873 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.26 140.4 22.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.586 0.232 . . . . 0.0 110.873 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' SER . 6.9 mt-10 -99.07 109.69 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -122.01 145.2 48.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.329 0.585 . . . . 0.0 111.209 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.4 144.43 40.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.401 179.109 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -89.05 -171.21 3.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.645 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.73 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.149 0.499 . . . . 0.0 111.234 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.47 -23.7 53.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.2 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.56 1.67 43.5 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.841 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.5 t-20 -85.2 145.34 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -77.07 126.56 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.895 0.379 . . . . 0.0 110.634 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.27 126.55 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.304 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.8 m -79.69 106.18 11.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.574 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 4.4 m -110.43 144.98 38.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.083 0.468 . . . . 0.0 111.446 -177.696 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 14.6 mt-10 -135.23 133.31 38.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.8 120.02 26.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -68.2 107.01 2.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.663 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.817 HD11 HD11 ' A' ' 12' ' ' LEU . 53.5 mt -61.69 -45.66 93.06 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.461 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.74 -5.53 2.83 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -102.05 -11.5 18.84 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.21 -179.611 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.464 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -143.89 11.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.002 0.429 . . . . 0.0 112.113 -179.57 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 132.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.75 159.99 21.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.75 -179.134 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.78 111.74 23.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.23 0.538 . . . . 0.0 109.732 179.164 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -105.93 87.53 2.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.373 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.08 57.93 6.11 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.624 0.578 . . . . 0.0 112.161 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.78 42.85 52.6 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.982 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -161.07 120.67 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.527 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 59.0 m-85 -62.66 142.17 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.81 115.95 15.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -70.09 116.11 10.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.232 0.539 . . . . 0.0 109.681 178.806 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.06 31.45 6.58 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.752 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.45 -51.6 1.11 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.084 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 25.0 tt0 70.75 143.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.016 0.526 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.634 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 92.0 m-20 76.36 29.19 0.73 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.526 0.73 . . . . 0.0 111.189 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -77.5 -32.15 54.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.753 0.311 . . . . 0.0 110.591 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.703 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.6 p -63.56 -26.67 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.6 pt-20 -70.74 -16.37 62.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.728 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.632 HG23 ' HG3' ' A' ' 57' ' ' GLU . 60.2 p -124.31 12.97 8.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.268 0.556 . . . . 0.0 110.351 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.97 152.8 43.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.188 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.71 173.7 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 11.3 t70 47.92 52.88 12.3 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.321 0.581 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.415 HG22 HD21 ' A' ' 76' ' ' LEU . 2.4 mt -85.93 110.25 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -123.1 120.5 33.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.232 178.928 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.623 ' HB2' HD22 ' A' ' 12' ' ' LEU . 10.0 t80 -91.58 128.47 37.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.78 -178.676 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 0.6 OUTLIER -120.18 87.7 40.11 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.027 178.737 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 10.3 Cg_endo -56.29 -32.66 88.81 Favored 'Trans proline' 0 CA--C 1.505 -0.959 0 C-N-CA 124.086 3.191 . . . . 0.0 113.752 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -133.68 88.94 2.53 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.949 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -66.43 116.56 7.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.277 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.86 -145.17 8.9 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 124.403 1.065 . . . . 0.0 113.829 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.73 -8.2 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.2 -23.88 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.552 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 36.9 mm-40 56.54 44.4 24.16 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -106.44 125.9 31.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.074 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.469 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 67.4 Cg_endo -74.84 108.66 2.76 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.65 2.233 . . . . 0.0 112.468 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.708 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.64 141.09 41.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.384 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -112.69 125.85 54.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.243 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.708 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.1 139.75 52.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.078 0.466 . . . . 0.0 110.302 178.828 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.72 168.34 27.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.13 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.708 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.3 mmt85 -85.29 116.0 23.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.608 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -101.1 133.43 45.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.37 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -83.72 138.68 33.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.572 -179.895 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.59 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 1.7 m-20 -98.12 164.42 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.826 178.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.4 m -57.35 -23.42 48.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.136 0.426 . . . . 0.0 111.696 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -68.9 -20.6 64.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.196 178.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.68 39.4 5.28 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -121.6 -177.06 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 93.2 m-85 -137.04 137.2 39.12 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.002 0.906 . . . . 0.0 111.672 -178.64 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -139.72 119.8 13.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.597 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 p-10 -66.11 114.05 4.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.593 ' HB2' HD22 ' A' ' 80' ' ' LEU . 35.6 mmt180 -114.44 172.31 7.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HB2' HD13 ' A' ' 75' ' ' ILE . 10.0 p-10 -137.02 149.07 47.23 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.837 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.527 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -134.5 146.46 30.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.306 0.574 . . . . 0.0 110.891 -179.612 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -82.12 109.71 16.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.454 -179.48 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.619 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.7 mt -80.05 2.46 23.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.932 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.469 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 13.6 m120 -63.45 -12.08 28.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.428 0.632 . . . . 0.0 109.842 178.004 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.606 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.7 -21.53 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.657 178.658 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.7 mt -85.98 124.29 40.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.315 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 80.5 mt-30 -120.05 167.09 12.55 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.432 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.82 122.07 46.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.4 t -112.4 93.89 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.22 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.4 t30 58.29 25.65 12.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.064 179.269 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.5 18.78 8.77 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.849 178.08 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.443 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 16.9 ptp180 -130.78 136.46 48.74 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.314 -0.521 . . . . 0.0 110.42 179.258 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 69.8 mt -83.19 126.22 32.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -134.82 128.1 49.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.179 0.514 . . . . 0.0 111.265 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.83 146.06 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.811 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 107' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 24.4 mm-40 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.353 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.577 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 49.6 m -162.07 177.31 9.84 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -60.43 -38.08 82.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.03 -23.73 21.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.798 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.62 -30.39 68.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.866 179.442 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.4 m -133.57 32.49 3.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 66.4 m -121.33 156.62 32.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 112.248 -179.05 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -154.86 170.74 20.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 81.7 m-20 55.01 32.33 17.93 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.622 0.576 . . . . 0.0 110.918 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.23 113.76 15.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -142.5 151.76 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.35 135.43 33.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.129 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.8 m -121.8 167.14 13.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.892 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.7 t-20 70.15 6.87 5.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.993 0.517 . . . . 0.0 111.589 178.446 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 22.82 24.76 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 100.45 16.77 26.09 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.584 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.627 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.1 mtp180 -102.51 -15.51 16.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.677 0.275 . . . . 0.0 110.377 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 25.0 m -130.86 129.46 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.824 0.345 . . . . 0.0 111.714 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.3 tp -100.7 107.94 19.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.652 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.9 tmm_? -105.17 123.37 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -149.14 146.88 27.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.7 mt-10 -103.3 109.55 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' SER . 6.5 p -115.13 140.84 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.339 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -74.72 143.2 44.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.341 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.45 ' HB3' HG21 ' A' ' 31' ' ' VAL . 24.4 p-10 -85.94 -177.16 6.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.661 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.64 -15.92 61.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -86.33 -24.34 25.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.42 7.21 30.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.541 -179.533 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 14.5 t-20 -97.27 147.33 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.479 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 51.9 m0 -78.06 128.84 34.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.962 0.411 . . . . 0.0 110.584 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 25' ' ' ASN . 6.5 t -123.58 128.64 74.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.45 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 m -82.32 110.38 17.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.846 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.1 t -111.57 148.72 32.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.545 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -135.43 132.12 37.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.679 HD11 HG12 ' A' ' 40' ' ' ILE . 13.7 tp -133.88 116.71 15.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.44 178.168 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 39' ' ' THR . 19.3 m-20 -68.01 107.77 2.82 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.649 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 12' ' ' LEU . 53.7 mt -57.54 -45.21 85.34 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.475 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.94 -5.04 2.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.973 -179.42 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -103.09 -10.76 18.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.819 -179.846 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.679 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.97 12.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.867 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -128.29 131.68 68.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -127.41 159.31 21.38 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 -178.767 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -112.49 108.15 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 19.4 t-20 -101.16 79.91 2.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.855 0.36 . . . . 0.0 110.131 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 70.1 m-20 53.15 57.74 5.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.19 36.45 35.02 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.739 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 61.7 m-70 -147.89 111.88 5.14 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.027 0.131 . . . . 0.0 110.82 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.489 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.6 m-85 -60.96 132.01 52.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.864 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -124.78 117.44 24.18 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.161 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -72.76 114.7 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.54 26.78 7.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.106 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.26 -52.48 1.46 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.602 -179.136 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.3 tt0 75.12 145.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.377 0.671 . . . . 0.0 110.884 -178.806 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.9 m-20 72.92 29.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.406 0.683 . . . . 0.0 111.939 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -77.04 -27.57 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.9 p -66.95 -28.11 68.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -178.839 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.609 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.6 pt-20 -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.609 HG23 ' HG3' ' A' ' 57' ' ' GLU . 69.9 p -121.79 13.74 10.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -122.84 151.89 41.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.903 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.52 167.9 21.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.488 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 1.6 t70 49.39 51.98 15.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.101 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.58 110.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.262 0.553 . . . . 0.0 111.384 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -127.48 122.18 32.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.643 179.534 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.4 t80 -91.97 131.84 36.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.358 0.599 . . . . 0.0 111.483 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 4.8 t-160 -121.84 87.65 46.78 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.908 178.457 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.8 Cg_endo -58.61 -35.21 98.97 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.748 2.965 . . . . 0.0 113.872 -178.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -124.1 83.58 2.16 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.169 -179.397 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 16.1 tt0 -64.3 110.29 2.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.224 177.597 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.42 -152.75 14.73 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.289 179.469 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.16 -0.91 26.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.227 0.537 . . . . 0.0 110.471 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.35 -18.26 32.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' OE1' ' HG2' ' A' ' 67' ' ' LYS . 27.5 mt-10 52.3 44.64 29.6 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.439 -178.019 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 68' ' ' GLU . 5.9 tp60 -91.83 113.39 58.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.03 -179.537 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.2 Cg_endo -72.91 106.64 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.32 2.013 . . . . 0.0 112.044 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.769 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -136.14 141.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -111.64 127.99 55.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.202 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.769 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.84 143.72 49.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.21 166.57 25.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.839 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 5.4 mmt180 -85.63 115.06 23.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.601 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -99.15 124.68 44.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 111.596 -178.544 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -85.06 142.42 29.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.94 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.653 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -103.14 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.331 179.702 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.5 -25.35 62.27 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -72.34 -24.73 61.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.73 36.66 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.742 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.653 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 7.1 pt-20 -111.16 -166.29 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -144.13 132.39 21.89 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.46 111.45 7.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.702 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.6 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.6 p-10 -64.42 114.08 4.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.585 ' HB2' HD22 ' A' ' 80' ' ' LEU . 39.2 mmt180 -115.67 177.39 4.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.08 178.461 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' HB2' HD13 ' A' ' 75' ' ' ILE . 3.6 p30 -143.37 148.76 36.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.597 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -132.07 145.56 34.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.325 0.583 . . . . 0.0 110.746 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.487 ' HB3' HD22 ' A' ' 95' ' ' ASN . 86.6 m-20 -83.66 109.25 17.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.608 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.9 mt -78.06 1.78 19.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.441 -179.18 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.487 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.3 m-80 -65.6 -8.73 21.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.073 0.463 . . . . 0.0 110.04 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.415 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -72.72 -20.22 61.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.252 178.345 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.6 mt -84.64 122.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.384 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.577 ' OE1' ' HA ' ' A' ' 2' ' ' SER . 2.5 mp0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.635 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.2 t30 -105.15 119.32 38.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.112 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.02 93.87 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.394 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.25 25.77 14.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.565 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.5 8.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.482 178.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 11.8 ptp180 -130.05 138.64 50.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.14 0.47 . . . . 0.0 110.815 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.3 mt -85.92 114.26 22.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.79 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 103' ' ' ARG . 40.0 t -123.0 123.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.546 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -79.37 145.65 33.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.167 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.695 0.622 . . . . 0.0 111.829 179.454 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m -163.09 174.34 12.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -68.22 -32.95 73.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.748 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -19.2 44.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.329 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.78 -27.65 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.106 0.479 . . . . 0.0 110.721 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -143.86 39.57 1.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.9 p -115.69 155.36 27.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.72 -178.783 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.47 HH12 ' HB3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -151.6 164.77 36.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.799 179.444 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 52.85 35.29 18.53 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.715 0.634 . . . . 0.0 111.239 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -76.65 114.34 15.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.56 154.37 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.85 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.7 tp -91.08 141.15 29.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.47 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.4 m -126.25 162.73 24.78 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.2 t-20 72.5 9.39 5.73 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.688 0.618 . . . . 0.0 111.121 178.082 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.68 21.2 34.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.308 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 103.16 20.43 11.23 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.245 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.627 ' HG2' HG21 ' A' ' 56' ' ' THR . 21.5 mtp180 -103.75 -18.97 14.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.864 0.364 . . . . 0.0 110.42 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 49.3 m -129.45 128.44 42.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 112.114 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.502 ' HB2' HD21 ' A' ' 37' ' ' LEU . 50.6 tp -97.79 110.19 22.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.55 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.1 tmm_? -114.37 124.69 52.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 -178.899 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.59 162.65 40.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.926 0.393 . . . . 0.0 111.053 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.8 mt-10 -110.47 114.61 28.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' SER . 30.3 t -131.53 142.74 50.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.732 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 145.32 49.28 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.24 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.59 ' HB3' HG21 ' A' ' 31' ' ' VAL . 32.4 p-10 -85.92 -167.48 1.87 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.677 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 101' ' ' ASN . . . -63.41 -34.95 78.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.711 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.8 -23.73 61.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.883 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 10.03 35.43 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.0 t30 -91.0 145.35 24.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.47 ' HB3' HH12 ' A' ' 8' ' ' ARG . 33.9 m0 -73.17 122.92 22.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.047 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.9 t -126.1 143.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.7 m -99.76 111.28 23.62 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.204 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.3 143.97 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.204 0.526 . . . . 0.0 111.816 -178.461 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.6 mt-10 -130.37 133.33 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.348 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -131.07 117.74 19.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.176 178.779 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.674 ' O ' HG22 ' A' ' 39' ' ' THR . 29.9 m-20 -69.0 109.78 4.13 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.81 178.912 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 12' ' ' LEU . 40.2 mt -60.61 -40.0 90.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.82 0.819 . . . . 0.0 109.927 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -63.16 -5.35 3.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.78 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.45 -12.53 15.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.478 -179.332 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.624 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.36 12.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.8 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.59 159.48 22.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.361 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.14 111.86 23.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.085 0.469 . . . . 0.0 109.827 179.084 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -104.48 87.97 2.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.9 t70 49.3 59.24 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.046 178.744 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.66 40.96 36.51 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.601 179.016 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.455 ' N ' HD23 ' A' ' 80' ' ' LEU . 44.2 t-80 -159.22 127.14 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.862 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 52.6 m-85 -68.0 139.41 56.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -132.11 116.38 16.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.427 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -70.5 115.12 9.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.109 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 28.23 6.77 Favored Glycine 0 C--N 1.32 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.462 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.19 -50.37 1.46 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.513 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 9.7 tt0 73.92 143.46 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.208 0.603 . . . . 0.0 111.727 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.625 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 95.8 m-20 65.64 38.66 5.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.597 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.29 -30.0 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.608 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 17' ' ' ARG . 74.3 p -62.91 -23.05 67.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.75 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 58' ' ' THR . 8.0 pt-20 -72.3 -14.98 61.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.276 0.56 . . . . 0.0 110.031 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 57' ' ' GLU . 68.0 p -126.19 7.02 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.119 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.9 144.76 49.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.33 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -138.27 172.32 13.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.053 -179.317 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.6 t70 48.15 50.96 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.071 0.462 . . . . 0.0 110.125 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.533 ' C ' ' HE ' ' A' ' 63' ' ' ARG . 2.8 mt -83.11 105.8 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.192 0.52 . . . . 0.0 110.691 -178.584 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -112.23 118.63 35.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.313 -179.848 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.627 ' CE1' HD12 ' A' ' 94' ' ' LEU . 6.2 t80 -93.04 124.69 37.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.863 0.363 . . . . 0.0 110.709 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -118.44 88.99 35.28 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.2 Cg_endo -57.65 -35.13 98.91 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 123.934 3.089 . . . . 0.0 113.538 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.506 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -129.02 88.14 2.67 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.73 -179.458 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -70.6 114.59 8.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.513 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.63 -152.08 10.11 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 124.16 0.912 . . . . 0.0 112.828 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -5.08 54.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.447 0.642 . . . . 0.0 109.527 178.666 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -23.52 59.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' OE1' ' HG2' ' A' ' 67' ' ' LYS . 28.6 mm-40 58.65 43.56 18.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.105 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.5 119.79 55.04 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.534 ' HD2' ' ND2' ' A' ' 95' ' ' ASN . 58.7 Cg_endo -74.39 108.16 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.368 2.046 . . . . 0.0 111.897 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.604 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -131.7 141.53 45.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.46 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 62' ' ' ILE . 2.0 tm? -112.73 123.43 50.29 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.271 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.604 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -119.85 138.16 53.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -155.9 166.39 33.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.397 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.5 mmt180 -85.83 114.5 22.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.5 mp -99.42 129.22 45.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.056 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -75.23 136.46 40.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.319 179.857 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -96.13 169.68 9.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.316 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 61.7 m -62.71 -15.2 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.027 0.441 . . . . 0.0 111.114 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.69 -27.01 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.658 0.742 . . . . 0.0 109.681 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.85 44.57 2.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.694 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.76 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.5 pt-20 -133.32 -166.47 1.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 52.8 p90 -134.61 139.36 45.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.655 0.741 . . . . 0.0 111.577 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -139.18 119.19 13.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.348 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -66.45 116.81 7.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.576 0.703 . . . . 0.0 112.557 -178.131 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD22 ' A' ' 80' ' ' LEU . 24.2 mmt180 -116.9 172.61 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.162 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -141.56 147.22 37.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.1 p -134.0 151.34 32.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.212 0.529 . . . . 0.0 111.126 -178.541 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -83.34 112.5 19.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.887 -179.334 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.627 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.3 mt -82.33 3.44 27.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.916 0.389 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.534 ' ND2' ' HD2' ' A' ' 74' ' ' PRO . 14.0 m120 -65.2 -16.78 63.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.52 67.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.127 179.351 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.9 mt -82.69 126.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.22 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 49.6 tt0 -120.29 162.94 18.58 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -106.55 119.96 40.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.023 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.7 t -109.67 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.481 179.801 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.423 ' HA ' ' H ' ' A' ' 26' ' ' ALA . 63.4 t30 60.06 21.69 10.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.026 179.044 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.44 17.57 7.04 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.995 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.29 146.05 51.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.084 0.442 . . . . 0.0 110.856 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 73.4 mt -89.5 119.04 29.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.102 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 57.7 t -121.22 123.4 69.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.624 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.12 145.14 32.53 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.469 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.333 179.88 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.424 0.154 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -155.99 -171.48 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -56.81 -38.56 72.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.059 0.457 . . . . 0.0 110.365 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.26 -26.13 37.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.896 -178.356 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.56 -32.09 64.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.0 m -132.76 32.94 3.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 62.0 m -115.08 152.76 31.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 111.515 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -145.78 163.93 33.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.022 -179.312 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.454 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 9.9 m120 52.66 33.28 13.43 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.727 0.642 . . . . 0.0 111.761 179.14 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -74.89 114.01 12.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.4 t -141.56 152.36 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.057 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -87.41 140.71 29.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.433 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 12.2 m -126.48 163.7 22.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.034 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.7 t-20 73.23 5.69 5.11 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.687 0.617 . . . . 0.0 111.368 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.85 23.4 15.51 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.52 21.63 16.41 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.942 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.699 ' HG2' HG21 ' A' ' 56' ' ' THR . 29.8 mtp180 -104.12 -19.1 14.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.652 0.263 . . . . 0.0 110.811 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.7 m -129.26 126.94 40.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.955 0.407 . . . . 0.0 111.703 -178.91 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.504 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.8 tp -94.68 105.67 17.62 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.014 178.176 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' NH2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 tmm_? -101.97 123.68 46.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -147.32 144.13 28.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 111.137 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 32' ' ' THR . 3.9 mt-10 -105.17 113.02 26.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 45.4 t -127.17 147.63 50.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.199 0.523 . . . . 0.0 111.674 -178.526 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.72 145.67 40.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.426 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.48 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.7 p30 -93.05 -173.43 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.521 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -34.38 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 112.204 -178.838 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.26 -20.29 61.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.659 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 4.16 54.67 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.926 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 t-20 -87.59 143.69 27.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -73.86 122.23 22.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 25' ' ' ASN . 8.2 t -120.52 146.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.616 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 22' ' ' GLU . 37.0 m -114.86 110.15 19.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.899 0.38 . . . . 0.0 110.191 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -118.29 164.18 15.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 112.102 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.5 mt-10 -136.69 140.04 42.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.229 -179.389 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.426 HD21 HG12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -132.01 113.88 13.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.291 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 39' ' ' THR . 26.8 m-20 -66.65 108.65 2.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 12' ' ' LEU . 54.1 mt -59.92 -47.39 85.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.212 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -64.2 -4.54 3.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.928 -179.447 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.14 -14.72 20.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.908 179.731 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.96 13.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 3.0 mt -126.4 131.42 71.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.15 160.1 19.75 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.837 -178.627 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.36 104.41 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -92.77 75.48 4.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.791 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 48.93 65.8 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.023 178.503 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.5 34.79 34.72 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.778 178.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -159.33 120.61 3.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 61.9 m-85 -63.25 143.54 57.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 111.271 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -133.82 117.4 16.81 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -72.7 114.58 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 40.58 3.08 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.98 -49.23 0.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.281 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.2 tt0 71.52 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.328 0.651 . . . . 0.0 111.582 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.683 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 91.5 m-20 71.06 35.19 1.68 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.523 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.79 -32.08 40.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.699 HG21 ' HG2' ' A' ' 17' ' ' ARG . 23.8 p -63.47 -30.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.523 -179.159 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 20.2 pt-20 -67.19 -17.0 64.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.075 0.464 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.547 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.7 p -122.56 12.71 10.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.69 149.95 48.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.47 169.09 18.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 49.05 57.93 5.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.471 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -88.06 111.59 22.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.371 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -116.66 118.83 33.66 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.882 179.624 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.8 t80 -92.77 128.06 38.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 178.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 4.0 t-160 -117.19 84.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 19.5 Cg_endo -58.95 -44.9 31.71 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.613 2.875 . . . . 0.0 114.488 -177.609 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 84.32 2.25 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.864 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 8.3 tt0 -67.81 113.33 5.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.769 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.61 11.04 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 124.299 0.999 . . . . 0.0 112.72 179.535 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.53 58.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.338 0.59 . . . . 0.0 109.548 178.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.78 -18.04 58.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.046 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 51.4 43.33 29.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.926 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.76 118.54 56.1 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.865 -177.724 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.3 Cg_endo -75.25 111.46 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.447 2.098 . . . . 0.0 111.766 178.644 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.492 HD11 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -132.48 140.47 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.06 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -113.65 121.15 43.28 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.243 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.85 140.12 50.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.904 0.383 . . . . 0.0 110.201 179.261 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.83 169.36 23.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.6 mmt180 -85.12 115.15 22.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.2 mp -100.9 130.82 46.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 -178.658 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -78.32 137.67 38.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.02 -179.533 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -99.08 171.5 7.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.129 179.5 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 69.6 m -54.63 -29.91 53.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.611 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -67.82 -23.05 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.689 -178.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.62 36.68 5.26 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.6 pt-20 -122.09 -166.85 1.45 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.931 -0.634 . . . . 0.0 109.482 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 45.6 p90 -134.58 141.25 46.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.808 0.813 . . . . 0.0 111.725 -179.024 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -140.18 112.71 7.92 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -68.28 115.49 7.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.376 0.608 . . . . 0.0 111.169 -179.064 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.9 mmt180 -116.16 177.28 4.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.414 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -140.32 148.73 41.81 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.539 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.8 p -132.74 148.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.549 -179.473 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.544 ' HB3' HD22 ' A' ' 95' ' ' ASN . 4.6 m-20 -86.11 109.01 18.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.995 -179.064 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.673 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.2 mt -78.98 4.04 15.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' A' ' 93' ' ' ASN . 15.4 m-80 -64.63 -12.58 47.31 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.043 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -69.7 -16.69 63.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.183 179.096 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.8 mt -88.28 122.59 40.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.618 0.723 . . . . 0.0 111.362 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -110.71 166.42 11.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.592 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.7 t30 -114.94 115.71 27.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.566 178.846 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 56.2 t -112.69 101.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.36 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' HB2' ' A' ' 25' ' ' ASN . 4.6 t30 60.33 21.68 11.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.006 179.422 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.58 11.27 27.32 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.597 178.336 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.4 ptp180 -118.16 141.48 48.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 0.0 110.506 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 21' ' ' ALA . 79.1 mt -89.63 126.45 35.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.769 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.8 p -134.41 134.67 54.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.248 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -88.79 144.86 25.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.815 0.697 . . . . 0.0 111.506 178.885 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.544 0.211 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -154.21 -178.63 7.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -64.95 -35.43 81.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.032 0.444 . . . . 0.0 109.835 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.669 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.61 -24.07 45.28 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.384 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.54 -31.67 64.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.4 m -144.85 42.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.669 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.3 p -115.54 149.4 38.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.022 0.439 . . . . 0.0 111.253 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.15 166.19 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' ASN . . . . . 0.415 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.1 m-20 52.05 33.25 11.65 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.677 0.61 . . . . 0.0 111.734 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.05 114.54 15.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.086 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.18 155.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.891 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -91.66 143.31 26.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.0 110.135 179.394 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.9 m -129.67 165.23 22.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.765 -179.243 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.1 t-20 72.06 9.82 6.05 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.512 0.507 . . . . 0.0 110.947 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 8.8 57.99 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 112.36 25.75 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.099 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.693 ' HG2' HG21 ' A' ' 56' ' ' THR . 21.6 mtp180 -108.45 -18.56 13.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 0.0 110.521 -178.903 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 46.7 m -127.68 126.57 42.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -178.832 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.476 ' CD2' HD13 ' A' ' 97' ' ' ILE . 45.6 tp -98.01 108.84 21.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.158 178.396 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -104.14 122.52 45.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -146.89 137.61 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.743 0.306 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.6 mt-10 -98.25 110.84 23.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.761 0.315 . . . . 0.0 110.285 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' SER . 49.6 t -125.83 147.88 49.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.853 0.359 . . . . 0.0 110.814 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.2 145.72 43.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.274 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -85.58 -168.56 2.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.724 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -32.99 74.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.163 0.506 . . . . 0.0 111.289 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.31 -24.31 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.32 4.25 40.88 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.398 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 m-80 -83.78 139.06 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.262 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.8 m0 -72.51 121.95 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.984 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.0 t -123.26 150.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -99.32 109.63 22.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.613 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.5 m -109.38 139.44 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.256 0.55 . . . . 0.0 111.43 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.0 mt-10 -130.39 131.79 45.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.041 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.542 HD11 HG12 ' A' ' 40' ' ' ILE . 13.3 tp -131.96 124.01 28.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 178.603 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 39' ' ' THR . 39.0 m-20 -72.25 108.64 5.5 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.123 179.179 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 12' ' ' LEU . 34.8 mt -61.1 -41.24 96.31 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.618 0.723 . . . . 0.0 109.718 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.36 -5.91 4.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.471 179.639 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -103.91 -12.05 17.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.401 -179.231 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.542 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.0 12.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.536 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.53 132.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.456 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.34 157.32 21.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.567 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 8.9 t30 -110.88 110.31 20.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.102 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -103.17 87.05 2.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 1.1 m-20 48.34 54.8 9.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.551 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.67 41.99 12.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.997 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' HIS . . . . . 0.417 ' N ' HD23 ' A' ' 80' ' ' LEU . 80.4 t60 -158.72 118.26 3.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 53.3 m-85 -64.56 137.29 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.78 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -131.26 115.83 16.82 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.281 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -69.13 116.08 9.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.439 178.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.7 33.28 5.37 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.168 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -104.1 -52.66 0.88 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.15 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 35.4 tt0 73.65 142.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 111.213 -179.254 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.557 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.2 m-20 71.92 34.99 1.41 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 111.602 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.4 p90 -78.84 -27.91 44.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.693 HG21 ' HG2' ' A' ' 17' ' ' ARG . 62.1 p -66.31 -24.0 66.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.615 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.668 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.3 pt-20 -74.91 -11.27 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.668 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -129.29 14.97 6.16 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.443 0.639 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.4 153.48 47.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.639 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.33 171.57 14.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.204 -179.673 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.612 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 12.7 t70 46.51 55.11 7.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.401 0.438 . . . . 0.0 110.541 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.514 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -84.72 107.35 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.261 0.553 . . . . 0.0 111.664 -178.026 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.557 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -114.34 118.2 33.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.23 179.728 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.641 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.1 t80 -92.99 128.76 38.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 111.302 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -120.49 87.86 41.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.744 177.794 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -58.86 -35.73 98.13 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.678 2.919 . . . . 0.0 112.693 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.65 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -131.52 85.56 2.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.437 178.995 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.14 121.77 16.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.299 -179.643 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.27 -136.08 1.03 Allowed Glycine 0 C--N 1.333 0.403 0 O-C-N 124.929 1.393 . . . . 0.0 114.818 177.122 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.23 -9.91 58.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.105 -0.548 . . . . 0.0 110.022 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -26.14 59.79 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.284 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 54.48 43.67 29.99 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.747 0.654 . . . . 0.0 109.892 -178.869 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -114.57 131.02 23.57 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.164 -178.813 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 66.2 Cg_endo -75.46 108.74 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.82 2.347 . . . . 0.0 112.032 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.654 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.8 141.19 43.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.254 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -112.59 123.87 51.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.395 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.654 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.28 139.21 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.26 166.63 32.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.426 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.639 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.0 mmt85 -85.9 115.04 23.28 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.309 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.655 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.8 mp -98.73 126.48 44.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.248 -178.732 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.51 141.19 30.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.067 -179.628 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 2.2 p-10 -100.39 174.1 6.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.27 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.8 p -57.7 -29.26 64.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -69.15 -28.36 66.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.848 -179.174 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.17 33.74 3.36 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.605 178.202 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 8.4 pt-20 -113.68 -164.08 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -146.78 132.3 18.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 0.0 110.623 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -133.68 119.61 19.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.024 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.8 p-10 -65.65 112.02 3.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 111.454 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.655 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -115.08 171.29 7.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.188 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -141.42 147.01 37.27 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.17 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.7 p -132.82 147.95 31.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.902 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.523 ' HB3' HD22 ' A' ' 95' ' ' ASN . 41.6 m-80 -83.2 111.94 19.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.641 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.35 3.3 21.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.171 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.523 HD22 ' HB3' ' A' ' 93' ' ' ASN . 31.3 m-80 -63.23 -16.5 60.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.089 0.471 . . . . 0.0 109.863 178.514 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.84 -28.68 70.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.553 0.692 . . . . 0.0 109.978 178.76 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.5 mt -76.44 123.65 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.212 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -116.06 164.02 15.07 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -111.31 118.26 35.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.133 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.9 t -109.85 94.44 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.19 25.16 13.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.045 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.13 17.22 9.67 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.887 177.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.1 ptp180 -130.37 135.99 48.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.133 0.467 . . . . 0.0 110.612 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.613 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 71.1 mt -84.48 125.04 32.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -133.66 132.32 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.21 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.41 144.82 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.371 179.015 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.8 p90 . . . . . 0 N--CA 1.454 -0.239 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.709 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.85 -27.87 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.675 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -33.29 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.3 m -134.94 37.32 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.709 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 69.6 p -119.43 152.37 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.492 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.2 ptp180 -151.42 168.93 23.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.6 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.0 t30 56.2 30.87 17.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.662 0.744 . . . . 0.0 110.135 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.34 113.52 16.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.178 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.96 146.47 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.4 tp -82.37 141.98 32.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -131.9 165.93 22.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.986 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.58 HD22 ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER 71.42 7.17 5.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.574 . . . . 0.0 111.584 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.4 9.9 Favored Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 91.75 18.66 43.49 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.946 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.3 mtp180 -103.43 -16.92 15.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.729 0.3 . . . . 0.0 110.3 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -128.58 129.39 45.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.408 ' CD2' HD13 ' A' ' 97' ' ' ILE . 52.8 tp -100.71 104.98 16.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.358 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.4 tmm_? -104.35 124.73 49.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.414 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.92 153.25 32.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.6 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 32.7 mt-10 -103.4 110.34 22.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.6 p -119.74 139.6 52.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.087 0.47 . . . . 0.0 111.415 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.49 144.11 44.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.222 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -89.25 -171.57 3.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.279 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.2 -21.53 65.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.64 -19.0 29.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.285 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.11 0.62 41.46 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 66.1 m-20 -80.83 136.3 36.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.447 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 49.5 m0 -77.98 119.48 21.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.005 0.431 . . . . 0.0 110.077 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.32 132.31 65.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -83.08 107.89 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.678 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 21.0 m -110.89 146.1 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.551 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.8 mt-10 -133.15 130.68 39.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.392 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.583 HD11 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -123.04 120.09 32.27 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.246 0.546 . . . . 0.0 110.101 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 39' ' ' THR . 9.3 m-20 -69.32 106.23 2.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.623 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 12' ' ' LEU . 21.2 mt -62.71 -40.23 96.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.929 0.871 . . . . 0.0 109.75 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.6 p-10 -64.27 -5.04 4.33 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.639 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.58 -16.14 16.18 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.556 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.583 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.08 14.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.29 130.75 70.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.97 157.54 21.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.335 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.428 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.3 t30 -111.97 113.94 26.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.044 0.45 . . . . 0.0 110.527 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -101.51 81.44 2.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.639 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 49.93 47.92 22.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.384 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 90.64 39.09 5.98 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.863 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -158.09 113.57 2.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.526 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 58.0 m-85 -60.27 136.64 58.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 0.0 111.007 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -127.22 114.49 17.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.168 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -71.22 114.53 9.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.8 28.64 6.89 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.705 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -98.5 -52.08 1.36 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.927 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 3.1 tt0 72.85 141.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.134 0.573 . . . . 0.0 111.213 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.655 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 94.6 m-20 70.48 37.87 1.43 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.544 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.7 p90 -81.4 -27.26 34.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.691 HG21 ' HG2' ' A' ' 17' ' ' ARG . 11.9 p -65.16 -19.54 66.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.699 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HG3' HG23 ' A' ' 58' ' ' THR . 8.3 pt-20 -77.32 -14.82 59.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.197 0.522 . . . . 0.0 110.136 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -125.89 12.89 7.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.664 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.27 145.71 47.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.554 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -139.3 169.22 18.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.476 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.2 t70 47.39 54.57 9.39 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.353 0.408 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.34 114.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 112.153 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -128.45 121.97 30.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.124 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.4 t80 -92.04 134.73 34.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -123.22 85.44 51.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.927 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 25.8 Cg_endo -62.22 -45.13 16.39 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 123.622 2.882 . . . . 0.0 113.89 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.809 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.9 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 . . . . . 0 N--CA 1.448 -0.559 0 CA-C-O 120.55 0.214 . . . . 0.0 111.016 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 64.2 Cg_endo -74.04 106.58 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.465 2.11 . . . . 0.0 111.678 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.494 HD11 HH21 ' A' ' 77' ' ' ARG . 0.8 OUTLIER -132.35 140.92 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.975 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -114.15 124.02 51.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.148 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.494 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.08 142.71 48.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 110.434 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.56 167.66 26.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.709 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.71 115.13 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.0 mp -97.87 121.44 39.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.462 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.726 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.549 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.606 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.1 pt-20 . . . . . 0 C--O 1.217 -0.647 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -147.73 134.59 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.465 0.65 . . . . 0.0 111.492 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -140.72 118.82 11.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.052 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 p-10 -64.37 114.73 4.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.469 0.652 . . . . 0.0 111.659 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.695 ' HB2' HD22 ' A' ' 80' ' ' LEU . 30.0 mmt180 -115.84 174.21 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -144.04 144.93 31.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -129.45 145.66 35.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.393 0.616 . . . . 0.0 111.082 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.495 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -81.57 107.17 14.11 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.61 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.702 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.3 mt -78.75 4.2 14.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.355 . . . . 0.0 110.995 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.34 -18.99 64.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 109.814 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.73 -24.46 67.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.003 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.7 mt -81.28 124.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -121.0 167.5 12.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.946 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.0 t30 -109.71 121.26 44.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.8 t -112.77 94.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.24 22.98 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.827 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.26 22.15 6.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.082 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 14.9 ptp180 -132.39 143.01 49.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.374 0.587 . . . . 0.0 111.15 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.678 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 67.3 mt -92.22 122.69 34.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.25 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.9 p -138.91 135.86 42.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -82.29 146.27 29.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.198 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.258 -179.799 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.533 0.293 0 CA-C-O 120.732 0.301 . . . . 0.0 110.635 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.2 -25.72 24.42 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -56.91 -33.76 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.24 0.543 . . . . 0.0 110.676 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 22.5 m -130.04 30.51 4.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.367 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 68.7 m -115.99 154.76 29.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 0.0 112.103 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -155.45 171.76 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.322 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.574 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.6 t-20 55.38 31.12 16.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.559 0.537 . . . . 0.0 110.694 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.51 113.86 16.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.425 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.48 151.34 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.825 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -90.78 134.52 34.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.529 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.2 m -120.69 164.39 16.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.63 5.07 4.87 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.69 0.619 . . . . 0.0 111.342 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.94 13.89 41.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 109.68 20.68 7.56 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.64 ' HG2' HG21 ' A' ' 56' ' ' THR . 22.5 mtp180 -104.27 -21.34 13.54 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.529 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 8.9 m -123.75 131.14 53.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.066 0.46 . . . . 0.0 111.723 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -103.62 105.51 15.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.263 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.6 tmm_? -103.81 124.35 48.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.219 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -147.27 150.25 34.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.801 0.334 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 11.4 mt-10 -107.35 112.41 25.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.7 t -125.67 147.9 49.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.232 0.539 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.89 145.17 40.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 178.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 31' ' ' VAL . 31.5 p-10 -87.8 -171.38 3.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.07 68.32 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.45 -24.55 50.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.431 . . . . 0.0 110.923 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.89 11.51 32.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.2 t30 -94.77 146.12 24.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -72.87 125.64 28.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.654 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.0 t -129.33 126.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -81.49 122.94 28.17 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.816 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 1.4 t -125.21 151.33 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.688 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.507 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.02 136.46 40.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.517 HD11 HG12 ' A' ' 40' ' ' ILE . 13.1 tp -130.63 126.11 35.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 39' ' ' THR . 5.5 m-20 -72.33 107.02 4.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 12' ' ' LEU . 47.7 mt -63.61 -41.4 98.31 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.874 0.845 . . . . 0.0 108.97 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -62.59 -4.77 2.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.527 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -104.54 -15.76 15.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.55 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.567 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -140.54 13.25 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.26 130.78 70.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.42 160.52 22.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.298 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -111.81 116.83 31.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 110.173 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -102.93 84.12 2.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.916 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.5 p30 46.01 43.15 10.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.322 1.049 . . . . 0.0 112.953 179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 98.82 37.13 4.28 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.911 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -157.3 117.06 3.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -60.85 136.51 58.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -129.29 114.26 16.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -67.84 115.32 7.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 39.71 3.52 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.993 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -109.83 -55.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.591 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.0 tt0 76.02 138.48 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.564 0.746 . . . . 0.0 111.875 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.4 t30 68.29 40.17 2.14 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.93 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 11.2 p90 -76.19 -30.37 58.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.758 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.64 HG21 ' HG2' ' A' ' 17' ' ' ARG . 42.5 p -61.85 -21.45 64.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.018 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.75 ' HG3' HG23 ' A' ' 58' ' ' THR . 1.1 pt-20 -72.16 -15.68 61.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.336 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.75 HG23 ' HG3' ' A' ' 57' ' ' GLU . 60.7 p -125.42 2.79 7.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -115.92 149.31 38.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.24 172.43 12.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.28 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.56 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 48.78 52.31 14.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.068 0.461 . . . . 0.0 110.202 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 76' ' ' LEU . 2.2 mt -86.44 109.18 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.45 0.643 . . . . 0.0 111.754 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.9 122.96 39.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.62 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.644 ' CE1' HD12 ' A' ' 94' ' ' LEU . 10.2 t80 -91.6 135.11 34.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.736 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -123.66 87.07 52.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.083 178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 9.4 Cg_endo -58.13 -38.27 92.11 Favored 'Trans proline' 0 CA--C 1.514 -0.515 0 C-N-CA 123.725 2.95 . . . . 0.0 114.836 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.745 ' HD3' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.696 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.03 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.875 0.369 . . . . 0.0 111.358 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.9 Cg_endo -72.89 109.68 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.52 2.146 . . . . 0.0 112.017 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.678 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 141.1 43.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -112.68 127.23 56.06 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.976 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.678 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.91 141.81 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.965 0.412 . . . . 0.0 109.904 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.09 169.42 23.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.06 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.56 ' HG2' ' CB ' ' A' ' 61' ' ' ASP . 4.2 mmt180 -85.97 115.19 23.43 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.0 mp -101.86 134.64 44.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.09 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.734 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.79 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.1 pt-20 . . . . . 0 C--O 1.219 -0.528 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -140.66 136.08 32.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.946 0.879 . . . . 0.0 111.725 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -139.8 125.54 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.102 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 3.7 p-10 -67.53 114.59 6.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 112.078 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 29.3 mmt180 -115.34 173.31 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.91 147.85 37.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 9.8 p -133.12 146.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.021 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.588 ' HB3' HD22 ' A' ' 95' ' ' ASN . 75.3 m-20 -82.91 110.58 18.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.728 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.644 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -79.28 3.95 16.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.588 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.3 m-80 -63.19 -14.36 48.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.053 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -24.93 67.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -79.22 126.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.836 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -118.91 160.56 21.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.932 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.27 120.95 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 52.9 t -112.48 93.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.38 25.73 13.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.84 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.96 14.86 15.95 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.646 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 14.4 ptp180 -124.17 134.57 53.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.347 . . . . 0.0 110.212 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.816 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 79.3 mt -85.17 120.31 26.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.4 t -128.46 136.37 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.914 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.415 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 2.1 p90 -87.59 143.69 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.893 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.964 179.31 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 p90 . . . . . 0 C--O 1.231 0.094 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.743 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.29 -21.25 48.24 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.929 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -57.66 -35.41 70.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.377 0.608 . . . . 0.0 110.186 178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -140.29 46.56 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.951 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.743 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 88.9 p -116.1 155.79 27.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 111.29 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -149.33 163.99 36.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 91.3 m-20 51.24 35.96 14.82 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.506 0.504 . . . . 0.0 111.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -79.11 113.81 17.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.411 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -144.67 149.72 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -83.99 142.46 30.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 m -127.87 164.96 21.1 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 7.2 t-20 73.29 9.23 5.2 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 123.575 0.547 . . . . 0.0 110.861 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.12 13.92 50.67 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 108.47 15.94 12.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.056 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HG2' HG21 ' A' ' 56' ' ' THR . 23.6 mtp180 -99.51 -16.98 18.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.583 0.23 . . . . 0.0 111.035 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -131.3 131.0 43.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.026 0.441 . . . . 0.0 111.67 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 37' ' ' LEU . 59.4 tp -98.55 105.09 17.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.796 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -104.91 123.87 48.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.47 41.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -112.4 113.08 25.09 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -126.49 141.07 52.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.095 0.474 . . . . 0.0 111.589 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -67.79 144.06 55.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.448 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.529 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.6 p-10 -85.9 -173.85 4.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.509 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.86 75.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.741 0.305 . . . . 0.0 111.527 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.53 -24.24 63.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.082 0.468 . . . . 0.0 111.096 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.84 35.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.721 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 t30 -91.69 146.44 23.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -75.0 124.1 26.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.293 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -127.54 154.59 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.3 m -104.73 114.16 28.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.897 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.0 p -110.7 134.08 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.495 0.664 . . . . 0.0 111.413 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.45 131.83 50.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.647 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.546 HD11 HG12 ' A' ' 40' ' ' ILE . 12.9 tp -131.44 119.59 21.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.955 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 39' ' ' THR . 9.6 t70 -68.88 111.32 4.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 12' ' ' LEU . 33.8 mt -61.73 -45.16 95.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.683 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -63.5 -3.8 2.37 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -101.3 -13.13 18.17 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.823 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.546 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.53 11.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.46 129.54 70.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.46 160.3 22.11 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.312 -0.946 . . . . 0.0 112.518 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.6 t30 -110.88 109.61 19.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.52 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.53 76.56 6.57 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.002 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 39.3 62.07 1.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.802 0.841 . . . . 0.0 112.14 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 88.89 36.89 7.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.794 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -163.24 118.13 1.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.77 0.285 . . . . 0.0 110.483 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CG ' ' HB ' ' A' ' 92' ' ' VAL . 41.5 m-85 -61.57 138.51 58.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.959 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.52 116.14 15.59 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.648 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.24 115.02 8.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.04 38.87 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -110.66 -50.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.258 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 1.7 tt0 74.76 144.32 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.218 0.607 . . . . 0.0 111.527 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 10.9 m120 64.02 46.03 3.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.749 0.785 . . . . 0.0 111.117 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -85.16 -28.56 25.42 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.39 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 17' ' ' ARG . 77.7 p -68.58 -19.58 64.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.559 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 58' ' ' THR . 12.2 pt-20 -71.37 -17.52 62.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.797 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 57' ' ' GLU . 62.8 p -124.33 9.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.905 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 56' ' ' THR . . . -115.69 150.37 36.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.093 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -137.04 170.09 16.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 7.3 t70 43.54 57.21 4.04 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.594 0.558 . . . . 0.0 111.33 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.442 HG22 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -87.94 113.39 25.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.187 0.518 . . . . 0.0 112.241 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 121.86 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.866 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 94' ' ' LEU . 12.8 t80 -91.47 132.1 36.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.292 0.567 . . . . 0.0 111.679 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.18 87.74 40.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 11.2 Cg_endo -57.63 -37.24 97.56 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 123.951 3.101 . . . . 0.0 114.105 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? . . . . . 0 C--N 1.295 -1.775 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 179.939 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 . . . . . 0 N--CA 1.449 -0.495 0 CA-C-O 121.059 0.456 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 60.2 Cg_endo -73.62 109.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.941 2.428 . . . . 0.0 111.882 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.497 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 140.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.07 124.63 52.83 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.105 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.501 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.89 141.48 50.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.856 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.23 170.56 20.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.276 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.47 115.14 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -100.63 125.98 47.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.913 0.387 . . . . 0.0 111.575 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.627 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.5 pt-20 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -136.11 139.87 43.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.63 0.729 . . . . 0.0 111.424 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -139.48 109.75 6.52 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.1 p-10 -62.83 114.09 3.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.393 0.616 . . . . 0.0 111.374 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.646 ' HB2' HD22 ' A' ' 80' ' ' LEU . 31.2 mmt180 -115.06 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.519 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.84 148.34 32.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CG ' ' A' ' 48' ' ' PHE . 12.7 p -135.31 143.56 36.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.375 0.607 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.53 ' HB3' HD22 ' A' ' 95' ' ' ASN . 7.5 m-20 -84.02 106.22 15.51 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.887 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.611 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.0 mt -75.67 2.17 12.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.53 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.4 m-80 -62.32 -17.22 58.21 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.697 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -21.55 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.155 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.8 mt -86.74 125.2 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -118.25 159.9 22.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -102.04 119.04 38.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.202 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 41.0 t -111.84 96.62 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.317 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 61.69 20.74 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.466 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 33' ' ' SER . . . 108.62 18.41 9.58 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.33 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 5.5 ptp180 -125.86 150.63 47.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.897 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 78.6 mt -97.78 118.1 33.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.5 p -118.42 126.19 74.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -86.78 144.38 27.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.763 178.4 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 4.9 p90 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.682 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.18 -30.08 59.16 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.003 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -56.87 -32.55 65.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.306 0.574 . . . . 0.0 111.196 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 56.2 m -136.69 41.12 2.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.209 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.8 p -115.96 145.15 43.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 111.419 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.88 166.03 27.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.016 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.22 31.07 13.4 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.641 0.588 . . . . 0.0 111.309 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.575 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.59 114.85 16.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.601 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.14 149.58 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.147 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -86.93 134.5 33.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.708 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 m -123.32 165.36 17.11 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.118 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER 71.24 8.79 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.229 0.612 . . . . 0.0 111.325 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 22.17 22.3 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.532 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.01 14.11 37.51 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.576 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.631 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.3 mtp180 -98.08 -17.11 19.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.402 0.144 . . . . 0.0 111.02 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 26.5 m -130.6 124.52 31.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 37' ' ' LEU . 60.6 tp -95.7 105.92 17.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -103.32 124.15 48.12 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 104' ' ' LEU . . . -147.42 145.06 29.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.027 0.441 . . . . 0.0 111.153 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.2 mt-10 -100.25 113.46 26.16 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 6' ' ' SER . 20.1 t -128.02 143.85 51.09 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.949 0.404 . . . . 0.0 110.441 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.08 144.46 48.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.729 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -84.42 -171.44 3.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.704 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.1 72.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.513 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.68 -24.44 63.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.32 38.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.498 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.0 m-80 -96.49 143.85 27.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -73.66 122.72 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 112.026 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 153.76 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.94 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 22' ' ' GLU . 20.2 m -108.55 111.0 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.506 ' HB3' HD13 ' A' ' 104' ' ' LEU . 9.3 t -112.62 155.97 23.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.135 0.493 . . . . 0.0 111.184 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.536 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.2 mt-10 -137.87 131.96 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.868 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.84 117.45 20.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.532 ' O ' HG22 ' A' ' 39' ' ' THR . 21.5 m-20 -68.15 107.04 2.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 109.579 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -59.19 -45.89 89.87 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.504 0.668 . . . . 0.0 110.536 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -62.7 -5.26 2.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.818 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.56 -14.23 18.29 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.992 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.11 10.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.499 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.08 129.94 71.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.77 158.65 20.86 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.883 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 12.1 t30 -110.7 111.48 22.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -93.07 79.29 4.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.537 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.4 49.84 4.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.174 0.921 . . . . 0.0 112.811 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 102.33 33.09 4.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.233 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -162.38 123.5 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.118 0.459 . . . . 0.0 111.061 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -64.08 139.79 58.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.18 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -133.02 117.49 17.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.65 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.17 114.59 8.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.26 34.86 5.2 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.759 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -107.7 -49.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.06 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.5 tt0 72.07 145.46 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.3 m-20 69.91 34.89 2.42 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.486 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.5 p90 -77.77 -28.46 50.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.631 HG21 ' HG2' ' A' ' 17' ' ' ARG . 40.0 p -68.86 -28.52 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.293 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.625 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.3 pt-20 -70.82 -13.83 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 109.979 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.0 p -126.09 17.51 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.04 163.5 26.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.09 166.39 29.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.35 61.43 3.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 110.749 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 78' ' ' ALA . 1.8 mt -93.61 116.76 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.704 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.556 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.48 126.77 30.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.28 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.668 ' CE1' HD12 ' A' ' 94' ' ' LEU . 16.5 t80 -92.2 137.93 31.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.349 0.595 . . . . 0.0 112.206 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -119.44 84.56 29.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.567 178.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.756 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 Cg_endo -58.72 -39.15 84.83 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.566 2.844 . . . . 0.0 114.177 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.244 179.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.611 0.244 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 59.7 Cg_endo -74.57 107.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.21 1.94 . . . . 0.0 111.452 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.73 141.61 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.9 124.94 53.76 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.222 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HD3' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.62 141.11 50.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.23 179.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.27 166.17 30.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.628 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 11.8 mmt180 -85.69 115.18 23.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -98.05 129.83 44.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.232 0.539 . . . . 0.0 112.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.051 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.7 pt-20 . . . . . 0 C--O 1.223 -0.303 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -147.76 128.2 14.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.0 110.135 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -137.42 120.94 17.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.7 p-10 -64.62 125.53 25.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.587 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -120.57 178.09 4.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.752 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -144.73 147.69 33.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 p -136.22 140.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.582 0.706 . . . . 0.0 110.999 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.516 ' HB3' HD22 ' A' ' 95' ' ' ASN . 26.0 m-80 -79.2 108.42 12.69 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.641 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.668 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -78.97 5.82 10.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.331 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 93' ' ' ASN . 18.8 m-80 -67.23 -8.61 33.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 110.281 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -72.84 -15.61 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.932 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.0 mt -89.05 126.13 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -115.87 169.93 8.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.508 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -115.2 118.77 34.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.226 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.444 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -113.75 100.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.57 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.73 24.64 13.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.37 0.605 . . . . 0.0 110.801 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.99 23.0 10.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.304 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.5 ptp180 -129.92 134.76 47.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.951 0.376 . . . . 0.0 110.069 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.1 mp -83.67 128.41 34.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.2 130.29 21.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.99 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -82.04 145.92 29.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.249 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.738 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.415 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 11.7 p90 . . . . . 0 N--CA 1.455 -0.195 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -52.4 -26.39 12.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.465 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.65 -29.63 27.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.011 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 25.5 m -141.47 34.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 66.7 m -115.64 152.92 32.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.389 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 167.64 26.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.96 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 74.0 m-20 55.6 31.71 17.77 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.524 0.515 . . . . 0.0 111.457 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -73.41 114.47 11.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.314 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.8 t -142.3 150.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.083 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.1 138.35 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -125.81 165.3 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 9.3 t30 72.49 6.36 5.44 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.57 0.544 . . . . 0.0 111.531 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.71 28.74 11.81 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 93.28 20.92 31.2 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.686 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.5 mtp180 -106.78 -13.99 15.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.687 0.28 . . . . 0.0 110.275 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 28.7 m -133.15 129.24 37.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.913 0.387 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' HD13 ' A' ' 97' ' ' ILE . 55.5 tp -100.33 108.7 20.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.609 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.7 tmm_? -103.96 123.54 47.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.75 151.0 36.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.006 0.431 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.7 mt-10 -106.44 114.47 28.61 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 6' ' ' SER . 12.6 t -130.32 147.93 52.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.307 0.575 . . . . 0.0 111.677 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.74 144.72 36.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.829 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -87.72 -168.6 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.791 0.329 . . . . 0.0 111.645 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.81 75.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.44 -24.24 61.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.147 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.8 5.84 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -86.48 144.69 27.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -77.47 125.34 29.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.482 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.15 131.75 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.869 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -83.58 110.05 17.92 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.531 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.8 p -111.36 143.43 42.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.321 0.581 . . . . 0.0 111.642 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -130.7 133.15 45.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.34 119.17 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.5 m-20 -68.88 108.48 3.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 12' ' ' LEU . 55.3 mt -59.28 -46.76 87.66 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.108 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -62.77 -4.91 2.33 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.85 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.12 -13.97 20.68 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.872 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -143.99 12.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.008 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.577 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -126.63 130.83 71.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.22 163.06 19.36 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.819 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.14 108.75 17.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 0.0 110.328 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -101.67 82.93 2.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.301 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 48.99 57.21 6.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.124 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.14 41.86 20.84 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -159.39 113.0 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.557 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.0 m-85 -58.76 136.28 57.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.244 0.545 . . . . 0.0 111.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -123.74 114.77 20.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.51 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.78 114.47 8.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.62 35.4 4.92 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.647 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.18 -49.54 0.82 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.148 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 28.9 tt0 70.15 145.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.026 0.53 . . . . 0.0 111.123 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.651 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.8 m120 72.35 31.78 1.77 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.215 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.577 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.1 p90 -76.57 -31.51 57.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.686 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.1 p -64.12 -27.18 68.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.876 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.3 pt-20 -72.04 -14.41 61.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.199 0.523 . . . . 0.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -125.09 14.05 8.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.922 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.8 157.32 37.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.654 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -148.93 170.66 17.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.322 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.438 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.2 t70 49.07 52.44 14.37 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.385 0.428 . . . . 0.0 110.74 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.429 HG22 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -84.79 112.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -126.54 124.89 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.643 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.65 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.8 t80 -91.6 137.65 32.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.352 0.596 . . . . 0.0 111.486 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -122.89 82.3 49.92 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 6.9 Cg_endo -56.94 -43.07 57.68 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.384 2.723 . . . . 0.0 113.947 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 3.3 mptt . . . . . 0 C--N 1.295 -1.791 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.438 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 . . . . . 0 N--CA 1.453 -0.29 0 CA-C-O 120.723 0.297 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 42.8 Cg_endo -70.01 108.94 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.568 2.179 . . . . 0.0 112.072 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -136.34 142.19 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.532 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.06 126.96 56.05 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.964 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.52 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.75 142.39 50.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.099 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.16 171.1 19.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.734 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.3 mmt180 -85.12 115.87 23.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -101.74 124.71 47.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.941 0.4 . . . . 0.0 111.666 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER . . . . . 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.469 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.3 pt-20 . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -140.43 139.71 35.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.036 0.922 . . . . 0.0 111.503 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -138.79 112.73 8.5 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.682 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.569 ' HB3' ' CD ' ' A' ' 79' ' ' ARG . 5.4 p-10 -64.43 113.15 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.518 0.675 . . . . 0.0 111.341 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.627 ' HB2' HD22 ' A' ' 80' ' ' LEU . 25.7 mmt180 -114.39 177.11 4.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HB2' HD13 ' A' ' 75' ' ' ILE . 7.7 p-10 -142.57 148.74 38.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.557 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -134.31 147.59 30.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.493 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.558 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -85.42 110.09 18.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.709 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.65 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.5 mt -77.5 2.48 16.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.293 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.558 HD22 ' HB3' ' A' ' 93' ' ' ASN . 16.6 m-80 -62.73 -12.75 25.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 109.91 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.7 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -69.51 -18.06 63.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.692 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.593 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.9 mt -87.06 123.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.443 0.64 . . . . 0.0 110.626 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -116.96 164.6 14.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.217 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.6 t30 -108.27 121.06 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 61.4 t -113.01 94.62 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.69 22.56 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.985 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.62 16.73 9.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.594 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.2 ptp180 -129.22 143.71 50.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 82.7 mt -89.37 133.23 34.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.71 131.4 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -82.48 145.78 29.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 57.6 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.47 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 p90 . . . . . 0 CA--C 1.53 0.18 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.761 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.15 -24.1 51.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.422 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -59.16 -24.24 62.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.5 m -148.01 39.32 0.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.761 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.7 p -116.22 158.27 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.938 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -155.32 166.8 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.517 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.511 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.8 m-20 52.89 35.47 19.12 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.788 0.68 . . . . 0.0 111.332 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -79.31 114.36 18.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.427 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 t -143.84 151.58 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -85.17 145.22 27.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 m -131.99 164.73 25.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 73.77 5.22 4.83 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.602 0.564 . . . . 0.0 111.234 177.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.06 23.58 19.65 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.505 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 99.1 16.86 29.07 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.824 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.721 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.7 mtp180 -100.75 -18.38 16.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.581 0.229 . . . . 0.0 110.783 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 50.5 m -130.22 128.42 41.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 0.0 111.54 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD2' HD13 ' A' ' 97' ' ' ILE . 58.8 tp -97.59 108.8 21.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.72 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.2 tmm_? -103.4 124.94 49.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.25 138.95 20.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -98.83 109.85 22.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD11 ' A' ' 104' ' ' LEU . 3.3 m -121.29 144.28 48.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.028 0.442 . . . . 0.0 111.035 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.29 143.32 47.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.94 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HB3' HG21 ' A' ' 31' ' ' VAL . 25.2 p-10 -90.26 -172.77 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.595 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.51 66.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.721 0.296 . . . . 0.0 111.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.18 -25.03 59.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.114 0.483 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.21 39.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.515 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.7 t-20 -88.94 146.32 24.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -78.55 119.63 22.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.057 0.456 . . . . 0.0 110.99 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -115.9 125.18 72.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.801 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.5 m -80.36 107.3 13.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.4 t -112.52 149.23 32.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.325 0.583 . . . . 0.0 110.584 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.9 mt-10 -134.96 131.77 37.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.85 119.18 23.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 39' ' ' THR . 47.4 m-20 -68.41 108.73 3.37 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.028 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 12' ' ' LEU . 68.3 mt -61.86 -42.35 98.95 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.55 -5.21 2.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.09 -12.08 16.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.439 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.538 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.94 10.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 130.44 70.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.59 160.79 20.95 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.966 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -110.94 107.85 17.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.505 0.669 . . . . 0.0 110.214 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -87.83 75.73 8.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.107 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 39.16 59.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 112.588 -179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 91.36 36.29 6.64 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.551 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -165.5 121.72 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.542 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.7 m-85 -60.93 143.78 54.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.346 0.593 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -132.91 115.81 15.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.422 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -73.01 115.08 11.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 31.91 6.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.784 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -102.03 -50.8 1.13 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.194 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.7 tt0 72.61 144.96 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.901 0.48 . . . . 0.0 111.422 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 2.6 t-20 68.74 34.71 3.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.244 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.2 p90 -77.27 -28.49 53.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.95 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.721 HG21 ' HG2' ' A' ' 17' ' ' ARG . 33.0 p -64.63 -22.23 66.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.555 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.674 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.6 pt-20 -73.16 -15.32 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.038 0.446 . . . . 0.0 110.371 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.8 p -128.19 16.32 6.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.271 0.558 . . . . 0.0 110.031 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.21 150.27 50.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.144 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.32 173.07 11.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.503 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.491 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 48.43 50.86 16.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.545 0.528 . . . . 0.0 110.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.05 108.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.337 0.589 . . . . 0.0 111.536 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.52 123.16 37.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.68 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.629 ' CE1' HD12 ' A' ' 94' ' ' LEU . 18.3 t80 -92.15 135.32 34.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.247 0.546 . . . . 0.0 111.895 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.43 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 16.5 t60 -124.5 89.33 52.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.04 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.2 Cg_endo -57.11 -36.86 99.31 Favored 'Trans proline' 0 CA--C 1.51 -0.712 0 C-N-CA 124.11 3.207 . . . . 0.0 114.633 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.78 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.656 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 N--CA 1.447 -0.59 0 N-CA-C 109.522 -0.547 . . . . 0.0 109.522 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 56.9 Cg_endo -71.37 110.43 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.779 2.32 . . . . 0.0 112.642 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.703 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 140.24 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -111.66 126.83 55.45 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.081 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.703 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.0 142.53 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.84 24.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.675 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.588 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.4 mmt180 -86.3 115.09 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.32 124.06 45.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.365 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.872 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.4 pt-20 . . . . . 0 C--O 1.22 -0.489 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.12 142.61 36.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.784 0.802 . . . . 0.0 111.417 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -140.99 112.04 7.2 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.073 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.2 p-10 -62.02 115.27 3.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.31 0.576 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -116.44 175.44 5.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.953 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.39 149.08 38.88 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.542 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -137.52 143.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.459 0.647 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HB3' HD22 ' A' ' 95' ' ' ASN . 36.5 m-20 -79.36 110.04 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.551 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.629 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.5 mt -79.04 1.11 25.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.798 0.332 . . . . 0.0 111.238 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.475 HD22 ' HB3' ' A' ' 93' ' ' ASN . 14.9 m-80 -61.93 -13.87 29.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -26.5 67.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.447 0.641 . . . . 0.0 109.39 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.2 mt -80.13 127.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.415 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -121.01 161.99 20.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -104.88 120.6 41.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.024 0.44 . . . . 0.0 110.63 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 60.2 t -113.1 94.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.32 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.94 24.91 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.714 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 23.14 8.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.0 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.587 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 7.6 ptp180 -130.6 134.15 46.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.95 0.375 . . . . 0.0 110.271 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.2 mp -80.89 119.46 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' A' ' 103' ' ' ARG . 48.3 t -127.14 125.37 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.226 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.56 144.02 34.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.205 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.909 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.7 p90 . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.717 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.3 -27.68 37.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.62 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.38 -31.83 66.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 110.976 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.9 m -138.11 41.31 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.717 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.2 p -122.67 154.55 37.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.597 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -151.37 167.51 27.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 84.9 m-20 53.69 34.43 18.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.659 0.599 . . . . 0.0 111.214 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.588 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -80.03 112.96 17.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.91 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.25 153.64 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.043 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.58 142.78 27.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 14' ' ' ASN . 20.4 m -130.37 163.53 26.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.4 t30 72.67 9.06 5.63 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.725 0.641 . . . . 0.0 111.657 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 25.27 15.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.037 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 93.08 26.18 17.16 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.611 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.588 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.7 mtp180 -108.09 -18.3 13.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.835 0.35 . . . . 0.0 110.196 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 42.1 m -128.73 129.91 46.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.768 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.1 tp -102.77 111.99 24.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.578 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -110.4 126.05 53.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.043 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -150.16 138.46 20.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 110.6 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.6 mt-10 -96.09 110.04 22.36 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' SER . 5.1 p -117.5 141.16 48.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.133 0.492 . . . . 0.0 111.643 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.16 143.89 40.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.771 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 p30 -90.58 -172.98 3.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.74 -34.07 70.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.627 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.64 -17.9 61.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.277 0.56 . . . . 0.0 110.83 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.45 6.71 56.41 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.6 t-20 -86.9 142.26 28.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.499 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.1 m0 -77.63 116.73 18.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.025 0.44 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.57 122.57 67.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 m -76.4 109.75 10.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.752 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 24.0 m -109.93 143.46 39.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.0 mt-10 -135.5 132.72 37.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.556 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.61 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -136.74 119.58 16.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.661 ' O ' HG22 ' A' ' 39' ' ' THR . 18.2 m-20 -69.67 110.34 4.82 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.722 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 12' ' ' LEU . 11.1 mt -60.6 -39.96 90.03 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.836 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -64.45 -5.93 6.3 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.492 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.56 -9.77 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.658 -178.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.61 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.16 10.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.71 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.43 131.16 70.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.12 158.03 20.2 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.755 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -111.45 108.53 18.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.15 0.5 . . . . 0.0 110.319 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -93.58 78.99 4.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.317 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 41.24 60.73 1.98 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.817 0.847 . . . . 0.0 112.432 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.23 35.5 9.59 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.771 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -158.5 117.35 3.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.801 -0.235 . . . . 0.0 110.736 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -62.93 139.48 58.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -133.5 116.78 16.37 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.43 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.419 ' HH2' HD22 ' A' ' 94' ' ' LEU . 90.6 m95 -69.67 115.62 9.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 39.14 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.873 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -111.58 -51.21 0.58 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.375 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.4 tt0 72.98 144.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.23 0.612 . . . . 0.0 111.344 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.7 m-20 72.47 28.99 2.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.82 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -74.1 -29.16 61.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.588 HG21 ' HG2' ' A' ' 17' ' ' ARG . 17.8 p -67.7 -20.43 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.004 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.2 pt-20 -76.49 -12.91 60.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.8 p -127.1 13.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.974 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.31 150.91 51.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.589 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.06 173.42 11.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.998 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.425 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 47.5 58.79 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 110.423 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.503 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 1.8 mt -94.9 110.7 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.4 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 126.41 39.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.413 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.0 t80 -91.38 134.99 34.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.363 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.8 t-160 -120.34 84.66 35.45 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.336 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -56.77 -41.11 79.07 Favored 'Trans proline' 0 CA--C 1.512 -0.607 0 C-N-CA 123.254 2.636 . . . . 0.0 113.89 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.595 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.774 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.743 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 . . . . . 0 N--CA 1.452 -0.351 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 58.9 Cg_endo -71.99 111.08 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.592 2.194 . . . . 0.0 112.669 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.411 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -134.37 141.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.24 125.43 54.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.517 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.05 142.5 49.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.147 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -161.71 169.72 20.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.223 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.605 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -86.0 115.0 23.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.6 mp -101.4 131.51 47.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.824 0.345 . . . . 0.0 111.303 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.323 -0.583 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.022 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 N--CA 1.448 -0.547 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 98.4 m-85 -135.95 136.36 40.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.707 0.765 . . . . 0.0 111.332 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -138.29 119.14 14.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.701 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 12.6 p-10 -64.49 113.26 3.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.433 0.635 . . . . 0.0 111.332 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD22 ' A' ' 80' ' ' LEU . 31.0 mmt180 -115.0 176.47 5.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -144.44 151.95 39.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.49 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.9 p -139.6 146.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.209 0.528 . . . . 0.0 110.78 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.495 ' HB3' HD22 ' A' ' 95' ' ' ASN . 40.5 m-80 -81.73 111.73 18.25 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.775 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.688 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.3 mt -80.55 -0.75 39.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.306 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 93' ' ' ASN . 23.7 m-80 -62.08 -14.22 34.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -68.05 -24.2 65.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -80.85 126.9 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.319 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -120.66 162.69 19.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.07 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -105.77 118.44 36.59 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.215 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.546 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.5 t -113.52 96.95 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.563 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.8 t30 59.87 24.7 13.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 111.482 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.94 24.32 7.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.998 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -132.9 139.25 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.322 0.561 . . . . 0.0 110.978 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.752 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 53.8 mt -84.99 117.29 23.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 47.3 t -122.78 122.47 65.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.818 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.84 143.85 34.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--O 1.249 1.074 0 O-C-N 123.722 0.639 . . . . 0.0 111.659 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.4 p90 . . . . . 0 N--CA 1.455 -0.215 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.46 -25.85 38.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.156 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.61 -30.56 55.09 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -136.64 33.09 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.417 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 69.4 m -120.22 156.45 31.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.022 0.439 . . . . 0.0 112.041 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.98 170.79 19.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.545 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 95.6 m-20 53.02 33.56 15.09 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.683 0.614 . . . . 0.0 111.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.45 114.14 13.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.95 157.02 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.551 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.81 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -94.34 134.54 36.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 109.882 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -119.42 163.32 17.4 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.091 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.0 t30 70.27 9.61 7.05 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.712 0.632 . . . . 0.0 111.561 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.2 26.72 17.75 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.902 -0.665 . . . . 0.0 111.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.33 22.8 21.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.969 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.9 mtp180 -106.33 -18.0 14.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.845 0.355 . . . . 0.0 110.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -132.52 127.76 35.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.094 0.473 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.444 ' HB2' HD21 ' A' ' 37' ' ' LEU . 55.5 tp -95.69 105.18 17.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.611 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -102.09 124.17 47.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.039 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.73 29.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.2 mt-10 -99.59 109.14 21.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 6.3 p -116.43 140.23 49.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.3 143.38 40.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.451 ' HB3' HG21 ' A' ' 31' ' ' VAL . 23.9 p-10 -87.26 -176.45 5.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.363 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.94 -30.55 66.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.533 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.68 -24.57 59.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.18 5.35 40.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.835 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.2 t-20 -89.01 144.77 25.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.432 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.5 m0 -77.65 121.1 23.51 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.978 0.418 . . . . 0.0 110.968 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -118.95 125.12 74.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.791 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -80.16 110.23 15.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.474 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.2 t -111.75 150.03 30.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 110.555 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.2 mt-10 -134.93 131.56 37.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.383 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.9 116.24 19.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 39' ' ' THR . 12.8 m-20 -67.61 107.68 2.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.509 0.671 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.81 HD11 HD11 ' A' ' 12' ' ' LEU . 38.0 mt -59.92 -42.5 94.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.453 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 2.4 p-10 -63.43 -5.67 3.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.8 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -105.66 -10.29 16.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.575 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.508 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -142.78 10.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 111.769 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -127.57 131.22 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.68 159.14 20.91 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.071 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -111.06 112.55 24.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -99.36 76.82 2.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 52.25 58.22 5.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.563 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.99 32.47 29.26 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.358 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -149.44 122.06 8.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.9 m-85 -66.3 135.18 54.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.809 0.337 . . . . 0.0 110.837 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -128.34 117.17 20.97 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -71.34 115.51 10.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.33 33.27 5.74 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.107 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -103.95 -51.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.107 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 28.5 tt0 70.69 143.31 0.05 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.089 0.556 . . . . 0.0 110.689 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.663 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 11.7 m120 76.89 31.23 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.322 0.649 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.4 p90 -80.69 -29.7 36.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.246 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.648 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.1 p -65.64 -17.36 64.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.007 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 12.4 pt-20 -80.25 -15.55 56.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.148 0.499 . . . . 0.0 109.996 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -124.6 14.66 8.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.23 150.1 49.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.682 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.768 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -141.03 172.81 12.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.405 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 1.1 t70 43.67 58.17 3.65 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.859 0.724 . . . . 0.0 111.129 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.4 mt -88.75 111.39 22.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.203 0.525 . . . . 0.0 112.139 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.487 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.55 123.21 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.069 179.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.68 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.2 t80 -92.88 134.6 34.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.14 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.411 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 8.1 t-160 -126.19 89.42 52.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 65' ' ' HIS . 20.7 Cg_endo -62.42 -36.58 65.61 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.886 3.058 . . . . 0.0 114.144 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.869 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.308 -179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.654 0.264 . . . . 0.0 110.459 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 53.0 Cg_endo -71.47 110.42 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.833 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.752 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.42 141.36 42.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -114.13 127.91 56.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.369 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.752 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.01 141.8 51.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.203 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.54 168.94 23.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.812 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.768 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.1 mmt85 -85.54 114.9 22.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -100.26 129.18 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.65 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.963 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.4 pt-20 . . . . . 0 C--O 1.221 -0.399 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -140.57 132.99 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.863 0.839 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -137.8 112.95 9.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.211 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.5 p-10 -64.02 116.08 5.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.291 0.567 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.585 ' HB2' HD22 ' A' ' 80' ' ' LEU . 36.4 mmt180 -115.84 174.54 5.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -141.46 142.97 33.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.6 p -130.33 148.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.571 ' HB3' HD22 ' A' ' 95' ' ' ASN . 12.6 m120 -83.45 110.59 18.31 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.04 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.68 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.99 1.18 32.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.562 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.571 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.6 m-80 -60.73 -17.29 47.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.429 . . . . 0.0 110.486 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.04 66.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.256 0.55 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -81.75 132.86 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.29 167.36 14.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -113.05 123.42 50.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.097 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.557 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 39.2 t -114.07 93.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.97 27.69 13.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.827 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.34 19.27 8.06 Favored Glycine 0 C--N 1.32 -0.353 0 C-N-CA 120.293 -0.956 . . . . 0.0 114.133 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 6.6 ptp180 -130.55 141.79 50.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.388 0.594 . . . . 0.0 111.116 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.3 mp -90.58 124.02 34.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.621 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.1 p -132.56 128.24 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -84.98 145.49 27.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.491 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.743 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.0 p90 . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -58.67 -19.29 38.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.081 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -55.88 -38.35 70.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.443 0.64 . . . . 0.0 109.945 178.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 61.0 m -130.01 33.83 4.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.517 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.0 m -120.02 155.23 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.0 ptp180 -151.78 170.77 18.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.499 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.5 m-20 54.18 32.52 16.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.14 0.495 . . . . 0.0 110.906 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.33 113.36 12.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.961 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.98 155.29 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.555 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -92.15 138.05 31.85 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.478 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.9 m -123.91 163.59 20.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.128 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 71.0 6.53 5.9 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.665 0.603 . . . . 0.0 111.666 178.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.38 23.63 14.0 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.543 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.36 17.77 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.812 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.702 ' HG2' HG21 ' A' ' 56' ' ' THR . 29.8 mtp180 -100.07 -18.11 17.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.592 0.234 . . . . 0.0 110.922 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.8 m -131.39 124.76 30.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.075 0.464 . . . . 0.0 111.52 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD2' HD13 ' A' ' 97' ' ' ILE . 60.4 tp -92.77 104.95 17.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.489 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.8 tmm_? -101.78 125.46 48.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.091 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.37 144.47 25.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 6.8 mt-10 -98.6 108.84 21.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.7 p -115.87 141.25 48.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.584 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.12 141.09 42.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.492 ' HB3' HG21 ' A' ' 31' ' ' VAL . 29.0 p-10 -86.87 -175.33 5.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.311 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.09 68.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.74 -23.87 61.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.067 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.11 8.58 44.28 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.262 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.5 t-20 -93.72 147.25 23.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -77.61 117.87 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.508 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 25' ' ' ASN . 9.8 t -113.25 122.95 68.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.2 m -78.58 105.22 9.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -111.1 154.04 24.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.2 mt-10 -139.57 132.47 29.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.42 114.88 18.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 39' ' ' THR . 21.3 m-20 -65.4 107.34 1.62 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.104 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 12' ' ' LEU . 85.6 mt -60.32 -45.59 92.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.652 0.739 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -62.62 -5.23 2.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.79 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.07 -13.15 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.036 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.523 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -142.95 12.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 111.923 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.64 131.45 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.85 156.85 19.67 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.442 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.467 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.2 t30 -111.58 107.19 16.26 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.52 82.16 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 40.6 51.98 3.02 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.319 1.012 . . . . 0.0 113.329 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 99.44 35.08 4.81 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.145 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -163.2 122.07 2.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.774 0.287 . . . . 0.0 110.628 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 47.1 m-85 -65.17 141.09 58.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 111.325 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.21 117.87 19.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.411 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -73.01 114.44 11.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.77 29.3 6.99 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.67 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.86 -53.76 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.978 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 31.5 tt0 73.07 143.89 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.387 0.675 . . . . 0.0 111.474 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 83.6 m-20 74.25 29.03 1.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.383 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -75.75 -33.44 60.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.517 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.702 HG21 ' HG2' ' A' ' 17' ' ' ARG . 22.6 p -61.71 -30.38 70.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.8 pt-20 -68.3 -13.58 62.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.837 0.351 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.549 HG23 ' HG3' ' A' ' 57' ' ' GLU . 76.6 p -126.22 13.63 7.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 109.924 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.51 146.11 50.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.625 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -136.91 172.86 12.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.637 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.462 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER 46.79 52.39 11.44 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.828 0.705 . . . . 0.0 110.473 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.62 112.01 21.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.0 111.659 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.48 124.61 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.548 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.704 ' CE1' HD12 ' A' ' 94' ' ' LEU . 21.5 t80 -92.37 136.66 33.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.363 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.9 t-160 -122.72 85.65 49.48 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 18.7 Cg_endo -62.32 -43.7 21.97 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 123.228 2.619 . . . . 0.0 113.671 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.753 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.729 179.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 . . . . . 0 N--CA 1.452 -0.371 0 CA-C-O 120.573 0.225 . . . . 0.0 110.52 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.58 109.83 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.662 2.241 . . . . 0.0 112.369 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -133.51 141.58 43.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.1 tm? -114.29 125.79 54.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.176 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.488 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.21 141.39 51.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.87 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.55 167.53 26.95 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.042 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.2 mmt180 -85.16 114.59 22.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -98.22 121.56 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.923 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.8 pt-20 . . . . . 0 C--O 1.219 -0.512 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -143.28 128.92 19.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.04 111.63 8.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.224 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.4 p-10 -65.65 120.29 12.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 112.445 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.69 ' HB2' HD22 ' A' ' 80' ' ' LEU . 36.3 mmt180 -115.94 174.88 5.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.979 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -139.42 150.62 45.47 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -140.54 144.66 26.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.391 0.615 . . . . 0.0 110.912 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.568 ' HB3' HD22 ' A' ' 95' ' ' ASN . 38.0 m-80 -80.87 109.0 15.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 64' ' ' PHE . 3.8 mt -79.01 1.12 25.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.453 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.568 HD22 ' HB3' ' A' ' 93' ' ' ASN . 15.6 m-80 -60.8 -16.63 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.273 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -23.52 67.42 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.941 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -82.22 125.61 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -117.0 163.34 16.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.219 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.65 117.66 34.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.533 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 48.5 t -113.11 94.22 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 57.75 27.32 14.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.598 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.98 23.69 8.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.485 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -131.61 134.48 46.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.079 0.439 . . . . 0.0 110.38 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 mp -85.92 124.36 32.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.3 p -137.1 131.62 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.593 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.52 145.91 29.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.978 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.196 -179.82 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.3 p90 . . . . . 0 CA--C 1.534 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.147 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.16 -24.55 41.99 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.635 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.19 -33.35 65.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.006 0.432 . . . . 0.0 110.926 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.4 m -132.38 33.24 3.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.167 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 71.8 m -119.38 156.6 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.433 . . . . 0.0 111.699 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -153.09 169.94 21.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.0 m120 52.92 33.88 15.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.686 0.617 . . . . 0.0 111.176 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.77 113.38 16.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.749 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 t -143.44 156.3 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.836 HD11 HD11 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -91.39 141.61 28.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 7.9 m -125.39 165.05 19.09 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.2 t-20 71.1 8.85 6.58 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.623 0.577 . . . . 0.0 111.657 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.02 26.3 16.89 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.05 27.09 11.35 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.054 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.719 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.7 mtp180 -111.37 -17.09 13.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.704 0.288 . . . . 0.0 110.497 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 40.4 m -128.76 126.44 39.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD2' HD13 ' A' ' 97' ' ' ILE . 39.6 tp -94.97 107.54 19.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.578 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -107.62 124.83 50.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.26 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.46 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -150.72 148.48 28.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.671 0.272 . . . . 0.0 111.12 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.9 mt-10 -103.67 109.47 21.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -118.59 148.17 42.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -79.86 141.99 35.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.461 ' HB3' HG11 ' A' ' 31' ' ' VAL . 34.3 p30 -89.46 -175.03 4.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.602 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.46 -28.86 69.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 111.04 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.04 -24.57 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.09 5.84 46.28 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.571 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.7 m-80 -95.18 149.28 21.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.424 0.29 . . . . 0.0 111.069 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.507 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 54.3 m0 -81.4 110.43 16.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 109.922 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -112.17 121.81 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.048 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -74.78 114.71 13.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.822 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.0 t -112.87 149.94 32.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -136.11 131.68 35.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.14 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 HG12 ' A' ' 40' ' ' ILE . 15.8 tp -129.05 118.75 23.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.0 0.429 . . . . 0.0 110.611 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 39' ' ' THR . 2.9 m-20 -68.07 110.02 3.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.755 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.836 HD11 HD11 ' A' ' 12' ' ' LEU . 23.8 mt -62.06 -39.16 91.43 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.491 0.662 . . . . 0.0 109.604 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -63.53 -6.12 4.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.227 178.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -101.89 -15.2 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.243 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.505 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.36 10.8 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -127.25 129.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.06 158.32 21.46 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.11 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.429 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.0 t30 -110.89 114.17 27.29 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.18 82.35 1.66 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.288 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 53.29 65.1 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.247 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.86 34.72 62.13 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.816 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -156.26 120.36 4.46 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.629 -0.336 . . . . 0.0 110.182 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 46.6 m-85 -62.08 142.98 57.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.148 0.499 . . . . 0.0 111.198 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -132.13 117.07 17.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.461 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -74.08 114.05 11.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.55 31.44 6.1 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.581 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.39 -51.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.084 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 25.8 tt0 73.26 143.09 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.188 0.595 . . . . 0.0 112.063 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 t30 68.78 31.78 4.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.694 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.0 p90 -72.31 -27.96 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.719 HG21 ' HG2' ' A' ' 17' ' ' ARG . 20.1 p -63.81 -19.6 65.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.111 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.678 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -74.58 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.134 0.493 . . . . 0.0 110.371 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -126.83 14.08 7.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.75 143.91 51.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.856 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.62 173.96 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.338 179.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.561 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 17.6 t0 48.17 50.61 16.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.234 0.54 . . . . 0.0 110.315 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.75 108.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.049 0.452 . . . . 0.0 111.738 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -125.46 123.95 40.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.047 178.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 94' ' ' LEU . 4.5 t80 -91.28 130.61 37.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.927 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.0 t60 -121.11 85.46 41.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.538 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 65' ' ' HIS . 9.2 Cg_endo -56.3 -36.37 96.89 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 123.933 3.088 . . . . 0.0 114.677 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.264 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.919 0.39 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 41.7 Cg_endo -68.07 112.1 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.681 2.254 . . . . 0.0 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.462 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -134.12 141.5 43.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -112.75 124.21 52.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.303 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.502 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.05 140.73 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.958 0.408 . . . . 0.0 109.961 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.0 169.83 22.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.839 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.4 mmt85 -86.34 115.59 23.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.9 mp -101.5 128.8 47.58 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 123.463 0.477 . . . . 0.0 111.074 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.318 -0.766 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.742 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.9 pt-20 . . . . . 0 N--CA 1.447 -0.611 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 90.5 m-85 -134.5 138.59 44.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.761 0.791 . . . . 0.0 111.575 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -139.64 118.12 12.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.649 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.4 p-10 -65.02 112.37 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.344 0.592 . . . . 0.0 111.283 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.646 ' HB2' HD22 ' A' ' 80' ' ' LEU . 28.2 mmt180 -115.41 174.56 5.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -141.9 152.44 43.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -138.67 144.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HB3' HD22 ' A' ' 95' ' ' ASN . 6.4 m-20 -82.62 110.37 17.63 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.672 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.647 ' HB3' HD12 ' A' ' 97' ' ' ILE . 8.5 mt -79.49 3.05 19.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.308 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' ' 93' ' ' ASN . 32.5 m-80 -62.19 -14.07 34.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.199 0.523 . . . . 0.0 109.819 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -21.21 66.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.186 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.647 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -83.6 127.94 39.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 0.0 111.505 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -121.45 160.91 23.17 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.125 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -108.43 120.73 43.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.071 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 48.3 t -113.72 94.38 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.001 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.48 23.48 12.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.451 ' CA ' HG11 ' A' ' 31' ' ' VAL . . . 114.15 14.34 9.23 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 119.287 -1.435 . . . . 0.0 113.695 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.8 ptp180 -130.18 135.57 48.31 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.425 -0.456 . . . . 0.0 111.161 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.822 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.8 mt -87.84 125.45 34.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.101 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.3 p -137.99 136.37 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.652 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -85.83 145.73 27.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.091 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.8 p90 . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.015 0.436 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.55 -27.31 37.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.942 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.13 -31.37 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 m -130.16 31.0 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 73.4 m -116.83 156.8 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.455 0.645 . . . . 0.0 112.204 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.1 ptp180 -152.33 170.87 19.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.084 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.577 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.9 t-20 56.11 30.4 16.32 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.624 0.578 . . . . 0.0 110.266 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -76.98 113.04 14.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.64 147.13 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.648 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.5 tp -84.46 140.82 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 14' ' ' ASN . 10.8 m -126.26 163.24 23.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.025 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.1 t-20 72.05 8.97 6.03 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.619 0.574 . . . . 0.0 111.607 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.6 23.25 24.21 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 97.49 24.92 11.47 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.101 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.2 mtp180 -107.59 -18.15 13.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.864 0.364 . . . . 0.0 110.288 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 m -130.1 128.51 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.358 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 37' ' ' LEU . 49.5 tp -97.32 108.65 21.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.648 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.2 tmm_? -105.42 123.98 48.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.309 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.08 26.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -106.09 110.05 22.18 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 41.8 t -121.69 145.6 47.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.87 144.01 52.64 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.277 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.542 ' HB3' HG21 ' A' ' 31' ' ' VAL . 22.6 p-10 -88.13 -167.52 1.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.952 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.24 68.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.599 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.34 -23.56 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.209 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.68 0.59 32.4 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.888 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 56.5 t30 -83.53 143.01 30.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -75.41 119.85 20.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.134 0.492 . . . . 0.0 110.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.1 t -117.92 124.42 73.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.317 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 22' ' ' GLU . 7.8 m -77.18 107.15 9.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.431 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.09 141.32 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.243 0.544 . . . . 0.0 111.088 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.0 mt-10 -130.14 131.01 45.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.664 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.579 HD11 HG12 ' A' ' 40' ' ' ILE . 15.2 tp -125.15 120.35 31.12 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.619 ' O ' HG22 ' A' ' 39' ' ' THR . 53.6 m-20 -68.61 107.77 3.09 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.369 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 12' ' ' LEU . 37.8 mt -60.36 -39.79 88.45 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.873 0.844 . . . . 0.0 109.621 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.672 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.5 p-10 -63.35 -5.04 3.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.758 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -107.63 -9.16 15.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.786 -179.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.579 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.62 10.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.91 132.4 68.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.7 158.18 22.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.426 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -112.02 114.2 26.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.777 0.322 . . . . 0.0 110.214 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -105.5 82.94 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.545 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 54.04 52.8 12.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.908 179.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.54 35.69 22.06 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -148.53 118.05 6.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.7 m-85 -63.97 134.99 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.165 0.507 . . . . 0.0 110.571 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -126.58 116.51 21.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.456 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -72.88 114.13 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.47 30.47 6.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.923 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.58 -50.44 1.2 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.895 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 23.4 tt0 70.68 144.97 0.06 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.127 0.571 . . . . 0.0 111.345 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.559 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 6.3 m-20 71.08 33.65 2.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.343 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.91 -27.46 39.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.933 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.618 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.9 p -65.72 -17.29 64.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.977 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 58' ' ' THR . 7.9 pt-20 -76.8 -18.19 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 109.852 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -123.31 9.79 9.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.473 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -118.85 144.05 46.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.24 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -136.02 166.93 22.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.095 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 45.74 55.86 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.584 HG22 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -83.18 106.61 14.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.308 0.575 . . . . 0.0 110.806 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.55 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -109.86 118.43 36.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.607 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.1 t80 -93.1 128.59 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.065 0.459 . . . . 0.0 111.103 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.41 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 39.7 t60 -124.38 88.77 52.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.151 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 19.7 Cg_endo -59.99 -35.94 91.47 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 124.156 3.237 . . . . 0.0 115.163 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.292 -1.894 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.587 -178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 . . . . . 0 CA--C 1.522 -0.105 0 N-CA-C 110.32 -0.252 . . . . 0.0 110.32 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 60.2 Cg_endo -72.87 112.36 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.154 1.903 . . . . 0.0 112.21 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -132.14 141.72 44.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.584 HD21 HG22 ' A' ' 62' ' ' ILE . 1.8 tm? -114.93 122.57 46.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.93 140.42 50.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.345 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -156.63 166.67 32.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.298 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.2 mmt180 -85.58 114.75 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.617 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.4 mp -99.35 127.75 45.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.199 0.523 . . . . 0.0 111.164 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.873 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.6 pt-20 . . . . . 0 C--O 1.22 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -145.9 129.38 16.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.47 117.98 12.17 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.971 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.7 p-10 -66.61 114.01 5.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.0 111.706 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.575 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -115.78 172.21 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.69 146.45 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.0 p -128.2 150.64 34.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.74 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.503 ' HB3' HD22 ' A' ' 95' ' ' ASN . 78.2 m-20 -87.07 103.98 15.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.892 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.538 ' HB3' HD12 ' A' ' 97' ' ' ILE . 7.9 mt -75.43 0.53 16.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.81 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.503 HD22 ' HB3' ' A' ' 93' ' ' ASN . 26.0 m-80 -60.9 -19.94 61.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.7 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -65.73 -22.01 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.783 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.6 mt -82.95 128.39 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.184 0.516 . . . . 0.0 111.267 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -119.1 168.29 10.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.81 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -112.59 121.05 43.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.499 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -112.25 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.401 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.89 24.73 13.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.556 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.78 20.58 8.37 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.699 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.499 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.5 ptp180 -129.8 139.98 51.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.152 0.476 . . . . 0.0 110.037 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 76.0 mt -87.08 124.05 32.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 0.0 110.992 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.6 p -127.98 128.78 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -84.12 146.73 27.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.551 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.947 0.78 . . . . 0.0 111.266 178.492 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 p90 . . . . . 0 CA--C 1.535 0.379 0 CA-C-O 121.306 0.574 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.763 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.3 -25.47 34.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.196 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -53.84 -33.07 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.037 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.14 37.39 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.987 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.763 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.3 p -115.28 157.26 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 111.466 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -147.91 169.73 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 25.6 m-80 50.45 34.44 9.29 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.748 0.655 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -85.74 112.42 21.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.39 178.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.306 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.9 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.15 146.54 28.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.0 m -132.12 161.5 33.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.4 t-20 74.04 9.48 4.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.692 0.62 . . . . 0.0 111.178 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.74 24.85 22.22 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 97.07 23.16 15.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.98 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.68 ' HG2' HG21 ' A' ' 56' ' ' THR . 31.0 mtp180 -107.99 -17.07 14.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.588 0.232 . . . . 0.0 110.525 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.6 m -129.99 127.95 41.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.585 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.69 107.39 19.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmm_? -104.54 124.64 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.079 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.43 151.28 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.63 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.771 ' HG2' HG23 ' A' ' 32' ' ' THR . 13.8 mt-10 -113.06 110.96 21.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.1 t -123.17 147.5 46.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.77 143.68 43.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.922 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.535 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.5 p-10 -91.31 -175.09 4.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.809 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.37 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 111.463 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.76 -24.85 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.828 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.75 10.38 37.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.648 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.6 t-20 -96.13 146.79 24.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.454 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.8 m0 -77.07 121.43 23.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -120.5 120.89 64.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.724 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 22' ' ' GLU . 11.2 m -81.73 109.47 16.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -113.26 150.74 32.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.137 0.494 . . . . 0.0 111.585 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.0 mt-10 -132.7 135.03 45.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.71 116.24 18.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' THR . 16.0 m-20 -68.32 109.81 3.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.526 0.679 . . . . 0.0 110.196 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.9 HD11 HD11 ' A' ' 12' ' ' LEU . 15.9 mt -61.42 -41.02 96.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.531 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -65.02 -4.91 5.19 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.192 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -104.66 -14.15 15.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.455 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.517 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -141.28 10.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.13 132.09 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.216 -0.303 . . . . 0.0 110.23 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.87 159.74 22.24 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.256 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.8 t30 -111.51 116.65 31.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 0.0 110.198 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.29 85.15 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 40.66 59.41 2.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.0 112.943 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 86.43 38.6 8.2 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.997 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.416 ' N ' HD23 ' A' ' 80' ' ' LEU . 50.6 t-80 -162.11 124.23 2.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -67.07 138.81 57.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.109 0.48 . . . . 0.0 110.633 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 49' ' ' GLN . 2.4 tt0 -130.1 116.94 19.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.607 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.4 ' HH2' HD22 ' A' ' 94' ' ' LEU . 91.9 m95 -69.42 115.64 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 30.13 6.35 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.199 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -100.5 -53.59 1.05 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.071 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.5 tt0 73.55 139.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.377 0.608 . . . . 0.0 111.738 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 t30 70.35 36.69 1.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.133 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -76.1 -26.93 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.041 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.68 HG21 ' HG2' ' A' ' 17' ' ' ARG . 36.3 p -63.66 -24.31 67.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 58' ' ' THR . 1.7 pt-20 -70.24 -17.1 63.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.269 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.7 p -125.78 16.0 8.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.503 0.668 . . . . 0.0 109.984 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.94 150.1 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.636 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -143.4 172.5 12.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.479 -179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.421 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.3 t70 48.22 57.22 6.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.082 0.467 . . . . 0.0 110.012 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -91.93 113.86 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.498 -177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.421 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -132.69 129.67 39.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 178.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.5 t80 -92.29 139.63 30.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 112.223 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -120.38 82.06 31.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.75 178.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.808 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.8 Cg_endo -55.88 -45.84 35.81 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 123.908 3.072 . . . . 0.0 114.539 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.808 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.293 -1.879 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.107 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 . . . . . 0 CA--C 1.518 -0.284 0 CA-C-O 120.65 0.262 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.4 Cg_endo -72.5 110.85 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.476 2.118 . . . . 0.0 111.533 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -134.73 141.97 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.57 124.73 53.06 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.918 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.541 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.06 144.36 48.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.496 . . . . 0.0 110.498 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.04 170.55 19.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.87 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.636 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -85.48 114.86 22.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.15 126.37 46.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.316 -0.85 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.261 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.8 pt-20 . . . . . 0 N--CA 1.449 -0.496 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -138.36 139.28 38.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.769 0.795 . . . . 0.0 111.257 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -138.7 111.64 7.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.281 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.2 p-10 -63.4 111.92 2.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.692 0.758 . . . . 0.0 111.777 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 33.2 mmt180 -114.56 175.22 5.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.447 ' HB2' HD13 ' A' ' 75' ' ' ILE . 5.9 p-10 -143.55 146.12 33.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.4 p -128.86 144.23 38.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.616 0.722 . . . . 0.0 111.096 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.496 ' HB3' HD22 ' A' ' 95' ' ' ASN . 36.9 m-20 -79.87 106.11 11.65 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.732 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.679 ' HB3' HD12 ' A' ' 97' ' ' ILE . 3.8 mt -78.57 1.83 21.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -59.92 -19.95 54.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.426 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -62.92 -22.95 67.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.188 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.2 mt -83.8 128.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.011 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 38.6 tt0 -122.4 162.34 21.79 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.944 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.475 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 4.8 t30 -102.01 117.91 35.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.179 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 51.3 t -113.0 95.82 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.343 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.29 23.36 13.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.239 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.06 8.23 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.428 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 17.9 ptp180 -130.39 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.807 0.304 . . . . 0.0 110.259 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.05 115.6 23.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.8 t -117.93 121.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -81.49 146.47 30.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.166 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.427 ' H ' ' HB3' ' A' ' 96' ' ' ARG . 36.6 tt0 . . . . . 0 C--O 1.247 0.957 0 O-C-N 123.67 0.607 . . . . 0.0 111.372 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.73 -25.36 54.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -55.61 -32.51 63.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 110.923 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.0 m -133.04 32.3 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 65.8 m -116.53 156.51 26.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.593 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.6 ptp180 -153.41 168.79 24.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.616 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.57 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 55.6 t30 55.44 31.25 16.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.431 0.634 . . . . 0.0 110.806 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.563 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.24 114.73 17.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.904 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 153.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -89.23 146.0 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.4 m -131.68 165.47 23.63 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.4 t-20 71.81 8.31 6.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 111.638 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.21 25.08 14.88 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.552 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.33 27.96 10.25 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.783 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.742 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -112.71 -15.49 12.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.815 0.34 . . . . 0.0 110.413 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.2 m -129.85 130.23 44.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 0.0 111.717 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.1 tp -99.28 111.47 23.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.508 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -113.07 124.29 52.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.55 153.53 33.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 9.0 mt-10 -106.05 109.92 22.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -117.98 143.61 46.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.56 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.84 144.27 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.682 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -88.42 -173.7 4.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.952 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.35 67.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.99 -24.48 55.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.945 0.402 . . . . 0.0 111.294 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.46 0.76 32.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.512 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.5 t30 -82.8 143.56 30.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -77.5 129.14 35.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.38 123.72 65.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.558 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -77.29 107.79 9.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.503 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.8 m -110.3 143.44 40.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.305 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -128.06 143.51 51.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -141.82 120.53 12.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 39' ' ' THR . 14.4 m-20 -70.45 107.16 3.7 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 110.004 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 12' ' ' LEU . 52.6 mt -60.69 -40.59 92.76 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.797 0.808 . . . . 0.0 109.675 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.57 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 5.2 p-10 -63.02 -4.95 2.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.86 -12.19 15.95 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.706 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.539 HG23 HG23 ' A' ' 39' ' ' THR . 2.4 pp -141.24 10.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.018 0.437 . . . . 0.0 112.11 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.32 129.36 70.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 158.1 21.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.189 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.437 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.0 t30 -111.56 114.73 28.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.111 0.481 . . . . 0.0 109.973 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -103.74 87.28 2.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.258 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.9 p30 45.24 57.51 4.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.561 0.744 . . . . 0.0 112.46 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.646 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.62 36.24 26.66 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.998 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -150.57 115.33 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.8 m-85 -61.8 135.72 57.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.634 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -129.69 115.06 16.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -69.67 114.89 8.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.0 5.95 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.823 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.11 -53.41 0.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.685 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.1 tt0 74.91 144.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.22 0.608 . . . . 0.0 110.961 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.7 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.7 m-20 68.36 36.94 2.86 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.265 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.26 -29.27 47.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.742 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.8 p -63.79 -23.28 67.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.044 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.791 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.9 pt-20 -71.39 -16.12 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 109.843 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.791 HG23 ' HG3' ' A' ' 57' ' ' GLU . 76.8 p -126.04 9.15 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -119.52 142.31 48.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.157 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 169.28 17.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.776 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.6 t70 47.22 54.91 8.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.072 0.463 . . . . 0.0 110.973 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.57 109.45 20.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 124.45 41.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.803 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.3 t80 -92.08 137.19 32.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.718 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.441 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 10.5 t60 -123.97 86.71 53.57 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.976 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 5.7 Cg_endo -53.09 -41.0 75.0 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 124.575 3.517 . . . . 0.0 115.131 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.291 -1.94 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.302 -178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 . . . . . 0 CA--C 1.518 -0.277 0 CA-C-O 121.035 0.445 . . . . 0.0 111.871 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.9 Cg_endo -73.22 112.93 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.754 2.303 . . . . 0.0 112.206 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.508 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.3 pp -134.45 140.71 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -110.78 125.02 53.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.522 ' HD2' ' H ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -119.31 139.86 51.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.652 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -161.77 168.36 23.33 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.043 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 4.2 mmt85 -85.82 114.86 23.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.646 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.3 131.73 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.897 0.38 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER . . . . . 0 C--N 1.315 -0.911 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.751 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.679 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 C--O 1.221 -0.414 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -142.61 137.56 30.13 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.815 0.817 . . . . 0.0 111.204 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.56 117.45 13.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.499 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.0 p-10 -66.11 113.28 4.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.614 ' HB2' HD22 ' A' ' 80' ' ' LEU . 33.6 mmt180 -115.05 172.23 7.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.86 151.61 47.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.552 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.8 p -139.68 144.68 28.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.38 0.61 . . . . 0.0 110.755 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.542 ' HB3' HD22 ' A' ' 95' ' ' ASN . 31.0 m-80 -81.69 110.31 16.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.756 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.7 mt -79.33 3.02 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.115 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.542 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.8 m-80 -62.86 -18.29 62.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.55 -28.36 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.908 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -77.75 130.19 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.494 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -125.96 166.28 17.23 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.3 t30 -109.06 123.9 49.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.69 94.04 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.0 t30 58.82 27.15 15.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.916 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 20.96 7.97 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.814 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 12.7 ptp180 -131.25 139.6 49.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.356 0.578 . . . . 0.0 110.612 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.8 mp -90.29 124.9 35.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.792 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.23 130.65 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.435 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 3.3 p90 -79.97 145.16 32.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.475 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.489 0.493 . . . . 0.0 111.114 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 p90 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.734 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.13 -23.25 54.41 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.798 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.93 -23.37 63.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 111.038 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.0 m -148.6 38.03 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.734 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.8 p -116.74 153.29 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.496 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 9.6 t-20 54.23 30.64 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.534 0.522 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.12 113.54 12.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -143.38 149.17 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.934 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -84.04 144.56 29.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 12.7 m -131.33 161.36 32.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.655 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.54 10.44 5.68 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 123.559 0.537 . . . . 0.0 111.237 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.13 24.84 23.61 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.453 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 96.86 22.02 19.31 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.851 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.644 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -104.85 -19.03 14.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.626 0.251 . . . . 0.0 110.407 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 34.5 m -130.44 126.75 37.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.779 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.469 ' CD2' HD13 ' A' ' 97' ' ' ILE . 61.0 tp -96.97 109.55 22.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.517 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.1 tmm_? -109.08 124.24 50.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.52 149.91 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.0 mt-10 -104.67 112.2 25.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.9 p -124.21 147.51 47.98 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 111.844 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.29 144.52 36.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.575 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 8.5 p30 -86.07 -175.0 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.52 69.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.84 -23.51 59.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.56 3.2 30.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.959 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.477 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 5.2 t30 -86.07 145.57 27.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.113 0.456 . . . . 0.0 110.078 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -74.14 126.03 29.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.718 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -126.99 128.97 71.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -86.7 112.99 22.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.403 ' HB3' HD13 ' A' ' 104' ' ' LEU . 4.1 t -112.1 151.81 28.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.039 0.447 . . . . 0.0 110.749 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.444 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -139.05 132.0 29.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.196 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.614 HD11 HG12 ' A' ' 40' ' ' ILE . 12.8 tp -133.76 123.99 25.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.01 0.433 . . . . 0.0 110.122 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 39' ' ' THR . 38.9 m-20 -72.21 108.36 5.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 12' ' ' LEU . 24.8 mt -59.53 -45.88 90.49 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.087 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.448 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -63.97 -5.08 3.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.674 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.73 -9.79 20.54 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.056 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.614 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.23 11.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 111.669 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.64 132.55 68.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.03 157.97 21.32 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.774 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.436 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.3 t30 -110.13 106.31 15.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.48 80.99 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.189 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 51.15 56.64 7.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.143 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.53 39.32 18.52 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.273 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -157.41 117.78 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 0.0 110.366 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.4 m-85 -61.95 137.76 58.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.315 0.578 . . . . 0.0 111.701 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -133.36 118.47 18.51 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.03 115.22 10.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 29.21 6.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.13 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.99 -53.26 1.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.086 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 35.1 tt0 72.13 141.93 0.06 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.309 0.644 . . . . 0.0 111.136 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.57 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 79.9 m-20 76.83 30.63 0.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.937 0.895 . . . . 0.0 110.997 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.5 p90 -78.0 -29.28 49.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.374 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.644 HG21 ' HG2' ' A' ' 17' ' ' ARG . 53.8 p -66.02 -25.16 66.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.558 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.666 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.7 pt-20 -70.63 -19.3 62.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.273 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.666 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -122.68 15.74 10.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.332 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.92 151.22 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.59 173.09 11.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.251 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 5.6 t70 47.53 52.41 12.47 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.563 0.54 . . . . 0.0 110.449 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.39 108.75 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.333 0.587 . . . . 0.0 111.74 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.428 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -123.52 123.16 39.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.561 178.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.8 t80 -91.77 133.81 35.28 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.015 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -121.67 86.54 45.15 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.491 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.614 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.2 Cg_endo -56.34 -38.6 94.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.754 2.969 . . . . 0.0 113.727 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.614 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.298 -1.65 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.46 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 . . . . . 0 N--CA 1.446 -0.659 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.8 Cg_endo -72.75 109.03 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.365 2.043 . . . . 0.0 112.0 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.449 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -135.26 141.61 42.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.3 tm? -112.04 123.41 50.19 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.47 ' HD2' ' H ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -119.91 138.75 53.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.609 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.35 168.19 27.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.006 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.62 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.9 mmt180 -85.79 115.0 23.18 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.623 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -98.45 124.36 43.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 . . . . . 0 C--O 1.223 -0.34 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.66 130.2 16.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.268 0.556 . . . . 0.0 110.294 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.19 117.76 13.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.157 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.9 p-10 -66.68 120.07 12.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.438 0.637 . . . . 0.0 112.209 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.564 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.3 mmt180 -116.42 177.67 4.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -143.91 147.51 34.09 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.2 p -135.3 144.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.791 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HB3' HD22 ' A' ' 95' ' ' ASN . 60.7 m-20 -81.53 110.12 16.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.9 mt -78.24 2.45 18.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.505 HD22 ' HB3' ' A' ' 93' ' ' ASN . 19.6 m-80 -63.61 -16.19 60.23 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -25.05 67.45 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.538 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.629 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.9 mt -80.11 121.47 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.783 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -113.7 164.01 14.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.019 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.0 t30 -107.13 116.38 31.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.71 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 60.6 t -112.16 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.06 0.457 . . . . 0.0 110.279 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.18 24.73 14.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.762 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.4 19.14 9.57 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.509 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -130.59 142.81 50.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.039 0.42 . . . . 0.0 110.606 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.403 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.0 mp -85.01 119.24 25.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.0 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.31 123.59 70.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.885 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -81.69 145.17 30.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.452 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.596 178.369 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.2 p90 . . . . . 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.17 -25.89 35.39 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.787 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -57.54 -31.8 66.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.209 0.528 . . . . 0.0 110.631 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.1 m -130.15 34.96 4.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.971 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.1 m -117.32 158.54 24.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 0.0 112.027 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -155.97 166.22 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.966 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.452 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.8 t-20 54.71 33.97 20.63 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.619 0.574 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.87 113.85 16.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.217 0.532 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.71 155.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.735 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -94.79 135.29 36.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 14' ' ' ASN . 11.2 m -120.31 165.36 14.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.691 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.0 t-20 74.12 5.98 4.72 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.575 0.547 . . . . 0.0 111.067 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.94 16.16 39.67 Favored Glycine 0 CA--C 1.506 -0.48 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 105.3 27.03 5.99 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.735 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.1 mtp180 -110.86 -18.16 13.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.645 0.26 . . . . 0.0 110.455 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 63.1 m -129.6 128.46 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.369 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.9 tp -97.85 110.05 22.69 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.627 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.3 tmm_? -108.47 124.16 49.99 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.71 151.32 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.949 0.404 . . . . 0.0 110.191 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.2 mt-10 -106.94 113.17 26.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 6' ' ' SER . 7.8 p -124.22 146.78 48.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.184 0.516 . . . . 0.0 112.228 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.58 144.88 39.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.02 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -86.25 -173.17 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.804 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.19 73.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.149 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.58 -24.19 63.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.726 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.7 44.23 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.463 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.3 t-20 -84.35 144.89 28.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.169 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -76.25 121.19 22.56 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 t -120.67 154.99 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.374 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -107.53 112.96 25.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' LEU . 11.6 m -112.97 144.23 42.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.237 0.541 . . . . 0.0 111.386 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.2 mt-10 -132.8 131.52 41.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.653 HD11 HG12 ' A' ' 40' ' ' ILE . 12.1 tp -131.49 120.53 23.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.191 0.519 . . . . 0.0 109.907 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 39' ' ' THR . 36.0 m-20 -70.04 110.01 4.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.179 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 12' ' ' LEU . 37.7 mt -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.874 0.845 . . . . 0.0 109.151 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.5 OUTLIER -63.22 -3.66 2.0 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.548 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.89 -14.62 15.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.326 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.653 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -141.7 13.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.53 131.89 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.21 158.12 21.46 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.569 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.456 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.8 t30 -110.35 106.79 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.05 84.13 3.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 53.09 59.32 4.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.258 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.605 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.56 40.27 39.21 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.729 -1.225 . . . . 0.0 111.969 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -160.32 121.15 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.499 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 49.4 m-85 -63.69 138.83 58.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 111.228 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -134.48 117.08 15.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -69.51 115.79 9.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.883 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.7 36.79 3.89 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.219 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.25 -52.12 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.615 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.7 tt0 73.57 143.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.56 0.695 . . . . 0.0 111.976 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t30 66.64 31.76 7.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.421 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -69.46 -27.38 65.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.735 HG21 ' HG2' ' A' ' 17' ' ' ARG . 17.0 p -64.38 -17.6 63.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.701 ' HG3' HG23 ' A' ' 58' ' ' THR . 5.5 pt-20 -72.7 -21.78 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.6 p -122.91 12.91 9.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -121.86 145.7 47.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.223 0.535 . . . . 0.0 111.311 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.5 171.27 14.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.222 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.1 t70 45.45 56.1 6.0 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.538 0.524 . . . . 0.0 110.963 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.3 mt -88.42 111.28 22.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.051 0.453 . . . . 0.0 112.03 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 125.25 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.91 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.599 ' CE1' HD12 ' A' ' 94' ' ' LEU . 25.3 t80 -91.09 137.05 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.297 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.6 t-160 -121.27 86.76 43.68 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.316 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 8.5 Cg_endo -57.4 -44.58 41.31 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.442 2.761 . . . . 0.0 113.921 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? . . . . . 0 C--N 1.295 -1.768 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.802 179.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 120.639 0.257 . . . . 0.0 111.364 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.5 Cg_endo -73.21 110.0 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.737 2.291 . . . . 0.0 112.141 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.2 pp -136.5 141.98 39.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.5 124.96 53.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.333 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.509 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.93 145.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.006 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -162.14 169.7 20.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.1 mmt180 -86.89 115.33 24.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.605 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.6 mp -99.35 123.0 43.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.025 0.44 . . . . 0.0 110.762 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.701 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.359 -179.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.629 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.8 pt-20 . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -141.38 135.13 30.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.968 0.89 . . . . 0.0 111.133 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -130.68 108.13 9.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.7 p-10 -67.1 112.37 4.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.371 0.605 . . . . 0.0 110.61 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.522 ' HB2' HD22 ' A' ' 80' ' ' LEU . 35.9 mmt180 -113.62 177.41 4.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.726 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.17 148.9 39.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.499 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.1 p -136.81 145.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.375 0.607 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HB3' HD22 ' A' ' 95' ' ' ASN . 13.5 m120 -83.11 114.03 21.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.153 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.599 HD12 ' CE1' ' A' ' 64' ' ' PHE . 2.2 mt -82.02 2.11 32.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 111.106 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.2 m-80 -63.45 -10.48 17.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.299 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.579 ' HD2' ' N ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -70.27 -20.13 63.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.017 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.3 mt -85.18 131.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.63 159.19 27.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.231 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.9 t30 -106.28 118.97 38.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 39.4 t -113.0 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.035 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 60.07 21.87 11.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.825 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.43 23.39 6.32 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.55 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.5 ptp180 -132.57 141.07 48.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.122 0.461 . . . . 0.0 110.594 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.2 mp -89.9 118.17 29.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.653 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.75 127.3 68.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.321 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -82.75 144.91 29.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.583 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.317 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.7 p90 . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.049 0.452 . . . . 0.0 109.783 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.63 -24.5 21.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.52 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.51 -29.9 59.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -138.78 35.04 2.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.7 m -115.92 155.67 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 111.825 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.76 164.5 36.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.552 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 94.5 m-20 53.3 36.34 22.54 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.615 0.572 . . . . 0.0 111.484 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.44 113.43 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.691 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 t -142.28 150.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.87 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.1 tp -85.91 143.98 27.91 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 m -130.37 162.44 29.08 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.4 t-20 73.76 9.14 4.88 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 0.0 111.216 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.95 19.45 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 96.79 21.0 22.56 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.074 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 56' ' ' THR . 31.5 mtp180 -102.74 -18.16 15.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.728 0.299 . . . . 0.0 110.697 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 92.9 m -130.49 129.24 42.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.098 0.475 . . . . 0.0 111.773 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 97' ' ' ILE . 56.9 tp -95.6 110.86 22.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.278 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.7 tmm_? -109.05 123.75 49.66 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.44 145.17 29.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.0 mt-10 -102.05 110.69 22.73 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.4 t -125.9 147.84 49.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 111.754 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.68 145.64 38.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.37 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -87.16 -172.85 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.459 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.02 -14.29 62.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.256 0.55 . . . . 0.0 111.773 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.23 -17.22 31.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.252 0.549 . . . . 0.0 110.141 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.03 56.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.547 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 63.2 t30 -90.47 145.99 24.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -79.8 126.66 31.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.029 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.862 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -91.06 113.38 25.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 104' ' ' LEU . 2.3 m -110.75 142.6 42.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.094 0.473 . . . . 0.0 111.89 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.83 131.5 42.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.051 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.19 122.89 24.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.092 0.472 . . . . 0.0 110.128 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 39' ' ' THR . 74.1 m-20 -69.37 109.45 4.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.323 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD11 HD11 ' A' ' 12' ' ' LEU . 18.9 mt -61.89 -43.17 99.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.742 0.782 . . . . 0.0 109.655 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.23 -4.65 1.86 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.516 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -102.35 -15.06 16.67 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.355 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.5 HD12 HG13 ' A' ' 41' ' ' ILE . 2.6 pp -141.54 13.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -128.08 129.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.08 154.84 20.02 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.617 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.473 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -111.06 111.42 22.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.381 . . . . 0.0 110.154 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.09 85.25 2.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.984 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 50.0 58.73 5.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.623 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 80.57 34.31 28.75 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.746 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -153.28 119.58 5.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.577 0.227 . . . . 0.0 111.148 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.498 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 48.8 m-85 -67.19 137.59 56.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.226 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' A' ' 49' ' ' GLN . 1.3 tt0 -133.2 117.14 17.08 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.226 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -68.61 116.15 8.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.776 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.33 25.98 8.5 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.946 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.42 -52.63 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.917 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 2.8 tt0 74.59 143.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.52 0.676 . . . . 0.0 111.883 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 t30 68.52 35.41 3.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.357 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.6 p90 -76.9 -24.35 52.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.611 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.675 HG21 ' HG2' ' A' ' 17' ' ' ARG . 13.1 p -67.58 -21.57 65.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.925 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.669 ' HG3' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -74.85 -15.8 60.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.254 0.549 . . . . 0.0 109.713 179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.669 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.9 p -126.14 14.18 7.82 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.061 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.47 141.33 52.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.755 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -135.52 168.97 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.501 -179.228 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 48.65 50.99 16.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.105 0.479 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.6 mt -83.58 112.41 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.43 123.07 37.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.684 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.679 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.3 t80 -92.09 131.18 37.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.684 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.433 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 20.8 t60 -120.19 87.15 39.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.9 Cg_endo -55.21 -33.18 83.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 124.387 3.391 . . . . 0.0 115.279 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.293 -1.882 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.502 -178.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 . . . . . 0 C--O 1.226 -0.156 0 CA-C-O 120.902 0.382 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 57.2 Cg_endo -71.07 114.02 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.508 2.139 . . . . 0.0 112.898 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.442 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 141.59 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.3 127.97 56.32 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.298 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.511 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.48 141.35 51.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 110.315 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.43 168.17 25.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.003 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.693 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.8 mmt180 -85.25 115.44 23.03 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.641 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -98.13 120.9 39.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 111.627 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.555 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.78 -179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 pt-20 . . . . . 0 C--O 1.222 -0.352 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.78 128.94 15.64 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.381 0.61 . . . . 0.0 109.78 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.58 110.79 6.96 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.0 p-10 -58.8 120.2 8.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.999 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.641 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.5 mmt180 -120.87 173.43 7.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.065 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.42 144.33 33.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 p -131.03 148.8 33.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.362 0.601 . . . . 0.0 111.389 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.471 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.8 OUTLIER -82.04 107.28 14.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.751 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.679 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.3 mt -79.85 5.57 13.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 16.1 m-80 -65.28 -17.18 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.041 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.94 -25.31 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.386 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.2 mt -79.13 129.87 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.207 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -124.09 163.39 21.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.59 122.06 45.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.954 0.407 . . . . 0.0 110.733 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.63 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.521 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 60.79 19.19 9.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 111.523 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.47 20.55 8.51 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.068 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.14 138.01 50.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.1 mp -84.14 123.73 30.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.64 127.65 56.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -79.16 145.6 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.404 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.1 p90 . . . . . 0 CA--C 1.536 0.413 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.797 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.97 -24.56 54.02 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.733 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.51 -33.16 67.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.71 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -129.09 31.42 4.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.797 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 37.5 p -121.14 155.92 33.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -151.21 170.49 19.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.2 m120 54.79 30.92 14.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.533 0.521 . . . . 0.0 111.34 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.7 114.23 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.602 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.4 t -142.39 149.64 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.858 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.584 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.2 tp -86.35 138.36 31.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 14.1 m -123.24 164.0 19.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.629 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.5 t-20 71.33 9.58 6.55 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.552 0.533 . . . . 0.0 111.259 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.63 17.19 46.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 107.4 19.43 9.35 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.069 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.663 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.1 mtp180 -102.77 -20.0 14.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 110.675 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.6 m -128.45 126.75 41.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 0.0 111.811 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -96.66 105.55 17.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.96 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 tmm_? -101.38 123.61 45.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.53 140.94 22.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.642 0.258 . . . . 0.0 110.552 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 4.0 mt-10 -98.55 109.48 22.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.1 p -118.1 142.29 47.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.19 0.519 . . . . 0.0 111.42 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.93 143.13 47.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.889 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.42 ' HB3' HG21 ' A' ' 31' ' ' VAL . 22.4 p-10 -91.17 -174.05 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.56 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.27 -26.74 63.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.1 -24.0 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.951 0.405 . . . . 0.0 111.258 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.64 4.83 42.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.637 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.9 t-20 -91.03 144.57 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.466 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.9 m0 -77.21 126.52 31.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.963 0.411 . . . . 0.0 110.815 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -120.49 125.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 m -74.93 107.28 6.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.549 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.8 m -111.22 143.42 42.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.177 0.513 . . . . 0.0 111.365 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 10.2 mt-10 -130.19 131.78 45.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.565 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 113.77 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 39' ' ' THR . 26.9 m-20 -67.43 108.72 2.91 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.782 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 12' ' ' LEU . 26.5 mt -60.71 -39.46 88.66 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.797 0.808 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -64.12 -3.82 3.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.68 -14.51 15.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.254 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.551 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -140.43 13.95 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -129.29 131.45 67.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.86 157.81 22.02 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.353 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -111.8 112.73 24.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.847 0.355 . . . . 0.0 110.472 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -106.9 86.46 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 53.68 52.25 13.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.153 179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.31 37.95 23.05 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.746 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.59 120.98 7.35 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.5 m-85 -67.24 132.72 48.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.038 0.447 . . . . 0.0 110.98 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -125.18 117.61 24.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.218 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.46 115.36 10.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.584 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 22.03 11.63 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.347 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -90.18 -51.18 2.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.987 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.8 tt0 72.57 142.14 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 6.6 t-20 67.04 38.83 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.987 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.27 -26.7 47.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.709 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.663 HG21 ' HG2' ' A' ' 17' ' ' ARG . 41.6 p -64.01 -21.95 66.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.627 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.689 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.9 pt-20 -74.65 -14.05 60.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.114 0.483 . . . . 0.0 109.998 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.8 p -128.35 15.93 6.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.86 148.91 52.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.904 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -142.59 172.7 12.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.888 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 2.0 t70 46.7 53.35 10.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.556 0.535 . . . . 0.0 110.778 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.431 HG22 HD21 ' A' ' 76' ' ' LEU . 2.3 mt -85.31 114.17 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.42 0.629 . . . . 0.0 111.707 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.532 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.91 120.47 29.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.129 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.625 ' CE1' HD12 ' A' ' 94' ' ' LEU . 12.0 t80 -92.22 132.27 36.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.717 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 3.0 t60 -123.55 89.31 51.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -59.04 -38.4 87.74 Favored 'Trans proline' 0 N--CA 1.479 0.662 0 C-N-CA 124.106 3.204 . . . . 0.0 115.085 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.711 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.885 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.677 0.275 . . . . 0.0 110.94 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.2 Cg_endo -71.71 110.46 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.16 1.907 . . . . 0.0 112.24 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.485 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.43 141.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.84 125.31 53.93 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.136 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.24 140.76 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 110.235 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.53 168.51 25.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.564 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -86.23 115.07 23.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 2.3 mp -99.15 126.51 44.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.32 -0.678 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.798 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.665 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.1 pt-20 . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -142.75 127.81 18.51 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 113.89 12.34 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 6.6 p-10 -65.87 114.65 5.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.486 0.66 . . . . 0.0 111.507 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.617 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.4 mmt180 -114.27 179.56 3.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.938 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.12 148.87 39.03 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -133.05 140.05 48.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.806 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.564 ' HB3' HD22 ' A' ' 95' ' ' ASN . 5.8 m-20 -82.76 104.99 13.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.174 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.625 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.1 mt -74.0 1.41 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.586 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.564 HD22 ' HB3' ' A' ' 93' ' ' ASN . 28.9 m-80 -61.28 -17.53 53.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.322 0.582 . . . . 0.0 109.779 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.06 -25.58 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.149 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.58 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -80.81 126.84 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.752 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -117.46 163.09 16.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.809 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.7 t30 -107.88 120.31 41.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.127 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.3 t -114.02 94.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.503 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.27 27.97 17.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.222 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.04 26.34 7.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.617 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.8 ptp180 -133.15 137.08 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.991 0.395 . . . . 0.0 110.297 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 74.6 mt -85.6 122.66 30.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.774 0.321 . . . . 0.0 110.188 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.4 t -132.85 128.04 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.523 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -79.24 146.02 33.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 -179.737 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 121.329 0.585 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.731 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.86 -21.74 63.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.735 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.21 -30.67 68.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 m -139.18 39.43 2.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.749 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 89.3 p -113.64 156.98 22.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -149.03 163.28 37.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.444 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 92.5 m-20 51.42 35.48 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.909 0.756 . . . . 0.0 111.429 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.695 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -76.59 112.61 13.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.755 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 t -142.99 155.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.851 HD11 HD11 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -89.02 148.43 23.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.3 m -131.89 162.01 31.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.362 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 3.7 t-20 70.62 12.76 7.33 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 123.699 0.625 . . . . 0.0 111.327 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.47 19.2 33.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.565 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 100.69 24.04 9.6 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.5 mtp180 -105.56 -19.44 13.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.545 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.0 m -129.79 125.84 36.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.295 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 12' ' ' LEU . 48.5 tp -94.08 107.36 19.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.426 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.53 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 tmm_? -102.03 123.12 45.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -148.19 138.86 22.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.926 0.394 . . . . 0.0 110.655 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 4.3 mt-10 -103.24 110.76 22.85 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.7 t -124.12 146.86 48.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 111.085 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.84 145.28 45.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.732 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -83.41 -172.08 3.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -33.6 74.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.951 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.34 -24.41 59.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.212 0.53 . . . . 0.0 110.776 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.83 8.47 27.97 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.855 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 59.0 t30 -86.15 145.08 27.16 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -77.64 117.8 19.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.066 0.46 . . . . 0.0 111.1 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.92 153.15 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.6 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 47.4 m -114.68 122.3 46.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.914 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t -124.52 151.15 45.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 0.0 110.493 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -133.62 131.23 39.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.656 HD11 HG12 ' A' ' 40' ' ' ILE . 14.2 tp -127.47 120.29 28.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 0.0 110.278 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 39' ' ' THR . 32.3 m-20 -68.41 107.5 2.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.737 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.851 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -62.2 -40.47 96.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.724 0.773 . . . . 0.0 109.227 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.1 p-10 -64.31 -4.95 4.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.528 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -106.21 -12.06 15.85 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.414 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.656 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -141.71 11.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 112.083 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.3 mt -128.1 131.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.535 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.48 157.64 20.94 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.782 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.9 t30 -111.62 108.4 17.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.998 0.428 . . . . 0.0 110.094 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -96.5 78.1 2.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.628 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 72.6 m-20 48.97 63.77 1.99 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.057 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.11 34.69 36.68 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.542 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -155.41 114.74 3.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.762 -0.257 . . . . 0.0 110.576 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.0 m-85 -60.75 140.99 57.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 111.389 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.66 117.33 16.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.502 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -71.66 115.11 10.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.8 28.15 7.56 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.843 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.535 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -97.41 -52.48 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.452 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.7 tt0 73.26 141.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.263 0.625 . . . . 0.0 111.475 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.601 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 7.4 m-20 71.0 34.56 1.84 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.631 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.9 p90 -77.5 -31.11 53.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.629 HG21 ' HG2' ' A' ' 17' ' ' ARG . 26.8 p -62.54 -26.65 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.931 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 58' ' ' THR . 17.7 pt-20 -70.31 -14.85 62.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.325 0.583 . . . . 0.0 109.955 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.617 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.1 p -127.03 13.97 7.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.3 145.09 51.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.144 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.16 172.63 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.606 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.472 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 49.14 48.36 20.99 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.059 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.37 108.2 15.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.0 111.43 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -125.08 125.63 44.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.66 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.695 ' HE2' ' HB1' ' A' ' 10' ' ' ALA . 8.9 t80 -92.28 134.78 34.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.351 0.596 . . . . 0.0 111.879 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -121.65 85.3 43.82 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.156 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -53.91 -35.5 80.31 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.15 3.233 . . . . 0.0 114.472 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.747 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.436 179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.0 Cg_endo -71.51 110.65 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.302 2.002 . . . . 0.0 112.033 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.678 HD11 HH21 ' A' ' 77' ' ' ARG . 1.3 pp -135.76 141.54 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -111.84 124.14 51.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.678 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.98 142.66 47.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.4 167.83 26.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.2 mmt180 -86.27 114.55 23.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.5 mp -99.19 126.97 45.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.368 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.322 -0.629 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.1 -179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.669 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 24.4 pt-20 . . . . . 0 N--CA 1.448 -0.535 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.16 137.55 32.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.673 0.749 . . . . 0.0 111.011 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.16 112.78 8.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.207 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -63.32 110.35 1.88 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.635 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.529 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.7 mmt180 -115.09 170.45 8.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.495 ' HB2' HD13 ' A' ' 75' ' ' ILE . 3.4 p30 -135.98 153.96 51.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.509 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -138.73 144.74 29.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.398 0.618 . . . . 0.0 110.685 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.507 ' HB3' HD22 ' A' ' 95' ' ' ASN . 1.0 OUTLIER -80.2 111.39 16.52 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.854 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.675 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.6 mt -82.32 4.59 23.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.489 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.507 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.4 m-80 -63.35 -18.65 63.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.153 0.502 . . . . 0.0 109.799 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.98 -24.48 67.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.075 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.2 mt -80.36 127.49 39.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.358 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 44.6 mm-40 -117.66 166.69 12.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.345 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -110.21 118.31 36.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.52 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -108.61 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 59.91 22.84 11.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.269 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.55 19.04 8.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.772 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -130.36 141.06 50.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.277 0.538 . . . . 0.0 110.55 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.914 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 82.0 mt -83.95 120.46 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.017 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 60.0 t -125.31 124.29 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.298 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.82 143.9 32.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.619 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.708 ' HA ' HE21 ' A' ' 107' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.547 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.454 -0.27 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.795 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.85 -19.49 29.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.74 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.38 -24.32 67.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.323 0.582 . . . . 0.0 109.909 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.6 m -142.11 36.86 1.56 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.705 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.795 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 60.5 p -125.68 153.36 43.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 110.681 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -149.57 171.8 16.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.3 m-20 55.02 30.97 15.17 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.686 0.617 . . . . 0.0 110.984 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.578 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -73.8 114.59 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.758 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 t -144.22 149.72 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.512 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -85.48 139.08 31.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 179.309 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.638 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.7 m -121.08 165.57 15.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.401 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 69.46 8.18 6.63 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.397 0.436 . . . . 0.0 111.34 178.012 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.48 23.92 27.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.721 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.542 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 101.88 23.4 9.3 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.057 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.682 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.6 mtp180 -109.89 -15.65 14.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.64 0.257 . . . . 0.0 110.524 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.638 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 31.3 m -130.3 126.99 38.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.615 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.0 tp -97.54 107.1 19.53 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.1 tmm_? -104.35 125.22 50.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.127 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.422 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.05 138.0 20.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.398 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.2 mt-10 -94.8 109.24 21.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.5 p -114.68 142.82 45.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.423 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.33 141.99 43.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.538 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.484 ' HB3' HG21 ' A' ' 31' ' ' VAL . 30.9 p-10 -88.09 -178.79 6.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.265 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.02 62.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.9 0.381 . . . . 0.0 111.715 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.26 -23.91 60.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 0.0 111.545 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.46 36.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.9 t-20 -95.99 144.82 25.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.437 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.6 m0 -76.18 123.0 25.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.934 0.397 . . . . 0.0 110.988 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 25' ' ' ASN . 5.2 t -119.47 124.2 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.437 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 m -78.05 107.73 10.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 t -110.83 149.64 30.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.317 0.58 . . . . 0.0 110.524 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 8.1 mt-10 -135.25 131.25 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.403 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.77 114.86 17.82 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.712 ' O ' HG22 ' A' ' 39' ' ' THR . 29.7 m-20 -67.87 109.42 3.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.139 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 12' ' ' LEU . 25.3 mt -60.77 -40.08 91.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.259 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.6 OUTLIER -64.01 -4.61 3.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -105.17 -13.69 15.63 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.525 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.14 12.64 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.85 130.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.2 158.49 21.59 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.404 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -111.33 110.35 20.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.93 77.2 2.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.145 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 53.02 59.39 4.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.514 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.21 34.55 36.65 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.69 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -149.67 110.7 4.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.2 m-85 -59.09 137.09 58.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.074 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.433 HE21 ' HB2' ' A' ' 49' ' ' GLN . 2.7 tt0 -132.25 117.39 18.15 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.902 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.439 ' HH2' HD22 ' A' ' 94' ' ' LEU . 92.1 m95 -70.79 114.71 9.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.62 27.02 7.34 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.295 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.86 -52.53 1.5 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.247 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.7 tt0 73.69 142.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.496 0.665 . . . . 0.0 111.45 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.65 38.54 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.377 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.23 -27.21 47.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.682 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.2 p -62.63 -28.21 69.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.956 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.619 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -70.39 -18.16 63.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.373 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.619 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.6 p -122.56 14.78 10.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.16 149.49 46.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -135.15 170.64 15.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.4 t70 43.17 57.64 3.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.475 0.484 . . . . 0.0 111.56 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.53 109.03 19.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.277 0.561 . . . . 0.0 112.077 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 126.22 42.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.324 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.638 ' CE1' HD12 ' A' ' 94' ' ' LEU . 19.4 t80 -91.35 136.73 32.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.277 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.5 t-160 -118.36 83.03 19.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.367 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.6 Cg_endo -57.35 -43.64 50.17 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.345 2.697 . . . . 0.0 113.702 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mptt . . . . . 0 C--N 1.297 -1.692 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.669 179.771 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 . . . . . 0 CA--C 1.517 -0.298 0 CA-C-O 120.59 0.233 . . . . 0.0 111.488 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 44.7 Cg_endo -69.39 108.32 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.28 1.987 . . . . 0.0 111.196 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.469 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.2 pp -134.53 142.48 40.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.1 tm? -112.02 126.62 55.35 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.497 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.83 141.45 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.35 168.6 21.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.757 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.7 mmt180 -86.07 115.15 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.607 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.87 131.85 45.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.875 0.369 . . . . 0.0 111.096 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.245 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.4 pt-20 . . . . . 0 N--CA 1.45 -0.463 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.9 p90 -144.65 128.74 17.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.87 118.9 16.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.485 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 8.8 p-10 -60.22 115.06 3.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.544 0.687 . . . . 0.0 112.561 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.607 ' HB2' HD22 ' A' ' 80' ' ' LEU . 28.9 mmt180 -115.3 175.11 5.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.33 146.09 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.6 p -136.22 143.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.905 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.529 ' HB3' HD22 ' A' ' 95' ' ' ASN . 23.0 m-80 -81.91 110.89 17.6 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.327 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.638 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.0 mt -79.26 0.88 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.529 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.4 m-80 -61.32 -16.29 44.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.426 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.4 -29.95 71.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 109.715 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 94' ' ' LEU . 15.0 mt -74.9 130.93 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.871 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.485 ' HG3' HG13 ' A' ' 105' ' ' VAL . 10.9 pt20 -122.9 167.9 12.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.64 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.2 t30 -112.25 121.91 46.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.306 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.1 t -113.15 94.13 2.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.341 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.43 26.32 12.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.104 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.79 19.38 8.25 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.885 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.7 ptp180 -130.55 135.03 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.22 0.51 . . . . 0.0 110.863 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.06 124.66 32.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.485 HG13 ' HG3' ' A' ' 98' ' ' GLN . 6.9 p -135.04 132.22 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -78.86 140.01 38.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.403 1.081 . . . . 0.0 112.921 -178.671 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 p90 . . . . . 0 C--O 1.234 0.277 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.77 -23.92 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.57 -32.81 63.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.7 m -137.64 38.61 2.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 66.7 m -117.31 154.6 30.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.366 0.603 . . . . 0.0 112.033 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.35 164.44 34.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.596 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 85.3 m-20 54.93 32.64 18.37 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.594 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -74.72 113.4 11.95 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.4 147.85 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.88 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 37' ' ' LEU . 1.5 tp -85.37 132.69 34.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.243 0.544 . . . . 0.0 109.725 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.4 m -118.87 165.21 14.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.667 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.0 t-20 70.65 8.7 6.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.049 0.54 . . . . 0.0 111.659 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.0 13.5 52.69 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.696 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.485 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 109.85 19.65 8.07 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.692 ' HG2' HG21 ' A' ' 56' ' ' THR . 18.5 mtp180 -105.92 -16.73 14.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.648 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 24.7 m -130.27 121.49 26.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.353 . . . . 0.0 111.78 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.493 ' CD2' HD13 ' A' ' 97' ' ' ILE . 63.1 tp -92.56 105.28 17.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 tmm_? -100.95 124.1 46.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.65 139.22 25.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.9 mt-10 -97.96 113.12 24.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.7 p -125.03 145.6 49.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -76.6 144.17 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.46 -171.8 2.89 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.188 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -32.17 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 111.74 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.03 -24.52 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.198 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.24 53.1 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.1 m-80 -88.81 142.46 27.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.473 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.0 m0 -74.91 125.64 29.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 t -124.64 137.45 57.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.539 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 26.4 m -94.81 109.91 21.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 104' ' ' LEU . 9.7 t -111.38 151.92 27.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 110.672 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.22 132.35 35.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.91 116.34 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 11.0 m-20 -67.22 108.54 2.74 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.194 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 12' ' ' LEU . 42.7 mt -59.34 -46.44 88.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -61.98 -4.84 1.78 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.895 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.72 -12.16 19.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.487 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.55 12.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.34 132.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.8 158.82 20.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.751 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -112.96 109.44 18.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -99.42 84.12 2.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.585 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 50.23 46.91 24.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.422 179.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.616 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.74 43.11 5.85 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.679 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -160.47 114.06 2.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.7 m-85 -59.91 138.49 57.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.045 0.45 . . . . 0.0 111.272 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -131.07 116.21 17.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -69.33 115.13 8.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.939 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.16 31.45 6.2 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.236 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.54 -51.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.176 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.9 tt0 72.84 146.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.218 0.607 . . . . 0.0 111.172 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.3 m-20 73.08 30.07 1.67 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.0 p90 -76.29 -31.43 58.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.692 HG21 ' HG2' ' A' ' 17' ' ' ARG . 20.0 p -62.45 -30.5 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.882 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.623 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.5 pt-20 -67.79 -15.59 63.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 110.477 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.623 HG23 ' HG3' ' A' ' 57' ' ' GLU . 67.2 p -124.1 10.74 8.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.426 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.63 147.3 47.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.05 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.91 166.11 24.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.329 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.5 t70 49.08 56.03 8.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.022 0.439 . . . . 0.0 110.639 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.39 109.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.213 0.53 . . . . 0.0 111.603 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.91 123.72 41.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.812 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CE1' HD12 ' A' ' 94' ' ' LEU . 13.6 t80 -92.51 135.49 34.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.691 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.421 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 13.7 t60 -123.2 86.61 51.5 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 11.5 Cg_endo -57.06 -37.68 97.74 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 124.213 3.276 . . . . 0.0 114.839 -177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.291 -1.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.155 -178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 . . . . . 0 N--CA 1.45 -0.429 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.74 109.51 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.076 1.851 . . . . 0.0 112.087 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.407 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -133.69 141.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.71 126.28 55.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.512 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.65 139.83 53.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.035 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.95 167.72 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.959 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.2 mmt180 -84.78 115.59 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.616 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -100.61 126.57 47.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.82 0.343 . . . . 0.0 111.445 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.604 179.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.9 pt-20 . . . . . 0 C--O 1.22 -0.491 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.06 129.42 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -139.59 117.46 11.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.631 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 5.6 p-10 -63.3 122.89 17.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.302 0.572 . . . . 0.0 111.353 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.605 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.1 mmt180 -115.94 179.49 3.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.5 146.63 32.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.0 p -136.24 146.93 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-O 121.325 0.583 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.5 ' HB3' HD22 ' A' ' 95' ' ' ASN . 10.2 m120 -81.83 109.64 16.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.191 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.683 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.2 mt -80.14 4.45 17.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.384 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.5 HD22 ' HB3' ' A' ' 93' ' ' ASN . 17.4 m-80 -65.14 -10.82 33.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.271 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.38 -18.78 63.05 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 109.653 178.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.049 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -122.25 161.78 22.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.927 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -105.69 117.66 34.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.569 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 53.4 t -113.73 96.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.78 23.15 13.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.78 21.59 9.01 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.38 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.2 ptp180 -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 110.857 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 33' ' ' SER . 3.0 mp -84.34 129.21 34.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 131.54 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.22 145.53 27.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.231 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 86.5 mm-40 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.468 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.3 p90 . . . . . 0 CA--C 1.531 0.215 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -23.63 13.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.688 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.84 -34.52 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.671 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.7 m -134.96 36.2 3.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.579 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 70.4 m -119.95 153.43 35.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 111.458 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -150.02 169.75 20.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.578 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.557 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t-20 56.89 28.21 14.23 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.438 0.461 . . . . 0.0 110.692 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.562 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -74.45 113.78 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.87 153.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.801 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.82 136.01 33.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 23.9 m -116.77 163.06 16.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.5 t-20 71.26 6.57 5.84 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.491 0.494 . . . . 0.0 111.554 177.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.4 22.95 27.9 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.634 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 103.26 21.07 10.28 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.154 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.5 mtp180 -107.27 -16.42 14.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.514 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.0 m -131.72 130.48 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 111.624 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HB2' HD21 ' A' ' 37' ' ' LEU . 54.4 tp -99.91 108.7 21.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -110.7 125.13 53.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.088 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.414 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -146.84 155.09 42.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.639 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -107.85 112.87 25.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 5.1 p -123.97 146.22 48.64 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.94 143.86 35.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -90.23 -171.99 3.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.9 -27.37 69.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 0.0 111.214 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -73.54 -20.88 60.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.555 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.42 10.22 54.11 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.6 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.8 t-20 -96.31 145.06 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.467 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 43.8 m0 -77.21 125.53 29.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.47 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 140.85 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 m -91.77 112.88 24.99 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.493 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.5 m -111.21 146.96 36.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 0.0 111.187 -178.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.6 mt-10 -133.39 139.72 46.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.06 113.85 8.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' THR . 20.8 m-20 -67.57 110.99 3.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.142 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 12' ' ' LEU . 80.4 mt -61.23 -43.13 99.37 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.678 0.751 . . . . 0.0 109.778 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.5 -3.79 2.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.796 -179.902 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.32 -9.59 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.291 179.45 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -144.08 10.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 132.59 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -128.92 159.05 22.15 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.87 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.477 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.3 t30 -111.43 113.34 25.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -97.76 78.57 2.61 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.07 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 40.4 63.5 1.1 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.143 0.902 . . . . 0.0 112.48 179.858 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 83.87 38.21 10.69 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -159.27 115.86 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.705 -0.291 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.532 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 40.4 m-85 -60.96 138.0 58.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -128.06 115.23 18.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.483 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -73.98 113.68 11.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.12 41.27 3.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -112.53 -50.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.601 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 20.0 tt0 73.32 141.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.309 0.643 . . . . 0.0 112.033 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 5.8 t-20 68.58 38.56 2.28 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.078 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.2 p90 -77.13 -26.6 53.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.529 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.684 HG21 ' HG2' ' A' ' 17' ' ' ARG . 38.4 p -64.14 -19.78 65.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.634 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.676 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.1 pt-20 -74.76 -19.68 60.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.148 0.499 . . . . 0.0 109.848 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.676 HG23 ' HG3' ' A' ' 57' ' ' GLU . 72.6 p -123.34 18.12 9.8 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.936 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -133.56 150.35 51.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.88 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.741 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.82 172.86 12.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.209 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 3.5 t70 44.91 55.1 6.34 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.786 0.679 . . . . 0.0 110.997 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.03 109.13 17.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 112.033 -178.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -120.11 123.24 42.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.122 179.18 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' HD12 ' A' ' 94' ' ' LEU . 11.3 t80 -93.38 133.49 36.58 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.671 -178.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.427 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.5 t60 -124.81 87.41 55.02 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.378 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.7 Cg_endo -55.99 -34.5 92.39 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.157 3.238 . . . . 0.0 114.14 -178.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.771 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.962 179.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 . . . . . 0 CA--C 1.512 -0.49 0 CA-C-O 120.925 0.393 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.2 Cg_endo -73.63 109.2 2.81 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.524 2.149 . . . . 0.0 111.584 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.594 HD11 HH21 ' A' ' 77' ' ' ARG . 1.2 pp -134.43 142.25 41.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -113.41 123.97 51.33 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.284 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.594 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.5 139.45 52.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.909 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.15 169.44 24.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.741 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.9 mmt85 -85.1 115.12 22.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -101.63 130.54 48.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.698 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.759 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.317 -0.825 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.211 179.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 16.3 pt-20 . . . . . 0 C--O 1.22 -0.491 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.57 133.4 34.41 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.962 0.887 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -138.67 118.45 13.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.594 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.8 p-10 -66.57 118.42 10.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.542 0.686 . . . . 0.0 111.009 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.544 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.4 mmt180 -114.06 175.0 5.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.7 148.34 40.62 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.532 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.4 p -136.8 144.11 33.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.588 0.709 . . . . 0.0 111.402 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.448 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -78.62 107.48 11.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.576 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.612 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.6 mt -79.97 3.43 20.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.265 0.555 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.426 HD22 ' HB3' ' A' ' 93' ' ' ASN . 24.0 m-80 -61.5 -19.08 61.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.915 178.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -64.67 -21.94 66.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.512 179.279 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 10.6 mt -85.38 126.96 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -125.09 151.65 45.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.206 -179.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 1.5 t30 -92.17 117.67 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.586 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 58.3 t -113.65 97.13 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.595 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.75 25.9 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.719 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.54 20.74 9.84 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.527 178.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -131.09 140.76 50.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.931 0.366 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.7 mp -86.07 115.69 23.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.9 t -115.04 121.92 68.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.688 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -83.33 144.82 29.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.529 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.468 179.26 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.9 p90 . . . . . 0 CA--C 1.533 0.308 0 CA-C-O 120.945 0.402 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.79 -25.33 27.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.595 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -53.94 -32.48 53.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.068 0.461 . . . . 0.0 110.973 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.6 m -134.82 33.38 3.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.3 m -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 112.355 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.8 ptp180 -154.02 169.22 24.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.615 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.3 t30 56.13 32.43 20.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.423 0.63 . . . . 0.0 110.476 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.89 113.7 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.446 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 t -143.43 146.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -80.88 143.26 32.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.01 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -128.5 163.31 25.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.12 6.15 5.49 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.676 0.61 . . . . 0.0 111.472 178.437 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.6 23.8 17.66 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.524 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 100.55 14.95 30.94 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.193 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.5 mtp180 -98.75 -16.76 18.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.82 -0.224 . . . . 0.0 111.034 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 31.7 m -133.27 129.97 38.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.0 111.873 -178.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.99 108.39 21.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 tmm_? -106.61 124.45 49.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.152 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.93 159.9 44.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 5.1 mt-10 -114.91 110.4 19.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 6' ' ' SER . 48.2 t -119.7 144.67 47.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.15 144.34 48.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.614 179.385 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.1 p30 -90.89 -171.74 3.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.29 68.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 0.0 111.7 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.19 -24.47 60.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.444 . . . . 0.0 111.123 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.18 -0.95 33.21 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.709 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.6 t30 -83.63 144.95 29.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -75.3 125.23 28.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.509 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.2 t -120.73 130.62 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 m -80.22 106.94 12.61 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.622 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.4 m -110.08 135.75 50.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.434 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.4 mt-10 -126.87 131.95 51.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.539 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.78 116.21 19.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 39' ' ' THR . 16.2 m-20 -67.3 109.41 3.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 12' ' ' LEU . 34.6 mt -59.59 -46.56 88.57 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.652 0.739 . . . . 0.0 110.052 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.648 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 10.3 t70 -63.79 -4.41 3.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.09 -11.67 20.32 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.571 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -145.82 13.41 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 121.066 0.46 . . . . 0.0 112.053 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.55 130.85 70.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.36 159.03 21.85 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.509 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.423 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 9.2 t30 -111.19 111.43 22.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -105.74 85.96 2.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.735 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 51.59 50.97 17.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.306 178.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.17 41.19 10.48 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.193 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -158.18 118.27 3.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.0 m-85 -63.71 136.37 57.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.119 0.485 . . . . 0.0 110.607 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -128.78 115.64 18.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.151 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -69.49 115.04 8.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.13 22.63 8.16 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.41 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -92.99 -54.37 1.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.382 -0.914 . . . . 0.0 114.002 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.5 tt0 72.59 139.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.188 0.595 . . . . 0.0 110.803 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.641 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.7 m120 74.1 39.78 0.48 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.615 0.721 . . . . 0.0 110.516 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.3 p90 -84.79 -26.33 27.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.282 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.667 HG21 ' HG2' ' A' ' 17' ' ' ARG . 71.2 p -68.4 -17.95 64.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.393 -179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 58' ' ' THR . 9.5 pt-20 -78.03 -13.13 59.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.235 0.54 . . . . 0.0 109.857 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.711 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.5 p -127.67 14.97 7.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.772 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.46 149.95 49.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.848 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -140.79 171.01 14.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.82 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 49.02 54.69 10.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.952 0.406 . . . . 0.0 110.393 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.66 108.91 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.306 0.574 . . . . 0.0 112.326 -177.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 123.63 40.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.551 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.656 ' CE1' HD12 ' A' ' 94' ' ' LEU . 15.3 t80 -91.67 133.28 35.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.781 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.82 87.94 43.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.143 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -36.8 79.67 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 123.633 2.889 . . . . 0.0 113.623 -178.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.764 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.745 179.832 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.901 0.381 . . . . 0.0 111.223 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -72.23 110.48 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.762 2.308 . . . . 0.0 112.467 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.724 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.38 141.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.31 128.44 56.47 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.724 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.94 144.57 49.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.059 0.457 . . . . 0.0 110.21 178.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.37 170.05 18.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.93 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.603 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -85.91 115.71 23.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.2 mp -98.52 127.15 44.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.096 0.474 . . . . 0.0 111.629 -178.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.806 179.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.641 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.9 pt-20 . . . . . 0 C--O 1.22 -0.479 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -147.19 132.98 18.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.847 0.832 . . . . 0.0 111.034 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -140.19 120.45 13.89 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.752 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.8 p-10 -67.13 116.4 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.184 0.516 . . . . 0.0 111.585 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.731 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.1 mmt180 -116.79 177.51 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.94 147.15 32.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -134.37 143.38 38.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.389 0.614 . . . . 0.0 110.86 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.584 ' HB3' HD22 ' A' ' 95' ' ' ASN . 31.1 m-80 -82.83 110.7 18.07 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.817 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.656 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -80.61 3.15 22.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.584 HD22 ' HB3' ' A' ' 93' ' ' ASN . 18.9 m-80 -61.47 -15.47 37.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.015 178.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -23.5 67.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.139 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.596 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.6 mt -84.54 124.19 39.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.005 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -119.65 163.79 16.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.714 179.164 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.9 t30 -106.22 120.19 41.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.061 0.458 . . . . 0.0 111.635 -178.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.8 t -112.61 94.14 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.349 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.22 23.43 13.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.929 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 20.85 7.95 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.549 178.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.8 ptp180 -130.29 138.96 50.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.996 0.398 . . . . 0.0 110.477 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 64.1 mt -85.47 117.48 24.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.461 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 61.7 t -121.56 123.45 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -85.89 145.75 27.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.584 178.724 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.774 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.06 -29.13 63.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.643 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.43 -33.55 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.168 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 58.7 m -134.13 35.83 3.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.774 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.7 p -117.21 155.88 28.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.443 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.31 167.62 28.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 55.01 32.53 18.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.63 0.581 . . . . 0.0 111.17 -179.056 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.529 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.08 113.76 15.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.56 151.61 19.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.298 -178.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -87.58 142.37 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.415 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 11.7 m -129.68 163.58 25.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.934 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.6 t-20 73.12 9.12 5.34 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.165 0.586 . . . . 0.0 111.441 178.258 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.8 25.92 16.33 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 94.92 22.18 23.86 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.71 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.9 mtp180 -106.32 -18.74 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.607 0.242 . . . . 0.0 110.641 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.4 m -128.37 125.64 39.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 111.846 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.17 106.73 18.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.853 178.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -103.02 124.28 48.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.1 142.71 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 111.114 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.3 mt-10 -98.94 110.03 22.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' SER . 15.4 t -122.36 139.52 53.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.32 144.07 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.892 179.85 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.481 ' HB3' HG21 ' A' ' 31' ' ' VAL . 8.9 p30 -91.42 -170.25 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -33.83 66.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -76.29 -22.53 54.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 110.992 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.95 33.82 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.694 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 m-80 -84.84 141.63 30.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.561 0.18 . . . . 0.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 54.0 m0 -72.51 124.33 24.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 111.149 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 25' ' ' ASN . 6.3 t -116.57 119.77 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.924 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.7 m -78.43 104.34 8.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.7 t -111.52 152.94 26.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.149 0.5 . . . . 0.0 110.425 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.0 mt-10 -134.74 131.37 37.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.486 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.613 HD11 HG12 ' A' ' 40' ' ' ILE . 12.0 tp -125.52 115.09 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.775 178.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -66.28 109.13 2.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.914 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 12' ' ' LEU . 37.2 mt -60.8 -43.44 98.13 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.702 0.763 . . . . 0.0 109.499 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.35 -5.43 3.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.487 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.16 -14.59 17.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.426 -179.263 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.613 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.51 13.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.52 130.3 70.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.52 160.89 21.62 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.221 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.18 112.8 24.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -109.52 87.16 2.44 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.299 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 53.27 58.62 5.07 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.6 179.046 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 69.72 42.53 70.81 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.992 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -158.3 117.17 3.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.515 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 57.4 m-85 -61.9 138.56 58.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.227 0.537 . . . . 0.0 110.79 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.45 116.68 20.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.303 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.24 115.02 8.95 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.3 28.75 7.04 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.15 -52.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.878 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 27.9 tt0 73.05 143.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 0.0 111.021 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.599 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 80.4 m-20 69.14 36.66 2.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.576 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -77.28 -30.08 54.14 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.71 HG21 ' HG2' ' A' ' 17' ' ' ARG . 21.4 p -63.9 -23.98 67.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.187 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.645 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.1 pt-20 -73.69 -15.75 61.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.211 0.529 . . . . 0.0 109.929 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.645 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -123.86 14.26 9.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.996 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.58 154.43 47.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.95 173.65 11.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.042 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 13.4 t70 50.45 53.31 13.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.11 0.481 . . . . 0.0 110.211 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.9 mt -88.52 109.24 19.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.513 . . . . 0.0 111.947 -178.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.452 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.7 123.93 38.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.762 178.8 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.664 ' CE1' HD12 ' A' ' 94' ' ' LEU . 24.2 t80 -92.58 136.04 33.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.27 0.557 . . . . 0.0 112.01 -178.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.7 t60 -123.32 89.75 50.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.987 178.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.7 Cg_endo -60.63 -41.01 50.84 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.836 3.024 . . . . 0.0 114.519 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.687 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.891 -179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 . . . . . 0 N--CA 1.447 -0.592 0 CA-C-O 120.671 0.272 . . . . 0.0 110.487 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.558 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 52.7 Cg_endo -71.49 108.12 2.31 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.287 1.991 . . . . 0.0 111.331 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.465 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -131.87 140.74 47.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -112.41 125.0 53.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.085 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.494 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.58 139.56 52.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 179.285 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.16 169.55 23.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.792 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 5.0 mmt85 -84.96 115.67 22.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -101.26 132.11 46.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.56 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.803 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.055 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.803 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.0 pt-20 . . . . . 0 C--O 1.22 -0.475 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 85.4 m-85 -138.7 130.45 27.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.064 0.459 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -138.88 123.31 18.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.436 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.9 p-10 -61.81 116.89 5.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.357 0.598 . . . . 0.0 112.423 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.654 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.8 mmt180 -114.69 179.29 3.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -143.51 151.0 39.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.903 0.382 . . . . 0.0 110.023 -179.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.515 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.5 p -138.85 145.24 28.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.362 0.601 . . . . 0.0 110.918 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.491 ' HB3' HD22 ' A' ' 95' ' ' ASN . 29.8 m-80 -82.66 109.95 17.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.572 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.664 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -81.0 3.72 22.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.011 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.558 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -63.11 -17.87 62.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.726 178.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -29.24 69.71 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.944 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -77.24 127.3 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.403 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -121.19 165.97 14.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 7.1 t30 -110.77 117.95 34.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.2 t -113.14 96.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.337 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.43 22.21 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.051 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 22.67 8.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.592 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -130.21 136.38 49.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.177 0.488 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -80.65 116.76 20.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 0.0 110.888 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.89 123.96 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.48 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -82.06 145.69 30.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.868 0.366 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.994 178.875 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.923 0.392 . . . . 0.0 110.092 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.766 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -24.74 63.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.73 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.13 -33.64 67.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.106 0.479 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.2 m -133.42 36.86 3.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.362 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.766 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.5 p -117.28 155.82 28.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.162 0.505 . . . . 0.0 111.815 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -148.09 168.4 22.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.064 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.428 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.8 m-20 52.23 33.95 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.386 0.613 . . . . 0.0 110.701 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -84.55 114.43 21.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.331 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 64' ' ' PHE . 5.9 m -147.27 177.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.22 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.9 139.42 39.66 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.055 179.247 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 14' ' ' ASN . 26.0 m -123.98 162.98 22.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.482 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.9 t-20 74.03 7.64 4.78 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.671 0.607 . . . . 0.0 111.009 178.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.28 22.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.46 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.95 21.54 13.71 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.924 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.9 mtp180 -104.42 -19.09 14.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 37.4 m -127.54 126.53 42.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.006 0.432 . . . . 0.0 111.362 -178.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.476 ' CD2' HD13 ' A' ' 97' ' ' ILE . 54.7 tp -95.56 106.82 18.95 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.584 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -106.21 123.9 48.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.887 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.93 137.35 19.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.381 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.9 mt-10 -96.24 109.27 21.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' SER . 16.5 t -118.57 143.7 46.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.963 0.411 . . . . 0.0 110.139 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 143.48 50.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.835 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 31' ' ' VAL . 24.7 p-10 -85.28 -172.4 4.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.68 -21.5 65.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.47 -22.08 26.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.94 3.59 34.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.4 t30 -88.29 146.65 25.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -75.62 126.68 31.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 25' ' ' ASN . 10.8 t -124.46 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 m -80.06 109.02 14.11 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.514 ' HB2' HD13 ' A' ' 104' ' ' LEU . 1.9 m -109.78 139.04 45.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.909 0.385 . . . . 0.0 110.376 -178.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.69 130.99 42.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.91 117.6 21.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 39' ' ' THR . 27.0 m-20 -68.59 107.72 3.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.967 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 12' ' ' LEU . 24.6 mt -60.59 -40.27 91.13 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.592 0.71 . . . . 0.0 110.569 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.66 -5.28 2.56 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -104.93 -14.37 15.48 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.481 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.546 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.28 11.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.32 156.74 21.01 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.802 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.417 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.9 t30 -110.19 108.71 18.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.283 0.563 . . . . 0.0 109.547 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -100.19 82.53 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.1 60.88 3.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.298 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.22 35.86 36.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.693 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -154.97 121.33 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.842 -0.21 . . . . 0.0 110.649 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.4 m-85 -65.41 138.46 58.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.084 0.468 . . . . 0.0 111.07 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -130.45 116.85 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.744 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.51 114.31 9.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.91 29.15 7.41 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.828 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.79 -53.06 1.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.43 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 2.4 tt0 76.96 142.54 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.303 0.641 . . . . 0.0 111.333 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.671 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.1 m-20 66.72 38.84 3.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.024 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.5 p90 -79.43 -28.1 41.71 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.629 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.8 p -65.51 -25.17 67.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.601 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.79 ' HG3' HG23 ' A' ' 58' ' ' THR . 5.4 pt-20 -72.59 -12.36 61.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.328 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.79 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -130.37 15.93 5.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.31 0.576 . . . . 0.0 109.805 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.15 144.53 51.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -134.46 173.08 12.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.285 -179.683 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.461 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER 46.01 54.38 8.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.684 0.615 . . . . 0.0 111.046 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.43 HG22 HD23 ' A' ' 12' ' ' LEU . 2.2 mt -89.33 112.77 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.778 -178.212 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -130.86 125.23 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.847 179.283 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.618 ' CE1' HD12 ' A' ' 94' ' ' LEU . 21.5 t80 -92.61 133.75 35.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.516 0.674 . . . . 0.0 112.435 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 17.0 t-160 -117.57 87.71 26.8 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.525 177.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 Cg_endo -58.42 -42.95 50.25 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 124.067 3.178 . . . . 0.0 114.637 -177.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.633 -178.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.2 Cg_endo -72.38 109.63 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.327 2.018 . . . . 0.0 111.977 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.642 HD11 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -133.04 140.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.93 126.57 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.465 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.642 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.01 143.45 49.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.184 179.028 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.65 168.01 22.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.99 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.5 mmt180 -86.32 114.66 23.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.0 mp -97.43 127.27 43.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 110.465 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.1 tmt_? . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.743 -179.22 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.8 pt-20 . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.3 p90 -142.28 138.18 31.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.98 0.895 . . . . 0.0 111.488 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -133.86 111.24 10.32 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.221 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.2 p-10 -64.21 114.97 4.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.018 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.545 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -114.18 176.72 4.92 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -145.76 142.46 28.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.68 144.3 37.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.063 -178.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.478 ' HB3' HD22 ' A' ' 95' ' ' ASN . 43.7 m-20 -81.35 111.66 17.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.696 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.618 HD12 ' CE1' ' A' ' 64' ' ' PHE . 3.7 mt -81.35 3.72 23.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.681 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.56 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 25.6 m-80 -63.47 -18.03 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.102 0.477 . . . . 0.0 109.773 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -61.87 -28.15 69.29 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.798 178.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.532 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.0 mt -78.09 124.55 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.167 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -114.99 163.29 15.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.359 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.8 t30 -111.99 119.99 40.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.579 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.3 t -113.57 95.03 3.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.727 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.8 25.54 15.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.56 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.97 23.38 7.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.391 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.28 137.54 50.03 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 122.458 -0.436 . . . . 0.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.0 mp -90.31 128.74 36.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.607 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.3 p -142.44 132.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -79.07 145.32 33.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.961 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.333 -179.075 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 p90 . . . . . 0 CA--C 1.532 0.262 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.751 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.17 -25.61 61.72 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.823 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.28 -20.8 63.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.089 -179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 32.3 m -145.14 35.51 1.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.835 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.751 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.7 p -116.61 158.13 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.1 ptp180 -152.58 167.82 27.62 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.437 ' HA ' HD22 ' A' ' 9' ' ' ASN . 9.2 m120 50.21 36.38 12.4 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.942 0.776 . . . . 0.0 111.566 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -78.07 113.7 16.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.04 148.89 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -82.59 147.68 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.3 m -132.12 163.05 29.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.07 4.5 5.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.615 0.572 . . . . 0.0 111.543 178.142 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.65 23.22 19.15 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 100.97 22.82 10.36 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.979 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.673 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.4 mtp180 -106.59 -18.28 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.671 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 67.7 m -132.37 128.03 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.927 0.394 . . . . 0.0 111.355 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 37' ' ' LEU . 42.9 tp -96.72 108.77 21.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.021 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.5 tmm_? -103.28 124.37 48.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.9 138.47 20.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.568 0.223 . . . . 0.0 110.628 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 5.9 mt-10 -97.82 108.87 21.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 6' ' ' SER . 2.2 p -119.13 141.43 48.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.086 0.469 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.6 143.46 44.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -85.15 -173.61 4.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.414 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.84 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.797 0.332 . . . . 0.0 111.449 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 111.231 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.65 3.38 34.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.78 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.1 m-80 -89.75 144.18 26.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.335 0.112 . . . . 0.0 110.819 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -72.79 128.85 36.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 0.0 111.533 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.11 119.63 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.352 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 m -75.09 106.5 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.607 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.0 m -110.74 144.01 40.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.204 0.526 . . . . 0.0 111.259 -178.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.6 mt-10 -133.39 134.97 44.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -132.32 118.1 19.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' THR . 42.6 m-20 -67.42 107.43 2.43 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.391 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 12' ' ' LEU . 46.9 mt -60.67 -42.46 97.11 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.598 0.713 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -63.8 -5.78 4.78 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.672 179.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.36 -10.61 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.207 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.67 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -145.01 11.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.05 0.453 . . . . 0.0 112.07 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 131.16 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 157.16 20.76 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.42 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.0 t30 -111.1 109.97 20.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.179 0.514 . . . . 0.0 110.38 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -89.63 78.8 6.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.261 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 39.63 48.63 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.003 0.921 . . . . 0.0 113.109 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 103.45 36.07 3.41 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.851 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -162.26 120.19 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.498 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.3 m-85 -65.29 135.1 54.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -125.78 117.14 22.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.638 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.61 114.05 10.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 29.04 5.93 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.398 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.478 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.3 -51.6 1.13 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.687 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 28.9 tt0 72.56 143.53 0.06 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.049 0.54 . . . . 0.0 110.915 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 73.0 31.31 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.652 0.781 . . . . 0.0 111.501 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.3 p90 -77.56 -27.7 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.673 HG21 ' HG2' ' A' ' 17' ' ' ARG . 28.9 p -64.92 -22.53 67.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.826 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 58' ' ' THR . 3.9 pt-20 -73.86 -18.47 60.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.045 0.45 . . . . 0.0 110.087 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.9 p -123.34 15.46 9.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.194 0.521 . . . . 0.0 110.064 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.45 153.15 45.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.617 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -146.22 170.43 16.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.162 -179.942 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.49 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.3 t70 46.11 56.06 6.54 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.946 0.403 . . . . 0.0 110.436 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.551 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -85.03 106.38 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.274 0.559 . . . . 0.0 111.333 -177.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.63 118.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.902 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' HB2' HD22 ' A' ' 12' ' ' LEU . 8.5 t80 -92.82 127.53 38.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.0 110.924 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.41 86.31 38.77 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.424 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.672 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 14.6 Cg_endo -58.8 -38.3 89.42 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 123.414 2.743 . . . . 0.0 112.618 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.296 -1.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.397 179.303 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.863 0.363 . . . . 0.0 110.817 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.6 Cg_endo -73.61 108.38 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.776 2.318 . . . . 0.0 112.4 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.579 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.13 140.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.551 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.245 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.579 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.84 140.64 49.64 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.966 0.413 . . . . 0.0 109.898 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.64 169.11 25.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.1 mmt180 -85.87 114.56 22.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.763 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -99.65 121.4 41.17 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.296 0.57 . . . . 0.0 111.099 -178.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.318 -0.764 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.022 -179.663 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.788 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.2 pt-20 . . . . . 0 C--O 1.218 -0.605 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 44.4 p90 -138.47 140.7 39.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.682 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -137.79 120.64 16.43 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.421 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -64.05 112.93 3.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.482 0.658 . . . . 0.0 111.202 -179.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.763 ' HB2' HD22 ' A' ' 80' ' ' LEU . 26.5 mmt180 -114.93 172.6 6.95 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -140.74 151.44 44.48 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -136.1 142.05 39.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.398 0.618 . . . . 0.0 110.34 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.455 ' HB3' HD22 ' A' ' 95' ' ' ASN . 26.7 m-80 -81.24 109.19 15.52 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.569 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.616 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.2 mt -79.62 0.75 28.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.952 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.455 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.8 m-80 -62.82 -13.63 35.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 0.0 109.504 177.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -67.13 -24.38 65.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.046 178.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -83.11 125.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.147 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.62 159.37 24.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.6 t30 -102.87 117.95 35.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.46 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.51 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -111.97 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.824 0.345 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.54 21.64 12.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.27 25.87 5.91 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.53 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -132.66 139.68 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.094 0.447 . . . . 0.0 110.798 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 75.0 mt -87.12 116.31 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 110.534 178.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.6 p -125.6 130.42 72.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.865 0.364 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -86.71 143.66 27.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.292 179.844 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 p90 . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -25.37 19.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.453 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.43 -34.41 57.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.578 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.4 m -136.04 36.03 2.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.348 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 67.6 m -116.05 157.1 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.336 0.589 . . . . 0.0 112.19 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.0 ptp180 -154.59 166.63 32.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 10.0 m120 51.92 38.18 22.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.648 0.593 . . . . 0.0 111.336 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -81.93 114.0 20.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.66 159.03 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.78 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.817 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -95.38 138.52 32.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.3 m -122.53 165.38 16.49 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.566 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 71.59 6.22 5.64 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.525 0.516 . . . . 0.0 111.484 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.06 21.4 23.11 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.535 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 99.75 24.27 10.11 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.786 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.1 mtp180 -107.29 -18.47 13.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.797 0.332 . . . . 0.0 110.486 -179.25 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 61.3 m -129.13 126.06 38.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.073 0.463 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' A' ' 97' ' ' ILE . 47.4 tp -94.42 107.62 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.274 178.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -101.69 124.5 47.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.873 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.26 140.4 22.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.586 0.232 . . . . 0.0 110.873 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' SER . 6.9 mt-10 -99.07 109.69 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -122.01 145.2 48.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.329 0.585 . . . . 0.0 111.209 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.4 144.43 40.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.401 179.109 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -89.05 -171.21 3.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.645 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.73 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.149 0.499 . . . . 0.0 111.234 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.47 -23.7 53.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.2 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.56 1.67 43.5 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.841 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.5 t-20 -85.2 145.34 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -77.07 126.56 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.895 0.379 . . . . 0.0 110.634 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.27 126.55 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.304 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.8 m -79.69 106.18 11.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.574 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 4.4 m -110.43 144.98 38.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.083 0.468 . . . . 0.0 111.446 -177.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 14.6 mt-10 -135.23 133.31 38.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.8 120.02 26.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -68.2 107.01 2.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.663 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.817 HD11 HD11 ' A' ' 12' ' ' LEU . 53.5 mt -61.69 -45.66 93.06 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.461 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.74 -5.53 2.83 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -102.05 -11.5 18.84 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.21 -179.611 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.464 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -143.89 11.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.002 0.429 . . . . 0.0 112.113 -179.57 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 132.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.75 159.99 21.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.75 -179.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.78 111.74 23.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.23 0.538 . . . . 0.0 109.732 179.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -105.93 87.53 2.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.373 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.08 57.93 6.11 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.624 0.578 . . . . 0.0 112.161 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.78 42.85 52.6 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.982 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -161.07 120.67 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.527 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 59.0 m-85 -62.66 142.17 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.81 115.95 15.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -70.09 116.11 10.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.232 0.539 . . . . 0.0 109.681 178.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.06 31.45 6.58 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.752 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.45 -51.6 1.11 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.084 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 3.6 tt0 70.75 143.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.016 0.526 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.634 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 92.0 m-20 76.36 29.19 0.73 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.526 0.73 . . . . 0.0 111.189 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -77.5 -32.15 54.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.753 0.311 . . . . 0.0 110.591 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.703 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.6 p -63.56 -26.67 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.6 pt-20 -70.74 -16.37 62.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.728 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.632 HG23 ' HG3' ' A' ' 57' ' ' GLU . 60.2 p -124.31 12.97 8.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.268 0.556 . . . . 0.0 110.351 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.97 152.8 43.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.188 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.71 173.7 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 11.3 t70 47.92 52.88 12.3 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.321 0.581 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.415 HG22 HD21 ' A' ' 76' ' ' LEU . 2.4 mt -85.93 110.25 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -123.1 120.5 33.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.232 178.928 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.623 ' HB2' HD22 ' A' ' 12' ' ' LEU . 10.0 t80 -91.58 128.47 37.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.78 -178.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 m170 -120.18 87.7 40.11 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.027 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 10.3 Cg_endo -56.29 -32.66 88.81 Favored 'Trans proline' 0 CA--C 1.505 -0.959 0 C-N-CA 124.086 3.191 . . . . 0.0 113.752 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.295 -1.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.949 -179.743 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 . . . . . 0 CA--C 1.519 -0.249 0 CA-C-O 120.719 0.295 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 67.4 Cg_endo -74.84 108.66 2.76 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.65 2.233 . . . . 0.0 112.468 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.708 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.64 141.09 41.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.384 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -112.69 125.85 54.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.243 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.708 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.1 139.75 52.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.078 0.466 . . . . 0.0 110.302 178.828 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.72 168.34 27.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.13 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.708 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.3 mmt85 -85.29 116.0 23.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.608 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -101.1 133.43 45.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER . . . . . 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.572 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 . . . . . 0 CA--C 1.509 -0.62 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 93.2 m-85 -137.04 137.2 39.12 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.002 0.906 . . . . 0.0 111.672 -178.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -139.72 119.8 13.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.597 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 p-10 -66.11 114.05 4.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.593 ' HB2' HD22 ' A' ' 80' ' ' LEU . 35.6 mmt180 -114.44 172.31 7.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HB2' HD13 ' A' ' 75' ' ' ILE . 10.0 p-10 -137.02 149.07 47.23 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.527 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -134.5 146.46 30.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.306 0.574 . . . . 0.0 110.891 -179.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.532 ' HB3' HD22 ' A' ' 95' ' ' ASN . 34.8 m-80 -82.12 109.71 16.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.454 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.619 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.7 mt -80.05 2.46 23.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.932 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.532 HD22 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.45 -12.08 28.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.428 0.632 . . . . 0.0 109.842 178.004 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.606 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.7 -21.53 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.657 178.658 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.7 mt -85.98 124.29 40.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.315 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 80.5 mt-30 -120.05 167.09 12.55 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.432 179.47 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.82 122.07 46.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.443 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.4 t -112.4 93.89 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.22 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.4 t30 58.29 25.65 12.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.064 179.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.5 18.78 8.77 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.849 178.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.443 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 16.9 ptp180 -130.78 136.46 48.74 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.314 -0.521 . . . . 0.0 110.42 179.258 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 69.8 mt -83.19 126.22 32.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -134.82 128.1 49.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.179 0.514 . . . . 0.0 111.265 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.83 146.06 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.811 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 24.4 mm-40 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.353 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 . . . . . 0 CA--C 1.531 0.217 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.03 -23.73 21.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.798 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.62 -30.39 68.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.866 179.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.4 m -133.57 32.49 3.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 66.4 m -121.33 156.62 32.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 112.248 -179.05 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -154.86 170.74 20.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.504 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 81.7 m-20 55.01 32.33 17.93 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.622 0.576 . . . . 0.0 110.918 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.23 113.76 15.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -142.5 151.76 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.35 135.43 33.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.129 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.8 m -121.8 167.14 13.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.892 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.7 t-20 70.15 6.87 5.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.993 0.517 . . . . 0.0 111.589 178.446 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 22.82 24.76 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 100.45 16.77 26.09 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.584 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.627 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.1 mtp180 -102.51 -15.51 16.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.677 0.275 . . . . 0.0 110.377 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 25.0 m -130.86 129.46 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.824 0.345 . . . . 0.0 111.714 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.3 tp -100.7 107.94 19.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.652 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.9 tmm_? -105.17 123.37 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -149.14 146.88 27.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.7 mt-10 -103.3 109.55 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' SER . 6.5 p -115.13 140.84 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.339 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -74.72 143.2 44.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.341 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.45 ' HB3' HG21 ' A' ' 31' ' ' VAL . 24.4 p-10 -85.94 -177.16 6.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.661 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.64 -15.92 61.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -86.33 -24.34 25.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.42 7.21 30.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.541 -179.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 14.5 t-20 -97.27 147.33 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.479 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 51.9 m0 -78.06 128.84 34.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.962 0.411 . . . . 0.0 110.584 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 25' ' ' ASN . 6.5 t -123.58 128.64 74.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.45 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 m -82.32 110.38 17.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.846 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.1 t -111.57 148.72 32.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.545 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -135.43 132.12 37.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.679 HD11 HG12 ' A' ' 40' ' ' ILE . 13.7 tp -133.88 116.71 15.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.44 178.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 39' ' ' THR . 19.3 m-20 -68.01 107.77 2.82 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.649 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 12' ' ' LEU . 53.7 mt -57.54 -45.21 85.34 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.475 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.94 -5.04 2.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.973 -179.42 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -103.09 -10.76 18.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.819 -179.846 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.679 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.97 12.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.867 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -128.29 131.68 68.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -127.41 159.31 21.38 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 -178.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -112.49 108.15 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 19.4 t-20 -101.16 79.91 2.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.855 0.36 . . . . 0.0 110.131 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 53.15 57.74 5.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.19 36.45 35.02 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.739 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 61.7 m-70 -147.89 111.88 5.14 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.027 0.131 . . . . 0.0 110.82 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.489 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.6 m-85 -60.96 132.01 52.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.864 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -124.78 117.44 24.18 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.161 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -72.76 114.7 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.54 26.78 7.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.106 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.26 -52.48 1.46 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.602 -179.136 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.3 tt0 75.12 145.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.377 0.671 . . . . 0.0 110.884 -178.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.9 m-20 72.92 29.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.406 0.683 . . . . 0.0 111.939 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -77.04 -27.57 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.9 p -66.95 -28.11 68.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -178.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.609 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.6 pt-20 -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.609 HG23 ' HG3' ' A' ' 57' ' ' GLU . 69.9 p -121.79 13.74 10.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -122.84 151.89 41.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.903 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.52 167.9 21.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.488 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 1.6 t70 49.39 51.98 15.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.101 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.58 110.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.262 0.553 . . . . 0.0 111.384 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.451 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -127.48 122.18 32.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.643 179.534 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.4 t80 -91.97 131.84 36.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.358 0.599 . . . . 0.0 111.483 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -121.84 87.65 46.78 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.908 178.457 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.8 Cg_endo -58.61 -35.21 98.97 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.748 2.965 . . . . 0.0 113.872 -178.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.835 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.169 -179.397 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 73' ' ' GLN . 5.9 tp60 . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.2 Cg_endo -72.91 106.64 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.32 2.013 . . . . 0.0 112.044 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.769 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -136.14 141.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -111.64 127.99 55.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.202 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.769 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.84 143.72 49.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.21 166.57 25.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.839 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 5.4 mmt180 -85.63 115.06 23.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.601 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -99.15 124.68 44.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 111.596 -178.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.94 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 . . . . . 0 CA--C 1.516 -0.357 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -144.13 132.39 21.89 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.46 111.45 7.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.702 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.6 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.6 p-10 -64.42 114.08 4.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.585 ' HB2' HD22 ' A' ' 80' ' ' LEU . 39.2 mmt180 -115.67 177.39 4.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.08 178.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . 0.462 ' HB2' HD13 ' A' ' 75' ' ' ILE . 3.6 p30 -143.37 148.76 36.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -132.07 145.56 34.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.325 0.583 . . . . 0.0 110.746 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.487 ' HB3' HD22 ' A' ' 95' ' ' ASN . 9.0 m120 -83.66 109.25 17.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.608 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.9 mt -78.06 1.78 19.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.441 -179.18 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.487 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.3 m-80 -65.6 -8.73 21.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.073 0.463 . . . . 0.0 110.04 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.415 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -72.72 -20.22 61.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.252 178.345 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.6 mt -84.64 122.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.384 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.635 -179.974 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.2 t30 -105.15 119.32 38.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.112 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.02 93.87 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.394 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.25 25.77 14.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.565 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.5 8.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.482 178.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 11.8 ptp180 -130.05 138.64 50.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.14 0.47 . . . . 0.0 110.815 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.3 mt -85.92 114.26 22.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.79 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 103' ' ' ARG . 40.0 t -123.0 123.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.546 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -79.37 145.65 33.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.695 0.622 . . . . 0.0 111.829 179.454 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.9 p90 . . . . . 0 N--CA 1.452 -0.347 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.748 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -19.2 44.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.329 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.78 -27.65 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.106 0.479 . . . . 0.0 110.721 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -143.86 39.57 1.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.9 p -115.69 155.36 27.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.72 -178.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.47 HH12 ' HB3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -151.6 164.77 36.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.799 179.444 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 52.85 35.29 18.53 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.715 0.634 . . . . 0.0 111.239 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -76.65 114.34 15.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.56 154.37 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.85 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.7 tp -91.08 141.15 29.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.47 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.4 m -126.25 162.73 24.78 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.2 t-20 72.5 9.39 5.73 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.688 0.618 . . . . 0.0 111.121 178.082 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.68 21.2 34.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.308 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 103.16 20.43 11.23 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.245 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.627 ' HG2' HG21 ' A' ' 56' ' ' THR . 21.5 mtp180 -103.75 -18.97 14.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.864 0.364 . . . . 0.0 110.42 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 49.3 m -129.45 128.44 42.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 112.114 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.502 ' HB2' HD21 ' A' ' 37' ' ' LEU . 50.6 tp -97.79 110.19 22.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.1 tmm_? -114.37 124.69 52.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 -178.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.59 162.65 40.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.926 0.393 . . . . 0.0 111.053 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.8 mt-10 -110.47 114.61 28.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' SER . 30.3 t -131.53 142.74 50.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.732 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 145.32 49.28 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.24 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.59 ' HB3' HG21 ' A' ' 31' ' ' VAL . 32.4 p-10 -85.92 -167.48 1.87 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.677 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 101' ' ' ASN . . . -63.41 -34.95 78.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.711 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.8 -23.73 61.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.883 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 10.03 35.43 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.0 t30 -91.0 145.35 24.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . 0.47 ' HB3' HH12 ' A' ' 8' ' ' ARG . 33.9 m0 -73.17 122.92 22.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.047 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.9 t -126.1 143.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.7 m -99.76 111.28 23.62 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.3 143.97 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.204 0.526 . . . . 0.0 111.816 -178.461 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.523 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.6 mt-10 -130.37 133.33 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.348 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -131.07 117.74 19.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.176 178.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.674 ' O ' HG22 ' A' ' 39' ' ' THR . 29.9 m-20 -69.0 109.78 4.13 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.81 178.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 12' ' ' LEU . 40.2 mt -60.61 -40.0 90.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.82 0.819 . . . . 0.0 109.927 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -63.16 -5.35 3.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.78 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.45 -12.53 15.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.478 -179.332 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.624 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.36 12.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.8 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.59 159.48 22.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.361 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.14 111.86 23.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.085 0.469 . . . . 0.0 109.827 179.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -104.48 87.97 2.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.9 t70 49.3 59.24 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.046 178.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.66 40.96 36.51 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.601 179.016 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.455 ' N ' HD23 ' A' ' 80' ' ' LEU . 44.2 t-80 -159.22 127.14 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 52.6 m-85 -68.0 139.41 56.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -132.11 116.38 16.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.427 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -70.5 115.12 9.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 28.23 6.77 Favored Glycine 0 C--N 1.32 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.462 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.19 -50.37 1.46 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.513 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 9.7 tt0 73.92 143.46 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.208 0.603 . . . . 0.0 111.727 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.625 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 95.8 m-20 65.64 38.66 5.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.597 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.29 -30.0 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.608 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 17' ' ' ARG . 74.3 p -62.91 -23.05 67.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.75 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 58' ' ' THR . 8.0 pt-20 -72.3 -14.98 61.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.276 0.56 . . . . 0.0 110.031 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 57' ' ' GLU . 68.0 p -126.19 7.02 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.119 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.9 144.76 49.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.33 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -138.27 172.32 13.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.053 -179.317 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.6 t70 48.15 50.96 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.071 0.462 . . . . 0.0 110.125 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.533 ' C ' ' HE ' ' A' ' 63' ' ' ARG . 2.8 mt -83.11 105.8 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.192 0.52 . . . . 0.0 110.691 -178.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -112.23 118.63 35.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.313 -179.848 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.627 ' CE1' HD12 ' A' ' 94' ' ' LEU . 6.2 t80 -93.04 124.69 37.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.863 0.363 . . . . 0.0 110.709 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -118.44 88.99 35.28 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.2 Cg_endo -57.65 -35.13 98.91 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 123.934 3.089 . . . . 0.0 113.538 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.799 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.73 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 . . . . . 0 CA--C 1.519 -0.248 0 CA-C-O 120.766 0.317 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.7 Cg_endo -74.39 108.16 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.368 2.046 . . . . 0.0 111.897 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.604 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -131.7 141.53 45.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.46 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 62' ' ' ILE . 2.0 tm? -112.73 123.43 50.29 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.271 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.604 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -119.85 138.16 53.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -155.9 166.39 33.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.397 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.5 mmt180 -85.83 114.5 22.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.5 mp -99.42 129.22 45.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.056 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.319 -0.738 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.319 179.857 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.76 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.5 pt-20 . . . . . 0 C--O 1.22 -0.499 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 52.8 p90 -134.61 139.36 45.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.655 0.741 . . . . 0.0 111.577 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -139.18 119.19 13.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.348 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -66.45 116.81 7.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.576 0.703 . . . . 0.0 112.557 -178.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD22 ' A' ' 80' ' ' LEU . 24.2 mmt180 -116.9 172.61 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -141.56 147.22 37.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.1 p -134.0 151.34 32.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.212 0.529 . . . . 0.0 111.126 -178.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.507 ' HB3' HD22 ' A' ' 95' ' ' ASN . 37.1 m-80 -83.34 112.5 19.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.887 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.627 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.3 mt -82.33 3.44 27.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.916 0.389 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.507 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.7 m-80 -65.2 -16.78 63.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.52 67.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.127 179.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.9 mt -82.69 126.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.22 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 49.6 tt0 -120.29 162.94 18.58 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -106.55 119.96 40.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.023 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.7 t -109.67 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.481 179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.423 ' HA ' ' H ' ' A' ' 26' ' ' ALA . 63.4 t30 60.06 21.69 10.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.026 179.044 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.44 17.57 7.04 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.995 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.29 146.05 51.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.084 0.442 . . . . 0.0 110.856 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 73.4 mt -89.5 119.04 29.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.102 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 57.7 t -121.22 123.4 69.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.624 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.12 145.14 32.53 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.469 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.333 179.88 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 . . . . . 0 CA--C 1.537 0.452 0 CA-C-O 121.059 0.457 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.26 -26.13 37.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.896 -178.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.56 -32.09 64.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.0 m -132.76 32.94 3.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 62.0 m -115.08 152.76 31.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 111.515 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -145.78 163.93 33.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.022 -179.312 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.454 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 9.9 m120 52.66 33.28 13.43 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.727 0.642 . . . . 0.0 111.761 179.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -74.89 114.01 12.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.4 t -141.56 152.36 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.057 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -87.41 140.71 29.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.433 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 12.2 m -126.48 163.7 22.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.034 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.7 t-20 73.23 5.69 5.11 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.687 0.617 . . . . 0.0 111.368 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.85 23.4 15.51 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.52 21.63 16.41 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.942 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.699 ' HG2' HG21 ' A' ' 56' ' ' THR . 29.8 mtp180 -104.12 -19.1 14.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.652 0.263 . . . . 0.0 110.811 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.7 m -129.26 126.94 40.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.955 0.407 . . . . 0.0 111.703 -178.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.504 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.8 tp -94.68 105.67 17.62 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.014 178.176 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' NH2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 tmm_? -101.97 123.68 46.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -147.32 144.13 28.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 111.137 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 32' ' ' THR . 3.9 mt-10 -105.17 113.02 26.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' SER . 45.4 t -127.17 147.63 50.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.199 0.523 . . . . 0.0 111.674 -178.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.72 145.67 40.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.426 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.48 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.7 p30 -93.05 -173.43 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.521 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -34.38 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 112.204 -178.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.26 -20.29 61.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 4.16 54.67 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.926 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 t-20 -87.59 143.69 27.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -73.86 122.23 22.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 25' ' ' ASN . 8.2 t -120.52 146.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.616 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 22' ' ' GLU . 37.0 m -114.86 110.15 19.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.899 0.38 . . . . 0.0 110.191 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -118.29 164.18 15.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 112.102 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.5 mt-10 -136.69 140.04 42.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.229 -179.389 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.426 HD21 HG12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -132.01 113.88 13.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.291 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 39' ' ' THR . 26.8 m-20 -66.65 108.65 2.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 12' ' ' LEU . 54.1 mt -59.92 -47.39 85.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.212 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -64.2 -4.54 3.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.928 -179.447 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.14 -14.72 20.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.908 179.731 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.96 13.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 3.0 mt -126.4 131.42 71.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.15 160.1 19.75 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.837 -178.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.36 104.41 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -92.77 75.48 4.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.791 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 48.93 65.8 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.023 178.503 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.5 34.79 34.72 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.778 178.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -159.33 120.61 3.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 61.9 m-85 -63.25 143.54 57.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 111.271 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -133.82 117.4 16.81 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -72.7 114.58 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 40.58 3.08 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.98 -49.23 0.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.281 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.2 tt0 71.52 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.328 0.651 . . . . 0.0 111.582 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.683 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 91.5 m-20 71.06 35.19 1.68 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.523 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.79 -32.08 40.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.699 HG21 ' HG2' ' A' ' 17' ' ' ARG . 23.8 p -63.47 -30.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.523 -179.159 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 20.2 pt-20 -67.19 -17.0 64.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.075 0.464 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.547 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.7 p -122.56 12.71 10.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.69 149.95 48.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.47 169.09 18.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 49.05 57.93 5.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.471 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -88.06 111.59 22.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.371 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -116.66 118.83 33.66 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.882 179.624 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.8 t80 -92.77 128.06 38.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 178.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 4.0 t-160 -117.19 84.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 19.5 Cg_endo -58.95 -44.9 31.71 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.613 2.875 . . . . 0.0 114.488 -177.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.845 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.864 -179.662 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 120.982 0.42 . . . . 0.0 111.865 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.3 Cg_endo -75.25 111.46 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.447 2.098 . . . . 0.0 111.766 178.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.492 HD11 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -132.48 140.47 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.06 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -113.65 121.15 43.28 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.243 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.85 140.12 50.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.904 0.383 . . . . 0.0 110.201 179.261 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.83 169.36 23.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.6 mmt180 -85.12 115.15 22.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.2 mp -100.9 130.82 46.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 -178.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER . . . . . 0 C--N 1.323 -0.57 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.02 -179.533 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.6 pt-20 . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 45.6 p90 -134.58 141.25 46.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.808 0.813 . . . . 0.0 111.725 -179.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -140.18 112.71 7.92 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -68.28 115.49 7.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.376 0.608 . . . . 0.0 111.169 -179.064 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.9 mmt180 -116.16 177.28 4.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.414 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -140.32 148.73 41.81 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.539 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.8 p -132.74 148.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.549 -179.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.544 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -86.11 109.01 18.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.995 -179.064 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.673 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.2 mt -78.98 4.04 15.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' A' ' 93' ' ' ASN . 15.4 m-80 -64.63 -12.58 47.31 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -69.7 -16.69 63.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.183 179.096 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.8 mt -88.28 122.59 40.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.618 0.723 . . . . 0.0 111.362 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -110.71 166.42 11.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.592 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.7 t30 -114.94 115.71 27.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.566 178.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 56.2 t -112.69 101.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.36 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' HB2' ' A' ' 25' ' ' ASN . 4.6 t30 60.33 21.68 11.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.006 179.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.58 11.27 27.32 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.597 178.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.4 ptp180 -118.16 141.48 48.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 0.0 110.506 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 21' ' ' ALA . 79.1 mt -89.63 126.45 35.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.769 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.8 p -134.41 134.67 54.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.248 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -88.79 144.86 25.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.815 0.697 . . . . 0.0 111.506 178.885 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.4 p90 . . . . . 0 CA--C 1.532 0.256 0 CA-C-O 121.032 0.444 . . . . 0.0 109.835 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.669 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.61 -24.07 45.28 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.384 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.54 -31.67 64.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.4 m -144.85 42.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.669 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.3 p -115.54 149.4 38.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.022 0.439 . . . . 0.0 111.253 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.15 166.19 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' ASN . . . . . 0.415 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.1 m-20 52.05 33.25 11.65 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.677 0.61 . . . . 0.0 111.734 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.05 114.54 15.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.086 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.18 155.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.891 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -91.66 143.31 26.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.0 110.135 179.394 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.9 m -129.67 165.23 22.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.765 -179.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.1 t-20 72.06 9.82 6.05 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.512 0.507 . . . . 0.0 110.947 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 8.8 57.99 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 112.36 25.75 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.099 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.693 ' HG2' HG21 ' A' ' 56' ' ' THR . 21.6 mtp180 -108.45 -18.56 13.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 0.0 110.521 -178.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 46.7 m -127.68 126.57 42.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -178.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.476 ' CD2' HD13 ' A' ' 97' ' ' ILE . 45.6 tp -98.01 108.84 21.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.158 178.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -104.14 122.52 45.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -146.89 137.61 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.743 0.306 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.6 mt-10 -98.25 110.84 23.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.761 0.315 . . . . 0.0 110.285 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' SER . 49.6 t -125.83 147.88 49.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.853 0.359 . . . . 0.0 110.814 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.2 145.72 43.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.274 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -85.58 -168.56 2.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.724 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -32.99 74.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.163 0.506 . . . . 0.0 111.289 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.31 -24.31 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.32 4.25 40.88 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.398 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 m-80 -83.78 139.06 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.262 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.8 m0 -72.51 121.95 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.984 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.0 t -123.26 150.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -99.32 109.63 22.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.613 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.5 m -109.38 139.44 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.256 0.55 . . . . 0.0 111.43 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.0 mt-10 -130.39 131.79 45.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.041 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.542 HD11 HG12 ' A' ' 40' ' ' ILE . 13.3 tp -131.96 124.01 28.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 178.603 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 39' ' ' THR . 39.0 m-20 -72.25 108.64 5.5 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.123 179.179 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 12' ' ' LEU . 34.8 mt -61.1 -41.24 96.31 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.618 0.723 . . . . 0.0 109.718 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.36 -5.91 4.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.471 179.639 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -103.91 -12.05 17.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.401 -179.231 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.542 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.0 12.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.536 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.53 132.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.456 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.34 157.32 21.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.567 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 8.9 t30 -110.88 110.31 20.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.102 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -103.17 87.05 2.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 48.34 54.8 9.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.551 179.201 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.67 41.99 12.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.997 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' HIS . . . . . 0.417 ' N ' HD23 ' A' ' 80' ' ' LEU . 80.4 t60 -158.72 118.26 3.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 53.3 m-85 -64.56 137.29 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.78 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.424 HE21 ' HB2' ' A' ' 49' ' ' GLN . 1.8 tt0 -131.26 115.83 16.82 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.281 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -69.13 116.08 9.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.439 178.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.7 33.28 5.37 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.168 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -104.1 -52.66 0.88 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.15 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 35.4 tt0 73.65 142.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 111.213 -179.254 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.557 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.2 m-20 71.92 34.99 1.41 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 111.602 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.4 p90 -78.84 -27.91 44.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.693 HG21 ' HG2' ' A' ' 17' ' ' ARG . 62.1 p -66.31 -24.0 66.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.615 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.668 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.3 pt-20 -74.91 -11.27 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.668 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -129.29 14.97 6.16 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.443 0.639 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.4 153.48 47.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.639 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.33 171.57 14.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.204 -179.673 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.612 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 12.7 t70 46.51 55.11 7.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.401 0.438 . . . . 0.0 110.541 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.514 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -84.72 107.35 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.261 0.553 . . . . 0.0 111.664 -178.026 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.557 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -114.34 118.2 33.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.23 179.728 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.641 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.1 t80 -92.99 128.76 38.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 111.302 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -120.49 87.86 41.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.744 177.794 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -58.86 -35.73 98.13 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.678 2.919 . . . . 0.0 112.693 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.65 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.709 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.437 178.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 120.788 0.328 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 66.2 Cg_endo -75.46 108.74 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.82 2.347 . . . . 0.0 112.032 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.654 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.8 141.19 43.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.254 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -112.59 123.87 51.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.395 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.654 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.28 139.21 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.26 166.63 32.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.426 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.639 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.0 mmt85 -85.9 115.04 23.28 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.655 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.8 mp -98.73 126.48 44.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.248 -178.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.067 -179.628 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 8.4 pt-20 . . . . . 0 C--O 1.221 -0.444 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -146.78 132.3 18.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 0.0 110.623 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -133.68 119.61 19.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.024 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.8 p-10 -65.65 112.02 3.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 111.454 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' ARG . . . . . 0.655 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -115.08 171.29 7.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.188 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -141.42 147.01 37.27 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.7 p -132.82 147.95 31.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.902 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.523 ' HB3' HD22 ' A' ' 95' ' ' ASN . 41.6 m-80 -83.2 111.94 19.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.641 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.35 3.3 21.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.523 HD22 ' HB3' ' A' ' 93' ' ' ASN . 31.3 m-80 -63.23 -16.5 60.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.089 0.471 . . . . 0.0 109.863 178.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.84 -28.68 70.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.553 0.692 . . . . 0.0 109.978 178.76 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.5 mt -76.44 123.65 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.212 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -116.06 164.02 15.07 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -111.31 118.26 35.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.133 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.9 t -109.85 94.44 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.19 25.16 13.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.045 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.13 17.22 9.67 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.887 177.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.1 ptp180 -130.37 135.99 48.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.133 0.467 . . . . 0.0 110.612 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.613 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 71.1 mt -84.48 125.04 32.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -133.66 132.32 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.21 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.41 144.82 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.371 179.015 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.476 0.861 0 N-CA-C 110.504 -0.184 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.563 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 12.9 m -158.3 179.84 8.78 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 109.743 -0.466 . . . . 0.0 109.743 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -64.9 -33.34 75.8 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.709 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.85 -27.87 45.68 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.23 -0.896 . . . . 0.0 112.675 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -55.51 -33.29 63.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.968 0.413 . . . . 0.0 110.857 179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.504 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 30.3 m -134.94 37.32 3.04 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.929 -179.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.709 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 69.6 p -119.43 152.37 36.97 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.261 0.553 . . . . 0.0 111.492 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.54 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.2 ptp180 -151.42 168.93 23.32 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.6 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.0 t30 56.2 30.87 17.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.662 0.744 . . . . 0.0 110.135 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.34 113.52 16.4 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.178 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.5 t -142.96 146.47 21.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.608 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.4 tp -82.37 141.98 32.38 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.9 m -131.9 165.93 22.77 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.986 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.58 HD22 ' HD3' ' A' ' 17' ' ' ARG . 0.9 OUTLIER 71.42 7.17 5.98 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.134 0.574 . . . . 0.0 111.584 178.361 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.18 28.4 9.9 Favored Glycine 0 CA--C 1.505 -0.568 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 91.75 18.66 43.49 Favored Glycine 0 N--CA 1.443 -0.833 0 C-N-CA 120.734 -0.746 . . . . 0.0 111.946 -179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.691 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.3 mtp180 -103.43 -16.92 15.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.729 0.3 . . . . 0.0 110.3 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.3 m -128.58 129.39 45.87 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.045 0.45 . . . . 0.0 111.509 -179.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' CD2' HD13 ' A' ' 97' ' ' ILE . 52.8 tp -100.71 104.98 16.29 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.358 178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.551 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.4 tmm_? -104.35 124.73 49.71 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.414 -178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.92 153.25 32.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.876 0.37 . . . . 0.0 110.817 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.6 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 32.7 mt-10 -103.4 110.34 22.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.6 p -119.74 139.6 52.03 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.087 0.47 . . . . 0.0 111.415 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.57 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.49 144.11 44.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.222 179.786 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.8 p-10 -89.25 -171.57 3.3 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.654 -0.248 . . . . 0.0 111.279 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.2 -21.53 65.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.148 0.425 . . . . 0.0 112.148 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -86.64 -19.0 29.95 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.003 0.43 . . . . 0.0 111.285 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.11 0.62 41.46 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.708 -0.758 . . . . 0.0 111.726 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.57 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 66.1 m-20 -80.83 136.3 36.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.552 -0.324 . . . . 0.0 111.162 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.447 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 49.5 m0 -77.98 119.48 21.48 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.005 0.431 . . . . 0.0 110.077 179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -115.32 132.31 65.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.575 -178.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.5 m -83.08 107.89 15.98 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.678 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 21.0 m -110.89 146.1 37.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.888 -178.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.551 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.8 mt-10 -133.15 130.68 39.52 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.392 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.583 HD11 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -123.04 120.09 32.27 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.246 0.546 . . . . 0.0 110.101 179.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 39' ' ' THR . 9.3 m-20 -69.32 106.23 2.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 115.173 -0.921 . . . . 0.0 108.623 178.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.452 HD11 HD11 ' A' ' 12' ' ' LEU . 21.2 mt -62.71 -40.23 96.52 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-O 121.929 0.871 . . . . 0.0 109.75 -179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.493 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.6 p-10 -64.27 -5.04 4.33 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 114.547 -1.206 . . . . 0.0 110.639 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.58 -16.14 16.18 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.556 -179.346 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.583 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.08 14.04 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.29 130.75 70.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.97 157.54 21.15 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.335 -179.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.428 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.3 t30 -111.97 113.94 26.54 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.044 0.45 . . . . 0.0 110.527 179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -101.51 81.44 2.18 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.639 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.0 m-20 49.93 47.92 22.54 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.562 -0.745 . . . . 0.0 112.384 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.597 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 90.64 39.09 5.98 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.863 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -158.09 113.57 2.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.526 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 58.0 m-85 -60.27 136.64 58.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.222 0.534 . . . . 0.0 111.007 179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -127.22 114.49 17.72 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.168 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -71.22 114.53 9.38 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.8 28.64 6.89 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.575 -0.738 . . . . 0.0 111.705 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -98.5 -52.08 1.36 Allowed Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.927 -179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 3.1 tt0 72.85 141.54 0.06 Allowed 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.134 0.573 . . . . 0.0 111.213 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.655 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 94.6 m-20 70.48 37.87 1.43 Allowed 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.544 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.7 p90 -81.4 -27.26 34.86 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.691 HG21 ' HG2' ' A' ' 17' ' ' ARG . 11.9 p -65.16 -19.54 66.02 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.699 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.677 ' HG3' HG23 ' A' ' 58' ' ' THR . 8.3 pt-20 -77.32 -14.82 59.66 Favored 'General case' 0 N--CA 1.453 -0.317 0 CA-C-O 121.197 0.522 . . . . 0.0 110.136 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.677 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.3 p -125.89 12.89 7.89 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.664 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -121.27 145.71 47.58 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.554 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.46 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -139.3 169.22 18.16 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.476 -179.287 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.465 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.2 t70 47.39 54.57 9.39 Favored 'General case' 0 N--CA 1.471 0.583 0 O-C-N 123.353 0.408 . . . . 0.0 110.592 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -84.34 114.47 24.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.219 0.533 . . . . 0.0 112.153 -177.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.472 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -128.45 121.97 30.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.124 179.116 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.702 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.4 t80 -92.04 134.73 34.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.607 -0.724 . . . . 0.0 112.344 -178.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 3.3 t-160 -123.22 85.44 51.61 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.927 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.409 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 25.8 Cg_endo -62.22 -45.13 16.39 Favored 'Trans proline' 0 CA--C 1.508 -0.789 0 C-N-CA 123.622 2.882 . . . . 0.0 113.89 -178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.409 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -121.95 81.57 1.84 Allowed 'General case' 0 C--N 1.294 -1.809 0 CA-C-N 114.765 -1.107 . . . . 0.0 109.9 179.992 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.498 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 3.3 tt0 -65.21 111.78 3.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.092 -0.958 . . . . 0.0 112.404 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.11 -142.03 8.14 Favored Glycine 0 C--N 1.335 0.503 0 O-C-N 124.493 1.121 . . . . 0.0 113.94 178.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.1 -6.88 58.46 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.082 0.468 . . . . 0.0 110.651 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -83.78 -20.21 33.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.63 -179.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.92 42.5 24.4 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.564 -178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -98.57 120.72 58.5 Favored Pre-proline 0 C--N 1.321 -0.647 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.016 -178.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.5 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 64.2 Cg_endo -74.04 106.58 2.24 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 122.465 2.11 . . . . 0.0 111.678 179.296 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.494 HD11 HH21 ' A' ' 77' ' ' ARG . 0.8 OUTLIER -132.35 140.92 46.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 115.508 -0.769 . . . . 0.0 108.975 179.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.479 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -114.15 124.02 51.05 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.148 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.494 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.08 142.71 48.62 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.22 0.533 . . . . 0.0 110.434 179.247 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.56 167.66 26.64 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.067 -0.97 . . . . 0.0 109.709 179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.71 115.13 23.19 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.695 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.0 mp -97.87 121.44 39.79 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.462 -178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.606 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -84.83 141.47 30.45 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.869 -1.059 . . . . 0.0 110.549 -179.841 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.684 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 0.9 OUTLIER -97.07 174.26 6.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.5 -179.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 71.7 m -61.36 -24.56 66.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -73.11 -29.15 62.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.859 0.361 . . . . 0.0 110.56 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.06 34.38 2.56 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.763 -0.732 . . . . 0.0 113.256 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.635 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 11.1 pt-20 -112.08 -168.18 1.28 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.9 p90 -147.73 134.59 20.13 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.465 0.65 . . . . 0.0 111.492 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -140.72 118.82 11.94 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.939 -1.028 . . . . 0.0 110.052 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.3 p-10 -64.37 114.73 4.49 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.469 0.652 . . . . 0.0 111.659 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.695 ' HB2' HD22 ' A' ' 80' ' ' LEU . 30.0 mmt180 -115.84 174.21 6.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.536 178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -144.04 144.93 31.87 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.526 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -129.45 145.66 35.38 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.037 0 CA-C-O 121.393 0.616 . . . . 0.0 111.082 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.495 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -81.57 107.17 14.11 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.61 -179.819 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.702 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.3 mt -78.75 4.2 14.5 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.844 0.355 . . . . 0.0 110.995 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.34 -18.99 64.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.089 0.471 . . . . 0.0 109.814 178.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.73 -24.46 67.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.003 179.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.561 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.7 mt -81.28 124.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.703 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.563 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 22.7 mt-30 -121.0 167.5 12.53 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.946 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.593 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.0 t30 -109.71 121.26 44.82 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.638 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.532 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.8 t -112.77 94.17 2.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.58 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 61.24 22.98 13.25 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.827 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.26 22.15 6.29 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.056 -1.069 . . . . 0.0 114.082 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.593 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 14.9 ptp180 -132.39 143.01 49.53 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.374 0.587 . . . . 0.0 111.15 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.678 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 67.3 mt -92.22 122.69 34.94 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.587 -0.279 . . . . 0.0 110.25 178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.9 p -138.91 135.86 42.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.609 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 p90 -82.29 146.27 29.54 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.198 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--O 1.251 1.18 0 CA-C-O 118.344 -0.836 . . . . 0.0 110.258 -179.799 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 16.6 tpp . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.429 ' H ' ' HG3' ' A' ' 1' ' ' MET . 17.5 m -132.83 174.86 9.88 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.23 -0.285 . . . . 0.0 110.23 -179.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -56.16 -37.97 70.25 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.203 0.314 . . . . 0.0 110.635 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.2 -25.72 24.42 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 113.02 0.748 . . . . 0.0 113.02 -178.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.507 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 4.1 t70 -56.91 -33.76 67.26 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.24 0.543 . . . . 0.0 110.676 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.603 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 22.5 m -130.04 30.51 4.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.367 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 68.7 m -115.99 154.76 29.27 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.453 0.644 . . . . 0.0 112.103 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -155.45 171.76 19.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.322 179.703 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.574 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.6 t-20 55.38 31.12 16.19 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.559 0.537 . . . . 0.0 110.694 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.604 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.51 113.86 16.9 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.425 -179.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -141.48 151.34 19.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.788 -0.642 . . . . 0.0 109.825 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -90.78 134.52 34.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.529 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.2 m -120.69 164.39 16.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.731 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 73.63 5.07 4.87 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 123.69 0.619 . . . . 0.0 111.342 177.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.94 13.89 41.63 Favored Glycine 0 N--CA 1.448 -0.522 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 109.68 20.68 7.56 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.64 ' HG2' HG21 ' A' ' 56' ' ' THR . 22.5 mtp180 -104.27 -21.34 13.54 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.529 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 8.9 m -123.75 131.14 53.54 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.066 0.46 . . . . 0.0 111.723 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.456 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -103.62 105.51 15.76 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.263 177.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.507 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.6 tmm_? -103.81 124.35 48.76 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.219 -179.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.524 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -147.27 150.25 34.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.801 0.334 . . . . 0.0 110.725 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 11.4 mt-10 -107.35 112.41 25.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.7 t -125.67 147.9 49.19 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.232 0.539 . . . . 0.0 111.761 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.89 145.17 40.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.53 178.868 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' HB3' HG21 ' A' ' 31' ' ' VAL . 31.5 p-10 -87.8 -171.38 3.39 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -178.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.67 -28.07 68.32 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -77.45 -24.55 50.29 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.004 0.431 . . . . 0.0 110.923 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.89 11.51 32.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.311 -0.716 . . . . 0.0 111.311 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.2 t30 -94.77 146.12 24.4 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 38.7 m0 -72.87 125.64 28.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.843 0.354 . . . . 0.0 111.654 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.0 t -129.33 126.25 63.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.76 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -81.49 122.94 28.17 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 178.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.816 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 1.4 t -125.21 151.33 46.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.102 0.477 . . . . 0.0 110.688 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.507 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.02 136.46 40.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.368 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.517 HD11 HG12 ' A' ' 40' ' ' ILE . 13.1 tp -130.63 126.11 35.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.32 0.581 . . . . 0.0 110.274 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.543 ' O ' HG22 ' A' ' 39' ' ' THR . 5.5 m-20 -72.33 107.02 4.71 Favored 'General case' 0 N--CA 1.44 -0.958 0 CA-C-N 115.21 -0.905 . . . . 0.0 109.436 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.841 HD11 HD11 ' A' ' 12' ' ' LEU . 47.7 mt -63.61 -41.4 98.31 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.874 0.845 . . . . 0.0 108.97 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.59 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -62.59 -4.77 2.15 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 114.364 -1.289 . . . . 0.0 110.527 178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.567 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -104.54 -15.76 15.24 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 119.886 -0.726 . . . . 0.0 111.55 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.567 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -140.54 13.25 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.209 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.26 130.78 70.95 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.42 160.52 22.65 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.575 -0.821 . . . . 0.0 112.298 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -111.81 116.83 31.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.869 0.366 . . . . 0.0 110.173 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -102.93 84.12 2.33 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.916 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.499 ' HB2' ' H ' ' A' ' 83' ' ' CYS . 3.5 p30 46.01 43.15 10.3 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.322 1.049 . . . . 0.0 112.953 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.583 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 98.82 37.13 4.28 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 119.772 -1.204 . . . . 0.0 111.911 -179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -157.3 117.06 3.41 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -60.85 136.51 58.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 178.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -129.29 114.26 16.01 Favored 'General case' 0 N--CA 1.441 -0.921 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.729 -179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.3 m95 -67.84 115.32 7.24 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.85 39.71 3.52 Favored Glycine 0 C--N 1.315 -0.587 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.993 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.525 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -109.83 -55.08 0.55 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.591 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.59 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.0 tt0 76.02 138.48 0.06 Allowed 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.564 0.746 . . . . 0.0 111.875 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 61.4 t30 68.29 40.17 2.14 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 114.674 -1.148 . . . . 0.0 110.93 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 11.2 p90 -76.19 -30.37 58.0 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.758 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.64 HG21 ' HG2' ' A' ' 17' ' ' ARG . 42.5 p -61.85 -21.45 64.67 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.018 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.75 ' HG3' HG23 ' A' ' 58' ' ' THR . 1.1 pt-20 -72.16 -15.68 61.97 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.336 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.75 HG23 ' HG3' ' A' ' 57' ' ' GLU . 60.7 p -125.42 2.79 7.71 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.185 0.517 . . . . 0.0 110.359 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.443 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -115.92 149.31 38.93 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.707 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -143.24 172.43 12.75 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.28 -179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.56 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 48.78 52.31 14.29 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.068 0.461 . . . . 0.0 110.202 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 76' ' ' LEU . 2.2 mt -86.44 109.18 18.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.45 0.643 . . . . 0.0 111.754 -177.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.9 122.96 39.37 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.62 179.184 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.644 ' CE1' HD12 ' A' ' 94' ' ' LEU . 10.2 t80 -91.6 135.11 34.11 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.736 -178.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.515 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 2.1 t60 -123.66 87.07 52.6 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.083 178.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.745 ' HB2' ' HD3' ' A' ' 67' ' ' LYS . 9.4 Cg_endo -58.13 -38.27 92.11 Favored 'Trans proline' 0 CA--C 1.514 -0.515 0 C-N-CA 123.725 2.95 . . . . 0.0 114.836 -178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.745 ' HD3' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.2 85.13 2.36 Favored 'General case' 0 C--N 1.297 -1.696 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.03 -179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.515 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 20.8 tt0 -67.2 116.4 7.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.329 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.26 -148.89 8.13 Favored Glycine 0 C--N 1.334 0.428 0 O-C-N 124.305 1.003 . . . . 0.0 113.239 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.77 -2.72 55.23 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.455 0.645 . . . . 0.0 109.57 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.42 -22.51 51.43 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.831 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 57.22 42.5 25.29 Favored 'General case' 0 C--N 1.342 0.259 0 O-C-N 124.104 0.877 . . . . 0.0 109.992 -179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -102.12 119.49 56.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.358 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.9 Cg_endo -72.89 109.68 2.86 Favored 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 122.52 2.146 . . . . 0.0 112.017 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.678 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 141.1 43.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 179.357 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -112.68 127.23 56.06 Favored 'General case' 0 C--N 1.313 -0.998 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.976 -179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.678 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -122.91 141.81 51.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.965 0.412 . . . . 0.0 109.904 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.09 169.42 23.38 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.06 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.56 ' HG2' ' CB ' ' A' ' 61' ' ' ASP . 4.2 mmt180 -85.97 115.19 23.43 Favored 'General case' 0 CA--C 1.515 -0.389 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.0 mp -101.86 134.64 44.73 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.09 -178.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.2 135.72 39.73 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.79 179.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 3.9 m-20 -90.96 172.27 8.7 Favored 'General case' 0 CA--C 1.512 -0.496 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.756 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.499 ' H ' ' HB2' ' A' ' 45' ' ' ASP . 29.9 t -59.36 -26.73 65.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.22 0.533 . . . . 0.0 110.743 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -72.32 -26.35 61.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.035 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.68 40.07 2.81 Favored Glycine 0 N--CA 1.451 -0.355 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 -179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.1 pt-20 -125.98 -165.45 1.43 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 28.1 p90 -140.66 136.08 32.32 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.946 0.879 . . . . 0.0 111.725 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -139.8 125.54 19.43 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 113.903 -1.499 . . . . 0.0 110.102 -179.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.498 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 3.7 p-10 -67.53 114.59 6.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.09 0.471 . . . . 0.0 112.078 -179.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 29.3 mmt180 -115.34 173.31 6.58 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 177.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -141.91 147.85 37.76 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 9.8 p -133.12 146.28 32.68 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.021 -179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.588 ' HB3' HD22 ' A' ' 95' ' ' ASN . 75.3 m-20 -82.91 110.58 18.02 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.728 -179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.644 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -79.28 3.95 16.55 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.19 -179.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.588 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.3 m-80 -63.19 -14.36 48.15 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.022 0.439 . . . . 0.0 110.053 178.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.77 -24.93 67.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.594 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -79.22 126.02 38.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.836 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -118.91 160.56 21.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.357 -0.838 . . . . 0.0 108.932 179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.0 t30 -104.27 120.95 42.3 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.495 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.646 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 52.9 t -112.48 93.99 2.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.284 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 57.9 t30 58.38 25.73 13.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.84 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.96 14.86 15.95 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.439 -0.886 . . . . 0.0 113.188 178.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.646 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 14.4 ptp180 -124.17 134.57 53.28 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.83 0.347 . . . . 0.0 110.212 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.816 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 79.3 mt -85.17 120.31 26.52 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.514 179.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 25.4 t -128.46 136.37 60.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.914 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.415 ' H ' ' HD1' ' A' ' 106' ' ' PHE . 2.1 p90 -87.59 143.69 27.06 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.893 -179.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 51.9 mt-30 . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.143 -0.932 . . . . 0.0 111.964 179.31 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 6.2 ptt? . . . . . 0 N--CA 1.485 1.283 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 m -99.7 -166.08 1.3 Allowed 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -178.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -62.91 -35.4 79.93 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 179.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.743 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.29 -21.25 48.24 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.929 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.554 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 9.2 t70 -57.66 -35.41 70.51 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.377 0.608 . . . . 0.0 110.186 178.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 50.4 m -140.29 46.56 1.82 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.951 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.743 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 88.9 p -116.1 155.79 27.55 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.984 0.421 . . . . 0.0 111.29 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.2 OUTLIER -149.33 163.99 36.15 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.202 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.521 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 91.3 m-20 51.24 35.96 14.82 Favored 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.506 0.504 . . . . 0.0 111.725 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -79.11 113.81 17.54 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.411 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 36.9 t -144.67 149.72 16.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.806 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -83.99 142.46 30.48 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.1 m -127.87 164.96 21.1 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 7.2 t-20 73.29 9.23 5.2 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 123.575 0.547 . . . . 0.0 110.861 177.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.12 13.92 50.67 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.48 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 108.47 15.94 12.91 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.056 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.61 ' HG2' HG21 ' A' ' 56' ' ' THR . 23.6 mtp180 -99.51 -16.98 18.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.583 0.23 . . . . 0.0 111.035 -178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.7 m -131.3 131.0 43.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.026 0.441 . . . . 0.0 111.67 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 37' ' ' LEU . 59.4 tp -98.55 105.09 17.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.796 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -104.91 123.87 48.5 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -148.4 155.47 41.27 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.521 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -112.4 113.08 25.09 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 2.2 m -126.49 141.07 52.0 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.095 0.474 . . . . 0.0 111.589 -178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -67.79 144.06 55.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.448 178.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.529 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.6 p-10 -85.9 -173.85 4.81 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.509 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.86 75.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.741 0.305 . . . . 0.0 111.527 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -69.53 -24.24 63.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.082 0.468 . . . . 0.0 111.096 -179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.1 8.84 35.46 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.721 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.452 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 t30 -91.69 146.44 23.77 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 31.7 m0 -75.0 124.1 26.36 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.293 -179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.529 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -127.54 154.59 38.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.008 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.451 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 28.3 m -104.73 114.16 28.19 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.897 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.0 p -110.7 134.08 52.77 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.495 0.664 . . . . 0.0 111.413 -178.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -127.45 131.83 50.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.647 -179.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.546 HD11 HG12 ' A' ' 40' ' ' ILE . 12.9 tp -131.44 119.59 21.83 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.955 178.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 39' ' ' THR . 9.6 t70 -68.88 111.32 4.86 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.037 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.696 HD11 HD11 ' A' ' 12' ' ' LEU . 33.8 mt -61.73 -45.16 95.16 Favored 'General case' 0 CA--C 1.498 -1.022 0 CA-C-O 121.554 0.692 . . . . 0.0 110.168 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.683 ' OD2' ' HA ' ' A' ' 54' ' ' ASN . 0.8 OUTLIER -63.5 -3.8 2.37 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 114.769 -1.105 . . . . 0.0 110.919 -179.86 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -101.3 -13.13 18.17 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.823 179.913 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.546 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.53 11.79 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.09 0.404 . . . . 0.0 112.09 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.46 129.54 70.51 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.46 160.3 22.11 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.312 -0.946 . . . . 0.0 112.518 -179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.6 t30 -110.88 109.61 19.85 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.303 0.573 . . . . 0.0 110.52 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -90.53 76.56 6.57 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.002 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 39.3 62.07 1.21 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.802 0.841 . . . . 0.0 112.14 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 88.89 36.89 7.53 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.794 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -163.24 118.13 1.68 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.77 0.285 . . . . 0.0 110.483 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CG ' ' HB ' ' A' ' 92' ' ' VAL . 41.5 m-85 -61.57 138.51 58.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.955 0.407 . . . . 0.0 110.959 179.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -133.52 116.14 15.59 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.648 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.2 m95 -70.24 115.02 8.94 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 177.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.04 38.87 3.46 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.728 -179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.554 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -110.66 -50.81 0.63 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.258 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.532 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 1.7 tt0 74.76 144.32 0.08 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.218 0.607 . . . . 0.0 111.527 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.683 ' HA ' ' OD2' ' A' ' 38' ' ' ASP . 10.9 m120 64.02 46.03 3.94 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.749 0.785 . . . . 0.0 111.117 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.539 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -85.16 -28.56 25.42 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.39 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.61 HG21 ' HG2' ' A' ' 17' ' ' ARG . 77.7 p -68.58 -19.58 64.47 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.559 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.74 ' HG3' HG23 ' A' ' 58' ' ' THR . 12.2 pt-20 -71.37 -17.52 62.41 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 120.308 -0.557 . . . . 0.0 109.797 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.74 HG23 ' HG3' ' A' ' 57' ' ' GLU . 62.8 p -124.33 9.68 8.55 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.905 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.588 ' HB3' ' HA ' ' A' ' 56' ' ' THR . . . -115.69 150.37 36.9 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.093 -179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -137.04 170.09 16.68 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.32 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 7.3 t70 43.54 57.21 4.04 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 123.594 0.558 . . . . 0.0 111.33 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.442 HG22 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -87.94 113.39 25.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.187 0.518 . . . . 0.0 112.241 -177.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.68 121.86 31.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.406 -0.816 . . . . 0.0 109.866 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.611 ' CE1' HD12 ' A' ' 94' ' ' LEU . 12.8 t80 -91.47 132.1 36.47 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.292 0.567 . . . . 0.0 111.679 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.433 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 1.0 OUTLIER -120.18 87.74 40.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 115.324 -0.853 . . . . 0.0 108.949 178.874 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 11.2 Cg_endo -57.63 -37.24 97.56 Favored 'Trans proline' 0 CA--C 1.508 -0.816 0 C-N-CA 123.951 3.101 . . . . 0.0 114.105 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -127.31 83.64 2.18 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 114.835 -1.075 . . . . 0.0 110.689 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.433 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 28.0 tt0 -68.63 115.5 8.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.842 179.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.52 -149.81 4.9 Favored Glycine 0 C--N 1.334 0.457 0 CA-C-N 115.001 -0.999 . . . . 0.0 113.921 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -75.99 -9.44 58.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.402 0.62 . . . . 0.0 109.706 179.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.59 -27.55 61.36 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.785 179.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 54.47 43.12 30.84 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.474 -179.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 33.3 mt-30 -107.31 129.92 23.59 Favored Pre-proline 0 C--N 1.323 -0.565 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.377 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.519 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 60.2 Cg_endo -73.62 109.7 2.91 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.941 2.428 . . . . 0.0 111.882 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.497 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.25 140.53 44.81 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.77 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.501 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.07 124.63 52.83 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.105 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.501 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.89 141.48 50.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.856 179.025 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.23 170.56 20.04 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.276 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.571 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 4.0 mmt180 -85.47 115.14 23.01 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -100.63 125.98 47.08 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.913 0.387 . . . . 0.0 111.575 -178.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.708 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -74.26 139.64 44.43 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.648 -179.915 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -98.49 171.27 8.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.887 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 84.4 m -60.06 -23.94 64.16 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -70.88 -25.7 62.91 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.35 0.595 . . . . 0.0 110.235 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.06 40.83 3.19 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.703 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.708 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.5 pt-20 -123.33 -163.44 1.12 Allowed 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.7 p90 -136.11 139.87 43.29 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.63 0.729 . . . . 0.0 111.424 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -139.48 109.75 6.52 Favored 'General case' 0 C--N 1.315 -0.891 0 CA-C-N 114.206 -1.361 . . . . 0.0 110.108 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.1 p-10 -62.83 114.09 3.43 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.393 0.616 . . . . 0.0 111.374 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.646 ' HB2' HD22 ' A' ' 80' ' ' LEU . 31.2 mmt180 -115.06 179.53 3.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.519 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -145.84 148.34 32.79 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CG ' ' A' ' 48' ' ' PHE . 12.7 p -135.31 143.56 36.61 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.039 0 CA-C-O 121.375 0.607 . . . . 0.0 110.496 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.53 ' HB3' HD22 ' A' ' 95' ' ' ASN . 7.5 m-20 -84.02 106.22 15.51 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.887 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.611 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.0 mt -75.67 2.17 12.66 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.225 -179.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.53 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.4 m-80 -62.32 -17.22 58.21 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.395 0.617 . . . . 0.0 109.697 178.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -21.55 66.77 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.155 179.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.8 mt -86.74 125.2 40.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.257 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.8 tt0 -118.25 159.9 22.54 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.571 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -102.04 119.04 38.16 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.202 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.491 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 41.0 t -111.84 96.62 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.317 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 61.69 20.74 11.6 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.466 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.432 ' O ' ' HB3' ' A' ' 33' ' ' SER . . . 108.62 18.41 9.58 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.33 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.571 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 5.5 ptp180 -125.86 150.63 47.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.897 -0.409 . . . . 0.0 109.897 179.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.897 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 78.6 mt -97.78 118.1 33.58 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.862 0.363 . . . . 0.0 111.09 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.578 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.5 p -118.42 126.19 74.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.945 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -86.78 144.38 27.08 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.24 -178.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 . . . . . 0 C--O 1.248 1.01 0 CA-C-O 118.195 -0.907 . . . . 0.0 111.763 178.4 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 4.7 tpt . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HA ' ' HG3' ' A' ' 98' ' ' GLN . 11.6 m -129.02 -177.28 4.15 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 121.237 -0.185 . . . . 0.0 110.635 -178.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 4.9 p90 -63.35 -30.42 71.55 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.682 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.18 -30.08 59.16 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.264 -0.88 . . . . 0.0 113.003 -179.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.548 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 8.8 t70 -56.87 -32.55 65.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.306 0.574 . . . . 0.0 111.196 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 56.2 m -136.69 41.12 2.55 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.209 -179.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.682 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.8 p -115.96 145.15 43.17 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.905 0.383 . . . . 0.0 111.419 -179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -146.88 166.03 27.97 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.016 179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 54.22 31.07 13.4 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.641 0.588 . . . . 0.0 111.309 179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.575 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.59 114.85 16.86 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.601 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.1 t -141.14 149.58 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.147 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -86.93 134.5 33.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.124 0.488 . . . . 0.0 109.708 178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.1 m -123.32 165.36 17.11 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.118 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.6 OUTLIER 71.24 8.79 6.48 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 123.229 0.612 . . . . 0.0 111.325 178.362 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.53 22.17 22.3 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.532 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.01 14.11 37.51 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.576 -179.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.631 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.3 mtp180 -98.08 -17.11 19.28 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.402 0.144 . . . . 0.0 111.02 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 26.5 m -130.6 124.52 31.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.904 0.383 . . . . 0.0 111.631 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 37' ' ' LEU . 60.6 tp -95.7 105.92 17.98 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 178.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.536 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -103.32 124.15 48.12 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.428 ' HB3' HD21 ' A' ' 104' ' ' LEU . . . -147.42 145.06 29.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.027 0.441 . . . . 0.0 111.153 -179.238 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.407 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.2 mt-10 -100.25 113.46 26.16 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.542 ' HA ' ' O ' ' A' ' 6' ' ' SER . 20.1 t -128.02 143.85 51.09 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.949 0.404 . . . . 0.0 110.441 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.404 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.08 144.46 48.69 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.044 -0.526 . . . . 0.0 109.729 179.523 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 33.3 p30 -84.42 -171.44 3.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.704 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -31.1 72.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.176 0.513 . . . . 0.0 110.884 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -69.68 -24.44 63.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.273 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.72 10.32 38.12 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.848 -0.691 . . . . 0.0 111.498 -179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.0 m-80 -96.49 143.85 27.13 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.534 0.207 . . . . 0.0 110.444 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 34.4 m0 -73.66 122.72 22.77 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 112.026 -179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.7 t -122.01 153.76 26.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.94 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.407 HG23 ' HG2' ' A' ' 22' ' ' GLU . 20.2 m -108.55 111.0 22.61 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 178.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.506 ' HB3' HD13 ' A' ' 104' ' ' LEU . 9.3 t -112.62 155.97 23.52 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.135 0.493 . . . . 0.0 111.184 -178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.536 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.2 mt-10 -137.87 131.96 31.79 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.868 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -129.84 117.45 20.22 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' O ' HG22 ' A' ' 39' ' ' THR . 21.5 m-20 -68.15 107.04 2.61 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.231 0.539 . . . . 0.0 109.579 179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -59.19 -45.89 89.87 Favored 'General case' 0 CA--C 1.496 -1.103 0 CA-C-O 121.504 0.668 . . . . 0.0 110.536 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.1 OUTLIER -62.7 -5.26 2.56 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.818 -179.456 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.56 -14.23 18.29 Favored 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.992 179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.11 10.34 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.499 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.08 129.94 71.14 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.77 158.65 20.86 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 119.98 -1.105 . . . . 0.0 112.883 -178.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 12.1 t30 -110.7 111.48 22.7 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 178.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -93.07 79.29 4.56 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.537 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 42.4 49.84 4.63 Favored 'General case' 0 N--CA 1.47 0.57 0 O-C-N 124.174 0.921 . . . . 0.0 112.811 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.505 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 102.33 33.09 4.66 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.408 -0.901 . . . . 0.0 113.233 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -162.38 123.5 2.58 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.118 0.459 . . . . 0.0 111.061 179.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.464 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -64.08 139.79 58.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.102 0.477 . . . . 0.0 111.18 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -133.02 117.49 17.66 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.65 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.17 114.59 8.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 177.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.26 34.86 5.2 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.759 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -107.7 -49.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.573 -0.822 . . . . 0.0 113.06 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.5 tt0 72.07 145.46 0.07 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 122.953 0.501 . . . . 0.0 111.325 -179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.578 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.3 m-20 69.91 34.89 2.42 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.486 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.499 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.5 p90 -77.77 -28.46 50.59 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 179.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.631 HG21 ' HG2' ' A' ' 17' ' ' ARG . 40.0 p -68.86 -28.52 66.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.293 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.625 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.3 pt-20 -70.82 -13.83 62.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.094 0.473 . . . . 0.0 109.979 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.625 HG23 ' HG3' ' A' ' 57' ' ' GLU . 61.0 p -126.09 17.51 7.82 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.923 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.04 163.5 26.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.832 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.09 166.39 29.92 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 48.35 61.43 3.04 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.242 0.544 . . . . 0.0 110.749 -179.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 78' ' ' ALA . 1.8 mt -93.61 116.76 35.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.704 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.556 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -134.48 126.77 30.11 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.28 178.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.668 ' CE1' HD12 ' A' ' 94' ' ' LEU . 16.5 t80 -92.2 137.93 31.95 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.349 0.595 . . . . 0.0 112.206 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.75 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 11.0 t-160 -119.44 84.56 29.55 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.163 -0.926 . . . . 0.0 108.567 178.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.756 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.3 Cg_endo -58.72 -39.15 84.83 Favored 'Trans proline' 0 CA--C 1.512 -0.615 0 C-N-CA 123.566 2.844 . . . . 0.0 114.177 -177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.756 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -127.64 87.07 2.56 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 114.873 -1.058 . . . . 0.0 110.244 179.555 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.75 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 4.4 tt0 -70.55 113.76 7.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.603 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.17 -145.85 8.9 Favored Glycine 0 C--N 1.339 0.697 0 O-C-N 124.305 1.003 . . . . 0.0 113.148 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.47 -1.76 51.27 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.62 -21.92 47.73 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.699 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 55.45 40.02 31.22 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.8 tp60 -99.46 115.81 65.4 Favored Pre-proline 0 C--N 1.326 -0.447 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.522 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.591 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 59.7 Cg_endo -74.57 107.74 2.53 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 122.21 1.94 . . . . 0.0 111.452 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.1 pp -133.73 141.61 43.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.518 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.9 124.94 53.76 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.222 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.556 ' HD3' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.62 141.11 50.65 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.043 0.449 . . . . 0.0 110.23 179.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.27 166.17 30.03 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.628 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.619 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 11.8 mmt180 -85.69 115.18 23.21 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -98.05 129.83 44.88 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.232 0.539 . . . . 0.0 112.021 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -80.55 143.39 33.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.952 -1.022 . . . . 0.0 111.051 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.569 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 2.3 p-10 -98.56 177.84 5.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.314 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 48.4 t -62.87 -24.07 67.62 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 111.914 0.338 . . . . 0.0 111.914 -178.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -79.4 -28.49 41.82 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.733 -0.387 . . . . 0.0 110.799 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.28 40.63 1.36 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.618 -0.801 . . . . 0.0 113.073 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.666 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.7 pt-20 -112.6 -163.99 0.89 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 25.5 p90 -147.76 128.2 14.02 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.071 0.462 . . . . 0.0 110.135 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -137.42 120.94 17.18 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 7.7 p-10 -64.62 125.53 25.01 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.587 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -120.57 178.09 4.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.989 -1.005 . . . . 0.0 108.752 177.015 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -144.73 147.69 33.28 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.464 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.9 p -136.22 140.62 43.39 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-O 121.582 0.706 . . . . 0.0 110.999 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.516 ' HB3' HD22 ' A' ' 95' ' ' ASN . 26.0 m-80 -79.2 108.42 12.69 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 114.581 -1.19 . . . . 0.0 110.641 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.668 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -78.97 5.82 10.77 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.331 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.516 HD22 ' HB3' ' A' ' 93' ' ' ASN . 18.8 m-80 -67.23 -8.61 33.04 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 121.074 0.464 . . . . 0.0 110.281 178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.402 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -72.84 -15.61 61.61 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.932 179.015 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.516 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.0 mt -89.05 126.13 42.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.583 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.456 ' HG3' ' HA ' ' A' ' 2' ' ' SER . 2.1 mp0 -115.87 169.93 8.85 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.508 179.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -115.2 118.77 34.24 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.226 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.444 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -113.75 100.49 10.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.57 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.73 24.64 13.56 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 121.37 0.605 . . . . 0.0 110.801 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.99 23.0 10.14 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.482 -0.866 . . . . 0.0 113.304 178.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.5 ptp180 -129.92 134.76 47.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.951 0.376 . . . . 0.0 110.069 179.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.506 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.1 mp -83.67 128.41 34.5 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.67 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -142.2 130.29 21.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.07 0.462 . . . . 0.0 110.99 179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -82.04 145.92 29.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.249 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 . . . . . 0 C--O 1.25 1.115 0 CA-C-O 118.997 -0.525 . . . . 0.0 111.738 179.996 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.2 tpp . . . . . 0 N--CA 1.48 1.063 0 CA-C-O 120.806 0.336 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.0 m -151.35 -169.29 3.34 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.415 ' HD1' ' O ' ' A' ' 97' ' ' ILE . 11.7 p90 -61.92 -38.61 89.05 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.512 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -52.4 -26.39 12.44 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.465 -179.19 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -52.65 -29.63 27.34 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.912 0.387 . . . . 0.0 111.011 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 25.5 m -141.47 34.13 1.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.088 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 22' ' ' GLU . 66.7 m -115.64 152.92 32.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.238 0.542 . . . . 0.0 112.389 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 167.64 26.47 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.128 -0.942 . . . . 0.0 108.96 179.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 74.0 m-20 55.6 31.71 17.77 Favored 'General case' 0 N--CA 1.465 0.31 0 O-C-N 123.524 0.515 . . . . 0.0 111.457 179.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.527 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -73.41 114.47 11.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.314 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 32.8 t -142.3 150.74 18.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.083 -178.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.1 138.35 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.7 m -125.81 165.3 18.92 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.519 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 9.3 t30 72.49 6.36 5.44 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.57 0.544 . . . . 0.0 111.531 178.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.71 28.74 11.81 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 93.28 20.92 31.2 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.913 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.686 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.5 mtp180 -106.78 -13.99 15.11 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.687 0.28 . . . . 0.0 110.275 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 28.7 m -133.15 129.24 37.6 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-O 120.913 0.387 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.509 ' CD2' HD13 ' A' ' 97' ' ' ILE . 55.5 tp -100.33 108.7 20.8 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.609 177.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.473 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.7 tmm_? -103.96 123.54 47.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.75 151.0 36.45 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.006 0.431 . . . . 0.0 110.776 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.633 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.7 mt-10 -106.44 114.47 28.61 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.552 ' HA ' ' O ' ' A' ' 6' ' ' SER . 12.6 t -130.32 147.93 52.09 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.307 0.575 . . . . 0.0 111.677 -178.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -77.74 144.72 36.99 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.829 179.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.7 p-10 -87.72 -168.6 2.28 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.791 0.329 . . . . 0.0 111.645 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.16 -33.81 75.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.302 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.44 -24.24 61.99 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.147 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.8 5.84 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.8 t-20 -86.48 144.69 27.14 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 -179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -77.47 125.34 29.18 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 116.543 -0.298 . . . . 0.0 110.482 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.0 t -128.15 131.75 69.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.869 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.2 m -83.58 110.05 17.92 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.531 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 2.8 p -111.36 143.43 42.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.321 0.581 . . . . 0.0 111.642 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.473 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -130.7 133.15 45.82 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.699 -179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -131.34 119.17 21.33 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 5.5 m-20 -68.88 108.48 3.49 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 121.284 0.564 . . . . 0.0 110.034 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.604 HD11 HD11 ' A' ' 12' ' ' LEU . 55.3 mt -59.28 -46.76 87.66 Favored 'General case' 0 CA--C 1.503 -0.858 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.108 -179.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -62.77 -4.91 2.33 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.85 -179.592 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.489 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.12 -13.97 20.68 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.872 -179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.477 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -143.99 12.6 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.382 0 CA-C-O 120.89 0.376 . . . . 0.0 112.008 -179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.577 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -126.63 130.83 71.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.22 163.06 19.36 Favored Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.819 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -113.14 108.75 17.73 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.142 0.496 . . . . 0.0 110.328 179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -101.67 82.93 2.34 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.301 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.539 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.4 m-20 48.99 57.21 6.69 Favored 'General case' 0 N--CA 1.471 0.61 0 CA-C-N 115.796 -0.638 . . . . 0.0 112.124 179.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.577 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.14 41.86 20.84 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 120.085 -1.055 . . . . 0.0 111.713 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -159.39 113.0 2.29 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.557 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.0 m-85 -58.76 136.28 57.7 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.244 0.545 . . . . 0.0 111.081 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -123.74 114.77 20.36 Favored 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.51 -179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -70.78 114.47 8.89 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.62 35.4 4.92 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.647 -179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.425 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.18 -49.54 0.82 Allowed Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.549 -0.834 . . . . 0.0 113.148 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 28.9 tt0 70.15 145.51 0.06 Allowed 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 123.026 0.53 . . . . 0.0 111.123 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.651 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.8 m120 72.35 31.78 1.77 Allowed 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.215 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.577 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.1 p90 -76.57 -31.51 57.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.686 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.1 p -64.12 -27.18 68.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.876 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.651 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.3 pt-20 -72.04 -14.41 61.87 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.199 0.523 . . . . 0.0 110.254 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -125.09 14.05 8.41 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.922 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.8 157.32 37.83 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.654 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.734 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -148.93 170.66 17.81 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.322 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.2 t70 49.07 52.44 14.37 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 123.385 0.428 . . . . 0.0 110.74 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.429 HG22 HD21 ' A' ' 76' ' ' LEU . 2.1 mt -84.79 112.01 21.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -177.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -126.54 124.89 41.04 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.643 178.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.65 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.8 t80 -91.6 137.65 32.2 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.352 0.596 . . . . 0.0 111.486 -178.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.684 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 7.6 t-160 -122.89 82.3 49.92 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.334 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' HG2' ' HD2' ' A' ' 67' ' ' LYS . 6.9 Cg_endo -56.94 -43.07 57.68 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 123.384 2.723 . . . . 0.0 113.947 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.464 ' HD2' ' HG2' ' A' ' 66' ' ' PRO . 3.3 mptt -120.2 83.71 2.1 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 114.902 -1.044 . . . . 0.0 109.438 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.684 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 1.8 tt0 -66.84 109.04 2.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.02 -0.537 . . . . 0.0 112.421 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.29 -140.74 12.74 Favored Glycine 0 C--N 1.333 0.411 0 O-C-N 124.376 1.047 . . . . 0.0 114.129 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -80.13 -9.46 59.71 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.886 0.374 . . . . 0.0 110.339 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -78.76 -24.91 44.45 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.111 0.481 . . . . 0.0 109.787 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.71 41.15 31.39 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 114.77 -1.105 . . . . 0.0 109.477 -179.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -100.13 123.05 48.33 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 114.932 -1.031 . . . . 0.0 110.833 -178.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 42.8 Cg_endo -70.01 108.94 2.24 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.568 2.179 . . . . 0.0 112.072 179.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -136.34 142.19 39.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.532 179.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.52 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.06 126.96 56.05 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.964 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.52 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.75 142.39 50.77 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-O 121.245 0.545 . . . . 0.0 110.099 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -161.16 171.1 19.07 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.174 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.734 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.3 mmt180 -85.12 115.87 23.17 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.627 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -101.74 124.71 47.84 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.941 0.4 . . . . 0.0 111.666 -178.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.732 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -79.29 142.95 35.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.469 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.687 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.9 OUTLIER -105.93 171.8 7.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.782 178.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 75.9 m -56.14 -27.28 53.57 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.324 0.491 . . . . 0.0 112.324 -179.243 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -69.27 -27.3 65.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.351 0.596 . . . . 0.0 109.924 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.4 ' HA2' ' HE ' ' A' ' 81' ' ' ARG . . . 102.08 38.27 3.16 Favored Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.146 177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.732 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.3 pt-20 -122.03 -165.86 1.32 Allowed 'General case' 0 C--N 1.318 -0.788 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 43.4 p90 -140.43 139.71 35.28 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 122.036 0.922 . . . . 0.0 111.503 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -138.79 112.73 8.5 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 113.723 -1.58 . . . . 0.0 109.682 -179.538 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.569 ' HB3' ' CD ' ' A' ' 79' ' ' ARG . 5.4 p-10 -64.43 113.15 3.46 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.518 0.675 . . . . 0.0 111.341 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.627 ' HB2' HD22 ' A' ' 80' ' ' LEU . 25.7 mmt180 -114.39 177.11 4.76 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.664 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.425 ' HB2' HD13 ' A' ' 75' ' ' ILE . 7.7 p-10 -142.57 148.74 38.04 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.557 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -134.31 147.59 30.1 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.076 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.493 -179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.558 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -85.42 110.09 18.9 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.709 -179.4 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.65 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.5 mt -77.5 2.48 16.13 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.293 -179.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.558 HD22 ' HB3' ' A' ' 93' ' ' ASN . 16.6 m-80 -62.73 -12.75 25.92 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.241 0.543 . . . . 0.0 109.91 177.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.7 ' O ' ' HG3' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -69.51 -18.06 63.65 Favored 'General case' 0 C--O 1.221 -0.437 0 CA-C-N 115.789 -0.642 . . . . 0.0 109.692 178.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.593 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.9 mt -87.06 123.48 39.93 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.443 0.64 . . . . 0.0 110.626 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -116.96 164.6 14.46 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.494 -0.775 . . . . 0.0 109.217 179.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.489 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.6 t30 -108.27 121.06 44.12 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.601 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 61.4 t -113.01 94.62 3.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.602 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 61.69 22.56 13.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.985 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.62 16.73 9.8 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 119.674 -1.25 . . . . 0.0 113.594 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.601 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.2 ptp180 -129.22 143.71 50.95 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.531 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 82.7 mt -89.37 133.23 34.6 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.9 p -145.71 131.4 13.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.062 0.458 . . . . 0.0 110.638 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.5 p90 -82.48 145.78 29.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.529 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.7 ' HG3' ' O ' ' A' ' 96' ' ' ARG . 57.6 mt-30 . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.467 -0.777 . . . . 0.0 110.47 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HB3' ' HB2' ' A' ' 5' ' ' ASP . 15.3 tpt . . . . . 0 N--CA 1.477 0.919 0 CA-C-O 120.738 0.304 . . . . 0.0 110.436 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.4 m -155.17 -172.16 4.07 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -66.24 -33.95 76.9 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.761 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.15 -24.1 51.97 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.269 -0.878 . . . . 0.0 112.422 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.427 ' HB2' ' HB3' ' A' ' 1' ' ' MET . 17.3 t0 -59.16 -24.24 62.87 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.058 0.456 . . . . 0.0 111.189 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.5 m -148.01 39.32 0.93 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.726 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.761 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 92.7 p -116.22 158.27 23.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.026 0.441 . . . . 0.0 111.938 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -155.32 166.8 32.43 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.517 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.511 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.8 m-20 52.89 35.47 19.12 Favored 'General case' 0 C--O 1.235 0.326 0 O-C-N 123.788 0.68 . . . . 0.0 111.332 179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.544 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -79.31 114.36 18.18 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.427 179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.1 t -143.84 151.58 16.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.547 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -85.17 145.22 27.72 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 179.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.1 m -131.99 164.73 25.54 Favored 'General case' 0 C--N 1.315 -0.921 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 73.77 5.22 4.83 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.602 0.564 . . . . 0.0 111.234 177.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.06 23.58 19.65 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.505 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 99.1 16.86 29.07 Favored Glycine 0 N--CA 1.443 -0.886 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.824 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.721 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.7 mtp180 -100.75 -18.38 16.5 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.581 0.229 . . . . 0.0 110.783 -179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.429 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 50.5 m -130.22 128.42 41.62 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.962 0.411 . . . . 0.0 111.54 -178.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' CD2' HD13 ' A' ' 97' ' ' ILE . 58.8 tp -97.59 108.8 21.59 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.72 178.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.51 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.2 tmm_? -103.4 124.94 49.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.097 -179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.25 138.95 20.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.793 0.33 . . . . 0.0 110.98 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.5 mt-10 -98.83 109.85 22.55 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.431 ' SG ' HD11 ' A' ' 104' ' ' LEU . 3.3 m -121.29 144.28 48.71 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.028 0.442 . . . . 0.0 111.035 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.608 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.29 143.32 47.04 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.94 179.775 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.483 ' HB3' HG21 ' A' ' 31' ' ' VAL . 25.2 p-10 -90.26 -172.77 3.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.595 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.51 66.8 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.721 0.296 . . . . 0.0 111.662 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -74.18 -25.03 59.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.114 0.483 . . . . 0.0 111.282 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.09 6.21 39.83 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.515 -178.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.608 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.7 t-20 -88.94 146.32 24.98 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.936 -0.394 . . . . 0.0 109.936 -179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -78.55 119.63 22.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.057 0.456 . . . . 0.0 110.99 -179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -115.9 125.18 72.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.801 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 19.5 m -80.36 107.3 13.04 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.498 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.4 t -112.52 149.23 32.96 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.325 0.583 . . . . 0.0 110.584 -179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.51 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.9 mt-10 -134.96 131.77 37.6 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.316 -0.857 . . . . 0.0 109.938 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.85 119.18 23.99 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.635 ' O ' HG22 ' A' ' 39' ' ' THR . 47.4 m-20 -68.41 108.73 3.37 Favored 'General case' 0 N--CA 1.44 -0.928 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.028 179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.651 HD11 HD11 ' A' ' 12' ' ' LEU . 68.3 mt -61.86 -42.35 98.95 Favored 'General case' 0 CA--C 1.503 -0.841 0 CA-C-O 121.584 0.707 . . . . 0.0 110.012 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -62.55 -5.21 2.41 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.751 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.09 -12.08 16.3 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.439 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.538 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -141.94 10.6 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 130.44 70.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.59 160.79 20.95 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.657 -0.782 . . . . 0.0 111.966 -179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -110.94 107.85 17.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.505 0.669 . . . . 0.0 110.214 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -87.83 75.73 8.84 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 114.837 -1.074 . . . . 0.0 109.107 179.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.446 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 7.1 p-10 39.16 59.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.355 1.062 . . . . 0.0 112.588 -179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.529 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 91.36 36.29 6.64 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.551 179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -165.5 121.72 1.38 Allowed 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.542 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.7 m-85 -60.93 143.78 54.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.346 0.593 . . . . 0.0 111.644 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -132.91 115.81 15.69 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.109 -0.951 . . . . 0.0 110.422 -179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 86.7 m95 -73.01 115.08 11.89 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 178.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.17 31.91 6.34 Favored Glycine 0 N--CA 1.447 -0.577 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.784 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -102.03 -50.8 1.13 Allowed Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.677 -0.773 . . . . 0.0 113.194 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 13.7 tt0 72.61 144.96 0.07 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 122.901 0.48 . . . . 0.0 111.422 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.486 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 2.6 t-20 68.74 34.71 3.29 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.244 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.2 p90 -77.27 -28.49 53.48 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.95 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.721 HG21 ' HG2' ' A' ' 17' ' ' ARG . 33.0 p -64.63 -22.23 66.92 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.555 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.674 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.6 pt-20 -73.16 -15.32 61.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.038 0.446 . . . . 0.0 110.371 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.674 HG23 ' HG3' ' A' ' 57' ' ' GLU . 74.8 p -128.19 16.32 6.68 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.271 0.558 . . . . 0.0 110.031 -179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.21 150.27 50.66 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.144 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.32 173.07 11.87 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.503 179.716 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.491 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 48.43 50.86 16.14 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 123.545 0.528 . . . . 0.0 110.518 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.05 108.6 17.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.337 0.589 . . . . 0.0 111.536 -178.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.463 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.52 123.16 37.13 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.208 -0.905 . . . . 0.0 109.68 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.629 ' CE1' HD12 ' A' ' 94' ' ' LEU . 18.3 t80 -92.15 135.32 34.08 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.247 0.546 . . . . 0.0 111.895 -178.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.535 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 16.5 t60 -124.5 89.33 52.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.04 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.517 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.2 Cg_endo -57.11 -36.86 99.31 Favored 'Trans proline' 0 CA--C 1.51 -0.712 0 C-N-CA 124.11 3.207 . . . . 0.0 114.633 -178.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.08 88.78 2.94 Favored 'General case' 0 C--N 1.295 -1.78 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.656 -179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.535 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 14.7 tt0 -70.42 114.25 8.35 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.095 178.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.0 -153.01 7.33 Favored Glycine 0 C--N 1.335 0.509 0 O-C-N 124.025 0.828 . . . . 0.0 113.714 178.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.76 -13.37 60.94 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.224 0.535 . . . . 0.0 109.694 179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.92 -25.15 59.84 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.969 179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 49.3 52.56 14.21 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.879 0.737 . . . . 0.0 110.764 -179.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -104.97 124.51 36.44 Favored Pre-proline 0 N--CA 1.447 -0.59 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.522 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.54 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 56.9 Cg_endo -71.37 110.43 2.85 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 122.779 2.32 . . . . 0.0 112.642 -179.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.703 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 140.24 44.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -111.66 126.83 55.45 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.081 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.703 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.0 142.53 48.71 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.095 0.474 . . . . 0.0 109.971 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -161.58 167.84 24.59 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.675 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.588 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.4 mmt180 -86.3 115.09 23.62 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.32 124.06 45.33 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.365 -178.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.671 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.78 137.37 40.5 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.872 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -93.37 166.27 12.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.493 179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.446 ' SG ' ' HB3' ' A' ' 45' ' ' ASP . 95.9 m -58.57 -20.93 51.11 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.856 0.36 . . . . 0.0 111.418 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 49.3 t30 -71.06 -26.83 63.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.282 0.563 . . . . 0.0 110.56 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 99.92 41.14 2.93 Favored Glycine 0 N--CA 1.451 -0.328 0 N-CA-C 111.245 -0.742 . . . . 0.0 111.245 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.671 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.4 pt-20 -126.97 -163.72 1.28 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -140.12 142.61 36.02 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.784 0.802 . . . . 0.0 111.417 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m80 -140.99 112.04 7.2 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.013 -1.449 . . . . 0.0 110.073 -179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.547 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.2 p-10 -62.02 115.27 3.94 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.31 0.576 . . . . 0.0 110.924 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.697 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -116.44 175.44 5.56 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.991 -0.549 . . . . 0.0 109.953 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -142.39 149.08 38.88 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.542 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -137.52 143.05 35.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-O 121.459 0.647 . . . . 0.0 111.31 -179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.475 ' HB3' HD22 ' A' ' 95' ' ' ASN . 36.5 m-20 -79.36 110.04 14.28 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.905 -1.043 . . . . 0.0 110.551 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.629 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.5 mt -79.04 1.11 25.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.798 0.332 . . . . 0.0 111.238 -179.065 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.475 HD22 ' HB3' ' A' ' 93' ' ' ASN . 14.9 m-80 -61.93 -13.87 29.14 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.685 178.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.8 -26.5 67.72 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.447 0.641 . . . . 0.0 109.39 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.512 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.2 mt -80.13 127.25 39.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.415 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -121.01 161.99 20.7 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.314 -179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -104.88 120.6 41.82 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.024 0.44 . . . . 0.0 110.63 -179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.587 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 60.2 t -113.1 94.2 2.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.32 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.9 t30 59.94 24.91 14.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.714 179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 23.14 8.32 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.0 178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.587 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 7.6 ptp180 -130.6 134.15 46.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.95 0.375 . . . . 0.0 110.271 179.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.498 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.2 mp -80.89 119.46 23.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.685 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.425 HG23 ' HG3' ' A' ' 103' ' ' ARG . 48.3 t -127.14 125.37 66.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.226 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.8 p90 -79.56 144.02 34.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.205 179.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 26.6 tt0 . . . . . 0 C--O 1.246 0.882 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.909 179.48 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.6 tpt . . . . . 0 N--CA 1.479 0.986 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.0 p 177.48 -178.88 0.21 Allowed 'General case' 0 CA--C 1.512 -0.514 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -63.6 -31.17 72.26 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 177.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.717 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -54.3 -27.68 37.11 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 115.074 -0.967 . . . . 0.0 112.62 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -57.38 -31.83 66.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.164 0.506 . . . . 0.0 110.976 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.539 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.9 m -138.11 41.31 2.28 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.971 -179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.717 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.2 p -122.67 154.55 37.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.933 0.397 . . . . 0.0 111.597 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -151.37 167.51 27.7 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.436 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 84.9 m-20 53.69 34.43 18.86 Favored 'General case' 0 C--O 1.236 0.374 0 O-C-N 123.659 0.599 . . . . 0.0 111.214 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.588 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -80.03 112.96 17.84 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.91 179.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -144.25 153.64 15.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.043 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.58 142.78 27.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 14' ' ' ASN . 20.4 m -130.37 163.53 26.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.171 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 11.4 t30 72.67 9.06 5.63 Favored 'General case' 0 N--CA 1.463 0.193 0 O-C-N 123.725 0.641 . . . . 0.0 111.657 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 25.27 15.68 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.037 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.503 ' HA3' ' HB ' ' A' ' 62' ' ' ILE . . . 93.08 26.18 17.16 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.758 -0.735 . . . . 0.0 111.611 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.588 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.7 mtp180 -108.09 -18.3 13.82 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.835 0.35 . . . . 0.0 110.196 -179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 42.1 m -128.73 129.91 46.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.768 -179.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.439 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.1 tp -102.77 111.99 24.57 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.578 178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -110.4 126.05 53.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.043 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -150.16 138.46 20.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.779 0.323 . . . . 0.0 110.6 179.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.6 mt-10 -96.09 110.04 22.36 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 6' ' ' SER . 5.1 p -117.5 141.16 48.68 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.133 0.492 . . . . 0.0 111.643 -178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.16 143.89 40.89 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.771 179.394 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 38.4 p30 -90.58 -172.98 3.6 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.023 0.379 . . . . 0.0 112.023 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.74 -34.07 70.96 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.627 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -73.64 -17.9 61.1 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.277 0.56 . . . . 0.0 110.83 -179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 98.45 6.71 56.41 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 120.753 -0.737 . . . . 0.0 111.883 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.6 t-20 -86.9 142.26 28.15 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.499 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.1 m0 -77.63 116.73 18.41 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.025 0.44 . . . . 0.0 110.756 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.9 t -112.57 122.57 67.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.809 -179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.7 m -76.4 109.75 10.37 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.752 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 24.0 m -109.93 143.46 39.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.167 0.508 . . . . 0.0 110.545 -178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 7.0 mt-10 -135.5 132.72 37.67 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.556 -178.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.61 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -136.74 119.58 16.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.592 179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.661 ' O ' HG22 ' A' ' 39' ' ' THR . 18.2 m-20 -69.67 110.34 4.82 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.263 -0.881 . . . . 0.0 109.722 179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.897 HD11 HD11 ' A' ' 12' ' ' LEU . 11.1 mt -60.6 -39.96 90.03 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.836 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.565 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -64.45 -5.93 6.3 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.382 -0.827 . . . . 0.0 110.492 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.661 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.56 -9.77 17.23 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 119.915 -0.714 . . . . 0.0 111.658 -178.999 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.61 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.16 10.8 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.71 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.43 131.16 70.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.462 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.12 158.03 20.2 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.755 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -111.45 108.53 18.11 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.15 0.5 . . . . 0.0 110.319 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -93.58 78.99 4.31 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.317 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 41.24 60.73 1.98 Allowed 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.817 0.847 . . . . 0.0 112.432 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.23 35.5 9.59 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.771 179.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 52.4 t-80 -158.5 117.35 3.06 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.801 -0.235 . . . . 0.0 110.736 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.49 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.2 m-85 -62.93 139.48 58.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.902 0.382 . . . . 0.0 110.978 179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -133.5 116.78 16.37 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.43 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.419 ' HH2' HD22 ' A' ' 94' ' ' LEU . 90.6 m95 -69.67 115.62 9.13 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.19 39.14 3.84 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.873 -179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -111.58 -51.21 0.58 Allowed Glycine 0 CA--C 1.519 0.29 0 C-N-CA 120.49 -0.862 . . . . 0.0 113.375 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.565 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.4 tt0 72.98 144.56 0.07 Allowed 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.23 0.612 . . . . 0.0 111.344 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.539 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.7 m-20 72.47 28.99 2.18 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 115.421 -0.808 . . . . 0.0 111.82 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -74.1 -29.16 61.71 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.588 HG21 ' HG2' ' A' ' 17' ' ' ARG . 17.8 p -67.7 -20.43 65.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.004 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.607 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.2 pt-20 -76.49 -12.91 60.11 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.171 0.51 . . . . 0.0 109.73 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.607 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.8 p -127.1 13.65 7.25 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.974 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.31 150.91 51.34 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.589 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.605 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -142.06 173.42 11.53 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.998 179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.425 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 47.5 58.79 4.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.299 0.571 . . . . 0.0 110.423 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.503 ' HB ' ' HA3' ' A' ' 16' ' ' GLY . 1.8 mt -94.9 110.7 24.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.4 -178.369 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.79 126.41 39.87 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.413 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.688 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.0 t80 -91.38 134.99 34.14 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.363 -177.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.566 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 8.8 t-160 -120.34 84.66 35.45 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.336 179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -56.77 -41.11 79.07 Favored 'Trans proline' 0 CA--C 1.512 -0.607 0 C-N-CA 123.254 2.636 . . . . 0.0 113.89 -178.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.595 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -121.46 82.54 1.95 Allowed 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 115.004 -0.998 . . . . 0.0 109.743 179.691 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.566 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 13.1 tt0 -69.68 113.64 7.13 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.88 -151.16 7.25 Favored Glycine 0 C--N 1.338 0.644 0 O-C-N 124.4 1.062 . . . . 0.0 114.138 178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.88 -9.07 58.2 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.459 0.647 . . . . 0.0 109.898 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.99 -25.1 47.87 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.422 179.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 47.61 55.06 8.89 Favored 'General case' 0 C--O 1.238 0.49 0 O-C-N 123.929 0.768 . . . . 0.0 110.47 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -118.09 127.22 26.74 Favored Pre-proline 0 C--N 1.325 -0.49 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.058 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.511 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 58.9 Cg_endo -71.99 111.08 3.08 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.592 2.194 . . . . 0.0 112.669 -179.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.411 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -134.37 141.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 178.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.517 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -112.24 125.43 54.15 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.308 -179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.517 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.05 142.5 49.76 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.147 179.116 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.493 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -161.71 169.72 20.98 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.223 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.605 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -86.0 115.0 23.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.6 mp -101.4 131.51 47.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.824 0.345 . . . . 0.0 111.303 -178.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.78 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -75.87 136.17 40.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.022 179.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.535 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 4.1 m-20 -94.72 172.6 8.07 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.285 -0.87 . . . . 0.0 110.54 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 23.8 t -61.18 -25.85 67.31 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.302 0.572 . . . . 0.0 110.229 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -69.51 -19.32 63.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.76 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 90.85 37.66 6.33 Favored Glycine 0 CA--C 1.505 -0.55 0 N-CA-C 110.539 -1.024 . . . . 0.0 110.539 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.78 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -122.64 -169.1 1.85 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -178.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.486 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 98.4 m-85 -135.95 136.36 40.33 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.707 0.765 . . . . 0.0 111.332 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -138.29 119.14 14.2 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.701 -178.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 12.6 p-10 -64.49 113.26 3.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.433 0.635 . . . . 0.0 111.332 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD22 ' A' ' 80' ' ' LEU . 31.0 mmt180 -115.0 176.47 5.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 178.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -144.44 151.95 39.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.49 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.9 p -139.6 146.99 24.54 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-O 121.209 0.528 . . . . 0.0 110.78 -179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.495 ' HB3' HD22 ' A' ' 95' ' ' ASN . 40.5 m-80 -81.73 111.73 18.25 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.775 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.688 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.3 mt -80.55 -0.75 39.08 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.893 0.378 . . . . 0.0 110.306 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.495 HD22 ' HB3' ' A' ' 93' ' ' ASN . 23.7 m-80 -62.08 -14.22 34.21 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.014 178.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.412 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -68.05 -24.2 65.06 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.179 179.381 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.511 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.0 mt -80.85 126.9 39.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.319 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -120.66 162.69 19.25 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.07 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.44 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -105.77 118.44 36.59 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.215 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.546 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.5 t -113.52 96.95 5.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.563 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.8 t30 59.87 24.7 13.75 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 111.482 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.94 24.32 7.33 Favored Glycine 0 C--O 1.226 -0.371 0 C-N-CA 120.401 -0.904 . . . . 0.0 113.998 177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.546 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -132.9 139.25 47.29 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.322 0.561 . . . . 0.0 110.978 178.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.752 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 53.8 mt -84.99 117.29 23.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.804 0.335 . . . . 0.0 110.509 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 47.3 t -122.78 122.47 65.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.224 -0.444 . . . . 0.0 109.818 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -79.84 143.85 34.0 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.936 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 7.1 tp60 . . . . . 0 C--O 1.249 1.074 0 O-C-N 123.722 0.639 . . . . 0.0 111.659 178.728 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.3 tpp . . . . . 0 N--CA 1.481 1.124 0 CA-C-O 120.678 0.275 . . . . 0.0 110.658 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -142.89 -172.44 3.66 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -62.96 -38.05 89.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.46 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.46 -25.85 38.98 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.156 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -54.61 -30.56 55.09 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 120.898 0.38 . . . . 0.0 111.053 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -136.64 33.09 2.72 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.417 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.461 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 69.4 m -120.22 156.45 31.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.022 0.439 . . . . 0.0 112.041 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.98 170.79 19.54 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.545 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 95.6 m-20 53.02 33.56 15.09 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 123.683 0.614 . . . . 0.0 111.352 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.598 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.45 114.14 13.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.168 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -139.95 157.02 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.551 -178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.81 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -94.34 134.54 36.72 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 121.044 0.449 . . . . 0.0 109.882 179.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.3 m -119.42 163.32 17.4 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.624 -0.717 . . . . 0.0 110.091 -178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.544 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 4.0 t30 70.27 9.61 7.05 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 123.712 0.632 . . . . 0.0 111.561 178.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.2 26.72 17.75 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.902 -0.665 . . . . 0.0 111.776 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.52 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.33 22.8 21.17 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.969 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.9 mtp180 -106.33 -18.0 14.12 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.845 0.355 . . . . 0.0 110.289 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.6 m -132.52 127.76 35.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.094 0.473 . . . . 0.0 111.436 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.444 ' HB2' HD21 ' A' ' 37' ' ' LEU . 55.5 tp -95.69 105.18 17.14 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.611 178.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.568 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -102.09 124.17 47.23 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.039 -179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.58 144.73 29.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.455 -0.338 . . . . 0.0 110.342 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.545 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.2 mt-10 -99.59 109.14 21.67 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.461 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 6.3 p -116.43 140.23 49.58 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.685 -178.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.514 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.3 143.38 40.89 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.987 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.451 ' HB3' HG21 ' A' ' 31' ' ' VAL . 23.9 p-10 -87.26 -176.45 5.66 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.363 -178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.94 -30.55 66.06 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.915 0.388 . . . . 0.0 111.533 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -73.68 -24.57 59.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.454 -179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.18 5.35 40.6 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.835 -179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.2 t-20 -89.01 144.77 25.92 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.432 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 48.5 m0 -77.65 121.1 23.51 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.978 0.418 . . . . 0.0 110.968 -179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.451 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.6 t -118.95 125.12 74.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.791 -179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.2 m -80.16 110.23 15.37 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 178.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.474 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.2 t -111.75 150.03 30.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.146 0.498 . . . . 0.0 110.555 -179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.568 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.2 mt-10 -134.93 131.56 37.4 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.383 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -128.9 116.24 19.11 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 39' ' ' THR . 12.8 m-20 -67.61 107.68 2.61 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-O 121.509 0.671 . . . . 0.0 110.368 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.81 HD11 HD11 ' A' ' 12' ' ' LEU . 38.0 mt -59.92 -42.5 94.05 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.453 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.523 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 2.4 p-10 -63.43 -5.67 3.95 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.8 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -105.66 -10.29 16.87 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.462 -0.495 . . . . 0.0 111.575 -179.727 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.508 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -142.78 10.36 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-O 121.243 0.544 . . . . 0.0 111.769 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -127.57 131.22 70.33 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 -179.669 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -126.68 159.14 20.91 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.071 -179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 12.2 t30 -111.06 112.55 24.44 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.223 0.535 . . . . 0.0 110.154 179.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -99.36 76.82 2.07 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.267 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 52.25 58.22 5.64 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.563 179.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.99 32.47 29.26 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.091 -1.052 . . . . 0.0 112.358 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 76.8 m-70 -149.44 122.06 8.6 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.458 -0.201 . . . . 0.0 110.458 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.9 m-85 -66.3 135.18 54.04 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.809 0.337 . . . . 0.0 110.837 178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -128.34 117.17 20.97 Favored 'General case' 0 N--CA 1.445 -0.718 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 83.3 m95 -71.34 115.51 10.58 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.734 178.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.33 33.27 5.74 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.107 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.468 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -103.95 -51.58 0.94 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.429 -0.891 . . . . 0.0 113.107 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HG3' ' HA ' ' A' ' 39' ' ' THR . 28.5 tt0 70.69 143.31 0.05 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.089 0.556 . . . . 0.0 110.689 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.663 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 11.7 m120 76.89 31.23 0.54 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.322 0.649 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.572 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.4 p90 -80.69 -29.7 36.47 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.246 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.648 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.1 p -65.64 -17.36 64.54 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.348 -0.387 . . . . 0.0 112.007 -179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.663 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 12.4 pt-20 -80.25 -15.55 56.72 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-O 121.148 0.499 . . . . 0.0 109.996 179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -124.6 14.66 8.77 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.883 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.23 150.1 49.7 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.682 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.768 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -141.03 172.81 12.17 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.486 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.405 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 1.1 t70 43.67 58.17 3.65 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 123.859 0.724 . . . . 0.0 111.129 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.46 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.4 mt -88.75 111.39 22.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.203 0.525 . . . . 0.0 112.139 -178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.487 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.55 123.21 39.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.069 179.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.68 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.2 t80 -92.88 134.6 34.93 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.14 -178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.431 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 8.1 t-160 -126.19 89.42 52.33 Favored Pre-proline 0 C--N 1.327 -0.398 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 177.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 65' ' ' HIS . 20.7 Cg_endo -62.42 -36.58 65.61 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 123.886 3.058 . . . . 0.0 114.144 -178.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.41 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.89 84.6 2.26 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.308 -179.752 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.431 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 8.8 tt0 -71.04 117.05 12.05 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.625 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.13 -147.45 21.6 Favored Glycine 0 C--N 1.334 0.456 0 O-C-N 123.9 0.75 . . . . 0.0 113.509 178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.88 -9.45 58.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.45 0.643 . . . . 0.0 109.557 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.19 -27.64 59.71 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.347 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 55.41 51.11 13.43 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.988 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 -104.17 124.31 37.84 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.459 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.456 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 53.0 Cg_endo -71.47 110.42 2.86 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 122.769 2.313 . . . . 0.0 112.833 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.752 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -135.42 141.36 42.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.516 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -114.13 127.91 56.13 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.369 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.752 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.01 141.8 51.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.107 0.479 . . . . 0.0 110.203 179.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.54 168.94 23.98 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.812 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.768 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.1 mmt85 -85.54 114.9 22.9 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -100.26 129.18 46.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.65 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.47 137.13 40.73 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.963 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.671 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 1.1 m-20 -91.17 174.45 7.39 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.331 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 35.4 t -64.66 -25.1 67.8 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.037 0.446 . . . . 0.0 110.615 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -73.58 -18.87 61.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.823 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.98 41.77 3.97 Favored Glycine 0 N--CA 1.45 -0.4 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.687 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 15.4 pt-20 -123.37 -162.63 1.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -140.57 132.99 28.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.863 0.839 . . . . 0.0 111.547 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 12.6 m-70 -137.8 112.95 9.19 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.385 -1.279 . . . . 0.0 110.211 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.623 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.5 p-10 -64.02 116.08 5.53 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.291 0.567 . . . . 0.0 111.311 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.585 ' HB2' HD22 ' A' ' 80' ' ' LEU . 36.4 mmt180 -115.84 174.54 5.97 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -141.46 142.97 33.62 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.6 p -130.33 148.33 33.15 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-O 121.354 0.597 . . . . 0.0 111.444 -178.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.571 ' HB3' HD22 ' A' ' 95' ' ' ASN . 12.6 m120 -83.45 110.59 18.31 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.04 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.68 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.99 1.18 32.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.562 -179.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.571 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.6 m-80 -60.73 -17.29 47.6 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.0 0.429 . . . . 0.0 110.486 178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.15 -24.04 66.94 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.256 0.55 . . . . 0.0 110.351 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -81.75 132.86 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.361 -0.836 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -124.29 167.36 14.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.32 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.0 t30 -113.05 123.42 50.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.097 -179.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.557 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 39.2 t -114.07 93.78 2.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.608 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.7 t30 56.97 27.69 13.59 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.827 179.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.34 19.27 8.06 Favored Glycine 0 C--N 1.32 -0.353 0 C-N-CA 120.293 -0.956 . . . . 0.0 114.133 178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.584 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 6.6 ptp180 -130.55 141.79 50.47 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 117.388 0.594 . . . . 0.0 111.116 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.474 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.3 mp -90.58 124.02 34.7 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.621 178.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.1 p -132.56 128.24 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.61 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.5 p90 -84.98 145.49 27.7 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.491 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.888 -0.577 . . . . 0.0 111.743 178.47 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.603 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 7.5 ptt? . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 111.578 0.214 . . . . 0.0 111.578 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.5 m -104.99 -165.74 1.16 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -58.2 -37.38 74.67 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 178.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -58.67 -19.29 38.16 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.511 -0.768 . . . . 0.0 112.081 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.603 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 5.7 t70 -55.88 -38.35 70.05 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-O 121.443 0.64 . . . . 0.0 109.945 178.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.476 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 61.0 m -130.01 33.83 4.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.517 -179.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.0 m -120.02 155.23 33.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.07 0.462 . . . . 0.0 111.798 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.0 ptp180 -151.78 170.77 18.95 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.118 -1.067 . . . . 0.0 108.118 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.499 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 68.5 m-20 54.18 32.52 16.12 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.14 0.495 . . . . 0.0 110.906 -179.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.33 113.36 12.62 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.961 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.3 t -139.98 155.29 24.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.555 -178.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -92.15 138.05 31.85 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 178.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.478 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.9 m -123.91 163.59 20.99 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.128 -178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.552 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 71.0 6.53 5.9 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 123.665 0.603 . . . . 0.0 111.666 178.04 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.38 23.63 14.0 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.091 -0.804 . . . . 0.0 111.091 -179.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.543 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.36 17.77 28.19 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.727 -0.749 . . . . 0.0 111.812 -179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.702 ' HG2' HG21 ' A' ' 56' ' ' THR . 29.8 mtp180 -100.07 -18.11 17.14 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.592 0.234 . . . . 0.0 110.922 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 29.8 m -131.39 124.76 30.99 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.075 0.464 . . . . 0.0 111.52 -179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.505 ' CD2' HD13 ' A' ' 97' ' ' ILE . 60.4 tp -92.77 104.95 17.16 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 177.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.489 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.8 tmm_? -101.78 125.46 48.45 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.091 -179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.37 144.47 25.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.762 0.315 . . . . 0.0 110.492 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 6.8 mt-10 -98.6 108.84 21.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 7.7 p -115.87 141.25 48.34 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.584 -178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.591 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.12 141.09 42.04 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 178.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.492 ' HB3' HG21 ' A' ' 31' ' ' VAL . 29.0 p-10 -86.87 -175.33 5.34 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.311 -179.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.8 -30.09 68.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.103 0.478 . . . . 0.0 110.977 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.74 -23.87 61.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.067 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.11 8.58 44.28 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.262 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.591 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.5 t-20 -93.72 147.25 23.21 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.953 -0.388 . . . . 0.0 109.953 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 48.7 m0 -77.61 117.87 19.45 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.092 0.472 . . . . 0.0 110.508 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 25' ' ' ASN . 9.8 t -113.25 122.95 68.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.643 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.2 m -78.58 105.22 9.71 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 108.949 -0.759 . . . . 0.0 108.949 178.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 5.2 m -111.1 154.04 24.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.2 mt-10 -139.57 132.47 29.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.143 -179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -126.42 114.88 18.77 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.573 ' O ' HG22 ' A' ' 39' ' ' THR . 21.3 m-20 -65.4 107.34 1.62 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.104 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 12' ' ' LEU . 85.6 mt -60.32 -45.59 92.85 Favored 'General case' 0 CA--C 1.499 -1.001 0 CA-C-O 121.652 0.739 . . . . 0.0 110.121 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -62.62 -5.23 2.48 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.79 -179.542 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.573 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.07 -13.15 18.33 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.036 179.933 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.523 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -142.95 12.9 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.984 0.421 . . . . 0.0 111.923 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.64 131.45 70.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -125.85 156.85 19.67 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.442 -178.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.467 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.2 t30 -111.58 107.19 16.26 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -93.52 82.16 4.39 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 5.2 p-10 40.6 51.98 3.02 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.319 1.012 . . . . 0.0 113.329 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 99.44 35.08 4.81 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.145 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.4 t-160 -163.2 122.07 2.08 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.774 0.287 . . . . 0.0 110.628 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 47.1 m-85 -65.17 141.09 58.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.172 0.51 . . . . 0.0 111.325 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -131.21 117.87 19.63 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.411 179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -73.01 114.44 11.18 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.77 29.3 6.99 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.67 -179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.485 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.86 -53.76 1.09 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.978 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 31.5 tt0 73.07 143.89 0.07 Allowed 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.387 0.675 . . . . 0.0 111.474 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 83.6 m-20 74.25 29.03 1.32 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.383 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -75.75 -33.44 60.23 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.517 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.702 HG21 ' HG2' ' A' ' 17' ' ' ARG . 22.6 p -61.71 -30.38 70.72 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.969 -178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.549 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.8 pt-20 -68.3 -13.58 62.37 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.837 0.351 . . . . 0.0 110.459 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.549 HG23 ' HG3' ' A' ' 57' ' ' GLU . 76.6 p -126.22 13.63 7.75 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-O 121.48 0.657 . . . . 0.0 109.924 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.51 146.11 50.92 Favored 'General case' 0 N--CA 1.445 -0.701 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.625 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -136.91 172.86 12.39 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.637 -179.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.462 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 0.5 OUTLIER 46.79 52.39 11.44 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 123.828 0.705 . . . . 0.0 110.473 179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.443 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.62 112.01 21.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.034 0.445 . . . . 0.0 111.659 -178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -124.48 124.61 42.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.548 178.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.704 ' CE1' HD12 ' A' ' 94' ' ' LEU . 21.5 t80 -92.37 136.66 33.02 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.363 -178.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.703 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.9 t-160 -122.72 85.65 49.48 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 178.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 18.7 Cg_endo -62.32 -43.7 21.97 Favored 'Trans proline' 0 CA--C 1.511 -0.663 0 C-N-CA 123.228 2.619 . . . . 0.0 113.671 -178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.45 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -118.65 82.42 1.85 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.729 179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.703 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 2.4 tt0 -66.85 113.69 5.11 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.521 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.21 -142.43 10.15 Favored Glycine 0 C--N 1.335 0.525 0 O-C-N 124.407 1.067 . . . . 0.0 113.374 178.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.77 -9.75 59.2 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 120.982 0.42 . . . . 0.0 109.918 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.74 -26.33 57.36 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.986 -0.552 . . . . 0.0 109.795 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 54.16 46.52 25.16 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.469 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.7 tp60 -107.27 124.1 36.21 Favored Pre-proline 0 C--N 1.323 -0.547 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.52 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.412 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.58 109.83 2.73 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.662 2.241 . . . . 0.0 112.369 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.471 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -133.51 141.58 43.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.488 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.1 tm? -114.29 125.79 54.29 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.176 -179.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.488 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.21 141.39 51.52 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.87 178.753 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.55 167.53 26.95 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.042 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.2 mmt180 -85.16 114.59 22.39 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.69 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -98.22 121.56 40.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.149 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -77.68 142.18 38.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.923 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.589 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.7 p-10 -96.69 178.8 5.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.222 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 12.5 t -63.15 -21.91 66.51 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.812 0.301 . . . . 0.0 111.812 -178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -79.48 -28.19 41.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.128 0.489 . . . . 0.0 110.77 -179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.58 32.41 2.94 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.026 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.63 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.8 pt-20 -104.25 -166.12 1.22 Allowed 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -143.28 128.92 19.21 Favored 'General case' 0 C--N 1.312 -1.042 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.04 111.63 8.68 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.224 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.635 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.4 p-10 -65.65 120.29 12.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.942 0.877 . . . . 0.0 112.445 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.69 ' HB2' HD22 ' A' ' 80' ' ' LEU . 36.3 mmt180 -115.94 174.88 5.8 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 114.504 -1.226 . . . . 0.0 108.979 178.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -139.42 150.62 45.47 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -140.54 144.66 26.97 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.085 0 CA-C-O 121.391 0.615 . . . . 0.0 110.912 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.568 ' HB3' HD22 ' A' ' 95' ' ' ASN . 38.0 m-80 -80.87 109.0 15.02 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.515 -179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.704 HD12 ' CE1' ' A' ' 64' ' ' PHE . 3.8 mt -79.01 1.12 25.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.453 -179.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.568 HD22 ' HB3' ' A' ' 93' ' ' ASN . 15.6 m-80 -60.8 -16.63 42.81 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.994 0.426 . . . . 0.0 110.273 178.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -23.52 67.42 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.941 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -82.22 125.61 39.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.637 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.427 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 51.2 mt-30 -117.0 163.34 16.37 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.219 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -108.65 117.66 34.77 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.259 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.533 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 48.5 t -113.11 94.22 3.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.48 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 57.75 27.32 14.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.598 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 103.98 23.69 8.04 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.326 -0.94 . . . . 0.0 113.485 178.087 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -131.61 134.48 46.06 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 117.079 0.439 . . . . 0.0 110.38 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.8 mp -85.92 124.36 32.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.344 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.3 p -137.1 131.62 46.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.593 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -82.52 145.91 29.51 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.274 -0.421 . . . . 0.0 109.978 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.6 tp-100 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.639 -0.696 . . . . 0.0 110.196 -179.82 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.4 tpp . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.837 0.351 . . . . 0.0 110.777 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 41.9 m -153.97 -164.49 1.88 Allowed 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -55.93 -37.26 68.71 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 120.941 0.401 . . . . 0.0 110.147 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.498 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.16 -24.55 41.99 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 115.758 -0.656 . . . . 0.0 112.635 -179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -56.19 -33.35 65.2 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.006 0.432 . . . . 0.0 110.926 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.405 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 50.4 m -132.38 33.24 3.85 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.167 -179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.527 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 71.8 m -119.38 156.6 29.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.008 0.433 . . . . 0.0 111.699 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.3 ptp180 -153.09 169.94 21.7 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.431 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.0 m120 52.92 33.88 15.5 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 123.686 0.617 . . . . 0.0 111.176 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.77 113.38 16.8 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.749 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 19.7 t -143.44 156.3 16.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.836 HD11 HD11 ' A' ' 37' ' ' LEU . 0.8 OUTLIER -91.39 141.61 28.57 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.134 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 7.9 m -125.39 165.05 19.09 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -179.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.2 t-20 71.1 8.85 6.58 Favored 'General case' 0 N--CA 1.463 0.194 0 O-C-N 123.623 0.577 . . . . 0.0 111.657 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.02 26.3 16.89 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.127 -0.789 . . . . 0.0 111.127 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.5 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.05 27.09 11.35 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.054 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.719 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.7 mtp180 -111.37 -17.09 13.21 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.704 0.288 . . . . 0.0 110.497 -179.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.528 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 40.4 m -128.76 126.44 39.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.106 0.479 . . . . 0.0 111.599 -178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.516 ' CD2' HD13 ' A' ' 97' ' ' ILE . 39.6 tp -94.97 107.54 19.57 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.578 177.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.405 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -107.62 124.83 50.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.26 -179.649 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.46 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -150.72 148.48 28.61 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.671 0.272 . . . . 0.0 111.12 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.9 mt-10 -103.67 109.47 21.17 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 4.1 p -118.59 148.17 42.96 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.988 -178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -79.86 141.99 35.64 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.461 ' HB3' HG11 ' A' ' 31' ' ' VAL . 34.3 p30 -89.46 -175.03 4.58 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.602 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.46 -28.86 69.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.001 0.429 . . . . 0.0 111.04 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.04 -24.57 63.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.942 179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 103.09 5.84 46.28 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.571 -179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.7 m-80 -95.18 149.28 21.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 122.424 0.29 . . . . 0.0 111.069 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.507 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 54.3 m0 -81.4 110.43 16.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.121 0.486 . . . . 0.0 109.922 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.461 HG11 ' HB3' ' A' ' 25' ' ' ASN . 1.0 OUTLIER -112.17 121.81 65.27 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.048 -179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -74.78 114.71 13.53 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.129 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.822 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.0 t -112.87 149.94 32.43 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -136.11 131.68 35.09 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.14 -179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.484 HD11 HG12 ' A' ' 40' ' ' ILE . 15.8 tp -129.05 118.75 23.05 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.0 0.429 . . . . 0.0 110.611 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 39' ' ' THR . 2.9 m-20 -68.07 110.02 3.76 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.755 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.836 HD11 HD11 ' A' ' 12' ' ' LEU . 23.8 mt -62.06 -39.16 91.43 Favored 'General case' 0 CA--C 1.5 -0.974 0 CA-C-O 121.491 0.662 . . . . 0.0 109.604 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.538 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -63.53 -6.12 4.72 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.193 -0.912 . . . . 0.0 110.227 178.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.505 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -101.89 -15.2 16.94 Favored 'General case' 0 C--N 1.324 -0.509 0 C-N-CA 120.214 -0.594 . . . . 0.0 111.243 -179.533 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.505 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.36 10.8 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -127.25 129.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.06 158.32 21.46 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.367 -0.92 . . . . 0.0 112.11 -179.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.429 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.0 t30 -110.89 114.17 27.29 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 63.5 t30 -107.18 82.35 1.66 Allowed 'General case' 0 C--N 1.315 -0.915 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.288 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 41.6 m-20 53.29 65.1 1.61 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 114.978 -1.01 . . . . 0.0 112.247 178.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.86 34.72 62.13 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.816 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -156.26 120.36 4.46 Favored 'General case' 0 C--N 1.322 -0.61 0 O-C-N 122.629 -0.336 . . . . 0.0 110.182 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.535 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 46.6 m-85 -62.08 142.98 57.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.148 0.499 . . . . 0.0 111.198 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 30.3 tt0 -132.13 117.07 17.82 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.461 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -74.08 114.05 11.96 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.55 31.44 6.1 Favored Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.581 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.563 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.39 -51.17 1.15 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.756 -0.735 . . . . 0.0 113.084 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.538 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 25.8 tt0 73.26 143.09 0.07 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.188 0.595 . . . . 0.0 112.063 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 48.4 t30 68.78 31.78 4.32 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.694 179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.516 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.0 p90 -72.31 -27.96 62.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.013 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.719 HG21 ' HG2' ' A' ' 17' ' ' ARG . 20.1 p -63.81 -19.6 65.14 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.485 -0.779 . . . . 0.0 112.111 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.678 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -74.58 -16.15 60.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.134 0.493 . . . . 0.0 110.371 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.678 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -126.83 14.08 7.42 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.118 -179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.75 143.91 51.1 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.856 -179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.77 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.62 173.96 11.1 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.338 179.295 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.561 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 17.6 t0 48.17 50.61 16.0 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.234 0.54 . . . . 0.0 110.315 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.6 mt -85.75 108.97 17.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.773 0 CA-C-O 121.049 0.452 . . . . 0.0 111.738 -178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' HE ' ' C ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -125.46 123.95 40.34 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.047 178.851 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 94' ' ' LEU . 4.5 t80 -91.28 130.61 37.13 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.927 -178.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.413 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 2.0 t60 -121.11 85.46 41.25 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.538 178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 65' ' ' HIS . 9.2 Cg_endo -56.3 -36.37 96.89 Favored 'Trans proline' 0 CA--C 1.511 -0.648 0 C-N-CA 123.933 3.088 . . . . 0.0 114.677 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.87 80.57 1.56 Allowed 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.264 -179.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -66.15 114.46 5.28 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.577 0.227 . . . . 0.0 111.321 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.22 -144.16 14.37 Favored Glycine 0 C--N 1.334 0.422 0 O-C-N 124.148 0.905 . . . . 0.0 113.76 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.4 -10.04 58.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.236 0.541 . . . . 0.0 109.811 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.22 -25.09 57.88 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.841 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 54.54 44.01 29.39 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 114.772 -1.103 . . . . 0.0 110.796 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -102.44 124.38 39.63 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.401 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.534 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 41.7 Cg_endo -68.07 112.1 2.64 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.681 2.254 . . . . 0.0 112.248 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.462 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -134.12 141.5 43.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 178.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.502 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -112.75 124.21 52.06 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.303 -179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.502 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.05 140.73 50.56 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.958 0.408 . . . . 0.0 109.961 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -160.0 169.83 22.6 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.839 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.77 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.4 mmt85 -86.34 115.59 23.96 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.646 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.9 mp -101.5 128.8 47.58 Favored 'General case' 0 C--N 1.318 -0.797 0 O-C-N 123.463 0.477 . . . . 0.0 111.074 -179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.742 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -78.8 138.6 38.27 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.244 179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.463 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 10.2 m-20 -95.16 169.16 10.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.62 179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.5 t -59.63 -25.04 64.33 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.91 0.386 . . . . 0.0 111.37 -179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -71.77 -20.89 61.81 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.062 0.458 . . . . 0.0 110.441 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 97.55 38.27 4.26 Favored Glycine 0 CA--C 1.505 -0.582 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.81 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.742 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.9 pt-20 -122.44 -172.42 2.47 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 -179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.436 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 90.5 m-85 -134.5 138.59 44.81 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.761 0.791 . . . . 0.0 111.575 -178.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -139.64 118.12 12.17 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.649 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.505 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.4 p-10 -65.02 112.37 3.3 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.344 0.592 . . . . 0.0 111.283 -179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.646 ' HB2' HD22 ' A' ' 80' ' ' LEU . 28.2 mmt180 -115.41 174.56 5.94 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -141.9 152.44 43.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.535 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.2 p -138.67 144.32 30.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.304 0.573 . . . . 0.0 110.2 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HB3' HD22 ' A' ' 95' ' ' ASN . 6.4 m-20 -82.62 110.37 17.63 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.133 -0.94 . . . . 0.0 110.672 -179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.647 ' HB3' HD12 ' A' ' 97' ' ' ILE . 8.5 mt -79.49 3.05 19.82 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.308 -179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' ' 93' ' ' ASN . 32.5 m-80 -62.19 -14.07 34.0 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.199 0.523 . . . . 0.0 109.819 177.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.08 -21.21 66.35 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.186 178.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.647 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.3 mt -83.6 127.94 39.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-O 121.413 0.625 . . . . 0.0 111.505 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -121.45 160.91 23.17 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.252 -0.886 . . . . 0.0 109.125 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -108.43 120.73 43.26 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.071 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.521 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 48.3 t -113.72 94.38 3.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.001 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 59.48 23.48 12.1 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.023 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.451 ' CA ' HG11 ' A' ' 31' ' ' VAL . . . 114.15 14.34 9.23 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 119.287 -1.435 . . . . 0.0 113.695 178.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.521 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 19.8 ptp180 -130.18 135.57 48.31 Favored 'General case' 0 C--N 1.321 -0.672 0 O-C-N 122.425 -0.456 . . . . 0.0 111.161 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.822 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.8 mt -87.84 125.45 34.47 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.101 178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 12.3 p -137.99 136.37 45.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.971 0.415 . . . . 0.0 110.652 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -85.83 145.73 27.08 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.117 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.481 -0.771 . . . . 0.0 110.091 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.7 tpt . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 120.58 0.228 . . . . 0.0 110.541 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.6 m -157.15 174.39 15.55 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.8 p90 -58.11 -39.17 77.99 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.015 0.436 . . . . 0.0 110.157 178.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.568 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.55 -27.31 37.7 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.942 -178.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -56.13 -31.37 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.974 0.416 . . . . 0.0 110.809 179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.6 m -130.16 31.0 4.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.045 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.568 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 73.4 m -116.83 156.8 26.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.455 0.645 . . . . 0.0 112.204 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.1 ptp180 -152.33 170.87 19.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.732 -1.122 . . . . 0.0 108.084 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.577 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 7.9 t-20 56.11 30.4 16.32 Favored 'General case' 0 C--O 1.237 0.419 0 O-C-N 123.624 0.578 . . . . 0.0 110.266 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.512 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -76.98 113.04 14.24 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.48 -179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.7 t -145.64 147.13 18.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.648 -179.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.607 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.5 tp -84.46 140.82 31.23 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.404 HG22 ' N ' ' A' ' 14' ' ' ASN . 10.8 m -126.26 163.24 23.62 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.025 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.437 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.1 t-20 72.05 8.97 6.03 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.619 0.574 . . . . 0.0 111.607 178.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.6 23.25 24.21 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.495 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 97.49 24.92 11.47 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.101 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.618 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.2 mtp180 -107.59 -18.15 13.92 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.864 0.364 . . . . 0.0 110.288 -179.198 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 62.2 m -130.1 128.51 42.02 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.358 -179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' HB2' HD21 ' A' ' 37' ' ' LEU . 49.5 tp -97.32 108.65 21.42 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.648 178.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 6.2 tmm_? -105.42 123.98 48.79 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.309 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.85 147.08 26.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.525 179.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.577 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -106.09 110.05 22.18 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.504 ' HB2' ' OG ' ' A' ' 7' ' ' SER . 41.8 t -121.69 145.6 47.85 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.025 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.605 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.87 144.01 52.64 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.277 179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.542 ' HB3' HG21 ' A' ' 31' ' ' VAL . 22.6 p-10 -88.13 -167.52 1.91 Allowed 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.952 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.74 -27.24 68.58 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.599 179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.34 -23.56 35.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.091 0.472 . . . . 0.0 111.209 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.68 0.59 32.4 Favored Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.888 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.605 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 56.5 t30 -83.53 143.01 30.47 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.2 m0 -75.41 119.85 20.06 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.134 0.492 . . . . 0.0 110.497 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.1 t -117.92 124.42 73.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.317 -179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.427 HG23 ' HG2' ' A' ' 22' ' ' GLU . 7.8 m -77.18 107.15 9.36 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.431 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.09 141.32 44.74 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.243 0.544 . . . . 0.0 111.088 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.0 mt-10 -130.14 131.01 45.5 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.664 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.579 HD11 HG12 ' A' ' 40' ' ' ILE . 15.2 tp -125.15 120.35 31.12 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.668 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.619 ' O ' HG22 ' A' ' 39' ' ' THR . 53.6 m-20 -68.61 107.77 3.09 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.369 178.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.553 HD11 HD11 ' A' ' 12' ' ' LEU . 37.8 mt -60.36 -39.79 88.45 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.873 0.844 . . . . 0.0 109.621 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.5 p-10 -63.35 -5.04 3.06 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.469 -1.241 . . . . 0.0 110.758 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.619 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -107.63 -9.16 15.93 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.786 -179.338 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.579 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -142.62 10.05 0.39 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.295 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.525 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -127.91 132.4 68.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.7 158.18 22.11 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.426 -179.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.4 t30 -112.02 114.2 26.94 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.777 0.322 . . . . 0.0 110.214 179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -105.5 82.94 1.88 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.545 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.54 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 5.3 m-20 54.04 52.8 12.15 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.908 179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.617 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.54 35.69 22.06 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 120.082 -1.056 . . . . 0.0 111.974 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 69.8 m80 -148.53 118.05 6.98 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.7 m-85 -63.97 134.99 56.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.165 0.507 . . . . 0.0 110.571 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -126.58 116.51 21.16 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.456 -179.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -72.88 114.13 10.68 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.47 30.47 6.21 Favored Glycine 0 N--CA 1.447 -0.581 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.923 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.58 -50.44 1.2 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.895 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.672 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 23.4 tt0 70.68 144.97 0.06 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 123.127 0.571 . . . . 0.0 111.345 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.559 ' HB3' ' OE1' ' A' ' 57' ' ' GLU . 6.3 m-20 71.08 33.65 2.01 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.452 -0.794 . . . . 0.0 111.343 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.525 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.91 -27.46 39.91 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.306 -0.407 . . . . 0.0 109.933 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.618 HG21 ' HG2' ' A' ' 17' ' ' ARG . 18.9 p -65.72 -17.29 64.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.977 -178.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.6 ' HG3' HG23 ' A' ' 58' ' ' THR . 7.9 pt-20 -76.8 -18.19 58.57 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.072 0.463 . . . . 0.0 109.852 179.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.6 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.2 p -123.31 9.79 9.19 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.473 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -118.85 144.05 46.59 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.24 -179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -136.02 166.93 22.2 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.095 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 45.74 55.86 6.45 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.07 0.462 . . . . 0.0 110.763 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.584 HG22 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -83.18 106.61 14.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-O 121.308 0.575 . . . . 0.0 110.806 -178.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.55 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -109.86 118.43 36.46 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.174 -179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.607 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.1 t80 -93.1 128.59 39.07 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.065 0.459 . . . . 0.0 111.103 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.525 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 39.7 t60 -124.38 88.77 52.8 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.151 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 19.7 Cg_endo -59.99 -35.94 91.47 Favored 'Trans proline' 0 CA--C 1.51 -0.695 0 C-N-CA 124.156 3.237 . . . . 0.0 115.163 -177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -127.07 90.25 3.12 Favored 'General case' 0 C--N 1.292 -1.894 0 CA-C-N 115.261 -0.882 . . . . 0.0 112.587 -178.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 17.5 tt0 -69.97 109.54 4.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.52 177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 57.36 -148.77 33.12 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.165 179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.67 -1.05 53.17 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.377 0.608 . . . . 0.0 109.797 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -85.45 -20.08 30.32 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.584 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 54.87 43.17 30.4 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.706 -179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 68' ' ' GLU . 15.6 mm100 -90.5 114.48 61.3 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.32 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.492 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 60.2 Cg_endo -72.87 112.36 3.49 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.154 1.903 . . . . 0.0 112.21 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.459 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -132.14 141.72 44.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.584 HD21 HG22 ' A' ' 62' ' ' ILE . 1.8 tm? -114.93 122.57 46.69 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.061 -179.568 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.55 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.93 140.42 50.02 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.345 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -156.63 166.67 32.73 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.298 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.2 mmt180 -85.58 114.75 22.82 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.617 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.4 mp -99.35 127.75 45.4 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.199 0.523 . . . . 0.0 111.164 -178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.38 142.84 29.86 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.873 -179.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.64 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -99.62 172.94 6.97 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.127 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 41.9 t -57.13 -27.65 62.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.406 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 23.9 t-20 -75.77 -28.19 58.32 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.691 -0.403 . . . . 0.0 110.707 -179.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 111.03 37.08 1.73 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.608 -0.805 . . . . 0.0 113.63 178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.64 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 9.6 pt-20 -105.98 -167.36 1.3 Allowed 'General case' 0 C--O 1.22 -0.483 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -145.9 129.38 16.92 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.47 117.98 12.17 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.971 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.7 p-10 -66.61 114.01 5.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.418 0.628 . . . . 0.0 111.706 -178.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.575 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.6 mmt180 -115.78 172.21 7.28 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 177.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -138.69 146.45 41.58 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.0 p -128.2 150.64 34.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.047 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.74 -178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.503 ' HB3' HD22 ' A' ' 95' ' ' ASN . 78.2 m-20 -87.07 103.98 15.9 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.892 -179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' HB3' HD12 ' A' ' 97' ' ' ILE . 7.9 mt -75.43 0.53 16.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.785 0.326 . . . . 0.0 110.81 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.503 HD22 ' HB3' ' A' ' 93' ' ' ASN . 26.0 m-80 -60.9 -19.94 61.21 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.015 -0.539 . . . . 0.0 109.7 178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.422 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -65.73 -22.01 66.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.783 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.6 mt -82.95 128.39 38.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.184 0.516 . . . . 0.0 111.267 -179.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -119.1 168.29 10.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.81 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.457 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -112.59 121.05 43.66 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.879 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.499 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.5 t -112.25 94.47 3.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.401 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.0 t30 59.89 24.73 13.8 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.503 -0.772 . . . . 0.0 111.556 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.78 20.58 8.37 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.172 -1.013 . . . . 0.0 113.699 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.499 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 18.5 ptp180 -129.8 139.98 51.14 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 117.152 0.476 . . . . 0.0 110.037 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.431 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 76.0 mt -87.08 124.05 32.82 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.795 0.331 . . . . 0.0 110.992 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.6 p -127.98 128.78 69.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.074 0.464 . . . . 0.0 110.578 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -84.12 146.73 27.73 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.551 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 . . . . . 0 C--O 1.247 0.956 0 O-C-N 123.947 0.78 . . . . 0.0 111.266 178.492 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 tpt . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 120.869 0.366 . . . . 0.0 110.6 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -162.74 -175.27 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 16.4 p90 -59.45 -34.32 72.37 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 121.306 0.574 . . . . 0.0 109.615 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.763 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -55.3 -25.47 34.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.196 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -53.84 -33.07 55.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.037 179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 m -137.14 37.39 2.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.987 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.763 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.3 p -115.28 157.26 24.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.066 0.46 . . . . 0.0 111.466 -179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.557 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 1.1 ptp180 -147.91 169.73 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.183 -1.044 . . . . 0.0 108.183 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.478 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 25.6 m-80 50.45 34.44 9.29 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.748 0.655 . . . . 0.0 111.316 -179.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -85.74 112.42 21.04 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.171 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.39 178.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.538 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.306 178.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.9 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.15 146.54 28.6 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.806 179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 24.0 m -132.12 161.5 33.14 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.403 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.471 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.4 t-20 74.04 9.48 4.64 Favored 'General case' 0 N--CA 1.465 0.301 0 O-C-N 123.692 0.62 . . . . 0.0 111.178 178.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.74 24.85 22.22 Favored Glycine 0 CA--C 1.506 -0.504 0 C-N-CA 120.887 -0.673 . . . . 0.0 111.711 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.527 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 97.07 23.16 15.49 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.733 -0.746 . . . . 0.0 111.98 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.68 ' HG2' HG21 ' A' ' 56' ' ' THR . 31.0 mtp180 -107.99 -17.07 14.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.588 0.232 . . . . 0.0 110.525 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.6 m -129.99 127.95 41.05 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.789 0.328 . . . . 0.0 111.585 -179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 57.6 tp -97.69 107.39 19.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.898 178.18 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.8 tmm_? -104.54 124.64 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.079 -179.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.43 151.28 32.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.735 0.302 . . . . 0.0 110.63 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.771 ' HG2' HG23 ' A' ' 32' ' ' THR . 13.8 mt-10 -113.06 110.96 21.33 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.314 -0.254 . . . . 0.0 110.314 179.628 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 48.1 t -123.17 147.5 46.78 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.99 0.424 . . . . 0.0 110.728 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.508 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.77 143.68 43.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.922 179.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.535 ' HB3' HG21 ' A' ' 31' ' ' VAL . 26.5 p-10 -91.31 -175.09 4.14 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.809 -178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.01 -32.37 69.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.071 0.462 . . . . 0.0 111.463 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -69.76 -24.85 63.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.828 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 102.75 10.38 37.86 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.983 -0.627 . . . . 0.0 111.648 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 9.6 t-20 -96.13 146.79 24.37 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.454 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.8 m0 -77.07 121.43 23.55 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.535 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -120.5 120.89 64.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.724 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.771 HG23 ' HG2' ' A' ' 22' ' ' GLU . 11.2 m -81.73 109.47 16.17 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.5 p -113.26 150.74 32.0 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.137 0.494 . . . . 0.0 111.585 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.0 mt-10 -132.7 135.03 45.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.917 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.71 116.24 18.51 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.546 ' O ' HG22 ' A' ' 39' ' ' THR . 16.0 m-20 -68.32 109.81 3.8 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.526 0.679 . . . . 0.0 110.196 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.9 HD11 HD11 ' A' ' 12' ' ' LEU . 15.9 mt -61.42 -41.02 96.5 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.902 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.531 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -65.02 -4.91 5.19 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.192 179.301 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.546 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -104.66 -14.15 15.7 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.455 -179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.517 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -141.28 10.53 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.532 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.13 132.09 70.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 O-C-N 122.216 -0.303 . . . . 0.0 110.23 -179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.87 159.74 22.24 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.619 -0.801 . . . . 0.0 112.256 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.408 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.8 t30 -111.51 116.65 31.23 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.062 0.458 . . . . 0.0 110.198 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.29 85.15 2.31 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 40.66 59.41 2.16 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 124.143 0.977 . . . . 0.0 112.943 -179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.523 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 86.43 38.6 8.2 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.997 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.416 ' N ' HD23 ' A' ' 80' ' ' LEU . 50.6 t-80 -162.11 124.23 2.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.472 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 56.1 m-85 -67.07 138.81 57.42 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.109 0.48 . . . . 0.0 110.633 179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.43 HE21 ' HB2' ' A' ' 49' ' ' GLN . 2.4 tt0 -130.1 116.94 19.21 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.607 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.4 ' HH2' HD22 ' A' ' 94' ' ' LEU . 91.9 m95 -69.42 115.64 8.92 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.642 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.49 30.13 6.35 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.617 -0.719 . . . . 0.0 112.199 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -100.5 -53.59 1.05 Allowed Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.071 -179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.5 tt0 73.55 139.0 0.06 Allowed 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.377 0.608 . . . . 0.0 111.738 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 52.1 t30 70.35 36.69 1.72 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.133 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.532 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.1 p90 -76.1 -26.93 56.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.041 179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.68 HG21 ' HG2' ' A' ' 17' ' ' ARG . 36.3 p -63.66 -24.31 67.73 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.519 -178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.49 ' HG3' HG23 ' A' ' 58' ' ' THR . 1.7 pt-20 -70.24 -17.1 63.11 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.919 0.39 . . . . 0.0 110.269 179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.49 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.7 p -125.78 16.0 8.06 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.503 0.668 . . . . 0.0 109.984 -179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.94 150.1 52.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.869 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.636 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -143.4 172.5 12.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.479 -179.636 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.421 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.3 t70 48.22 57.22 6.37 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 121.082 0.467 . . . . 0.0 110.012 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.413 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -91.93 113.86 28.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.498 -177.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.421 ' HG2' ' HD3' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -132.69 129.67 39.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.729 178.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CE1' HD12 ' A' ' 94' ' ' LEU . 17.5 t80 -92.29 139.63 30.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.16 0.505 . . . . 0.0 112.223 -177.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.523 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 5.5 t-160 -120.38 82.06 31.33 Favored Pre-proline 0 CA--C 1.536 0.414 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.75 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.808 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.8 Cg_endo -55.88 -45.84 35.81 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 123.908 3.072 . . . . 0.0 114.539 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.808 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -124.52 85.31 2.4 Favored 'General case' 0 C--N 1.293 -1.879 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.107 179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.523 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 5.1 tt0 -69.73 114.3 7.8 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.165 -0.925 . . . . 0.0 112.613 -178.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.35 -145.41 6.09 Favored Glycine 0 C--N 1.338 0.672 0 O-C-N 124.596 1.185 . . . . 0.0 113.528 178.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.33 -5.81 58.84 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.62 -23.59 56.39 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.32 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 54.57 45.78 26.19 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.216 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -112.22 122.57 36.37 Favored Pre-proline 0 C--N 1.325 -0.473 0 C-N-CA 120.205 -0.598 . . . . 0.0 111.69 -178.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.512 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.4 Cg_endo -72.5 110.85 3.08 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 122.476 2.118 . . . . 0.0 111.533 178.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.447 HD13 ' HB2' ' A' ' 91' ' ' ASP . 1.0 OUTLIER -134.73 141.97 41.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 179.47 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.541 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.57 124.73 53.06 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.918 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.541 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.06 144.36 48.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.496 . . . . 0.0 110.498 179.409 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.04 170.55 19.04 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.87 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.636 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -85.48 114.86 22.83 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.9 mp -100.15 126.37 46.39 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.893 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.692 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -73.6 136.29 43.92 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.261 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -95.08 173.18 7.7 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.185 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 76.6 m -62.54 -21.55 65.63 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.989 0.423 . . . . 0.0 110.729 179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -71.68 -19.97 62.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.611 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 91.27 37.95 6.1 Favored Glycine 0 CA--C 1.504 -0.639 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.692 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.8 pt-20 -124.32 -162.92 1.11 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -138.36 139.28 38.94 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.769 0.795 . . . . 0.0 111.257 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 -138.7 111.64 7.83 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.327 -1.306 . . . . 0.0 110.281 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.568 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 1.2 p-10 -63.4 111.92 2.51 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.692 0.758 . . . . 0.0 111.777 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.662 ' HB2' HD22 ' A' ' 80' ' ' LEU . 33.2 mmt180 -114.56 175.22 5.58 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 178.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.447 ' HB2' HD13 ' A' ' 75' ' ' ILE . 5.9 p-10 -143.55 146.12 33.08 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.472 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.4 p -128.86 144.23 38.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-O 121.616 0.722 . . . . 0.0 111.096 -178.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.496 ' HB3' HD22 ' A' ' 95' ' ' ASN . 36.9 m-20 -79.87 106.11 11.65 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.61 -1.177 . . . . 0.0 110.732 -179.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.679 ' HB3' HD12 ' A' ' 97' ' ' ILE . 3.8 mt -78.57 1.83 21.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.954 0.407 . . . . 0.0 110.198 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.512 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -59.92 -19.95 54.62 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.412 0.625 . . . . 0.0 109.426 178.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.446 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -62.92 -22.95 67.12 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.188 179.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.679 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.2 mt -83.8 128.15 39.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.011 -179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 38.6 tt0 -122.4 162.34 21.79 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.944 179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.475 ' N ' ' HG2' ' A' ' 98' ' ' GLN . 4.8 t30 -102.01 117.91 35.79 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.179 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.424 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 51.3 t -113.0 95.82 4.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.343 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 62.29 23.36 13.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.239 179.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.31 23.06 8.23 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.35 -0.929 . . . . 0.0 113.428 178.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 17.9 ptp180 -130.39 142.25 50.52 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.807 0.304 . . . . 0.0 110.259 179.405 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 77.8 mt -86.05 115.6 23.75 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.383 179.072 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.559 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.8 t -117.93 121.84 68.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.7 p90 -81.49 146.47 30.19 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.166 -178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.427 ' H ' ' HB3' ' A' ' 96' ' ' ARG . 36.6 tt0 . . . . . 0 C--O 1.247 0.957 0 O-C-N 123.67 0.607 . . . . 0.0 111.372 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.1 tpp . . . . . 0 N--CA 1.484 1.247 0 CA-C-O 120.607 0.241 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 p -174.16 -177.94 1.38 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.276 -179.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -62.66 -32.93 74.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.586 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -56.73 -25.36 54.52 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.347 -0.842 . . . . 0.0 112.636 -178.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -55.61 -32.51 63.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.026 0.441 . . . . 0.0 110.923 179.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.0 m -133.04 32.3 3.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.91 -0.587 . . . . 0.0 110.887 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.586 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 65.8 m -116.53 156.51 26.8 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.217 0.532 . . . . 0.0 111.593 -179.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.433 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.6 ptp180 -153.41 168.79 24.9 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.616 179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.57 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 55.6 t30 55.44 31.25 16.54 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.431 0.634 . . . . 0.0 110.806 179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.563 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.24 114.73 17.39 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.904 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 24.5 t -142.05 153.27 18.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 -179.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -89.23 146.0 25.03 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.222 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.4 m -131.68 165.47 23.63 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 -179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.477 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 5.4 t-20 71.81 8.31 6.05 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.295 0.638 . . . . 0.0 111.638 178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.21 25.08 14.88 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.217 -0.753 . . . . 0.0 111.217 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.552 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 95.33 27.96 10.25 Favored Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.86 -0.685 . . . . 0.0 111.783 -179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.742 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -112.71 -15.49 12.97 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.815 0.34 . . . . 0.0 110.413 -179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.438 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.2 m -129.85 130.23 44.99 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.174 0.511 . . . . 0.0 111.717 -179.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.1 tp -99.28 111.47 23.83 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.508 177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -113.07 124.29 52.26 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -152.55 153.53 33.6 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.386 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 9.0 mt-10 -106.05 109.92 22.02 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -117.98 143.61 46.23 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.141 0.496 . . . . 0.0 110.56 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.535 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.84 144.27 43.53 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.682 179.492 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.9 p-10 -88.42 -173.7 4.29 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.952 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.45 -31.35 67.7 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.818 0.342 . . . . 0.0 111.733 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -75.99 -24.48 55.35 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.945 0.402 . . . . 0.0 111.294 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.46 0.76 32.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.512 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.535 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.5 t30 -82.8 143.56 30.74 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 51.0 m0 -77.5 129.14 35.32 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -125.38 123.72 65.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.558 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.8 m -77.29 107.79 9.95 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 178.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.503 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.8 m -110.3 143.44 40.5 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.305 -177.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -128.06 143.51 51.07 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.661 -0.7 . . . . 0.0 110.149 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -141.82 120.53 12.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.583 ' O ' HG22 ' A' ' 39' ' ' THR . 14.4 m-20 -70.45 107.16 3.7 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.397 0.618 . . . . 0.0 110.004 178.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 12' ' ' LEU . 52.6 mt -60.69 -40.59 92.76 Favored 'General case' 0 CA--C 1.502 -0.902 0 CA-C-O 121.797 0.808 . . . . 0.0 109.675 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.57 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 5.2 p-10 -63.02 -4.95 2.54 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 114.543 -1.208 . . . . 0.0 110.943 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.583 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.86 -12.19 15.95 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.283 -0.567 . . . . 0.0 111.706 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.539 HG23 HG23 ' A' ' 39' ' ' THR . 2.4 pp -141.24 10.47 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-O 121.018 0.437 . . . . 0.0 112.11 -179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.32 129.36 70.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 -179.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.498 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 158.1 21.06 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.305 -0.95 . . . . 0.0 112.189 -179.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.437 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.0 t30 -111.56 114.73 28.0 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.111 0.481 . . . . 0.0 109.973 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -103.74 87.28 2.78 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.258 179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HB3' ' SG ' ' A' ' 83' ' ' CYS . 1.9 p30 45.24 57.51 4.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 123.561 0.744 . . . . 0.0 112.46 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.646 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.62 36.24 26.66 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.266 -0.969 . . . . 0.0 111.998 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -150.57 115.33 5.25 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 110.309 -0.256 . . . . 0.0 110.309 -179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.552 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.8 m-85 -61.8 135.72 57.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.95 0.405 . . . . 0.0 110.634 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 -129.69 115.06 16.78 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.628 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -69.67 114.89 8.29 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.0 5.95 Favored Glycine 0 N--CA 1.45 -0.397 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.823 -179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.536 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.11 -53.41 0.89 Allowed Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.685 -179.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.1 tt0 74.91 144.74 0.08 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 123.22 0.608 . . . . 0.0 110.961 -179.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.7 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.7 m-20 68.36 36.94 2.86 Favored 'General case' 0 C--O 1.225 -0.207 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.265 -179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.26 -29.27 47.95 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.742 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.8 p -63.79 -23.28 67.3 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 114.977 -1.01 . . . . 0.0 112.044 -179.285 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.791 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.9 pt-20 -71.39 -16.12 62.4 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.321 0.582 . . . . 0.0 109.843 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.791 HG23 ' HG3' ' A' ' 57' ' ' GLU . 76.8 p -126.04 9.15 7.42 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.502 -179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -119.52 142.31 48.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.157 -179.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -134.14 169.28 17.39 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.366 -0.833 . . . . 0.0 108.776 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.598 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 6.6 t70 47.22 54.91 8.81 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.072 0.463 . . . . 0.0 110.973 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.447 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.57 109.45 20.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-O 121.176 0.512 . . . . 0.0 112.227 -178.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.31 124.45 41.61 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.803 178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 94' ' ' LEU . 14.3 t80 -92.08 137.19 32.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.718 -178.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.721 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 10.5 t60 -123.97 86.71 53.57 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 108.976 178.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 5.7 Cg_endo -53.09 -41.0 75.0 Favored 'Trans proline' 0 N--CA 1.477 0.531 0 C-N-CA 124.575 3.517 . . . . 0.0 115.131 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.514 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -125.27 85.99 2.49 Favored 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.302 -178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.721 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 24.6 tt0 -66.54 115.49 6.47 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.217 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.09 -150.84 3.73 Favored Glycine 0 C--N 1.333 0.414 0 O-C-N 124.455 1.097 . . . . 0.0 113.449 179.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.84 -5.77 56.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.089 0.471 . . . . 0.0 109.813 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.78 -22.68 59.75 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.486 179.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 57.51 42.88 23.7 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 114.943 -1.026 . . . . 0.0 111.374 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -109.92 125.38 31.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 C-N-CA 120.174 -0.61 . . . . 0.0 111.871 -178.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.533 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.9 Cg_endo -73.22 112.93 3.64 Favored 'Trans proline' 0 N--CA 1.457 -0.646 0 C-N-CA 122.754 2.303 . . . . 0.0 112.206 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.508 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.3 pp -134.45 140.71 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -110.78 125.02 53.11 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.952 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.522 ' HD2' ' H ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -119.31 139.86 51.25 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.652 179.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.447 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -161.77 168.36 23.33 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.043 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.598 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 4.2 mmt85 -85.82 114.86 23.09 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.646 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.3 131.73 45.12 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 120.897 0.38 . . . . 0.0 110.159 -179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -77.0 137.45 39.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.751 179.836 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -96.85 168.94 10.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.861 179.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.43 ' SG ' ' HB3' ' A' ' 45' ' ' ASP . 72.2 m -54.17 -28.32 39.58 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.862 0.363 . . . . 0.0 111.602 -179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -67.19 -25.11 65.97 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.211 0.529 . . . . 0.0 111.558 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.29 33.51 5.67 Favored Glycine 0 CA--C 1.506 -0.484 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.679 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -118.07 -160.37 0.78 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.974 -0.613 . . . . 0.0 109.611 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -142.61 137.56 30.13 Favored 'General case' 0 CA--C 1.508 -0.672 0 CA-C-O 121.815 0.817 . . . . 0.0 111.204 -179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -137.56 117.45 13.25 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 113.989 -1.459 . . . . 0.0 109.499 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.0 p-10 -66.11 113.28 4.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.385 0.612 . . . . 0.0 111.184 -178.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.614 ' HB2' HD22 ' A' ' 80' ' ' LEU . 33.6 mmt180 -115.05 172.23 7.18 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -138.86 151.61 47.13 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.552 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.8 p -139.68 144.68 28.08 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-O 121.38 0.61 . . . . 0.0 110.755 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.542 ' HB3' HD22 ' A' ' 95' ' ' ASN . 31.0 m-80 -81.69 110.31 16.92 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 110.756 -179.512 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.7 mt -79.33 3.02 19.41 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.115 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.542 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.8 m-80 -62.86 -18.29 62.7 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.975 0.417 . . . . 0.0 110.361 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.428 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.55 -28.36 69.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.908 179.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.523 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -77.75 130.19 36.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.494 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -125.96 166.28 17.23 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.788 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.572 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.3 t30 -109.06 123.9 49.89 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.271 -179.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.428 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.69 94.04 2.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.449 179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 53.0 t30 58.82 27.15 15.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.916 179.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.14 20.96 7.97 Favored Glycine 0 CA--C 1.519 0.281 0 C-N-CA 120.29 -0.957 . . . . 0.0 113.814 178.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.572 ' O ' ' HA ' ' A' ' 99' ' ' ASN . 12.7 ptp180 -131.25 139.6 49.68 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.356 0.578 . . . . 0.0 110.612 179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.503 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.8 mp -90.29 124.9 35.28 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.792 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p -138.23 130.65 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.435 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 97' ' ' ILE . 3.3 p90 -79.97 145.16 32.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.475 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 . . . . . 0 C--O 1.251 1.135 0 O-C-N 123.489 0.493 . . . . 0.0 111.114 179.442 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.1 tpt . . . . . 0 N--CA 1.482 1.132 0 CA-C-O 120.723 0.297 . . . . 0.0 110.74 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.7 m -153.44 -177.42 6.33 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -64.13 -34.15 77.41 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.734 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.13 -23.25 54.41 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.798 -179.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -59.93 -23.37 63.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.043 0.449 . . . . 0.0 111.038 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 51.0 m -148.6 38.03 0.84 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.681 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.734 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.8 p -116.74 153.29 32.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.795 0.331 . . . . 0.0 111.001 -179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.05 169.63 20.78 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.496 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 9.6 t-20 54.23 30.64 12.68 Favored 'General case' 0 C--N 1.328 -0.357 0 O-C-N 123.534 0.522 . . . . 0.0 111.004 179.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.514 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.12 113.54 12.58 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.095 -179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 31.2 t -143.38 149.17 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.934 -178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -84.04 144.56 29.0 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 178.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.407 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 12.7 m -131.33 161.36 32.53 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.655 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.543 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.54 10.44 5.68 Favored 'General case' 0 N--CA 1.461 0.114 0 O-C-N 123.559 0.537 . . . . 0.0 111.237 178.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.13 24.84 23.61 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.453 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 96.86 22.02 19.31 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.608 -0.806 . . . . 0.0 111.851 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.644 ' HG2' HG21 ' A' ' 56' ' ' THR . 30.6 mtp180 -104.85 -19.03 14.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.626 0.251 . . . . 0.0 110.407 -179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 34.5 m -130.44 126.75 37.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.043 0.449 . . . . 0.0 111.779 -178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.469 ' CD2' HD13 ' A' ' 97' ' ' ILE . 61.0 tp -96.97 109.55 22.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.517 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.444 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.1 tmm_? -109.08 124.24 50.45 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.52 149.91 33.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.562 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.496 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.0 mt-10 -104.67 112.2 25.2 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.526 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.9 p -124.21 147.51 47.98 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-O 121.098 0.475 . . . . 0.0 111.844 -178.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.446 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.29 144.52 36.04 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.575 179.256 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' ND2' ' HB3' ' A' ' 29' ' ' ASN . 8.5 p30 -86.07 -175.0 5.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.405 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -36.52 69.02 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -73.84 -23.51 59.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.952 0.406 . . . . 0.0 110.973 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 109.56 3.2 30.76 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.959 179.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.477 ' HB3' ' ND2' ' A' ' 25' ' ' ASN . 5.2 t30 -86.07 145.57 27.0 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 117.113 0.456 . . . . 0.0 110.078 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 43.7 m0 -74.14 126.03 29.67 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.718 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG21 ' HB3' ' A' ' 25' ' ' ASN . 3.2 t -126.99 128.97 71.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.503 -179.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.9 m -86.7 112.99 22.18 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.403 ' HB3' HD13 ' A' ' 104' ' ' LEU . 4.1 t -112.1 151.81 28.99 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.039 0.447 . . . . 0.0 110.749 -178.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.444 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.7 mt-10 -139.05 132.0 29.4 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.196 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.614 HD11 HG12 ' A' ' 40' ' ' ILE . 12.8 tp -133.76 123.99 25.84 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.01 0.433 . . . . 0.0 110.122 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 39' ' ' THR . 38.9 m-20 -72.21 108.36 5.33 Favored 'General case' 0 N--CA 1.439 -1.015 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.822 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.895 HD11 HD11 ' A' ' 12' ' ' LEU . 24.8 mt -59.53 -45.88 90.49 Favored 'General case' 0 CA--C 1.501 -0.923 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.087 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.448 ' HA ' ' HD1' ' A' ' 55' ' ' PHE . 0.8 OUTLIER -63.97 -5.08 3.97 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.674 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.513 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.73 -9.79 20.54 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 119.845 -0.742 . . . . 0.0 111.056 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.614 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.23 11.53 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 CA-C-O 120.952 0.406 . . . . 0.0 111.669 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.559 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.64 132.55 68.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.03 157.97 21.32 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.317 -0.944 . . . . 0.0 112.774 -179.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.436 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.3 t30 -110.13 106.31 15.73 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -95.48 80.99 3.51 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.189 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.9 t70 51.15 56.64 7.67 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.143 178.553 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.623 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.53 39.32 18.52 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.273 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -157.41 117.78 3.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.791 0.295 . . . . 0.0 110.366 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.4 m-85 -61.95 137.76 58.29 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.315 0.578 . . . . 0.0 111.701 179.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 25.1 tt0 -133.36 118.47 18.51 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 115.419 -0.809 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 91.7 m95 -72.03 115.22 10.99 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.14 29.21 6.5 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.13 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.475 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.99 -53.26 1.11 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.208 -0.996 . . . . 0.0 113.086 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.5 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 35.1 tt0 72.13 141.93 0.06 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 123.309 0.644 . . . . 0.0 111.136 -179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.57 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 79.9 m-20 76.83 30.63 0.57 Allowed 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.937 0.895 . . . . 0.0 110.997 -179.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.559 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 3.5 p90 -78.0 -29.28 49.53 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.374 -179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.644 HG21 ' HG2' ' A' ' 17' ' ' ARG . 53.8 p -66.02 -25.16 66.94 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.558 -179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.666 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.7 pt-20 -70.63 -19.3 62.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.273 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.666 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -122.68 15.74 10.24 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 121.067 0.46 . . . . 0.0 110.332 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.92 151.22 49.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.924 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.62 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.59 173.09 11.83 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.251 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.534 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 5.6 t70 47.53 52.41 12.47 Favored 'General case' 0 N--CA 1.471 0.615 0 O-C-N 123.563 0.54 . . . . 0.0 110.449 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.2 mt -85.39 108.75 17.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.333 0.587 . . . . 0.0 111.74 -178.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.428 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -123.52 123.16 39.99 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.561 178.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.8 t80 -91.77 133.81 35.28 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.015 -178.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.766 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 2.1 t60 -121.67 86.54 45.15 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.491 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.614 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.2 Cg_endo -56.34 -38.6 94.87 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.754 2.969 . . . . 0.0 113.727 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.614 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -130.48 88.22 2.6 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-N 114.709 -1.132 . . . . 0.0 111.46 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.766 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 16.9 tt0 -69.66 115.72 9.23 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.203 -0.908 . . . . 0.0 111.949 179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 52.21 -146.47 14.97 Favored Glycine 0 C--N 1.334 0.43 0 CA-C-N 115.161 -0.927 . . . . 0.0 113.536 178.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.75 -14.38 59.31 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.13 -27.21 62.47 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.985 179.233 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 52.0 46.95 25.72 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.178 -178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 tt0 -99.47 122.74 50.64 Favored Pre-proline 0 N--CA 1.446 -0.659 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.631 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.444 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.8 Cg_endo -72.75 109.03 2.7 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.365 2.043 . . . . 0.0 112.0 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.449 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -135.26 141.61 42.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.3 tm? -112.04 123.41 50.19 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.098 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.47 ' HD2' ' H ' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -119.91 138.75 53.25 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.609 179.033 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.539 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.35 168.19 27.66 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.006 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.62 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.9 mmt180 -85.79 115.0 23.18 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.623 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -98.45 124.36 43.11 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.847 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.619 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -79.48 142.18 36.06 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.403 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.554 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 2.6 p-10 -97.71 175.98 5.99 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.371 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 33.8 m -61.4 -22.44 65.0 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 112.123 0.416 . . . . 0.0 112.123 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -78.99 -27.78 43.42 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.436 . . . . 0.0 110.574 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 109.8 33.21 2.68 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.829 178.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.619 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 7.1 pt-20 -109.47 -162.46 0.81 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -146.66 130.2 16.86 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.268 0.556 . . . . 0.0 110.294 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -138.19 117.76 13.0 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.157 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.556 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.9 p-10 -66.68 120.07 12.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.438 0.637 . . . . 0.0 112.209 -178.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.564 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.3 mmt180 -116.42 177.67 4.61 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 177.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -143.91 147.51 34.09 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.2 p -135.3 144.11 35.09 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.791 -179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HB3' HD22 ' A' ' 95' ' ' ASN . 60.7 m-20 -81.53 110.12 16.62 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.698 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.9 mt -78.24 2.45 18.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.013 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.505 HD22 ' HB3' ' A' ' 93' ' ' ASN . 19.6 m-80 -63.61 -16.19 60.23 Favored 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.31 -25.05 67.45 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.538 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.629 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.9 mt -80.11 121.47 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.783 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -113.7 164.01 14.26 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.019 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.425 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.0 t30 -107.13 116.38 31.82 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.65 -0.705 . . . . 0.0 109.71 179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.584 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 60.6 t -112.16 94.14 2.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-O 121.06 0.457 . . . . 0.0 110.279 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 61.3 t30 61.18 24.73 14.81 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.762 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.4 19.14 9.57 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.339 -0.934 . . . . 0.0 113.509 177.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.584 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.3 ptp180 -130.59 142.81 50.46 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.039 0.42 . . . . 0.0 110.606 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.403 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.0 mp -85.01 119.24 25.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.0 179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.489 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.31 123.59 70.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.164 -0.471 . . . . 0.0 109.885 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -81.69 145.17 30.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.452 -178.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 5.0 tp-100 . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.492 -0.766 . . . . 0.0 111.596 178.369 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' HG3' ' HB2' ' A' ' 5' ' ' ASP . 3.1 ptt? . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.442 ' H ' ' HG3' ' A' ' 1' ' ' MET . 3.3 m -138.58 -165.37 1.81 Allowed 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 -178.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -54.5 -36.34 64.09 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.101 0.477 . . . . 0.0 110.506 179.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.17 -25.89 35.39 Favored 'General case' 0 N--CA 1.461 0.075 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.787 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . 0.446 ' HB2' ' HG3' ' A' ' 1' ' ' MET . 20.4 t70 -57.54 -31.8 66.46 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 121.209 0.528 . . . . 0.0 110.631 179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.508 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 20.1 m -130.15 34.96 4.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.971 -179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.1 m -117.32 158.54 24.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.244 0.545 . . . . 0.0 112.027 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -155.97 166.22 34.13 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.966 179.612 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.452 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.8 t-20 54.71 33.97 20.63 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 123.619 0.574 . . . . 0.0 111.288 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.534 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.87 113.85 16.16 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 121.217 0.532 . . . . 0.0 110.448 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.9 t -140.71 155.56 22.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.735 -178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -94.79 135.29 36.45 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.995 0.426 . . . . 0.0 110.059 179.277 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 14' ' ' ASN . 11.2 m -120.31 165.36 14.97 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.691 -178.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.531 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.0 t-20 74.12 5.98 4.72 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 123.575 0.547 . . . . 0.0 111.067 177.719 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.94 16.16 39.67 Favored Glycine 0 CA--C 1.506 -0.48 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 105.3 27.03 5.99 Favored Glycine 0 N--CA 1.444 -0.778 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.735 ' HG2' HG21 ' A' ' 56' ' ' THR . 28.1 mtp180 -110.86 -18.16 13.16 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.645 0.26 . . . . 0.0 110.455 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 63.1 m -129.6 128.46 42.72 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.948 0.404 . . . . 0.0 111.369 -179.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.453 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.9 tp -97.85 110.05 22.69 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.627 178.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.3 tmm_? -108.47 124.16 49.99 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.9 -0.408 . . . . 0.0 109.9 -179.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.71 151.32 37.02 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.949 0.404 . . . . 0.0 110.191 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 10.2 mt-10 -106.94 113.17 26.5 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 6' ' ' SER . 7.8 p -124.22 146.78 48.51 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.184 0.516 . . . . 0.0 112.228 -178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.537 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.58 144.88 39.34 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.02 179.108 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.2 p30 -86.25 -173.17 4.42 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.804 -179.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.46 -34.19 73.65 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.149 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -69.58 -24.19 63.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.726 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.18 4.7 44.23 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.463 -179.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.537 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 10.3 t-20 -84.35 144.89 28.54 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.792 0.329 . . . . 0.0 110.169 -179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.5 m0 -76.25 121.19 22.56 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.988 -179.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 9.2 t -120.67 154.99 24.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.374 -179.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.3 m -107.53 112.96 25.97 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.501 ' HB2' HD13 ' A' ' 104' ' ' LEU . 11.6 m -112.97 144.23 42.9 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.237 0.541 . . . . 0.0 111.386 -178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.2 mt-10 -132.8 131.52 41.17 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.219 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.653 HD11 HG12 ' A' ' 40' ' ' ILE . 12.1 tp -131.49 120.53 23.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.191 0.519 . . . . 0.0 109.907 179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.59 ' O ' HG22 ' A' ' 39' ' ' THR . 36.0 m-20 -70.04 110.01 4.87 Favored 'General case' 0 N--CA 1.438 -1.052 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.179 179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 12' ' ' LEU . 37.7 mt -61.97 -41.63 98.23 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.874 0.845 . . . . 0.0 109.151 179.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.5 OUTLIER -63.22 -3.66 2.0 Allowed 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.548 179.293 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.59 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.89 -14.62 15.15 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.007 -0.677 . . . . 0.0 111.326 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.653 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -141.7 13.32 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.344 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 -179.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.556 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.7 mt -127.53 131.89 69.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.21 158.12 21.46 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.461 -0.876 . . . . 0.0 112.569 -179.48 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.456 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 13.8 t30 -110.35 106.79 16.28 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -99.05 84.13 3.0 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.009 -179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 53.09 59.32 4.52 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.258 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.605 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.56 40.27 39.21 Favored Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 119.729 -1.225 . . . . 0.0 111.969 179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.2 t-80 -160.32 121.15 2.99 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.203 -0.295 . . . . 0.0 110.203 178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.499 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 49.4 m-85 -63.69 138.83 58.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.919 0.39 . . . . 0.0 111.228 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -134.48 117.08 15.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.533 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -69.51 115.79 9.18 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.883 178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.7 36.79 3.89 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.825 -0.625 . . . . 0.0 112.219 -179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -108.25 -52.12 0.69 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.615 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.7 tt0 73.57 143.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.56 0.695 . . . . 0.0 111.976 -179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 49.3 t30 66.64 31.76 7.52 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.421 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.556 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -69.46 -27.38 65.18 Favored 'General case' 0 CA--C 1.517 -0.326 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.735 HG21 ' HG2' ' A' ' 17' ' ' ARG . 17.0 p -64.38 -17.6 63.9 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 115.197 -0.911 . . . . 0.0 112.002 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.701 ' HG3' HG23 ' A' ' 58' ' ' THR . 5.5 pt-20 -72.7 -21.78 61.0 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.701 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.6 p -122.91 12.91 9.79 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.457 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -121.86 145.7 47.82 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.223 0.535 . . . . 0.0 111.311 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.606 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -138.5 171.27 14.61 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.222 179.913 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.46 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.1 t70 45.45 56.1 6.0 Favored 'General case' 0 N--CA 1.47 0.532 0 O-C-N 123.538 0.524 . . . . 0.0 110.963 179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.3 mt -88.42 111.28 22.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-O 121.051 0.453 . . . . 0.0 112.03 -178.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.99 125.25 42.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.846 -0.615 . . . . 0.0 109.91 178.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.599 ' CE1' HD12 ' A' ' 94' ' ' LEU . 25.3 t80 -91.09 137.05 32.66 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.297 -178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.647 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.6 t-160 -121.27 86.76 43.68 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.38 -0.827 . . . . 0.0 109.316 179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.534 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 8.5 Cg_endo -57.4 -44.58 41.31 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 123.442 2.761 . . . . 0.0 113.921 -178.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 mppt? -123.43 84.12 2.23 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.922 -1.036 . . . . 0.0 109.802 179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.647 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 2.2 tt0 -66.92 120.17 13.16 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -179.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 43.24 -140.73 2.55 Favored Glycine 0 C--N 1.339 0.746 0 O-C-N 124.574 1.172 . . . . 0.0 114.096 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.82 -11.71 58.04 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.6 -27.29 63.98 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.352 -0.84 . . . . 0.0 110.193 179.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 55.65 46.17 23.24 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.2 129.18 25.07 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.364 -178.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.462 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.5 Cg_endo -73.21 110.0 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.737 2.291 . . . . 0.0 112.141 179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.46 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.2 pp -136.5 141.98 39.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.509 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.5 124.96 53.64 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.333 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.509 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.93 145.1 48.06 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-O 121.007 0.432 . . . . 0.0 110.006 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.481 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -162.14 169.7 20.39 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.606 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.1 mmt180 -86.89 115.33 24.22 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.605 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.6 mp -99.35 123.0 43.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.025 0.44 . . . . 0.0 110.762 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -76.36 137.55 39.87 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.359 -179.403 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -96.83 170.48 9.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.428 -0.806 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 20.2 m -58.05 -25.17 60.86 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -71.96 -18.89 61.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.906 0.384 . . . . 0.0 110.931 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 94.76 36.9 5.41 Favored Glycine 0 CA--C 1.507 -0.411 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.994 179.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.629 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.8 pt-20 -118.7 -161.7 0.86 Allowed 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -141.38 135.13 30.12 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.968 0.89 . . . . 0.0 111.133 179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -130.68 108.13 9.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 113.995 -1.457 . . . . 0.0 109.226 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.7 p-10 -67.1 112.37 4.38 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.371 0.605 . . . . 0.0 110.61 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.522 ' HB2' HD22 ' A' ' 80' ' ' LEU . 35.9 mmt180 -113.62 177.41 4.64 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.726 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -142.17 148.9 39.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 -179.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.499 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.1 p -136.81 145.68 29.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.969 0 CA-C-O 121.375 0.607 . . . . 0.0 110.78 -179.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.514 ' HB3' HD22 ' A' ' 95' ' ' ASN . 13.5 m120 -83.11 114.03 21.03 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.153 -178.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.599 HD12 ' CE1' ' A' ' 64' ' ' PHE . 2.2 mt -82.02 2.11 32.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.746 0.308 . . . . 0.0 111.106 -179.008 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.514 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.2 m-80 -63.45 -10.48 17.57 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.076 0.465 . . . . 0.0 110.299 177.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.579 ' HD2' ' N ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -70.27 -20.13 63.06 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.017 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.3 mt -85.18 131.14 34.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.82 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -121.63 159.19 27.01 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.231 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.9 t30 -106.28 118.97 38.03 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.183 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.533 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 39.4 t -113.0 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.035 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 66.1 t30 60.07 21.87 11.06 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.825 178.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.43 23.39 6.32 Favored Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.247 -0.978 . . . . 0.0 113.55 178.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.5 ptp180 -132.57 141.07 48.54 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 117.122 0.461 . . . . 0.0 110.594 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.501 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.2 mp -89.9 118.17 29.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.653 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 18.1 t -127.75 127.3 68.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.538 -0.301 . . . . 0.0 110.321 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -82.75 144.91 29.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.664 -0.243 . . . . 0.0 110.583 -179.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.784 -0.626 . . . . 0.0 111.317 179.946 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.3 tpt . . . . . 0 N--CA 1.479 1.004 0 CA-C-O 120.581 0.229 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.8 m -152.39 -178.14 6.64 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -63.96 -38.44 91.1 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.049 0.452 . . . . 0.0 109.783 179.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.63 -24.5 21.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.52 -178.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -55.51 -29.9 59.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.134 0.493 . . . . 0.0 110.962 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -138.78 35.04 2.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.799 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 72.7 m -115.92 155.67 27.57 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 111.825 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -150.76 164.5 36.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.088 -0.96 . . . . 0.0 108.552 179.842 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.402 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 94.5 m-20 53.3 36.34 22.54 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 123.615 0.572 . . . . 0.0 111.484 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.559 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.44 113.43 15.24 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.691 179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.7 t -142.28 150.32 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.914 -0.585 . . . . 0.0 109.87 -178.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.587 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.1 tp -85.91 143.98 27.91 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.9 m -130.37 162.44 29.08 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -179.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.51 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.4 t-20 73.76 9.14 4.88 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 123.701 0.626 . . . . 0.0 111.216 178.475 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.7 23.95 19.45 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.493 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 96.79 21.0 22.56 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.074 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.675 ' HG2' HG21 ' A' ' 56' ' ' THR . 31.5 mtp180 -102.74 -18.16 15.29 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.728 0.299 . . . . 0.0 110.697 -179.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 92.9 m -130.49 129.24 42.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.098 0.475 . . . . 0.0 111.773 -178.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.462 ' CD2' HD13 ' A' ' 97' ' ' ILE . 56.9 tp -95.6 110.86 22.9 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.278 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 2.7 tmm_? -109.05 123.75 49.66 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -147.44 145.17 29.1 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.295 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 7' ' ' SER . 7.0 mt-10 -102.05 110.69 22.73 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HA ' ' O ' ' A' ' 6' ' ' SER . 42.4 t -125.9 147.84 49.36 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.452 0.644 . . . . 0.0 111.754 -178.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.554 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.68 145.64 38.61 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.37 178.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 34.6 p-10 -87.16 -172.85 4.14 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.459 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -67.02 -14.29 62.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.256 0.55 . . . . 0.0 111.773 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -88.23 -17.22 31.27 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.252 0.549 . . . . 0.0 110.141 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.8 7.03 56.9 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.547 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 63.2 t30 -90.47 145.99 24.47 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.3 m0 -79.8 126.66 31.25 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.029 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.9 t -130.57 140.4 48.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.862 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 16.9 m -91.06 113.38 25.63 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.502 ' HB2' HD13 ' A' ' 104' ' ' LEU . 2.3 m -110.75 142.6 42.49 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.094 0.473 . . . . 0.0 111.89 -177.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.83 131.5 42.89 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.051 179.295 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.6 tp -133.19 122.89 24.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.092 0.472 . . . . 0.0 110.128 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.451 ' O ' HG22 ' A' ' 39' ' ' THR . 74.1 m-20 -69.37 109.45 4.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.323 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD11 HD11 ' A' ' 12' ' ' LEU . 18.9 mt -61.89 -43.17 99.38 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 121.742 0.782 . . . . 0.0 109.655 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.23 -4.65 1.86 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 114.445 -1.252 . . . . 0.0 110.516 179.801 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 40' ' ' ILE . 0.5 OUTLIER -102.35 -15.06 16.67 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.056 -0.657 . . . . 0.0 111.355 -179.126 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.5 HD12 HG13 ' A' ' 41' ' ' ILE . 2.6 pp -141.54 13.47 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 112.195 0.442 . . . . 0.0 112.195 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.5 mt -128.08 129.88 69.59 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 179.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.08 154.84 20.02 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.4 -0.905 . . . . 0.0 112.617 -179.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.473 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -111.06 111.42 22.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.901 0.381 . . . . 0.0 110.154 179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -104.09 85.25 2.36 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.984 178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 6.7 m-20 50.0 58.73 5.14 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 115.501 -0.772 . . . . 0.0 112.623 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 80.57 34.31 28.75 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.311 -0.947 . . . . 0.0 112.746 178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -153.28 119.58 5.51 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.577 0.227 . . . . 0.0 111.148 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.498 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 48.8 m-85 -67.19 137.59 56.35 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.226 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.457 HE21 ' HB2' ' A' ' 49' ' ' GLN . 1.3 tt0 -133.2 117.14 17.08 Favored 'General case' 0 N--CA 1.442 -0.848 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.226 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.6 m95 -68.61 116.15 8.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.776 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.33 25.98 8.5 Favored Glycine 0 C--N 1.32 -0.352 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.946 -179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.552 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.42 -52.63 1.55 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.917 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 2.8 tt0 74.59 143.39 0.07 Allowed 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 121.52 0.676 . . . . 0.0 111.883 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 59.9 t30 68.52 35.41 3.26 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 114.599 -1.182 . . . . 0.0 111.357 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.6 p90 -76.9 -24.35 52.51 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.611 179.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.675 HG21 ' HG2' ' A' ' 17' ' ' ARG . 13.1 p -67.58 -21.57 65.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.925 -178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.669 ' HG3' HG23 ' A' ' 58' ' ' THR . 0.1 OUTLIER -74.85 -15.8 60.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.254 0.549 . . . . 0.0 109.713 179.568 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.669 HG23 ' HG3' ' A' ' 57' ' ' GLU . 77.9 p -126.14 14.18 7.82 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.061 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.47 141.33 52.16 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.755 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.693 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -135.52 168.97 18.25 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.501 -179.228 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 48.65 50.99 16.36 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.105 0.479 . . . . 0.0 110.422 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.409 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.6 mt -83.58 112.41 21.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 121.196 0.522 . . . . 0.0 112.08 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.43 123.07 37.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.684 178.582 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.679 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.3 t80 -92.09 131.18 37.55 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.684 -178.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.506 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 20.8 t60 -120.19 87.15 39.17 Favored Pre-proline 0 C--N 1.328 -0.351 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.9 Cg_endo -55.21 -33.18 83.53 Favored 'Trans proline' 0 CA--C 1.508 -0.812 0 C-N-CA 124.387 3.391 . . . . 0.0 115.279 -177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.423 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -131.82 91.64 3.01 Favored 'General case' 0 C--N 1.293 -1.882 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.502 -178.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.506 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 33.7 tt0 -65.24 114.12 4.49 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.086 178.158 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.61 -147.18 6.77 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 115.275 -0.875 . . . . 0.0 113.595 179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.91 -0.58 49.06 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.159 0.504 . . . . 0.0 110.086 179.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -82.69 -19.66 37.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.963 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 23.5 mm-40 57.26 42.27 25.49 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.107 179.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -101.8 118.73 58.88 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.02 -178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.523 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 57.2 Cg_endo -71.07 114.02 3.77 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.508 2.139 . . . . 0.0 112.898 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.442 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.69 141.59 41.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 178.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.511 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.3 127.97 56.32 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.298 -179.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.511 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.48 141.35 51.73 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.136 0.493 . . . . 0.0 110.315 179.268 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.43 168.17 25.73 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.003 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.693 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.8 mmt180 -85.25 115.44 23.03 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.641 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.5 mp -98.13 120.9 39.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 111.627 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.59 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.14 141.56 30.99 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.78 -179.866 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 1.0 OUTLIER -99.04 173.58 6.76 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.183 -179.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 78.1 m -59.25 -25.1 63.76 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -75.03 -27.37 60.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.178 0.513 . . . . 0.0 110.413 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.37 38.39 2.11 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.665 -0.779 . . . . 0.0 113.497 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.6 pt-20 -109.84 -167.19 1.17 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 18.8 p90 -146.78 128.94 15.64 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.381 0.61 . . . . 0.0 109.78 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -139.58 110.79 6.96 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.892 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.0 p-10 -58.8 120.2 8.55 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.999 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.641 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.5 mmt180 -120.87 173.43 7.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.065 177.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -142.42 144.33 33.04 Favored 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.5 p -131.03 148.8 33.02 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.362 0.601 . . . . 0.0 111.389 -178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.471 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.8 OUTLIER -82.04 107.28 14.63 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.751 -179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.679 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.3 mt -79.85 5.57 13.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.99 0.424 . . . . 0.0 110.846 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.523 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 16.1 m-80 -65.28 -17.18 64.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.041 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.94 -25.31 67.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.386 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.2 mt -79.13 129.87 36.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.207 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -124.09 163.39 21.58 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -106.59 122.06 45.56 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.954 0.407 . . . . 0.0 110.733 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 60.9 t -112.63 99.02 7.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.521 179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 60.79 19.19 9.36 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 121.096 0.474 . . . . 0.0 111.523 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.47 20.55 8.51 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.254 -0.974 . . . . 0.0 113.068 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 15.8 ptp180 -130.14 138.01 50.43 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.502 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.1 mp -84.14 123.73 30.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.17 -179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 40.8 t -132.64 127.65 56.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.065 179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -79.16 145.6 33.6 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.404 -179.203 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.1 tpt . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 110.347 -0.242 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.6 m -165.4 176.3 8.38 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -59.54 -35.9 75.12 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.797 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.97 -24.56 54.02 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.145 -0.934 . . . . 0.0 112.733 -178.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -57.51 -33.16 67.76 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.204 0.526 . . . . 0.0 110.71 179.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.481 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 33.2 m -129.09 31.42 4.89 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.593 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.797 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 37.5 p -121.14 155.92 33.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.864 0.364 . . . . 0.0 111.052 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.426 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -151.21 170.49 19.34 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.55 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 11.2 m120 54.79 30.92 14.53 Favored 'General case' 0 N--CA 1.464 0.246 0 O-C-N 123.533 0.521 . . . . 0.0 111.34 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.547 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -75.7 114.23 14.05 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.602 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 39.4 t -142.39 149.64 19.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.858 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.584 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.2 tp -86.35 138.36 31.87 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 179.107 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 14.1 m -123.24 164.0 19.59 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.629 -179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 5.5 t-20 71.33 9.58 6.55 Favored 'General case' 0 N--CA 1.464 0.241 0 O-C-N 123.552 0.533 . . . . 0.0 111.259 178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.63 17.19 46.12 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.548 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 107.4 19.43 9.35 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.069 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.663 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.1 mtp180 -102.77 -20.0 14.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.722 0.296 . . . . 0.0 110.675 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.477 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.6 m -128.45 126.75 41.18 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 0.0 111.811 -178.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.455 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.3 tp -96.66 105.55 17.68 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.96 177.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 4.3 tmm_? -101.38 123.61 45.74 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.53 140.94 22.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.642 0.258 . . . . 0.0 110.552 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.55 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 4.0 mt-10 -98.55 109.48 22.23 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 6' ' ' SER . 3.1 p -118.1 142.29 47.57 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.19 0.519 . . . . 0.0 111.42 -178.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.531 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.93 143.13 47.81 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.889 179.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.42 ' HB3' HG21 ' A' ' 31' ' ' VAL . 22.4 p-10 -91.17 -174.05 3.84 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.56 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.27 -26.74 63.31 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.888 0.329 . . . . 0.0 111.888 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -78.1 -24.0 47.69 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.951 0.405 . . . . 0.0 111.258 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.64 4.83 42.73 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.637 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.531 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 6.9 t-20 -91.03 144.57 25.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.466 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.9 m0 -77.21 126.52 31.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.963 0.411 . . . . 0.0 110.815 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.42 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.8 t -120.49 125.76 74.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.765 -179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 20.4 m -74.93 107.28 6.9 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.549 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.8 m -111.22 143.42 42.0 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.177 0.513 . . . . 0.0 111.365 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 10.2 mt-10 -130.19 131.78 45.74 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.565 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -129.11 113.77 15.52 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.676 ' O ' HG22 ' A' ' 39' ' ' THR . 26.9 m-20 -67.43 108.72 2.91 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.782 179.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.554 HD11 HD11 ' A' ' 12' ' ' LEU . 26.5 mt -60.71 -39.46 88.66 Favored 'General case' 0 CA--C 1.499 -1.004 0 CA-C-O 121.797 0.808 . . . . 0.0 109.89 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.633 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 1.8 p-10 -64.12 -3.82 3.03 Favored 'General case' 0 C--N 1.312 -1.045 0 CA-C-N 114.689 -1.141 . . . . 0.0 110.494 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.68 -14.51 15.0 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.341 -0.543 . . . . 0.0 111.254 179.9 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.551 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -140.43 13.95 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 N-CA-C 112.422 0.527 . . . . 0.0 112.422 -179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.557 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.2 mt -129.29 131.45 67.55 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.848 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -129.86 157.81 22.02 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.353 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -111.8 112.73 24.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.847 0.355 . . . . 0.0 110.472 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -106.9 86.46 2.32 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.501 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.538 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 22.1 m-20 53.68 52.25 13.52 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.153 179.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.644 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.31 37.95 23.05 Favored Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.603 -1.284 . . . . 0.0 111.746 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 93.4 m-70 -150.59 120.98 7.35 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 110.069 -0.345 . . . . 0.0 110.069 179.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.485 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.5 m-85 -67.24 132.72 48.32 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.038 0.447 . . . . 0.0 110.98 178.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -125.18 117.61 24.25 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.218 -179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 82.3 m95 -71.46 115.36 10.54 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.584 178.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.74 22.03 11.63 Favored Glycine 0 C--N 1.317 -0.495 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.347 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.531 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -90.18 -51.18 2.84 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.987 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 18.8 tt0 72.57 142.14 0.06 Allowed 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 121.57 0.7 . . . . 0.0 112.002 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.419 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 6.6 t-20 67.04 38.83 3.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 114.685 -1.143 . . . . 0.0 110.987 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.557 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.27 -26.7 47.27 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.709 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.663 HG21 ' HG2' ' A' ' 17' ' ' ARG . 41.6 p -64.01 -21.95 66.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.627 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.689 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.9 pt-20 -74.65 -14.05 60.71 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.114 0.483 . . . . 0.0 109.998 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.689 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.8 p -128.35 15.93 6.62 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.922 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.86 148.91 52.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.904 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.564 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -142.59 172.7 12.33 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.888 -179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 2.0 t70 46.7 53.35 10.22 Favored 'General case' 0 N--CA 1.473 0.705 0 O-C-N 123.556 0.535 . . . . 0.0 110.778 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.431 HG22 HD21 ' A' ' 76' ' ' LEU . 2.3 mt -85.31 114.17 24.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 121.42 0.629 . . . . 0.0 111.707 -178.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.532 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.91 120.47 29.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.129 179.36 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.625 ' CE1' HD12 ' A' ' 94' ' ' LEU . 12.0 t80 -92.22 132.27 36.79 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.717 -178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.418 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 3.0 t60 -123.55 89.31 51.32 Favored Pre-proline 0 CA--C 1.534 0.33 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.445 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -59.04 -38.4 87.74 Favored 'Trans proline' 0 N--CA 1.479 0.662 0 C-N-CA 124.106 3.204 . . . . 0.0 115.085 -178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.445 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -120.87 83.52 2.08 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.885 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -62.06 110.42 1.58 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.984 178.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.29 -141.71 16.03 Favored Glycine 0 C--N 1.332 0.324 0 O-C-N 123.944 0.777 . . . . 0.0 113.968 179.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.38 -5.66 59.3 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.382 0.61 . . . . 0.0 109.98 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.99 -20.6 38.13 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.438 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 52.8 42.49 31.88 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 114.719 -1.128 . . . . 0.0 110.872 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -94.4 119.35 66.54 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.94 -179.317 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.472 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 57.2 Cg_endo -71.71 110.46 2.9 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 122.16 1.907 . . . . 0.0 112.24 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.485 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.43 141.28 43.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 64' ' ' PHE . 1.9 tm? -113.84 125.31 53.93 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.136 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.532 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -120.24 140.76 50.7 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.039 0.447 . . . . 0.0 110.235 179.327 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.531 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.53 168.51 25.98 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.02 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.564 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 6.0 mmt180 -86.23 115.07 23.55 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.644 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 2.3 mp -99.15 126.51 44.94 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.992 0.425 . . . . 0.0 111.012 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -81.96 142.25 32.58 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.798 -179.793 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.644 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -100.66 174.19 6.18 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.063 179.678 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.95 -24.27 62.38 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -77.13 -28.21 54.23 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.28 0.562 . . . . 0.0 110.103 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.11 40.05 1.73 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.582 -0.818 . . . . 0.0 112.945 178.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.665 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.1 pt-20 -111.35 -167.18 1.15 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -142.75 127.81 18.51 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 178.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -134.41 113.89 12.34 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 -179.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.531 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 6.6 p-10 -65.87 114.65 5.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.486 0.66 . . . . 0.0 111.507 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.617 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.4 mmt180 -114.27 179.56 3.92 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.506 -0.77 . . . . 0.0 108.938 178.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -142.12 148.87 39.03 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.485 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.1 p -133.05 140.05 48.1 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 CA-C-N 115.827 -0.624 . . . . 0.0 109.806 179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.564 ' HB3' HD22 ' A' ' 95' ' ' ASN . 5.8 m-20 -82.76 104.99 13.41 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.174 -178.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.625 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.1 mt -74.0 1.41 10.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.586 -178.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.564 HD22 ' HB3' ' A' ' 93' ' ' ASN . 28.9 m-80 -61.28 -17.53 53.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-O 121.322 0.582 . . . . 0.0 109.779 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.401 ' HA ' ' HE ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -64.06 -25.58 68.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.149 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.58 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.8 mt -80.81 126.84 39.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.752 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -117.46 163.09 16.92 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.485 -0.78 . . . . 0.0 109.809 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.7 t30 -107.88 120.31 41.91 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.127 178.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.49 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 47.3 t -114.02 94.18 2.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.503 179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 59.27 27.97 17.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.222 179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 102.04 26.34 7.5 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.33 -0.938 . . . . 0.0 113.617 177.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.8 ptp180 -133.15 137.08 46.12 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.991 0.395 . . . . 0.0 110.297 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.549 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 74.6 mt -85.6 122.66 30.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.774 0.321 . . . . 0.0 110.188 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 27.4 t -132.85 128.04 56.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.523 -179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -79.24 146.02 33.26 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.286 -0.864 . . . . 0.0 110.869 -179.737 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.9 tpt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 120.616 0.246 . . . . 0.0 110.415 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.616 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 41.5 p 174.56 -179.38 0.11 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -56.33 -30.3 62.4 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.329 0.585 . . . . 0.0 109.639 177.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.731 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -60.86 -21.74 63.55 Favored 'General case' 0 CA--C 1.523 -0.092 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.735 -178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.21 -30.67 68.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.081 0.467 . . . . 0.0 110.949 179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 40.5 m -139.18 39.43 2.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.749 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.731 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 89.3 p -113.64 156.98 22.73 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -149.03 163.28 37.98 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -179.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.444 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 92.5 m-20 51.42 35.48 14.23 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.909 0.756 . . . . 0.0 111.429 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.695 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -76.59 112.61 13.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.755 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.3 t -142.99 155.07 17.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.99 -0.55 . . . . 0.0 109.835 -178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.851 HD11 HD11 ' A' ' 37' ' ' LEU . 0.9 OUTLIER -89.02 148.43 23.75 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 179.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.3 m -131.89 162.01 31.64 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.362 -178.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.469 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 3.7 t-20 70.62 12.76 7.33 Favored 'General case' 0 N--CA 1.462 0.155 0 O-C-N 123.699 0.625 . . . . 0.0 111.327 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.47 19.2 33.18 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.87 -0.681 . . . . 0.0 111.565 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.433 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 100.69 24.04 9.6 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.831 -179.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.5 mtp180 -105.56 -19.44 13.78 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.716 0.293 . . . . 0.0 110.545 -179.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.427 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 89.0 m -129.79 125.84 36.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.176 0.512 . . . . 0.0 111.295 -178.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.449 ' HA ' HD12 ' A' ' 12' ' ' LEU . 48.5 tp -94.08 107.36 19.29 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.426 178.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.53 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.4 tmm_? -102.03 123.12 45.38 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.538 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.511 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -148.19 138.86 22.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.926 0.394 . . . . 0.0 110.655 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.464 ' HA ' ' HA ' ' A' ' 32' ' ' THR . 4.3 mt-10 -103.24 110.76 22.85 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 33.7 t -124.12 146.86 48.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.062 0.458 . . . . 0.0 111.085 -178.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -73.84 145.28 45.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.732 179.326 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.0 p30 -83.41 -172.08 3.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.54 -33.6 74.12 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.951 -179.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -74.34 -24.41 59.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.212 0.53 . . . . 0.0 110.776 -179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.83 8.47 27.97 Favored Glycine 0 N--CA 1.444 -0.833 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.855 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 59.0 t30 -86.15 145.08 27.16 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 35.7 m0 -77.64 117.8 19.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-O 121.066 0.46 . . . . 0.0 111.1 -179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 t -119.92 153.15 22.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.6 -179.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 47.4 m -114.68 122.3 46.02 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.484 -0.562 . . . . 0.0 109.484 178.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.914 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 6.6 t -124.52 151.15 45.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.243 0.544 . . . . 0.0 110.493 -179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.53 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 16.3 mt-10 -133.62 131.23 39.36 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.269 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.656 HD11 HG12 ' A' ' 40' ' ' ILE . 14.2 tp -127.47 120.29 28.03 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.167 0.508 . . . . 0.0 110.278 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.562 ' O ' HG22 ' A' ' 39' ' ' THR . 32.3 m-20 -68.41 107.5 2.9 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.737 179.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.851 HD11 HD11 ' A' ' 12' ' ' LEU . 34.1 mt -62.2 -40.47 96.17 Favored 'General case' 0 CA--C 1.5 -0.949 0 CA-C-O 121.724 0.773 . . . . 0.0 109.227 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.485 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 3.1 p-10 -64.31 -4.95 4.26 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.528 179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.562 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -106.21 -12.06 15.85 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 120.241 -0.584 . . . . 0.0 111.414 -179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.656 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -141.71 11.84 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 121.012 0.434 . . . . 0.0 112.083 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.53 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.3 mt -128.1 131.12 69.68 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.535 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.48 157.64 20.94 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.279 -0.962 . . . . 0.0 112.782 -179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.9 t30 -111.62 108.4 17.87 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.998 0.428 . . . . 0.0 110.094 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -96.5 78.1 2.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.628 179.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . 72.6 m-20 48.97 63.77 1.99 Allowed 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.057 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.11 34.69 36.68 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.233 -0.984 . . . . 0.0 112.542 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -155.41 114.74 3.62 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 122.762 -0.257 . . . . 0.0 110.576 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.509 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 43.0 m-85 -60.75 140.99 57.37 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.1 0.476 . . . . 0.0 111.389 179.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -133.66 117.33 16.88 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.502 179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -71.66 115.11 10.46 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.8 28.15 7.56 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.843 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.535 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -97.41 -52.48 1.44 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.578 -0.82 . . . . 0.0 113.452 -179.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.7 tt0 73.26 141.79 0.06 Allowed 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.263 0.625 . . . . 0.0 111.475 -179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.601 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 7.4 m-20 71.0 34.56 1.84 Allowed 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.631 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.9 p90 -77.5 -31.11 53.35 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 179.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.629 HG21 ' HG2' ' A' ' 17' ' ' ARG . 26.8 p -62.54 -26.65 68.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.931 -179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.617 ' HG3' HG23 ' A' ' 58' ' ' THR . 17.7 pt-20 -70.31 -14.85 62.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.325 0.583 . . . . 0.0 109.955 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.617 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.1 p -127.03 13.97 7.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.218 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.486 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -129.3 145.09 51.43 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.144 -179.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.558 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -137.16 172.63 12.72 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.606 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.472 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 2.4 t70 49.14 48.36 20.99 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 121.053 0.454 . . . . 0.0 110.059 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.37 108.2 15.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 121.224 0.535 . . . . 0.0 111.43 -178.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.456 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -125.08 125.63 44.09 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.66 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.695 ' HE2' ' HB1' ' A' ' 10' ' ' ALA . 8.9 t80 -92.28 134.78 34.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.351 0.596 . . . . 0.0 111.879 -177.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.506 ' CD2' ' HA ' ' A' ' 68' ' ' GLU . 1.6 t60 -121.65 85.3 43.82 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.156 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.521 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 8.0 Cg_endo -53.91 -35.5 80.31 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.15 3.233 . . . . 0.0 114.472 -178.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.521 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -131.69 86.2 2.32 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.436 179.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 65' ' ' HIS . 27.3 tt0 -63.36 116.55 5.62 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.312 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.92 -144.18 10.28 Favored Glycine 0 C--N 1.335 0.497 0 O-C-N 124.415 1.072 . . . . 0.0 113.83 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.76 -16.01 52.41 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.46 0.648 . . . . 0.0 109.55 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.96 -24.08 65.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.357 179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 52.24 52.47 14.21 Favored 'General case' 0 C--O 1.233 0.229 0 O-C-N 123.71 0.631 . . . . 0.0 110.56 -179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -110.89 122.14 38.9 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.802 -179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.453 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.0 Cg_endo -71.51 110.65 2.92 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 122.302 2.002 . . . . 0.0 112.033 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.678 HD11 HH21 ' A' ' 77' ' ' ARG . 1.3 pp -135.76 141.54 41.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.195 179.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.507 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -111.84 124.14 51.73 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.177 -179.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.678 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.98 142.66 47.59 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.4 167.83 26.5 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.004 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.558 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.2 mmt180 -86.27 114.55 23.17 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.5 mp -99.19 126.97 45.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.089 0.471 . . . . 0.0 111.368 -178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.669 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -82.92 143.34 30.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.1 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.417 ' OD1' ' HB3' ' A' ' 45' ' ' ASP . 9.9 t70 -105.76 167.24 9.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.987 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 98.6 m -51.26 -31.25 20.44 Favored 'General case' 0 C--N 1.321 -0.634 0 O-C-N 123.359 0.412 . . . . 0.0 111.784 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -66.06 -26.71 67.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.357 0.599 . . . . 0.0 110.908 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 98.87 38.8 3.76 Favored Glycine 0 CA--C 1.504 -0.616 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.59 179.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.669 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 24.4 pt-20 -118.34 -169.45 1.71 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -141.16 137.55 32.8 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.673 0.749 . . . . 0.0 111.011 -179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -138.16 112.78 8.88 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.751 -1.113 . . . . 0.0 110.207 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 0.8 OUTLIER -63.32 110.35 1.88 Allowed 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.635 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.529 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.7 mmt180 -115.09 170.45 8.35 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.495 ' HB2' HD13 ' A' ' 75' ' ' ILE . 3.4 p30 -135.98 153.96 51.24 Favored 'General case' 0 CA--C 1.507 -0.687 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.509 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.3 p -138.73 144.74 29.2 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 CA-C-O 121.398 0.618 . . . . 0.0 110.685 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.507 ' HB3' HD22 ' A' ' 95' ' ' ASN . 1.0 OUTLIER -80.2 111.39 16.52 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.854 -179.032 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.675 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.6 mt -82.32 4.59 23.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.972 0.415 . . . . 0.0 110.489 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.507 HD22 ' HB3' ' A' ' 93' ' ' ASN . 25.4 m-80 -63.35 -18.65 63.88 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.153 0.502 . . . . 0.0 109.799 178.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.445 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.98 -24.48 67.92 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.075 179.215 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.648 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.2 mt -80.36 127.49 39.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.358 -179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.616 ' NE2' ' HA ' ' A' ' 2' ' ' SER . 44.6 mm-40 -117.66 166.69 12.11 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.345 179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.418 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.4 t30 -110.21 118.31 36.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.52 179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -108.61 94.21 2.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.036 0.446 . . . . 0.0 110.337 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 59.91 22.84 11.87 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.269 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.55 19.04 8.09 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.541 -0.838 . . . . 0.0 113.772 178.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -130.36 141.06 50.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 117.277 0.538 . . . . 0.0 110.55 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.914 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 82.0 mt -83.95 120.46 26.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.017 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.411 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 60.0 t -125.31 124.29 66.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.298 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.8 p90 -80.82 143.9 32.46 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.619 -179.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.708 ' HA ' HE21 ' A' ' 107' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.102 0 CA-C-O 119.009 -0.519 . . . . 0.0 111.547 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.6 tpt . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.637 0.256 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.0 m -161.73 178.55 8.89 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.732 -0.469 . . . . 0.0 109.732 -179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -62.97 -34.91 78.52 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 177.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.795 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.85 -19.49 29.47 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 114.906 -1.043 . . . . 0.0 112.74 -179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -64.38 -24.32 67.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.323 0.582 . . . . 0.0 109.909 179.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.482 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.6 m -142.11 36.86 1.56 Allowed 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.705 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.795 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 60.5 p -125.68 153.36 43.96 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.528 0.204 . . . . 0.0 110.681 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -149.57 171.8 16.04 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.466 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 90.3 m-20 55.02 30.97 15.17 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.686 0.617 . . . . 0.0 110.984 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.578 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -73.8 114.59 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.758 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.9 t -144.22 149.72 17.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.512 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -85.48 139.08 31.79 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.852 0.358 . . . . 0.0 110.693 179.309 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.638 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.7 m -121.08 165.57 15.13 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.401 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.511 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.1 OUTLIER 69.46 8.18 6.63 Favored 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.397 0.436 . . . . 0.0 111.34 178.012 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.48 23.92 27.55 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.721 -179.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.542 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 101.88 23.4 9.3 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.057 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.682 ' HG2' HG21 ' A' ' 56' ' ' THR . 25.6 mtp180 -109.89 -15.65 14.04 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.64 0.257 . . . . 0.0 110.524 -179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.638 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 31.3 m -130.3 126.99 38.58 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.615 -179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.487 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.0 tp -97.54 107.1 19.53 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.569 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.1 tmm_? -104.35 125.22 50.39 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.127 -179.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.422 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -150.05 138.0 20.21 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.398 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.466 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.2 mt-10 -94.8 109.24 21.23 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 179.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.5 p -114.68 142.82 45.98 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.423 -178.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.506 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.33 141.99 43.28 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.538 179.249 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.484 ' HB3' HG21 ' A' ' 31' ' ' VAL . 30.9 p-10 -88.09 -178.79 6.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.265 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -31.02 62.58 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.9 0.381 . . . . 0.0 111.715 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -73.26 -23.91 60.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.013 0.435 . . . . 0.0 111.545 -179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.36 9.46 36.05 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.9 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.9 t-20 -95.99 144.82 25.95 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.437 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 53.6 m0 -76.18 123.0 25.16 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.934 0.397 . . . . 0.0 110.988 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG21 ' HB3' ' A' ' 25' ' ' ASN . 5.2 t -119.47 124.2 72.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.437 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.9 m -78.05 107.73 10.83 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.0 t -110.83 149.64 30.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.317 0.58 . . . . 0.0 110.524 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.541 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 8.1 mt-10 -135.25 131.25 36.37 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.403 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -127.77 114.86 17.82 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 178.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.712 ' O ' HG22 ' A' ' 39' ' ' THR . 29.7 m-20 -67.87 109.42 3.4 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.139 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.783 HD11 HD11 ' A' ' 12' ' ' LEU . 25.3 mt -60.77 -40.08 91.2 Favored 'General case' 0 CA--C 1.505 -0.78 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.259 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.6 OUTLIER -64.01 -4.61 3.57 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.175 -0.921 . . . . 0.0 110.675 -179.79 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.712 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.7 OUTLIER -105.17 -13.69 15.63 Favored 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 119.945 -0.702 . . . . 0.0 111.525 -179.883 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.545 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.14 12.64 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.273 0.471 . . . . 0.0 112.273 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.553 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.85 130.54 70.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.2 158.49 21.59 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.583 -0.817 . . . . 0.0 112.404 -179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -111.33 110.35 20.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.976 0.417 . . . . 0.0 110.105 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -98.93 77.2 2.18 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.145 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' HB3' ' OD1' ' A' ' 82' ' ' ASP . 69.1 m-20 53.02 59.39 4.49 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.514 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.607 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.21 34.55 36.65 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.351 -0.928 . . . . 0.0 111.69 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -149.67 110.7 4.36 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.426 -0.213 . . . . 0.0 110.426 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.479 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 44.2 m-85 -59.09 137.09 58.09 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.069 0.461 . . . . 0.0 111.074 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.433 HE21 ' HB2' ' A' ' 49' ' ' GLN . 2.7 tt0 -132.25 117.39 18.15 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.902 -179.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.439 ' HH2' HD22 ' A' ' 94' ' ' LEU . 92.1 m95 -70.79 114.71 9.14 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 177.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.62 27.02 7.34 Favored Glycine 0 CA--C 1.52 0.387 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.295 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.562 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -96.86 -52.53 1.5 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.564 -0.827 . . . . 0.0 113.247 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.573 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 24.7 tt0 73.69 142.46 0.07 Allowed 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 121.496 0.665 . . . . 0.0 111.45 -179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 66.65 38.54 3.96 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.377 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.553 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.3 p90 -78.23 -27.21 47.66 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.125 -0.695 . . . . 0.0 109.125 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.682 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.2 p -62.63 -28.21 69.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.956 -179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.619 ' HG3' HG23 ' A' ' 58' ' ' THR . 2.3 pt-20 -70.39 -18.16 63.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.116 0.484 . . . . 0.0 110.373 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.619 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.6 p -122.56 14.78 10.27 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-O 121.294 0.568 . . . . 0.0 110.163 -179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.45 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.16 149.49 46.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.863 179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -135.15 170.64 15.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 8.4 t70 43.17 57.64 3.66 Favored 'General case' 0 N--CA 1.471 0.577 0 O-C-N 123.475 0.484 . . . . 0.0 111.56 178.449 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.53 109.03 19.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.277 0.561 . . . . 0.0 112.077 -178.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.88 126.22 42.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.388 -0.823 . . . . 0.0 109.324 178.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.638 ' CE1' HD12 ' A' ' 94' ' ' LEU . 19.4 t80 -91.35 136.73 32.9 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.277 -178.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 6.5 t-160 -118.36 83.03 19.78 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.298 -0.864 . . . . 0.0 109.367 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.482 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 9.6 Cg_endo -57.35 -43.64 50.17 Favored 'Trans proline' 0 CA--C 1.509 -0.767 0 C-N-CA 123.345 2.697 . . . . 0.0 113.702 -178.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.7 mptt -118.48 82.04 1.78 Allowed 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.669 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 1.0 OUTLIER -63.41 109.81 1.73 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.271 179.432 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 48.53 -140.11 11.05 Favored Glycine 0 C--N 1.335 0.493 0 O-C-N 124.435 1.084 . . . . 0.0 113.623 178.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.61 -10.98 59.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.326 -0.437 . . . . 0.0 110.345 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.42 -23.23 53.99 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 55.54 39.4 31.02 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-N 115.014 -0.994 . . . . 0.0 110.266 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -99.25 120.38 58.24 Favored Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.488 -178.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 44.7 Cg_endo -69.39 108.32 1.98 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.28 1.987 . . . . 0.0 111.196 178.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.469 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.2 pp -134.53 142.48 40.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.497 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.1 tm? -112.02 126.62 55.35 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.411 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.497 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.83 141.45 51.22 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 178.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.35 168.6 21.94 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.757 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.7 mmt180 -86.07 115.15 23.49 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.607 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.7 mp -99.87 131.85 45.58 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.875 0.369 . . . . 0.0 111.096 -178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -78.22 140.02 38.92 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.245 179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 45' ' ' ASP . 27.4 t70 -106.94 171.51 7.33 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.032 -0.986 . . . . 0.0 109.438 179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 74.1 m -55.33 -27.23 45.72 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.0 0.429 . . . . 0.0 111.297 179.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.446 HD22 ' HB3' ' A' ' 86' ' ' GLU . 9.8 t30 -66.7 -20.28 65.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.233 0.539 . . . . 0.0 110.359 179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 87.7 39.69 7.03 Favored Glycine 0 CA--C 1.503 -0.692 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 11.4 pt-20 -117.19 -163.47 0.92 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.605 -0.797 . . . . 0.0 109.645 -178.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.422 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.9 p90 -144.65 128.74 17.6 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -135.87 118.9 16.4 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.485 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.5 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 8.8 p-10 -60.22 115.06 3.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.544 0.687 . . . . 0.0 112.561 -178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.607 ' HB2' HD22 ' A' ' 80' ' ' LEU . 28.9 mmt180 -115.3 175.11 5.66 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 177.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -144.33 146.09 32.36 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.741 -0.466 . . . . 0.0 109.741 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.479 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.6 p -136.22 143.72 35.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.905 -179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.529 ' HB3' HD22 ' A' ' 95' ' ' ASN . 23.0 m-80 -81.91 110.89 17.6 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.327 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.638 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.0 mt -79.26 0.88 26.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.529 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.4 m-80 -61.32 -16.29 44.4 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.151 0.5 . . . . 0.0 110.426 178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.43 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -63.4 -29.95 71.16 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.368 0.604 . . . . 0.0 109.715 179.047 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.526 HD12 ' HB3' ' A' ' 94' ' ' LEU . 15.0 mt -74.9 130.93 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 CA-C-N 115.215 -0.902 . . . . 0.0 110.871 -179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.485 ' HG3' HG13 ' A' ' 105' ' ' VAL . 10.9 pt20 -122.9 167.9 12.97 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.64 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 3.2 t30 -112.25 121.91 46.25 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.306 -179.198 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.1 t -113.15 94.13 2.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.341 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.3 t30 57.43 26.32 12.43 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.104 179.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.79 19.38 8.25 Favored Glycine 0 C--N 1.322 -0.232 0 C-N-CA 120.337 -0.935 . . . . 0.0 113.885 178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.502 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.7 ptp180 -130.55 135.03 47.51 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 117.22 0.51 . . . . 0.0 110.863 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 1.9 mp -86.06 124.66 32.75 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.121 179.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.485 HG13 ' HG3' ' A' ' 98' ' ' GLN . 6.9 p -135.04 132.22 53.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -78.86 140.01 38.22 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.632 -178.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.4 pt20 . . . . . 0 C--O 1.25 1.111 0 C-N-CA 124.403 1.081 . . . . 0.0 112.921 -178.671 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tpt . . . . . 0 N--CA 1.481 1.087 0 CA-C-O 120.548 0.214 . . . . 0.0 110.684 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.1 m -156.67 -176.18 5.83 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -68.8 -36.95 78.89 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.77 -23.92 32.42 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.355 -178.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -55.57 -32.81 63.33 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.118 0.485 . . . . 0.0 110.715 179.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.7 m -137.64 38.61 2.43 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.034 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.471 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 66.7 m -117.31 154.6 30.97 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.366 0.603 . . . . 0.0 112.033 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -149.35 164.44 34.89 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.956 -1.02 . . . . 0.0 108.596 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.522 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 85.3 m-20 54.93 32.64 18.37 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 123.486 0.491 . . . . 0.0 111.603 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.594 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -74.72 113.4 11.95 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.1 t -141.4 147.85 21.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.019 -0.537 . . . . 0.0 109.88 -178.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 37' ' ' LEU . 1.5 tp -85.37 132.69 34.2 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.243 0.544 . . . . 0.0 109.725 179.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.502 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.4 m -118.87 165.21 14.33 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.667 -178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.523 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.0 t-20 70.65 8.7 6.67 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 123.049 0.54 . . . . 0.0 111.659 178.333 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.0 13.5 52.69 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.696 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.485 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 109.85 19.65 8.07 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 -179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.692 ' HG2' HG21 ' A' ' 56' ' ' THR . 18.5 mtp180 -105.92 -16.73 14.56 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.648 -178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.562 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 24.7 m -130.27 121.49 26.23 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.84 0.353 . . . . 0.0 111.78 -178.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.493 ' CD2' HD13 ' A' ' 97' ' ' ILE . 63.1 tp -92.56 105.28 17.47 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 177.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.517 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.2 tmm_? -100.95 124.1 46.15 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -146.65 139.22 25.1 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.921 0.391 . . . . 0.0 110.7 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.522 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.9 mt-10 -97.96 113.12 24.87 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.469 ' HA ' ' O ' ' A' ' 6' ' ' SER . 4.7 p -125.03 145.6 49.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -76.6 144.17 39.76 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 178.498 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -92.46 -171.8 2.89 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.188 -179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.84 -32.17 69.18 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.058 0.456 . . . . 0.0 111.74 -178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -70.03 -24.52 63.29 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.198 179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.4 4.24 53.1 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.1 m-80 -88.81 142.46 27.64 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.473 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 42.0 m0 -74.91 125.64 29.28 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.215 -179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.8 t -124.64 137.45 57.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.539 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.425 ' HA ' ' HA ' ' A' ' 22' ' ' GLU . 26.4 m -94.81 109.91 21.83 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 178.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.519 ' HB3' HD13 ' A' ' 104' ' ' LEU . 9.7 t -111.38 151.92 27.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.207 0.527 . . . . 0.0 110.672 -178.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.517 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.8 mt-10 -136.22 132.35 35.74 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.283 179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.91 116.34 18.5 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 178.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.562 ' HA ' ' HA ' ' A' ' 18' ' ' THR . 11.0 m-20 -67.22 108.54 2.74 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.194 179.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.614 HD11 HD11 ' A' ' 12' ' ' LEU . 42.7 mt -59.34 -46.44 88.6 Favored 'General case' 0 CA--C 1.501 -0.921 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.851 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.48 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER -61.98 -4.84 1.78 Allowed 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.895 -179.594 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.544 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.72 -12.16 19.35 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 120.35 -0.54 . . . . 0.0 110.974 -179.692 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.487 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.55 12.51 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.887 0.375 . . . . 0.0 111.839 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.594 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.34 132.24 69.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.8 158.82 20.18 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.751 -178.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.411 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.6 t30 -112.96 109.44 18.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.795 0.331 . . . . 0.0 110.51 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -99.42 84.12 2.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.585 179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 2.0 m-20 50.23 46.91 24.42 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.422 179.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.616 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 87.74 43.11 5.85 Favored Glycine 0 N--CA 1.438 -1.176 0 C-N-CA 119.691 -1.242 . . . . 0.0 111.679 -179.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -160.47 114.06 2.11 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 62.7 m-85 -59.91 138.49 57.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.045 0.45 . . . . 0.0 111.272 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -131.07 116.21 17.46 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.214 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -69.33 115.13 8.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.939 178.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.16 31.45 6.2 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.236 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -103.54 -51.7 0.96 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.61 -0.805 . . . . 0.0 113.176 -179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.48 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.9 tt0 72.84 146.54 0.08 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.218 0.607 . . . . 0.0 111.172 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.573 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.3 m-20 73.08 30.07 1.67 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.112 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.594 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.0 p90 -76.29 -31.43 58.23 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.692 HG21 ' HG2' ' A' ' 17' ' ' ARG . 20.0 p -62.45 -30.5 71.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.882 -179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.623 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.5 pt-20 -67.79 -15.59 63.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.249 0.547 . . . . 0.0 110.477 179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.623 HG23 ' HG3' ' A' ' 57' ' ' GLU . 67.2 p -124.1 10.74 8.79 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.426 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.63 147.3 47.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.05 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.91 166.11 24.86 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.329 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.448 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 2.5 t70 49.08 56.03 8.4 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.022 0.439 . . . . 0.0 110.639 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.497 HG23 ' HB2' ' A' ' 78' ' ' ALA . 2.1 mt -88.39 109.4 19.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 CA-C-O 121.213 0.53 . . . . 0.0 111.603 -178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -123.91 123.72 41.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.812 179.11 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.683 ' CE1' HD12 ' A' ' 94' ' ' LEU . 13.6 t80 -92.51 135.49 34.02 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.691 -178.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.585 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 13.7 t60 -123.2 86.61 51.5 Favored Pre-proline 0 C--N 1.326 -0.428 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.474 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 11.5 Cg_endo -57.06 -37.68 97.74 Favored 'Trans proline' 0 CA--C 1.507 -0.834 0 C-N-CA 124.213 3.276 . . . . 0.0 114.839 -177.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.525 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 0.2 OUTLIER -128.15 87.77 2.65 Favored 'General case' 0 C--N 1.291 -1.939 0 CA-C-N 115.098 -0.956 . . . . 0.0 112.155 -178.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.585 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 27.3 tt0 -66.51 107.06 1.94 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.852 178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 56.1 -150.91 23.04 Favored Glycine 0 C--N 1.334 0.461 0 CA-C-N 115.363 -0.835 . . . . 0.0 113.538 179.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -74.3 -18.16 60.75 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.057 0.456 . . . . 0.0 110.051 179.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.64 -25.24 62.92 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.875 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.525 ' HG2' ' HB3' ' A' ' 67' ' ' LYS . 40.2 mt-10 50.2 57.13 6.92 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.687 -179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 4.1 tp60 -102.83 117.99 59.36 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.16 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 56.4 Cg_endo -71.74 109.51 2.67 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.076 1.851 . . . . 0.0 112.087 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.407 HD11 ' HE ' ' A' ' 77' ' ' ARG . 1.1 pp -133.69 141.61 43.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.512 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -113.71 126.28 55.06 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.979 -179.694 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.512 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -122.65 139.83 53.51 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.035 179.303 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.631 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.95 167.72 28.64 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.959 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.59 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.2 mmt180 -84.78 115.59 22.8 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.616 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.2 mp -100.61 126.57 47.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.82 0.343 . . . . 0.0 111.445 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -85.0 141.98 29.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.604 179.581 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 4.1 p-10 -101.33 175.34 5.61 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.535 -0.302 . . . . 0.0 110.714 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 72.6 m -60.36 -24.41 65.04 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 -179.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -74.54 -28.32 60.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.913 0.387 . . . . 0.0 110.58 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.96 37.31 2.37 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.619 -0.8 . . . . 0.0 113.194 178.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.653 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 6.9 pt-20 -113.26 -168.43 1.33 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -147.06 129.42 15.77 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 179.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -139.59 117.46 11.68 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.631 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 5.6 p-10 -63.3 122.89 17.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.302 0.572 . . . . 0.0 111.353 -179.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.605 ' HB2' HD22 ' A' ' 80' ' ' LEU . 38.1 mmt180 -115.94 179.49 3.97 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 177.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -144.5 146.63 32.51 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 13.0 p -136.24 146.93 28.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.023 0 CA-C-O 121.325 0.583 . . . . 0.0 111.089 -179.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.5 ' HB3' HD22 ' A' ' 95' ' ' ASN . 10.2 m120 -81.83 109.64 16.4 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.191 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.683 HD12 ' CE1' ' A' ' 64' ' ' PHE . 5.2 mt -80.14 4.45 17.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.384 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.5 HD22 ' HB3' ' A' ' 93' ' ' ASN . 17.4 m-80 -65.14 -10.82 33.97 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.077 0.465 . . . . 0.0 110.271 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.529 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.38 -18.78 63.05 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.0 109.653 178.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.509 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -86.96 126.63 40.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.049 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -122.25 161.78 22.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.927 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -105.69 117.66 34.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.569 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.507 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 53.4 t -113.73 96.3 4.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.721 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 62.78 23.15 13.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.371 179.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.78 21.59 9.01 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.431 -0.89 . . . . 0.0 113.38 178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.507 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 12.2 ptp180 -131.03 137.56 49.23 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.99 0.395 . . . . 0.0 110.857 179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.519 HD13 ' HB3' ' A' ' 33' ' ' SER . 3.0 mp -84.34 129.21 34.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.802 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p -143.32 131.54 19.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.548 179.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -85.22 145.53 27.53 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.231 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.529 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 86.5 mm-40 . . . . . 0 C--O 1.252 1.184 0 CA-C-O 118.414 -0.803 . . . . 0.0 110.468 -179.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.481 1.086 0 N-CA-C 110.451 -0.203 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 19.9 m -157.0 -177.37 6.57 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 15.3 p90 -68.14 -38.5 82.22 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 178.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -23.63 13.5 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 115.395 -0.82 . . . . 0.0 112.688 -178.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -54.84 -34.52 62.96 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.081 0.467 . . . . 0.0 110.671 179.238 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.498 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 34.7 m -134.96 36.2 3.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.525 179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.579 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 70.4 m -119.95 153.43 35.95 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.171 0.51 . . . . 0.0 111.458 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.41 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -150.02 169.75 20.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.578 179.774 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.557 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 6.0 t-20 56.89 28.21 14.23 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.438 0.461 . . . . 0.0 110.692 178.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.562 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -74.45 113.78 12.07 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.759 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 23.1 t -142.87 153.93 17.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.801 -179.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -88.82 136.01 33.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.061 0.458 . . . . 0.0 110.076 179.281 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 23.9 m -116.77 163.06 16.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.567 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.542 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 3.5 t-20 71.26 6.57 5.84 Favored 'General case' 0 N--CA 1.463 0.212 0 O-C-N 123.491 0.494 . . . . 0.0 111.554 177.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.4 22.95 27.9 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.893 -0.67 . . . . 0.0 111.634 -179.485 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.592 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 103.26 21.07 10.28 Favored Glycine 0 N--CA 1.444 -0.81 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.154 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.684 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.5 mtp180 -107.27 -16.42 14.4 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.562 0.22 . . . . 0.0 110.514 -179.266 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.668 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 28.0 m -131.72 130.48 42.01 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.897 0.38 . . . . 0.0 111.624 -178.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.499 ' HB2' HD21 ' A' ' 37' ' ' LEU . 54.4 tp -99.91 108.7 21.01 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.562 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.6 tmm_? -110.7 125.13 53.15 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.088 -179.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.414 ' N ' ' HD2' ' A' ' 20' ' ' ARG . . . -146.84 155.09 42.07 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.639 179.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.557 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 7.7 mt-10 -107.85 112.87 25.71 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.553 ' HB3' ' OG ' ' A' ' 7' ' ' SER . 5.1 p -123.97 146.22 48.64 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.606 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -78.94 143.86 35.39 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.636 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -90.23 -171.99 3.31 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 111.766 0.284 . . . . 0.0 111.766 -179.132 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.9 -27.37 69.11 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.082 0.468 . . . . 0.0 111.214 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -73.54 -20.88 60.53 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.555 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.42 10.22 54.11 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.6 -179.672 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.8 t-20 -96.31 145.06 25.92 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 -179.591 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.467 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 43.8 m0 -77.21 125.53 29.48 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.47 -179.672 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.2 t -126.5 140.85 47.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.72 -179.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.7 m -91.77 112.88 24.99 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.328 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.493 ' HB2' HD13 ' A' ' 104' ' ' LEU . 5.5 m -111.21 146.96 36.0 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.045 0.45 . . . . 0.0 111.187 -178.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.562 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.6 mt-10 -133.39 139.72 46.94 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.537 -179.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -141.06 113.85 8.33 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.09 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' THR . 20.8 m-20 -67.57 110.99 3.91 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.142 179.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.687 HD11 HD11 ' A' ' 12' ' ' LEU . 80.4 mt -61.23 -43.13 99.37 Favored 'General case' 0 CA--C 1.502 -0.891 0 CA-C-O 121.678 0.751 . . . . 0.0 109.778 179.889 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.505 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.5 -3.79 2.37 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.796 -179.902 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -106.32 -9.59 16.73 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.291 179.45 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.532 HG23 HG23 ' A' ' 39' ' ' THR . 2.5 pp -144.08 10.25 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.181 0.437 . . . . 0.0 112.181 -179.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.504 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 132.59 69.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 -179.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -128.92 159.05 22.15 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.623 -0.799 . . . . 0.0 111.87 -179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.477 ' HB3' ' OG1' ' A' ' 58' ' ' THR . 13.3 t30 -111.43 113.34 25.72 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.205 0.526 . . . . 0.0 110.054 178.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -97.76 78.57 2.61 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.525 -0.762 . . . . 0.0 109.07 179.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.506 ' HB2' ' H ' ' A' ' 83' ' ' CYS . 4.4 p-10 40.4 63.5 1.1 Allowed 'General case' 0 N--CA 1.471 0.622 0 O-C-N 124.143 0.902 . . . . 0.0 112.48 179.858 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 83.87 38.21 10.69 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.072 179.493 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -159.27 115.86 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 122.705 -0.291 . . . . 0.0 110.309 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.532 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 40.4 m-85 -60.96 138.0 58.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.901 0.381 . . . . 0.0 110.613 178.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 13.1 tt0 -128.06 115.23 18.14 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.483 -178.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 78.0 m95 -73.98 113.68 11.43 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 177.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.12 41.27 3.3 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.691 -179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -112.53 -50.87 0.55 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.601 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.505 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 20.0 tt0 73.32 141.46 0.06 Allowed 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.309 0.643 . . . . 0.0 112.033 -179.881 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.461 ' OD1' ' HB3' ' A' ' 57' ' ' GLU . 5.8 t-20 68.58 38.56 2.28 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 114.583 -1.19 . . . . 0.0 111.078 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.504 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 9.2 p90 -77.13 -26.6 53.34 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.529 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.684 HG21 ' HG2' ' A' ' 17' ' ' ARG . 38.4 p -64.14 -19.78 65.53 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.634 -179.47 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.676 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.1 pt-20 -74.76 -19.68 60.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.148 0.499 . . . . 0.0 109.848 179.275 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.676 HG23 ' HG3' ' A' ' 57' ' ' GLU . 72.6 p -123.34 18.12 9.8 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.839 -0.618 . . . . 0.0 109.936 -179.524 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -133.56 150.35 51.65 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.88 -179.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.741 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -141.82 172.86 12.11 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.209 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' HB3' ' HE ' ' A' ' 79' ' ' ARG . 3.5 t70 44.91 55.1 6.34 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 123.786 0.679 . . . . 0.0 110.997 179.578 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 2.8 mt -84.03 109.13 17.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.177 0.513 . . . . 0.0 112.033 -178.035 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.448 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -120.11 123.24 42.88 Favored 'General case' 0 CA--C 1.517 -0.307 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.122 179.18 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' HD12 ' A' ' 94' ' ' LEU . 11.3 t80 -93.38 133.49 36.58 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.671 -178.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.732 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 2.5 t60 -124.81 87.41 55.02 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.378 178.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.524 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 9.7 Cg_endo -55.99 -34.5 92.39 Favored 'Trans proline' 0 N--CA 1.479 0.646 0 C-N-CA 124.157 3.238 . . . . 0.0 114.14 -178.664 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.524 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -129.18 85.82 2.36 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.962 179.583 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.732 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 32.8 tt0 -68.46 113.92 6.43 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.559 179.772 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.61 -147.43 10.94 Favored Glycine 0 C--N 1.337 0.633 0 O-C-N 124.322 1.014 . . . . 0.0 113.695 178.384 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -78.57 -13.72 59.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.55 0.69 . . . . 0.0 109.356 179.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.75 -25.5 65.67 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.739 -1.119 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 56.45 42.36 27.6 Favored 'General case' 0 CA--C 1.519 -0.224 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.825 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -107.89 128.27 26.12 Favored Pre-proline 0 C--N 1.325 -0.498 0 C-N-CA 120.456 -0.497 . . . . 0.0 111.535 -178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.432 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.2 Cg_endo -73.63 109.2 2.81 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.524 2.149 . . . . 0.0 111.584 178.985 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.594 HD11 HH21 ' A' ' 77' ' ' ARG . 1.2 pp -134.43 142.25 41.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.493 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.0 tm? -113.41 123.97 51.33 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.284 -179.042 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.594 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.5 139.45 52.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.909 178.86 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.558 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.15 169.44 24.52 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.745 -179.677 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.741 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.9 mmt85 -85.1 115.12 22.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -101.63 130.54 48.0 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.698 -179.336 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.759 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -74.23 135.86 42.72 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.211 179.211 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.424 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 3.1 m-20 -96.13 172.76 7.78 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.438 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . 0.506 ' H ' ' HB2' ' A' ' 45' ' ' ASP . 12.1 p -56.78 -27.95 60.51 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -74.26 -18.67 60.7 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.04 0.448 . . . . 0.0 111.526 -179.206 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.17 36.7 5.11 Favored Glycine 0 CA--C 1.506 -0.477 0 N-CA-C 111.165 -0.774 . . . . 0.0 111.165 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.759 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 16.3 pt-20 -119.24 -167.46 1.4 Allowed 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 -179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -137.57 133.4 34.41 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.962 0.887 . . . . 0.0 110.874 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -138.67 118.45 13.18 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-N 114.161 -1.381 . . . . 0.0 109.594 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 6.8 p-10 -66.57 118.42 10.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.542 0.686 . . . . 0.0 111.009 -179.345 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.544 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.4 mmt180 -114.06 175.0 5.66 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 178.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -140.7 148.34 40.62 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.183 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.532 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.4 p -136.8 144.11 33.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.588 0.709 . . . . 0.0 111.402 -179.067 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.448 ' O ' ' HD2' ' A' ' 96' ' ' ARG . 0.8 OUTLIER -78.62 107.48 11.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.718 -1.128 . . . . 0.0 110.576 -179.659 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.612 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.6 mt -79.97 3.43 20.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.265 0.555 . . . . 0.0 109.897 179.49 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.426 HD22 ' HB3' ' A' ' 93' ' ' ASN . 24.0 m-80 -61.5 -19.08 61.68 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.474 -0.784 . . . . 0.0 109.915 178.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.448 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -64.67 -21.94 66.86 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.565 -0.743 . . . . 0.0 110.512 179.279 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.59 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 10.6 mt -85.38 126.96 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.964 179.857 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.443 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 92.1 mt-30 -125.09 151.65 45.4 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.206 -179.193 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.428 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 1.5 t30 -92.17 117.67 30.09 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.586 -179.609 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 58.3 t -113.65 97.13 5.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.595 179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 65.1 t30 58.75 25.9 14.02 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.719 179.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.54 20.74 9.84 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.28 -0.962 . . . . 0.0 113.527 178.045 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -131.09 140.76 50.07 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.931 0.366 . . . . 0.0 110.496 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.493 HD13 ' HB2' ' A' ' 33' ' ' SER . 1.7 mp -86.07 115.69 23.81 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 178.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 52.9 t -115.04 121.92 68.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.688 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -83.33 144.82 29.43 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.428 -0.806 . . . . 0.0 110.529 179.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 54.1 mt-30 . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.294 -0.86 . . . . 0.0 111.468 179.26 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tpt . . . . . 0 N--CA 1.479 0.985 0 CA-C-O 120.592 0.234 . . . . 0.0 110.656 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.462 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 39.7 m -159.33 -178.76 7.4 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -64.54 -39.56 93.98 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.945 0.402 . . . . 0.0 110.177 179.492 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -54.79 -25.33 27.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.678 -0.692 . . . . 0.0 112.595 -178.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -53.94 -32.48 53.86 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.068 0.461 . . . . 0.0 110.973 179.457 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.507 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 37.6 m -134.82 33.38 3.19 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 -179.739 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 74.3 m -116.2 156.17 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.564 0.697 . . . . 0.0 112.355 -179.274 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 2.8 ptp180 -154.02 169.22 24.03 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.057 -1.09 . . . . 0.0 108.057 179.223 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.615 ' HB3' ' HG3' ' A' ' 22' ' ' GLU . 61.3 t30 56.13 32.43 20.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.423 0.63 . . . . 0.0 110.476 -179.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.57 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -78.89 113.7 17.21 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.446 -179.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 35.4 t -143.43 146.56 21.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 -179.127 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -80.88 143.26 32.84 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 179.01 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.8 m -128.5 163.31 25.23 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.42 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.12 6.15 5.49 Favored 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.676 0.61 . . . . 0.0 111.472 178.437 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.6 23.8 17.66 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.178 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.524 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 100.55 14.95 30.94 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.193 -179.8 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.5 mtp180 -98.75 -16.76 18.83 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.82 -0.224 . . . . 0.0 111.034 -178.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 31.7 m -133.27 129.97 38.34 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.841 0.353 . . . . 0.0 111.873 -178.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.452 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.99 108.39 21.12 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.522 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.5 tmm_? -106.61 124.45 49.63 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.152 -179.672 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.93 159.9 44.26 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 179.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.615 ' HG3' ' HB3' ' A' ' 9' ' ' ASN . 5.1 mt-10 -114.91 110.4 19.6 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.587 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.507 ' HA ' ' O ' ' A' ' 6' ' ' SER . 48.2 t -119.7 144.67 47.08 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -178.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.536 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -72.15 144.34 48.62 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.969 -0.56 . . . . 0.0 109.614 179.385 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.1 p30 -90.89 -171.74 3.12 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.955 -179.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.83 -35.29 68.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.903 0.382 . . . . 0.0 111.7 -179.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -73.19 -24.47 60.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.031 0.444 . . . . 0.0 111.123 -179.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.18 -0.95 33.21 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.709 -179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.536 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.6 t30 -83.63 144.95 29.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 -179.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 54.2 m0 -75.3 125.23 28.54 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.509 -179.885 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.2 t -120.73 130.62 74.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.394 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 10.8 m -80.22 106.94 12.61 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.622 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.4 m -110.08 135.75 50.4 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.434 -178.11 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.522 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 15.4 mt-10 -126.87 131.95 51.05 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.539 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.78 116.21 19.15 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.086 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.584 ' O ' HG22 ' A' ' 39' ' ' THR . 16.2 m-20 -67.3 109.41 3.11 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.66 179.868 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD11 HD11 ' A' ' 12' ' ' LEU . 34.6 mt -59.59 -46.56 88.57 Favored 'General case' 0 CA--C 1.497 -1.058 0 CA-C-O 121.652 0.739 . . . . 0.0 110.052 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.648 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 10.3 t70 -63.79 -4.41 3.14 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.593 179.851 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.584 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -100.09 -11.67 20.32 Favored 'General case' 0 C--N 1.317 -0.823 0 C-N-CA 119.679 -0.808 . . . . 0.0 110.571 179.734 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.515 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -145.82 13.41 0.2 Allowed 'Isoleucine or valine' 0 C--O 1.223 -0.34 0 CA-C-O 121.066 0.46 . . . . 0.0 112.053 -179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.564 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.55 130.85 70.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.938 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.36 159.03 21.85 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.219 -0.991 . . . . 0.0 112.509 -179.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.423 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 9.2 t30 -111.19 111.43 22.5 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 178.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -105.74 85.96 2.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.735 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.658 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 6.6 m-20 51.59 50.97 17.67 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.306 178.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 81.17 41.19 10.48 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.193 179.811 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 53.8 t-80 -158.18 118.27 3.3 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 178.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.507 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 54.0 m-85 -63.71 136.37 57.42 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.119 0.485 . . . . 0.0 110.607 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -128.78 115.64 18.26 Favored 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.151 -179.56 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -69.49 115.04 8.29 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.639 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.13 22.63 8.16 Favored Glycine 0 N--CA 1.449 -0.476 0 CA-C-N 115.493 -0.776 . . . . 0.0 112.41 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -92.99 -54.37 1.76 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.382 -0.914 . . . . 0.0 114.002 -178.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.648 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 21.5 tt0 72.59 139.03 0.05 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.188 0.595 . . . . 0.0 110.803 -178.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.641 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 14.7 m120 74.1 39.78 0.48 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.615 0.721 . . . . 0.0 110.516 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.564 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.3 p90 -84.79 -26.33 27.59 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.282 -179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.667 HG21 ' HG2' ' A' ' 17' ' ' ARG . 71.2 p -68.4 -17.95 64.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.393 -179.238 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.711 ' HG3' HG23 ' A' ' 58' ' ' THR . 9.5 pt-20 -78.03 -13.13 59.98 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.235 0.54 . . . . 0.0 109.857 179.402 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.711 HG23 ' HG3' ' A' ' 57' ' ' GLU . 73.5 p -127.67 14.97 7.02 Favored 'General case' 0 N--CA 1.447 -0.615 0 CA-C-N 115.793 -0.639 . . . . 0.0 109.772 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -127.46 149.95 49.87 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.848 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.603 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -140.79 171.01 14.69 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.078 -0.965 . . . . 0.0 108.82 -179.768 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.0 t70 49.02 54.69 10.49 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.952 0.406 . . . . 0.0 110.393 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 1.9 mt -88.66 108.91 19.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.306 0.574 . . . . 0.0 112.326 -177.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.17 123.63 40.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.551 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.656 ' CE1' HD12 ' A' ' 94' ' ' LEU . 15.3 t80 -91.67 133.28 35.71 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.781 -178.441 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.82 87.94 43.36 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.143 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.11 -36.8 79.67 Favored 'Trans proline' 0 CA--C 1.509 -0.74 0 C-N-CA 123.633 2.889 . . . . 0.0 113.623 -178.376 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.37 83.48 2.14 Favored 'General case' 0 C--N 1.295 -1.764 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.745 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -67.17 113.92 5.51 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.317 179.472 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 50.74 -143.95 12.85 Favored Glycine 0 C--N 1.335 0.491 0 O-C-N 124.335 1.022 . . . . 0.0 113.807 178.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -81.83 -11.43 58.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.267 0.556 . . . . 0.0 109.956 179.324 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.15 -26.05 61.05 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.15 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 57.25 42.66 24.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 115.001 -1.0 . . . . 0.0 110.284 -179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.98 125.18 36.08 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.223 -178.539 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.465 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 58.9 Cg_endo -72.23 110.48 2.96 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.762 2.308 . . . . 0.0 112.467 179.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.724 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.38 141.89 39.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.024 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.522 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -113.31 128.44 56.47 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.3 -179.35 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.724 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -123.94 144.57 49.71 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.059 0.457 . . . . 0.0 110.21 178.878 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.37 170.05 18.08 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.93 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.603 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 3.9 mmt180 -85.91 115.71 23.7 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.731 HD22 ' HB2' ' A' ' 90' ' ' ARG . 3.2 mp -98.52 127.15 44.34 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.096 0.474 . . . . 0.0 111.629 -178.494 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -87.79 142.11 28.07 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.806 179.611 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.669 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -97.94 173.74 6.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.672 -179.603 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 74.8 m -60.4 -23.41 64.33 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.433 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.403 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 50.0 t30 -77.12 -28.64 54.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.964 0.411 . . . . 0.0 110.623 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.09 38.04 1.74 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.294 179.141 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.669 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 15.9 pt-20 -113.65 -168.92 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.183 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 p90 -147.19 132.98 18.96 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.847 0.832 . . . . 0.0 111.034 179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 5.7 m-70 -140.19 120.45 13.89 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 114.234 -1.348 . . . . 0.0 109.752 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.571 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 9.8 p-10 -67.13 116.4 7.89 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.184 0.516 . . . . 0.0 111.585 -178.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.731 ' HB2' HD22 ' A' ' 80' ' ' LEU . 32.1 mmt180 -116.79 177.51 4.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.181 -0.463 . . . . 0.0 109.941 178.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -144.94 147.15 32.39 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 -179.346 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.507 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.8 p -134.37 143.38 38.17 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.389 0.614 . . . . 0.0 110.86 -179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.584 ' HB3' HD22 ' A' ' 95' ' ' ASN . 31.1 m-80 -82.83 110.7 18.07 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.817 -179.269 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.656 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.1 mt -80.61 3.15 22.86 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 -179.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.584 HD22 ' HB3' ' A' ' 93' ' ' ASN . 18.9 m-80 -61.47 -15.47 37.88 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.029 0.442 . . . . 0.0 110.015 178.392 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.29 -23.5 67.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.139 178.703 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.596 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.6 mt -84.54 124.19 39.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.005 -179.57 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 77.3 mt-30 -119.65 163.79 16.85 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.714 179.164 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.461 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 4.9 t30 -106.22 120.19 41.18 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.061 0.458 . . . . 0.0 111.635 -178.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.506 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.8 t -112.61 94.14 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.349 179.242 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 62.4 t30 61.22 23.43 13.65 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.929 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.4 20.85 7.95 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 119.965 -1.112 . . . . 0.0 113.549 178.533 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.506 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 17.8 ptp180 -130.29 138.96 50.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.996 0.398 . . . . 0.0 110.477 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.622 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 64.1 mt -85.47 117.48 24.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.461 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 61.7 t -121.56 123.45 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.667 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -85.89 145.75 27.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.516 -179.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 . . . . . 0 C--O 1.246 0.917 0 CA-C-O 118.736 -0.649 . . . . 0.0 110.584 178.724 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 tpt . . . . . 0 N--CA 1.477 0.916 0 CA-C-O 120.764 0.316 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.4 m -150.46 -176.58 5.54 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 -179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -67.07 -36.2 81.49 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.177 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.774 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -57.06 -29.13 63.17 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.643 -179.126 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -54.43 -33.55 59.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.168 179.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.527 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 58.7 m -134.13 35.83 3.26 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.857 -179.36 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.774 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.7 p -117.21 155.88 28.67 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.018 0.437 . . . . 0.0 111.443 -179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -152.31 167.62 28.07 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 178.493 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 55.01 32.53 18.35 Favored 'General case' 0 C--N 1.327 -0.378 0 O-C-N 123.63 0.581 . . . . 0.0 111.17 -179.056 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.529 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.08 113.76 15.15 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.738 179.755 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 38.7 t -141.56 151.61 19.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.298 -178.57 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 37' ' ' LEU . 1.2 tp -87.58 142.37 27.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 178.861 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.415 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 11.7 m -129.68 163.58 25.81 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.934 -179.304 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 2.6 t-20 73.12 9.12 5.34 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 123.165 0.586 . . . . 0.0 111.441 178.258 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.8 25.92 16.33 Favored Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.991 -0.843 . . . . 0.0 110.991 -179.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 94.92 22.18 23.86 Favored Glycine 0 N--CA 1.442 -0.906 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.845 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.71 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.9 mtp180 -106.32 -18.74 13.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.607 0.242 . . . . 0.0 110.641 -178.927 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.489 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.4 m -128.37 125.64 39.07 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.372 . . . . 0.0 111.846 -178.63 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.482 ' HB2' HD21 ' A' ' 37' ' ' LEU . 65.4 tp -96.17 106.73 18.97 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.853 178.2 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 5.4 tmm_? -103.02 124.28 48.21 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 -179.608 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.1 142.71 24.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.9 0.381 . . . . 0.0 111.114 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 7' ' ' SER . 8.3 mt-10 -98.94 110.03 22.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.396 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 6' ' ' SER . 15.4 t -122.36 139.52 53.74 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.999 0.428 . . . . 0.0 110.617 -178.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.473 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -69.32 144.07 53.62 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.892 179.85 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.481 ' HB3' HG21 ' A' ' 31' ' ' VAL . 8.9 p30 -91.42 -170.25 2.56 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.179 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -33.83 66.25 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.354 0.501 . . . . 0.0 112.354 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -76.29 -22.53 54.93 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.092 0.472 . . . . 0.0 110.992 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.87 -0.95 33.82 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.694 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.473 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 5.4 m-80 -84.84 141.63 30.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.561 0.18 . . . . 0.0 110.517 179.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 24' ' ' ARG . 54.0 m0 -72.51 124.33 24.97 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.197 0.522 . . . . 0.0 111.149 -179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.481 HG21 ' HB3' ' A' ' 25' ' ' ASN . 6.3 t -116.57 119.77 62.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.924 179.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 15.7 m -78.43 104.34 8.96 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.491 ' HB3' HD13 ' A' ' 104' ' ' LEU . 8.7 t -111.52 152.94 26.92 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.149 0.5 . . . . 0.0 110.425 -178.128 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.544 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.0 mt-10 -134.74 131.37 37.52 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.486 -179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.613 HD11 HG12 ' A' ' 40' ' ' ILE . 12.0 tp -125.52 115.09 19.65 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.775 178.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.579 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -66.28 109.13 2.56 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.914 179.17 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.605 HD11 HD11 ' A' ' 12' ' ' LEU . 37.2 mt -60.8 -43.44 98.13 Favored 'General case' 0 CA--C 1.499 -0.989 0 CA-C-O 121.702 0.763 . . . . 0.0 109.499 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.492 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.35 -5.43 3.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.487 179.638 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.579 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -101.16 -14.59 17.67 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 120.463 -0.495 . . . . 0.0 111.426 -179.263 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.613 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -144.51 13.68 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 120.903 0.383 . . . . 0.0 112.029 -179.238 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.538 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.52 130.3 70.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.492 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.52 160.89 21.62 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.455 -0.878 . . . . 0.0 112.221 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -111.18 112.8 24.84 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 178.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -109.52 87.16 2.44 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.299 -179.83 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 33.1 t70 53.27 58.62 5.07 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.791 -0.641 . . . . 0.0 111.6 179.046 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 69.72 42.53 70.81 Favored Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 119.929 -1.129 . . . . 0.0 111.992 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 26.8 t60 -158.3 117.17 3.1 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 179.188 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.515 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 57.4 m-85 -61.9 138.56 58.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.227 0.537 . . . . 0.0 110.79 179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.8 tt0 -128.45 116.68 20.1 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.303 -179.838 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 87.5 m95 -70.24 115.02 8.95 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.42 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.3 28.75 7.04 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.024 -179.735 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.15 -52.44 1.25 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.878 -179.814 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 27.9 tt0 73.05 143.45 0.07 Allowed 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.178 0.591 . . . . 0.0 111.021 -179.077 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.599 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 80.4 m-20 69.14 36.66 2.34 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.576 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.9 p90 -77.28 -30.08 54.14 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.584 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.71 HG21 ' HG2' ' A' ' 17' ' ' ARG . 21.4 p -63.9 -23.98 67.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.14 -0.937 . . . . 0.0 112.187 -178.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.645 ' HG3' HG23 ' A' ' 58' ' ' THR . 6.1 pt-20 -73.69 -15.75 61.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.211 0.529 . . . . 0.0 109.929 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.645 HG23 ' HG3' ' A' ' 57' ' ' GLU . 82.5 p -123.86 14.26 9.26 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.996 -179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.58 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -130.58 154.43 47.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.463 -179.503 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.555 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -145.95 173.65 11.96 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.042 179.063 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.582 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 13.4 t70 50.45 53.31 13.15 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 121.11 0.481 . . . . 0.0 110.211 179.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.403 ' HA ' ' HB2' ' A' ' 78' ' ' ALA . 1.9 mt -88.52 109.24 19.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.176 0.513 . . . . 0.0 111.947 -178.025 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.452 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -126.7 123.93 38.63 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.762 178.8 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.664 ' CE1' HD12 ' A' ' 94' ' ' LEU . 24.2 t80 -92.58 136.04 33.56 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.27 0.557 . . . . 0.0 112.01 -178.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.603 ' HD2' ' HA ' ' A' ' 68' ' ' GLU . 4.7 t60 -123.32 89.75 50.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.398 -0.819 . . . . 0.0 108.987 178.316 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.447 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.7 Cg_endo -60.63 -41.01 50.84 Favored 'Trans proline' 0 N--CA 1.477 0.556 0 C-N-CA 123.836 3.024 . . . . 0.0 114.519 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -124.84 88.29 2.86 Favored 'General case' 0 C--N 1.297 -1.687 0 CA-C-N 115.112 -0.949 . . . . 0.0 110.891 -179.832 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.603 ' HA ' ' HD2' ' A' ' 65' ' ' HIS . 15.6 tt0 -73.26 108.64 6.25 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.528 178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.51 -149.02 14.56 Favored Glycine 0 C--N 1.331 0.3 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.713 178.337 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.52 -18.85 61.04 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.107 0.479 . . . . 0.0 110.001 179.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.74 -25.82 63.1 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.163 178.849 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 48.6 49.62 18.25 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.622 -179.47 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -102.3 122.42 46.72 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.487 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.558 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 52.7 Cg_endo -71.49 108.12 2.31 Favored 'Trans proline' 0 N--CA 1.455 -0.749 0 C-N-CA 122.287 1.991 . . . . 0.0 111.331 179.013 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.465 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -131.87 140.74 47.32 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.651 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.494 HD22 ' N ' ' A' ' 77' ' ' ARG . 2.0 tm? -112.41 125.0 53.73 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.085 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.494 ' N ' HD22 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -120.58 139.56 52.78 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.134 179.285 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.573 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -160.16 169.55 23.04 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.576 -0.738 . . . . 0.0 109.792 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.582 ' HG2' ' HB3' ' A' ' 61' ' ' ASP . 5.0 mmt85 -84.96 115.67 22.94 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 -179.714 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.654 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.1 mp -101.26 132.11 46.94 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.56 -178.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.803 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -77.4 140.41 39.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.438 179.055 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.633 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -102.94 174.97 5.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.478 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 57.5 m -59.56 -24.37 63.66 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -179.554 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . 0.42 ' H ' ' CG ' ' A' ' 82' ' ' ASP . 5.2 t30 -73.65 -28.08 61.58 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.074 0.464 . . . . 0.0 110.833 179.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 103.71 37.62 2.95 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.156 179.607 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.803 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 9.0 pt-20 -119.46 -170.2 1.89 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 179.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.627 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 85.4 m-85 -138.7 130.45 27.76 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-O 121.064 0.459 . . . . 0.0 110.709 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -138.88 123.31 18.32 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.436 -179.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.573 ' HA ' ' O ' ' A' ' 78' ' ' ALA . 4.9 p-10 -61.81 116.89 5.2 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.357 0.598 . . . . 0.0 112.423 -179.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.654 ' HB2' HD22 ' A' ' 80' ' ' LEU . 37.8 mmt180 -114.69 179.29 3.99 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 177.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -143.51 151.0 39.74 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.903 0.382 . . . . 0.0 110.023 -179.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.515 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.5 p -138.85 145.24 28.09 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 121.362 0.601 . . . . 0.0 110.918 179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.491 ' HB3' HD22 ' A' ' 95' ' ' ASN . 29.8 m-80 -82.66 109.95 17.29 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.572 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.664 HD12 ' CE1' ' A' ' 64' ' ' PHE . 4.1 mt -81.0 3.72 22.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.011 -179.402 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.558 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 22.1 m-80 -63.11 -17.87 62.79 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.197 0.522 . . . . 0.0 109.726 178.732 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -29.24 69.71 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.944 178.533 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.543 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.0 mt -77.24 127.3 38.18 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.403 -179.746 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -121.19 165.97 14.63 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.828 -178.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.402 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 7.1 t30 -110.77 117.95 34.84 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.456 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.484 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 43.2 t -113.14 96.74 4.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.337 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 63.43 22.21 13.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.051 179.116 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.73 22.67 8.31 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.532 -0.842 . . . . 0.0 113.592 178.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.6 ptp180 -130.21 136.38 49.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 117.177 0.488 . . . . 0.0 110.661 179.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.491 HD13 ' HB3' ' A' ' 33' ' ' SER . 2.8 mp -80.65 116.76 20.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.12 0.486 . . . . 0.0 110.888 179.283 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 62.0 t -121.89 123.96 70.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.48 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -82.06 145.69 30.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.868 0.366 . . . . 0.0 110.871 -179.314 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.994 178.875 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' HG3' ' H ' ' A' ' 2' ' ' SER . 6.5 tpt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.507 ' H ' ' HG3' ' A' ' 1' ' ' MET . 15.7 m -102.26 -179.75 4.08 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 -179.535 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -62.5 -37.68 86.94 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.923 0.392 . . . . 0.0 110.092 179.855 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.766 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -24.74 63.52 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.73 -178.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -57.13 -33.64 67.58 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.106 0.479 . . . . 0.0 110.274 179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.442 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 18.2 m -133.42 36.86 3.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.362 179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.766 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 82.5 p -117.28 155.82 28.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.162 0.505 . . . . 0.0 111.815 -179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -148.09 168.4 22.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.064 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.428 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.8 m-20 52.23 33.95 13.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.386 0.613 . . . . 0.0 110.701 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 20' ' ' ARG . . . -84.55 114.43 21.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.057 -0.974 . . . . 0.0 111.331 -179.172 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.404 ' HA ' ' HD2' ' A' ' 64' ' ' PHE . 5.9 m -147.27 177.81 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.22 179.107 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -104.9 139.42 39.66 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.055 179.247 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.401 HG22 ' N ' ' A' ' 14' ' ' ASN . 26.0 m -123.98 162.98 22.29 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.482 -179.209 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.9 t-20 74.03 7.64 4.78 Favored 'General case' 0 C--N 1.333 -0.136 0 O-C-N 123.671 0.607 . . . . 0.0 111.009 178.216 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.65 21.28 22.07 Favored Glycine 0 N--CA 1.445 -0.729 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.46 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 99.95 21.54 13.71 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.924 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' HG21 ' A' ' 56' ' ' THR . 32.9 mtp180 -104.42 -19.09 14.16 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.658 0.266 . . . . 0.0 110.912 -178.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.4 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 37.4 m -127.54 126.53 42.35 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.006 0.432 . . . . 0.0 111.362 -178.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.476 ' CD2' HD13 ' A' ' 97' ' ' ILE . 54.7 tp -95.56 106.82 18.95 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.934 -0.576 . . . . 0.0 109.584 178.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.511 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 5.4 tmm_? -106.21 123.9 48.75 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.887 -179.668 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.93 137.35 19.84 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.381 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.428 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.9 mt-10 -96.24 109.27 21.78 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 6' ' ' SER . 16.5 t -118.57 143.7 46.59 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.963 0.411 . . . . 0.0 110.139 -178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.564 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 143.48 50.01 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.835 179.786 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.496 ' HB3' HG21 ' A' ' 31' ' ' VAL . 24.7 p-10 -85.28 -172.4 4.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.42 -178.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.68 -21.5 65.79 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.683 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -86.47 -22.08 26.66 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.001 0.429 . . . . 0.0 110.964 -179.732 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.94 3.59 34.04 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.689 -179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 4.4 t30 -88.29 146.65 25.2 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -75.62 126.68 31.5 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-O 120.856 0.36 . . . . 0.0 110.588 179.772 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.496 HG21 ' HB3' ' A' ' 25' ' ' ASN . 10.8 t -124.46 129.69 73.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.352 -179.737 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.1 m -80.06 109.02 14.11 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.514 ' HB2' HD13 ' A' ' 104' ' ' LEU . 1.9 m -109.78 139.04 45.3 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.909 0.385 . . . . 0.0 110.376 -178.563 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.5 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 11.3 mt-10 -131.69 130.99 42.73 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.381 -179.856 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -128.91 117.6 21.26 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.643 ' O ' HG22 ' A' ' 39' ' ' THR . 27.0 m-20 -68.59 107.72 3.06 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.967 179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.513 HD11 HD11 ' A' ' 12' ' ' LEU . 24.6 mt -60.59 -40.27 91.13 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.592 0.71 . . . . 0.0 110.569 -179.492 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -62.66 -5.28 2.56 Favored 'General case' 0 C--N 1.312 -1.05 0 CA-C-N 114.942 -1.026 . . . . 0.0 110.808 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.643 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -104.93 -14.37 15.48 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.406 -0.518 . . . . 0.0 111.481 -179.419 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.546 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -141.28 11.96 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.503 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.95 129.97 69.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 179.571 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.537 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.32 156.74 21.01 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.802 -178.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.417 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 12.9 t30 -110.19 108.71 18.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.283 0.563 . . . . 0.0 109.547 178.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -100.19 82.53 2.54 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.971 179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 51.1 60.88 3.56 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.483 -0.78 . . . . 0.0 112.298 179.396 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.632 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.22 35.86 36.71 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.693 178.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -154.97 121.33 5.29 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 122.842 -0.21 . . . . 0.0 110.649 179.283 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.486 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.4 m-85 -65.41 138.46 58.14 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.084 0.468 . . . . 0.0 111.07 179.02 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.7 tt0 -130.45 116.85 18.81 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.744 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 79.5 m95 -71.51 114.31 9.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.91 29.15 7.41 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.828 -179.335 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.549 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.79 -53.06 1.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.658 -0.782 . . . . 0.0 113.43 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.549 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 2.4 tt0 76.96 142.54 0.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.303 0.641 . . . . 0.0 111.333 -179.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.671 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 4.1 m-20 66.72 38.84 3.77 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.089 -0.96 . . . . 0.0 112.024 179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.503 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 7.5 p90 -79.43 -28.1 41.71 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.629 HG21 ' HG2' ' A' ' 17' ' ' ARG . 34.8 p -65.51 -25.17 67.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.052 -0.977 . . . . 0.0 111.601 -179.173 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.79 ' HG3' HG23 ' A' ' 58' ' ' THR . 5.4 pt-20 -72.59 -12.36 61.03 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.328 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.79 HG23 ' HG3' ' A' ' 57' ' ' GLU . 81.4 p -130.37 15.93 5.52 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.31 0.576 . . . . 0.0 109.805 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.15 144.53 51.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.186 -179.85 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.657 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -134.46 173.08 12.03 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.007 -0.997 . . . . 0.0 109.285 -179.683 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.461 ' CB ' ' HG2' ' A' ' 79' ' ' ARG . 0.9 OUTLIER 46.01 54.38 8.15 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.684 0.615 . . . . 0.0 111.046 179.584 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.43 HG22 HD23 ' A' ' 12' ' ' LEU . 2.2 mt -89.33 112.77 24.78 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.778 -178.212 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.407 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -130.86 125.23 33.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.847 179.283 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.618 ' CE1' HD12 ' A' ' 94' ' ' LEU . 21.5 t80 -92.61 133.75 35.68 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.516 0.674 . . . . 0.0 112.435 -178.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.695 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 17.0 t-160 -117.57 87.71 26.8 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 115.113 -0.949 . . . . 0.0 108.525 177.835 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.513 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 Cg_endo -58.42 -42.95 50.25 Favored 'Trans proline' 0 CA--C 1.508 -0.785 0 C-N-CA 124.067 3.178 . . . . 0.0 114.637 -177.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.73 87.29 2.71 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.633 -178.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.695 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 25.2 tt0 -68.39 106.83 2.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.072 -0.967 . . . . 0.0 111.258 178.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 54.35 -152.78 10.8 Favored Glycine 0 C--N 1.332 0.322 0 O-C-N 124.029 0.831 . . . . 0.0 113.71 178.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.85 -9.18 58.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 0.0 110.061 179.621 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -80.18 -21.4 43.06 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.472 -0.786 . . . . 0.0 109.83 178.694 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 46.52 54.39 8.76 Favored 'General case' 0 C--O 1.236 0.388 0 O-C-N 123.881 0.738 . . . . 0.0 110.546 -179.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -103.22 118.45 57.86 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 114.816 -1.084 . . . . 0.0 110.182 179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.56 ' HD2' ' OD1' ' A' ' 95' ' ' ASN . 59.2 Cg_endo -72.38 109.63 2.78 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.327 2.018 . . . . 0.0 111.977 179.174 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.642 HD11 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -133.04 140.9 46.19 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.078 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.549 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.8 tm? -113.93 126.57 55.3 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.465 -179.218 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.642 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.01 143.45 49.04 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.184 179.028 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.65 168.01 22.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.359 -0.837 . . . . 0.0 109.99 179.954 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.657 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 7.5 mmt180 -86.32 114.66 23.3 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 179.566 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.632 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 4.0 mp -97.43 127.27 43.26 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.0 110.465 -179.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.658 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 2.1 tmt_? -80.16 139.69 36.69 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.743 -179.22 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -101.16 162.36 12.95 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.979 -1.009 . . . . 0.0 108.739 178.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 32.9 t -47.95 -29.34 3.31 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -179.177 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 29.5 t30 -66.4 -26.92 67.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.105 0.479 . . . . 0.0 111.029 -179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.589 ' HA2' ' HE ' ' A' ' 81' ' ' ARG . . . 100.53 33.97 4.9 Favored Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 111.315 -0.714 . . . . 0.0 111.315 -179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.658 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.8 pt-20 -116.02 -167.23 1.23 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 -179.349 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.513 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 39.3 p90 -142.28 138.18 31.18 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.98 0.895 . . . . 0.0 111.488 -179.502 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -133.86 111.24 10.32 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 113.75 -1.568 . . . . 0.0 109.221 -179.616 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.557 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.2 p-10 -64.21 114.97 4.57 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.444 0.64 . . . . 0.0 111.018 -179.425 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.545 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -114.18 176.72 4.92 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -145.76 142.46 28.93 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -178.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.486 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 14.7 p -131.68 144.3 37.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.063 -178.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.478 ' HB3' HD22 ' A' ' 95' ' ' ASN . 43.7 m-20 -81.35 111.66 17.93 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.125 -0.943 . . . . 0.0 110.696 -179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.618 HD12 ' CE1' ' A' ' 64' ' ' PHE . 3.7 mt -81.35 3.72 23.26 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.681 -179.722 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.56 ' OD1' ' HD2' ' A' ' 74' ' ' PRO . 25.6 m-80 -63.47 -18.03 63.35 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.102 0.477 . . . . 0.0 109.773 178.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -61.87 -28.15 69.29 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.798 178.672 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.532 HD12 ' HB3' ' A' ' 94' ' ' LEU . 14.0 mt -78.09 124.55 36.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.387 -0.824 . . . . 0.0 111.167 -179.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -114.99 163.29 15.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.437 -0.802 . . . . 0.0 109.359 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.497 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.8 t30 -111.99 119.99 40.35 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -179.585 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.579 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.3 t -113.57 95.03 3.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.727 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 63.9 t30 60.8 25.54 15.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.56 179.303 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.97 23.38 7.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.2 -1.0 . . . . 0.0 113.391 178.428 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.579 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.28 137.54 50.03 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 122.458 -0.436 . . . . 0.0 110.381 179.099 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.514 HD13 ' HB2' ' A' ' 33' ' ' SER . 2.0 mp -90.31 128.74 36.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.607 179.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.3 p -142.44 132.1 22.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.558 179.489 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -79.07 145.32 33.87 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.083 -0.508 . . . . 0.0 109.961 179.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 8.5 tt0 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.333 -179.075 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.2 tpt . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 120.91 0.385 . . . . 0.0 110.315 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -161.23 174.76 13.14 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.293 -1.002 . . . . 0.0 108.293 179.94 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -59.51 -35.6 74.47 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 179.119 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.751 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -58.17 -25.61 61.72 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.823 -179.662 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -61.28 -20.8 63.3 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 120.953 0.406 . . . . 0.0 111.089 -179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 32.3 m -145.14 35.51 1.1 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.835 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.751 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 85.7 p -116.61 158.13 24.21 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.94 0.4 . . . . 0.0 111.139 -179.22 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.511 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.1 ptp180 -152.58 167.82 27.62 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.437 ' HA ' HD22 ' A' ' 9' ' ' ASN . 9.2 m120 50.21 36.38 12.4 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 123.942 0.776 . . . . 0.0 111.566 179.472 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -78.07 113.7 16.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.859 179.955 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.3 t -143.04 148.89 19.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 -179.015 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -82.59 147.68 28.45 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 178.836 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 5.3 m -132.12 163.05 29.36 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.54 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 72.07 4.5 5.04 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 123.615 0.572 . . . . 0.0 111.543 178.142 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.65 23.22 19.15 Favored Glycine 0 CA--C 1.506 -0.496 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.738 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.545 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 100.97 22.82 10.36 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.979 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.673 ' HG2' HG21 ' A' ' 56' ' ' THR . 24.4 mtp180 -106.59 -18.28 14.01 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.684 0.278 . . . . 0.0 110.671 -179.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.428 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 67.7 m -132.37 128.03 36.75 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.927 0.394 . . . . 0.0 111.355 -179.12 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.441 ' HB2' HD21 ' A' ' 37' ' ' LEU . 42.9 tp -96.72 108.77 21.47 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.021 178.314 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.5 tmm_? -103.28 124.37 48.51 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -149.9 138.47 20.74 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.568 0.223 . . . . 0.0 110.628 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' HB2' ' HG2' ' A' ' 8' ' ' ARG . 5.9 mt-10 -97.82 108.87 21.68 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 6' ' ' SER . 2.2 p -119.13 141.43 48.81 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 121.086 0.469 . . . . 0.0 111.304 -178.31 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.6 143.46 44.37 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.758 179.708 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.4 p30 -85.15 -173.61 4.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.414 -179.873 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.49 -29.84 68.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.797 0.332 . . . . 0.0 111.449 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -73.85 -25.82 60.26 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.173 0.511 . . . . 0.0 111.231 -179.747 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 107.65 3.38 34.78 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.78 -179.084 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.1 m-80 -89.75 144.18 26.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.335 0.112 . . . . 0.0 110.819 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 53.1 m0 -72.79 128.85 36.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.024 0.44 . . . . 0.0 111.533 -179.285 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.0 t -125.11 119.63 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.352 179.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 18.6 m -75.09 106.5 6.62 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.607 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 13.0 m -110.74 144.01 40.36 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.204 0.526 . . . . 0.0 111.259 -178.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.427 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 12.6 mt-10 -133.39 134.97 44.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.333 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.67 HD11 HG12 ' A' ' 40' ' ' ILE . 13.6 tp -132.32 118.1 19.0 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 178.487 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.64 ' O ' HG22 ' A' ' 39' ' ' THR . 42.6 m-20 -67.42 107.43 2.43 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.391 178.713 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.812 HD11 HD11 ' A' ' 12' ' ' LEU . 46.9 mt -60.67 -42.46 97.11 Favored 'General case' 0 CA--C 1.5 -0.973 0 CA-C-O 121.598 0.713 . . . . 0.0 109.671 -179.964 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.459 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -63.8 -5.78 4.78 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.036 -0.983 . . . . 0.0 110.672 179.887 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.64 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -102.36 -10.61 19.31 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.207 -179.27 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.67 HG12 HD11 ' A' ' 35' ' ' LEU . 2.5 pp -145.01 11.65 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 CA-C-O 121.05 0.453 . . . . 0.0 112.07 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.554 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.9 mt -127.23 131.16 70.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.478 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.43 157.16 20.76 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.506 -0.854 . . . . 0.0 112.115 -179.404 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.42 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 11.0 t30 -111.1 109.97 20.29 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.179 0.514 . . . . 0.0 110.38 179.362 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -89.63 78.8 6.94 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.261 179.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 p30 39.63 48.63 1.9 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.003 0.921 . . . . 0.0 113.109 179.9 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 103.45 36.07 3.41 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.851 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -162.26 120.19 2.16 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 110.222 -0.288 . . . . 0.0 110.222 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.498 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 45.3 m-85 -65.29 135.1 54.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.079 0.466 . . . . 0.0 111.173 179.504 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -125.78 117.14 22.79 Favored 'General case' 0 N--CA 1.444 -0.753 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.638 -179.647 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.9 m95 -72.61 114.05 10.32 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 177.473 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.99 29.04 5.93 Favored Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.398 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.478 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.3 -51.6 1.13 Allowed Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.331 -0.938 . . . . 0.0 113.687 -179.152 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 28.9 tt0 72.56 143.53 0.06 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.049 0.54 . . . . 0.0 110.915 -178.769 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 73.0 31.31 1.51 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.652 0.781 . . . . 0.0 111.501 179.915 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.554 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.3 p90 -77.56 -27.7 51.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.772 0.32 . . . . 0.0 110.329 -179.864 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.673 HG21 ' HG2' ' A' ' 17' ' ' ARG . 28.9 p -64.92 -22.53 67.01 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.826 -178.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.553 ' HG3' HG23 ' A' ' 58' ' ' THR . 3.9 pt-20 -73.86 -18.47 60.92 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.045 0.45 . . . . 0.0 110.087 179.321 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.553 HG23 ' HG3' ' A' ' 57' ' ' GLU . 66.9 p -123.34 15.46 9.72 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.194 0.521 . . . . 0.0 110.064 -179.248 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.406 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -126.45 153.15 45.46 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.617 -179.972 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.596 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -146.22 170.43 16.76 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.162 -179.942 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.49 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 4.3 t70 46.11 56.06 6.54 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 120.946 0.403 . . . . 0.0 110.436 179.753 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.551 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -85.03 106.38 14.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.274 0.559 . . . . 0.0 111.333 -177.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.555 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -110.63 118.07 35.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.327 -0.852 . . . . 0.0 110.902 179.474 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' HB2' HD22 ' A' ' 12' ' ' LEU . 8.5 t80 -92.82 127.53 38.36 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.08 0.467 . . . . 0.0 110.924 179.522 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.41 86.31 38.77 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.424 179.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.672 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 14.6 Cg_endo -58.8 -38.3 89.42 Favored 'Trans proline' 0 CA--C 1.51 -0.689 0 C-N-CA 123.414 2.743 . . . . 0.0 112.618 -179.56 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.672 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -123.58 82.03 1.97 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 114.061 -1.427 . . . . 0.0 109.397 179.303 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.0 118.75 9.58 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 42.3 -138.31 2.74 Favored Glycine 0 C--N 1.333 0.369 0 O-C-N 124.643 1.214 . . . . 0.0 114.776 177.293 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.39 -5.83 59.32 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.01 -0.595 . . . . 0.0 110.436 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -81.16 -23.84 37.98 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.913 179.544 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 53.02 46.48 26.67 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.282 -179.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.5 mt-30 -113.7 129.96 24.21 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.817 -179.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.467 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.6 Cg_endo -73.61 108.38 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.776 2.318 . . . . 0.0 112.4 -179.946 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.579 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -135.13 140.39 45.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.551 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -110.51 122.84 48.71 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.245 -179.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.579 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -118.84 140.64 49.64 Favored 'General case' 0 N--CA 1.45 -0.453 0 CA-C-O 120.966 0.413 . . . . 0.0 109.898 179.145 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.64 169.11 25.41 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.778 -179.987 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.596 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 5.1 mmt180 -85.87 114.56 22.89 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 179.102 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.763 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.4 mp -99.65 121.4 41.17 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 121.296 0.57 . . . . 0.0 111.099 -178.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.788 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -75.04 141.25 43.9 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.022 -179.663 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.585 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 1.6 p-10 -98.29 177.34 5.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.6 -179.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 43.4 t -62.94 -22.54 66.85 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 111.9 0.333 . . . . 0.0 111.9 -179.083 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -77.39 -28.58 52.84 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 120.899 0.381 . . . . 0.0 110.845 -179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 110.04 30.46 3.42 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.075 178.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.788 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 10.2 pt-20 -115.7 -169.58 1.61 Allowed 'General case' 0 C--O 1.218 -0.605 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 -179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 44.4 p90 -138.47 140.7 39.34 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.946 0.879 . . . . 0.0 111.682 -179.341 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 16.1 m-70 -137.79 120.64 16.43 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 113.979 -1.464 . . . . 0.0 109.421 -179.88 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -64.05 112.93 3.2 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.482 0.658 . . . . 0.0 111.202 -179.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.763 ' HB2' HD22 ' A' ' 80' ' ' LEU . 26.5 mmt180 -114.93 172.6 6.95 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 178.309 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -140.74 151.44 44.48 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 -178.511 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.498 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -136.1 142.05 39.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.171 0 CA-C-O 121.398 0.618 . . . . 0.0 110.34 179.648 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.455 ' HB3' HD22 ' A' ' 95' ' ' ASN . 26.7 m-80 -81.24 109.19 15.52 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.569 -179.049 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.616 HD12 ' CE1' ' A' ' 64' ' ' PHE . 8.2 mt -79.62 0.75 28.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.876 0.37 . . . . 0.0 110.952 -179.434 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.455 HD22 ' HB3' ' A' ' 93' ' ' ASN . 22.8 m-80 -62.82 -13.63 35.79 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 121.465 0.65 . . . . 0.0 109.504 177.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.442 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -67.13 -24.38 65.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.243 -0.89 . . . . 0.0 110.046 178.697 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.525 HD12 ' HB3' ' A' ' 94' ' ' LEU . 11.8 mt -83.11 125.71 40.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.147 -178.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.62 159.37 24.54 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.204 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.6 t30 -102.87 117.95 35.74 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.46 -179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.51 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 59.6 t -111.97 94.93 3.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.824 0.345 . . . . 0.0 110.578 179.907 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 62.54 21.64 12.78 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 179.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.27 25.87 5.91 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.365 -0.921 . . . . 0.0 113.53 178.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.51 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 16.3 ptp180 -132.66 139.68 47.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 117.094 0.447 . . . . 0.0 110.798 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.607 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 75.0 mt -87.12 116.31 25.1 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.792 0.329 . . . . 0.0 110.534 178.853 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 8.6 p -125.6 130.42 72.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.865 0.364 . . . . 0.0 110.374 179.669 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 4.7 p90 -86.71 143.66 27.46 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.112 -179.641 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.649 -0.691 . . . . 0.0 110.292 179.844 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.8 tpt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 120.465 0.174 . . . . 0.0 110.636 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.468 ' HA ' ' HG2' ' A' ' 98' ' ' GLN . 7.2 m -157.31 177.07 11.87 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.589 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -62.62 -37.25 85.55 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.523 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -53.92 -25.37 19.99 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.453 -178.925 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -53.43 -34.41 57.73 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-O 121.137 0.494 . . . . 0.0 110.578 179.062 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 49.4 m -136.04 36.03 2.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.348 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.523 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 67.6 m -116.05 157.1 25.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.336 0.589 . . . . 0.0 112.19 -179.319 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.448 ' HG2' ' HB2' ' A' ' 22' ' ' GLU . 2.0 ptp180 -154.59 166.63 32.74 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.282 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.459 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 10.0 m120 51.92 38.18 22.9 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.648 0.593 . . . . 0.0 111.336 -179.852 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.533 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -81.93 114.0 20.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.095 179.913 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 10.6 t -140.66 159.03 24.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.78 -178.9 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.817 HD11 HD11 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -95.38 138.52 32.95 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.042 -0.355 . . . . 0.0 110.042 179.315 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 9.3 m -122.53 165.38 16.49 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.566 -179.213 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.557 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER 71.59 6.22 5.64 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.525 0.516 . . . . 0.0 111.484 177.679 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.06 21.4 23.11 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.194 -0.762 . . . . 0.0 111.194 -179.4 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.535 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 99.75 24.27 10.11 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 121.043 -0.599 . . . . 0.0 111.786 -179.239 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HG2' HG21 ' A' ' 56' ' ' THR . 27.1 mtp180 -107.29 -18.47 13.87 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.797 0.332 . . . . 0.0 110.486 -179.25 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.464 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 61.3 m -129.13 126.06 38.47 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.073 0.463 . . . . 0.0 111.289 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.49 ' CD2' HD13 ' A' ' 97' ' ' ILE . 47.4 tp -94.42 107.62 19.58 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.274 178.594 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.516 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 0.8 OUTLIER -101.69 124.5 47.44 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.204 -0.453 . . . . 0.0 109.873 179.98 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.26 140.4 22.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.586 0.232 . . . . 0.0 110.873 179.76 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 7' ' ' SER . 6.9 mt-10 -99.07 109.69 22.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 6' ' ' SER . 37.4 t -122.01 145.2 48.36 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.329 0.585 . . . . 0.0 111.209 -178.698 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.552 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -76.4 144.43 40.03 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.401 179.109 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 26.4 p-10 -89.05 -171.21 3.19 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.645 -179.058 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.0 -28.73 69.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.149 0.499 . . . . 0.0 111.234 179.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -76.47 -23.7 53.83 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.2 -179.775 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.56 1.67 43.5 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.841 -179.489 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 2.5 t-20 -85.2 145.34 27.64 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -179.674 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -77.07 126.56 31.17 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.895 0.379 . . . . 0.0 110.634 179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.8 t -123.27 126.55 73.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.304 -179.55 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 25.8 m -79.69 106.18 11.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.574 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 4.4 m -110.43 144.98 38.41 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.083 0.468 . . . . 0.0 111.446 -177.696 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 14.6 mt-10 -135.23 133.31 38.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.486 179.493 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.1 tt -127.8 120.02 26.96 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.387 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.501 ' O ' HG22 ' A' ' 39' ' ' THR . 27.6 m-20 -68.2 107.01 2.62 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.663 179.02 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.817 HD11 HD11 ' A' ' 12' ' ' LEU . 53.5 mt -61.69 -45.66 93.06 Favored 'General case' 0 CA--C 1.5 -0.952 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.461 -179.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -62.74 -5.53 2.83 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.689 -179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -102.05 -11.5 18.84 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 120.486 -0.485 . . . . 0.0 111.21 -179.611 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.464 HD12 ' CG1' ' A' ' 41' ' ' ILE . 2.5 pp -143.89 11.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 121.002 0.429 . . . . 0.0 112.113 -179.57 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.4 mt -127.24 132.06 69.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -127.75 159.99 21.65 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.554 -0.831 . . . . 0.0 112.75 -179.134 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.78 111.74 23.12 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.23 0.538 . . . . 0.0 109.732 179.164 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -105.93 87.53 2.6 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.373 -179.976 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 51.08 57.93 6.11 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.624 0.578 . . . . 0.0 112.161 179.466 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.608 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 71.78 42.85 52.6 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 119.429 -1.367 . . . . 0.0 111.982 179.385 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -161.07 120.67 2.63 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 179.207 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.527 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 59.0 m-85 -62.66 142.17 58.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.029 0.442 . . . . 0.0 111.405 -179.924 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -133.81 115.95 15.11 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.394 -0.821 . . . . 0.0 110.165 179.93 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.1 m95 -70.09 116.11 10.07 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.232 0.539 . . . . 0.0 109.681 178.806 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 98.06 31.45 6.58 Favored Glycine 0 N--CA 1.446 -0.695 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.752 -179.766 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.483 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -101.45 -51.6 1.11 Allowed Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.501 -0.857 . . . . 0.0 113.084 -179.592 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 54' ' ' ASN . 3.6 tt0 70.75 143.22 0.05 Allowed 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.016 0.526 . . . . 0.0 110.879 -179.197 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.634 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 92.0 m-20 76.36 29.19 0.73 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.526 0.73 . . . . 0.0 111.189 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.1 p90 -77.5 -32.15 54.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.753 0.311 . . . . 0.0 110.591 -179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.703 HG21 ' HG2' ' A' ' 17' ' ' ARG . 24.6 p -63.56 -26.67 68.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.852 -178.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 6.6 pt-20 -70.74 -16.37 62.76 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.728 179.829 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.632 HG23 ' HG3' ' A' ' 57' ' ' GLU . 60.2 p -124.31 12.97 8.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.268 0.556 . . . . 0.0 110.351 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.536 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -124.97 152.8 43.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.188 -179.554 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.708 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.71 173.7 11.61 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.88 179.802 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.564 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 11.3 t70 47.92 52.88 12.3 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 121.321 0.581 . . . . 0.0 110.488 179.426 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.415 HG22 HD21 ' A' ' 76' ' ' LEU . 2.4 mt -85.93 110.25 19.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.011 -177.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.414 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -123.1 120.5 33.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.232 178.928 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.623 ' HB2' HD22 ' A' ' 12' ' ' LEU . 10.0 t80 -91.58 128.47 37.42 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.78 -178.676 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 66' ' ' PRO . 14.8 m170 -120.18 87.7 40.11 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.027 178.737 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.483 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 10.3 Cg_endo -56.29 -32.66 88.81 Favored 'Trans proline' 0 CA--C 1.505 -0.959 0 C-N-CA 124.086 3.191 . . . . 0.0 113.752 -179.089 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.422 ' HB3' ' HA ' ' A' ' 72' ' ' GLU . 0.1 OUTLIER -133.68 88.94 2.53 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.452 -1.249 . . . . 0.0 110.949 -179.743 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -66.43 116.56 7.56 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.277 179.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 49.86 -145.17 8.9 Favored Glycine 0 C--N 1.337 0.586 0 O-C-N 124.403 1.065 . . . . 0.0 113.829 178.66 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -82.73 -8.2 59.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.344 0.592 . . . . 0.0 109.774 179.514 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.2 -23.88 60.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.552 179.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.422 ' HA ' ' HB3' ' A' ' 67' ' ' LYS . 36.9 mm-40 56.54 44.4 24.16 Favored 'General case' 0 C--N 1.339 0.128 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -106.44 125.9 31.75 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.074 -178.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.431 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 67.4 Cg_endo -74.84 108.66 2.76 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.65 2.233 . . . . 0.0 112.468 -179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.708 HD11 HH21 ' A' ' 77' ' ' ARG . 1.1 pp -136.64 141.09 41.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.384 179.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.5 HD23 ' HA ' ' A' ' 64' ' ' PHE . 2.1 tm? -112.69 125.85 54.76 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.243 -179.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.708 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.1 139.75 52.9 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.078 0.466 . . . . 0.0 110.302 178.828 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.487 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -158.72 168.34 27.12 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.13 -179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.708 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 8.3 mmt85 -85.29 116.0 23.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -179.713 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.608 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -101.1 133.43 45.63 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.885 -179.37 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.735 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.6 OUTLIER -83.72 138.68 33.17 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.572 -179.895 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.59 ' HB2' ' HG2' ' A' ' 86' ' ' GLU . 1.7 m-20 -98.12 164.42 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.826 178.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 68.4 m -57.35 -23.42 48.85 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.136 0.426 . . . . 0.0 111.696 -179.922 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -68.9 -20.6 64.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.344 0.592 . . . . 0.0 110.196 178.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 92.68 39.4 5.28 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.962 -0.855 . . . . 0.0 110.962 -179.877 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.735 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 13.8 pt-20 -121.6 -177.06 3.45 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.655 ' CE1' ' HB2' ' A' ' 81' ' ' ARG . 93.2 m-85 -137.04 137.2 39.12 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 122.002 0.906 . . . . 0.0 111.672 -178.64 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 76.1 m-70 -139.72 119.8 13.64 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 113.77 -1.559 . . . . 0.0 110.597 -179.096 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.4 p-10 -66.11 114.05 4.96 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.124 0.488 . . . . 0.0 110.858 179.716 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.593 ' HB2' HD22 ' A' ' 80' ' ' LEU . 35.6 mmt180 -114.44 172.31 7.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.349 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.418 ' HB2' HD13 ' A' ' 75' ' ' ILE . 10.0 p-10 -137.02 149.07 47.23 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -178.837 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.527 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 10.8 p -134.5 146.46 30.98 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.254 0 CA-C-O 121.306 0.574 . . . . 0.0 110.891 -179.612 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.532 ' HB3' HD22 ' A' ' 95' ' ' ASN . 34.8 m-80 -82.12 109.71 16.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.096 -0.956 . . . . 0.0 110.454 -179.48 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.619 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.7 mt -80.05 2.46 23.77 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.971 0.415 . . . . 0.0 110.932 -179.54 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.532 HD22 ' HB3' ' A' ' 93' ' ' ASN . 21.5 m-80 -63.45 -12.08 28.55 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.428 0.632 . . . . 0.0 109.842 178.004 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.606 ' O ' ' HG2' ' A' ' 107' ' ' GLN . 0.0 OUTLIER -70.7 -21.53 62.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.657 178.658 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.553 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.7 mt -85.98 124.29 40.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.315 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.468 ' HG2' ' HA ' ' A' ' 2' ' ' SER . 80.5 mt-30 -120.05 167.09 12.55 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.432 179.47 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -109.82 122.07 46.67 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.229 -179.579 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.443 ' HB ' ' HG2' ' A' ' 103' ' ' ARG . 59.4 t -112.4 93.89 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.22 179.643 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 60.4 t30 58.29 25.65 12.97 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.064 179.269 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 109.5 18.78 8.77 Favored Glycine 0 N--CA 1.453 -0.169 0 C-N-CA 120.385 -0.912 . . . . 0.0 113.849 178.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.443 ' HG2' ' HB ' ' A' ' 100' ' ' VAL . 16.9 ptp180 -130.78 136.46 48.74 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 122.314 -0.521 . . . . 0.0 110.42 179.258 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.574 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 69.8 mt -83.19 126.22 32.39 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.223 179.81 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -134.82 128.1 49.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 121.179 0.514 . . . . 0.0 111.265 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.83 146.06 27.52 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.811 179.636 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . 0.606 ' HG2' ' O ' ' A' ' 96' ' ' ARG . 24.4 mm-40 . . . . . 0 C--O 1.247 0.947 0 CA-C-O 118.647 -0.692 . . . . 0.0 111.353 179.503 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.0 tpp . . . . . 0 N--CA 1.48 1.041 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.577 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 49.6 m -162.07 177.31 9.84 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.792 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 9.7 p90 -60.43 -38.08 82.97 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.138 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.4 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.03 -23.73 21.13 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.52 -0.764 . . . . 0.0 112.798 -179.141 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -59.62 -30.39 68.67 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.202 0.525 . . . . 0.0 110.866 179.442 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.521 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 40.4 m -133.57 32.49 3.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.437 -179.416 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.498 ' OG ' ' HB3' ' A' ' 23' ' ' CYS . 66.4 m -121.33 156.62 32.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.209 0.528 . . . . 0.0 112.248 -179.05 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.449 HH11 ' HD3' ' A' ' 8' ' ' ARG . 1.8 ptp180 -154.86 170.74 20.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.112 -0.949 . . . . 0.0 108.614 178.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.504 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 81.7 m-20 55.01 32.33 17.93 Favored 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.622 0.576 . . . . 0.0 110.918 -179.74 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.577 ' HB1' ' HE2' ' A' ' 64' ' ' PHE . . . -77.23 113.76 15.33 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.265 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 40.7 t -142.5 151.76 17.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -89.35 135.43 33.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.058 0.456 . . . . 0.0 110.129 178.987 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.444 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 4.8 m -121.8 167.14 13.33 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.892 -179.467 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.537 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 1.7 t-20 70.15 6.87 5.97 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 122.993 0.517 . . . . 0.0 111.589 178.446 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 93.86 22.82 24.76 Favored Glycine 0 CA--C 1.508 -0.376 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.511 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 100.45 16.77 26.09 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.584 -179.536 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.627 ' HG2' HG21 ' A' ' 56' ' ' THR . 26.1 mtp180 -102.51 -15.51 16.43 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.677 0.275 . . . . 0.0 110.377 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.533 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 25.0 m -130.86 129.46 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.824 0.345 . . . . 0.0 111.714 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.527 ' HB2' HD21 ' A' ' 37' ' ' LEU . 57.3 tp -100.7 107.94 19.68 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.652 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 10' ' ' ALA . 2.9 tmm_? -105.17 123.37 47.71 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.905 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.507 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -149.14 146.88 27.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 179.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.504 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 5.7 mt-10 -103.3 109.55 21.2 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.888 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 6' ' ' SER . 6.5 p -115.13 140.84 48.74 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.339 -178.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.479 ' HB2' ' HD1' ' A' ' 30' ' ' TRP . 0.0 OUTLIER -74.72 143.2 44.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.608 -0.516 . . . . 0.0 109.608 179.341 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.45 ' HB3' HG21 ' A' ' 31' ' ' VAL . 24.4 p-10 -85.94 -177.16 6.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.661 -178.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.64 -15.92 61.97 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -86.33 -24.34 25.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.048 0.451 . . . . 0.0 110.684 -179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 108.42 7.21 30.52 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.541 -179.533 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 14.5 t-20 -97.27 147.33 24.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.903 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.479 ' HD1' ' HB2' ' A' ' 24' ' ' ARG . 51.9 m0 -78.06 128.84 34.46 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.962 0.411 . . . . 0.0 110.584 -179.938 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.45 HG21 ' HB3' ' A' ' 25' ' ' ASN . 6.5 t -123.58 128.64 74.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.45 -179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.4 m -82.32 110.38 17.43 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.846 ' HB3' ' HG ' ' A' ' 104' ' ' LEU . 2.1 t -111.57 148.72 32.67 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.107 0.48 . . . . 0.0 110.545 -179.283 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -135.43 132.12 37.06 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.458 -179.858 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.679 HD11 HG12 ' A' ' 40' ' ' ILE . 13.7 tp -133.88 116.71 15.96 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.44 178.168 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.605 ' O ' HG22 ' A' ' 39' ' ' THR . 19.3 m-20 -68.01 107.77 2.82 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.649 179.428 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.666 HD11 HD11 ' A' ' 12' ' ' LEU . 53.7 mt -57.54 -45.21 85.34 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.475 -179.849 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.507 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.4 OUTLIER -62.94 -5.04 2.54 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.123 -0.944 . . . . 0.0 110.973 -179.42 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.605 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -103.09 -10.76 18.6 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.274 -0.57 . . . . 0.0 110.819 -179.846 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.679 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.97 12.53 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 CA-C-O 120.939 0.399 . . . . 0.0 111.867 -179.539 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.8 mt -128.29 131.68 68.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 179.802 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.417 ' HA2' ' HB3' ' A' ' 55' ' ' PHE . . . -127.41 159.31 21.38 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.91 -178.767 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 11.1 t30 -112.49 108.15 17.17 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 179.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 47' ' ' HIS . 19.4 t-20 -101.16 79.91 2.05 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.855 0.36 . . . . 0.0 110.131 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 70.1 m-20 53.15 57.74 5.98 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.372 179.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 77.19 36.45 35.02 Favored Glycine 0 N--CA 1.442 -0.905 0 C-N-CA 120.251 -0.976 . . . . 0.0 111.739 -179.957 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.424 ' HB2' ' O ' ' A' ' 44' ' ' ASN . 61.7 m-70 -147.89 111.88 5.14 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 122.027 0.131 . . . . 0.0 110.82 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.489 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 41.6 m-85 -60.96 132.01 52.49 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.207 0.527 . . . . 0.0 110.864 178.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -124.78 117.44 24.18 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.161 -179.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 84.8 m95 -72.76 114.7 11.18 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 177.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.54 26.78 7.94 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.106 179.806 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -97.26 -52.48 1.46 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.602 -179.136 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.507 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 33.3 tt0 75.12 145.13 0.08 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.377 0.671 . . . . 0.0 110.884 -178.806 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.484 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 3.9 m-20 72.92 29.81 1.78 Allowed 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.406 0.683 . . . . 0.0 111.939 179.953 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.535 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 4.2 p90 -77.04 -27.57 54.5 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 179.448 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 17' ' ' ARG . 14.9 p -66.95 -28.11 68.01 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -178.839 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.609 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.6 pt-20 -70.03 -18.68 63.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.03 0.443 . . . . 0.0 110.314 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.609 HG23 ' HG3' ' A' ' 57' ' ' GLU . 69.9 p -121.79 13.74 10.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 -179.396 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -122.84 151.89 41.25 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.903 -179.952 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -140.52 167.9 21.08 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.462 -0.79 . . . . 0.0 108.983 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.488 ' CB ' ' HE ' ' A' ' 79' ' ' ARG . 1.6 t70 49.39 51.98 15.33 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 120.864 0.364 . . . . 0.0 111.101 178.877 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 2.1 mt -84.58 110.36 18.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 121.262 0.553 . . . . 0.0 111.384 -178.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.451 ' H ' ' HG2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -127.48 122.18 32.73 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.643 179.534 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.637 ' CE1' HD12 ' A' ' 94' ' ' LEU . 9.4 t80 -91.97 131.84 36.97 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.358 0.599 . . . . 0.0 111.483 -178.711 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 68' ' ' GLU . 4.8 t-160 -121.84 87.65 46.78 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.353 -0.839 . . . . 0.0 108.908 178.457 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.8 Cg_endo -58.61 -35.21 98.97 Favored 'Trans proline' 0 CA--C 1.505 -0.944 0 C-N-CA 123.748 2.965 . . . . 0.0 113.872 -178.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.441 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -124.1 83.58 2.16 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.169 -179.397 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 73' ' ' GLN . 16.1 tt0 -64.3 110.29 2.19 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.224 177.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 55.42 -152.75 14.73 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.499 -0.773 . . . . 0.0 113.289 179.469 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -77.16 -0.91 26.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.227 0.537 . . . . 0.0 110.471 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -86.35 -18.26 32.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.295 -179.572 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' OE1' ' HG2' ' A' ' 67' ' ' LYS . 27.5 mt-10 52.3 44.64 29.6 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.439 -178.019 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.539 ' HB3' ' HB3' ' A' ' 68' ' ' GLU . 5.9 tp60 -91.83 113.39 58.72 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.03 -179.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.437 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 59.2 Cg_endo -72.91 106.64 2.18 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.32 2.013 . . . . 0.0 112.044 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.769 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -136.14 141.11 42.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 179.51 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.528 HD22 ' N ' ' A' ' 77' ' ' ARG . 1.9 tm? -111.64 127.99 55.92 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.202 -179.301 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.769 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -121.84 143.72 49.25 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.114 0.483 . . . . 0.0 110.173 179.379 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -162.21 166.57 25.33 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.839 179.654 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.6 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 5.4 mmt180 -85.63 115.06 23.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.867 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.601 ' HB3' ' HA2' ' A' ' 46' ' ' GLY . 3.0 mp -99.15 124.68 44.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.958 0.409 . . . . 0.0 111.596 -178.544 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.565 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -85.06 142.42 29.57 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.94 179.721 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.653 ' OD1' ' HG2' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -103.14 173.81 6.14 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.331 179.702 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 79.9 m -58.5 -25.35 62.27 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -72.34 -24.73 61.34 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.173 0.511 . . . . 0.0 110.447 179.946 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 100.73 36.66 3.93 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.742 178.553 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.653 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 7.1 pt-20 -111.16 -166.29 1.06 Allowed 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -144.13 132.39 21.89 Favored 'General case' 0 C--N 1.313 -0.979 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -139.46 111.45 7.39 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.702 -179.777 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.6 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.6 p-10 -64.42 114.08 4.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.389 0.614 . . . . 0.0 111.587 -179.6 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.585 ' HB2' HD22 ' A' ' 80' ' ' LEU . 39.2 mmt180 -115.67 177.39 4.69 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.08 178.461 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . 0.462 ' HB2' HD13 ' A' ' 75' ' ' ILE . 3.6 p30 -143.37 148.76 36.72 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 -179.597 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.489 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 12.7 p -132.07 145.56 34.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.045 0 CA-C-O 121.325 0.583 . . . . 0.0 110.746 -179.463 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.487 ' HB3' HD22 ' A' ' 95' ' ' ASN . 9.0 m120 -83.66 109.25 17.3 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.339 -0.846 . . . . 0.0 110.608 -179.089 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.637 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.9 mt -78.06 1.78 19.93 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.441 -179.18 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.487 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.3 m-80 -65.6 -8.73 21.65 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.073 0.463 . . . . 0.0 110.04 177.861 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.415 ' HE ' ' HA ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -72.72 -20.22 61.25 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.252 178.345 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.538 HD12 ' HB3' ' A' ' 94' ' ' LEU . 12.6 mt -84.64 122.43 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.384 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.577 ' OE1' ' HA ' ' A' ' 2' ' ' SER . 2.5 mp0 -112.37 160.48 17.66 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.635 -179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 2.2 t30 -105.15 119.32 38.75 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.112 179.93 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.6 t -113.02 93.87 2.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.394 179.723 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.25 25.77 14.44 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.565 179.437 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.44 20.5 8.55 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.215 -0.993 . . . . 0.0 113.482 178.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 11.8 ptp180 -130.05 138.64 50.86 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 117.14 0.47 . . . . 0.0 110.815 179.77 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 33' ' ' SER . 80.3 mt -85.92 114.26 22.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.79 179.245 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 103' ' ' ARG . 40.0 t -123.0 123.07 67.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.546 -179.72 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 8.1 p90 -79.37 145.65 33.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.865 -179.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 . . . . . 0 C--O 1.249 1.058 0 O-C-N 123.695 0.622 . . . . 0.0 111.829 179.454 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.2 tpt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.0 m -163.09 174.34 12.35 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 8.9 p90 -68.22 -32.95 73.53 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.941 -0.762 . . . . 0.0 108.941 178.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.748 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -59.29 -19.2 44.24 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.077 -0.965 . . . . 0.0 112.329 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -62.78 -27.65 69.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.106 0.479 . . . . 0.0 110.721 179.771 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 19.9 m -143.86 39.57 1.37 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.652 179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.748 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 87.9 p -115.69 155.36 27.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.115 0.483 . . . . 0.0 111.72 -178.783 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.47 HH12 ' HB3' ' A' ' 30' ' ' TRP . 0.2 OUTLIER -151.6 164.77 36.15 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.348 -0.842 . . . . 0.0 108.799 179.444 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 1.4 t30 52.85 35.29 18.53 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 123.715 0.634 . . . . 0.0 111.239 179.148 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -76.65 114.34 15.28 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.464 -179.705 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 15.7 t -141.56 154.37 19.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.0 109.85 -179.191 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.623 HD22 ' HB2' ' A' ' 64' ' ' PHE . 1.7 tp -91.08 141.15 29.14 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.008 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.47 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 8.4 m -126.25 162.73 24.78 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.512 ' O ' ' HG3' ' A' ' 17' ' ' ARG . 6.2 t-20 72.5 9.39 5.73 Favored 'General case' 0 N--CA 1.464 0.245 0 O-C-N 123.688 0.618 . . . . 0.0 111.121 178.082 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 91.68 21.2 34.77 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.308 -179.646 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.537 ' HA2' ' CD2' ' A' ' 12' ' ' LEU . . . 103.16 20.43 11.23 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.245 -179.545 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.627 ' HG2' HG21 ' A' ' 56' ' ' THR . 21.5 mtp180 -103.75 -18.97 14.46 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.864 0.364 . . . . 0.0 110.42 -179.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 49.3 m -129.45 128.44 42.94 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.161 0.505 . . . . 0.0 112.114 -178.822 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.502 ' HB2' HD21 ' A' ' 37' ' ' LEU . 50.6 tp -97.79 110.19 22.8 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.55 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.523 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 1.1 tmm_? -114.37 124.69 52.6 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.638 0.256 . . . . 0.0 110.789 -178.899 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -150.59 162.65 40.24 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.926 0.393 . . . . 0.0 111.053 179.878 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 7' ' ' SER . 10.8 mt-10 -110.47 114.61 28.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 179.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 6' ' ' SER . 30.3 t -131.53 142.74 50.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.007 0.432 . . . . 0.0 110.732 -179.256 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.451 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -71.48 145.32 49.28 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.24 179.916 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.59 ' HB3' HG21 ' A' ' 31' ' ' VAL . 32.4 p-10 -85.92 -167.48 1.87 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.64 -0.254 . . . . 0.0 111.677 -179.485 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.423 ' H ' ' HA ' ' A' ' 101' ' ' ASN . . . -63.41 -34.95 78.85 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.711 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -71.8 -23.73 61.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.075 0.464 . . . . 0.0 110.883 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.07 10.03 35.43 Favored Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 111.16 -0.776 . . . . 0.0 111.16 -179.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 3.0 t30 -91.0 145.35 24.77 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 -179.963 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.47 ' HB3' HH12 ' A' ' 8' ' ' ARG . 33.9 m0 -73.17 122.92 22.65 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.319 -0.4 . . . . 0.0 112.047 -179.18 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.59 HG21 ' HB3' ' A' ' 25' ' ' ASN . 4.9 t -126.1 143.61 39.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.437 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.7 m -99.76 111.28 23.62 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 178.204 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.54 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.3 p -111.3 143.97 41.23 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.204 0.526 . . . . 0.0 111.816 -178.461 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.523 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 6.6 mt-10 -130.37 133.33 46.32 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.348 -179.965 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.624 HD11 HG12 ' A' ' 40' ' ' ILE . 15.1 tp -131.07 117.74 19.57 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.215 0.531 . . . . 0.0 110.176 178.779 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.674 ' O ' HG22 ' A' ' 39' ' ' THR . 29.9 m-20 -69.0 109.78 4.13 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.81 178.912 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 12' ' ' LEU . 40.2 mt -60.61 -40.0 90.24 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.82 0.819 . . . . 0.0 109.927 179.641 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -63.16 -5.35 3.13 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.78 179.787 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.674 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.6 OUTLIER -105.45 -12.53 15.97 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.128 -0.629 . . . . 0.0 111.478 -179.332 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.624 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.36 12.75 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.662 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.549 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.8 130.67 70.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.786 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.59 159.48 22.05 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.361 -179.313 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -111.14 111.86 23.25 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.085 0.469 . . . . 0.0 109.827 179.084 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -104.48 87.97 2.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.3 179.913 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.9 t70 49.3 59.24 4.62 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.046 178.744 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.59 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 74.66 40.96 36.51 Favored Glycine 0 N--CA 1.441 -1.01 0 C-N-CA 119.892 -1.147 . . . . 0.0 112.601 179.016 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.455 ' N ' HD23 ' A' ' 80' ' ' LEU . 44.2 t-80 -159.22 127.14 4.97 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.862 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.501 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 52.6 m-85 -68.0 139.41 56.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.193 0.521 . . . . 0.0 111.213 179.935 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -132.11 116.38 16.95 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.427 179.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -70.5 115.12 9.3 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.109 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 101.63 28.23 6.77 Favored Glycine 0 C--N 1.32 -0.356 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.462 -179.879 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.548 ' HA3' ' HA3' ' A' ' 42' ' ' GLY . . . -99.19 -50.37 1.46 Allowed Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.445 -0.883 . . . . 0.0 113.513 -179.394 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 52' ' ' GLY . 9.7 tt0 73.92 143.46 0.07 Allowed 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.208 0.603 . . . . 0.0 111.727 -179.567 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.625 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 95.8 m-20 65.64 38.66 5.28 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.597 179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.549 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 8.4 p90 -78.29 -30.0 48.19 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.608 179.789 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.627 HG21 ' HG2' ' A' ' 17' ' ' ARG . 74.3 p -62.91 -23.05 67.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.75 -178.891 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.631 ' HG3' HG23 ' A' ' 58' ' ' THR . 8.0 pt-20 -72.3 -14.98 61.88 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.276 0.56 . . . . 0.0 110.031 -179.688 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.631 HG23 ' HG3' ' A' ' 57' ' ' GLU . 68.0 p -126.19 7.02 7.14 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.119 179.867 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -123.9 144.76 49.57 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.33 -179.483 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.3 OUTLIER -138.27 172.32 13.09 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.134 -0.939 . . . . 0.0 109.053 -179.317 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.562 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 10.6 t70 48.15 50.96 15.5 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 121.071 0.462 . . . . 0.0 110.125 -179.58 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.533 ' C ' ' HE ' ' A' ' 63' ' ' ARG . 2.8 mt -83.11 105.8 13.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.192 0.52 . . . . 0.0 110.691 -178.584 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.559 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -112.23 118.63 35.83 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.52 -0.763 . . . . 0.0 111.313 -179.848 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.627 ' CE1' HD12 ' A' ' 94' ' ' LEU . 6.2 t80 -93.04 124.69 37.19 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.863 0.363 . . . . 0.0 110.709 179.531 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 7.1 t-160 -118.44 88.99 35.28 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.661 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.487 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 12.2 Cg_endo -57.65 -35.13 98.91 Favored 'Trans proline' 0 CA--C 1.504 -0.979 0 C-N-CA 123.934 3.089 . . . . 0.0 113.538 -178.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.506 ' HG2' ' OE1' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -129.02 88.14 2.67 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 114.486 -1.234 . . . . 0.0 111.73 -179.458 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -70.6 114.59 8.85 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.513 178.038 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 53.63 -152.08 10.11 Favored Glycine 0 C--N 1.334 0.444 0 O-C-N 124.16 0.912 . . . . 0.0 112.828 179.436 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -79.82 -5.08 54.71 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.447 0.642 . . . . 0.0 109.527 178.666 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.06 -23.52 59.38 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.906 -179.955 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' OE1' ' HG2' ' A' ' 67' ' ' LYS . 28.6 mm-40 58.65 43.56 18.75 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.105 -179.23 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 45.5 mt-30 -102.5 119.79 55.04 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.372 -178.479 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 58.7 Cg_endo -74.39 108.16 2.62 Favored 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 122.368 2.046 . . . . 0.0 111.897 178.929 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.604 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -131.7 141.53 45.45 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.46 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.522 HD21 HG22 ' A' ' 62' ' ' ILE . 2.0 tm? -112.73 123.43 50.29 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.271 -179.38 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.604 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -119.85 138.16 53.56 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.122 0.486 . . . . 0.0 110.047 179.149 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.471 ' HB2' HG23 ' A' ' 62' ' ' ILE . . . -155.9 166.39 33.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.602 -0.727 . . . . 0.0 110.397 -179.707 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.573 ' O ' ' HA ' ' A' ' 59' ' ' ALA . 3.5 mmt180 -85.83 114.5 22.82 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 179.619 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.621 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.5 mp -99.42 129.22 45.59 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 120.988 0.423 . . . . 0.0 111.056 -178.816 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.76 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.2 OUTLIER -75.23 136.46 40.97 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.319 179.857 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.3 m-20 -96.13 169.68 9.79 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.153 -0.931 . . . . 0.0 109.316 179.371 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 61.7 m -62.71 -15.2 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.027 0.441 . . . . 0.0 111.114 179.722 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -74.69 -27.01 60.21 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.658 0.742 . . . . 0.0 109.681 178.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.85 44.57 2.84 Favored Glycine 0 N--CA 1.451 -0.347 0 CA-C-N 115.052 -0.976 . . . . 0.0 111.694 179.681 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.76 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 14.5 pt-20 -133.32 -166.47 1.77 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 -179.876 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 52.8 p90 -134.61 139.36 45.28 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.655 0.741 . . . . 0.0 111.577 -179.677 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -139.18 119.19 13.41 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.348 -179.852 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.504 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -66.45 116.81 7.84 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.576 0.703 . . . . 0.0 112.557 -178.131 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.621 ' HB2' HD22 ' A' ' 80' ' ' LEU . 24.2 mmt180 -116.9 172.61 7.14 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.162 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -141.56 147.22 37.36 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -179.943 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.501 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.1 p -134.0 151.34 32.44 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.212 0.529 . . . . 0.0 111.126 -178.541 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.507 ' HB3' HD22 ' A' ' 95' ' ' ASN . 37.1 m-80 -83.34 112.5 19.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.887 -179.334 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.627 HD12 ' CE1' ' A' ' 64' ' ' PHE . 6.3 mt -82.33 3.44 27.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.916 0.389 . . . . 0.0 110.853 -179.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.507 HD22 ' HB3' ' A' ' 93' ' ' ASN . 20.7 m-80 -65.2 -16.78 63.89 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 178.266 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.59 -23.52 67.29 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.127 179.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.472 ' HA ' ' O ' ' A' ' 105' ' ' VAL . 11.9 mt -82.69 126.2 40.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.22 -179.535 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.445 ' HG2' ' N ' ' A' ' 99' ' ' ASN . 49.6 tt0 -120.29 162.94 18.58 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.274 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 6.2 t30 -106.55 119.96 40.67 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.023 -179.986 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.609 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 44.7 t -109.67 94.5 3.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.481 179.801 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.423 ' HA ' ' H ' ' A' ' 26' ' ' ALA . 63.4 t30 60.06 21.69 10.87 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.026 179.044 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 114.44 17.57 7.04 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.081 -1.057 . . . . 0.0 113.995 178.363 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.0 ptp180 -130.29 146.05 51.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 117.084 0.442 . . . . 0.0 110.856 179.456 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 73.4 mt -89.5 119.04 29.59 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.102 179.213 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 57.7 t -121.22 123.4 69.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.624 -179.107 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 3.9 p90 -80.12 145.14 32.53 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.469 179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.333 179.88 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.0 tpp . . . . . 0 N--CA 1.478 0.969 0 CA-C-O 120.424 0.154 . . . . 0.0 110.671 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.7 m -155.99 -171.48 3.75 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -179.368 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -56.81 -38.56 72.76 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.059 0.457 . . . . 0.0 110.365 179.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 7' ' ' SER . . . -55.26 -26.13 37.99 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.896 -178.356 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -56.56 -32.09 64.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.943 0.401 . . . . 0.0 111.097 -179.877 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 24.0 m -132.76 32.94 3.78 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.946 -179.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 4' ' ' ALA . 62.0 m -115.08 152.76 31.95 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.319 0.581 . . . . 0.0 111.515 -179.34 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.453 HH11 ' HD2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -145.78 163.93 33.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.022 -0.99 . . . . 0.0 109.022 -179.312 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.454 ' HB3' ' NH2' ' A' ' 20' ' ' ARG . 9.9 m120 52.66 33.28 13.43 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 123.727 0.642 . . . . 0.0 111.761 179.14 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -74.89 114.01 12.85 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.669 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 25.4 t -141.56 152.36 19.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.057 -178.821 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 37' ' ' LEU . 1.1 tp -87.41 140.71 29.26 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 179.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.433 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 12.2 m -126.48 163.7 22.78 Favored 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 -179.034 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.549 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 7.7 t-20 73.23 5.69 5.11 Favored 'General case' 0 N--CA 1.464 0.254 0 O-C-N 123.687 0.617 . . . . 0.0 111.368 178.18 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.85 23.4 15.51 Favored Glycine 0 CA--C 1.506 -0.519 0 N-CA-C 110.696 -0.961 . . . . 0.0 110.696 -179.234 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' HG ' ' A' ' 12' ' ' LEU . . . 98.52 21.63 16.41 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.999 -0.62 . . . . 0.0 111.942 -179.611 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.699 ' HG2' HG21 ' A' ' 56' ' ' THR . 29.8 mtp180 -104.12 -19.1 14.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.652 0.263 . . . . 0.0 110.811 -179.006 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 36' ' ' ASP . 32.7 m -129.26 126.94 40.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.955 0.407 . . . . 0.0 111.703 -178.91 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.504 ' HB2' HD21 ' A' ' 37' ' ' LEU . 58.8 tp -94.68 105.67 17.62 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.014 178.176 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' NH2' ' HB3' ' A' ' 9' ' ' ASN . 1.3 tmm_? -101.97 123.68 46.28 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.887 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -147.32 144.13 28.55 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.012 0.434 . . . . 0.0 111.137 -179.808 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.429 ' HG2' HG23 ' A' ' 32' ' ' THR . 3.9 mt-10 -105.17 113.02 26.36 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 179.334 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.468 ' HA ' ' O ' ' A' ' 6' ' ' SER . 45.4 t -127.17 147.63 50.19 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.199 0.523 . . . . 0.0 111.674 -178.526 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.423 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -75.72 145.67 40.71 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.426 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.48 ' HB3' HG21 ' A' ' 31' ' ' VAL . 7.7 p30 -93.05 -173.43 3.27 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.521 -179.456 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.29 -34.38 68.62 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.058 0.456 . . . . 0.0 112.204 -178.838 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.26 -20.29 61.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.977 -179.659 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.76 4.16 54.67 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.926 -179.401 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 t-20 -87.59 143.69 27.07 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.147 -0.316 . . . . 0.0 110.147 -179.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 37.2 m0 -73.86 122.23 22.17 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.26 -179.867 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.48 HG21 ' HB3' ' A' ' 25' ' ' ASN . 8.2 t -120.52 146.6 25.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.616 -179.995 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.429 HG23 ' HG2' ' A' ' 22' ' ' GLU . 37.0 m -114.86 110.15 19.23 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 120.899 0.38 . . . . 0.0 110.191 179.506 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -118.29 164.18 15.59 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.387 0.613 . . . . 0.0 112.102 -179.026 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.423 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 9.5 mt-10 -136.69 140.04 42.39 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.229 -179.389 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.426 HD21 HG12 ' A' ' 40' ' ' ILE . 0.8 OUTLIER -132.01 113.88 13.92 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 177.291 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.558 ' O ' HG22 ' A' ' 39' ' ' THR . 26.8 m-20 -66.65 108.65 2.54 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.766 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.719 HD11 HD11 ' A' ' 12' ' ' LEU . 54.1 mt -59.92 -47.39 85.95 Favored 'General case' 0 CA--C 1.499 -1.01 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.212 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.595 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.3 OUTLIER -64.2 -4.54 3.74 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.928 -179.447 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.558 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -98.14 -14.72 20.26 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.415 -0.514 . . . . 0.0 110.908 179.731 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.5 HG23 HG23 ' A' ' 39' ' ' THR . 2.6 pp -143.96 13.69 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.232 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.569 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 3.0 mt -126.4 131.42 71.43 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.935 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -125.15 160.1 19.75 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.331 -0.937 . . . . 0.0 112.837 -178.627 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -111.36 104.41 12.87 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.185 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -92.77 75.48 4.93 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.791 179.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 48.93 65.8 1.27 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.234 -0.893 . . . . 0.0 112.023 178.503 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.468 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 78.5 34.79 34.72 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.778 178.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . . . . . . . . . 15.7 t-80 -159.33 120.61 3.28 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 178.339 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.539 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 61.9 m-85 -63.25 143.54 57.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.06 0.457 . . . . 0.0 111.271 179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -133.82 117.4 16.81 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.328 179.626 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -72.7 114.58 11.0 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 177.609 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 40.58 3.08 Favored Glycine 0 N--CA 1.446 -0.676 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.773 -179.207 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -115.98 -49.23 0.47 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.281 179.947 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.595 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 32.2 tt0 71.52 145.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.328 0.651 . . . . 0.0 111.582 -179.145 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.683 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 91.5 m-20 71.06 35.19 1.68 Allowed 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.523 179.652 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.569 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 5.8 p90 -79.79 -32.08 40.81 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.699 HG21 ' HG2' ' A' ' 17' ' ' ARG . 23.8 p -63.47 -30.55 71.66 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.523 -179.159 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 54' ' ' ASN . 20.2 pt-20 -67.19 -17.0 64.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.075 0.464 . . . . 0.0 110.342 179.512 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.547 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.7 p -122.56 12.71 10.04 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.202 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -125.69 149.95 48.05 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.722 179.871 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.47 169.09 18.22 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -179.614 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.487 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 1.7 t70 49.05 57.93 5.92 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.098 0.475 . . . . 0.0 110.043 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.471 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -88.06 111.59 22.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.371 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.585 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.3 OUTLIER -116.66 118.83 33.66 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.882 179.624 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.673 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.8 t80 -92.77 128.06 38.5 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.984 178.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 4.0 t-160 -117.19 84.77 17.73 Favored Pre-proline 0 C--N 1.326 -0.432 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 178.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.541 ' HB3' ' HB3' ' A' ' 10' ' ' ALA . 19.5 Cg_endo -58.95 -44.9 31.71 Favored 'Trans proline' 0 CA--C 1.507 -0.833 0 C-N-CA 123.613 2.875 . . . . 0.0 114.488 -177.609 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.82 84.32 2.25 Favored 'General case' 0 C--N 1.294 -1.845 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.864 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . 0.437 ' HA ' ' CE1' ' A' ' 65' ' ' HIS . 8.3 tt0 -67.81 113.33 5.46 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.769 -179.688 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 51.34 -146.61 11.04 Favored Glycine 0 N--CA 1.449 -0.496 0 O-C-N 124.299 0.999 . . . . 0.0 112.72 179.535 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -84.55 -3.53 58.48 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.338 0.59 . . . . 0.0 109.548 178.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.78 -18.04 58.68 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.046 179.539 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 51.4 43.33 29.56 Favored 'General case' 0 CA--C 1.516 -0.355 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.926 -179.79 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -104.76 118.54 56.1 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.865 -177.724 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.595 ' HB2' ' HB2' ' A' ' 94' ' ' LEU . 61.3 Cg_endo -75.25 111.46 3.32 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.447 2.098 . . . . 0.0 111.766 178.644 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.492 HD11 HH21 ' A' ' 77' ' ' ARG . 0.9 OUTLIER -132.48 140.47 47.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 179.06 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -113.65 121.15 43.28 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.243 -179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.585 ' HD2' ' O ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -118.85 140.12 50.49 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.904 0.383 . . . . 0.0 110.201 179.261 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.536 ' O ' ' HA ' ' A' ' 89' ' ' ASP . . . -159.83 169.36 23.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.225 -179.943 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.572 ' HA ' ' HA ' ' A' ' 89' ' ' ASP . 3.6 mmt180 -85.12 115.15 22.75 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 179.625 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.523 HD22 ' HB2' ' A' ' 90' ' ' ARG . 4.2 mp -100.9 130.82 46.96 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.219 -178.658 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -78.32 137.67 38.18 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.02 -179.533 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -99.08 171.5 7.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.129 179.5 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 69.6 m -54.63 -29.91 53.49 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.827 0.346 . . . . 0.0 111.611 179.897 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -67.82 -23.05 65.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.689 -178.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 95.62 36.68 5.26 Favored Glycine 0 CA--C 1.506 -0.476 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.927 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.722 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 12.6 pt-20 -122.09 -166.85 1.45 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 114.931 -0.634 . . . . 0.0 109.482 -178.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.415 ' HB2' ' HB3' ' A' ' 79' ' ' ARG . 45.6 p90 -134.58 141.25 46.59 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.808 0.813 . . . . 0.0 111.725 -179.024 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.7 m80 -140.18 112.71 7.92 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 113.816 -1.538 . . . . 0.0 109.51 179.794 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 5.9 p-10 -68.28 115.49 7.79 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.376 0.608 . . . . 0.0 111.169 -179.064 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.523 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.9 mmt180 -116.16 177.28 4.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.414 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -140.32 148.73 41.81 Favored 'General case' 0 CA--C 1.506 -0.727 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 -179.651 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.539 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 8.8 p -132.74 148.54 31.6 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.189 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.549 -179.473 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.544 ' HB3' HD22 ' A' ' 95' ' ' ASN . 0.9 OUTLIER -86.11 109.01 18.56 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.995 -179.064 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.673 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.2 mt -78.98 4.04 15.45 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.933 -179.701 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.544 HD22 ' HB3' ' A' ' 93' ' ' ASN . 15.4 m-80 -64.63 -12.58 47.31 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.043 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.4 ' HD2' ' O ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -69.7 -16.69 63.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.183 179.096 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.548 HD12 ' HB3' ' A' ' 94' ' ' LEU . 10.8 mt -88.28 122.59 40.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.618 0.723 . . . . 0.0 111.362 -179.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -110.71 166.42 11.03 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.592 179.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . 0.422 ' HA ' ' O ' ' A' ' 103' ' ' ARG . 5.7 t30 -114.94 115.71 27.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.566 178.846 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.516 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 56.2 t -112.69 101.81 13.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.317 -0.402 . . . . 0.0 110.36 -179.417 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' C ' ' HB2' ' A' ' 25' ' ' ASN . 4.6 t30 60.33 21.68 11.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.576 -0.738 . . . . 0.0 111.006 179.422 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 106.58 11.27 27.32 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.585 -0.816 . . . . 0.0 113.597 178.336 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 18.4 ptp180 -118.16 141.48 48.45 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 117.122 0.461 . . . . 0.0 110.506 -179.959 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.461 HD11 ' HB3' ' A' ' 21' ' ' ALA . 79.1 mt -89.63 126.45 35.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.769 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.8 p -134.41 134.67 54.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.248 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -88.79 144.86 25.95 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.036 -179.018 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 . . . . . 0 C--O 1.25 1.108 0 O-C-N 123.815 0.697 . . . . 0.0 111.506 178.885 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.6 tpt . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.544 0.211 . . . . 0.0 110.689 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.5 m -154.21 -178.63 7.24 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -179.436 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -64.95 -35.43 81.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.032 0.444 . . . . 0.0 109.835 179.533 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.669 ' HA ' ' OG ' ' A' ' 7' ' ' SER . . . -56.61 -24.07 45.28 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.384 -179.734 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -56.54 -31.67 64.37 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.94 0.4 . . . . 0.0 110.87 179.328 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 23' ' ' CYS . 35.4 m -144.85 42.55 1.33 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.057 -179.737 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.669 ' OG ' ' HA ' ' A' ' 4' ' ' ALA . 96.3 p -115.54 149.4 38.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.022 0.439 . . . . 0.0 111.253 -179.029 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -147.15 166.19 27.71 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . 0.415 ' HB2' ' HG3' ' A' ' 22' ' ' GLU . 92.1 m-20 52.05 33.25 11.65 Favored 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.677 0.61 . . . . 0.0 111.734 179.9 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.548 ' HB3' ' HB3' ' A' ' 66' ' ' PRO . . . -77.05 114.54 15.97 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.086 179.738 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.2 t -141.18 155.04 21.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.891 -178.781 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 37' ' ' LEU . 1.4 tp -91.66 143.31 26.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.027 0.441 . . . . 0.0 110.135 179.394 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 18' ' ' THR . 6.9 m -129.67 165.23 22.25 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.765 -179.243 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 17' ' ' ARG . 6.1 t-20 72.06 9.82 6.05 Favored 'General case' 0 N--CA 1.463 0.21 0 O-C-N 123.512 0.507 . . . . 0.0 110.947 178.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.75 8.8 57.99 Favored Glycine 0 N--CA 1.452 -0.296 0 N-CA-C 111.363 -0.695 . . . . 0.0 111.363 -179.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.496 ' HA2' HD23 ' A' ' 12' ' ' LEU . . . 112.36 25.75 4.55 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.176 -0.77 . . . . 0.0 111.176 -179.099 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.693 ' HG2' HG21 ' A' ' 56' ' ' THR . 21.6 mtp180 -108.45 -18.56 13.71 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.71 0.29 . . . . 0.0 110.521 -178.903 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.501 ' HB ' ' HB ' ' A' ' 13' ' ' THR . 46.7 m -127.68 126.57 42.16 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.008 0.433 . . . . 0.0 111.503 -178.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.476 ' CD2' HD13 ' A' ' 97' ' ' ILE . 45.6 tp -98.01 108.84 21.64 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.158 178.396 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.542 ' HG2' ' HG2' ' A' ' 34' ' ' GLU . 4.6 tmm_? -104.14 122.52 45.5 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.705 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.473 ' HB3' HD11 ' A' ' 104' ' ' LEU . . . -146.89 137.61 23.8 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.743 0.306 . . . . 0.0 110.581 -179.97 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.415 ' HG3' ' HB2' ' A' ' 9' ' ' ASN . 7.6 mt-10 -98.25 110.84 23.35 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.761 0.315 . . . . 0.0 110.285 -179.824 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' SER . 49.6 t -125.83 147.88 49.31 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.853 0.359 . . . . 0.0 110.814 -179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.47 ' HA ' ' O ' ' A' ' 29' ' ' ASN . 0.0 OUTLIER -74.2 145.72 43.94 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.274 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -85.58 -168.56 2.27 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.724 -179.627 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.2 -32.99 74.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.163 0.506 . . . . 0.0 111.289 -179.826 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -72.31 -24.31 61.3 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.844 -179.897 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 105.32 4.25 40.88 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.398 -179.299 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.47 ' O ' ' HA ' ' A' ' 24' ' ' ARG . 1.9 m-80 -83.78 139.06 32.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.262 -179.831 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . . . . . . . . . 33.8 m0 -72.51 121.95 20.49 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.984 -179.858 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 6.0 t -123.26 150.36 27.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.936 -178.768 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.6 m -99.32 109.63 22.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 177.653 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.613 ' HB2' ' HG ' ' A' ' 104' ' ' LEU . 3.5 m -109.38 139.44 44.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.256 0.55 . . . . 0.0 111.43 -177.613 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.542 ' HG2' ' HG2' ' A' ' 20' ' ' ARG . 13.0 mt-10 -130.39 131.79 45.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.041 -179.873 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.542 HD11 HG12 ' A' ' 40' ' ' ILE . 13.3 tp -131.96 124.01 28.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.168 0.508 . . . . 0.0 110.006 178.603 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 39' ' ' THR . 39.0 m-20 -72.25 108.64 5.5 Favored 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.123 179.179 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.856 HD11 HD11 ' A' ' 12' ' ' LEU . 34.8 mt -61.1 -41.24 96.31 Favored 'General case' 0 CA--C 1.5 -0.955 0 CA-C-O 121.618 0.723 . . . . 0.0 109.718 179.373 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.51 ' O ' ' HG3' ' A' ' 53' ' ' GLN . 0.8 OUTLIER -63.36 -5.91 4.11 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.471 179.639 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.539 HG22 ' O ' ' A' ' 36' ' ' ASP . 0.5 OUTLIER -103.91 -12.05 17.1 Favored 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.089 -0.645 . . . . 0.0 111.401 -179.231 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.542 HG12 HD11 ' A' ' 35' ' ' LEU . 2.6 pp -143.0 12.4 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -179.536 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' O ' ' HB3' ' A' ' 55' ' ' PHE . 2.6 mt -127.53 132.03 69.62 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.456 ' HA3' ' HA3' ' A' ' 52' ' ' GLY . . . -128.34 157.32 21.25 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.567 -179.311 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASN . . . . . 0.409 ' CG ' ' HG ' ' A' ' 80' ' ' LEU . 8.9 t30 -110.88 110.31 20.85 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.102 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -103.17 87.05 2.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.348 179.593 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 82' ' ' ASP . 1.1 m-20 48.34 54.8 9.8 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.551 179.201 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.587 ' HA2' ' HB3' ' A' ' 80' ' ' LEU . . . 79.67 41.99 12.09 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.061 -1.066 . . . . 0.0 111.997 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' HIS . . . . . 0.417 ' N ' HD23 ' A' ' 80' ' ' LEU . 80.4 t60 -158.72 118.26 3.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 179.365 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.491 ' CD2' ' HB ' ' A' ' 92' ' ' VAL . 53.3 m-85 -64.56 137.29 57.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.139 0.495 . . . . 0.0 110.78 179.368 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.424 HE21 ' HB2' ' A' ' 49' ' ' GLN . 1.8 tt0 -131.26 115.83 16.82 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.281 -179.908 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 92.7 m95 -69.13 116.08 9.17 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.439 178.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.7 33.28 5.37 Favored Glycine 0 N--CA 1.449 -0.457 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.168 -179.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.487 ' O ' ' HB3' ' A' ' 53' ' ' GLN . . . -104.1 -52.66 0.88 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.688 -0.768 . . . . 0.0 113.15 -179.697 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.51 ' HG3' ' O ' ' A' ' 38' ' ' ASP . 35.4 tt0 73.65 142.09 0.07 Allowed 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 123.251 0.62 . . . . 0.0 111.213 -179.254 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.557 ' O ' ' HG2' ' A' ' 57' ' ' GLU . 5.2 m-20 71.92 34.99 1.41 Allowed 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 123.813 0.845 . . . . 0.0 111.602 -179.482 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . 0.542 ' HB3' ' O ' ' A' ' 41' ' ' ILE . 6.4 p90 -78.84 -27.91 44.24 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 179.868 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.693 HG21 ' HG2' ' A' ' 17' ' ' ARG . 62.1 p -66.31 -24.0 66.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.615 -178.985 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.668 ' HG3' HG23 ' A' ' 58' ' ' THR . 4.3 pt-20 -74.91 -11.27 60.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.177 0.513 . . . . 0.0 110.352 179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.668 HG23 ' HG3' ' A' ' 57' ' ' GLU . 70.2 p -129.29 14.97 6.16 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 121.443 0.639 . . . . 0.0 109.82 179.87 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 79' ' ' ARG . . . -128.4 153.48 47.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.744 -179.731 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.639 ' HG3' ' HB2' ' A' ' 79' ' ' ARG . 0.0 OUTLIER -144.33 171.57 14.14 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.204 -179.673 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.612 ' HB3' ' HG2' ' A' ' 79' ' ' ARG . 12.7 t70 46.51 55.11 7.9 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 123.401 0.438 . . . . 0.0 110.541 179.602 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.514 HG22 HD21 ' A' ' 76' ' ' LEU . 2.6 mt -84.72 107.35 15.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-O 121.261 0.553 . . . . 0.0 111.664 -178.026 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.557 ' O ' ' HD2' ' A' ' 77' ' ' ARG . 0.0 OUTLIER -114.34 118.2 33.2 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.23 179.728 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.641 ' CE1' HD12 ' A' ' 94' ' ' LEU . 8.1 t80 -92.99 128.76 38.97 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.142 0.496 . . . . 0.0 111.302 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER -120.49 87.86 41.78 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.744 177.794 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HB2' ' HD2' ' A' ' 67' ' ' LYS . 11.9 Cg_endo -58.86 -35.73 98.13 Favored 'Trans proline' 0 CA--C 1.51 -0.719 0 C-N-CA 123.678 2.919 . . . . 0.0 112.693 -179.563 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.65 ' HD2' ' HB2' ' A' ' 66' ' ' PRO . 0.0 OUTLIER -131.52 85.56 2.27 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 113.761 -1.563 . . . . 0.0 109.437 178.995 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.14 121.77 16.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.299 -179.643 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 38.27 -136.08 1.03 Allowed Glycine 0 C--N 1.333 0.403 0 O-C-N 124.929 1.393 . . . . 0.0 114.818 177.122 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -83.23 -9.91 58.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.105 -0.548 . . . . 0.0 110.022 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.52 -26.14 59.79 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.284 179.775 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 54.48 43.67 29.99 Favored 'General case' 0 CA--C 1.522 -0.111 0 O-C-N 123.747 0.654 . . . . 0.0 109.892 -178.869 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -114.57 131.02 23.57 Favored Pre-proline 0 CA--C 1.515 -0.396 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.164 -178.813 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.526 ' HG3' ' HB2' ' A' ' 4' ' ' ALA . 66.2 Cg_endo -75.46 108.74 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.82 2.347 . . . . 0.0 112.032 179.398 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.654 HD11 HH21 ' A' ' 77' ' ' ARG . 1.0 OUTLIER -134.8 141.19 43.83 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.254 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.514 HD21 HG22 ' A' ' 62' ' ' ILE . 1.9 tm? -112.59 123.87 51.26 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.395 -179.403 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.654 HH21 HD11 ' A' ' 75' ' ' ILE . 0.0 OUTLIER -120.28 139.21 53.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 110.571 179.164 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB2' ' HA ' ' A' ' 62' ' ' ILE . . . -157.26 166.63 32.62 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.426 -179.805 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.639 ' HB2' ' HG3' ' A' ' 60' ' ' GLU . 4.0 mmt85 -85.9 115.04 23.28 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.231 -1.025 . . . . 0.0 108.231 179.309 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.655 HD22 ' HB2' ' A' ' 90' ' ' ARG . 2.8 mp -98.73 126.48 44.36 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.248 -178.732 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -84.51 141.19 30.92 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.067 -179.628 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.545 ' HA ' ' HA ' ' A' ' 45' ' ' ASP . 2.2 p-10 -100.39 174.1 6.27 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.27 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' CYS . . . . . . . . . . . . . 9.8 p -57.7 -29.26 64.54 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.528 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -69.15 -28.36 66.36 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.947 0.403 . . . . 0.0 110.848 -179.174 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.17 33.74 3.36 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.436 -0.888 . . . . 0.0 113.605 178.202 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 81' ' ' ARG . 8.4 pt-20 -113.68 -164.08 0.9 Allowed 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 179.804 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 37.6 p90 -146.78 132.3 18.72 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.683 0.754 . . . . 0.0 110.623 179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -133.68 119.61 19.58 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.024 -179.495 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 79' ' ' ARG . 8.8 p-10 -65.65 112.02 3.46 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.184 0.516 . . . . 0.0 111.454 -179.091 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.655 ' HB2' HD22 ' A' ' 80' ' ' LEU . 34.6 mmt180 -115.08 171.29 7.76 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 178.188 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -141.42 147.01 37.27 Favored 'General case' 0 CA--C 1.508 -0.655 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.17 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.491 ' HB ' ' CD2' ' A' ' 48' ' ' PHE . 11.7 p -132.82 147.95 31.62 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.902 -179.033 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.523 ' HB3' HD22 ' A' ' 95' ' ' ASN . 41.6 m-80 -83.2 111.94 19.39 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.198 -179.703 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.641 HD12 ' CE1' ' A' ' 64' ' ' PHE . 7.7 mt -80.35 3.3 21.59 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.32 -179.171 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.523 HD22 ' HB3' ' A' ' 93' ' ' ASN . 31.3 m-80 -63.23 -16.5 60.4 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.089 0.471 . . . . 0.0 109.863 178.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.41 ' HD2' ' H ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -62.84 -28.68 70.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.553 0.692 . . . . 0.0 109.978 178.76 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.595 HD12 ' HB3' ' A' ' 94' ' ' LEU . 13.5 mt -76.44 123.65 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.212 -179.187 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.3 mt-30 -116.06 164.02 15.07 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.414 179.556 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -111.31 118.26 35.38 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.133 179.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.478 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 45.9 t -109.85 94.44 3.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.362 -179.876 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 64.4 t30 59.19 25.16 13.66 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.512 -0.767 . . . . 0.0 112.045 178.865 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 110.13 17.22 9.67 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.26 -0.972 . . . . 0.0 113.887 177.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 100' ' ' VAL . 20.1 ptp180 -130.37 135.99 48.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.133 0.467 . . . . 0.0 110.612 179.377 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.613 ' HG ' ' HB2' ' A' ' 33' ' ' SER . 71.1 mt -84.48 125.04 32.02 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.56 179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 97' ' ' ILE . 7.7 p -133.66 132.32 57.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.21 179.854 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -84.41 144.82 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.47 -179.505 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.278 -0.868 . . . . 0.0 109.371 179.015 . . . . . . . . 0 0 . 1 stop_ save_